Citrus Sinensis ID: 022118

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300--
Protein Sequence
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKER
Secondary Structure (PSIPRED)
ccccEEHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccHHHHHHHHHHHHHccccccccEEEEEEcccEEEEEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccHHHHcccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEcccccEEEEEEccccccHHHHHHHHHHHHHHcccHHEEEEEEEccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHccHHEEcccccccEEEEEEEcccccccHHHHHccccEccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLyrnrsvsrtsetgssepsvqpgrnvgIELSIREARRFQMEELSLATknfsdknligegkfgEVYKGLLQDGMLVAikkrpgaptqefIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEyipngsvsihlygpsqvsrqklEFKHRLSIALGAAKGLAhlhslsprvvhkdfktanvlVDEDFIAKVADAGLrnflgrtdvagpssqvtaDEIFLASEVKEFRrfseksdvySFGVFLLELVSgreassslspdssQDLVELMIKCMGKER
Flexible Loop (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSvsrtsetgssepsvqpgrnvGIELSIREARRFQMEELSLAtknfsdknligeGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFlgrtdvagpssqvtadEIFLASEVKEFRrfseksdvYSFGVFLLELVSGReassslspdssqdlVELMIKCMGKER
Low Complexity Region (SEG)
MSVTLaaifgaaagavalmgiiFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIalgaakglahlhslsPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAssslspdssqdlVELMIKCMGKER
Disordered region (IsUnstruct)
***********************************************************************LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV*****************************
Disordered Region (DISOPRED)
**VTLAAIFGAAAGAVALMGIIFFLSWFCL***********************************RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP*APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE***********DLVELMIKCMGK**
Disordered Region (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS****************GRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG************QDLVELMIKCMGKER
Disordered Region (DISPRO)
*SVTLAAIFGAAAGAVALMGIIFFLSWFCLYRN*****************************EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK**
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKER
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	302	2.2.26 [Sep-21-2011]
Q8LKZ1	924	Nodulation receptor kinas	N/A	no	0.923	0.301	0.397	7e-49
Q8L4H4	925	Nodulation receptor kinas	N/A	no	0.930	0.303	0.394	4e-47
Q9LX66	830	Receptor-like protein kin	no	no	0.956	0.348	0.376	1e-45
C0LGV0	895	Probable LRR receptor-lik	no	no	0.884	0.298	0.388	3e-45
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.735	0.312	0.430	1e-44
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.764	0.339	0.405	1e-44
Q9LK03	717	Proline-rich receptor-lik	no	no	0.738	0.311	0.423	7e-44
Q9LZM4	657	Wall-associated receptor	no	no	0.798	0.366	0.409	9e-44
Q9C821	509	Proline-rich receptor-lik	no	no	0.754	0.447	0.410	1e-43
Q9LK35	855	Receptor-like protein kin	no	no	0.956	0.338	0.352	2e-43

>sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1

 Score =  194 bits (493), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 118/297 (39%), Positives = 170/297 (57%), Gaps = 18/297 (6%)

Query: 8   IFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIRE---- 63
           + GA      L+ +   + +FC YR++S++     G + P      N+   L  ++    
Sbjct: 521 MIGAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPM---ATNIIFSLPSKDDFFI 577

Query: 64  ----ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---E 116
                + F +E + LAT+ +  K LIGEG FG VY+G L DG  VA+K R    TQ   E
Sbjct: 578 KSVSVKPFTLEYIELATEKY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTRE 635

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F +E+  L++IQH NLV LLGYC E + Q L+Y ++ NGS+   LYG     R+ L++  
Sbjct: 636 FDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYG-EPAKRKILDWPT 694

Query: 177 RLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
           RLSIALGAA+GLA+LH+   R V+H+D K++N+L+D    AKVAD G   +  +   +  
Sbjct: 695 RLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYV 754

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
           S +V     +L  E  + ++ SEKSDV+SFGV LLE+VSGRE  +   P     LVE
Sbjct: 755 SLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVE 811

Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.
Pisum sativum (taxid: 3888)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2

 Score =  188 bits (477), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 116/294 (39%), Positives = 172/294 (58%), Gaps = 13/294 (4%)

Query: 8   IFGAAAGAVALMGIIFFLSWFCLYRNRSVS-----RTSETGSSEPSVQPGRNVGIELSIR 62
           + GA      L+ +   + +FC YR++S++     +T    ++     P ++     S+ 
Sbjct: 523 VIGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYPMATNIIFSLPSKDDFFIKSV- 581

Query: 63  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 119
             + F +E +  AT+ +  K LIGEG FG VY+G L DG  VA+K R    TQ   EF +
Sbjct: 582 SVKPFTLEYIEQATEQY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDN 639

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  L++IQH NLV LLGYC E + Q L+Y ++ NGS+   LYG +   R+ L++  RLS
Sbjct: 640 ELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEAS-KRKILDWPTRLS 698

Query: 180 IALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
           IALGAA+GLA+LH+   R V+H+D K++N+L+D+   AKVAD G   +  +   +  S +
Sbjct: 699 IALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLE 758

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
           V     +L  E  + ++ SEKSDV+SFGV LLE+VSGRE  +   P     LVE
Sbjct: 759 VRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVE 812

Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Medicago truncatula (taxid: 3880)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  183 bits (465), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 117/311 (37%), Positives = 165/311 (53%), Gaps = 22/311 (7%)

Query: 5   LAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVG-------- 56
           L  I G+A G+  L+ ++F  S F LY+ R   +   + +  P    G ++G        
Sbjct: 404 LGLIVGSAIGS--LLAVVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTT 461

Query: 57  -IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ 115
              ++     R     +  AT NF +   IG G FG+VYKG L DG  VA+K+  G P  
Sbjct: 462 LTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKR--GNPKS 519

Query: 116 -----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ 170
                EF  E+  L+  +HR+LV+L+GYC ENN   LIYEY+ NG+V  HLYG    S  
Sbjct: 520 QQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPS-- 577

Query: 171 KLEFKHRLSIALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
            L +K RL I +GAA+GL +LH+  S  V+H+D K+AN+L+DE+F+AKVAD GL      
Sbjct: 578 -LTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPE 636

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 289
            D    S+ V     +L  E    ++ ++KSDVYSFGV L E++  R       P    +
Sbjct: 637 LDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 696

Query: 290 LVELMIKCMGK 300
           L E  +K   K
Sbjct: 697 LAEWAMKWQKK 707

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1

 Score =  182 bits (462), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 112/288 (38%), Positives = 168/288 (58%), Gaps = 21/288 (7%)

Query: 5   LAAIFGAAAGAVALMGIIF-FLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIRE 63
           +A + G + GA+    ++F F+S   ++  R  ++  +   ++  +Q         +   
Sbjct: 545 IAILLGVSGGALFATFLVFVFMS---IFTRRQRNKERDITRAQLKMQ---------NWNA 592

Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDE 120
           +R F  +E+  AT+NF  K +IG G FG VY+G L DG  VA+K    R       FI+E
Sbjct: 593 SRIFSHKEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINE 650

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V  L+ I+H+NLV+  G+C E   Q L+YEY+  GS++ HLYGP +  R  L +  RL +
Sbjct: 651 VHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGP-RSKRHSLNWVSRLKV 709

Query: 181 ALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           A+ AAKGL +LH+ S PR++H+D K++N+L+D+D  AKV+D GL     + D +  ++ V
Sbjct: 710 AVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVV 769

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDS 286
                +L  E     + +EKSDVYSFGV LLEL+ GRE  S S SPDS
Sbjct: 770 KGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDS 817

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  180 bits (457), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/230 (43%), Positives = 147/230 (63%), Gaps = 8/230 (3%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCF 123
           F  EEL+  T+ FS  N++GEG FG VYKG L DG LVA+K+     G   +EF  EV  
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           ++ + HR+LV+L+GYC  ++ + LIYEY+PN ++  HL+G     R  LE+  R+ IA+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG---KGRPVLEWARRVRIAIG 457

Query: 184 AAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
           +AKGLA+LH    P+++H+D K+AN+L+D++F A+VAD GL      T     S++V   
Sbjct: 458 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTH-VSTRVMGT 516

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
             +LA E  +  + +++SDV+SFGV LLEL++GR+      P   + LVE
Sbjct: 517 FGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVE 566

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  180 bits (456), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 146/239 (61%), Gaps = 8/239 (3%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCF 123
           F  +ELS  T  FS+KNL+GEG FG VYKG+L DG  VA+K+     +Q   EF  EV  
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           ++ + HR+LVTL+GYC     + L+Y+Y+PN ++  HL+ P    R  + ++ R+ +A G
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GRPVMTWETRVRVAAG 443

Query: 184 AAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTA 241
           AA+G+A+LH    PR++H+D K++N+L+D  F A VAD GL       D+    S++V  
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
              ++A E     + SEK+DVYS+GV LLEL++GR+   +  P   + LVE     +G+
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQ 562

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  177 bits (450), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 99/234 (42%), Positives = 148/234 (63%), Gaps = 11/234 (4%)

Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAI 106
           P   PG  +G  L I +   F  EELS AT  FS+ NL+G+G FG V+KG+L++G  VA+
Sbjct: 325 PPPSPGLALG--LGIYQGT-FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAV 381

Query: 107 KKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG 163
           K+     +Q   EF  EV  ++ + HR+LV L+GYC  +  + L+YE++PN ++  HL+G
Sbjct: 382 KQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG 441

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
                R  +E+  RL IA+G+AKGL++LH + +P+++H+D K +N+L+D  F AKVAD G
Sbjct: 442 K---GRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFG 498

Query: 223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           L      T+    S++V     +LA E     + +EKSDV+SFGV LLEL++GR
Sbjct: 499 LAKIASDTNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGR 551

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1

 Score =  177 bits (449), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 102/249 (40%), Positives = 150/249 (60%), Gaps = 8/249 (3%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFI 118
           + +R F   E++ AT NFS  NLIG G FGEV+K +L+DG + AIK+        T + +
Sbjct: 346 KSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQIL 405

Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L  + HR+LV LLG C +  L  LIYE+IPNG++  HL+G S  + + L ++ RL
Sbjct: 406 NEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWKPLTWRRRL 465

Query: 179 SIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
            IA   A+GLA+LHS + P + H+D K++N+L+DE   AKV+D GL   +  T+ A   S
Sbjct: 466 QIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNES 525

Query: 238 QV-TADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
            + T  +  L     E+ R    ++KSDVYSFGV LLE+V+ ++A      +   +LV  
Sbjct: 526 HIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLVMY 585

Query: 294 MIKCMGKER 302
           + K M +ER
Sbjct: 586 INKMMDQER 594

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  177 bits (448), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 99/241 (41%), Positives = 148/241 (61%), Gaps = 13/241 (5%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCF 123
           F  E+LS AT NFS+ NL+G+G FG V++G+L DG LVAIK+     G   +EF  E+  
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           ++ + HR+LV+LLGYC     + L+YE++PN ++  HL+   +  R  +E+  R+ IALG
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLH---EKERPVMEWSKRMKIALG 247

Query: 184 AAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
           AAKGLA+LH   +P+ +H+D K AN+L+D+ + AK+AD GL      TD    S+++   
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTH-VSTRIMGT 306

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV-----ELMIKC 297
             +LA E     + +EKSDV+S GV LLEL++GR       P +  D +      LMI+ 
Sbjct: 307 FGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQA 366

Query: 298 M 298
           +
Sbjct: 367 L 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  176 bits (446), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 114/323 (35%), Positives = 170/323 (52%), Gaps = 34/323 (10%)

Query: 6   AAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTS--ETGSSEPSVQPGRNVGIELSIRE 63
           A I G+  GAV L+ +I    + CL  +R    TS  E G+  P + P    G+  ++ +
Sbjct: 416 AVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWL-PLPLYGLSQTLTK 474

Query: 64  A--------------------RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGML 103
           +                    R F  +E+  AT  F + +L+G G FG VYKG L+DG  
Sbjct: 475 STASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTK 534

Query: 104 VAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS 158
           VA+K+  G P       EF  E+  L+ ++HR+LV+L+GYC E +   L+YEY+ NG + 
Sbjct: 535 VAVKR--GNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR 592

Query: 159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAK 217
            HLYG        L +K RL I +GAA+GL +LH+  S  ++H+D KT N+L+DE+ +AK
Sbjct: 593 SHLYG---ADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAK 649

Query: 218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 277
           VAD GL       D    S+ V     +L  E    ++ +EKSDVYSFGV L+E++  R 
Sbjct: 650 VADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRP 709

Query: 278 ASSSLSPDSSQDLVELMIKCMGK 300
           A + + P    ++ E  +    K
Sbjct: 710 ALNPVLPREQVNIAEWAMAWQKK 732

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	302
255543513	381	serine/threonine protein kinase, putativ	0.973	0.771	0.810	1e-135
224069640	378	predicted protein [Populus trichocarpa]	0.966	0.772	0.751	1e-125
351727579	379	protein kinase family protein [Glycine m	0.907	0.722	0.789	1e-122
225451635	381	PREDICTED: nodulation receptor kinase [V	0.907	0.719	0.770	1e-122
356571643	379	PREDICTED: probable receptor-like protei	0.907	0.722	0.789	1e-122
147805741	414	hypothetical protein VITISV_039777 [Viti	0.907	0.661	0.770	1e-121
388494484	380	unknown [Lotus japonicus]	0.910	0.723	0.768	1e-120
357508461	379	Nodulation receptor kinase [Medicago tru	0.897	0.715	0.768	1e-118
449452038	379	PREDICTED: nodulation receptor kinase-li	0.970	0.773	0.717	1e-117
30688460	380	protein kinase family protein [Arabidops	0.913	0.726	0.723	1e-113

>gi|255543513|ref|XP_002512819.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547830|gb|EEF49322.1| serine/threonine protein kinase, putative [Ricinus communis]

 Score =  488 bits (1256), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 239/295 (81%), Positives = 265/295 (89%), Gaps = 1/295 (0%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQ-PGRNVGIEL 59
           MS TLAAI G AAG VAL+GI+ FL WFCL   +SVSRTSETGSS+PS+Q PGR+VG+EL
Sbjct: 1   MSKTLAAILGGAAGVVALVGIVIFLIWFCLSHKKSVSRTSETGSSDPSIQAPGRHVGVEL 60

Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID 119
           S+REARRF+M+ELS ATKNF DKNLIG GKFGEVYKGLL DGMLVAIKKR GA +QEF+D
Sbjct: 61  SLREARRFEMDELSHATKNFVDKNLIGIGKFGEVYKGLLNDGMLVAIKKRSGASSQEFVD 120

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           EV +L+ IQHRN+VTLLGYCQENNLQFL+YEYIP+GSVS HLYGPSQ S  KLEFKHRLS
Sbjct: 121 EVRYLSPIQHRNIVTLLGYCQENNLQFLVYEYIPSGSVSSHLYGPSQFSDGKLEFKHRLS 180

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           IALGAAKGLAHLHSLSPR+VHKDFKTANVLVDE+FIAKVADAGL NFLGR DVAGPSSQV
Sbjct: 181 IALGAAKGLAHLHSLSPRLVHKDFKTANVLVDENFIAKVADAGLPNFLGRVDVAGPSSQV 240

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           TADEIF A EV+EFRRFS+K DV+SFGVFLLEL+SGREA+ S SPDSSQ+LVE +
Sbjct: 241 TADEIFQAPEVREFRRFSDKGDVFSFGVFLLELLSGREATESPSPDSSQNLVEWV 295

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224069640|ref|XP_002303015.1| predicted protein [Populus trichocarpa] gi|222844741|gb|EEE82288.1| predicted protein [Populus trichocarpa]

 Score =  452 bits (1164), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 221/294 (75%), Positives = 258/294 (87%), Gaps = 2/294 (0%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELS 60
           MS TLAAI G AAG +AL G++ F+ W CLY  ++VSRTSETGSSE S+Q GR+ GIELS
Sbjct: 1   MSRTLAAILGGAAGVMALAGVVIFVLW-CLYHKKTVSRTSETGSSETSIQVGRHAGIELS 59

Query: 61  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE 120
            +EARRF+MEEL LATK FS+KNLIG GKFGEVYKGLL +GM+VAIKKRPGAP+ EF+DE
Sbjct: 60  SQEARRFEMEELGLATKGFSEKNLIGLGKFGEVYKGLLNNGMIVAIKKRPGAPSPEFVDE 119

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V +L+SIQHRNLVTLLGYCQENNLQFL+YEYI +GSVS HLYG  Q    KLEFK+RL I
Sbjct: 120 VRYLSSIQHRNLVTLLGYCQENNLQFLVYEYISSGSVSNHLYGVGQTLEGKLEFKNRLPI 179

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           ALGAAKGLAHLHS +PR++HK+FKTANVLVDE+FIAKVADAGLRNFLGR D+AGPS+QVT
Sbjct: 180 ALGAAKGLAHLHSQTPRLLHKNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGPSTQVT 239

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           ADEIFLA EV+EFR+FSEKSDV+SFGVFLLEL+SG+EA+   SP++SQ+LVE +
Sbjct: 240 ADEIFLAPEVREFRQFSEKSDVFSFGVFLLELLSGKEATEP-SPETSQNLVEWV 292

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351727579|ref|NP_001235374.1| protein kinase family protein [Glycine max] gi|223452478|gb|ACM89566.1| protein kinase family protein [Glycine max]

 Score =  445 bits (1145), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 217/275 (78%), Positives = 243/275 (88%), Gaps = 1/275 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WFCL R R+VSRTSETGSS+PS Q GR+  +EL IR+ RRF+MEELSLATKNFS
Sbjct: 21  IAIILIWFCLSRQRNVSRTSETGSSDPS-QVGRHGAMELPIRDTRRFEMEELSLATKNFS 79

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SI HRNLV+LLGYCQ
Sbjct: 80  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVRYLSSIHHRNLVSLLGYCQ 139

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG  Q  R+KLEFKHRL IA GAAKGLAHLHSLSPR+VH
Sbjct: 140 ENNLQFLIYEYVPNGSVSSHLYGAGQQPREKLEFKHRLPIAQGAAKGLAHLHSLSPRLVH 199

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           K+FKTANVLVDE+FIAKVADAGLRNFLGR D+AG SSQV  DEIFLASEV+EFRRFSEKS
Sbjct: 200 KNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLASEVREFRRFSEKS 259

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELMI 295
           DVYSFGVFLLEL+SG++A+ S  PDS+Q+LVE ++
Sbjct: 260 DVYSFGVFLLELLSGKQATESPFPDSNQNLVEWVL 294

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225451635|ref|XP_002277073.1| PREDICTED: nodulation receptor kinase [Vitis vinifera] gi|296082255|emb|CBI21260.3| unnamed protein product [Vitis vinifera]

 Score =  442 bits (1138), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 212/275 (77%), Positives = 249/275 (90%), Gaps = 1/275 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I+  + WFCL  NRSVSRTSETGSS+PSVQ GRNVG+EL++REAR F+M ELSLATKNFS
Sbjct: 21  IVILIIWFCLSHNRSVSRTSETGSSDPSVQVGRNVGVELALREARHFEMAELSLATKNFS 80

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           D +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+HRNLVTLLGYCQ
Sbjct: 81  DISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIEHRNLVTLLGYCQ 140

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGP-SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           EN  QFLIYE+IP+GS+S +LYG  +QVS++KLEFK+RL IALGAAKGLAHLH+LSPR+V
Sbjct: 141 ENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKGLAHLHTLSPRLV 200

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           HKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA EV+EFRRFS+K
Sbjct: 201 HKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLAPEVREFRRFSDK 260

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           SDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE++
Sbjct: 261 SDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMV 295

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356571643|ref|XP_003553985.1| PREDICTED: probable receptor-like protein kinase At1g30570-like [Glycine max]

 Score =  442 bits (1137), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 217/275 (78%), Positives = 241/275 (87%), Gaps = 1/275 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WFCL R R+VSRTSETGSS+PS Q GR+  IEL IR+ RRF+MEELSLATKNFS
Sbjct: 21  IAIILIWFCLSRQRNVSRTSETGSSDPS-QVGRHGAIELPIRDTRRFEMEELSLATKNFS 79

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SI HRNLV+LLGYCQ
Sbjct: 80  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVHYLSSIHHRNLVSLLGYCQ 139

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG  Q  ++KLEFKHRLSIA GAAKGLAHLHSLSPR+VH
Sbjct: 140 ENNLQFLIYEYVPNGSVSSHLYGAGQNPQEKLEFKHRLSIAQGAAKGLAHLHSLSPRLVH 199

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           K+FKT NVLVDE+FIAKVADAGLRNFLGR D+AG SSQV  DEIFLASEV+EFRRFSEKS
Sbjct: 200 KNFKTTNVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLASEVREFRRFSEKS 259

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELMI 295
           DVYSFGVFLLEL+SG+EA     PDS+Q+LVE ++
Sbjct: 260 DVYSFGVFLLELLSGKEAIEPPFPDSNQNLVEWVL 294

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147805741|emb|CAN73905.1| hypothetical protein VITISV_039777 [Vitis vinifera]

 Score =  442 bits (1136), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 212/275 (77%), Positives = 249/275 (90%), Gaps = 1/275 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I+  + WFCL  NRSVSRTSETGSS+PSVQ GRNVG+EL++REAR F+M ELSLATKNFS
Sbjct: 54  IVILIIWFCLSHNRSVSRTSETGSSDPSVQVGRNVGVELALREARHFEMAELSLATKNFS 113

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           D +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+HRNLVTLLGYCQ
Sbjct: 114 DISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIEHRNLVTLLGYCQ 173

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGP-SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           EN  QFLIYE+IP+GS+S +LYG  +QVS++KLEFK+RL IALGAAKGLAHLH+LSPR+V
Sbjct: 174 ENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKGLAHLHTLSPRLV 233

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           HKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA EV+EFRRFS+K
Sbjct: 234 HKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLAPEVREFRRFSDK 293

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           SDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE++
Sbjct: 294 SDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMV 328

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388494484|gb|AFK35308.1| unknown [Lotus japonicus]

 Score =  436 bits (1122), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 212/276 (76%), Positives = 243/276 (88%), Gaps = 1/276 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WFCL R RSVSRTSETGSS+PS Q GR+  IEL IR+ RRF MEELSLATKNF+
Sbjct: 22  ISIILLWFCLCRQRSVSRTSETGSSDPS-QVGRHGAIELQIRDTRRFAMEELSLATKNFN 80

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           D NLIG+GKFGEVY GLLQDG+LVAIKKR G P+QEF+DEV +L+SIQHRN+VTL+GYCQ
Sbjct: 81  DGNLIGQGKFGEVYNGLLQDGVLVAIKKRFGTPSQEFVDEVRYLSSIQHRNIVTLIGYCQ 140

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG  Q S++KLEFK RLSIA GAAKGLAH+HSLSPR+VH
Sbjct: 141 ENNLQFLIYEYVPNGSVSSHLYGAGQQSQEKLEFKLRLSIAQGAAKGLAHIHSLSPRLVH 200

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           KDFKTANVLVDE+FIAKVADAGL++FLGR D+ G SSQV ADEIFLA EV+EFRRFSEKS
Sbjct: 201 KDFKTANVLVDENFIAKVADAGLKHFLGRVDIVGSSSQVAADEIFLAPEVREFRRFSEKS 260

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
           DVYS+GVFLLEL+SG+EA+ S SPDS+ +LVE +++
Sbjct: 261 DVYSYGVFLLELLSGKEATESPSPDSNLNLVEWVLR 296

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508461|ref|XP_003624519.1| Nodulation receptor kinase [Medicago truncatula] gi|355499534|gb|AES80737.1| Nodulation receptor kinase [Medicago truncatula]

 Score =  432 bits (1111), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 209/272 (76%), Positives = 238/272 (87%), Gaps = 1/272 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WF L+R  SVSRTSETGSS+PS Q GR+ GIEL +R+ RRF MEELS ATKNF+
Sbjct: 21  ISIILIWFYLFRQTSVSRTSETGSSDPS-QVGRHGGIELQMRDTRRFAMEELSHATKNFN 79

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SIQHRNLVTL+GYCQ
Sbjct: 80  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGVTSQEFVDEVRYLSSIQHRNLVTLIGYCQ 139

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG SQ  R+KLEFKHRLSIA GAAKGLAHLHSLSPR+VH
Sbjct: 140 ENNLQFLIYEYVPNGSVSSHLYGASQQPREKLEFKHRLSIAQGAAKGLAHLHSLSPRLVH 199

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           K+FKT+NVLVDE+FI+KVADAGLRNFL R ++ G SSQV  DEIFLA EV+EFR+FSEKS
Sbjct: 200 KNFKTSNVLVDENFISKVADAGLRNFLARVEIVGTSSQVATDEIFLAPEVREFRQFSEKS 259

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
           D YSFGVFLLEL+SG+EA+ S  P+++Q+LVE
Sbjct: 260 DAYSFGVFLLELLSGKEATESPHPNTNQNLVE 291

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452038|ref|XP_004143767.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus] gi|449529349|ref|XP_004171662.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus]

 Score =  428 bits (1100), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 211/294 (71%), Positives = 253/294 (86%), Gaps = 1/294 (0%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELS 60
           MS  LAAI G +AGAVAL+G+I  L  F L R+R+ +RTSETGSS+PSVQ GR+VGIEL+
Sbjct: 1   MSKVLAAILGGSAGAVALVGLIIILLRF-LARSRNTARTSETGSSDPSVQVGRHVGIELT 59

Query: 61  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE 120
           +R+ARRF+M EL LAT +FSDKNLIGEGKFGEVYKG+LQDGM VAIKKR GAP+Q+F+DE
Sbjct: 60  LRDARRFEMAELVLATNDFSDKNLIGEGKFGEVYKGMLQDGMFVAIKKRHGAPSQDFVDE 119

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V +L+SIQHRNLVTLLGYCQENNLQFLI++YIPNGSVS H+YG  Q S +KLEFK RLSI
Sbjct: 120 VHYLSSIQHRNLVTLLGYCQENNLQFLIFDYIPNGSVSSHIYGTEQRSAEKLEFKIRLSI 179

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           ALGAAKGL+HLHS+SPR+ H++FKT+NVLVDE+FIAKVADAGL N + R DV+  SS+ T
Sbjct: 180 ALGAAKGLSHLHSMSPRLTHRNFKTSNVLVDENFIAKVADAGLHNVMRRFDVSESSSRAT 239

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           ADEIFLA EVKEFR+FSEKSDVYSFGVFLLELVSG++A+ +   + +  LV+ +
Sbjct: 240 ADEIFLAPEVKEFRQFSEKSDVYSFGVFLLELVSGQKATDAPVSNPNYTLVDWI 293

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30688460|ref|NP_189304.2| protein kinase family protein [Arabidopsis thaliana] gi|332643680|gb|AEE77201.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  415 bits (1066), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 201/278 (72%), Positives = 243/278 (87%), Gaps = 2/278 (0%)

Query: 18  LMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATK 77
           L+ +  FL WFC++R +++SRTSETGSS+PS Q GRNV IELS+REARRF+MEEL+ ATK
Sbjct: 18  LIALFVFLLWFCVFRRKNLSRTSETGSSDPSTQEGRNVAIELSMREARRFEMEELAQATK 77

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++EV +L+SI HRNLVTLLG
Sbjct: 78  SFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIHHRNLVTLLG 137

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGP-SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           +CQE+N QFL+YEY+PNGSVS HLYG   +V   +LEF+HRL+I++GAAKGLAHLHSLSP
Sbjct: 138 FCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKGLAHLHSLSP 197

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS + AD+IFL+ EV+EF+RF
Sbjct: 198 RLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHIVADQIFLSPEVQEFKRF 256

Query: 257 SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           SEKSDVY+FGVFLLELVSGREAS      S+Q LV+ M
Sbjct: 257 SEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWM 294

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	302
TAIR|locus:2090797	380	AT3G26700 [Arabidopsis thalian	0.970	0.771	0.630	8.7e-95
TAIR|locus:2091980	432	CDG1 "CONSTITUTIVE DIFFERENTIA	0.814	0.569	0.359	4.9e-37
TAIR|locus:2014604	381	AT1G76370 [Arabidopsis thalian	0.698	0.553	0.423	1.3e-36
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.814	0.273	0.360	1.5e-36
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.801	0.217	0.399	8.5e-36
TAIR|locus:2016154	394	AT1G70450 [Arabidopsis thalian	0.791	0.606	0.366	9.2e-36
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.821	0.255	0.361	1e-35
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.768	0.355	0.381	1.3e-35
TAIR|locus:2034344	381	ASG5 "ALTERED SEED GERMINATION	0.705	0.559	0.4	1.5e-35
TAIR|locus:2185118	657	AT5G02070 [Arabidopsis thalian	0.798	0.366	0.373	1.7e-35

TAIR|locus:2090797 AT3G26700 [Arabidopsis thaliana (taxid:3702)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 186/295 (63%), Positives = 223/295 (75%)

Query:     1 MSVTLXXXXXXXXXXXXXXXXXFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELS 60
             MS  L                  FL WFC++R +++SRTSETGSS+PS Q GRNV IELS
Sbjct:     1 MSAILAAAIGGAVGALALIALFVFLLWFCVFRRKNLSRTSETGSSDPSTQEGRNVAIELS 60

Query:    61 IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE 120
             +REARRF+MEEL+ ATK+F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++E
Sbjct:    61 MREARRFEMEELAQATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNE 120

Query:   121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLS 179
             V +L+SI HRNLVTLLG+CQE+N QFL+YEY+PNGSVS HLYG   +V   +LEF+HRL+
Sbjct:   121 VRYLSSIHHRNLVTLLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLA 180

Query:   180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
             I               PR++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS +
Sbjct:   181 ISIGAAKGLAHLHSLSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHI 239

Query:   240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELM 294
              AD+IFL+ EV+EF+RFSEKSDVY+FGVFLLELVSGREA            V+ M
Sbjct:   240 VADQIFLSPEVQEFKRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWM 294

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 398 (145.2 bits), Expect = 4.9e-37, P = 4.9e-37
 Identities = 91/253 (35%), Positives = 143/253 (56%)

Query:    32 RNRSVSRTSETGSSEPSVQPGRNVGI--ELSIREARRFQMEELSLATKNFSDKNLIGEGK 89
             RN++ S +++   +   V    +  +  + S    + F   EL++AT +F +++LIG G 
Sbjct:    25 RNQTSSSSAQPAGTAKEVDSSSSQTVVQDSSRYRCQIFSYRELAIATNSFRNESLIGRGG 84

Query:    90 FGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQF 146
             FG VYKG L  G  +A+K    +  Q   EF+ EV  L+ + HRNLV L GYC E + + 
Sbjct:    85 FGTVYKGRLSTGQNIAVKMLDQSGIQGDKEFLVEVLMLSLLHHRNLVHLFGYCAEGDQRL 144

Query:   147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKDFKT 205
             ++YEY+P GSV  HLY  S+  ++ L++K R+ I                P V+++D KT
Sbjct:   145 VVYEYMPLGSVEDHLYDLSE-GQEALDWKTRMKIALGAAKGLAFLHNEAQPPVIYRDLKT 203

Query:   206 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF 265
             +N+L+D D+  K++D GL  F    D++  S++V     + A E     + + KSD+YSF
Sbjct:   204 SNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTRVMGTHGYCAPEYANTGKLTLKSDIYSF 263

Query:   266 GVFLLELVSGREA 278
             GV LLEL+SGR+A
Sbjct:   264 GVVLLELISGRKA 276

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0040007 "growth" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IDA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)]

 Score = 394 (143.8 bits), Expect = 1.3e-36, P = 1.3e-36
 Identities = 94/222 (42%), Positives = 130/222 (58%)

Query:    64 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAP--TQEFIDE 120
             AR F  +EL+ ATKNF + N+IG+G FG VYKG L  G +VAIK+  P      QEFI E
Sbjct:    60 ARSFTFKELAAATKNFREGNIIGKGGFGSVYKGRLDSGQVVAIKQLNPDGHQGNQEFIVE 119

Query:   121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
             VC L+   H NLVTL+GYC     + L+YEY+P GS+  HL+   +  +  L +  R+ I
Sbjct:   120 VCMLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFD-LEPDQTPLSWYTRMKI 178

Query:   181 XXXXXXXXXXXX-XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNF--LG-RTDVAGPS 236
                             P V+++D K+AN+L+D++F  K++D GL     +G RT V   S
Sbjct:   179 AVGAARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKVGPVGNRTHV---S 235

Query:   237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
             ++V     + A E     R + KSD+YSFGV LLEL+SGR+A
Sbjct:   236 TRVMGTYGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKA 277

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0009860 "pollen tube growth" evidence=RCA

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 403 (146.9 bits), Expect = 1.5e-36, P = 1.5e-36
 Identities = 94/261 (36%), Positives = 148/261 (56%)

Query:    29 CLYRNRSVSRTSETGSS----EPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNL 84
             C   NR +     T  S       +QP      +L IR A+ F  EEL  AT  FS+ + 
Sbjct:   454 CQCSNRELRLAKSTAYSFRKDNMKIQPDME---DLKIRRAQEFSYEELEQATGGFSEDSQ 510

Query:    85 IGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYC 139
             +G+G F  V+KG+L+DG +VA+K+   A      ++EF +E+  L+ + H +L+ LLGYC
Sbjct:   511 VGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNELDLLSRLNHAHLLNLLGYC 570

Query:   140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRV 198
             ++ + + L+YE++ +GS+  HL+G     +++L +  R++I                P V
Sbjct:   571 EDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIAVQAARGIEYLHGYACPPV 630

Query:   199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFS 257
             +H+D K++N+L+DED  A+VAD GL + LG  D   P S++ A  + +L  E       +
Sbjct:   631 IHRDIKSSNILIDEDHNARVADFGL-SILGPADSGTPLSELPAGTLGYLDPEYYRLHYLT 689

Query:   258 EKSDVYSFGVFLLELVSGREA 278
              KSDVYSFGV LLE++SGR+A
Sbjct:   690 TKSDVYSFGVVLLEILSGRKA 710

GO:0042803 "protein homodimerization activity" evidence=IDA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 398 (145.2 bits), Expect = 8.5e-36, P = 8.5e-36
 Identities = 99/248 (39%), Positives = 136/248 (54%)

Query:    35 SVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY 94
             S S  S TGS   S        I      A+ F   E+  AT NF +  ++GEG FG VY
Sbjct:   679 SGSARSLTGSRFSSTSLSFESSIAPFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVY 738

Query:    95 KGLLQDGMLVAIK--KRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 151
             +G+  DG  VA+K  KR     ++EF+ EV  L+ + HRNLV L+G C E+  + L+YE 
Sbjct:   739 EGVFDDGTKVAVKVLKRDDQQGSREFLAEVEMLSRLHHRNLVNLIGICIEDRNRSLVYEL 798

Query:   152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX-XXPRVVHKDFKTANVLV 210
             IPNGSV  HL+G  + S   L++  RL I                PRV+H+DFK++N+L+
Sbjct:   799 IPNGSVESHLHGIDKAS-SPLDWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILL 857

Query:   211 DEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
             + DF  KV+D GL RN L   D    S++V     ++A E         KSDVYS+GV L
Sbjct:   858 ENDFTPKVSDFGLARNALDDEDNRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL 917

Query:   270 LELVSGRE 277
             LEL++GR+
Sbjct:   918 LELLTGRK 925

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2016154 AT1G70450 [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 9.2e-36, P = 9.2e-36
 Identities = 92/251 (36%), Positives = 148/251 (58%)

Query:    32 RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFG 91
             +N+    T+++ SS P+  P  +  +  S +    F  EEL   T+ FS +N++GEG FG
Sbjct:     5 KNQKKKETADSPSSSPTA-PSVDSAVMGSGQT--HFTYEELEDITEGFSKQNILGEGGFG 61

Query:    92 EVYKGLLQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 148
              VYKG L+DG LVA+K+     G   +EF  EV  ++ + HR+LV+L+GYC  ++ + LI
Sbjct:    62 CVYKGKLKDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLI 121

Query:   149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIXXXXXXXXXXXXXXXPRVVHKDFKTA 206
             YEY+PN ++  HL+G     R  LE+  R  ++I               P+++H+D K+A
Sbjct:   122 YEYVPNQTLEHHLHGKG---RPVLEWARRVRIAIVLPKVWRICTKTVSHPKIIHRDIKSA 178

Query:   207 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFG 266
             N+L+D++F  +VAD GL   +  T     S++V     +LA E  +  + +++SDV+SFG
Sbjct:   179 NILLDDEFEVQVADFGLAK-VNDTTQTHVSTRVMGTFGYLAPEYAQSGQLTDRSDVFSFG 237

Query:   267 VFLLELVSGRE 277
             V LLEL++GR+
Sbjct:   238 VVLLELITGRK 248

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 396 (144.5 bits), Expect = 1.0e-35, P = 1.0e-35
 Identities = 94/260 (36%), Positives = 143/260 (55%)

Query:    25 LSWFCLYRNRSVSRTSETGSSEPSVQ---PGRNVGIELSIREARRFQMEELSLATKNFSD 81
             L  + +++ R   +    G S P V     G++ G    ++ AR F  EEL   T NFS 
Sbjct:   583 LGIYAMWQKRRAEQA--IGLSRPFVSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSV 640

Query:    82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGY 138
              + +G G +G+VYKG+LQDG +VAIK+     TQ   EF  E+  L+ + H+NLV L+G+
Sbjct:   641 SSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGF 700

Query:   139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PR 197
             C E   Q L+YEY+ NGS+   L G S ++   L++K RL +                P 
Sbjct:   701 CFEQGEQILVYEYMSNGSLKDSLTGRSGIT---LDWKRRLRVALGSARGLAYLHELADPP 757

Query:   198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
             ++H+D K+ N+L+DE+  AKVAD GL   +        S+QV     +L  E    ++ +
Sbjct:   758 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLGYLDPEYYTTQKLT 817

Query:   258 EKSDVYSFGVFLLELVSGRE 277
             EKSDVYSFGV ++EL++ ++
Sbjct:   818 EKSDVYSFGVVMMELITAKQ 837

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 390 (142.3 bits), Expect = 1.3e-35, P = 1.3e-35
 Identities = 93/244 (38%), Positives = 138/244 (56%)

Query:    40 SETGSSEPS---VQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
             S +G S+ S   V P  + G+ L   ++  F  EELS AT  FS+ NL+G+G FG V+KG
Sbjct:   239 SSSGGSDYSDLPVLPPPSPGLVLGFSKST-FTYEELSRATNGFSEANLLGQGGFGYVHKG 297

Query:    97 LLQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 153
             +L  G  VA+K+     G   +EF  EV  ++ + HR+LV+L+GYC     + L+YE++P
Sbjct:   298 ILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVP 357

Query:   154 NGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDE 212
             N ++  HL+G     R  +E+  RL I                P+++H+D K +N+L+D 
Sbjct:   358 NNNLEFHLHGKG---RPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDF 414

Query:   213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
              F AKVAD GL      T+    S++V     +LA E     + +EKSDV+SFGV LLEL
Sbjct:   415 KFEAKVADFGLAKIASDTNTH-VSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLEL 473

Query:   273 VSGR 276
             ++GR
Sbjct:   474 ITGR 477

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 384 (140.2 bits), Expect = 1.5e-35, P = 1.5e-35
 Identities = 88/220 (40%), Positives = 130/220 (59%)

Query:    64 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGA--PTQEFIDE 120
             AR F  +EL+ AT+NF + NL+GEG FG VYKG L  G +VAIK+  P      +EFI E
Sbjct:    63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVE 122

Query:   121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
             V  L+ + H NLVTL+GYC   + + L+YEY+P GS+  HL+   + +++ L +  R+ I
Sbjct:   123 VLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFD-LESNQEPLSWNTRMKI 181

Query:   181 XXXXXXXXXXXX-XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQ 238
                             P V+++D K+AN+L+D++F  K++D GL   LG   D    S++
Sbjct:   182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAK-LGPVGDRTHVSTR 240

Query:   239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
             V     + A E     + + KSD+Y FGV LLEL++GR+A
Sbjct:   241 VMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKA 280

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)]

 Score = 389 (142.0 bits), Expect = 1.7e-35, P = 1.7e-35
 Identities = 93/249 (37%), Positives = 138/249 (55%)

Query:    62 REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP---GAPTQEFI 118
             + +R F   E++ AT NFS  NLIG G FGEV+K +L+DG + AIK+        T + +
Sbjct:   346 KSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQIL 405

Query:   119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
             +EV  L  + HR+LV LLG C +  L  LIYE+IPNG++  HL+G S  + + L ++ RL
Sbjct:   406 NEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWKPLTWRRRL 465

Query:   179 SIXXXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
              I                P + H+D K++N+L+DE   AKV+D GL   +  T+ A   S
Sbjct:   466 QIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNES 525

Query:   238 QV-TADEIFLAS-EVKEFRRF--SEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVEL 293
              + T  +  L   + + +R F  ++KSDVYSFGV LLE+V+ ++A            V  
Sbjct:   526 HIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLVMY 585

Query:   294 MIKCMGKER 302
             + K M +ER
Sbjct:   586 INKMMDQER 594

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_II1100 hypothetical protein (378 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	302
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-26
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.001
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.002
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.003
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.003
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.004

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (383), Expect = 3e-44
 Identities = 74/245 (30%), Positives = 114/245 (46%), Gaps = 41/245 (16%)

Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTL 135
           +GEG FGEVYKG L          VA+K  + GA     +EF++E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C +    +++ EY+P G +   L    +   +KL  K  L +AL  AKG+ +L S  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 251
              VH+D    N LV E+ + K++D GL   +   D      +           +A E  
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWMAPESL 176

Query: 252 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP-----------------DSSQDLVEL 293
           +  +F+ KSDV+SFGV L E+ + G +    +S                  +   +L EL
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYEL 236

Query: 294 MIKCM 298
           M++C 
Sbjct: 237 MLQCW 241

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  150 bits (382), Expect = 3e-44
 Identities = 68/200 (34%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FGEVYKG L+       + VA+K  +  A  Q   EF+ E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C E    +++ EY+  G +  +L    + +R KL     LS AL  A+G+ +L S  
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKEFR 254
              +H+D    N LV E+ + K++D GL   L   D      +     I  +A E  +  
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIRWMAPESLKEG 178

Query: 255 RFSEKSDVYSFGVFLLELVS 274
           +F+ KSDV+SFGV L E+ +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  148 bits (375), Expect = 4e-43
 Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 85  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FGEVYKG L+       + VA+K  +  A  Q   EF+ E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C E     ++ EY+P G +  +L    +   ++L     LS AL  A+G+ +L S  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 251
              +H+D    N LV E+ + K++D GL   L   D                  +A E  
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-----YKVKGGKLPIRWMAPESL 176

Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           +  +F+ KSDV+SFGV L E+ +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  145 bits (369), Expect = 3e-42
 Identities = 74/250 (29%), Positives = 107/250 (42%), Gaps = 40/250 (16%)

Query: 83  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 134
             +GEG FGEVYKG L+        VA+K  +  A  +   +F+ E   +  + H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 135 LLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           LLG C E    +L+ EY+  G     +           +  L  K  LS A+  AKG+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----L 246
           L S   + VH+D    N LV ED + K++D G    L R        +           +
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFG----LSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----------------PDS-SQ 288
           A E  +   F+ KSDV+SFGV L E+ + G      LS                P+    
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234

Query: 289 DLVELMIKCM 298
           +L ELM+ C 
Sbjct: 235 ELYELMLSCW 244

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (333), Expect = 2e-37
 Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG FG VY     + G  VAIK    +   +  +E + E+  L  + H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           ++ N  +L+ EY   GS+   L    + +  KL     L I L   +GL +LHS    ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHSN--GII 114

Query: 200 HKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS 257
           H+D K  N+L+D D    K+AD GL   L        +   T    ++A EV   +  +S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT--PAYMAPEVLLGKGYYS 172

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM 298
           EKSD++S GV L EL                +L +L+ K +
Sbjct: 173 EKSDIWSLGVILYEL---------------PELKDLIRKML 198

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (326), Expect = 7e-36
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 133
           +     +GEG FG+VY     + G LVAIK     +     +  + E+  L  ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L    ++ +  +L+ EY   G +   L       R +L               L +LHS
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +VH+D K  N+L+DED   K+AD GL   L   +    +   T +  ++A EV   
Sbjct: 116 K--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPE--YMAPEVLLG 170

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
           + + +  D++S GV L EL++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  121 bits (307), Expect = 4e-33
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIK--KRPGAP---TQEFIDEVCFLASIQHRNLVTLLGY 138
           +G G FG VYK   +  G +VA+K  K+        Q    E+  L  + H N+V L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            ++ +  +L+ EY   G +  +L          L       IAL   +GL +LHS    +
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSN--GI 119

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEFRRFS 257
           +H+D K  N+L+DE+ + K+AD GL   L ++      +       ++A EV      + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 258 EKSDVYSFGVFLLELVSGR 276
            K DV+S GV L EL++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 9e-33
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
              IG+G+FG+V  G  + G  VA+K  K      Q F+ E   + +++H NLV LLG  
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            + N  +++ EY+  GS+  +L       R  +    +L  AL   +G+ +L       V
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFV 124

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVKEFR 254
           H+D    NVLV ED +AKV+D GL             +    D   L     A E    +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGL----------AKEASQGQDSGKLPVKWTAPEALREK 174

Query: 255 RFSEKSDVYSFGVFLLELVS-GR 276
           +FS KSDV+SFG+ L E+ S GR
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 3e-29
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCFLASIQHRNLV 133
           + F+ +  +G G FGEV++GL ++ + VAIK  K      Q +F  EV  L  ++H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           +L   C      ++I E +  GS+   L  P     Q L     + +A   A+G+A+L  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE 122

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
                +H+D    N+LV ED + KVAD GL   + + DV   S +    +I   + A E 
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDK----KIPYKWTAPEA 175

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
                FS KSDV+SFG+ L E+ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 5e-27
 Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 57/264 (21%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASI 127
           E L L  K       +G G+FGEV+ G       VA+K  +PG  + E F+ E   +  +
Sbjct: 6   ESLKLERK-------LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL 58

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +H  LV L   C E    +++ EY+  GS+   L        +KL     + +A   A+G
Sbjct: 59  RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEG 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           +A+L S     +H+D    N+LV E+ + K+AD GL             +++  D+ + A
Sbjct: 116 MAYLESR--NYIHRDLAARNILVGENLVCKIADFGL-------------ARLIEDDEYTA 160

Query: 248 SE-----VK-------EFRRFSEKSDVYSFGVFLLELV----------SGREASSSLS-- 283
            E     +K        + RF+ KSDV+SFG+ L E+V          + RE    +   
Sbjct: 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220

Query: 284 ------PDSSQDLVELMIKCMGKE 301
                 P+  ++L +LM++C  K+
Sbjct: 221 YRMPRPPNCPEELYDLMLQCWDKD 244

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (262), Expect = 1e-26
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 11/193 (5%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
           +   L++E++ +G +S +L    +  R K   +  L + L   +G+A+L S +  V+H+D
Sbjct: 72  SPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRD 125

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  +S EV  F ++S KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 184 VWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  104 bits (262), Expect = 1e-26
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 31/210 (14%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFID----EVCFLASIQHRNLVTLL 136
            L+G G FG VY  L +D G L+A+K       ++E ++    E+  L+S+QH N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 137 GYCQENNLQFL-IY-EYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAK 186
           G  ++     L I+ EY+  GS+S  +  +G        + +RQ LE             
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE------------- 112

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
           GLA+LHS    +VH+D K AN+LVD D + K+AD G    LG  +    +  V     ++
Sbjct: 113 GLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           A EV     +   +D++S G  ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 3e-26
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 35/216 (16%)

Query: 85  IGEGKFGEVYKGLL------QDGMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVT 134
           +GEG FG+V+ G         D  LVA+K  K   +    ++F  E   L + QH N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVS-------RQKLEFKHRLSIALGAA 185
             G C E +   +++EY+ +G ++  L  +GP             +L     L IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAG----PSSQ 238
            G+ +L S     VH+D  T N LV  D + K+ D G+   +  TD   V G    P   
Sbjct: 133 SGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  + I        +R+F+ +SDV+SFGV L E+ +
Sbjct: 191 MPPESIM-------YRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 6e-26
 Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V+ G  +  + VAIK  R GA +++ FI+E   +  + H NLV L G C + 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              F++ EY+ NG +  +L    +  + KL  +  L +     + + +L S     +H+D
Sbjct: 72  RPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRD 125

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV ED + KV+D GL  ++   D    SSQ T   +  A  EV ++ RFS KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 262 VYSFGVFLLELVSG 275
           V+SFGV + E+ S 
Sbjct: 184 VWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 7e-26
 Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 31/213 (14%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           N+   +LIG G FG VYKGL L+ G  VAIK     K      +  + E+  L +++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP---SQVSR---QKLEFKHRLSIALG 183
           +V  +G  + ++  ++I EY  NGS+   I  +GP   S V+    Q L+          
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ---------- 110

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
              GLA+LH     V+H+D K AN+L  +D + K+AD G+   L   DV+   + V    
Sbjct: 111 ---GLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTP 163

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            ++A EV E    S  SD++S G  ++EL++G 
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (257), Expect = 1e-25
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 20/212 (9%)

Query: 83  NLIGEGKFGEVYKGLL-----QDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 133
             +GEG FG+V            G  VA+K            +F  E+  L ++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 134 TLLGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
              G C+     +L+ LI EY+P+GS+  +L    Q  R ++  K  L  +    KG+ +
Sbjct: 70  KYKGVCEKPGGRSLR-LIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDY 124

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASE 249
           L S   R +H+D    N+LV+ + + K++D GL   L          +     IF  A E
Sbjct: 125 LGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSS 281
                +FS  SDV+SFGV L EL +  + S S
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  100 bits (252), Expect = 4e-25
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVT 134
           F     IG+G FGEVYK    + G  VAIK          ++ I+E+  L   +H N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGL 188
             G   + +  +++ E+   GS+         + +        L+      +     KGL
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLK-------DLLK---STNQTLTESQIAYVCKELLKGL 111

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +LHS    ++H+D K AN+L+  D   K+ D GL   L  T      + +     ++A 
Sbjct: 112 EYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPYWMAP 166

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EV   + +  K+D++S G+  +EL  G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 1e-24
 Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 44/245 (17%)

Query: 85  IGEGKFGEVYKGL-LQDG----MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G G FG VYKG+ + +G    + VAIK    +      +E +DE   +AS+ H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C  + +Q LI + +P G +  ++       +  +  ++ L+  +  AKG+++L    
Sbjct: 75  LGICLSSQVQ-LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE-- 127

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLASEV 250
            R+VH+D    NVLV      K+ D GL   L   +      +  A+       ++A E 
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMALES 182

Query: 251 KEFRRFSEKSDVYSFGVFLLEL----------VSGREASSSLS--------PDSSQDLVE 292
              R ++ KSDV+S+GV + EL          +   E    L         P  + D+  
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242

Query: 293 LMIKC 297
           +++KC
Sbjct: 243 VLVKC 247

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 3e-24
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 14/198 (7%)

Query: 84  LIGEGKFGEVYKGLLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
            IG+G FG+VYKG+L+    VA+K      P    ++F+ E   L    H N+V L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +P GS+   L         +L  K  L ++L AA G+ +L S +   +
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CI 115

Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E+ + K++D G+      G   V+    Q+     + A E   + R++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK--WTAPEALNYGRYT 173

Query: 258 EKSDVYSFGVFLLELVSG 275
            +SDV+S+G+ L E  S 
Sbjct: 174 SESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 5e-24
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 44/252 (17%)

Query: 83  NLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQEFIDEVCFL--ASI----QHRN 131
            +IG G+FGEV +G L+      + VAIK  + G+  ++ +D   FL  ASI     H N
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPN 66

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           ++ L G   ++    +I EY+ NGS    L    + +  K      + +  G A G+ +L
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGS----LDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLAS 248
             ++   VH+D    N+LV+ + + KV+D GL   L  ++    +      +I   + A 
Sbjct: 123 SEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKGGKIPIRWTAP 177

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSS------LSP--DSSQDL 290
           E   +R+F+  SDV+SFG+ + E++S           ++   +      L P  D    L
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL 237

Query: 291 VELMIKCMGKER 302
            +LM+ C  K+R
Sbjct: 238 YQLMLDCWQKDR 249

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 97.4 bits (242), Expect = 6e-24
 Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 17/198 (8%)

Query: 84  LIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 139
           L+G+G FGEV+KG L+D   VA+K  +   P +   +F+ E   L    H N+V L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +P G     L    +  + +L+ K  +  AL AA G+A+L   S   +
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLE--SKNCI 115

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 256
           H+D    N LV E+ + K++D G    + R +  G  S     +I   + A E   + R+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 257 SEKSDVYSFGVFLLELVS 274
           S +SDV+S+G+ L E  S
Sbjct: 172 SSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 97.9 bits (244), Expect = 6e-24
 Identities = 72/251 (28%), Positives = 114/251 (45%), Gaps = 33/251 (13%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG-----MLVAIK----KRPGAPTQEFIDE 120
           E+ L+   F ++  +GEG FG+VYKG L           VAIK           QEF  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 169
              ++ +QH N+V LLG C +     +++EY+ +G +   L   S  S           +
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L+    L IA+  A G+ +L   S   VH+D    N LV E    K++D GL   +  
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 286
            D     S+      ++  E   + +F+ +SD++SFGV L E+      S  L P    S
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF-----SYGLQPYYGFS 231

Query: 287 SQDLVELMIKC 297
           +Q+++E++   
Sbjct: 232 NQEVIEMIRSR 242

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.6 bits (243), Expect = 7e-24
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 16/213 (7%)

Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
           C      ++I E++  G++  +L    + +RQ++     L +A   +  + +L   +   
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKN--F 125

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 183

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 290
            KSDV++FGV L E+     A+  +SP    DL
Sbjct: 184 IKSDVWAFGVLLWEI-----ATYGMSPYPGIDL 211

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.3 bits (243), Expect = 2e-23
 Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 21/234 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH-R 130
           ++     +GEG FGEVY    +D  LVA+K             + F+ E+  LAS+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V L  + Q+    +L+ EY+  GS+   L       +  L     L I       L +
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEY 116

Query: 191 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 245
           LHS    ++H+D K  N+L+D D  + K+ D GL   L           + +  +    +
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 246 LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
           +A EV         S  SD++S G+ L EL++G          S+      +I 
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 5e-23
 Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 9/195 (4%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV++GL  +   VA+K  +PG    ++F+ E   +  ++H  L+ L   C   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              +++ E +  GS+  +L G +    + L+    + +A   A G+A+L + +   +H+D
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQN--YIHRD 128

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 262
               NVLV E+ I KVAD GL   +   D+            + A E   + RFS KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 263 YSFGVFLLELVS-GR 276
           +SFG+ L E+V+ GR
Sbjct: 188 WSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.7 bits (235), Expect = 6e-23
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-KRPGAPTQEFIDEVCFLA 125
             M+EL L          IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   + 
Sbjct: 3   LNMKELKL-------LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT 54

Query: 126 SIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
            ++H NLV LLG   +E    +++ EY+  GS+  +L       R  L     L  +L  
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDV 111

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADE 243
            + + +L + +   VH+D    NVLV ED +AKV+D GL      T D      + TA E
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE 169

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GR 276
                 ++E ++FS KSDV+SFG+ L E+ S GR
Sbjct: 170 -----ALRE-KKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.6 bits (235), Expect = 6e-23
 Identities = 73/212 (34%), Positives = 111/212 (52%), Gaps = 18/212 (8%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
           IGEG+FG V +G    G  VA+K  +     Q F++E   +  + H+NLV LLG    N 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72

Query: 144 LQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 201
           L +++ E +  G++   L   G + VS  +L     L  +L  A+G+ +L S   ++VH+
Sbjct: 73  L-YIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--KKLVHR 124

Query: 202 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
           D    N+LV ED +AKV+D GL   +G   V      V     + A E  + ++FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKHKKFSSKSD 179

Query: 262 VYSFGVFLLELVS-GREASSSLSPDSSQDLVE 292
           V+S+GV L E+ S GR     +S    ++ VE
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.7 bits (235), Expect = 9e-23
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)

Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGP--------SQVSRQKLEFKHRLSIALGAA 185
            G C E     +++EY+ +G ++  L  +GP          V+  +L     L+IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
            G+ +L SL    VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 133 SGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS 283
           +  E   +R+F+ +SD++SFGV L E+ + G++    LS
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 94.3 bits (234), Expect = 1e-22
 Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 17/219 (7%)

Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK---KRPGAPT-QEFIDEVCFLASIQHRNLVT 134
           L+G G FG V+KG+ + +G    + VAIK    R G  T QE  D +  + S+ H  +V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           LLG C   +LQ L+ +  P GS+  H+    +  R  L+ +  L+  +  AKG+ +L   
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAKGMYYLEE- 127

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             R+VH++    N+L+  D I ++AD G+ + L   D     S+      ++A E   F 
Sbjct: 128 -HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 255 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 292
           R++ +SDV+S+GV + E++S G E  + + P    DL+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.4 bits (232), Expect = 4e-22
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 31/218 (14%)

Query: 85  IGEGKFGEVYK----GLL--QDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 134
           IG+G FG V++    GLL  +   +VA+K  +  A      +F  E   +A   H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFK------------HR 177
           LLG C       L++EY+  G ++  L          +S      +             +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 178 LSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           L IA   A G+A+   LS R  VH+D  T N LV E+ + K+AD GL   +   D    S
Sbjct: 133 LCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                   ++  E   + R++ +SDV+++GV L E+ S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.9 bits (229), Expect = 7e-22
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 12/209 (5%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLL 136
           F     +GEG +G VYK +  + G +VAIK  P     QE I E+  L       +V   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 137 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           G Y +  +L +++ EY   GSVS  +    +++ + L  +   +I     KGL +LHS  
Sbjct: 65  GSYFKNTDL-WIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLHSN- 118

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
            + +H+D K  N+L++E+  AK+AD G+   L  TD     + V     ++A EV +   
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSP 284
           ++ K+D++S G+  +E+  G+   S + P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.5 bits (230), Expect = 8e-22
 Identities = 74/231 (32%), Positives = 110/231 (47%), Gaps = 27/231 (11%)

Query: 84  LIGEGKFGEVYK---GLLQD--GMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNLVTL 135
            +G+G FG V       LQD  G +VA+KK +       ++F  E+  L S+QH N+V  
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            G C      NL+ L+ EY+P GS+  +L    Q  R++L+ +  L  A    KG+ +L 
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVK 251
           S   R VH+D  T N+LV+ +   K+ D GL   L +        +     IF  A E  
Sbjct: 126 SK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKER 302
              +FS  SDV+SFGV L EL +  + S S             ++ MG ++
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPP--------AEFMRMMGNDK 226

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 91.0 bits (227), Expect = 1e-21
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEF-IDEVCFLASIQHRN 131
            +     IG+G FG+VY      DG L  +K+          +E  ++EV  L  + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR-----LSIALGAAK 186
           ++      +E     ++ EY   G +S  +       +QK E K       L   +    
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKI------KKQKKEGKPFPEEQILDWFVQLCL 114

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
            L +LHS   +++H+D K  N+ +  + + K+ D G+   L  T     +   T    +L
Sbjct: 115 ALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP--YYL 170

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           + E+ + + ++ KSD++S G  L EL + +
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLK 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 90.6 bits (225), Expect = 3e-21
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 39/225 (17%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIK---KRPGAPTQ-EFIDEVCFLASI 127
           N  +   +G G+FGEV+    +         LV +K   K      Q EF  E+     +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALG 183
            H+N+V LLG C+E    ++I EY   G +   L        ++    L  K ++++   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
            A G+ HL +   R VH+D    N LV      KV+   L            S  V   E
Sbjct: 126 IALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSL------------SKDVYNSE 171

Query: 244 IF-----------LASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 277
            +           LA E  +   FS KSDV+SFGV + E+ +  E
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.5 bits (222), Expect = 6e-21
 Identities = 73/239 (30%), Positives = 114/239 (47%), Gaps = 39/239 (16%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VAIK  + G+ + E F+ E   +  +QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I EY+ NGS+   L  P  +   KL     + +A   A+G+A +   +   +H+D
Sbjct: 74  PI-YIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV E    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 257 SEKSDVYSFGVFLLELVS-GR---------EASSSLS-------PDS-SQDLVELMIKC 297
           + KSDV+SFG+ L E+V+ GR         E   +L        PD+  ++L ELM  C
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC 239

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.2 bits (221), Expect = 8e-21
 Identities = 60/226 (26%), Positives = 110/226 (48%), Gaps = 36/226 (15%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---------QEFIDEVCFLASIQHRNLV 133
            ++G+G +G VY GL   G L+A+K+     +         ++  +EV  L S++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 185
             LG C ++N   +  E++P GS+S  ++ +GP       + ++Q L+            
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ----VTA 241
            G+A+LH+    VVH+D K  NV++  + I K+ D G    L    + G  S     +  
Sbjct: 114 -GVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS 287
              ++A EV     +  KSD++S G  + E+ +G+   +S+   ++
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 89.7 bits (222), Expect = 9e-21
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 30/242 (12%)

Query: 82  KNLIGEGKFGEVYKGL------LQDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 132
           K  +GEG FG+V+          +D MLVA+K  K P  A  ++F  E   L ++QH ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV---------SRQKLEFKHRLSIA 181
           V   G C + +   +++EY+ +G ++  L  +GP  +         ++ +L     L IA
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              A G+ +L   S   VH+D  T N LV  + + K+ D G+   +  TD          
Sbjct: 130 SQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELMIKCMGK 300
              ++  E   +R+F+ +SDV+SFGV L E+ + G++    LS          +I+C+ +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------TEVIECITQ 240

Query: 301 ER 302
            R
Sbjct: 241 GR 242

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.0 bits (220), Expect = 9e-21
 Identities = 72/238 (30%), Positives = 113/238 (47%), Gaps = 29/238 (12%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + +++ EY+  GS+   L G      + L     + +A   A G+A++  ++   VH+D
Sbjct: 74  PI-YIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 262 VYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVELMIKCMGKE 301
           V+SFG+ L EL +           RE    +         P+  + L +LM +C  KE
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 68/238 (28%), Positives = 115/238 (48%), Gaps = 29/238 (12%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  +PG  + E F++E   +  ++H  LV L     E 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + +++ EY+  GS+   L        + L+  + + +A   A G+A++  ++   +H+D
Sbjct: 74  PI-YIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            ++AN+LV +  + K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 262 VYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVELMIKCMGKE 301
           V+SFG+ L ELV+           RE    +          D    L ELM++C  K+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 82  KNLIGEGKFGEVYKGLLQD----GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLV 133
              IGEG+FG+VY+G+        + VA+K  K   +P   ++F+ E   +    H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L+G   EN + +++ E  P G +  +L    QV++  L+    +  +   +  LA+L S
Sbjct: 71  KLIGVITENPV-WIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 252
              R VH+D    NVLV      K+ D GL  +L        S       I ++A E   
Sbjct: 126 K--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS--KGKLPIKWMAPESIN 181

Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
           FRRF+  SDV+ FGV + E++ 
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 88.6 bits (219), Expect = 2e-20
 Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 37/259 (14%)

Query: 78  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQ 128
           N   K  +GEG FG+V+          QD +LVA+K    A     ++F  E   L ++Q
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV------SRQKLEFKHRLSI 180
           H ++V   G C E +   +++EY+ +G ++  L  +GP  V         +L     L I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           A   A G+ +L   S   VH+D  T N LV E+ + K+ D G+   +  TD         
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDS------------- 286
               ++  E   +R+F+ +SDV+S GV L E+ + G++    LS +              
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 243

Query: 287 ----SQDLVELMIKCMGKE 301
                +++ +LM+ C  +E
Sbjct: 244 PRTCPKEVYDLMLGCWQRE 262

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.0 bits (218), Expect = 3e-20
 Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 38/255 (14%)

Query: 83  NLIGEGKFGEVYKGLLQDGML-------VAIKK-RPGAPTQE---FIDEVCFLASIQHRN 131
           N +G G FGEVY+G   D +        VA+K  R GA  QE   F+ E   +++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK--LEFKHRLSIALGAAKGLA 189
           +V LLG C  N  Q++I E +  G +  +L            L  K  L I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 190 HLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           +L  +    +H+D    N LV E     D + K+ D GL   + ++D      +      
Sbjct: 121 YLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDS 286
           ++A E     +F+ +SDV+SFGV + E+++ G++   +L+                  + 
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238

Query: 287 SQDLVELMIKCMGKE 301
              + +LM  C  ++
Sbjct: 239 PDKIYQLMTNCWAQD 253

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.2 bits (219), Expect = 3e-20
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 67/278 (24%)

Query: 78  NFSDKNLIGEGKFGEVY------------KGLLQDGM-----LVAIKK-RPGAPT---QE 116
           NF +K  +GEG+FGEV+            K   ++       LVA+K  RP A     ++
Sbjct: 8   NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPS 165
           F+ EV  L+ +   N+  LLG C  +    +I EY+ NG ++  L               
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 166 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 225
            +S   L     L +A   A G+ +L SL+   VH+D  T N LV +++  K+AD G+  
Sbjct: 126 SLSFSTL-----LYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS----------- 274
            L  +D      +      ++A E     +F+ KSDV++FGV L E+++           
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 275 ---------------GREASSSLSPDSSQDLVELMIKC 297
                          GR+      P+  +D+ ELM++C
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLEC 276

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 26/214 (12%)

Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL ++       VA+K      T+    + I E+  +  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y P+QV  ++L FK  +S 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           A   A+G+ +L   S + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.6 bits (214), Expect = 6e-20
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              ++I EY+  GS+   L         K+     +  +   A+G+A++       +H+D
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER--KNYIHRD 128

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F  F
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 182 TIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.4 bits (214), Expect = 8e-20
 Identities = 69/256 (26%), Positives = 115/256 (44%), Gaps = 48/256 (18%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           +F   N IG+G FG V+K + + D  + A+K     K      +E IDE   LA +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE---FKHRLSIALGAAKGL 188
           ++       +     ++ EY  NG +  H     Q  R   E   ++  + I LG    L
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG------RTDVAGPSSQVTAD 242
           AHLHS   +++H+D K+ N+ +D     K+ D G+   L        T V  P       
Sbjct: 115 AHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP------- 165

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSS--------------LSPD 285
             +L+ E+ E + ++EKSDV++ GV L E  +G+   +A++               +S  
Sbjct: 166 -YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224

Query: 286 SSQDLVELMIKCMGKE 301
            SQ L +L+ +C+ K+
Sbjct: 225 YSQQLAQLIDQCLTKD 240

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 31/230 (13%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQEFID 119
              + L+L          +GEG FG+V K              VA+K  +  A  ++  D
Sbjct: 9   LPRDRLTLG-------KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD 61

Query: 120 ---EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGP 164
              E+  +  I +H+N++ LLG C +    +++ EY  +G++   L              
Sbjct: 62  LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121

Query: 165 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 224
            +   + L  K  +S A   A+G+  L S   + +H+D    NVLV ED + K+AD GL 
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +   D    ++       ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 1e-19
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G+VYK    + G LVA+KK      + G P    I E+  L  ++H N+V L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIREIKLLQKLRHPNIVRLKE 65

Query: 138 Y---CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
                 + ++ ++++EY+ +    +      + +  ++  K          +GL +LHS 
Sbjct: 66  IVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTESQI--KC---YMKQLLEGLQYLHS- 118

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 249
              ++H+D K +N+L++ D + K+AD GL R +  R      +  +T      E+ L + 
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR 276
                R+  + D++S G  L EL  G+
Sbjct: 178 -----RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.1 bits (213), Expect = 1e-19
 Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 22/212 (10%)

Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V    Y       G +VA+K  KR      T  +  E+  L ++ H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 136 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G C E   +   LI EY+P GS+  +L       + KL     L  A    +G+A+LHS
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 252
                +H+D    NVL+D D + K+ D GL   +          +     +F  A E  +
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
             +FS  SDV+SFGV L EL++     S  SP
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT--HCDSKQSP 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 82  KNLIGEGKFGEVYKGLLQDG-------MLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL 132
            +L+ EG FG ++ G+L D        + V   K   +  Q    + E C L  + H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 133 VTLLGYCQEN-NLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALGAAKG 187
           + +L  C E+    F++Y Y+  G++ + L     G +    Q L  +  + +A+  A G
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACG 129

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RN-FLGRTDVAGPSSQVTADEIF 245
           +++LH     V+HKD    N ++DE+   K+ D  L R+ F       G +       + 
Sbjct: 130 MSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L S V +   +S  SDV+SFGV L EL++
Sbjct: 188 LESLVNKE--YSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 68/246 (27%), Positives = 110/246 (44%), Gaps = 52/246 (21%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-------------QEFIDEVCFLASIQH 129
           LIG+G +G VY  L +  G ++A+K+     T             +    E+  L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIA 181
            N+V  LG+        +  EY+P GS+   +  YG          + Q LE        
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------- 119

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                GLA+LHS    ++H+D K  N+LVD D I K++D G+     ++D    + Q  +
Sbjct: 120 -----GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMS 169

Query: 242 --DEIF-LASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
               +F +A EV       +S K D++S G  +LE+ +GR       P S ++ +  M K
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR------PWSDEEAIAAMFK 223

Query: 297 CMGKER 302
            +G +R
Sbjct: 224 -LGNKR 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.8 bits (210), Expect = 3e-19
 Identities = 56/234 (23%), Positives = 108/234 (46%), Gaps = 31/234 (13%)

Query: 78  NFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           +F     +G+G +G VYK   L D    A+K+           ++ ++E+  LAS+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL--SIALGAAKGLA 189
           +++      + N   ++ EY P G +S      S+  +++     +    I +   +GL 
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLS---KAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIF 245
            LH    +++H+D K+AN+L+  + + K+ D G    L+  + +T +  P         +
Sbjct: 118 ALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP--------HY 167

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG 299
           +A EV + R +S KSD++S G  L E+ +         P  ++ + +L  K   
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFA------PPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.9 bits (210), Expect = 3e-19
 Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 35/248 (14%)

Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV +G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
            G   ++    +I E++ NG++   L    + +  +      + +  G A G+ +L  ++
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEI-FLASEVKE 252
              VH+D    N+LV+ + + KV+D GL  FL    +D    SS      I + A E   
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 253 FRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELM 294
           +R+F+  SDV+S+G+ + E++S G      +S                  D    L +LM
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLM 244

Query: 295 IKCMGKER 302
           + C  K+R
Sbjct: 245 LDCWQKDR 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 4e-19
 Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 11/193 (5%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   +  + H  LV L G C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              +++ EY+ NG +  +L    +   ++ +    L +     +G+A+L   S + +H+D
Sbjct: 72  RPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRD 125

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
               N LVD+    KV+D GL  ++   D    SS  +   + +   EV  + +FS KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 262 VYSFGVFLLELVS 274
           V++FGV + E+ S
Sbjct: 184 VWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG    E F+ E   +  ++H  LV L     E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + +++ E++  GS+   L    +   + L+    + +A   A G+A++  ++   +H+D
Sbjct: 74  PI-YIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV ++ + K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 262 VYSFGVFLLELVS-GR 276
           V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.9 bits (202), Expect = 4e-18
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 31/210 (14%)

Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPG---APTQEFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV++G+L+      + VAIK  +PG      Q+F+ E   +    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLSIALGAAKG 187
            L G   +     +I EY+ NG++  +L      +   Q+          + +  G A G
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL----------VGMLRGIAAG 119

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 244
           + +L  ++   VH+D    N+LV+ +   KV+D GL   L   D    +   +  +I   
Sbjct: 120 MKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIR 175

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   +R+F+  SDV+SFG+ + E++S
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 4e-18
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 32/214 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK------------KRPGAPTQEFIDEVCFLASIQHR 130
           LIG G FG VY G+    G L+A+K             R  +       E+  L  +QH 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGL 188
           N+V  LG   + +   +  EY+P GSV+  L  YG  + +  +   +  L       KGL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL------GRTDVAGPSSQVTAD 242
            +LH  +  ++H+D K AN+LVD     K++D G+   L       +T+ A PS Q +  
Sbjct: 120 NYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV- 176

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++A EV +   ++ K+D++S G  ++E+++G+
Sbjct: 177 -FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 27/223 (12%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQEF 117
           + ++   + ++  + K   ++N+I  GK G  YKG         ++  I      P+ E 
Sbjct: 678 KVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
            D    +  +QH N+V L+G C+     +LI+EYI   ++S  L   S   R+K      
Sbjct: 735 AD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRK------ 784

Query: 178 LSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
             IA+G AK L  LH   SP VV  +     +++D      +    L   L        S
Sbjct: 785 --IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 279
           S       ++A E +E +  +EKSD+Y FG+ L+EL++G+  +
Sbjct: 842 SA------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878

Length = 968

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.6 bits (201), Expect = 9e-18
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 40/220 (18%)

Query: 82  KNLIGEGKFGEVYKGLL-QDG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  + +DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 182
            LLG C+     +L  EY P+G++   L           +  +  +   L  +  L  A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 234
             A+G+ +L     + +H+D    N+LV E+++AK+AD GL        +  +GR  V  
Sbjct: 132 DVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                     ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 189 ----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.3 bits (200), Expect = 1e-17
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 28/206 (13%)

Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAPTQ--EFIDEVCFLASIQHRNLVT 134
           ++G G FG VYKG+ + +G    + VAIK       P    EF+DE   +AS+ H +LV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           LLG C    +Q L+ + +P+G +  +++     +  Q L     L+  +  AKG+ +L  
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLAS 248
              R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A 
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMAL 180

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E   +R+F+ +SDV+S+GV + EL++
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG  G V+K    + G  VA+KK        G P Q  + E+  L + QH  +V LL 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-ALREIKALQACQHPYVVKLLD 66

Query: 138 YCQENNLQFLIYEYIPNG--SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
                +   L+ EY+P+    V      P   ++ K   +  L       KG+A++H+  
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL-------KGVAYMHAN- 118

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEV 250
             ++H+D K AN+L+  D + K+AD GL       +    S QV      A E+   +  
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA-- 175

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
              R++    D+++ G    EL++G 
Sbjct: 176 ---RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 16/216 (7%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D   VA+K  R   P     +F+ E   L    H N+V L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +  G     L    +    +L+ K  + +   AA G+ +L S     +
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLES--KHCI 116

Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E  + K++D G+      G     G   Q+     + A E   + R+S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK--WTAPEALNYGRYS 174

Query: 258 EKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 292
            +SDV+SFG+ L E  S G    ++LS   +++ +E
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE 210

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 26/214 (12%)

Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
               A+G+ +L   S + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 143 TYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 76/250 (30%), Positives = 115/250 (46%), Gaps = 33/250 (13%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGM----LVAIK--KRPGAPTQ--EFIDEV 121
           EL L+   F ++  +GE  FG++YKG L   GM    LVAIK  K    P Q  EF  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS------------R 169
             +A + H N+V LLG   +     +++EY+  G +   L   S  S            +
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L+    L IA+  A G+ +L   S   VHKD    N+L+ E    K++D GL   +  
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 286
            D      +      ++  E   + +FS  SD++SFGV L E+      S  L P    S
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF-----SFGLQPYYGFS 231

Query: 287 SQDLVELMIK 296
           +Q+++E++ K
Sbjct: 232 NQEVIEMVRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 33/248 (13%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEFIDE 120
           E++L+T  F ++  +GE +FG+VYKG L      +    VAIK    K  G   +EF  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 169
               + +QH N+V LLG   +     +I+ Y  +  +   L   S  S           +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             LE    + I    A G+  L   S  VVHKD  T NVLV +    K++D GL   +  
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 286
            D             +++ E   + +FS  SD++S+GV L E+      S  L P    S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF-----SYGLQPYCGYS 231

Query: 287 SQDLVELM 294
           +QD++E++
Sbjct: 232 NQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 17/217 (7%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V+ G  +  + VAIK    GA ++E FI+E   +  + H  LV L G C + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 143 NLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
              +++ E++ NG +  +L    G  ++S+  L     LS+     +G+ +L   S   +
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQG--KLSKDML-----LSMCQDVCEGMEYLERNS--FI 122

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           H+D    N LV    + KV+D G+  ++   D    SS       +   EV  F ++S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
           SDV+SFGV + E+ +  E        S+ ++VE++ +
Sbjct: 182 SDVWSFGVLMWEVFT--EGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 40/220 (18%)

Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V + +++ DG  M  AIK      ++    +F  E+  L  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 182
            LLG C+     ++  EY P G++   L           +     +   L  +  L  A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 234
             A G+ +L     + +H+D    NVLV E+  +K+AD GL        +  +GR  V  
Sbjct: 127 DVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR- 183

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                     ++A E   +  ++ KSDV+SFGV L E+VS
Sbjct: 184 ----------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.0 bits (195), Expect = 4e-17
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRP----GAPTQEFI----DEVCFLASIQHRNLVT 134
           L+G G FG VY+GL L DG   A+K+      G   QE +     E+  L+ +QH N+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLSIALGAAK 186
            LG  +E +  ++  E +P GS++  L  YG          +RQ L              
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------------L 113

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
           GL +LH      VH+D K AN+LVD + + K+AD G+   +     A           ++
Sbjct: 114 GLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWM 168

Query: 247 ASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 276
           A EV  +   +   +D++S G  +LE+ +G+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.5 bits (193), Expect = 8e-17
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 66/278 (23%)

Query: 82  KNLIGEGKFGEVY----KGLL---------QDG--MLVAIKK-RPGAPT---QEFIDEVC 122
           K  +GEG+FGEV+    +GL           DG  +LVA+K  R         +F+ E+ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------PSQVSR 169
            ++ +++ N++ LLG C  ++   +I EY+ NG ++  L               PS VS 
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VSI 128

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L     L +A+  A G+ +L SL+   VH+D  T N LV   +  K+AD G+   L  
Sbjct: 129 ANL-----LYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--------------- 274
            D      +      ++A E     +F+  SDV++FGV L E+ +               
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241

Query: 275 -----------GREASSSLSPDSSQDLVELMIKCMGKE 301
                      GR+   S +P     + +LM++C  ++
Sbjct: 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD 279

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 26/214 (12%)

Query: 85  IGEGKFGEVYK----GLLQD----GMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V +    G+ +      + VA+K      T     + I E+  +  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GP------SQVSRQKLEFKHRLSI 180
           ++ LLG C +    ++I EY   G++   L      GP      ++V  ++L FK  +S 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           A   A+G+ +L S   R +H+D    NVLV ED + K+AD GL   +   D    +S   
Sbjct: 140 AYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFG+ + E+ +
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.9 bits (193), Expect = 1e-16
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 34/214 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNL 132
           +     +GEG +G VYK    + G +VA+KK R     +      + E+  L  ++H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V LL         +L++EY         L          L      SI     +GLA+ H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFL--GRT---DVAGPSSQVT----AD 242
           S   R++H+D K  N+L++ D + K+AD GL R F    RT   +V      VT    A 
Sbjct: 116 S--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV------VTLWYRAP 167

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EI L S     + +S   D++S G    E+++G+
Sbjct: 168 EILLGS-----KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.9 bits (192), Expect = 1e-16
 Identities = 70/253 (27%), Positives = 109/253 (43%), Gaps = 41/253 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQE----FIDEVCFLASIQH 129
           K F+D   IG G FG VY    ++   +VAIKK    G  + E     I EV FL  ++H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGLA 129

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS     +H+D K  N+L+ E    K+AD       G   +  P++       ++A E
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLAD------FGSASLVSPANSFVGTPYWMAPE 181

Query: 250 V---KEFRRFSEKSDVYSFGVFLLELVSGR-----------------EASSSLSPDS-SQ 288
           V    +  ++  K DV+S G+  +EL   +                   S +LS +  S 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD 241

Query: 289 DLVELMIKCMGKE 301
                +  C+ K 
Sbjct: 242 YFRNFVDSCLQKI 254

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.5 bits (191), Expect = 1e-16
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 128
             NF  +  IG+G+F  VYK + L DG +VA+KK            Q+ + E+  L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H N++  L    ENN   ++ E    G +S  +    +  ++ +  +      +     L
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA------D 242
            H+HS   R++H+D K ANV +    + K+ D GL  F         SS+ TA       
Sbjct: 120 EHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGT 169

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
             +++ E      ++ KSD++S G  L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 70/251 (27%), Positives = 119/251 (47%), Gaps = 34/251 (13%)

Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAP--TQEFIDEVCFL 124
           L    F    ++G G FG VYKGL + +G    + VAIK  +   +P   +E +DE   +
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           AS+ + ++  LLG C  + +Q LI + +P G +  ++    +  +  +  ++ L+  +  
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 118

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           AKG+ +L     R+VH+D    NVLV      K+ D GL   LG  +    +        
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDS 286
           ++A E    R ++ +SDV+S+GV + EL++            E SS L         P  
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 236

Query: 287 SQDLVELMIKC 297
           + D+  +M+KC
Sbjct: 237 TIDVYMIMVKC 247

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 42/246 (17%)

Query: 84  LIGEGKFGEVYKG----LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+G FG V +G         + VA+K     +      +F+ E   + S+ H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G    + L  ++ E  P GS+   +            L        A+  A G+ +L S
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLES 115

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEV 250
              R +H+D    N+L+  D   K+ D GL   L + +   V     +V     + A E 
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF--AWCAPES 171

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLV 291
              R FS  SDV+ FGV L E+ + G E  + LS                      QD+ 
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231

Query: 292 ELMIKC 297
            +M++C
Sbjct: 232 NVMLQC 237

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 34/218 (15%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----------------QEFIDEVCFLASI- 127
           +GEG FG+V   ++ + + +  K +P  P                  + + E+  +  I 
Sbjct: 20  LGEGCFGQV---VMAEAIGID-KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKH 176
           +H+N++ LLG C ++   +++ EY   G++  +L           +   ++  ++L FK 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
            +S A   A+G+ +L   S + +H+D    NVLV ED + K+AD GL   +   D    +
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +       ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 85  IGEGKFGEVYKGLLQ--DG--MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +G G FG V KG+     G  + VA+K    +   A  +EF+ E   +A + H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G C+   L  L+ E  P G +  +L    ++    L       +A   A G+A+L S   
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLES--K 114

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEV 250
             VH+D    NVL+     AK++D G+   LG    AG S    A         + A E 
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG----AG-SDYYRATTAGRWPLKWYAPEC 169

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             + +FS KSDV+S+GV L E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 3e-16
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 83  NLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLVT 134
           ++IGEG FG+V K  ++ DG  M  AIK+     ++    +F  E+  L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIALG 183
           LLG C+     +L  EY P+G++   L           +  +  +   L  +  L  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAGP 235
            A+G+ +L     + +H+D    N+LV E+++AK+AD GL        +  +GR  V   
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                    ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 177 ---------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.4 bits (188), Expect = 4e-16
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 21/207 (10%)

Query: 81  DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQE---FIDEVCFLASIQHRNLVTLL 136
           ++ ++G+G +G VY    L   + +AIK+ P   ++      +E+   + ++HRN+V  L
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 137 GYCQENNLQFLIY-EYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           G   EN   F I+ E +P GS+S  L   +GP + + Q + F  +  +     +GL +LH
Sbjct: 72  GSDSENGF-FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH 125

Query: 193 SLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
               ++VH+D K  NVLV+    + K++D G    L   +    +   T    ++A EV 
Sbjct: 126 DN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVI 181

Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGR 276
            K  R +   +D++S G  ++E+ +G+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAP--TQEFID-----EVCFLASIQHRNLV 133
             +GEG +  VYK    + G +VAIKK + G     ++ I+     E+  L  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 134 TLLG-YCQENNLQFLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
            LL  +  ++N+  L++E+        I + S+   +  P+ +           S  L  
Sbjct: 66  GLLDVFGHKSNIN-LVFEFMETDLEKVIKDKSI---VLTPADIK----------SYMLMT 111

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---- 240
            +GL +LHS    ++H+D K  N+L+  D + K+AD GL    G  +       VT    
Sbjct: 112 LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           A E+   +     R +    D++S G    EL+   
Sbjct: 170 APELLFGA-----RHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK      G +VAIKK +    ++      + E+  L  + H N++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            +     +L++E++        LY   +  ++ L      S      +GLA  HS    +
Sbjct: 67  FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGI 119

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 252
           +H+D K  N+L++ + + K+AD GL R+F   + V   +  V      A E+ L      
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGD---- 173

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
            + +S   D++S G    EL+S R
Sbjct: 174 -KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLLGYCQ 140
           IG G +G+VYK   +  G LVAIK     P  +F     E+  L   +H N+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL---GAAKGLAHLHSLSPR 197
             +  +++ EY   GS+   +Y   QV+R  L     L IA       KGLA+LH     
Sbjct: 71  RRDKLWIVMEYCGGGSLQ-DIY---QVTRGPLS---ELQIAYVCRETLKGLAYLHET--G 121

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKE 252
            +H+D K AN+L+ ED   K+AD G+   L  T +A   S +      A E+   + V+ 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEV---AAVER 177

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
              +  K D+++ G+  +EL   +     L P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHP 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.8 bits (186), Expect = 6e-16
 Identities = 69/244 (28%), Positives = 117/244 (47%), Gaps = 40/244 (16%)

Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           ++G G FG VYKG+ + DG    + VAIK       P A  +E +DE   +A +    + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYVC 72

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            LLG C  + +Q L+ + +P G +  ++    + ++ ++  +  L+  +  AKG+++L  
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSSQVTADEIFLASEVK 251
           +  R+VH+D    NVLV      K+ D GL   L    T+      +V    + L S + 
Sbjct: 128 V--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 252 EFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVEL 293
             RRF+ +SDV+S+GV + EL++           RE    L         P  + D+  +
Sbjct: 186 --RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMI 243

Query: 294 MIKC 297
           M+KC
Sbjct: 244 MVKC 247

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.7 bits (186), Expect = 6e-16
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 30/211 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQE-----FIDEVCFLASIQHRNLV 133
            +G G F   Y+   ++ G L+A+K+    R  +  QE        E+  +A + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIA--LGAAKGLA 189
            +LG   E++   L  E++  GSVS  +  YG          FK  + I       +GL+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---------FKEAVIINYTEQLLRGLS 117

Query: 190 HLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP---SSQVTADEIF 245
           +LH    +++H+D K AN+L+D      ++AD G    L      G      Q+     F
Sbjct: 118 YLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA-AKGTGAGEFQGQLLGTIAF 174

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +A EV    ++    DV+S G  ++E+ + +
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.6 bits (186), Expect = 7e-16
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 29/223 (13%)

Query: 73  SLATKNFSDKNLIGEGKFGEVYKGLL--QDG----MLVAIKKRPGAPTQE----FIDEVC 122
            +   + +    +G G FGEVY+GL   +DG    + VA+K  P + +++    F+ E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHRLSI 180
            ++   H+N+V L+G   E   +F++ E +  G +   L    P       L  K  L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV----- 232
           A   AKG  +L       +H+D    N L+       +AK+AD G+   + R        
Sbjct: 122 ARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179

Query: 233 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A    +    E FL         F+ K+DV+SFGV L E+ S
Sbjct: 180 RAMLPIKWMPPEAFLDG------IFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 75.3 bits (185), Expect = 8e-16
 Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 41/250 (16%)

Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHS 193
            G   ++    ++ EY+ NGS+   L       +   +F     + +  G A G+ +L  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
           +    VH+D    N+LV+ + + KV+D GL   L   D    +      +I   + A E 
Sbjct: 125 MG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS----------------GREASSSLSP--DSSQDLVE 292
             +R+F+  SDV+S+G+ + E++S                  E    L    D    L +
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240

Query: 293 LMIKCMGKER 302
           LM+ C  K+R
Sbjct: 241 LMLDCWQKDR 250

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 8e-16
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 85  IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+GL +          VAIK      +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY----------GPSQVSRQKLEFKHRLSIALGA 184
           LLG         ++ E +  G +  +L           G    + QK      + +A   
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-----IQMAAEI 128

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           A G+A+L +   + VH+D    N +V ED   K+ D G+   +  TD      +      
Sbjct: 129 ADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++A E  +   F+ KSDV+SFGV L E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 26/207 (12%)

Query: 85  IGEGKFGEVYKGLLQDGMLVA---IKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 137
           IG G FG+V  G    GM  A   +K+ R  A   E   F+ EV     + H N++  LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            C E+    L+ E+ P G +  +L     +  Q  +      +A   A GL  LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKE 252
            +H D    N  +  D   K+ D GL       D       +T D       +LA E+ E
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-----ITKDCHAVPLRWLAPELVE 175

Query: 253 FR-------RFSEKSDVYSFGVFLLEL 272
            R         ++KS+++S GV + EL
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 37/217 (17%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--------TQEFIDEVCFLASIQ 128
           N+    L+G+G FG VY     D G  +A+K+ P  P              E+  L ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 129 HRNLVTLLGYCQENNLQFLIY-EYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLS 179
           H  +V   G C  ++    I+ EY+P GSV   L  YG        + +RQ LE      
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------ 115

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSS 237
                  G+ +LH  S  +VH+D K AN+L D     K+ D G    L    +   G  S
Sbjct: 116 -------GVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            VT    +++ EV     +  K+DV+S G  ++E+++
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.5 bits (185), Expect = 1e-15
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K F+D   IG G FG VY    ++   +VAIKK      +     Q+ I EV FL  I+H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLA 139

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS +  ++H+D K  N+L+ E    K+AD       G   +A P++       ++A E
Sbjct: 140 YLHSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASIASPANSFVGTPYWMAPE 191

Query: 250 V---KEFRRFSEKSDVYSFGVFLLEL 272
           V    +  ++  K DV+S G+  +EL
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 77/288 (26%)

Query: 82  KNLIGEGKFGEVY--------------------KGLLQDGMLVAIK-KRPGAPTQ---EF 117
           K  +GEG+FGEV+                    KG     +LVA+K  RP A      +F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDF 66

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--------GPSQVSR 169
           + EV  L+ ++  N++ LLG C + +   +I EY+ NG ++  L              + 
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 170 QK------LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                   + +   L +AL  A G+ +L SL+   VH+D  T N LV E+   K+AD G 
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFG- 183

Query: 224 RNFLGRTDVAGPSSQVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELV------ 273
              + R   AG   ++    +    ++A E     +F+  SDV++FGV L E++      
Sbjct: 184 ---MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240

Query: 274 --------------------SGREASSSLSPDSSQDLVELMIKCMGKE 301
                                GR+      P   Q L ELM++C  ++
Sbjct: 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD 288

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.1 bits (185), Expect = 1e-15
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G VYKG   + G +VA+KK        G P+   I E+  L  +QH N+V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
              + +  +LI+E++   S+ +  Y  S    Q ++ +   S      +G+   HS   R
Sbjct: 67  VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RR 121

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 253
           V+H+D K  N+L+D   + K+AD GL    G          VT    A E+ L S     
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP---- 177

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
            R+S   D++S G    E+ + +
Sbjct: 178 -RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 34/232 (14%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 137
           ++GEG +G V K   +  G +VAIKK   +   E +      EV  L  ++H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             +     +L++EY+     ++       P  +    +      S      + +A+ HS 
Sbjct: 68  AFRRKGRLYLVFEYVER---TLLELLEASPGGLPPDAVR-----SYIWQLLQAIAYCHSH 119

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 249
              ++H+D K  N+LV E  + K+ D G  R    R          T    A E+ +   
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCMGK 300
                 + +  DV++ G  + EL+ G      L P DS  D + L+ KC+G 
Sbjct: 178 -----NYGKPVDVWAIGCIMAELLDGE----PLFPGDSDIDQLYLIQKCLGP 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 31/219 (14%)

Query: 85  IGEGKFGEVYKGL------LQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 134
           +GEG+FG+V K              VA+K  +  A + E  D   E   L  + H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSR--------------QKLEFK 175
           L G C ++    LI EY   GS+   L      GPS +                + L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 176 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
             +S A   ++G+ +L  +   +VH+D    NVLV E    K++D GL   +   D    
Sbjct: 128 DLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            S+      ++A E      ++ +SDV+SFGV L E+V+
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 22/201 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+         VA+K  +PG+ + E F+ E   + ++QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I E++  GS+ +      + S+Q L     +  +   A+G+A +   +   +H+D
Sbjct: 74  PI-YIITEFMAKGSL-LDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV    + K+AD GL   +         ++ TA E       + A E   F  F
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 257 SEKSDVYSFGVFLLELVS-GR 276
           + KSDV+SFG+ L+E+V+ GR
Sbjct: 181 TIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 5e-15
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 79  FSDKNLIGEGKFGEVYKGLL-QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEVYKG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G   +    ++I EY+  GS ++ L  P       LE  +  +I     KGL +LHS
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPG-----PLEETYIATILREILKGLDYLHS 119

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              R +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
             +  K+D++S G+  +EL  G   +S L P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHP 206

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++  GA +GLA
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS +  ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181

Query: 250 V---KEFRRFSEKSDVYSFGVFLLEL 272
           V    +  ++  K DV+S G+  +EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.5 bits (178), Expect = 7e-15
 Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 41/247 (16%)

Query: 83  NLIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVT 134
            +IG+G FG VY G L D     +  A+K           ++F+ E   +    H N+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 135 LLGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           LLG C  +     ++  Y+ +G +   +   +         K  +   L  AKG+ +L  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL-- 114

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVK 251
            S + VH+D    N ++DE F  KVAD GL R+   +        +       ++A E  
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 252 EFRRFSEKSDVYSFGVFLLELVS--------------------GRE-ASSSLSPDSSQDL 290
           + ++F+ KSDV+SFGV L EL++                    GR        PD    L
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDP---L 231

Query: 291 VELMIKC 297
            E+M+ C
Sbjct: 232 YEVMLSC 238

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.0 bits (179), Expect = 8e-15
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 43/232 (18%)

Query: 77  KNFSDKNLIGEGKFGEVY----KGLLQ-------------DGMLVAIKK-RPGA---PTQ 115
           K  + K  +GEG+FGEV+    +G+ +               +LVA+K  R  A      
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 116 EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY------GPSQVSR 169
           +F+ E+  ++ ++  N++ LL  C  ++   +I EY+ NG ++  L          +   
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             + +   + +A   A G+ +L SL+   VH+D  T N LV +++  K+AD G+   L  
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 230 TD---VAG----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            D   + G    P   ++ + I L        +F+  SDV++FGV L E+++
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLG-------KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNL 132
            + + +   IGEG  GEVYK      G  VAIKK R     +E  I+E+  +   +H N+
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V         +  +++ EY+  GS++  +      +  ++       +     +GL +LH
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQ----NFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLA 247
           S    V+H+D K+ N+L+ +D   K+AD G      +    R  V G     T    ++A
Sbjct: 134 SQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG-----TP--YWMA 184

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV + + +  K D++S G+  +E+  G
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 22/211 (10%)

Query: 85  IGEGKFGEVY------KGLLQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 134
           +GEG FG+V       +G    G  VA+K  +P +      D   E+  L ++ H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 135 LLGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
             G C E+  N   LI E++P+GS+  +L  P   +  K+  K +L  A+   KG+ +L 
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN--KINLKQQLKYAVQICKGMDYLG 126

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEV 250
           S   + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E 
Sbjct: 127 S--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREASSS 281
               +F   SDV+SFGV L EL++  ++ SS
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSESS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK    + G+  A K          ++F+ E+  L+  +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 140 QENNLQFLIYEYIPNGSV-SI-----HLYGPSQ---VSRQKLEFKHRLSIALGAAKGLAH 190
            EN L  LI E+   G++ SI           Q   V RQ LE              L  
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLE-------------ALNF 118

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD------VAGPSSQVTADEI 244
           LHS   +V+H+D K  N+L+  D   K+AD G+      T       +  P     A E+
Sbjct: 119 LHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP--YWMAPEV 174

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
            +A E  +   +  K+D++S G+ L+EL         L+P
Sbjct: 175 -VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 64/221 (28%), Positives = 92/221 (41%), Gaps = 45/221 (20%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           NF     IGEG +G VYK      G +VA+KK        G P+   I E+  L  + H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59

Query: 131 NLVTLLGYCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           N+V LL      N  +L++E++           P   + + L             K  L 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL------------IKSYLF 107

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
             L   +GLA  H  S RV+H+D K  N+L++ +   K+AD GL    G          V
Sbjct: 108 QLL---QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162

Query: 240 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           T    A EI L       + +S   D++S G    E+V+ R
Sbjct: 163 TLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 27/234 (11%)

Query: 78  NFSDKNLIGEGKFGEVY--KGLLQDGMLV----AIKKRPGAPTQEFIDEVCFLASIQHRN 131
            +     IGEG FG++Y  K        V     + K P    +    EV  LA ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK---LEFKHRLSIALGAAKGL 188
           +VT     QEN   F++ EY   G +        +++RQ+         LS  +  + GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLM------KRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 189 AHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
            H+H    +++H+D K+ N+ + ++  +AK+ D G+   L   D    +        +L+
Sbjct: 115 KHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLS 170

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK-CMGK 300
            E+ + R ++ K+D++S G  L EL + +       P    +L +L++K C G 
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKH------PFEGNNLHQLVLKICQGY 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.5 bits (173), Expect = 4e-14
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 14/209 (6%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G    VY  + L +   VAIK+    +      E   EV  ++   H N+V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 140 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
              +  +L+  Y+  GS+  I         R  L+     ++     KGL +LHS     
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSS---YPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ 123

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVKEFRR- 255
           +H+D K  N+L+ ED   K+AD G+   L  G                ++A EV E    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSP 284
           +  K+D++SFG+  +EL +G    S   P
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPP 212

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 70.3 bits (173), Expect = 4e-14
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 18/223 (8%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLLG-Y 138
           +G+G  G VYK   +  G + A+KK      +EF    + E+  L S +   +V   G +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            +E  +  ++ EY+  GS++  L    ++    L +     IA    KGL +LH+    +
Sbjct: 69  YKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKR-HI 121

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 258
           +H+D K +N+L++     K+AD G+   L  T     +   T    +++ E  +   +S 
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV--TYMSPERIQGESYSY 179

Query: 259 KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKE 301
            +D++S G+ LLE   G+       P       ELM       
Sbjct: 180 AADIWSLGLTLLECALGK---FPFLPPGQPSFFELMQAICDGP 219

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.3 bits (172), Expect = 4e-14
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQE---FIDEVCFLA 125
           L  K+   + ++G G+FGE+ +G L+      + VAI   R G   ++   F+ E   L 
Sbjct: 2   LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGA 184
              H N+V L G     N   ++ EY+ NG++   L     Q+   +L     + +  G 
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGL 116

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           A G+ +L  +    VHK      VLV+ D + K++  G R  L         + ++    
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKIS--GFRR-LQEDKSEAIYTTMSGKSP 171

Query: 245 FL--ASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            L  A E  ++  FS  SDV+SFG+ + E++S
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT----QEFIDEVCFLASIQHRN 131
           F   + IG G FG VY         +VA+KK    G  T    Q+ I EV FL  ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
            +   G   + +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA+L
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
           HS +  ++H+D K  N+L+ E    K+AD       G    + P++       ++A EV 
Sbjct: 138 HSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASKSSPANSFVGTPYWMAPEVI 189

Query: 251 --KEFRRFSEKSDVYSFGVFLLEL 272
              +  ++  K DV+S G+  +EL
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 5e-14
 Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 32/245 (13%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G   ++   ++I EY+  GS ++ L  P  +   ++      +I     KGL +LHS
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSP-----------------DSSQDLVELMIK 296
             +  K+D++S G+  +EL  G    S L P                 + S+ L E +  
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235

Query: 297 CMGKE 301
           C+ KE
Sbjct: 236 CLNKE 240

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.1 bits (172), Expect = 6e-14
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 46/219 (21%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFI-DEVCFLASIQHRNLVTLL 136
           N IG G FG+VY  + L  G L+A+K    +     T + I DE+  L  ++H NLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 137 G-------------YCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           G             YC    L + L +  I +  V I +Y     + Q LE         
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRVY-----TLQLLE--------- 110

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
               GLA+LHS    +VH+D K AN+ +D + + K+ D G    L   T   G   Q  A
Sbjct: 111 ----GLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 242 -DEIFLASEVKEFRRFSEK---SDVYSFGVFLLELVSGR 276
               ++A EV    +       +D++S G  +LE+ +G+
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 7e-14
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 133
           F+    IG+G FGEVYK +  +   +VAIK       ++ I+    E+ FL+  +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G   + +  ++I EY   GS    L  P      KL+  +   I      GL +LH 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------- 244
                +H+D K AN+L+ E+   K+AD G         V+G   Q+T+            
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFG---------VSG---QLTSTMSKRNTFVGTP 162

Query: 245 -FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
            ++A EV +   + EK+D++S G+  +EL  G    S L P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 9e-14
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           NF  +  IG G+F EVY+   L DG+ VA+KK             + I E+  L  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           N++       E+N   ++ E    G +S    H     ++  +K  +K+ + +       
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L H+HS   RV+H+D K ANV +    + K+ D GL  F      A  S  +     +++
Sbjct: 119 LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E      ++ KSD++S G  L E+ +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 47/233 (20%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE------FIDEVCFLAS 126
            +F    +IGEG F  V     +      AIK   KR     +E       I++      
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 127 IQHRNLVTLLGYCQ-ENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 183
             H  ++ L    Q E NL + + EY PNG +   I  YG        L+ K     A  
Sbjct: 59  NGHPGIIKLYYTFQDEENL-YFVLEYAPNGELLQYIRKYG-------SLDEKCTRFYAAE 110

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV---- 239
               L +LHS    ++H+D K  N+L+D+D   K+ D G    L        +       
Sbjct: 111 ILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 240 ----------------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                           TA+  +++ E+   +   + SD+++ G  + ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAE--YVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 41/242 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
             F   N IGEG +G VY+      G +VA+KK      R G P    + E+  L +++H
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRH 65

Query: 130 RNLVTLLGYCQENNLQ--FLIYEYIPN--GSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            N+V L       +L   FL+ EY      S+  ++  P   S+ K        + L   
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-------CLMLQLL 118

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--VT-- 240
           +GL +LH     ++H+D K +N+L+ +    K+AD GL R +      A P +   VT  
Sbjct: 119 RGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVVTLW 173

Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELMIKC 297
             A E+ L         ++   D+++ G  L EL++ +     L P  S+ + ++L+I+ 
Sbjct: 174 YRAPELLLGCTT-----YTTAIDMWAVGCILAELLAHK----PLLPGKSEIEQLDLIIQL 224

Query: 298 MG 299
           +G
Sbjct: 225 LG 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 57/220 (25%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G VYK      G +VA+KK        G P+   I E+  L  + H N+V LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65

Query: 138 YCQENNLQFLIYEY-----------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
                N  +L++E+            P   +      P  +      + ++L       +
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGL-----DPPLIKS----YLYQL------LQ 110

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RT---DVAGPSSQVT 240
           G+A+ H  S RV+H+D K  N+L+D +   K+AD GL    G   RT   +V      VT
Sbjct: 111 GIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV------VT 162

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A EI L S     R++S   D++S G    E+V+ R
Sbjct: 163 LWYRAPEILLGS-----RQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 17/209 (8%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLG-YC 139
           +G+G FG+VYK   ++ G L A   I+ +     ++++ E+  LA+  H  +V LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +  L  +I E+ P G+V   +    ++ R   E + ++ I     + L +LHS+  +++
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIML---ELDRGLTEPQIQV-ICRQMLEALQYLHSM--KII 132

Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNF--LGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           H+D K  NVL+  D   K+AD G+  +N   L R D    +    A E+ +   +K+   
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD-TP 191

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSP 284
           +  K+D++S G+ L+E+         L+P
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP 220

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-------HR 130
           F    +IGEG +G+VYK    + G LVAIK       ++  +E+              H 
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEI--KEEYNILRKYSNHP 63

Query: 131 NLVTLLG-------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           N+ T  G          ++ L +L+ E    GSV   L    +   ++L+ +    I   
Sbjct: 64  NIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSV-TDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 239
             +GLA+LH    +V+H+D K  N+L+ ++   K+ D G    L + LGR +    +   
Sbjct: 122 TLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            A E+    E  +   +  +SDV+S G+  +EL  G
Sbjct: 180 MAPEVIACDEQPD-ASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 6e-13
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
            ENNL  LI E+   G+V    + L  P    + ++  K  L       + L +LH    
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------EALNYLHE--N 122

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
            R +  K+DV+S G+ L+E+         L+P
Sbjct: 183 -RPYDYKADVWSLGITLIEMAQIEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.4 bits (164), Expect = 7e-13
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK       ++ I+    E+  L+      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
              G   +    ++I EY+  GS + +   GP    +     K  L       KGL +LH
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------KGLDYLH 118

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           S   + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV +
Sbjct: 119 S--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
              +  K+D++S G+  +EL  G   +S + P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 49/168 (29%), Positives = 68/168 (40%), Gaps = 46/168 (27%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNL 132
             IGEG +G VYK   L  G  VA+KK        G P    + E+  L  ++   H N+
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63

Query: 133 VTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLY---------GPSQ---VSRQKLEFK 175
           V LL  C            L++E++      +  Y          P     + RQ L   
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLL--- 117

Query: 176 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                     +G+  LH  S R+VH+D K  N+LV  D   K+AD GL
Sbjct: 118 ----------RGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGL 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 85  IGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY    KG+++D     VAIK    A +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYG-----PSQVSRQKLEFKHRLSIALGAAKGLA 189
           LLG   +     +I E +  G +  +L        +   +     K  + +A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L++   + VH+D    N +V EDF  K+ D G+   +  TD      +      +++ E
Sbjct: 134 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SDV+SFGV L E+ +
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           NF  +  IG G+F EVY+   L D   VA+KK            Q+ + E+  L  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           N++  L    E+N   ++ E    G +S    +     ++  ++  +K+ + +       
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + H+HS   RV+H+D K ANV +    + K+ D GL  F      A  S  +     +++
Sbjct: 119 VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E      ++ KSD++S G  L E+ +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 32/164 (19%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG FGEVYK   ++ G +VA+KK      + G P      E+  L  ++H N+V L+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74

Query: 138 YCQENNLQFLIYEYIPNGS---VSIHLYGPSQVS---------RQKLEFKHRLSIALGAA 185
                    +  E          S+++  P               KL         L   
Sbjct: 75  ---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 228
           +G+ +LH     ++H+D K AN+L+D   I K+AD GL R + G
Sbjct: 126 EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 85  IGEGKFGEVYK----GLLQDG--MLVAIKK-RPGA---PTQEFIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL +    M VA+K  +P A     +  + E+  ++ +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            LLG C       +I EY   G +   L    +     L  +  LS +   AKG+A L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 248
            +   +H+D    NVL+    I K+ D GL       D+   S+ V      L     A 
Sbjct: 160 KN--CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E      ++ +SDV+S+G+ L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 2e-12
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 46/214 (21%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID--EVCFLASIQ-HRNLVTLLGY 138
           +G+G FG VY     + G LVAIK  K+     +E ++  EV  L  +  H N+V L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL-------SIALGAAKGLAHL 191
            +EN+  + ++EY     +  +LY   Q+ + +   K +        SI     +GLAH+
Sbjct: 67  FRENDELYFVFEY-----MEGNLY---QLMKDR---KGKPFSESVIRSIIYQILQGLAHI 115

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL----RNFLGRTD-VAGPSSQVT----AD 242
           H       H+D K  N+LV    + K+AD GL    R+    TD V+      T    A 
Sbjct: 116 HKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS------TRWYRAP 167

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EI L S       +S   D+++ G  + EL + R
Sbjct: 168 EILLRSTS-----YSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 42/197 (21%), Positives = 95/197 (48%), Gaps = 19/197 (9%)

Query: 85  IGEGKFGE--VYKGLLQDGMLVAIK----KRPGAPTQEF-IDEVCFLASIQHRNLVTLLG 137
           +G+G FGE  +Y+   +D  LV  K     R     +   ++E+  L+ +QH N++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--GAAKGLAHLHSLS 195
           +  ++N   +  EY   G++   +     V ++   F+  + +         ++++H   
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             ++H+D KT N+ + +  + K+ D G+   LG ++ +   + V     +++ E+ +  +
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAET-VVGTPYYMSPELCQGVK 177

Query: 256 FSEKSDVYSFGVFLLEL 272
           ++ KSD+++ G  L EL
Sbjct: 178 YNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 32/212 (15%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G FG V K     DG ++  K            Q+ + EV  L  ++H N+V    Y
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64

Query: 139 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
                   N   +++ EY   G ++  L    +  R+ +E +    I       L   H+
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 194 L---SPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 244
                  V+H+D K AN+ +D +   K+ D GL       +   +T V  P         
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP--------Y 175

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +++ E      + EKSD++S G  + EL +  
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLG-Y 138
           L+G G +G+VYKG  ++ G L AIK     G   +E   E+  L     HRN+ T  G +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 139 CQEN-----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            ++N     +  +L+ E+   GSV+  L   ++ +  K E+   +   +   +GL+HLH 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREI--LRGLSHLHQ 129

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 250
              +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV   
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 185

Query: 251 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
                  +  KSD++S G+  +E+  G      + P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 85  IGEGKFGEVYKGLLQDGM---LVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IGEG +G VYK   +D +    +A+KK        G P+   I E+  L  +QH N+V L
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVRL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
                     +L++EY+ +  +  H+      ++     K  L   L   +G+A+ H  S
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH--S 120

Query: 196 PRVVHKDFKTANVLVDEDFIA-KVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEV 250
            RV+H+D K  N+L+D    A K+AD GL    G          VT    A EI L S  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS-- 178

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
              R +S   D++S G    E+V+ +
Sbjct: 179 ---RHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 38/213 (17%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASI-QHRNLVTLLG 137
           +G+G +G V+K +  +   +VA+KK   A    T  Q    E+ FL  +  H N+V LL 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 138 -YCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSL 194
               EN+   +L++EY+      +H      V R   LE  H+  I     K L ++HS 
Sbjct: 75  VIKAENDKDIYLVFEYM---ETDLH-----AVIRANILEDVHKRYIMYQLLKALKYIHS- 125

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTAD----------E 243
              V+H+D K +N+L++ D   K+AD GL R+         P + V  D          E
Sbjct: 126 -GNVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATRWYRAPE 182

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           I L S      R+++  D++S G  L E++ G+
Sbjct: 183 ILLGS-----TRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 7e-12
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           NF     +GEG +  VYKG  +  G +VA+K+       G P+   I E+  +  ++H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-IREISLMKELKHEN 59

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V L       N   L++EY+      +  Y  +   R  L+     S      KG+A  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFL 246
           H    RV+H+D K  N+L+++    K+AD GL    G   V   S++V      A ++ L
Sbjct: 117 HE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFG-IPVNTFSNEVVTLWYRAPDVLL 173

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            S     R +S   D++S G  + E+++GR
Sbjct: 174 GS-----RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.5 bits (158), Expect = 9e-12
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 45/223 (20%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRN 131
           +     IG G +G V   +  + G  VAIKK       + ID      E+  L  ++H N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPN-GSVSI--HLYGP--SQV--SRQKLEFKHRLSIALGA 184
           ++ LL          L      +   V I   L      +V  S Q L   H        
Sbjct: 61  IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ------ 238
            +GL +LHS +  V+H+D K +N+LV+ +   K+ D G    L R        +      
Sbjct: 113 LRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEY 166

Query: 239 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            VT    A E+ L+S      R+++  D++S G    EL++ +
Sbjct: 167 VVTRWYRAPELLLSSS-----RYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 24/202 (11%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLLGYC 139
           +G G  G V K L +  G ++A+K       +      + E+  L       +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 140 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
             N    +  EY+  GS+  I      ++  + L       IA+   KGL +LH    ++
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE-KHKI 122

Query: 199 VHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
           +H+D K +N+LV+     K+ D G    L N L +T V G SS       ++A E  +  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-GTSS-------YMAPERIQGN 174

Query: 255 RFSEKSDVYSFGVFLLELVSGR 276
            +S KSD++S G+ L+EL +GR
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.0 bits (153), Expect = 1e-11
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 85  IGEGKFGEVYKG---LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +G G FG V KG   + +  + VAIK    +   +   E + E   +  + +  +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
            C+   L  L+ E    G ++  L G          +E  H++S+      G+ +L    
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG-- 113

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASE 249
              VH+D    NVL+     AK++D GL   LG  D     S   A         + A E
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-----SYYKARSAGKWPLKWYAPE 168

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
              FR+FS +SDV+S+G+ + E  S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 15/208 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRN 131
            +    ++G G FG V+      D  LV IK+ P             +E   L  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           ++       E+    ++ EY P G+++ ++    +     L+    L   +     L H+
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 192 HSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
           H+    ++H+D KT N+L+D+   + K+ D G+   L     A     V     +++ E+
Sbjct: 118 HT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPEL 172

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREA 278
            E + +++KSD+++ G  L EL S + A
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 21/221 (9%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIK---KRPG-APTQEFIDEVCFLASIQHRN 131
           +   + + +GEG  G V K  L   GM+ A+K     P     ++ + E+    S +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 132 LVTLLGYC---QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           +V   G       +++  +  EY   GS+   +Y   +    ++  K    IA    KGL
Sbjct: 61  IVKYYGAFLDESSSSIG-IAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
           ++LHS   +++H+D K +N+L+      K+ D G+   L    +AG     T    ++A 
Sbjct: 119 SYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-NSLAG---TFTGTSFYMAP 172

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSP 284
           E  + + +S  SDV+S G+ LLE+   R     E    L P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 85  IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D         VA+K    + +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIALGAAKGLA 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +A   A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L++   + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 134 YLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 40/166 (24%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    +   +VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 78

Query: 138 YC-----QENNLQ---FLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
            C       N  +   +L++E+        + N +V   L      S  K   K  L+  
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL------SEIKKVMKMLLN-- 130

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
                GL ++H    +++H+D K AN+L+ +D I K+AD GL R F
Sbjct: 131 -----GLYYIHR--NKILHRDMKAANILITKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 33/234 (14%)

Query: 80  SDKNLIGEGKFGEVYKGLLQDGMLVAIK------KRPGAPTQEFIDEVCFLASIQHRNLV 133
           +D+N I +G F         +   V I+      K          +E+  L  I   N++
Sbjct: 31  NDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81

Query: 134 TLLGY----CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            + G+      +     LI EY   G +   L        + L FK +L +A+   KGL 
Sbjct: 82  KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLY 136

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L+  + +  +K+  + + LV E++  K+   GL   L     + P   V     F    
Sbjct: 137 NLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILS----SPPFKNVNFMVYFSYKM 191

Query: 250 VKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKER 302
           + + F  ++ K D+YS GV L E+ +G+    +L   +++++ +L+I      +
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEIYDLIINKNNSLK 242

Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.5 bits (150), Expect = 6e-11
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
            +   N I EG +G VY+    + G +VA+KK      + G P    + E+  L  +QH 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKLQHP 64

Query: 131 NLVTLLGYCQE----NNLQ--FLIYEYIPNGSVSI--HLYGPSQVSRQKLEFKHRLSIAL 182
           N+VT+    +E    +NL   +++ EY+ +   S+   +  P   S  K      LS   
Sbjct: 65  NIVTV----KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS--- 117

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 239
               G+AHLH     ++H+D KT+N+L++   I K+ D GL R +        P +Q  V
Sbjct: 118 ----GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVV 168

Query: 240 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           T    A E+ L +     + +S   D++S G    EL++ +
Sbjct: 169 TLWYRAPELLLGA-----KEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.2 bits (148), Expect = 7e-11
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 85  IGEGKFGEVYKGLL-QDG---------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +GEG+FG V +G L QD          M +AI  R  +  ++F+ E   +    H N++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMR 64

Query: 135 LLGYCQENNLQ------FLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           L+G C +           +I  ++ +G + S  LY       Q L  +  +      A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + +L S     +H+D    N +++E+    VAD GL   +   D             ++A
Sbjct: 125 MEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E    R ++ KSDV+SFGV + E+ +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 9e-11
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 21/218 (9%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQH---RNLVTL 135
           LIG G +G VY+G  +  G +VA+K      P     +   EV  L+ ++     N+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 136 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
            G Y +   L ++I EY   GSV       + +    +  K+   I       L ++H +
Sbjct: 68  YGSYLKGPRL-WIIMEYAEGGSVR------TLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEF 253
              V+H+D K AN+LV      K+ D G+   L     +   S       ++A EV  E 
Sbjct: 121 G--VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 291
           + +  K+D++S G+ + E+ +G    S +    +  L+
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 51/239 (21%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 137
           L+GEG +G V K   ++ G +VAIKK   +   + +      E+  L  ++H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 138 YCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
             +     +L++E++           PNG                L+            +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----------------LDESRVRKYLFQILR 111

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
           G+   HS +  ++H+D K  N+LV +  + K+ D G    L     A P    T   A  
Sbjct: 112 GIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYTDYVATR 164

Query: 244 IFLASE--VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCMG 299
            + A E  V +  ++    D+++ G  + E+++G      L P DS  D +  +IKC+G
Sbjct: 165 WYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 32/214 (14%)

Query: 84  LIGEGKFGEVYKGLL--QDGML--VAIK--KRPG---APTQEFIDEVCFLASIQHRNLVT 134
           ++GEG+FG V +G L   DG    VA+K  K      +  +EF+ E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 135 LLGYC-QENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIAL 182
           L+G C + ++LQ      +I  ++ +G +   L        P ++  Q L     L   +
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-----LKFMV 120

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQVT 240
             A G+ +L +     +H+D    N ++ ED    VAD GL   +   D    G  +++ 
Sbjct: 121 DIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ KSDV++FGV + E+ +
Sbjct: 179 VK--WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 41/216 (18%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRN-LVTLL 136
           IGEG +G+VYK      G LVA+KK        G P    + E+  L  +     +V LL
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA-LREISLLQMLSESIYIVRLL 67

Query: 137 G--YCQENN---LQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
              + +E N     +L++EY+ +     +   G      + L  K   S      KG+AH
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAH 125

Query: 191 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVAGPSSQVT-------- 240
            H     V+H+D K  N+LVD+   + K+AD GL R F      + P    T        
Sbjct: 126 CHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF------SIPVKSYTHEIVTLWY 177

Query: 241 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            A E+ L S       +S   D++S G    E+   
Sbjct: 178 RAPEVLLGS-----THYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 26/207 (12%)

Query: 85  IGEGKFGEVYKGLLQDGM---LVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 137
           IG G FG+V  G +  G     V +K+ R  A  QE   F++E     S+QH NL+  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            C E     L+ E+ P G +  +L    +      +      +A   A GL HLH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNN 120

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF---------LAS 248
            +H D    N L+  D   K+ D GL +   + D       VT D+++         L  
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVD 175

Query: 249 EVKE---FRRFSEKSDVYSFGVFLLEL 272
           EV         +++S+V+S GV + EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 55/233 (23%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIKK-------RPGAPTQEFIDEVCF----------L 124
             +GEG +G+V K      G +VAIKK             ++ +               +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 125 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 181
             I+H N++ L+  Y +         ++I N  + I      +V   + +L       I 
Sbjct: 75  NEIKHENIMGLVDVYVEG--------DFI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ--- 238
           L    GL  LH      +H+D   AN+ ++   I K+AD GL    G    +   S+   
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 239 -----------VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                      VT    A E+ + +E     ++    D++S G    EL++G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAE-----KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 27/230 (11%)

Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFI---D 119
           +RR   E+  L  +       IG G +G+VYK   +  G L AIK     P ++F     
Sbjct: 3   SRRNPQEDFELIQR-------IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ 55

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHR 177
           E+  +   +H N+V   G     +  ++  E+   GS+    H+ GP  +S  ++ +  R
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSR 113

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
            ++     +GL +LHS     +H+D K AN+L+ ++   K+AD G+   +  T +A   S
Sbjct: 114 ETL-----QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKS 165

Query: 238 QVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSP 284
            +     ++A EV    R   +++  D+++ G+  +EL   +     L P
Sbjct: 166 FI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 35/216 (16%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 135
             IGEG +G+VYK   +D G LVA+KK      + G P    I E+  L  + HRN+V L
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNHRNIVNL 71

Query: 136 ----------LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
                     L + ++    +L++EY+ +      L G  +         H  S      
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---- 241
           +GL + H  +   +H+D K +N+L++     K+AD GL       +    +++V      
Sbjct: 127 EGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 242 -DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             E+ L  E     R+    DV+S G  L EL + +
Sbjct: 185 PPELLLGEE-----RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 16/150 (10%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G V+K   ++   +VA+K+        G P+     E+C L  ++H+N+V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLYD 66

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
               +    L++EY       +  Y  S      ++ +   S      KGLA  H  S  
Sbjct: 67  VLHSDKKLTLVFEYCDQ---DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCH--SHN 119

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
           V+H+D K  N+L++++   K+AD GL R F
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.7 bits (142), Expect = 5e-10
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FGEV    ++  G + A        +KKR G   Q  ++E   L  +  R +V+L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58

Query: 136 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             Y  E      L+   +  G +  H+Y    V          +  A     GL HLH  
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASEVKEF 253
             R+V++D K  NVL+D+    +++D GL     G   + G +        ++A EV + 
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG----YMAPEVLQG 168

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
             +    D ++ G  L E+++GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEV----C---FLASIQ 128
           N+    L+G G FGEVY     D G  +A+K+ P  P +QE   EV    C    L +++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 129 HRNLVTLLGYC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           H  +V   G C    +E  L   + EY+P GS+   L     ++ + +  ++   I    
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALT-ENVTRRYTRQIL--- 116

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADE 243
            +G+++LHS    +VH+D K AN+L D     K+ D G    +    ++G     VT   
Sbjct: 117 -QGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            +++ EV     +  K+DV+S    ++E+++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 43/212 (20%)

Query: 85  IGEGKFGEVYKGLLQ---DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +G G FG V KG+ +       VA+K         A   E + E   +  + +  +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSLS 195
           G C+  +   L+ E    G ++  L     V+ + + E  H++S+      G+ +L   +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEETN 115

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--------- 246
              VH+D    NVL+     AK++D GL            S  + ADE +          
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGL------------SKALGADENYYKAKTHGKWP 161

Query: 247 ----ASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               A E   + +FS KSDV+SFGV + E  S
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 139
           ++G G +G+VYKG  ++ G L AIK         +E   E+  L     HRN+ T  G  
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 140 -------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
                   ++ L +L+ E+   GSV+  L   ++ +  K ++   +   +   +GLAHLH
Sbjct: 83  IKKSPPGHDDQL-WLVMEFCGAGSVT-DLVKNTKGNALKEDWIAYICREI--LRGLAHLH 138

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-- 250
           +   +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV  
Sbjct: 139 A--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIA 194

Query: 251 ---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
                   +  +SD++S G+  +E+  G      + P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 37/212 (17%)

Query: 85  IGEGKFGEVYKGLL----QDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IGEG FG   K +L    +DG    IK     K      +E   EV  L++++H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLH 192
               +EN   +++ +Y   G +   +     V     Q L++  ++ +AL       H+H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF------LGRTDVAGPSSQVTADEIFL 246
               +++H+D K+ N+ + +D   K+ D G+         L RT +  P         +L
Sbjct: 119 D--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP--------YYL 168

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
           + E+ E R ++ KSD+++ G  L E+ + + A
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 35/219 (15%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 128
           N+    L+G+G FG VY     D G  +A K+    P +P T + +     E+  L ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 129 HRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRL 178
           H  +V   G  ++   + L    EY+P GSV   L  YG        + +RQ LE     
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----- 117

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-S 237
                   G+++LHS    +VH+D K AN+L D     K+ D G    L    ++G    
Sbjct: 118 --------GMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            VT    +++ EV     +  K+DV+S G  ++E+++ +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 128
           N+    L+G+G FG VY     D G  +A+K+    P +P T + ++    E+  L ++ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 129 HRNLVTLLGYC---QENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHR 177
           H  +V   G      E  L   + E++P GS+   L  YG        + +RQ LE    
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQILE---- 117

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS- 236
                    G+++LHS    +VH+D K AN+L D     K+ D G    L    ++G   
Sbjct: 118 ---------GVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             VT    +++ EV     +  K+D++S G  ++E+++ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 19/230 (8%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIK-KRPGAPTQEFID-EVCFLA 125
           +E L   T  +     IG+G +G+VYK    +DG L A+K   P +   E I+ E   L 
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73

Query: 126 SI-QHRNLVTLLG------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           S+  H N+V   G            L +L+ E    GSV+  + G      Q+L+     
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICG-QRLDEAMIS 131

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I  GA  GL HLH  + R++H+D K  N+L+  +   K+ D G+   L  T +   +S 
Sbjct: 132 YILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 239 VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
            T    A E+ +A E +    +  + DV+S G+  +EL  G      + P
Sbjct: 190 GTPFWMAPEV-IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAIK+      P +E I +E+  +   +H N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 133 VTLL-GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           V  L  Y   + L +++ EY+  GS++        V+   ++     ++     + L  L
Sbjct: 79  VNYLDSYLVGDEL-WVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFL 131

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           HS   +V+H+D K+ N+L+  D   K+ D G    +  T      S +     ++A EV 
Sbjct: 132 HS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVV 187

Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             + +  K D++S G+  +E+V G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.9 bits (134), Expect = 6e-09
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAIK+      P +E I +E+  +   ++ N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASEVK 251
           S   +V+H+D K+ N+L+  D   K+ D G   F  + T      S +     ++A EV 
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             + +  K D++S G+  +E+V G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 20/197 (10%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G G +G+VYK   L  G L A   IK  PG        E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 141 ENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
                ++  EY   GS+    H+ GP  +S  ++ +  R ++     +GLA+LHS     
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETL-----QGLAYLHSKGK-- 127

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--- 255
           +H+D K AN+L+ ++   K+AD G+   +  T              ++A EV    +   
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 256 FSEKSDVYSFGVFLLEL 272
           +++  D+++ G+  +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 46/196 (23%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
             +  +++ E++  G+++        V+  ++  +   ++ L   K L+ LH+    V+H
Sbjct: 88  VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIH 139

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 259
           +D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 260 SDVYSFGVFLLELVSG 275
            D++S G+ ++E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 54.4 bits (132), Expect = 1e-08
 Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 36/209 (17%)

Query: 85  IGEGKFGEVYK-GLLQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FG+V        G L A+K        KR        + E   L+ I H  +V L
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--------G 187
               Q     +L+ EY P G +  HL                   +   A+         
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLS-------------KEGRFSEERARFYAAEIVLA 105

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L +LHSL   ++++D K  N+L+D D   K+ D GL   L        +   T +  +LA
Sbjct: 106 LEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE--YLA 161

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            EV   + + +  D +S GV L E+++G+
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.5 bits (131), Expect = 1e-08
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 22/201 (10%)

Query: 82  KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLL 136
           + ++G G  G VYK   L    ++A+K  P   T E     + E+  L       ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 137 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           G +  EN +  +  E++  GS+ ++   P  V  +         IA+   KGL +L SL 
Sbjct: 66  GAFFVENRIS-ICTEFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYLWSL- 114

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
            +++H+D K +N+LV+     K+ D G+   L    V   +        ++A E     +
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQ 169

Query: 256 FSEKSDVYSFGVFLLELVSGR 276
           +   SDV+S G+  +EL  GR
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASEVK 251
           S   +V+H+D K+ N+L+  D   K+ D G   F  + T      S +     ++A EV 
Sbjct: 134 S--NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             + +  K D++S G+  +E++ G
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 27/231 (11%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           R +V+L    +  +   L+   +  G +  H+Y    +     E    +  A     GL 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLE 116

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 245
            LH    R+V++D K  N+L+D+    +++D GL        V  P  Q     +    +
Sbjct: 117 DLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGY 167

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
           +A EV +  R++   D ++ G  L E+++G+           ++ VE ++K
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 32/228 (14%)

Query: 85  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +  V+KG   L +  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 14  LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSP 196
               +    L++EY+      +  Y     +   +   H + I L    +GLA+ H    
Sbjct: 72  IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCHR--R 123

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKE 252
           +V+H+D K  N+L++E    K+AD GL            +  VT      ++ L S    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS--- 180

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELMIKCMG 299
              +S + D++  G    E+ SGR     L P S+ +D + L+ + +G
Sbjct: 181 --EYSTQIDMWGVGCIFFEMASGR----PLFPGSTVEDELHLIFRLLG 222

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.0 bits (129), Expect = 2e-08
 Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G V+  + +  G  VAIK+      P +E I +E+  +  +++ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  F++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASEVK 251
           +   +V+H+D K+ NVL+  D   K+ D G   F  + T      S +     ++A EV 
Sbjct: 133 A--NQVIHRDIKSDNVLLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             + +  K D++S G+  +E+V G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 34/211 (16%)

Query: 85  IGEGKFGEVY---KGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTL 135
           I +G +G V+   K    D  + AIK    A         + + E   L+  Q   +V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 136 L-GYCQENNLQFLIYEYIPNGSVS--IHLYG--PSQVSRQKLEFKHRLSIALGAAKGLAH 190
              +  + NL +L+ EY+P G ++  +   G     V+R  +       I L     L +
Sbjct: 59  YYSFQGKKNL-YLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEY 108

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 244
           LHS    ++H+D K  N+L+D +   K+ D GL      R  +   D      ++     
Sbjct: 109 LHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           ++A EV   +  S+  D +S G  L E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G FG V+     +DG  VA+KK P         +    E+  L   +H N+++ L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            Q  ++      Y+    +   L+    VS Q L   H         +GL +LHS    +
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHVKVFLYQILRGLKYLHS--AGI 124

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---------ADEIFLASE 249
           +H+D K  N+LV+ + + K+ D G    L R +    S  +T         A EI + S 
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFG----LARVEEPDESKHMTQEVVTQYYRAPEILMGS- 179

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR---EASS 280
               R ++   D++S G    EL+  R   +A S
Sbjct: 180 ----RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 49/169 (28%), Positives = 70/169 (41%), Gaps = 48/169 (28%)

Query: 85  IGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTL 135
           IG G +G VYK   +   DG   AIKK  G         Q    E+  L  ++H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 136 LGYCQENNLQ--FLIYEYIP------------NGSVSIHLYGPSQVSR---QKLEFKHRL 178
           +    E+  +  +L+++Y                 VSI    PS V     Q L      
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP---PSMVKSLLWQILN----- 119

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL 223
                   G+ +LH  S  V+H+D K AN+LV     E  + K+ D GL
Sbjct: 120 --------GVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 41/211 (19%)

Query: 85  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +  VYKG   L D  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71

Query: 138 YCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
                    L++EY+         +   SI+++       Q L             +GL 
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL-------------RGLN 118

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIF 245
           + H    +V+H+D K  N+L++E    K+AD GL            +  VT      +I 
Sbjct: 119 YCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           L S       +S + D++  G    E+ +GR
Sbjct: 177 LGST-----DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 58/260 (22%), Positives = 108/260 (41%), Gaps = 50/260 (19%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-----APTQEFIDEVCFLASIQH 129
           F+   ++G+G+FG V +  L+        VA+K         +  +EF+ E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 130 RNLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHR 177
            N++ L+G    +  +       +I  ++ +G +   L        P  +  Q L     
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGP 235
           +   +  A G+ +L S     +H+D    N +++E+    VAD GL   +   D    G 
Sbjct: 116 VRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-------GREASSSLS----- 283
           +S++    + L S       ++  SDV++FGV + E+++       G E S   +     
Sbjct: 174 ASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231

Query: 284 ------PDSSQDLVELMIKC 297
                 PD  +D+ ELM +C
Sbjct: 232 NRLKQPPDCLEDVYELMCQC 251

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRN 131
             + + + IGEG +G V        G+ VAIKK      Q F    + E+  L   +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 132 LVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           ++ +L   +  + +     +++ E +        LY    +  Q L   H         +
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET-----DLY--KLIKTQHLSNDHIQYFLYQILR 117

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----- 240
           GL ++HS +  V+H+D K +N+L++ +   K+ D GL R      D    +  +T     
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD---HTGFLTEYVAT 172

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A EI L S     + +++  D++S G  L E++S R
Sbjct: 173 RWYRAPEIMLNS-----KGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 31/222 (13%)

Query: 84  LIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           ++G+G FG+V+    KG  Q   + A+KK       +     +++     + +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q     F + EY+  G +  H+      S  K +       A     GL  LHS  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQVTADEIFLASEVK 251
             +V++D K  N+L+D D   K+AD G+   N LG  +T     +    A EI L     
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG---- 170

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
             ++++   D +SFGV L E++ G+      SP    D  EL
Sbjct: 171 --QKYNTSVDWWSFGVLLYEMLIGQ------SPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 56/241 (23%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGL 188
                   +E N  +L+           HL G    + V  QKL   H   +     +GL
Sbjct: 84  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---- 244
            ++HS    ++H+D K +N+ V+ED   K+ D GL             ++ T DE+    
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGL-------------ARHTDDEMTGYV 178

Query: 245 ----FLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELMIKCM 298
               + A E+   +  +++  D++S G  + EL++GR    +L P +   D ++L+++ +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQLKLILRLV 234

Query: 299 G 299
           G
Sbjct: 235 G 235

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 29/146 (19%)

Query: 180 IALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAG 234
           IA+   K L +LHS LS  V+H+D K +NVL++ +   K+ D G    L + + +T  AG
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR------------------ 276
               +  + I      K +     KSDV+S G+ ++EL +GR                  
Sbjct: 166 CKPYMAPERINPELNQKGY---DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Query: 277 EASSSLSPDS-SQDLVELMIKCMGKE 301
           E S  L  +  S +  + + KC+ K 
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKN 248

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 75  ATKNFSD---KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLAS 126
           A K+ S+    N IG G  G VYK + +  G L A+K   G       ++   E+  L  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 127 IQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQ----VSRQKLEFKHRLSIA 181
           + H N+V     +     +Q L+ E++  GS+        Q    V+RQ L         
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVARQILS-------- 179

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-----DVAGPS 236
                G+A+LH     +VH+D K +N+L++     K+AD G+   L +T        G  
Sbjct: 180 -----GIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           + ++ + I   +++          D++S GV +LE   GR
Sbjct: 233 AYMSPERI--NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 3/155 (1%)

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  LA+  H  +V      + ++   LI EY   G ++  +    Q  ++ L F+    
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYEV 171

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
             L     LA     S +++H+D K+AN+ +    I K+ D G       +     +S  
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +LA E+ E +R+S+K+D++S GV L EL++
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 19/209 (9%)

Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81

Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           H+N++ LL  +  + +L+     YI    +  +L    QV + +L+ +    +      G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 138

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + HLHS    ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 139 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            EV     + E  D++S G  + E++ G 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V     +  G  VA+KK   R     +   +EV  +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
             +  +++ E++  G+++        V+  ++  +   ++ L   + L++LH+    V+H
Sbjct: 90  VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VIH 141

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 259
           +D K+ ++L+  D   K++D G   F  +     P  + +     ++A EV     +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 260 SDVYSFGVFLLELVSG 275
            D++S G+ ++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 30/227 (13%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  V+KG  +    LVA+K+       GAP    I EV  L +++H N+VTL   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSPR 197
                   L++EY+ +  +  +L          L   H + I +    +GL++ H    +
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH--KRK 123

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 253
           ++H+D K  N+L++E    K+AD GL            +  VT      ++ L S     
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST---- 179

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELMIKCMG 299
             +S   D++  G  L E+ +GR     + P S+ ++ + L+ + +G
Sbjct: 180 -EYSTPIDMWGVGCILYEMATGR----PMFPGSTVKEELHLIFRLLG 221

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 7e-07
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L     VAIKK  RP       +    E+  +  + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           H+N+++LL  +  + +L+     Y+    +  +L    QV + +L+ +    +      G
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 131

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + HLHS    ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 132 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 186

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELV 273
            EV     + E  D++S G  + E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.7 bits (118), Expect = 7e-07
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 84  LIGEGKFGEV----------YKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 133
           L+G+G FG+V          Y  +      V I K   A T   + E   L + +H  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHPFLT 58

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHL 191
           +L    Q  +    + EY+  G +  HL      SR+++ F    +   GA     L +L
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHL------SRERV-FSEDRTRFYGAEIVSALDYL 111

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           HS   ++V++D K  N+++D+D   K+ D GL    G TD A   +     E +LA EV 
Sbjct: 112 HS--GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPE-YLAPEVL 167

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR 276
           E   +    D +  GV + E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.3 bits (117), Expect = 8e-07
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V     +  G  VA+K    R     +   +EV  +   QH+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
                +++ E++  G+++        VS+ +L  +   ++     + L +LHS    V+H
Sbjct: 89  VGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG--VIH 140

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           +D K+ ++L+  D   K++D G    + + DV    S V     ++A EV     +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198

Query: 261 DVYSFGVFLLELVSGREASSSLSP 284
           D++S G+ ++E+V G     S SP
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)

Query: 84  LIGEGKFGEVY---KGLLQD-GMLVAIKKRPGAPTQEFIDEV------CFLASIQHRNLV 133
           ++G+G FG+V+   K    D G L A+K    A T +  D V        LA + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L    Q     +LI +++  G +   L      + + ++F +   +AL     L HLHS
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALA----LDHLHS 116

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           L   ++++D K  N+L+DE+   K+ D GL       +    S   T +  ++A EV   
Sbjct: 117 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE--YMAPEVVNR 172

Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
           R  ++ +D +SFGV + E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLV 133
              +   IGEG  G V        G  VA+KK   R     +   +EV  +   QH N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            +       +  +++ E++  G+++        V+  ++  +   ++ L   K L+ LH+
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKE 252
               V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A EV  
Sbjct: 134 --QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 253 FRRFSEKSDVYSFGVFLLELVSG 275
              +  + D++S G+ ++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 34/212 (16%)

Query: 85  IGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFL---ASIQHRNLV 133
           IGEG +G+V+K   L   G  VA+K+        G P    I EV  L    + +H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 67

Query: 134 TLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
            L   C      +E  L  L++E++ +  ++ +L    +V    +  +    +     +G
Sbjct: 68  RLFDVCTVSRTDRETKLT-LVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRG 122

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR---NFLGRTDVAGPSSQVTADEI 244
           L  LHS   RVVH+D K  N+LV      K+AD GL    +F         +    A E+
Sbjct: 123 LDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            L S       ++   D++S G    E+   +
Sbjct: 181 LLQSS------YATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FGEV    ++  G L A        +KKR G   +  + E   LA +  R +V+L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG--YEGAMVEKRILAKVHSRFIVSL 58

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 193
               Q      L+   +  G +  H+Y    V  +   F    +    A    GL HLH 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIY---NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVK 251
              R++++D K  NVL+D D   +++D GL   L  G++   G +        F+A E+ 
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG----FMAPELL 169

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR 276
           +   +    D ++ GV L E+++ R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHR 130
           +F     +G G FG V    +KG  +   +  +KKR        Q    E   L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA- 189
            +V ++   Q+ N  + + E++  G +  HL       R+   F + ++    A   LA 
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYHAELVLAF 131

Query: 190 -HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +LHS    ++++D K  N+L+D     KV D G   F  +  V   +  +     +LA 
Sbjct: 132 EYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFG---FAKK--VPDRTFTLCGTPEYLAP 184

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           EV + +   +  D ++ GV L E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 38/244 (15%)

Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 133
             K++   N+IG G FG VY+ +  D    VAIKK    P Q    E+  + ++ H N++
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINII 122

Query: 134 TLLGY----CQENNLQ--FL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--- 182
            L  Y    C + N +  FL  + E+IP    ++H Y     +R      H L + L   
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ---TVHKY-MKHYARN----NHALPLFLVKL 174

Query: 183 ---GAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG-LRNFL-GRTDVAGPS 236
                 + LA++H  S  + H+D K  N+L+D +    K+ D G  +N L G+  V+   
Sbjct: 175 YSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Query: 237 SQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMI 295
           S+   A E+ L +       ++   D++S G  + E++ G       S  SS D +  +I
Sbjct: 233 SRFYRAPELMLGAT-----NYTTHIDLWSLGCIIAEMILGYPI---FSGQSSVDQLVRII 284

Query: 296 KCMG 299
           + +G
Sbjct: 285 QVLG 288

Length = 440

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 26/216 (12%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQD---GMLVAIK--KRPGAPTQE---FIDEVCFLASIQ 128
           K+F  K+L+G G FGEV   ++++   G + A+K  K+     QE   F +E   + SI 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 129 HRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +   +  L Y  Q+ +  +L+ EY P G +       S ++R + +F   ++    A   
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL------SLLNRYEDQFDEDMAQFYLAELV 112

Query: 188 LAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
           LA +HS+     VH+D K  NVL+D     K+AD G    L    +      V   + ++
Sbjct: 113 LA-IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD-YI 170

Query: 247 ASEVKEFRRFSEKS------DVYSFGVFLLELVSGR 276
           A EV        K       D +S GV   E++ GR
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 36/248 (14%)

Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY------------ 94
           P+++  +N+   LS  E    ++ +L +  ++F    +IG G FGEV             
Sbjct: 13  PALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYA 72

Query: 95  -KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 153
            K L +  M+    KR  +    F +E   +A      +V L    Q++   +++ EY+P
Sbjct: 73  MKLLSKFEMI----KRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126

Query: 154 NGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 212
            G + ++L     +  +   F    + +AL A      +HS+    +H+D K  N+L+D+
Sbjct: 127 GGDL-VNLMSNYDIPEKWARFYTAEVVLALDA------IHSMG--FIHRDVKPDNMLLDK 177

Query: 213 DFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRR----FSEKSDVYSFGV 267
               K+AD G    +    +    + V T D  +++ EV + +     +  + D +S GV
Sbjct: 178 SGHLKLADFGTCMKMDANGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 268 FLLELVSG 275
           FL E++ G
Sbjct: 236 FLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 25/162 (15%)

Query: 138 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 193
           +C  Q     F + EY+  G +  H+       +    F    +    A    GL  LH 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVK 251
               ++++D K  NVL+D+D   K+AD G+   N  G     G +S       ++A E+ 
Sbjct: 115 KG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKASTFCGTPDYIAPEIL 168

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
           + ++++E  D +SFGV L E++ G+      SP   +D  EL
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ------SPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 33/214 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           + +V L    +  +   L+   +  G +  H+Y    +     E +  L  A     GL 
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEILCGLE 116

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVTAD 242
            LH      V++D K  N+L+D+    +++D GL        +  GR    G        
Sbjct: 117 DLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG-------- 166

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++A EV   +R++   D +  G  + E++ G+
Sbjct: 167 --YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 84  LIGEGKFGEVYKGLLQD---GMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRN 131
           L+G+G FG+V   L+++   G   A+K         K   A T   + E   L + +H  
Sbjct: 2   LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPF 56

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 189
           L  L    Q ++    + EY   G +  HL      SR+++ F    +   GA     L 
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHL------SRERV-FTEERARFYGAEIVSALE 109

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS    VV++D K  N+++D+D   K+ D GL    G +D A   +     E +LA E
Sbjct: 110 YLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAPE 165

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR 276
           V E   +    D +  GV + E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 36/209 (17%)

Query: 85  IGEGKFGEV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLA--SI 127
           +G G FG+V    YK     G L AIK    A  +  I   DEV         F    S 
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIK----ALKKGDIIARDEVESLMCEKRIFETANSE 59

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +H  LV L    Q  +    + EY   G + +H++     S  +  F      A     G
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVF-----YAACVVLG 113

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFL 246
           L +LH    ++V++D K  N+L+D +   K+AD GL +  +G  D    +S       FL
Sbjct: 114 LQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           A EV     ++   D +  GV + E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 63/251 (25%), Positives = 91/251 (36%), Gaps = 63/251 (25%)

Query: 84  LIGEGKFGEVYKGLL---QDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNL 132
           +IG G FGEV+  L+     G + A+K        KR          E   LA      +
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRN--QIAHVRAERDILADADSPWI 63

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAH 190
           V L    Q+    +L+ EY+P G +   L     + +     +  R  IA L  A  L  
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMNLL-----IRKDVFPEETARFYIAELVLA--LDS 116

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------------------RNFLGRTD 231
           +H L    +H+D K  N+L+D D   K+AD GL                     F     
Sbjct: 117 VHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 232 VAGPSSQV----------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 281
           V     +           T D  ++A EV     +  + D +S GV L E++ G      
Sbjct: 175 VRRRDHKQRRVRANSTVGTPD--YIAPEVLRGTPYGLECDWWSLGVILYEMLYGF----- 227

Query: 282 LSPDSSQDLVE 292
             P  S  L E
Sbjct: 228 -PPFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 31/101 (30%), Positives = 58/101 (57%), Gaps = 13/101 (12%)

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGP 235
           IA+   +GL +L+++  R++H+D K +N+LV+     K+ D G    L N +  T V G 
Sbjct: 108 IAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-GT 165

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           S+       +++ E  +  +++ KSDV+S G+ ++EL  G+
Sbjct: 166 ST-------YMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 84  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           +IG+G FG+V     + +    A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q  +  + + +YI  G +  HL    Q  R  LE + R   A   A  L +LHSL+
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARF-YAAEIASALGYLHSLN 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             +V++D K  N+L+D      + D GL       +  G +S       +LA EV   + 
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
           +    D +  G  L E++ G      L P  S++  E+    + K
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG------LPPFYSRNTAEMYDNILNK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 44/160 (27%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  VYKG  +  G LVA+K+       GAP    I E   L  ++H N+VTL   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA-IREASLLKDLKHANIVTLHDI 71

Query: 139 CQENNLQFLIYEYI-----------PNG----SVSIHLYGPSQVSRQKLEFKHRLSIALG 183
                   L++EY+             G    +V + L+   Q+ R              
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF---QLLR-------------- 114

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
              GLA+ H    RV+H+D K  N+L+ E    K+AD GL
Sbjct: 115 ---GLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 47/221 (21%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLV----------AIKKRPGAPTQEFIDEVCFLASI 127
           +F    +IG+G FG+V     +D   +           ++K      +  ++E   L  +
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS---VRNVLNERRILQEL 57

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIALGA 184
            H  LV L    Q+    +L+ + +  G +  HL        QK++F     +  I    
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFSEEQVKFWIC-EI 109

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
              L +LHS    ++H+D K  N+L+DE     + D  +            +++VT D +
Sbjct: 110 VLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI------------ATKVTPDTL 155

Query: 245 ---------FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                    ++A EV   + +S   D +S GV   E + G+
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 22/119 (18%)

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF--------LGRTDVAGPSSQV 239
           LA  H  S  ++H+D K+AN+L+  + + K+ D G            +GRT    P    
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP---- 209

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM 298
                ++A E+   + +S+K+D++S GV L EL++ +       P   +++ E+M K +
Sbjct: 210 ----YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR------PFDGENMEEVMHKTL 258

Length = 496

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 15/206 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQHR 130
           K +     IG G  G V        G+ VA+KK  RP       +    E+  L  + H+
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 131 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           N+++LL  +  + +L+     Y+    +  +L    QV   +L+ +    +      G+ 
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQMLCGIK 137

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           HLHS    ++H+D K +N++V  D   K+ D GL        +  P         + A E
Sbjct: 138 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP---YVVTRYYRAPE 192

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V     + E  D++S G  + ELV G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 34/155 (21%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQ-------HRNLVT 134
           IGEG F EV K    + G   AIK       + F  +++V  L  IQ       H N++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 135 LLGYCQENNLQFLIYEYIPNGSVS-------IHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           L+          ++++    G ++       ++LY   +  ++ L  K   S      K 
Sbjct: 63  LIE---------VLFD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
           L H+H     + H+D K  N+L+ +D I K+AD G
Sbjct: 113 LDHMHRNG--IFHRDIKPENILIKDD-ILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 55/246 (22%), Positives = 113/246 (45%), Gaps = 32/246 (13%)

Query: 47  PSVQPGRNVG-----IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY------- 94
           P+++  +N+       E  +R+ R+ QM+      +++    +IG G FGEV        
Sbjct: 13  PALRKNKNIDNFLNRYEKIVRKIRKLQMK-----AEDYDVVKVIGRGAFGEVQLVRHKSS 67

Query: 95  KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 154
           + +    +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P 
Sbjct: 68  QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127

Query: 155 GSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 213
           G + ++L     V  +  +F    + +AL A      +HS+   ++H+D K  N+L+D+ 
Sbjct: 128 GDL-VNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG--LIHRDVKPDNMLLDKH 178

Query: 214 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFL 269
              K+AD G    +  T +    + V   + +++ EV + +     +  + D +S GVFL
Sbjct: 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 270 LELVSG 275
            E++ G
Sbjct: 238 FEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           LV L    Q  +  FL+ EY+  G +  H+       ++KL  +H    A      L  L
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFL 112

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 250
           H     ++++D K  NVL+D D   K+ D G+ +  LG  D    +S       ++A E+
Sbjct: 113 HERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEI 167

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
                +    D ++ GV + E+++GR
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 36/159 (22%)

Query: 132 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGL 188
            +T L  C Q  +  + + EY+  G +   +    QV R    FK  H +  A   A GL
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGR----FKEPHAVFYAAEIAIGL 114

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSS 237
             LHS    ++++D K  NV++D +   K+AD G+           + F G  D      
Sbjct: 115 FFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD------ 166

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  ++A E+  ++ + +  D ++FGV L E+++G+
Sbjct: 167 -------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 29/118 (24%), Positives = 58/118 (49%), Gaps = 16/118 (13%)

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
             ++ ++ L  +  +S +   A+G+  L S   + +H+D    N+L+ E+ + K+ D GL
Sbjct: 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGL 219

Query: 224 R-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                   +++ + D   P   +  + IF        + ++ +SDV+SFGV L E+ S
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIF-------DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 21/204 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 137
           IG G FG+V    +     VA      +K    +  Q EF+ +      +QH N++  LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLS 195
            C E     L++EY   G +  +L       R  Q L  +    +A   A G+ H+H  +
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKHN 119

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE-VKEFR 254
              +H D    N  +  D   KV D G+     + D             +LA E V EF 
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 255 ------RFSEKSDVYSFGVFLLEL 272
                   ++ S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 21/230 (9%)

Query: 74  LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           L   +F   + +G G  G V+K      GL+    L+ ++ +P    Q  I E+  L   
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
               +V   G    +    +  E++  GS+   L    ++  Q L    ++SIA+   KG
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSIAV--IKG 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L +L     +++H+D K +N+LV+     K+ D G+   L    +   ++       +++
Sbjct: 116 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKC 297
            E  +   +S +SD++S G+ L+E+  GR     + P  +++L ELM  C
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR---YPIPPPDAKEL-ELMFGC 216

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.0 bits (109), Expect = 9e-06
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 85  IGEGKFGEVYKGL---LQDG--------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 133
           +G+G F +++KG+   + D         +L  + K     ++ F +    ++ + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LH 192
              G C   +   ++ EY+  GS+  +L        +K +    +S  L  AK LA  LH
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--------KKNKNLINISWKLEVAKQLAWALH 114

Query: 193 SLSPR-VVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 246
            L  + + H +    NVL+  +ED        G   F+  +D  G S  V   EI L   
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREED-----RKTGNPPFIKLSD-PGISITVLPKEILLERI 168

Query: 247 ---ASE-VKEFRRFSEKSDVYSFGVFLLELVSG 275
                E ++  +  S  +D +SFG  L E+ SG
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FGEV    +++ G + A        +KK+ G        E+  L  +    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 136 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             Y  E+     L+   +  G +  H+Y    V  + LE +  +  +     G+ HLHS+
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSSQVTADEIFLASEVKE 252
              +V++D K  NVL+D+    +++D GL       ++      +Q      ++A E+ +
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGL-----AVELKDGKTITQRAGTNGYMAPEILK 167

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
              +S   D ++ G  + E+V+GR
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 38/189 (20%), Positives = 77/189 (40%), Gaps = 37/189 (19%)

Query: 104 VAIKKRPGAPTQEFID---------EVCFLASIQHRNLVTLLGYCQENNLQFLI------ 148
           V +  +PG P    +          E   L ++ H +++ +        +  ++      
Sbjct: 82  VFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141

Query: 149 --YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 206
             Y Y+   S  + +     + +Q LE             GL +LH+   R++H+D KT 
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILE-------------GLRYLHAQ--RIIHRDVKTE 186

Query: 207 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEFRRFSEKSDVYSF 265
           N+ +++     + D G   F     V  P+    A  +   A EV    +++ K+D++S 
Sbjct: 187 NIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA 242

Query: 266 GVFLLELVS 274
           G+ L E+++
Sbjct: 243 GIVLFEMLA 251

Length = 357

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 25/227 (11%)

Query: 84  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           +IG+G FG+V     + DG   A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q     + + +++  G +  HL    Q  R   E + R   A   A  L +LHS+ 
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLHSI- 115

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             +V++D K  N+L+D      + D GL +  + ++D    ++       +LA EV   +
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIRKQ 171

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKE 301
            +    D +  G  L E++ G      L P   +D+ E+    + K 
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG------LPPFYCRDVAEMYDNILHKP 212

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 33/214 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAP---TQEFIDEVCFLASIQHRNL 132
           + D   +G G +G V   L  + G  VAIKK  RP       +    E+  L  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 133 VTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           + LL  +  + +L      +L+  ++  G+    L    ++S  +++F     +     K
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF-----LVYQMLK 129

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----AD 242
           GL ++H+    ++H+D K  N+ V+ED   K+ D GL     +TD       VT    A 
Sbjct: 130 GLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           E+ L      +  +++  D++S G  + E+++G+
Sbjct: 185 EVIL-----NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  VYKG+ + +G LVA+K        G P    I E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGLKHANIVLLHDI 71

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-FKHRLSIALGAAKGLAHLHSLSPR 197
                    ++EY+        +  P  +    +  F  +L       +GLA++H     
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------LRGLAYIHG--QH 123

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 252
           ++H+D K  N+L+      K+AD GL            S  VT      D +  A++   
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD--- 180

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLS 283
              +S   D++  G   +E++ G+ A   +S
Sbjct: 181 ---YSSALDIWGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 16/198 (8%)

Query: 84  LIGEGKFGE--VYKGLLQDGMLVAIKKR---PGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           ++GEG FG   + + +  D      + R     +  ++   E   LA ++H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSLSP 196
            + +   +++ EY   G     L    ++ R KL F     L   +    G+ H+H    
Sbjct: 67  FEADGHLYIVMEYCDGGD----LMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHE--K 119

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           RV+H+D K+ N+ + ++   K+ D G    L  T     +        ++  E+ E   +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPY 177

Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSD++S G  L EL +
Sbjct: 178 NNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 29/161 (18%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-------------EVCFLASIQHR 130
           IGEG +G V+K   ++ G +VAIKK        F++             E+  L  ++H 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK--------FVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           NLV L+   +      L++EY  +  ++     P  V    ++      I     + +  
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNF 115

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
            H  +   +H+D K  N+L+ +    K+ D G    L    
Sbjct: 116 CHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 74  LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           L   +F   + +G G  G V K      GL+    L+ ++ +P    Q  I E+  L   
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
               +V   G    +    +  E++  GS+   L    +  R   E   ++SIA+   +G
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAV--LRG 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           LA+L     +++H+D K +N+LV+     K+ D G+   L    +   ++       +++
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            E  +   +S +SD++S G+ L+EL  GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 37/216 (17%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKG 187
           R +V+L    +  +   L+   +  G +  H+Y  G      ++  F      A     G
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCG 114

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVT 240
           L  LH    R+V++D K  N+L+D+    +++D GL           GR    G      
Sbjct: 115 LEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG------ 166

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               ++A EV +  R++   D +  G  + E++ G+
Sbjct: 167 ----YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 40/218 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK--RPGAPT---QEFIDEVCFLASIQH 129
           T  + D   +G G FG V     Q  G  VAIKK  +P +     +    E+  L  ++H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 130 RNLVTLLG-YCQENNLQFLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKG 187
            N+++L   +       + + E +      +H L     + +Q +++           +G
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-----FLYQILRG 120

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT------- 240
           L ++HS    VVH+D K +N+L++E+   K+ D GL              Q+T       
Sbjct: 121 LKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI--------QDPQMTGYVSTRY 170

Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A EI L      ++++  + D++S G    E++ G+
Sbjct: 171 YRAPEIMLT-----WQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 25/225 (11%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  VYKG  + +G LVA+K     +  G P    I E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDI 71

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
                   L++EY+           P  +  + ++            +GL+++H     +
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-----FLFQLLRGLSYIHQ--RYI 124

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 254
           +H+D K  N+L+ +    K+AD GL            +  VT      ++ L S      
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST----- 179

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG 299
            +S   D++  G   +E++ G  A   +     QD +E +   +G
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLG 222

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 15/172 (8%)

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           F  +  H  LV L    Q  +  F + EY+  G +  H+       ++KL  +H    + 
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSA 103

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 241
             +  L +LH     ++++D K  NVL+D +   K+ D G+ +  L   D    +S    
Sbjct: 104 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 158

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQD 289
              ++A E+     +    D ++ GV + E+++GR       SS +PD + +
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 33/221 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEV-----CFLASIQHRNLVTLLGY 138
           IG+G +G+V+K L  ++G   A+K     P  +  +E+        A   H N+V   G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 139 CQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKG 187
             + +++     +L+ E    GSV+        + +  L+   R+       I   A  G
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVT-------DLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADE 243
           L HLH    + +H+D K  N+L+  +   K+ D G+   L  T +   +S  T    A E
Sbjct: 137 LQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
           + +A E +    +  + DV+S G+  +EL  G    + L P
Sbjct: 195 V-IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QE--FIDEVCFLASIQH 129
            +F     +G G FG V     +  G   A+K    A      Q    ++E   L SI+H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             LV L G  Q+++  +L+ EY+P G +  HL         +         A      L 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-----RKSGRFPEPVARFYAAQVVLALE 115

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRT-DVAGPSSQVTADEIFLA 247
           +LHSL   +V++D K  N+L+D D   K+ D G    + GRT  + G     T +  +LA
Sbjct: 116 YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG-----TPE--YLA 166

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            E+   + + +  D ++ G+ + E+++G
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 31/148 (20%)

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           LS     A+G+  L   S   VH+D    NVL+ +  I K+ D GL       D+   S+
Sbjct: 240 LSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSN 292

Query: 238 QVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-------GREASSSL--- 282
            V+    FL     A E      ++  SDV+S+G+ L E+ S       G    S+    
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352

Query: 283 --------SPD-SSQDLVELMIKCMGKE 301
                    PD ++Q++ ++M+KC   E
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSE 380

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 25/211 (11%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVC-------FLASIQHRNLVTLL 136
           +G+G +G+V+    +D G +VA+K R        ++EV         L + +   LV LL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLS 195
              Q++   +L  EY+P G     L     +S     F    +  A+ A      LH L 
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA------LHELG 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
              +H+D K  N L+D     K+ D GL +  +   +     S V + + ++A EV   +
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPD-YMAPEVLRGK 173

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPD 285
            +    D +S G  L E + G    S  +P+
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 59/223 (26%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK--RPGAPTQEFID------EVCFLASIQHRNLV 133
           + +G G +G+V        G  VAIKK  RP    Q  I       E+  L  + H N++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVI 77

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS--------IHLYGP--SQVSR-QKLEFKHRLSIAL 182
            LL              + P  S+          HL G   + + + QKL   H   +  
Sbjct: 78  GLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY 125

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
              +GL ++HS    ++H+D K +N+ V+ED   K+ D GL             ++ T D
Sbjct: 126 QILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGL-------------ARHTDD 170

Query: 243 EI--------FLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+        + A E+   +  +++  D++S G  + EL++G+
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 24/219 (10%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIK-------KRPGAPTQEFIDEVCF-LASIQHRNLVT 134
           +IG G FGEVY     D G + A+K       K     T    + +   L S      + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 135 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            + Y     + L F I + +  G +  HL      S  ++ F +   I LG    L H+H
Sbjct: 61  CMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILG----LEHMH 114

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 251
           +    VV++D K AN+L+DE    +++D GL     +     P + V     ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 290
           +   +   +D +S G  L +L+ G             ++
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 52/242 (21%), Positives = 108/242 (44%), Gaps = 24/242 (9%)

Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   L+  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 13  PALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 72

Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 73  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 131

Query: 160 HLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 218
           +L     V  +   F    + +AL A      +HS+    +H+D K  N+L+D+    K+
Sbjct: 132 NLMSNYDVPEKWARFYTAEVVLALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKL 183

Query: 219 ADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
           AD G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++
Sbjct: 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEML 241

Query: 274 SG 275
            G
Sbjct: 242 VG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 23/218 (10%)

Query: 84  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           +IG+G FG+V     + DG   A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q     + + +Y+  G +  HL    Q  R  LE + R   A   A  + +LHSL+
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARF-YAAEVASAIGYLHSLN 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             ++++D K  N+L+D      + D GL       +    +S       +LA EV     
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
           +    D +  G  L E++ G      L P  S+D+ ++
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG------LPPFYSRDVSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)

Query: 138 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           YC  Q     F + E++  G +  H+    +    +  F      A     GL  LHS  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSKG 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
             ++++D K  NV++D D   K+AD G+   N  G       +S       ++A E+ + 
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFCGTPDYIAPEILQG 170

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
            +++   D +SFGV L E++ G+   S    D   +L E
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ---SPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 79  FSDKNLI---GEGKFGEVYKGLLQDGML--VAIKK--RPGAPTQEFIDEVC----FLASI 127
           + D N I   G G FG V     ++     VAIK+  +     Q+ +D V      L  I
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
            H   V L G  ++ +  +L+ E++  G     L       R+   F + +     A   
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFYAAQIV 141

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 246
           L   +  S  +V++D K  N+L+D+D   K+ D G    +  RT     + +  A EI L
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL 201

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                      + +D ++ G+F+ E++ G
Sbjct: 202 NVG------HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 31/128 (24%), Positives = 56/128 (43%), Gaps = 27/128 (21%)

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----GRTDVAGPSSQVTADEIFLASEVKEF 253
           V+H+D K +N+L+D     K+ D G+   L     +T  AG ++ +  + I         
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI---DPPDPN 192

Query: 254 RRFSEKSDVYSFGVFLLELVSGR------------------EASSSLSPDS--SQDLVEL 293
            ++  ++DV+S G+ L+EL +G+                  E   SL P+   S D    
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252

Query: 294 MIKCMGKE 301
           +  C+ K+
Sbjct: 253 VDLCLTKD 260

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 16/200 (8%)

Query: 84  LIGEGKFGEVYKGLLQDGM-LVAIKKRPGAPTQEFIDEVCF-----LASIQHRNLVTLLG 137
           ++GEG +G V K   ++   +VAIKK   +   E + E        L +++  N+V L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
             +     +L++EY+    + +    P+ V  +K+      S      K +   H     
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHK--ND 120

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           +VH+D K  N+L+  + + K+ D G  RN    ++     ++  A   + + E+     +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELLLGAPY 178

Query: 257 SEKSDVYSFGVFLLELVSGR 276
            +  D++S G  L EL  G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 35/144 (24%)

Query: 146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHSLSPRVVHKDF 203
           + + EY+  G +  H+    QV +    FK  H +  A   A GL  LHS    ++++D 
Sbjct: 77  YFVMEYVNGGDLMYHI---QQVGK----FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDL 127

Query: 204 KTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           K  NV++D +   K+AD G+           R F G  D             ++A E+  
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD-------------YIAPEIIA 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
           ++ + +  D ++FGV L E+++G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 16/119 (13%)

Query: 163 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
               + ++ L  +  +  +   AKG+  L   S + +H+D    N+L+ E+ + K+ D G
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFG 224

Query: 223 LR-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L        +++ + D   P   +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 225 LARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLV 133
           + ++    +G G +G V   +  + G  VAIKK  RP      F  E+   A   +R L 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP------FQSEI--FAKRAYREL- 65

Query: 134 TLLGYCQENNLQFLIYEYIP----NGSVSIHLYGP-SQVSRQKLEFKHRLS------IAL 182
           TLL + Q  N+  L+  +      +     +L  P  Q   QK+   H LS      +  
Sbjct: 66  TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVY 124

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
               GL ++HS    ++H+D K  N+ V+ED   K+ D GL       D       VT  
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW 179

Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A E+ L      +  +++  D++S G  + E+++G+
Sbjct: 180 YRAPEVIL-----NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)

Query: 84  LIGEGKFGEVYKGLLQD---GMLVAIKKRPGAPTQEFI---DEVC-------FLASIQHR 130
           L+G+G FG+V   L+++   G   A+K       +E I   DEV         L + +H 
Sbjct: 2   LLGKGTFGKVI--LVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGL 188
            L  L    Q ++    + EY   G +  HL      S  +  F        GA     L
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 108

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +LHS    VV++D K  N+++D+D   K+ D GL    G +D A   +     E +LA 
Sbjct: 109 GYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAP 164

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EV E   +    D +  GV + E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.0 bits (101), Expect = 8e-05
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 85  IGEGKFGEVYKGLL---QDGMLVAIKK----------RPGAPTQEFIDEVCFLASIQHRN 131
           +G+G +GEV   L+    DG    IKK          R  A       E   L+ ++H N
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAE-----QEAQLLSQLKHPN 60

Query: 132 LVTLLGYCQ-ENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKG 187
           +V      + E+ L +++  +   G +   L    G      Q +E+  ++++AL     
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL----- 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 246
             +LH     ++H+D KT NV +    I KV D G+   L  + D+A   S +     ++
Sbjct: 116 -QYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYM 169

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
           + E+   + ++ KSDV++ G  + E+ + + A
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 29/220 (13%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IG+G FG+V       DG   A+K        K+         +    L +++H  LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q  +  + + +Y+  G +  HL    Q  R   E + R   A   A  L +LHSL+
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARF-YAAEIASALGYLHSLN 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--ADEIFLASEVKEF 253
             ++++D K  N+L+D      + D G    L +  +    +  T      +LA EV   
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
           + +    D +  G  L E++ G      L P  S+D  E+
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG------LPPFYSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 45/218 (20%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASIQHRNLVTLLG- 137
           IG G +G V   +  + G  VAIKK P A   PT  +  + E+  L   +H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 138 -----------YC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
                      Y      E++L  +I+                  S Q L  +H      
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIH------------------SDQPLTEEHIRYFLY 114

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--TDVAGPSSQVT 240
              +GL ++HS    V+H+D K +N+LV+ED   ++ D G+   L    T+     ++  
Sbjct: 115 QLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 241 ADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGRE 277
           A   + A E+      ++   D++S G    E++  R+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 11/93 (11%)

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
           G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T      
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVTR 181

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + A EV     + E  D++S G  + E++ G 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 64/243 (26%), Positives = 109/243 (44%), Gaps = 34/243 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIK--------KRPGAPTQEFIDEVCFLASI 127
           ++F    +IG G FGEV    L++   + A+K        KR  A T  F +E   L + 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFREERDVLVNG 58

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA--LGAA 185
            ++ + TL    Q+ N  +L+ +Y   G +   L   S+   +  E   R  +A  + A 
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAI 115

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVT 240
             +  LH      VH+D K  N+L+D +   ++AD G     + +   ++ VA  +    
Sbjct: 116 DSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG- 299
           + EI  A E  +  ++  + D +S GV + E++ G       +P  ++ LVE   K M  
Sbjct: 171 SPEILQAMEDGK-GKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNH 223

Query: 300 KER 302
           KER
Sbjct: 224 KER 226

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 5/112 (4%)

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
           S Q L   H  S       GL ++HS +  V+H+D K  N+LV+ D   K+ D GL R F
Sbjct: 98  SGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155

Query: 227 -LGRTDVAGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
                + AG  ++  A   + A E+   F+ +++  DV+S G  L EL+  +
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 14/148 (9%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA-AKGLAH 190
           LVTL    Q +    LI +Y+  G +  HLY      R+    +  + + +      L H
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFT-ESEVRVYIAEIVLALDH 120

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASE 249
           LH L   ++++D K  N+L+D +    + D GL + FL   +    S   T +  ++A E
Sbjct: 121 LHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE--YMAPE 176

Query: 250 V--KEFRRFSEKSDVYSFGVFLLELVSG 275
           V         +  D +S GV   EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAI----KKRPGAPTQEF--IDEVCFLASIQHRN--LVT 134
           +IG G FGEVY     D G + A+    KKR      E   ++E   L+ +   +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 135 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            + Y     + L F I + +  G +  HL      S +++ F +   I L    GL H+H
Sbjct: 61  CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIIL----GLEHMH 114

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 251
           +    VV++D K AN+L+DE    +++D GL     +     P + V     ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168

Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
           +   +   +D +S G  L +L+ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLY--GPSQVSRQKLEFKHRLSIALGAAK 186
           R +V+L  Y  E      +   I NG  +  H+Y  G      Q+  F      A     
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-----YAAELCC 113

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQV 239
           GL  L     R+V++D K  N+L+D+    +++D GL           GR    G     
Sbjct: 114 GLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG----- 166

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                ++A EV    +++   D +  G  + E++ G+
Sbjct: 167 -----YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 121 VCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           V F AS ++      +  YC+  +L   + E    G         +QV     E+  +L 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQV----CEWFIQLL 116

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQ 238
           +      G+ ++H    R++H+D K  N+ +  + + K+ D G+   L G  D+A   + 
Sbjct: 117 L------GVHYMHQ--RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA---TT 164

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
            T    +++ E  + + +  KSD++S G  L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 43/220 (19%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVC------FLASIQHR 130
           +F+   ++G+G FG+V     +    L AIK        +  D  C       LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 131 NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKG 187
             +T L  C Q  +  + + EY+  G +  H+       +Q  +FK   ++   A  + G
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQAVFYAAEISVG 113

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPS 236
           L  LH     ++++D K  NV++D +   K+AD G+           R F G  D     
Sbjct: 114 LFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD----- 166

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                   ++A E+  ++ + +  D +++GV L E+++G+
Sbjct: 167 --------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 20/221 (9%)

Query: 84  LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLA-----SIQHRN-LVTLL 136
           ++G+G FG+V    L + G L A+K        +  D  C +      S+   +  +T L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 137 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
             C Q  +  F + E++  G +  H+    Q SR+  E + R   A      L  LH   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAA-EITSALMFLHDKG 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             ++++D K  NVL+D +   K+AD G+            +   T D  ++A E+ +   
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD--YIAPEILQEML 172

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
           +    D ++ GV L E++ G    +    ++  DL E ++ 
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH---APFEAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 10/100 (10%)

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
           G+  LH     ++H+D K  N+L+D+    K+ D GL RN L      G     T D  +
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG-----TPD--Y 159

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 285
           LA E        + SD +S G  + E + G     + +PD
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 36/202 (17%)

Query: 99  QDGMLVAIK-KRPGAPTQE-----FIDEVCFLASIQHRNLVTLL--GYCQENNLQFLIYE 150
             G  VAIK  R  AP +E     F  E    A + H N+V LL  G      L F ++E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59

Query: 151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA------LGAAKGLAHLHSLSPRVVHKDFK 204
           Y+P  ++           R+ L     L         L     LA  H+    +VH+D K
Sbjct: 60  YVPGRTL-----------REVLAADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLK 106

Query: 205 TANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKEFRRF 256
             N++V        AKV D G+   L     A  ++     E+     + A E       
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 257 SEKSDVYSFGVFLLELVSGREA 278
           +  SD+Y++G+  LE ++G+  
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 32/146 (21%), Positives = 54/146 (36%), Gaps = 19/146 (13%)

Query: 80  SDKNLIGEGKFGEVYKGLLQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVT--L 135
           S   L+  G    VY  LL       +           +   EV  L  +  + L    +
Sbjct: 1   SSIKLLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV 58

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           L   + +   +L+ E+I   ++             ++  + +  IA   A+ LA LH L 
Sbjct: 59  LASGESDGWSYLLMEWIEGETLD------------EVSEEEKEDIAEQLAELLAKLHQLP 106

Query: 196 PRVV-HKDFKTANVLVDEDFIAKVAD 220
             V+ H D    N+LVD+  I  + D
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIID 132

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 24/155 (15%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNLVT 134
           IG G +G VYK      G  VA+K         G P    + EV  L  ++   H N+V 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST-VREVALLKRLEAFDHPNIVR 66

Query: 135 LLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           L+  C      +E  +  L++E++ +  +  +L    +V    L  +    +     +GL
Sbjct: 67  LMDVCATSRTDRETKVT-LVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGL 121

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
             LH+    +VH+D K  N+LV      K+AD GL
Sbjct: 122 DFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 27/210 (12%)

Query: 85  IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 138
           +G G +G VYK   +DG      A+K+  G   +     E+  L  ++H N++ L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 139 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 195
              +   +L+++Y  +     I  +  S+ +++ ++    +  S+      G+ +LH  +
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--A 126

Query: 196 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 244
             V+H+D K AN+LV     E    K+AD G           L   D    +    A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            L +     R +++  D+++ G    EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 16/110 (14%)

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 224
           L+ +  LS +   AKG++ L   S   +H+D    N+L+    I K+ D GL        
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 11/146 (7%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           LVTL    Q      LI +Y+  G +  HLY     S  ++ F +   I L     L HL
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-YSGEIILA----LEHL 121

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 250
           H L   +V++D K  N+L+D +    + D GL + FL        S   T +  ++A E+
Sbjct: 122 HKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE--YMAPEI 177

Query: 251 KEFRRFSEKS-DVYSFGVFLLELVSG 275
              +    K+ D +S G+ + EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 57/245 (23%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV--TLLGYC-- 139
           IG+G FG+VY+   +D   + A+K       +E + +     +I  RN++  TLL     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV---LSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 140 --------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGAAKGLAH 190
                   Q ++  +L+ +Y+  G +  HL    + S  + +F    L +AL       H
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EH 111

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQV 239
           LH     +V++D K  N+L+D      + D GL             F G T+   P  +V
Sbjct: 112 LHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP--EV 167

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK--C 297
             DE          + +++  D +S GV + E+  G       SP  ++D  + M +   
Sbjct: 168 LLDE----------KGYTKHVDFWSLGVLVFEMCCG------WSPFYAED-TQQMYRNIA 210

Query: 298 MGKER 302
            GK R
Sbjct: 211 FGKVR 215

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 85  IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 138
           +G G +G VYK   +DG      A+K+  G   +     E+  L  ++H N+++L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 139 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 195
              +   +L+++Y  +     I  +  S+ +++ ++    +  S+      G+ +LH  +
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--A 126

Query: 196 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 244
             V+H+D K AN+LV     E    K+AD G           L   D    +    A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            L +     R +++  D+++ G    EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 29/207 (14%)

Query: 84  LIGEGKFGEVY------------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 131
           L+G+G FG+V               +L+  ++VA  +     T+  +     L + +H  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV-----LQNSRHPF 56

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 189
           L  L    Q ++    + EY   G +  HL      S  +  F        GA     L 
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALD 109

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS    VV++D K  N+++D+D   K+ D GL    G  D A   +     E +LA E
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE-YLAPE 166

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR 276
           V E   +    D +  GV + E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 33/142 (23%), Positives = 59/142 (41%), Gaps = 31/142 (21%)

Query: 146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 205
           F + EY+  G +  H+    Q S  + +       A     GL  LH     ++++D K 
Sbjct: 72  FFVMEYVNGGDLMFHI----QRSG-RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKL 124

Query: 206 ANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
            NVL+D +   K+AD G+             F G  D             ++A E+  ++
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-------------YIAPEILSYQ 171

Query: 255 RFSEKSDVYSFGVFLLELVSGR 276
            +    D ++ GV L E+++G+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 84  LIGEGKFGEVYKGLLQD---GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVT 134
            +G G FG V+  L++D       A+K             Q   +E   L  + H  ++ 
Sbjct: 8   TVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLH 192
           L     +    +++ EY+P G +  +L       R    F +   +   +     L +LH
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYL-------RNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEV 250
           S    +V++D K  N+L+D++   K+ D G  +    RT  + G     T +  +LA EV
Sbjct: 119 SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG-----TPE--YLAPEV 169

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSG 275
            + +  ++  D ++ G+ + E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 32/204 (15%)

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F +    +  + H+++V L G C  +    ++ E++  G + + ++  S V     +FK 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK- 109

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP- 235
              +A   A  L++L      +VH +  T N+L+  + I    D     F+  +D   P 
Sbjct: 110 ---VAKQLASALSYLE--DKDLVHGNVCTKNILLAREGI----DGECGPFIKLSDPGIPI 160

Query: 236 ---SSQVTADEI-FLASE-VKEFRRFSEKSDVYSFGVFLLELVSGRE------------- 277
              S Q   + I ++A E V++ +  S  +D +SFG  L E+    E             
Sbjct: 161 TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER 220

Query: 278 ---ASSSLSPDSSQDLVELMIKCM 298
                  L   S ++L +LM  CM
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCM 244

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 45/210 (21%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 84  LIGEGKFGEVYKGLLQDG--MLVAIK-------------KRPGAPTQEFIDEVCFL-ASI 127
            +G G FG VYK   ++    L+A+K             +       + + EV  +   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +H N+V       EN+  +++ + I    +  H     +  +Q+   +   +I +     
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLA 125

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE---I 244
           L +LH    R+VH+D    N+++ ED    + D GL           P S++T+     +
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGL------AKQKQPESKLTSVVGTIL 178

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +   E+ +   + EK+DV++FG  L ++ +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 6e-04
 Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 62/237 (26%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEF-------------------IDEVCFLA 125
           IG G+FGEV+        LV  K+     TQEF                   + EV  + 
Sbjct: 21  IGNGRFGEVF--------LVKHKR-----TQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67

Query: 126 SIQHRNLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
            ++H+N+V  +     + N   +++ E+   G +S ++    ++   K+E    + I   
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF-GKIEEHAIVDITRQ 126

Query: 184 AAKGLAHLHSLS-----PRVVHKDFKTANVLVDEDF-----------------IAKVADA 221
               LA+ H+L       RV+H+D K  N+ +                     IAK+ D 
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 222 GLRNFLGRTDVAGPSSQVTADEIFLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 276
           GL   +G   +A           + + E+   E + + +KSD+++ G  + EL SG+
Sbjct: 187 GLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)

Query: 85  IGEGKFGEV---YKGLLQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTL 135
           +G G +G V   Y   L+    VA+KK    P Q  I       E+  L  ++H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK--VAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 136 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L  +    +++     Y+    +   L   + V  QKL  +H   +     +GL ++HS 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADL--NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK-EF 253
              ++H+D K +NV V+ED   ++ D GL     + D     +   A   + A E+   +
Sbjct: 138 G--IIHRDLKPSNVAVNEDCELRILDFGLAR---QAD--DEMTGYVATRWYRAPEIMLNW 190

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
             +++  D++S G  + EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 13/156 (8%)

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ-KLEFKHRLSIA 181
           F  +  H  LV L    Q  +  F + E++  G +  H+       RQ KL  +H    +
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM------QRQRKLPEEHARFYS 102

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 240
              +  L  LH     ++++D K  NVL+D +   K+ D G+ +  +   D    +S   
Sbjct: 103 AEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFC 157

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               ++A E+     +    D ++ GV + E+++GR
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.0 bits (94), Expect = 9e-04
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 40/224 (17%)

Query: 72  LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLAS 126
           L+L  K F D           + K       LVA+KK           +    E+     
Sbjct: 3   LTLIGKCFED------LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS---IAL- 182
           +QH N++  +     ++  +++   +  GS    L         K  F   L    IA  
Sbjct: 56  LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL---------KTHFPEGLPELAIAFI 106

Query: 183 --GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-------RTDVA 233
                  L ++HS     +H+  K +++L+  D   KV  +GLR  +        +  V 
Sbjct: 107 LKDVLNALDYIHSKG--FIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 234 GPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSG 275
                   +  +L+ EV +   + ++EKSD+YS G+   EL +G
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 42/147 (28%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGA-AKGLA 189
           LVTL    Q +    LI +YI  G +  HL        Q+  FK   + I  G     L 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIYSGEIVLALE 119

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           HLH L   ++++D K  N+L+D +    + D GL       +V    S     E      
Sbjct: 120 HLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 250 VKEFRRFSEKS-DVYSFGVFLLELVSG 275
           V+      +K+ D +S GV + EL++G
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 34/245 (13%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +G+G +G VYK L +  G+ +A+K+       +   + I E+  L       +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
                 ++  EY+  GS+   LY     +    E   R  I     KGL  L      ++
Sbjct: 69  FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKE-EHNII 125

Query: 200 HKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           H+D K  NVLV+ +   K+ D G    L   L +T++   S    A E   +    +   
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPNQNPT 183

Query: 256 FSEKSDVYSFGVFLLELVSGR-----EASSS---------------LSPDSSQDLVELMI 295
           ++ +SDV+S G+ +LE+  GR     E  ++               L    S D  + + 
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243

Query: 296 KCMGK 300
           KC+ K
Sbjct: 244 KCLNK 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 37/115 (32%)

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------DF---------IAKVADAGL 223
           IA+   K L +L     +++H+D K +N+L+D        DF         IAK  DAG 
Sbjct: 112 IAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 224 RNFLG--RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           R ++   R D     S     ++              +SDV+S G+ L E+ +G+
Sbjct: 171 RPYMAPERID----PSARDGYDV--------------RSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.002
 Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 20/136 (14%)

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------ 223
             L+    L  +   A+G+  L S     +H+D    NVL+ +  +AK+ D GL      
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 224 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSS 281
             N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S G+     
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Query: 282 LSPDSSQDLVELMIKC 297
           +  +S       M+K 
Sbjct: 318 ILVNSK---FYKMVKR 330

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVTAD 242
           A+G+  L   S + +H+D    N+L+ E+ + K+ D GL R+     D V   S+++   
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    + ++ +SDV+SFGV L E+ S
Sbjct: 242 --WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 24/134 (17%)

Query: 150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL---HSLSPRVVHKDFKTA 206
           E++  GS+   L    +  R       ++SIA+   +GL +L   H     ++H+D K +
Sbjct: 79  EHMDGGSLDQVL---KKAGRIPENILGKISIAV--LRGLTYLREKHK----IMHRDVKPS 129

Query: 207 NVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 262
           N+LV+     K+ D G    L + +  + V   S        +++ E  +   ++ +SD+
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--------YMSPERLQGTHYTVQSDI 181

Query: 263 YSFGVFLLELVSGR 276
           +S G+ L+E+  GR
Sbjct: 182 WSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 12/108 (11%)

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L +   +  +   A G+  L   S   VH+D    NVL+ E  + K+ D GL       D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----D 288

Query: 232 VAGPSSQVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +   S+ ++    FL     A E      ++  SDV+SFG+ L E+ +
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 37.7 bits (87), Expect = 0.004
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 31/239 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLV-AIK--------KRPGAPTQEFIDEVCFLASIQ 128
           +F    +IG G FGEV    ++    + A+K        KR  A T  F +E   L +  
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR--AETACFREERNVLVNGD 59

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
            + + TL    Q+ N  +L+ +Y   G +   L   S+   +  E   R  IA    + +
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIA----EMV 112

Query: 189 AHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTAD 242
             +HS+     VH+D K  NVL+D +   ++AD G      ++   ++ VA  +    + 
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKE 301
           EI  A E     ++  + D +S GV + E++ G       +P  ++ LVE   K M  E
Sbjct: 173 EILQAME-DGMGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHE 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	302
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
smart00090	237	RIO RIO-like kinase.	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.64
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.24
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.84
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.81
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.8
PRK09902	216	hypothetical protein; Provisional	98.72
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PLN02876	822	acyl-CoA dehydrogenase	98.41
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.34
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.32
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.12
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
PRK10593	297	hypothetical protein; Provisional	98.05
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.9
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.89
PRK05231	319	homoserine kinase; Provisional	97.88
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.86
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.83
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.78
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.77
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.75
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.64
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.61
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.41
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.29
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.27
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.25
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.18
PLN02756	418	S-methyl-5-thioribose kinase	97.16
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.67
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.61
KOG2270	520	consensus Serine/threonine protein kinase involved	96.42
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.41
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.31
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.93
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.92
PLN02236	344	choline kinase	95.89
COG2334	331	Putative homoserine kinase type II (protein kinase	95.62
PRK12396	409	5-methylribose kinase; Reviewed	95.44
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.36
PRK11768	325	serine/threonine protein kinase; Provisional	95.22
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.04
COG3231	266	Aph Aminoglycoside phosphotransferase [Translation	94.8
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.67
PRK06148	1013	hypothetical protein; Provisional	94.6
PHA03111	444	Ser/Thr kinase; Provisional	94.37

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-53  Score=361.07  Aligned_cols=197  Identities=26%  Similarity=0.449  Sum_probs=176.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...     ..+-+..|+.+++.++|||||++++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356888888999999999999965 4789999986655     2345788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC------CceEEccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED------FIAKVADAGL  223 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~------~~~kl~DfGl  223 (302)
                      |||+||||.+++.     ....+++..+..++.||+.||++||+  ++||||||||+|||++..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~-----~~~~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR-----RRGRLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            9999999999993     45588999999999999999999999  779999999999999764      4689999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      |+.+.+..   ...+.+|++.|||||++....|+.|+|+||+|+++|||++|+.||+..
T Consensus       162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99987533   345789999999999999999999999999999999999999999953

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=355.74  Aligned_cols=217  Identities=34%  Similarity=0.541  Sum_probs=189.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCC-eeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~  151 (302)
                      .+...+.+|+|+||+||+|.+.....||+|++....     .++|.+|+.+|.+++|||||+++|+|.++. ...+||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344456699999999999999865559999866543     458999999999999999999999999988 78999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCCCCeeeCCCC-ceEEcccccccccCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF-IAKVADAGLRNFLGR  229 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~  229 (302)
                      +++|+|..++...   ....+++..++.++.||++||+|||+  .+ ||||||||+|+|++.++ ++||||||+++....
T Consensus       122 ~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999999542   46789999999999999999999999  55 99999999999999998 999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQD  289 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~  289 (302)
                      ..  .......||..|||||++.  ...|+.|+||||||++||||+||+.||...+                  ..+++.
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            32  2233368999999999999  5699999999999999999999999998643                  357889


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +..+|.+||..+
T Consensus       275 l~~l~~~CW~~d  286 (362)
T KOG0192|consen  275 LSSLMERCWLVD  286 (362)
T ss_pred             HHHHHHHhCCCC
Confidence            999999999876

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-50  Score=353.48  Aligned_cols=233  Identities=46%  Similarity=0.743  Sum_probs=201.8

Q ss_pred             hhhccCHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEE
Q 022118           63 EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYC  139 (302)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~  139 (302)
                      ..+.+++.++..++++|...+.||+|+||.||+|...++..||||+.....   ..+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            566789999999999999999999999999999999999999999866544   45799999999999999999999999


Q ss_pred             eeCC-eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-CCCceecCCCCCCeeeCCCCceE
Q 022118          140 QENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       140 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      .+.+ ..+||+||+++|+|.++|+.....   .++|..+..||.++|+||+|||+. .+.||||||||+|||+|+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9998 499999999999999999764321   889999999999999999999985 34799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccc-cCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHH
Q 022118          218 VADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK  296 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~  296 (302)
                      |+|||+|+.....  ....... .||..|+|||+......+.|+|||||||+|.|++||+.|.+...+.....+.+|...
T Consensus       218 lsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999665431  1111122 789999999999999999999999999999999999998886544445568888877


Q ss_pred             Hhhc
Q 022118          297 CMGK  300 (302)
Q Consensus       297 ~~~~  300 (302)
                      ++..
T Consensus       296 ~~~~  299 (361)
T KOG1187|consen  296 LLEE  299 (361)
T ss_pred             HHHC
Confidence            7654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-50  Score=342.21  Aligned_cols=215  Identities=25%  Similarity=0.351  Sum_probs=190.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEec----CCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCe-eeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL-QFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv~e  150 (302)
                      .+++..+.||+|+.|+||++.++ +++.+|+|.+    +....+++.+|++++++.+||+||.+||.|..++. .+++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35667799999999999999976 5889999987    34445678999999999999999999999999994 999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ||++|+|.+.+.     ...++++.....++.++++||.|||+. .+||||||||+|+|++..|+|||||||.++.+..+
T Consensus       159 YMDgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999983     236688999999999999999999963 67999999999999999999999999999887654


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------------CCC-Ch
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------------SPD-SS  287 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------------~~~-~~  287 (302)
                          ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||...                      +.+ .+
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS  308 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS  308 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence                345778999999999999999999999999999999999999998752                      122 67


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      +++.++|-.|+.++
T Consensus       309 ~ef~~FV~~CL~Kd  322 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKD  322 (364)
T ss_pred             HHHHHHHHHHhcCC
Confidence            78999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-51  Score=359.01  Aligned_cols=218  Identities=31%  Similarity=0.530  Sum_probs=192.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCC--CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      .++..+.||+|.||.|+.|.+.....||+|.+..  ...+.|.+|+++|++|+|+|||+++|+|..++.+|||||||+.|
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3344678999999999999998888999997654  34578999999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.++|..   .....+...+.+.++.|||+||+||++  +++|||||.++|||++++..+||+|||||+.++++.+. .
T Consensus       287 sLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~  360 (468)
T KOG0197|consen  287 SLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-A  360 (468)
T ss_pred             cHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccCCCcee-e
Confidence            99999954   346778889999999999999999999  67999999999999999999999999999966654433 3


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHHHH
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMIKC  297 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~~~  297 (302)
                      .....-+..|.|||++....++.|||||||||+||||+| |+.||..+                 |+.++..+.++|+.|
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            444566788999999999999999999999999999999 88998843                 578899999999999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |+.+
T Consensus       441 W~~~  444 (468)
T KOG0197|consen  441 WHED  444 (468)
T ss_pred             hhCC
Confidence            9875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-50  Score=338.76  Aligned_cols=200  Identities=22%  Similarity=0.338  Sum_probs=178.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|++.++||+|+||+|++++.. +++.+|+|.+++.      ......+|..+|.+++||+||+++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3457899999999999999999965 4889999975433      34557889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |+||+.||+|..+|     ..+..+++..+..++.+|+.||.|||+  .+||||||||+|||+|.+|+++|+|||+++..
T Consensus       103 Vld~~~GGeLf~hL-----~~eg~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHL-----QREGRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHH-----HhcCCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999     456789999999999999999999999  77999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      -..+  ..+.+.+||+.|||||++.+.+|+..+|+||+|+++|||++|.+||...+
T Consensus       176 ~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  176 LKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             ccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            3322  23456899999999999999999999999999999999999999998643

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.6e-50  Score=370.88  Aligned_cols=229  Identities=31%  Similarity=0.492  Sum_probs=198.9

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEe
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ  140 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~  140 (302)
                      ...+...+.+..+.||+|+||+||+|+..      +.+.||||.++....    ++|++|++++..++|||||+|+|+|.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            33455666677899999999999999832      357899998765543    57999999999999999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCC---------CcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVS---------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~  211 (302)
                      +++..++|+|||..|||..||.......         ...++..+.+.||.|||.||+||.+  ..+|||||..+|+|+.
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVG  637 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceec
Confidence            9999999999999999999996543221         3348899999999999999999998  6799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC--------
Q 022118          212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL--------  282 (302)
Q Consensus       212 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~--------  282 (302)
                      ++..|||+||||++.+-..++........-+.+|||||.+..++|+++||||||||+|||+++ |+.||.++        
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            999999999999998776666665545566789999999999999999999999999999998 89999854        


Q ss_pred             ---------CCCChhhHHHHHHHHhhcc
Q 022118          283 ---------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---------~~~~~~~l~~~~~~~~~~~  301 (302)
                               +.+++.++.++|+.||+.+
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~  745 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNEN  745 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcC
Confidence                     4688999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-51  Score=331.82  Aligned_cols=222  Identities=27%  Similarity=0.412  Sum_probs=185.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecC-----CCChHHHHHHHHHhccCCCCceeeEEeE-EeeCCe-eeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGY-CQENNL-QFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~-~~~~~~-~~lv  148 (302)
                      .+|++.+.||+|+||.||++. ..+|..+|.|.+.     ...+++...|+.+|+.|+|||||+++++ +.+++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457778999999999999998 5679999999743     3445678999999999999999999994 444444 7999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~--ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ||||..|||...+...+ .....+++..++.++.|++.||.++|+.-++  |+||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999998884433 3467789999999999999999999984344  99999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~  288 (302)
                      +.....  .....+|||+||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+                  +..+.
T Consensus       178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~  255 (375)
T KOG0591|consen  178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST  255 (375)
T ss_pred             hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence            865432  2356789999999999999999999999999999999999999998642                  22345


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++..++..|+..+
T Consensus       256 ~l~~li~~ci~vd  268 (375)
T KOG0591|consen  256 DLRELINMCIAVD  268 (375)
T ss_pred             HHHHHHHHHccCC
Confidence            6667777776543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-48  Score=345.66  Aligned_cols=197  Identities=24%  Similarity=0.402  Sum_probs=180.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .+|...+.||+|+|+.+|.++. .+|..||+|.+++      ..++++.+|+++.++|+|||||+++++|++++++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999997 7799999997544      44677899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |+|+.++|..++     ..+..+++.++..+..||+.||.|||+  .+|+|||||..|+|++++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~-----Krrk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELL-----KRRKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHH-----HhcCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999998887     246789999999999999999999999  6799999999999999999999999999998875


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++.  ...+.+||+.|.|||++....++..+||||+||++|.|+.|++||+..
T Consensus       171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            433  356789999999999999999999999999999999999999999854

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=315.79  Aligned_cols=196  Identities=22%  Similarity=0.348  Sum_probs=178.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh------HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|+..+.||.|+||+|.+++.+ ++..+|+|.++....      +...+|..+++.+.||+++++++.+.+.+.+||
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            4457888999999999999999965 588999998765543      346789999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||.+||.|.++++     ...++++..+..++.||+.||+|||+  .+|++|||||+|||+|.+|.+||+|||+|+..
T Consensus       122 vmeyv~GGElFS~Lr-----k~~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLR-----KSGRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEeccCCccHHHHHH-----hcCCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            999999999999993     45789999999999999999999999  66999999999999999999999999999976


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ..     ...+.+||+.|+|||.+...+|+.++|+|||||++|||+.|.+||...
T Consensus       195 ~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  195 SG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             cC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            43     366789999999999999999999999999999999999999999854

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-48  Score=331.93  Aligned_cols=198  Identities=23%  Similarity=0.351  Sum_probs=171.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCC----------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      .+.|.+.+.||+|+||.|-+|. .++++.||+|.+.+.          ......+|+++|++|+|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            4457778999999999999998 456999999964322          12235799999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADA  221 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl~Df  221 (302)
                      .||||||++||+|.+++.     ....+.+.....++.|++.|+.|||+  .||+||||||+|||++.+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv-----~nk~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV-----ANKYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHH-----hccccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999993     45667777888999999999999999  779999999999999766   78999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCC---CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF---SEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      |+|+..+...   ...+.+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||+...
T Consensus       324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~  385 (475)
T KOG0615|consen  324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY  385 (475)
T ss_pred             chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence            9999987543   3567899999999999987653   348899999999999999999998643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-47  Score=332.66  Aligned_cols=222  Identities=21%  Similarity=0.309  Sum_probs=190.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~  144 (302)
                      ....++|...+.||+|+|++|++|+.. ++..+|||...+      ...+-+.+|-+.|..| .||.|++|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            345678999999999999999999854 588999997543      3345577899999999 89999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      +|+|+||+++|+|.+++.     .-..|++.....++.+|+.||+|||+  +|||||||||+|||+|+++++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~-----K~Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIK-----KYGSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHH-----HhCcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999999999994     34678999999999999999999998  77999999999999999999999999999


Q ss_pred             cccCCCCCC---------CCC--ccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------
Q 022118          225 NFLGRTDVA---------GPS--SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------  282 (302)
Q Consensus       225 ~~~~~~~~~---------~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------  282 (302)
                      +.+.+....         ...  ...+||..|.+||++.....+..+|+|+|||+||+|+.|.+||...           
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            988542211         112  4588999999999999999999999999999999999999999853           


Q ss_pred             -----CCCChhhHHHHHHHHhhcc
Q 022118          283 -----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----~~~~~~~l~~~~~~~~~~~  301 (302)
                           +++.+++..+++.+-+-.|
T Consensus       302 l~y~fp~~fp~~a~dLv~KLLv~d  325 (604)
T KOG0592|consen  302 LDYEFPEGFPEDARDLIKKLLVRD  325 (604)
T ss_pred             hcccCCCCCCHHHHHHHHHHHccC
Confidence                 4566677777777766543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=345.92  Aligned_cols=221  Identities=28%  Similarity=0.475  Sum_probs=191.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+...+.++||.|.||.|++|+++.    ...||||.++...    +.+|+.|..||.+++||||++|.|+.+......+
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            3445667999999999999999653    4679999876543    4569999999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |+|||++|+|+.||+.    ....+.+.+..-+.++|+.||.||.+  .++|||||..+|||++.+..+|++|||+++.+
T Consensus       708 iTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsd--m~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhh--cCchhhhhhhhheeeccceEEEeccccceeec
Confidence            9999999999999953    45678999999999999999999999  55999999999999999999999999999988


Q ss_pred             CCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChh
Q 022118          228 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~  288 (302)
                      .++.. .-......-+.+|.|||.+....++.+|||||||+++||.++ |..||-.+                 +.+++.
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~  861 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA  861 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence            65442 222233445788999999999999999999999999999655 99998753                 468899


Q ss_pred             hHHHHHHHHhhccC
Q 022118          289 DLVELMIKCMGKER  302 (302)
Q Consensus       289 ~l~~~~~~~~~~~~  302 (302)
                      .|.++|.+||++||
T Consensus       862 aL~qLMldCWqkdR  875 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDR  875 (996)
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999999997

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.7e-47  Score=311.16  Aligned_cols=212  Identities=22%  Similarity=0.349  Sum_probs=181.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh-----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      +.|+.+..+|+|+||+||+++.+ +|+.||||++.....     +-.++|++++++++|||+|.++++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777889999999999999976 499999998755443     346799999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ||+.--|. -|.    .....++...+..++.|++.|+.|+|+  +++|||||||+|||++.+|.+||||||+|+.+..+
T Consensus        82 ~~dhTvL~-eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVLH-ELE----RYPNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHHH-HHH----hccCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99874443 331    234567888899999999999999999  66999999999999999999999999999988642


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      .  ...+.++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|++.+   .-|+.=.|++|+|.
T Consensus       155 g--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S---DiDQLy~I~ktLG~  220 (396)
T KOG0593|consen  155 G--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS---DIDQLYLIRKTLGN  220 (396)
T ss_pred             c--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc---hHHHHHHHHHHHcc
Confidence            2  23456789999999999887 689999999999999999999999998755   45677778888774

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-46  Score=354.25  Aligned_cols=224  Identities=30%  Similarity=0.520  Sum_probs=193.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC--C----cEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD--G----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~--~----~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ..+.+..+.||+|.||.||.|...+  +    ..||+|...+..    ..+|.+|..+|++++|||||+++|+|.++...
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455667899999999999998653  3    359999866543    35699999999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcC--CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ++++|||++|||..||+..+..  ....+...+.+.++.|||+|++||++  +++|||||.++|+|++....|||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999654321  25678899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPD  285 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~  285 (302)
                      |+.+.+.++........-+..|||||.+....++.|+|||||||+|||++| |..||.+.                 +..
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~  928 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY  928 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence            997766665554444566788999999999999999999999999999999 88899853                 467


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      ++..+++.|.+||..+
T Consensus       929 CP~~ly~lM~~CW~~~  944 (1025)
T KOG1095|consen  929 CPEKLYQLMLQCWKHD  944 (1025)
T ss_pred             CChHHHHHHHHHccCC
Confidence            8899999999999865

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=330.76  Aligned_cols=195  Identities=28%  Similarity=0.423  Sum_probs=175.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChH-----HHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|..++..+.     .+.+|++++++++||||+.++++|++....++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777889999999999999854 5789999987655443     38899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ||.| +|..+|     .....+++..+..++.+++.||.|||+  ++|.|||+||+|||++.++++|+||||+|+.++..
T Consensus        82 ~a~g-~L~~il-----~~d~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTIL-----EQDGKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHH-----HhccCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9987 999998     456789999999999999999999999  77999999999999999999999999999987653


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  .......||+.|||||...+.+|+..+|+||+||++|||.+|++||-.
T Consensus       154 t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  154 T--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             c--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence            2  234567899999999999999999999999999999999999999973

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=322.67  Aligned_cols=204  Identities=24%  Similarity=0.358  Sum_probs=177.2

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ....++|+.++.||+|+||.||+|+.+ +|..+|+|++++..      ...++.|-.+|...++|+||+|+..|++.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            445678999999999999999999955 59999999876543      34578899999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ||||||++|||+..+|     .....|++..+..++.+++.|++-+|+  .|+|||||||+|+|||..|++||+||||+.
T Consensus       217 YLiMEylPGGD~mTLL-----~~~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLL-----MRKDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             EEEEEecCCccHHHHH-----HhcCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999     567889999999999999999999999  669999999999999999999999999984


Q ss_pred             ccCC----------------------CCCCC---C--------------------CccccCcccccchhhhccCCCCCcc
Q 022118          226 FLGR----------------------TDVAG---P--------------------SSQVTADEIFLASEVKEFRRFSEKS  260 (302)
Q Consensus       226 ~~~~----------------------~~~~~---~--------------------~~~~~~~~~~~aPE~~~~~~~~~~~  260 (302)
                      -+..                      .+...   .                    ....+|||-|+|||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            3211                      00010   0                    0124689999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCC
Q 022118          261 DVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       261 Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      |+||+|||+|||+.|-+||.+..
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~t  392 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSET  392 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=323.34  Aligned_cols=223  Identities=32%  Similarity=0.469  Sum_probs=192.0

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++.+...+.+.||+|.||.|.++....+.+||+|...+..    +.+|.+|+++|.+++||||++++|+|..++.+++++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            4455667789999999999999999888999999876554    357899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+|+....   .+.+......+++.||+.||+||.+  .++||||+.++|||+|.++++||||||+++.+-.
T Consensus       615 EYmEnGDLnqFl~ahe---apt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHE---LPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhcc---CcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999995432   1224556667899999999999999  4599999999999999999999999999997755


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh--CCCCCCC------------------------CC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSS------------------------LS  283 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~--g~~p~~~------------------------~~  283 (302)
                      .++.......+-+.+|||+|.+..++++++||||+||+++||+++  ...||..                        .+
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            555554555667889999999999999999999999999999776  5677763                        34


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      +-+++.+.++|.+||..|
T Consensus       770 ~~cp~~lyelml~Cw~~e  787 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRE  787 (807)
T ss_pred             CcCcHHHHHHHHHHhchh
Confidence            567899999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-45  Score=320.14  Aligned_cols=215  Identities=26%  Similarity=0.379  Sum_probs=179.6

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      .....|+.++.||+|.||.||+|+ ..+|..||+|++.-.     ...-..+||.+|++|+||||++|.+...+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345568888999999999999999 456999999975432     334467999999999999999999999877  689


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |||+|||+. ||.-++.    .....|++.++..++.|++.||+|+|+  ++|+|||||.+|||||.+|.+||+|||||+
T Consensus       194 YlVFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             EEEEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEecccccee
Confidence            999999986 6666652    345689999999999999999999998  789999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG  299 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~  299 (302)
                      ...... ....+..+.|.+|.|||++.+. .|+..+|+||.||||.||+.|++.|++..   .-+++..|-+.+|
T Consensus       267 ~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t---EveQl~kIfklcG  337 (560)
T KOG0600|consen  267 FYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT---EVEQLHKIFKLCG  337 (560)
T ss_pred             eccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc---HHHHHHHHHHHhC
Confidence            765433 2234556789999999998875 69999999999999999999999988754   3455555555444

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=326.15  Aligned_cols=224  Identities=29%  Similarity=0.476  Sum_probs=192.1

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      +++.+..+...+...||+|+||+||+|++.  ..||||.+...     ..+.|.+|+..+++-+|.||+-+.|+|..++.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            566666677778899999999999999975  34899975433     24569999999999999999999999999887


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                       .+|+.+|+|.+|..+++    ..+.+|...+...|++||++||.|||.  ++|||||||..|||+.++++|||+|||++
T Consensus       463 -AIiTqwCeGsSLY~hlH----v~etkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLH----VQETKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhcc----chhhhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccce
Confidence             89999999999999995    456889999999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      ..-.............+...|||||++..   .+|++++||||||+++|||++|..||...+                  
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence            76544433334455678888999998864   479999999999999999999999998322                  


Q ss_pred             ---CCChhhHHHHHHHHhhccC
Q 022118          284 ---PDSSQDLVELMIKCMGKER  302 (302)
Q Consensus       284 ---~~~~~~l~~~~~~~~~~~~  302 (302)
                         .++++++.+++..||..+|
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~  637 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDR  637 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCc
Confidence               3567899999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=313.56  Aligned_cols=219  Identities=28%  Similarity=0.403  Sum_probs=182.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCC--eeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e  150 (302)
                      .++...+.||+|+||.||++...+ |...|+|......   .+.+.+|+.+|++++|||||+++|......  ..+++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            346667999999999999999654 8899999865544   455899999999999999999999855444  6899999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR  229 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~~~~  229 (302)
                      |+++|+|.+++.+.    ...+++..+..+.+||++||+|||+  ++||||||||+|||++. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~----g~~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY----GGKLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999432    1268999999999999999999998  78999999999999999 79999999999987653


Q ss_pred             -CCCCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCCCCC-------------------CCCChh
Q 022118          230 -TDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSL-------------------SPDSSQ  288 (302)
Q Consensus       230 -~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------~~~~~~  288 (302)
                       ...........||+.|||||++.... .+.++||||+||++.||+||+.||...                   +..-+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence             12223344678999999999998632 335999999999999999999999862                   223355


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      +..+++++|+..+
T Consensus       251 ~a~~Fl~~C~~~~  263 (313)
T KOG0198|consen  251 EAKDFLRKCFKRD  263 (313)
T ss_pred             HHHHHHHHHhhcC
Confidence            7899999999876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=320.00  Aligned_cols=198  Identities=24%  Similarity=0.333  Sum_probs=175.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC--------ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~  144 (302)
                      ....|...+.||+|+||+|+.|.. .++..||+|..+..        ..+.+.+|+.+++.++ ||||+++++++..+..
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999985 46899999965442        2345668999999998 9999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL  223 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGl  223 (302)
                      .|+||||+.+|+|.+++.     ...++.+..+..+++|++.|++|+|+  ++|+||||||+|+|+|.+ +.+||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~-----~~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIV-----NKGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999993     35678889999999999999999999  679999999999999999 9999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCC-CC-CccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS-EKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +....  .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            98773  1223456789999999999999988 96 689999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=326.72  Aligned_cols=214  Identities=24%  Similarity=0.421  Sum_probs=186.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +++.+....++-||+|+-|.||+|+.. +..||||+.....    ..+++.|++|+||||+.|.|+|......++|||||
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            333344445688999999999999986 5789999764322    35788899999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ..|-|...|     .............+..+|+.||.|||.  +.|||||||.-||||+.+..|||+|||.++...+.  
T Consensus       195 a~GqL~~VL-----ka~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--  265 (904)
T KOG4721|consen  195 AQGQLYEVL-----KAGRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--  265 (904)
T ss_pred             ccccHHHHH-----hccCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence            999999999     345667778888999999999999998  66999999999999999999999999999876543  


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------------CCCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------------SPDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------------~~~~~~~l~~~~  294 (302)
                       .+...+.||..|||||++.+.+.++|+|||||||+||||+||..||...                  +..+++.+.-+|
T Consensus       266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence             3456788999999999999999999999999999999999999999842                  457789999999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||+.+
T Consensus       345 Kqcw~sK  351 (904)
T KOG4721|consen  345 KQCWNSK  351 (904)
T ss_pred             HHHHhcC
Confidence            9999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=325.20  Aligned_cols=201  Identities=24%  Similarity=0.338  Sum_probs=176.5

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~  144 (302)
                      .....+|...++||+|+||+|+++..+ +++.+|||.+++.      ..+....|.+++.-. +||.++++++.|++++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            445678999999999999999999965 5789999975543      345677888887666 69999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      +|+||||+.|||+..+.      ....+++..+..++..++.||.|||+  ++||+||||.+|||+|.+|++||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccc
Confidence            99999999999965554      45789999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +....  ....+.+.+||+.|||||++.+..|+..+|+|||||+||||+.|..||++.+
T Consensus       516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd  572 (694)
T KOG0694|consen  516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD  572 (694)
T ss_pred             cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            86431  2235678899999999999999999999999999999999999999999644

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=317.60  Aligned_cols=215  Identities=22%  Similarity=0.411  Sum_probs=189.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCC--C-ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG--A-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..|.....||+|+.|.||.+. ..+++.||+|++..  . ..+-+.+|+.+|+..+|+|||++++.+...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457778999999999999998 45688899998542  2 3344789999999999999999999999889999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+.+      ....+++.++..++++++.||+|||.  ++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       353 ~ggsLTDvV------t~~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVV------TKTRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhh------hcccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999888      34558999999999999999999998  7899999999999999999999999999988765443


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        .....+||++|||||+.....|++++||||||++++||+-|++||-..+                   +.-+..+.++
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence              3457789999999999999999999999999999999999999998422                   3456888999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.-|
T Consensus       503 L~~cL~~d  510 (550)
T KOG0578|consen  503 LDRCLVVD  510 (550)
T ss_pred             HHHHhhcc
Confidence            99998765

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-44  Score=298.27  Aligned_cols=213  Identities=24%  Similarity=0.369  Sum_probs=180.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChH-----HHHHHHHHhccCCCCceeeEEeEEeeC--CeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  147 (302)
                      .++|+.++.|++|+||.||+|+.+ ++..||+|+++....+     .-++|+.++.+++|||||.+..+....  +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            346788899999999999999954 6899999987655432     358999999999999999999988644  67899


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||||+. ||...+..    -.+.+...++..+..|+++|++|||.  +.|+||||||+|+|+++.|.+||||||+|+..
T Consensus       155 VMe~~Eh-DLksl~d~----m~q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET----MKQPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999975 88888843    34688999999999999999999999  66999999999999999999999999999988


Q ss_pred             CCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      +.+.  ...+..+.|.+|.|||.+.+. .|+++.|+||+|||+.||+++++-|.+..   ..+.++.|-+-+|.
T Consensus       228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s---E~dQl~~If~llGt  296 (419)
T KOG0663|consen  228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS---EIDQLDKIFKLLGT  296 (419)
T ss_pred             cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc---hHHHHHHHHHHhCC
Confidence            7542  234566789999999998876 58999999999999999999999887643   45667777666553

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-43  Score=314.19  Aligned_cols=226  Identities=23%  Similarity=0.411  Sum_probs=182.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEE------cCCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeC
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~  142 (302)
                      ++.++|++.+.||+|+||.||+|..      .++..||+|......    ...+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            4556789999999999999999974      234679999865432    24588999999999 899999999998765


Q ss_pred             C-eeeEEEeccCCCCccccccCCCcC------------------------------------------------------
Q 022118          143 N-LQFLIYEYIPNGSVSIHLYGPSQV------------------------------------------------------  167 (302)
Q Consensus       143 ~-~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------  167 (302)
                      + ..+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 578999999999999888532110                                                      


Q ss_pred             ---CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccc
Q 022118          168 ---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI  244 (302)
Q Consensus       168 ---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~  244 (302)
                         ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...............++..
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               02347788889999999999999998  6799999999999999999999999999986543222222233345678


Q ss_pred             ccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------------CCChhhHHHHHHHHhhcc
Q 022118          245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       245 ~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------------~~~~~~l~~~~~~~~~~~  301 (302)
                      |+|||++.+..++.++|||||||++|||++ |..||....                  ...+.++.+++.+||..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGD  317 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            999999999999999999999999999997 999987532                  234567899999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-43  Score=286.80  Aligned_cols=212  Identities=25%  Similarity=0.373  Sum_probs=180.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .+|...+.+|+|.||.||+|+. .+|+.||||++.-..     .....+|++.++.++||||+.++++|...+..-+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3577788999999999999994 569999999854332     3457899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |++. ||+..+.    .+...++..++..++.++++|++|||+  +.|+||||||.|+|++++|.+||+|||+|+..+..
T Consensus        82 fm~t-dLe~vIk----d~~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIK----DKNIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhc----ccccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9975 8888873    356778899999999999999999999  66999999999999999999999999999998765


Q ss_pred             CCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      +....  ..+.|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+.+   .-+++..+-+.+|.
T Consensus       155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~~LGT  220 (318)
T KOG0659|consen  155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFRALGT  220 (318)
T ss_pred             Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHHHcCC
Confidence            54332  23788999999988765 69999999999999999999998777644   35666666666654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-44  Score=285.52  Aligned_cols=218  Identities=24%  Similarity=0.350  Sum_probs=187.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|++.+.||+|.||.||+|+.+ ++-.||+|...+      ....++.+|+++-++|+||||+++|++|.++..+||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4567899999999999999999955 577899997543      334578899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ++||.+.|+|...|...   ....+++.....+..|++.|+.|+|.  +++|||||||+|+|++..+..|++|||.+-.-
T Consensus       100 ilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999998432   34567888889999999999999998  77999999999999999999999999998653


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHH
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLV  291 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~  291 (302)
                      .    .....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.+..                +.-+.+-.
T Consensus       175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~  250 (281)
T KOG0580|consen  175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAA  250 (281)
T ss_pred             C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHH
Confidence            2    234567899999999999999999999999999999999999999998643                33355666


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+|++++
T Consensus       251 dlI~~ll~~~  260 (281)
T KOG0580|consen  251 DLISRLLVKN  260 (281)
T ss_pred             HHHHHHhccC
Confidence            7777777654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=319.76  Aligned_cols=224  Identities=29%  Similarity=0.454  Sum_probs=186.4

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEcC--C---cEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeE
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD--G---MLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGY  138 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~  138 (302)
                      +.+++.-++....+.||+|+||.||+|.+..  +   ..||+|.....      ...++.+|.++|++++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445555566667999999999999998543  2   23899976542      23568999999999999999999999


Q ss_pred             EeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 022118          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                      +..+..+++|||+|+||+|.++|.+    ....++..+...++.+.+.||+|||+  +++|||||..+|||++.++.+||
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999999943    23368999999999999999999999  66999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC--------------
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS--------------  283 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~--------------  283 (302)
                      +|||+++.-.  .+.........+..|+|||.+....|++++|||||||++||+++ |..||.+..              
T Consensus       304 SDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  304 SDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR  381 (474)
T ss_pred             CccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence            9999987543  11111223357788999999999999999999999999999999 888998543              


Q ss_pred             ----CCChhhHHHHHHHHhhcc
Q 022118          284 ----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----~~~~~~l~~~~~~~~~~~  301 (302)
                          ...+.++...+.+||..+
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~  403 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKD  403 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCC
Confidence                456778888889999765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=302.44  Aligned_cols=207  Identities=25%  Similarity=0.296  Sum_probs=178.3

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      +....+.|+...+||.|..++||+|+. ..+..||||+++-.    ..+.+++|+..|+.++||||++++..|..+..+|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            345677899999999999999999984 56899999985422    2467889999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||.||.+|++.+.+...   -...+++..+..+.+++++||.|||.  +|.||||||+.||||+.+|.|||+|||.+-.
T Consensus       101 vVmpfMa~GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             EeehhhcCCcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeeee
Confidence            999999999999998542   34568999999999999999999999  7899999999999999999999999998766


Q ss_pred             cCCCCC-CCCC-ccccCcccccchhhhc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          227 LGRTDV-AGPS-SQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       227 ~~~~~~-~~~~-~~~~~~~~~~aPE~~~--~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +-.... .... .+..++++|||||++.  ...|+.|+||||||++..||.+|..||+..+
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            543221 1112 6678999999999854  3579999999999999999999999999765

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=305.01  Aligned_cols=213  Identities=20%  Similarity=0.280  Sum_probs=183.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||.||++... ++..+|+|.....      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999965 5889999986432      2345788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLR-----NSGRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999883     34567888899999999999999998  6799999999999999999999999999986543


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~  293 (302)
                      .     .....+++.|+|||.+.+..++.++|||||||++|||++|+.||....                ...+..+.++
T Consensus       154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  228 (291)
T cd05612         154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDL  228 (291)
T ss_pred             C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHH
Confidence            2     223468889999999999999999999999999999999999997532                2335677889


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +++|+..+
T Consensus       229 i~~~l~~d  236 (291)
T cd05612         229 IKKLLVVD  236 (291)
T ss_pred             HHHHcCCC
Confidence            99998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-42  Score=307.99  Aligned_cols=214  Identities=21%  Similarity=0.283  Sum_probs=184.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||+|... +++.+|+|....      ...+.+.+|+.++++++||||+++++.+..++..|++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357888999999999999999965 588999997543      2235678999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++...
T Consensus        97 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLR-----KAGRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999998883     33567888889999999999999998  679999999999999999999999999998664


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~  292 (302)
                      ..     .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....                ...+.++.+
T Consensus       170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  244 (329)
T PTZ00263        170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD  244 (329)
T ss_pred             CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHH
Confidence            32     223568889999999999999999999999999999999999996532                223456788


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       245 li~~~L~~d  253 (329)
T PTZ00263        245 LVKGLLQTD  253 (329)
T ss_pred             HHHHHhhcC
Confidence            999999765

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-42  Score=299.78  Aligned_cols=216  Identities=20%  Similarity=0.329  Sum_probs=182.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .|+..+.||+|+||.||++.. .++..+|+|......      ...+.+|++++++++|+||+++++.+.+.+..+++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999985 468999999754321      2346789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||++......
T Consensus        81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999998777432   23467889999999999999999998  67999999999999999999999999999875432


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l  290 (302)
                      ..   .....++..|+|||++.+..|+.++|||||||++|||++|+.||....                    ...+.++
T Consensus       156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  232 (285)
T cd05631         156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA  232 (285)
T ss_pred             Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHH
Confidence            21   223467889999999999999999999999999999999999997432                    2345678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++++||.++
T Consensus       233 ~~li~~~l~~~  243 (285)
T cd05631         233 KSICRMLLTKN  243 (285)
T ss_pred             HHHHHHHhhcC
Confidence            88999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.2e-44  Score=303.64  Aligned_cols=198  Identities=21%  Similarity=0.342  Sum_probs=177.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCCCh------HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..+|++.+.||+|.||+|-+|+ +..|+.||||.+.+...      -.+++|++||+.|+||||+.+|.+|++.+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3468889999999999999998 46799999996544322      2468999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||..+|+|.+++     .....+++.+...+++||+.|+.|+|.  ++++|||||.+|||+|.++.+||+|||++....
T Consensus       132 MEYaS~GeLYDYi-----Ser~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYI-----SERGSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHH-----HHhccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999     456789999999999999999999998  789999999999999999999999999998876


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +..   ...+++|++.|.+||.+.+.+| ++.+|-|||||+||.|++|.-||++.+
T Consensus       205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence            543   3457899999999999999999 578999999999999999999999653

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-42  Score=308.39  Aligned_cols=215  Identities=20%  Similarity=0.285  Sum_probs=183.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC--CcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|+..+.||+|+||.||+|....  +..||+|....      ...+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            34568889999999999999998543  36899997532      23456788999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       108 lv~Ey~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLR-----RNKRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999883     33568889999999999999999998  6799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhH
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDL  290 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l  290 (302)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....                ...+.+.
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  255 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC  255 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence            5431     234568889999999999999999999999999999999999997532                2235567


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+|+..+
T Consensus       256 ~~li~~~l~~d  266 (340)
T PTZ00426        256 KHLMKKLLSHD  266 (340)
T ss_pred             HHHHHHHcccC
Confidence            88888888754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=301.28  Aligned_cols=220  Identities=24%  Similarity=0.362  Sum_probs=177.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----------------hHHHHHHHHHhccCCCCceeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------------TQEFIDEVCFLASIQHRNLVTLL  136 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~  136 (302)
                      ..+.|++.+.||+|.||.|-+|+.. +++.||+|.+++..                 .++..+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3567999999999999999999954 68999999744321                 24688999999999999999999


Q ss_pred             eEEeeC--CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC
Q 022118          137 GYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  214 (302)
Q Consensus       137 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~  214 (302)
                      .+..++  +.+|||+|||..|.+...-     .....+++.+++.++++++.||+|||.  ++||||||||+|+|++++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCC
Confidence            998765  5789999999999875322     233348999999999999999999998  7799999999999999999


Q ss_pred             ceEEcccccccccCCCCC---CCCCccccCcccccchhhhccC---CC-CCccchhhHHHHHHHHHhCCCCCCCCC----
Q 022118          215 IAKVADAGLRNFLGRTDV---AGPSSQVTADEIFLASEVKEFR---RF-SEKSDVYSFGVFLLELVSGREASSSLS----  283 (302)
Q Consensus       215 ~~kl~DfGla~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~---~~-~~~~Dvws~Gvil~el~~g~~p~~~~~----  283 (302)
                      ++||+|||.+........   ........||+.|+|||+..+.   .| +.+.||||+||+||.|+.|+.||-...    
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            999999999876522211   1112336799999999998773   23 467899999999999999999997421    


Q ss_pred             --------------CCChhhHHHHHHHHhhcc
Q 022118          284 --------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------------~~~~~~l~~~~~~~~~~~  301 (302)
                                    ++..+++.+++.+.+.||
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~Kd  359 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKD  359 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcC
Confidence                          223566777777777665

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-43  Score=308.93  Aligned_cols=212  Identities=25%  Similarity=0.366  Sum_probs=182.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||+|... ++..||+|.....      ....+.+|++++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 4889999976532      2345788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999983     33567888999999999999999998  6799999999999999999999999999976533


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC------------------------C
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------------------D  285 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~------------------------~  285 (302)
                           ......+++.|+|||.+.+..++.++|||||||++|||++|+.||...+.                        .
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  228 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN  228 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence                 23445688899999999999999999999999999999999999964321                        1


Q ss_pred             ChhhHHHHHHHHhhc
Q 022118          286 SSQDLVELMIKCMGK  300 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~  300 (302)
                      .+.++.+++.+|+..
T Consensus       229 ~s~~~~~li~~~l~~  243 (333)
T cd05600         229 LSDEAWDLITKLIND  243 (333)
T ss_pred             cCHHHHHHHHHHhhC
Confidence            256788889988864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-42  Score=309.64  Aligned_cols=198  Identities=23%  Similarity=0.305  Sum_probs=170.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||+||++... ++..+|+|.....      ....+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999865 5889999986532      2245778999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999883     34568899999999999999999998  6799999999999999999999999999876532


Q ss_pred             CCCC---------------------------------CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCC
Q 022118          230 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  276 (302)
Q Consensus       230 ~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~  276 (302)
                      ....                                 .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 0012346899999999999999999999999999999999999


Q ss_pred             CCCCC
Q 022118          277 EASSS  281 (302)
Q Consensus       277 ~p~~~  281 (302)
                      .||..
T Consensus       234 ~Pf~~  238 (363)
T cd05628         234 PPFCS  238 (363)
T ss_pred             CCCCC
Confidence            99975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.3e-42  Score=300.38  Aligned_cols=224  Identities=30%  Similarity=0.468  Sum_probs=181.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-----------------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  134 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~  134 (302)
                      ..+|+..+.||+|+||.||++...+                 +..||+|......    ..++.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578888999999999999997532                 3469999865433    246889999999999999999


Q ss_pred             EEeEEeeCCeeeEEEeccCCCCccccccCCCc--------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 022118          135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ--------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH  200 (302)
Q Consensus       135 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivH  200 (302)
                      +++++.+.+..+++|||+++|+|.+++.....              .....+++..+..++.|++.||.|||+  .+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence            99999999999999999999999988743211              112356788899999999999999998  67999


Q ss_pred             cCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh--CCCC
Q 022118          201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREA  278 (302)
Q Consensus       201 rdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~--g~~p  278 (302)
                      |||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543322222233345678999999988899999999999999999987  5677


Q ss_pred             CCCCC------------------------CCChhhHHHHHHHHhhcc
Q 022118          279 SSSLS------------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       279 ~~~~~------------------------~~~~~~l~~~~~~~~~~~  301 (302)
                      |....                        +..+..+.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  288 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD  288 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCC
Confidence            75422                        234577899999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-42  Score=305.58  Aligned_cols=210  Identities=23%  Similarity=0.276  Sum_probs=178.5

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||++... ++..+|+|.....      ....+.+|++++++++||||+++++.+...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 5889999976532      2245778999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~  151 (323)
T cd05571          81 ELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence            9988883     34567899999999999999999998  679999999999999999999999999987532211  12


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHhh
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~~  299 (302)
                      .....||+.|+|||++.+..|+.++|||||||++|||++|+.||....                ...+.++.+++.+|+.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence            334568999999999999999999999999999999999999996432                2345678889999987


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      ++
T Consensus       232 ~d  233 (323)
T cd05571         232 KD  233 (323)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-43  Score=298.21  Aligned_cols=212  Identities=28%  Similarity=0.398  Sum_probs=173.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----eeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~  151 (302)
                      .|+..+++|+|+||.||+|... ++..||||+.-...+ --.+|+++|++++|||||++..+|....     ...+||||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            4667799999999999999955 478999998543322 1237999999999999999999886542     23589999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGla~~~~~~  230 (302)
                      ++. +|...++.. ...+..++...+.-+..||.+||+|||+  .+|+||||||+|+|+|.+ |.+||||||.|+.+...
T Consensus       104 mP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            986 787777421 1235667777788899999999999999  679999999999999977 89999999999998654


Q ss_pred             CCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      .   +...+.-+..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+   +++.++...+.+++|.
T Consensus       180 e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG---~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  180 E---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG---DSSVDQLVEIIKVLGT  244 (364)
T ss_pred             C---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC---CCHHHHHHHHHHHhCC
Confidence            3   33556678889999998875 699999999999999999999999887   4567888888888875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6e-42  Score=302.63  Aligned_cols=210  Identities=23%  Similarity=0.277  Sum_probs=177.7

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||++... ++..||+|.....      ....+.+|+++++.++||||+++++.+...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 5889999975432      2345678999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  151 (323)
T cd05595          81 ELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence            9988773     33467899999999999999999998  679999999999999999999999999987532211  11


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHhh
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~~  299 (302)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||....                ...++++.+++.+||.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence            234568889999999999999999999999999999999999996432                2345678889999987


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      ++
T Consensus       232 ~d  233 (323)
T cd05595         232 KD  233 (323)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=301.68  Aligned_cols=208  Identities=21%  Similarity=0.305  Sum_probs=177.5

Q ss_pred             eeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||+|+||.||++... ++..+|+|....      .....+.+|+.++++++||||+++++++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 478899997542      2234577899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  151 (312)
T cd05585          81 FHHLQ-----REGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN  151 (312)
T ss_pred             HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence            98883     24568889999999999999999998  679999999999999999999999999997643222  1233


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHHHHHHHhhcc
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~~~~~~~~~~  301 (302)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...                +...+.++.+++.+||..+
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            456889999999999999999999999999999999999999642                2344567889999998765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.1e-42  Score=309.70  Aligned_cols=197  Identities=22%  Similarity=0.276  Sum_probs=167.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .|+..+.||+|+||+||+|... ++..+|+|.+...      ....+.+|+++++.++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 5789999986432      23457889999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++++||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999998883     23457888889999999999999998  67999999999999999999999999997643110


Q ss_pred             CC---------------------------------------------CCCCccccCcccccchhhhccCCCCCccchhhH
Q 022118          231 DV---------------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  265 (302)
Q Consensus       231 ~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~  265 (302)
                      ..                                             ........||..|+|||.+.+..|+.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                             000123468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 022118          266 GVFLLELVSGREASSS  281 (302)
Q Consensus       266 Gvil~el~~g~~p~~~  281 (302)
                      ||++|||++|+.||..
T Consensus       235 G~il~elltG~~Pf~~  250 (381)
T cd05626         235 GVILFEMLVGQPPFLA  250 (381)
T ss_pred             hhHHHHHHhCCCCCcC
Confidence            9999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=312.47  Aligned_cols=194  Identities=24%  Similarity=0.355  Sum_probs=174.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      -|+..+.||.|+-|.|.+|++ .+|+.+|||.+.+..      ...+.+|+-+|+-+.||||+++|+++++...+|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            367789999999999999985 569999999876552      3457899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|.|++++     ..+..+++.++.+++.||+.|+.|+|.  .+|+||||||+|+|+|..+.+||+|||+|..-.+.
T Consensus        93 yv~gGELFdyl-----v~kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   93 YVPGGELFDYL-----VRKGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             ecCCchhHHHH-----HhhCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999     456788999999999999999999999  56999999999999999999999999999865433


Q ss_pred             CCCCCCccccCcccccchhhhccCCCC-CccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .   ...+.+|.+.|.+||++.+.+|+ .++||||+|||||.|++|++||+.
T Consensus       166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence            2   34567899999999999999995 689999999999999999999994

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-42  Score=294.92  Aligned_cols=223  Identities=23%  Similarity=0.274  Sum_probs=186.7

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      +..+.|+..+.||.|.-|+||+++... +...|+|.+++..      ..+...|-+||+.++||.++.||..++.++..|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            445567788999999999999999764 6899999876543      235677999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ++||||+||+|...+.+   +....+++..+..++.+++.||+|||.  .|||.|||||+|||+.++|++.|+||.|+..
T Consensus       154 l~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             EEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999887743   456789999999999999999999998  6799999999999999999999999998643


Q ss_pred             cCC---------------------------------C-C--------------------CCCCCccccCcccccchhhhc
Q 022118          227 LGR---------------------------------T-D--------------------VAGPSSQVTADEIFLASEVKE  252 (302)
Q Consensus       227 ~~~---------------------------------~-~--------------------~~~~~~~~~~~~~~~aPE~~~  252 (302)
                      ...                                 . .                    ........+||..|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            200                                 0 0                    011234467999999999999


Q ss_pred             cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC------------------CChhhHHHHHHHHhhcc
Q 022118          253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       253 ~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~------------------~~~~~l~~~~~~~~~~~  301 (302)
                      +...+.++|+|+|||++|||++|..||.+...                  ..+.+..++|++.+-||
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            99999999999999999999999999986431                  22366778888877665

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=309.14  Aligned_cols=198  Identities=21%  Similarity=0.298  Sum_probs=168.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||++... ++..||+|.....      ..+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999854 6889999975432      2345778999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999883     23567888889999999999999998  6799999999999999999999999999864311


Q ss_pred             CCC-------------CC--------------------------------CCccccCcccccchhhhccCCCCCccchhh
Q 022118          230 TDV-------------AG--------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYS  264 (302)
Q Consensus       230 ~~~-------------~~--------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws  264 (302)
                      ...             ..                                ......||+.|+|||++.+..|+.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000             00                                001246889999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCC
Q 022118          265 FGVFLLELVSGREASSS  281 (302)
Q Consensus       265 ~Gvil~el~~g~~p~~~  281 (302)
                      |||++|||++|+.||..
T Consensus       234 lGvil~elltG~~Pf~~  250 (377)
T cd05629         234 LGAIMFECLIGWPPFCS  250 (377)
T ss_pred             cchhhhhhhcCCCCCCC
Confidence            99999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.5e-41  Score=300.73  Aligned_cols=210  Identities=23%  Similarity=0.286  Sum_probs=177.9

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||++... ++..+|+|.....      ....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 5889999976432      2345778999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  151 (328)
T cd05593          81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT  151 (328)
T ss_pred             CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence            9988873     33568899999999999999999998  679999999999999999999999999987532211  11


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHhh
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~~  299 (302)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+|+.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcC
Confidence            234568889999999999999999999999999999999999996432                2335678888999987


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      ++
T Consensus       232 ~d  233 (328)
T cd05593         232 KD  233 (328)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.3e-42  Score=308.57  Aligned_cols=229  Identities=24%  Similarity=0.372  Sum_probs=184.8

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEE
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC  139 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~  139 (302)
                      .+....++|++.+.||+|+||.||++...      ++..||+|......    ...+.+|+++++.+ +||||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            33455668889999999999999998742      23579999875433    24578899999999 899999999999


Q ss_pred             eeCCeeeEEEeccCCCCccccccCCCc-----------------------------------------------------
Q 022118          140 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----------------------------------------------------  166 (302)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  166 (302)
                      ...+..++||||+++|+|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999988743210                                                     


Q ss_pred             ------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          167 ------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       167 ------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                                  .....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                        012347888899999999999999998  679999999999999999999999999997654322211


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------------CCChhhHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLVELMI  295 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------------~~~~~~l~~~~~  295 (302)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||....                  ...+.++.+++.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence            1222334567999999998999999999999999999997 999986432                  123578899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       350 ~cl~~d  355 (374)
T cd05106         350 MCWNLE  355 (374)
T ss_pred             HHcCCC
Confidence            999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1e-41  Score=306.86  Aligned_cols=228  Identities=24%  Similarity=0.377  Sum_probs=185.0

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEE------cCCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEe
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~  140 (302)
                      +.+..++|++.+.||+|+||.||+|..      .++..||+|..+...    .+.+.+|+.+++.+ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            344556788899999999999999963      235689999865432    34578999999999 8999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc------------------------------------------------------
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ------------------------------------------------------  166 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  166 (302)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999888843210                                                      


Q ss_pred             ----------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          167 ----------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       167 ----------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                                      .....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                            011247788899999999999999998  67999999999999999999999999999876443


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------------CCChhhHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLV  291 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------------~~~~~~l~  291 (302)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |..||...+                  ...+.++.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  347 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY  347 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence            22222222345567999999999999999999999999999998 888986532                  22356789


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||..+
T Consensus       348 ~li~~cl~~d  357 (375)
T cd05104         348 DIMKSCWDAD  357 (375)
T ss_pred             HHHHHHccCC
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-41  Score=299.47  Aligned_cols=213  Identities=24%  Similarity=0.335  Sum_probs=178.0

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHH---hccCCCCceeeEEeEEeeCCeeeEE
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCF---LASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~---l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      |++.+.||+|+||.||++... ++..||+|..+..      ..+.+.+|.++   ++.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999865 5889999986432      23445666555   4677899999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|..++.      ...+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999987762      3468899999999999999999998  679999999999999999999999999987532


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~  292 (302)
                      ...  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....                ...+.++.+
T Consensus       153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (324)
T cd05589         153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS  230 (324)
T ss_pred             CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            211  12334568889999999999999999999999999999999999997532                234677889


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+|+..+
T Consensus       231 li~~~L~~d  239 (324)
T cd05589         231 IMRRLLRRN  239 (324)
T ss_pred             HHHHHhhcC
Confidence            999999765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-42  Score=305.06  Aligned_cols=218  Identities=24%  Similarity=0.335  Sum_probs=188.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCe-eeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL-QFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv~  149 (302)
                      ++|+.++++|+|+||.+++.+++ ++..+++|.+.-     ..+.....|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999855 577899997432     223456889999999999999999999999988 89999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      +||+||+|.+.+...   ....+++..+..++.|++.|+.|||+  ++|+|||||+.|||+++++.|||+|||+|+.++.
T Consensus        84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            999999999998543   35778999999999999999999997  7899999999999999999999999999999876


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChhhHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                      ..  .......||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...                 +...+.++..
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~  236 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRS  236 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHH
Confidence            54  2356788999999999999999999999999999999999999999853                 2345667777


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      +|..|++++
T Consensus       237 lv~~~l~~~  245 (426)
T KOG0589|consen  237 LVKSMLRKN  245 (426)
T ss_pred             HHHHHhhcC
Confidence            777777654

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.2e-41  Score=291.87  Aligned_cols=208  Identities=23%  Similarity=0.368  Sum_probs=176.7

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEee----CCeeeEEEec
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIYEY  151 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~  151 (302)
                      ...||+|++|.||+|.. ++..||+|......      .+.+.+|+.+|++++||||++++|++.+    ....+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36899999999999988 58899999865432      2456799999999999999999999877    3467899999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++|+|.+++.     ....+++.....++.+++.|+.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHh-----hCCCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            99999999984     335678889999999999999999973 368999999999999999999999999998654322


Q ss_pred             CCCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhhHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQDLV  291 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~l~  291 (302)
                           ....++..|+|||++.+  ..|+.++|||||||++|||++|+.||...+                  ...+..+.
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~  252 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK  252 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence                 23456778999999976  689999999999999999999999998542                  24567889


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||..+
T Consensus       253 ~li~~cl~~d  262 (283)
T PHA02988        253 CIVEACTSHD  262 (283)
T ss_pred             HHHHHHhcCC
Confidence            9999999876

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.5e-42  Score=309.63  Aligned_cols=198  Identities=22%  Similarity=0.263  Sum_probs=168.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .|+..+.||+|+||.||+|... ++..+|+|......      ...+.+|+++++.++||||+++++.+.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999864 57889999865422      2457889999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++..     ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999988832     3457888889999999999999998  67999999999999999999999999997532110


Q ss_pred             C---------------------------------------------CCCCCccccCcccccchhhhccCCCCCccchhhH
Q 022118          231 D---------------------------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  265 (302)
Q Consensus       231 ~---------------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~  265 (302)
                      .                                             .........||+.|+|||++.+..|+.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                             0000123468899999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCC
Q 022118          266 GVFLLELVSGREASSSL  282 (302)
Q Consensus       266 Gvil~el~~g~~p~~~~  282 (302)
                      ||++|||++|+.||...
T Consensus       235 Gvil~elltG~~Pf~~~  251 (382)
T cd05625         235 GVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             hHHHHHHHhCCCCCCCC
Confidence            99999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-41  Score=299.73  Aligned_cols=210  Identities=21%  Similarity=0.312  Sum_probs=176.8

Q ss_pred             CeeeeCCCeeEEEEEEc----CCcEEEEEecCCC-------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +.||+|+||.||++...    ++..+|+|.....       ....+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999853    4788999975431       223567899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++|+|.+++.     ....+.+..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999998883     23456788888899999999999998  679999999999999999999999999987532221


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMI  295 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~  295 (302)
                        .......+++.|+|||++.+..++.++|||||||++|||++|+.||....                +..+.++.+++.
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK  232 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              11234568899999999999999999999999999999999999997532                334567889999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       233 ~~l~~~  238 (323)
T cd05584         233 KLLKRN  238 (323)
T ss_pred             HHcccC
Confidence            998765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-41  Score=298.44  Aligned_cols=196  Identities=22%  Similarity=0.295  Sum_probs=171.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|+..+.||+|+||.||++... ++..+|+|......    .+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999965 57889999765432    3468899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLK-----EAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999883     234578889999999999999999973 36999999999999999999999999998765432


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                          ......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                12344688899999999999999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=304.02  Aligned_cols=199  Identities=25%  Similarity=0.377  Sum_probs=172.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC--hHH--HHHHHHHhccCC-CCceeeEEeEEeeCC-eeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQE--FIDEVCFLASIQ-HRNLVTLLGYCQENN-LQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~--~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~l  147 (302)
                      ..++|...+.||.|+||.||+|+. .++..||||+++...  .++  -+||+..+++++ ||||+++.+++.+.+ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            345788889999999999999984 568899999865432  233  368999999998 999999999999988 8999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||||+. +|...+..    .+..|++..+..|+.||++||+|+|.  +|+.|||+||+|||+.....+||+|||+||.+
T Consensus        88 VfE~Md~-NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEeccccccccc
Confidence            9999976 77777732    36789999999999999999999999  77999999999999999999999999999976


Q ss_pred             CCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      ..   ..+.+.++.|.+|.|||++.. ..|+.+.|+||+|||++|+.+-++.|.+.+
T Consensus       161 ~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s  214 (538)
T KOG0661|consen  161 RS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS  214 (538)
T ss_pred             cc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence            43   334567889999999998765 568999999999999999999999988754

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.7e-42  Score=307.58  Aligned_cols=218  Identities=22%  Similarity=0.306  Sum_probs=180.9

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ....++|+..+.||+|+||.||++... ++..+|+|..+.      .....+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            344567999999999999999999865 588999997642      2234477899999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||+++|+|.+++.      ...+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++
T Consensus       119 ~lv~Ey~~gg~L~~~l~------~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            99999999999998873      2357788888999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccC----CCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      ........ ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....                  
T Consensus       191 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  269 (370)
T cd05596         191 KMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP  269 (370)
T ss_pred             eccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC
Confidence            76432211 22345689999999998654    47899999999999999999999997432                  


Q ss_pred             C--CChhhHHHHHHHHhh
Q 022118          284 P--DSSQDLVELMIKCMG  299 (302)
Q Consensus       284 ~--~~~~~l~~~~~~~~~  299 (302)
                      .  ..+.++.+++.+|+.
T Consensus       270 ~~~~~s~~~~~li~~~L~  287 (370)
T cd05596         270 DDIEISKQAKDLICAFLT  287 (370)
T ss_pred             CcCCCCHHHHHHHHHHcc
Confidence            1  235667778888875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.6e-41  Score=297.67  Aligned_cols=215  Identities=23%  Similarity=0.310  Sum_probs=179.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +|+..+.||+|+||.||++... ++..+|+|.....      ....+..|..++..+ +||+|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 4778999975432      123456677777766 6899999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999988873     23467889999999999999999998  6799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~  293 (302)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....                ...+.++.++
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  231 (323)
T cd05616         154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  231 (323)
T ss_pred             CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence            21  12234568899999999999999999999999999999999999997543                2345677788


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.++
T Consensus       232 i~~~l~~~  239 (323)
T cd05616         232 CKGLMTKH  239 (323)
T ss_pred             HHHHcccC
Confidence            88888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-41  Score=293.96  Aligned_cols=197  Identities=21%  Similarity=0.321  Sum_probs=168.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|++.+.||+|+||.||+++.. ++..+|+|+....     ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999975 5788999975432     23567889999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |++++++..+.     .....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLE-----EMPNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99988776443     123467888999999999999999998  67999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .. .......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~  203 (287)
T cd07848         154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence            21 122345678889999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-42  Score=306.57  Aligned_cols=198  Identities=24%  Similarity=0.339  Sum_probs=170.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||+||++... +++.||+|.....      ....+.+|++++..++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999965 5889999986432      2345678999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLM-----KKDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999883     23468899999999999999999998  6799999999999999999999999999875432


Q ss_pred             CCCCC------------------------------------CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHH
Q 022118          230 TDVAG------------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV  273 (302)
Q Consensus       230 ~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~  273 (302)
                      .....                                    ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11000                                    011235899999999999999999999999999999999


Q ss_pred             hCCCCCCC
Q 022118          274 SGREASSS  281 (302)
Q Consensus       274 ~g~~p~~~  281 (302)
                      +|+.||..
T Consensus       234 ~G~~Pf~~  241 (364)
T cd05599         234 VGYPPFCS  241 (364)
T ss_pred             cCCCCCCC
Confidence            99999964

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.9e-41  Score=297.55  Aligned_cols=215  Identities=23%  Similarity=0.309  Sum_probs=179.4

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCC-CceeeEEeEEeeCCeeeEEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +|++.+.||+|+||.||+|... ++..||+|....      ...+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999865 478899997543      233457789999998876 56888999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999998883     33467888999999999999999998  6799999999999999999999999999875321


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~  293 (302)
                      ..  .......||..|+|||++.+..++.++||||+||++|||++|+.||....                ...+.++.++
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  231 (324)
T cd05587         154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI  231 (324)
T ss_pred             CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            11  12234568899999999999999999999999999999999999997432                2345677888


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.++
T Consensus       232 i~~~l~~~  239 (324)
T cd05587         232 CKGLLTKH  239 (324)
T ss_pred             HHHHhhcC
Confidence            99998765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-43  Score=300.31  Aligned_cols=217  Identities=29%  Similarity=0.404  Sum_probs=188.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ...|+..+.||+|+||.||+|... +++.||+|.++-    ...++...|+.++..++++||.++|+.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            345777799999999999999854 588999998542    234567899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ||.+|++.+.|.     ....+++..+.-+.++++.|+.|||.  .+.+|||||+.|||+..+|.+|++|||.+-.+..+
T Consensus        92 y~~gGsv~~lL~-----~~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLK-----SGNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhc-----cCCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeeeeech
Confidence            999999999983     33444777777889999999999998  67999999999999999999999999999877654


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      ...  ..+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+...+                 ...+..+.++
T Consensus       165 ~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  165 VKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF  242 (467)
T ss_pred             hhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence            433  377899999999999999999999999999999999999999998543                 3556778999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      |..|+.++
T Consensus       243 V~~CL~k~  250 (467)
T KOG0201|consen  243 VEACLDKN  250 (467)
T ss_pred             HHHHhhcC
Confidence            99999876

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.6e-41  Score=296.11  Aligned_cols=210  Identities=25%  Similarity=0.356  Sum_probs=174.9

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhcc-CCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|... ++..||+|.....      ..+....|..++.. .+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5788999975432      23345567777654 4899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            99988873     23468889999999999999999998  679999999999999999999999999997643222  2


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+||
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            2344568899999999999999999999999999999999999997432                234567788999998


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~~  234 (316)
T cd05592         232 ERD  234 (316)
T ss_pred             cCC
Confidence            765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-41  Score=312.52  Aligned_cols=221  Identities=21%  Similarity=0.235  Sum_probs=184.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-C-CcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-D-GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .|...+.||+|+||.||+|... + +..|++|.......   ..+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999854 3 57788887543332   34678999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++.... .....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999998874321 123467888999999999999999998  6799999999999999999999999999987654332


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||....                 ...+.++.+++.
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  304 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD  304 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence            223345568999999999999999999999999999999999999987432                 234567899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       305 ~~L~~d  310 (478)
T PTZ00267        305 PLLSKN  310 (478)
T ss_pred             HHhccC
Confidence            999765

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.4e-42  Score=306.76  Aligned_cols=203  Identities=22%  Similarity=0.326  Sum_probs=172.4

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCC
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~  143 (302)
                      .+....++|+..+.||+|+||.||++... ++..+|+|....      .....+.+|+.+++.++||||+++++.+.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34445678999999999999999999975 478899997542      12345778999999999999999999999999


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+||||+++|+|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~------~~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence            9999999999999999883      2357888899999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCC----CCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++........ ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||...
T Consensus       189 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         189 CMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            9876432221 123457899999999987643    788999999999999999999999743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-41  Score=305.03  Aligned_cols=204  Identities=22%  Similarity=0.320  Sum_probs=173.0

Q ss_pred             HHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEee
Q 022118           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (302)
Q Consensus        69 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~  141 (302)
                      ..++....++|++.+.||+|+||.||++... ++..+|+|....      .....+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556789999999999999999999965 578899997542      122346789999999999999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      ++..|+||||+++|+|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999998873      2347788888999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCC----CCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |+++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||..
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            99987643221 1223456899999999987543    78999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-41  Score=299.22  Aligned_cols=216  Identities=24%  Similarity=0.308  Sum_probs=178.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCC-------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      +|++.+.||+|+||.||+++..    ++..+|+|.....       ..+.+.+|+.+++.+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999999753    5788999975421       234577899999999 599999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999998883     34567889999999999999999998  679999999999999999999999999997


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------C
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLS--------------------P  284 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~  284 (302)
                      ........ ......||..|+|||.+.+. .++.++|||||||++|||++|+.||....                    .
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS  232 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            65332211 12345689999999998865 47889999999999999999999996321                    1


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+..+.+++.+|+.++
T Consensus       233 ~~~~~~~~li~~~l~~d  249 (332)
T cd05614         233 FIGPEAQDLLHKLLRKD  249 (332)
T ss_pred             CCCHHHHHHHHHHcCCC
Confidence            23456788888888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.8e-41  Score=298.24  Aligned_cols=210  Identities=21%  Similarity=0.305  Sum_probs=175.6

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..||+|..+..      ....+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 5889999976532      223477899999888 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~  151 (329)
T cd05588          81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D  151 (329)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence            99988873     33568999999999999999999998  679999999999999999999999999987532111  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------------CCCChhh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-------------------------SPDSSQD  289 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------------~~~~~~~  289 (302)
                      ......||..|+|||++.+..++.++|+|||||++|||++|+.||...                         +...+.+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  231 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  231 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            233456889999999999999999999999999999999999999621                         1223456


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+.++
T Consensus       232 ~~~li~~~L~~d  243 (329)
T cd05588         232 ASSVLKGFLNKD  243 (329)
T ss_pred             HHHHHHHHhccC
Confidence            678888888765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.9e-42  Score=307.65  Aligned_cols=199  Identities=24%  Similarity=0.272  Sum_probs=169.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||++... ++..+|+|.+...      ....+.+|+++++.++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999865 5889999986432      2355788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999983     23457888888999999999999998  6799999999999999999999999999753210


Q ss_pred             CC-----------------------------------------CCCCCccccCcccccchhhhccCCCCCccchhhHHHH
Q 022118          230 TD-----------------------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVF  268 (302)
Q Consensus       230 ~~-----------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvi  268 (302)
                      ..                                         .........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                         0000123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCC
Q 022118          269 LLELVSGREASSSL  282 (302)
Q Consensus       269 l~el~~g~~p~~~~  282 (302)
                      +|||++|+.||...
T Consensus       234 lyell~G~~Pf~~~  247 (376)
T cd05598         234 LYEMLVGQPPFLAD  247 (376)
T ss_pred             eeehhhCCCCCCCC
Confidence            99999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-41  Score=298.62  Aligned_cols=211  Identities=23%  Similarity=0.273  Sum_probs=177.5

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||++... ++..+|+|.....      ....+.+|++++..++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 6889999975432      2345678999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|..++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9988873     345688999999999999999999962 479999999999999999999999999987532211  11


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHhh
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~~  299 (302)
                      .....+|..|+|||++.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+|+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~  232 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhh
Confidence            234568899999999999999999999999999999999999996432                2346678889999987


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      ++
T Consensus       233 ~d  234 (325)
T cd05594         233 KD  234 (325)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=292.03  Aligned_cols=191  Identities=32%  Similarity=0.493  Sum_probs=166.0

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhcc--CCCCceeeEEeEEeeCC----eeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----LQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lv~e~~  152 (302)
                      .+..+++|+|+||.||+|.+. ++.||||+++....+.|.+|-++.+.  ++|+||++++++-....    ..+||+||.
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            445678999999999999986 48999999999999999999998865  58999999999877655    679999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-------CCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-------~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      +.|+|.++|      .....+|....+++..+++||+|||+.       .++|+|||||.+|||+.+|+++.|+|||+|.
T Consensus       291 ~kGsL~dyL------~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  291 PKGSLCDYL------KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             cCCcHHHHH------HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999      457789999999999999999999972       3679999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCC-CC-----CccchhhHHHHHHHHHhCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS-----EKSDVYSFGVFLLELVSGR  276 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~Dvws~Gvil~el~~g~  276 (302)
                      .+......+....-+||.+|||||++.+.. ..     .+.||||+|.+||||++.-
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            887655444444568999999999998752 22     2689999999999999964

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-41  Score=284.79  Aligned_cols=212  Identities=25%  Similarity=0.350  Sum_probs=172.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCc-eeeEEeEEeeCC------e
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRN-LVTLLGYCQENN------L  144 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~  144 (302)
                      .|+..+.||+|+||+||+|+. .+|+.||+|+..-.     ......+|+.++++++|+| |+++++++.+.+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            455567899999999999994 56899999974322     3455789999999999999 999999999887      7


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++|+||++. +|..++....... ..++...++.++.||+.||+|||+  ++|+||||||+|+|++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999965 8888884432111 456668899999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHh
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM  298 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~  298 (302)
                      +..+-+..  ......+|.+|.|||++.+. .|++..||||+|||+.||+++++-|.+..+   .++...|-+.+
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~l  237 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLL  237 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHc
Confidence            97653221  23455788899999999987 799999999999999999999999887553   44444444433

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.5e-41  Score=287.64  Aligned_cols=219  Identities=26%  Similarity=0.431  Sum_probs=181.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|++.+.||+|+||.||+|...    .+..+|+|..+...    ...+.+|+..+++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456888899999999999999753    35689999866442    2357889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++..    ....+++..++.++.|++.||+|||+  .+++||||||+||+++.++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999998843    23468899999999999999999998  67999999999999999999999999987654


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~  289 (302)
                      ...... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...                 +...+..
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd05064         158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNL  236 (266)
T ss_pred             cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            322111 1122344567999999999999999999999999999775 99998643                 2344678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||.++
T Consensus       237 ~~~li~~c~~~~  248 (266)
T cd05064         237 LHQLMLDCWQKE  248 (266)
T ss_pred             HHHHHHHHcCCC
Confidence            899999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-41  Score=298.19  Aligned_cols=196  Identities=20%  Similarity=0.338  Sum_probs=163.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----eee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  146 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  146 (302)
                      +|++.+.||+|+||.||+|... ++..||+|.....     ...++.+|++++++++||||+++++++...+     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999965 5889999976432     2345789999999999999999999886442     479


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+. ++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 68887773     34568899999999999999999998  6799999999999999999999999999976


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          227 LGRTDV-AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ...... ........++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            532211 111234568889999999876  6789999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=303.74  Aligned_cols=220  Identities=33%  Similarity=0.542  Sum_probs=191.0

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcC---C--cEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQD---G--MLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      +..+..+..++||.|-||.||+|.+.+   |  ..||||..+.    ..++.|+.|..+|++++||||++++|+|.+. .
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            333444556899999999999998542   3  3588996443    3467899999999999999999999999875 5


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+|||.++.|.|..+|    +.++..++......++.||+.||+|||+  .++|||||..+|||+....-+||+|||++
T Consensus       465 ~WivmEL~~~GELr~yL----q~nk~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYL----QQNKDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             eeEEEecccchhHHHHH----HhccccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchh
Confidence            79999999999999999    3466788889999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCC-----------------CCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSS-----------------LSPDS  286 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~-----------------~~~~~  286 (302)
                      +.+.+..+...+ ...-+..|||||.+...+++.+||||.|||++||+++ |..||.+                 .++.+
T Consensus       539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC  617 (974)
T KOG4257|consen  539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC  617 (974)
T ss_pred             hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence            999887665543 5566788999999999999999999999999999888 8899984                 35788


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      ++.+..+|.+||..|
T Consensus       618 Pp~LYslmskcWaye  632 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYE  632 (974)
T ss_pred             ChHHHHHHHHHhccC
Confidence            999999999999886

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7e-41  Score=295.41  Aligned_cols=210  Identities=23%  Similarity=0.330  Sum_probs=176.2

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..||+|....      .....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 578999997543      2234567788888766 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++.     ....+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~i~-----~~~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~  151 (320)
T cd05590          81 GDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K  151 (320)
T ss_pred             chHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence            99998873     33568889999999999999999998  679999999999999999999999999987542211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  231 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFM  231 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            2334568899999999999999999999999999999999999997532                234567788899998


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~d  234 (320)
T cd05590         232 TKN  234 (320)
T ss_pred             ccC
Confidence            764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.6e-41  Score=296.29  Aligned_cols=210  Identities=21%  Similarity=0.308  Sum_probs=174.3

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..+|+|.....      ....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 5788999975532      123467788888766 899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~  151 (329)
T cd05618          81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D  151 (329)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence            99988773     33568899999999999999999998  679999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------------CCCChhh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-------------------------SPDSSQD  289 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------------~~~~~~~  289 (302)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||...                         +...+.+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~  231 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  231 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHH
Confidence            223456889999999999999999999999999999999999999521                         1223456


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+..+
T Consensus       232 ~~~ll~~~L~~d  243 (329)
T cd05618         232 AASVLKSFLNKD  243 (329)
T ss_pred             HHHHHHHHhcCC
Confidence            678888888765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4e-41  Score=297.10  Aligned_cols=210  Identities=22%  Similarity=0.298  Sum_probs=175.9

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|... ++..+|+|.....      ....+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 4789999976432      234467788888765 899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|...+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  151 (321)
T cd05591          81 GDLMFQIQ-----RSRKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V  151 (321)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence            99988873     33567888999999999999999998  679999999999999999999999999987543221  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            2234568889999999999999999999999999999999999997542                123577888999998


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~d  234 (321)
T cd05591         232 TKN  234 (321)
T ss_pred             ccC
Confidence            764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.5e-41  Score=303.22  Aligned_cols=229  Identities=25%  Similarity=0.388  Sum_probs=185.5

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCC-CCceeeEEeEE
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYC  139 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~  139 (302)
                      .+....++|++.+.||+|+||.||+|...      .+..||+|.+....    .+.+.+|+++++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34456778899999999999999999853      13479999875432    346889999999996 99999999999


Q ss_pred             eeCCeeeEEEeccCCCCccccccCCCc-----------------------------------------------------
Q 022118          140 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----------------------------------------------------  166 (302)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  166 (302)
                      .+.+..|+|||||++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999988743210                                                     


Q ss_pred             --------------------------------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          167 --------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       167 --------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                                                            .....+++..+..++.|++.||+|||+  .+++||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Ni  268 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhE
Confidence                                                  001247788889999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----  283 (302)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....    
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986643322222233346677999999999999999999999999999997 989986421    


Q ss_pred             --------------CCChhhHHHHHHHHhhcc
Q 022118          284 --------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------------~~~~~~l~~~~~~~~~~~  301 (302)
                                    ...+.++.+++.+||..+
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  380 (400)
T cd05105         349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSE  380 (400)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHCccC
Confidence                          234567899999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-40  Score=288.04  Aligned_cols=223  Identities=31%  Similarity=0.496  Sum_probs=185.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ++|++.+.||+|+||.||+|....      ...+++|......    ...+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998543      2579999865433    245788999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCC-----------CcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVS-----------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~  215 (302)
                      ++|||+++++|.+++.......           ...+++..+..++.|++.||.|||+  .+++|+||||+||++++++.
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCCCc
Confidence            9999999999999885432211           1567888999999999999999998  67999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------
Q 022118          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------  282 (302)
Q Consensus       216 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------  282 (302)
                      +||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...            
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999986644332222334456778999999988899999999999999999998 99998642            


Q ss_pred             -----CCCChhhHHHHHHHHhhcc
Q 022118          283 -----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----~~~~~~~l~~~~~~~~~~~  301 (302)
                           +...+.++.+++.+||.++
T Consensus       243 ~~~~~~~~~~~~~~~l~~~c~~~~  266 (283)
T cd05048         243 QLLPCPEDCPARVYALMIECWNEI  266 (283)
T ss_pred             CcCCCcccCCHHHHHHHHHHccCC
Confidence                 2345678899999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.6e-41  Score=294.92  Aligned_cols=215  Identities=22%  Similarity=0.311  Sum_probs=178.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +|+..+.||+|+||.||++... ++..||+|.....      ..+.+..|..++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999865 5889999975432      2345677888888775 578888999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999998883     33568899999999999999999998  6799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~  293 (302)
                      ...  ......||..|+|||++.+..++.++||||+||++|||++|+.||....                ...+.++.++
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  231 (323)
T cd05615         154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI  231 (323)
T ss_pred             CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            211  2234568889999999999999999999999999999999999997543                2345667788


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.++
T Consensus       232 i~~~l~~~  239 (323)
T cd05615         232 CKGLMTKH  239 (323)
T ss_pred             HHHHcccC
Confidence            88888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-40  Score=288.22  Aligned_cols=212  Identities=24%  Similarity=0.311  Sum_probs=177.7

Q ss_pred             eeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||+|+||+||++... +++.+|+|......      .+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 68899999865322      23467899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++.... .....+++..+..++.|++.||+|||+  .+|+||||||+||++++++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            88774322 234568899999999999999999998  6799999999999999999999999999976543221  123


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHHHHHHHH
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLVELMIKC  297 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~~~~~~~  297 (302)
                      ...+++.|+|||.+.+..++.++|||||||++|||++|+.||....                    ...+.++.+++.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            4467889999999999999999999999999999999999997431                    22456788899999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      +..+
T Consensus       236 l~~~  239 (280)
T cd05608         236 LAKD  239 (280)
T ss_pred             hcCC
Confidence            8765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=289.27  Aligned_cols=216  Identities=21%  Similarity=0.336  Sum_probs=181.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      +|+..+.||+|+||.||++... ++..||+|......      ...+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999864 58899999765322      2346789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++...   ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999998887432   23468899999999999999999998  67999999999999999999999999998765332


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------------------CChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--------------------DSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~--------------------~~~~~l  290 (302)
                      ..   .....++..|+|||.+.+..++.++||||+||++|||++|+.||.....                    ..+..+
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA  232 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHH
Confidence            21   2234678889999999988999999999999999999999999975321                    235667


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       233 ~~li~~~l~~~  243 (285)
T cd05605         233 RSICRQLLTKD  243 (285)
T ss_pred             HHHHHHHccCC
Confidence            88889998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-40  Score=293.22  Aligned_cols=219  Identities=30%  Similarity=0.477  Sum_probs=180.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..+|+..+.||+|+||.||+|.+. ++.    .||+|......    .+++.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            457899999999999999999853 233    48999865432    35688899999999999999999999865 568


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999998843    23457888899999999999999998  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ...............+..|+|||.+.+..++.++|||||||++|||++ |+.||...+                 +..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  238 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence            654322211222334567999999999999999999999999999997 999987532                 23456


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       239 ~~~~li~~cl~~~  251 (316)
T cd05108         239 DVYMIMVKCWMID  251 (316)
T ss_pred             HHHHHHHHHccCC
Confidence            7899999999765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=300.77  Aligned_cols=216  Identities=24%  Similarity=0.328  Sum_probs=183.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|... ++..||+|....      .....+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999965 588999998643      23346788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLI-----RKDVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999983     23568889999999999999999998  7799999999999999999999999999987644


Q ss_pred             CC---------------------------CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          230 TD---------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       230 ~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ..                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                           001223456889999999999999999999999999999999999999643


Q ss_pred             C------------------CC--ChhhHHHHHHHHhh
Q 022118          283 S------------------PD--SSQDLVELMIKCMG  299 (302)
Q Consensus       283 ~------------------~~--~~~~l~~~~~~~~~  299 (302)
                      .                  ..  .+.++.+++.+|+.
T Consensus       234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~  270 (350)
T cd05573         234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC  270 (350)
T ss_pred             CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc
Confidence            2                  11  25677788888874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-40  Score=292.40  Aligned_cols=210  Identities=23%  Similarity=0.332  Sum_probs=174.8

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhcc-CCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..||+|.....      .......|..++.. .+||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 5789999976432      23446677777765 4899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 g~L~~~i~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05620          81 GDLMFHIQ-----DKGRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence            99988873     23567888999999999999999998  679999999999999999999999999987432111  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLF  231 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence            2334568899999999999999999999999999999999999997532                123457788899998


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      ..+
T Consensus       232 ~~d  234 (316)
T cd05620         232 ERD  234 (316)
T ss_pred             cCC
Confidence            764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.5e-41  Score=302.05  Aligned_cols=199  Identities=22%  Similarity=0.299  Sum_probs=170.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||.||++... ++..+|+|....      .....+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999865 588999997642      22345778999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999883     34568889999999999999999998  6799999999999999999999999999875432


Q ss_pred             CCC---------------------------------CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCC
Q 022118          230 TDV---------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  276 (302)
Q Consensus       230 ~~~---------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~  276 (302)
                      ...                                 ........||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                 00012346899999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 022118          277 EASSSL  282 (302)
Q Consensus       277 ~p~~~~  282 (302)
                      .||...
T Consensus       234 ~Pf~~~  239 (360)
T cd05627         234 PPFCSE  239 (360)
T ss_pred             CCCCCC
Confidence            999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-40  Score=293.91  Aligned_cols=210  Identities=22%  Similarity=0.315  Sum_probs=173.7

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHH-HhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..+|+|.....      ....+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 5788999975432      1233555554 57889999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.||+.||.|||+  .+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (321)
T cd05603          81 GELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E  151 (321)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence            99988773     34567888889999999999999998  679999999999999999999999999987532221  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|+.||...+                +..+.++.+++.+|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLL  231 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            2334568889999999999999999999999999999999999996432                234566788888888


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~~  234 (321)
T cd05603         232 HKD  234 (321)
T ss_pred             cCC
Confidence            765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-40  Score=293.83  Aligned_cols=210  Identities=24%  Similarity=0.325  Sum_probs=174.3

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHH-HhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||+||++... +++.||+|.+...      ....+.+|.. +++.++||||+++++.+...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999965 5889999986432      1233455554 46789999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (323)
T cd05575          81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K  151 (323)
T ss_pred             CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence            99988883     34567888999999999999999998  679999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....                +..+.++.+++.+|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLL  231 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            2334568889999999999999999999999999999999999997432                234667788888888


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~~  234 (323)
T cd05575         232 QKD  234 (323)
T ss_pred             hcC
Confidence            765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-40  Score=294.93  Aligned_cols=197  Identities=21%  Similarity=0.298  Sum_probs=170.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..++|+..+.||+|+||.||++... ++..+|+|......    ...+.+|+++++.++||||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3468999999999999999999965 57888998754332    246889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++..     ...+++..+..++.|++.||.|||+. .+++||||||+|||+++++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999998832     34578888899999999999999972 4699999999999999999999999999876532


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .    ......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            2    12334678889999999998999999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-40  Score=291.64  Aligned_cols=210  Identities=25%  Similarity=0.360  Sum_probs=174.2

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhcc-CCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|... ++..||+|.....      .......|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 4788999975432      23446677777765 5999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05619          81 GDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence            99998883     23467888999999999999999998  679999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......+|..|+|||++.+..++.++|||||||++|||++|+.||....                ...+.++.+++.+||
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHh
Confidence            2234568889999999999999999999999999999999999997432                123456778888888


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~~  234 (316)
T cd05619         232 VRE  234 (316)
T ss_pred             ccC
Confidence            764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-40  Score=293.55  Aligned_cols=210  Identities=22%  Similarity=0.299  Sum_probs=174.8

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..+|+|.....      ..+.+.+|..++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 4788999986532      223467899998887 699999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  151 (327)
T cd05617          81 GDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D  151 (327)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence            99988773     23568899999999999999999998  679999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------CCChhhHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------PDSSQDLV  291 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------~~~~~~l~  291 (302)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....                       ...+..+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  231 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS  231 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            2234568899999999999999999999999999999999999996321                       12245567


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+|+.++
T Consensus       232 ~li~~~L~~d  241 (327)
T cd05617         232 HVLKGFLNKD  241 (327)
T ss_pred             HHHHHHhccC
Confidence            8888888764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-40  Score=288.80  Aligned_cols=197  Identities=22%  Similarity=0.333  Sum_probs=166.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|++.+.||+|+||.||+|... ++..+|+|.....    ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999975 5889999986432    23457789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |++ ++|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 577776632    23457888899999999999999998  67999999999999999999999999998754322


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..  ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21  1233457888999998865 4588999999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.6e-41  Score=309.87  Aligned_cols=224  Identities=20%  Similarity=0.322  Sum_probs=185.9

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCC-----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----  143 (302)
                      ..++|++.+.||+|+||+||++.. .++..||+|......     ...+.+|+..+..++|+||+++.+.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            356899999999999999999985 468999999864322     245778999999999999999988775432     


Q ss_pred             ---eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          144 ---LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       144 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                         ..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCEEEEe
Confidence               3589999999999999885322 123568899999999999999999998  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------C
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------S  283 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~  283 (302)
                      ||+++...............||+.|+|||++.+..|+.++|||||||++|||++|+.||...                 +
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~  266 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP  266 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            99998765433222334567899999999999999999999999999999999999999742                 2


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...++++.+++.+||.++
T Consensus       267 ~~~~~~l~~li~~~L~~d  284 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSD  284 (496)
T ss_pred             CCCCHHHHHHHHHHcccC
Confidence            345678899999999765

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-40  Score=287.79  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=166.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||.||+|... ++..||+|.....    ....+.+|+.++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999865 5789999975432    234677999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++ +|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            985 88877732    23456888899999999999999998  679999999999999999999999999997653322


Q ss_pred             CCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1233457888999998865 56899999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-40  Score=296.13  Aligned_cols=213  Identities=24%  Similarity=0.353  Sum_probs=175.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ..+|+..+.||+|+||.||++... +++.||+|......    ...+.+|++++++++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            345667789999999999999865 58899999864432    3457899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|....         ...+..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++.....
T Consensus       153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999986432         23456778899999999999998  67999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCCC--------------------CCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSL--------------------SPD  285 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~~--------------------~~~  285 (302)
                      ..  ......|+..|+|||.+..     ...+.++|||||||++|||++|+.||...                    +..
T Consensus       222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
T PLN00034        222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT  299 (353)
T ss_pred             cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence            11  1234468889999998743     23356899999999999999999999632                    123


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       300 ~~~~l~~li~~~l~~~  315 (353)
T PLN00034        300 ASREFRHFISCCLQRE  315 (353)
T ss_pred             cCHHHHHHHHHHccCC
Confidence            4567899999999865

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-40  Score=292.76  Aligned_cols=210  Identities=24%  Similarity=0.319  Sum_probs=172.8

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHH-HhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||+||++... ++..+|+|.....      ....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 4678999976432      1223444444 46788999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++.     ....+.+..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~  151 (325)
T cd05602          81 GELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G  151 (325)
T ss_pred             CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence            99998883     33557788888899999999999998  679999999999999999999999999987543211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||....                +..+..+.+++.+|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL  231 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHc
Confidence            2344568899999999999999999999999999999999999996432                234567788888888


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~~  234 (325)
T cd05602         232 QKD  234 (325)
T ss_pred             ccC
Confidence            765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.8e-41  Score=295.28  Aligned_cols=210  Identities=24%  Similarity=0.303  Sum_probs=178.2

Q ss_pred             CeeeeCCCeeEEEEEE----cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           83 NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      +.||+|+||.||++..    .++..+|+|.....     ....+.+|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    35789999976532     23456789999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999998883     34568899999999999999999998  679999999999999999999999999987654321  


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKC  297 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~  297 (302)
                      .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....                ...+.++.+++++|
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  232 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRAL  232 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            12234568889999999999899999999999999999999999997432                23456788899999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |.++
T Consensus       233 l~~~  236 (318)
T cd05582         233 FKRN  236 (318)
T ss_pred             hhcC
Confidence            9765

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-40  Score=295.31  Aligned_cols=198  Identities=22%  Similarity=0.280  Sum_probs=168.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||++... ++..+|+|.....      ....+.+|..++..++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 5788999976431      2234778899999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999842    23467888899999999999999998  6799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .... ......|+..|+|||++.+     ..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            3221 1233568899999999875     4678999999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.4e-40  Score=281.78  Aligned_cols=218  Identities=27%  Similarity=0.443  Sum_probs=183.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ++|+..+.||+|+||.||++...++..+|+|.....  ...++.+|++++++++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            457788999999999999999888888999976543  345788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++..    ....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+||+|||+++........ 
T Consensus        84 ~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          84 GCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999988842    12357889999999999999999998  67999999999999999999999999999865432221 


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~  296 (302)
                      ......++..|+|||...+..++.++|+||||+++|||++ |+.||....                 ...+..+.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            1122334567999999998899999999999999999999 899987432                 2235568899999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||..+
T Consensus       237 c~~~~  241 (256)
T cd05114         237 CWHEK  241 (256)
T ss_pred             HccCC
Confidence            99765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.5e-40  Score=286.07  Aligned_cols=196  Identities=26%  Similarity=0.356  Sum_probs=161.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc--CCcEEEEEecCCC-----ChHHHHHHHHHhccC---CCCceeeEEeEEee-----
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQE-----  141 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----  141 (302)
                      ++|++.+.||+|+||.||+|...  ++..||+|.....     ....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  3678999975422     223456777776655   79999999999863     


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      ....++||||++ ++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            345799999997 5888887432   23457889999999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |+++.....   .......++..|+|||.+.+..++.++|||||||++|||++|++||..
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence            999865432   123345678899999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-40  Score=290.87  Aligned_cols=210  Identities=22%  Similarity=0.322  Sum_probs=176.6

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||+||++... ++..+|+|.+...      ....+.+|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 4788999976532      234567888888877 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  151 (318)
T cd05570          81 GDLMFHIQ-----RSGRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V  151 (318)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence            99988873     33468899999999999999999998  679999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||....                ...+.++.+++++||
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence            1233468889999999999999999999999999999999999997432                234577889999999


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~d  234 (318)
T cd05570         232 TKN  234 (318)
T ss_pred             cCC
Confidence            765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-40  Score=285.61  Aligned_cols=224  Identities=28%  Similarity=0.498  Sum_probs=185.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ..+|.+.+.||+|+||.||+|...+      +..+|+|......    .+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3457788999999999999998532      4789999865443    34688999999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCC---------cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          146 FLIYEYIPNGSVSIHLYGPS---------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      +++|||+++++|.+++....         ......+++..+..++.|++.|+.|||+  ++++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeE
Confidence            99999999999999985432         1233567889999999999999999998  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-------------  282 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-------------  282 (302)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...             
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999976543322222233345677999999999999999999999999999998 99998532             


Q ss_pred             ----CCCChhhHHHHHHHHhhcc
Q 022118          283 ----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----~~~~~~~l~~~~~~~~~~~  301 (302)
                          +...+..+.+++++||..+
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~~  264 (280)
T cd05049         242 LLQRPRTCPSEVYDIMLGCWKRD  264 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCC
Confidence                2344678899999999765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=283.76  Aligned_cols=212  Identities=25%  Similarity=0.394  Sum_probs=175.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee-----CCee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~~  145 (302)
                      ..|...+.||+|+||.|..+... +|..||+|++...     ..++-.+|+.+++.++|+||+.+++.+..     -+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            34555789999999999999854 6899999986522     23567899999999999999999999875     2567


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+|+|+|+ -||...+     ..++.++...+..+..|+++||.|+|+  .+++||||||+|+|++.+...||||||+|+
T Consensus       102 YiV~elMe-tDL~~ii-----k~~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  102 YLVFELME-TDLHQII-----KSQQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             EEehhHHh-hHHHHHH-----HcCccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCEEecccccee
Confidence            99999994 5888887     244558999999999999999999999  669999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG  299 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~  299 (302)
                      ...........+.++.|.+|.|||.+. ...|+...||||+|||+.||++|++-|.+.+   .-+.+++|...+|
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d---~v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD---YVHQLQLILELLG  245 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc---hHHHHHHHHHhcC
Confidence            886543334456788999999999776 4579999999999999999999999988644   3455555554443

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-40  Score=293.25  Aligned_cols=198  Identities=23%  Similarity=0.270  Sum_probs=167.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||++.... +..+|+|.....      ....+.+|+.++..++|+||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            368889999999999999999654 778999976431      2234778999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999842    23467888899999999999999998  6799999999999999999999999999876533


Q ss_pred             CCCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            221 1123356889999999986     34688999999999999999999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=293.12  Aligned_cols=198  Identities=24%  Similarity=0.293  Sum_probs=168.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||++... ++..+|+|....      ...+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999965 588999998642      22345788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999998832    23567888999999999999999998  6799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .... ......+|+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            2211 1223468889999999863     4578899999999999999999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-40  Score=298.53  Aligned_cols=193  Identities=19%  Similarity=0.235  Sum_probs=166.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ..+|++.+.||+|+||.||++... +++.||+|...   ...+.+|++++++++||||+++++++......++++|++. 
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            467999999999999999999864 58899999653   3457789999999999999999999999999999999985 


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|..++.     ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       167 ~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        167 TDLYCYLA-----AKRNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            67877772     23567889999999999999999998  679999999999999999999999999997543221 11


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            2234578999999999999999999999999999999999998764

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-40  Score=292.81  Aligned_cols=210  Identities=22%  Similarity=0.313  Sum_probs=172.9

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHH-HhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++... ++..+|+|.....      ....+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999864 5889999976432      2234455554 46789999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||+++++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~  151 (325)
T cd05604          81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD  151 (325)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence            99988873     34568899999999999999999998  67999999999999999999999999998753221  11


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHh
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCM  298 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~  298 (302)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+                +..+..+.+++++|+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELL  231 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHh
Confidence            2334568899999999999999999999999999999999999997532                234456677788887


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      .++
T Consensus       232 ~~~  234 (325)
T cd05604         232 EKD  234 (325)
T ss_pred             ccC
Confidence            654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.2e-41  Score=296.21  Aligned_cols=216  Identities=25%  Similarity=0.311  Sum_probs=179.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||++... ++..+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999865 5889999976532      2345778999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNR----YEDQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999998842    23568889999999999999999998  6799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          230 TDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      .... ......+|+.|+|||++.      ...++.++|||||||++|||++|+.||....                    
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED  233 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence            3221 123346888999999987      4567899999999999999999999996421                    


Q ss_pred             CCChhhHHHHHHHHhh
Q 022118          284 PDSSQDLVELMIKCMG  299 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~  299 (302)
                      ...+.++.+++++|+.
T Consensus       234 ~~~~~~~~~li~~ll~  249 (330)
T cd05601         234 PKVSSDFLDLIQSLLC  249 (330)
T ss_pred             CCCCHHHHHHHHHHcc
Confidence            1235567778877774

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=283.65  Aligned_cols=194  Identities=28%  Similarity=0.492  Sum_probs=166.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhcc--CCCCceeeEEeEEeeCC----eeeE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----LQFL  147 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~l  147 (302)
                      ......+..+.||+|.||.||+|.++ |..||||.+.......|.+|.++...  |+|+||+.+++.-..++    ++||
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            34556777899999999999999987 78899999999999999999999876  49999999999876543    5699


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      |++|.+.|+|.|||      .+..++....+.++..++.||+|||..      .+.|.|||||+.|||+.+++++.|+|+
T Consensus       287 vTdYHe~GSL~DyL------~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYL------NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eeecccCCcHHHHH------hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999999999      457889999999999999999999952      366999999999999999999999999


Q ss_pred             ccccccCCC--CCCCCCccccCcccccchhhhccCC----CC--CccchhhHHHHHHHHHh
Q 022118          222 GLRNFLGRT--DVAGPSSQVTADEIFLASEVKEFRR----FS--EKSDVYSFGVFLLELVS  274 (302)
Q Consensus       222 Gla~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~----~~--~~~Dvws~Gvil~el~~  274 (302)
                      |||-.....  ......+..+||.+|||||++...-    +.  ..+||||||.++||+..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            999766443  3344567789999999999987542    22  25899999999999886

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-39  Score=282.87  Aligned_cols=223  Identities=30%  Similarity=0.464  Sum_probs=182.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+|++.+.||+|+||+||+|..     .++..+++|.......    ..+.+|++++++++||||+++++++...+..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999974     2457899998764332    457889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCc------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 022118          148 IYEYIPNGSVSIHLYGPSQ------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~  215 (302)
                      +|||+++++|.+++.....            .....+++.....++.|++.||+|||+  ++++||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCCCc
Confidence            9999999999988843211            112457888899999999999999998  67999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------
Q 022118          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------  283 (302)
Q Consensus       216 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------  283 (302)
                      +||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||....           
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999987644332222333345667999999988889999999999999999998 988985422           


Q ss_pred             ------CCChhhHHHHHHHHhhcc
Q 022118          284 ------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------~~~~~~l~~~~~~~~~~~  301 (302)
                            ...+..+.+++.+||.++
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~  266 (283)
T cd05090         243 QLLPCSEDCPPRMYSLMTECWQEG  266 (283)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccC
Confidence                  234677889999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=301.13  Aligned_cols=226  Identities=27%  Similarity=0.468  Sum_probs=197.5

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ++++....+......||-|.||.||.|.++. ...||||.++..  ..++|+.|..+|+.++|||+|+|+|+|..+...|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            5666666777788999999999999999876 678999987654  4678999999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +|+|||.+|+|.++|+.   .++..++.--.+.++.||..||+||..  +++|||||..+|+|+.++..+|++|||+++.
T Consensus       340 IiTEfM~yGNLLdYLRe---cnr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRE---CNRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEecccCccHHHHHHH---hchhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999954   355667777788999999999999998  6699999999999999999999999999999


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~  288 (302)
                      +..+.+.. .....-+..|.|||.+..+.++.|+|||+|||+|||+.| |-.||.+.                 +..|++
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence            87655443 233345678999999999999999999999999999988 88898853                 468899


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      .++++|+.||++.
T Consensus       494 kVYeLMraCW~Ws  506 (1157)
T KOG4278|consen  494 KVYELMRACWNWS  506 (1157)
T ss_pred             HHHHHHHHHhcCC
Confidence            9999999999864

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.8e-40  Score=279.42  Aligned_cols=218  Identities=28%  Similarity=0.453  Sum_probs=183.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ++|+..+.||+|+||+||++...++..+|+|......  .+.+.+|+.++++++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            4577889999999999999988776679999765432  45689999999999999999999999998889999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++..    ....+++..++.++.|++.||.|||+  .+++|+||||+||++++++.+||+|||.++........ 
T Consensus        84 ~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          84 GCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999998842    22367899999999999999999998  67999999999999999999999999998866443221 


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~  296 (302)
                      ......++..|++||...+..++.++||||||+++|||++ |+.||...+                 ...+..+.+++.+
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            1122335567999999998889999999999999999998 999986432                 2335678999999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||.++
T Consensus       237 cl~~~  241 (256)
T cd05113         237 CWHEK  241 (256)
T ss_pred             HcCCC
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7e-40  Score=283.11  Aligned_cols=225  Identities=26%  Similarity=0.404  Sum_probs=183.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      ..++|+..+.||+|+||.||+|...      .+..+|+|......    ..++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998743      24679999865432    2357889999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcC-----CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                      .++||||+++|+|.+++......     ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999988532211     12346778889999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC----------------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL----------------  282 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~----------------  282 (302)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...                
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD  241 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999986644332222223345677999999998899999999999999999999 78888643                


Q ss_pred             -CCCChhhHHHHHHHHhhcc
Q 022118          283 -SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -~~~~~~~l~~~~~~~~~~~  301 (302)
                       +...+..+.+++.+||..+
T Consensus       242 ~~~~~~~~~~~li~~~l~~~  261 (277)
T cd05062         242 KPDNCPDMLFELMRMCWQYN  261 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCC
Confidence             2334567889999999765

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=280.07  Aligned_cols=211  Identities=24%  Similarity=0.301  Sum_probs=182.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|..+++||+|.||+|.+++ ..+++.+|+|.+++..      ...-+.|-+++.+.+||.+..+...|+..+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            45678889999999999999998 4568999999765442      2334678899999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||..||.|.-+|     .....+++.....+...|+.||.|||+  ++||.||||.+|.|+|++|++||+|||+++.-
T Consensus       246 VMeyanGGeLf~HL-----srer~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  246 VMEYANGGELFFHL-----SRERVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEccCceEeeeh-----hhhhcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999998     346778888899999999999999999  67999999999999999999999999999853


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHH
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKC  297 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~  297 (302)
                      -  .......+.+||+.|+|||++....|+..+|+|.+||++|||++|+.||.+.+   ...+..+|..|
T Consensus       319 I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kLFeLIl~e  383 (516)
T KOG0690|consen  319 I--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKLFELILME  383 (516)
T ss_pred             c--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHHHHHHHhh
Confidence            2  23345678899999999999999999999999999999999999999998755   34556555443

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-41  Score=310.02  Aligned_cols=226  Identities=20%  Similarity=0.285  Sum_probs=183.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCC-cEEEEEecCCC---ChHHHHHHHHHhccCC-CCceeeEEe-EEeeC----
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRPGA---PTQEFIDEVCFLASIQ-HRNLVTLLG-YCQEN----  142 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~-~~~~~----  142 (302)
                      .+...++++.+.|.+|||+.||+|....+ ..+|+|++-..   ..+.+.+|+++|+.|+ |+|||.+++ .....    
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34455677889999999999999997765 99999985433   3456789999999996 999999999 33221    


Q ss_pred             --CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          143 --NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       143 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                        -..+|+||||.+|.|-+++...   ....|++.++++|+.++++|+++||.+.++|||||||-+||||+.+++.||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~R---lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTR---LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHH---HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence              2458999999999999999543   23459999999999999999999999888999999999999999999999999


Q ss_pred             cccccccCCCCCCC-------CCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCC--------
Q 022118          221 AGLRNFLGRTDVAG-------PSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSL--------  282 (302)
Q Consensus       221 fGla~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~--------  282 (302)
                      ||.|..........       ..-....|+.|.+||++.   +.++++|+|||||||+||.|++...||...        
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng  269 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG  269 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec
Confidence            99986542211100       011234678899999875   567899999999999999999999999853        


Q ss_pred             ------CCCChhhHHHHHHHHhhcc
Q 022118          283 ------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ------~~~~~~~l~~~~~~~~~~~  301 (302)
                            .+..+..+.++|+.|+..+
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~n  294 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPN  294 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccC
Confidence                  2466789999999998764

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6e-40  Score=280.96  Aligned_cols=221  Identities=27%  Similarity=0.490  Sum_probs=186.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||.||+|...++..+|+|.....  ..+.+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            34578889999999999999999888888999986543  3457889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.++|+|||+++.......
T Consensus        84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999988432   23467888889999999999999998  6799999999999999999999999999987654322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      .. .....++..|+|||...+..++.++|||||||++|||++ |+.||....                 ...+.++.+++
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11 222345667999999998899999999999999999998 999986432                 23457889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       238 ~~~l~~~  244 (261)
T cd05072         238 KTCWKEK  244 (261)
T ss_pred             HHHccCC
Confidence            9999754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=287.56  Aligned_cols=202  Identities=22%  Similarity=0.353  Sum_probs=178.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ++..+.|..-++||+|+||.|+-++.. +|+.+|.|++.+..      ....++|-.++.+++.+.||.+-..|++.+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            445677888999999999999999855 58889988654332      23467899999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||..|+||||.-+|+..   ..+.+++..+..++.+|+.||++||+  .+||.|||||+|||+|+.|+++|+|+|+|.
T Consensus       261 ClVLtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             EEEEEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEE
Confidence            9999999999999999764   44789999999999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .+.+..   +....+||..|||||++.+..|+.+.|+||+||+||||+.|+.||...
T Consensus       336 ei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  336 EIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             ecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            775543   233448999999999999999999999999999999999999999843

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-39  Score=283.06  Aligned_cols=224  Identities=29%  Similarity=0.497  Sum_probs=184.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..+|.+.+.||+|+||+||++...      ++..+|+|......   .+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356788899999999999999742      24568899866443   346889999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCc--------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 022118          147 LIYEYIPNGSVSIHLYGPSQ--------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                      ++|||+++++|.+++.....        .....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+||
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEe
Confidence            99999999999988853321        123458999999999999999999998  67999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC--------------
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS--------------  283 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~--------------  283 (302)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....              
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~  241 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  241 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999986643322222233345677999999999999999999999999999998 899986421              


Q ss_pred             ---CCChhhHHHHHHHHhhcc
Q 022118          284 ---PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---~~~~~~l~~~~~~~~~~~  301 (302)
                         ...+.++.+++.+||.++
T Consensus       242 ~~~~~~~~~l~~li~~~l~~~  262 (288)
T cd05093         242 QRPRTCPKEVYDLMLGCWQRE  262 (288)
T ss_pred             CCCCCCCHHHHHHHHHHccCC
Confidence               234578999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=279.07  Aligned_cols=221  Identities=29%  Similarity=0.503  Sum_probs=186.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|++|.||+|...++..+|+|.....  ..+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            44568889999999999999999877788999986543  3456889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++..+..++.|++.|+.|||+  ++++||||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999998432   23467899999999999999999998  6799999999999999999999999999987653322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      .. ......+..|+|||...+..++.++||||||+++|||++ |+.||....                 ...+.++.+++
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         159 EA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             cc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            11 112223457999999999999999999999999999999 999986532                 23467889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+|+..+
T Consensus       238 ~~~l~~~  244 (261)
T cd05068         238 LDCWKED  244 (261)
T ss_pred             HHHhhcC
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=291.62  Aligned_cols=198  Identities=25%  Similarity=0.348  Sum_probs=175.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC------hHHHHHHHHHhccCC-CCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~  146 (302)
                      ....|++.+.||+|.||.||++..+. |..+|+|.+++..      ...+.+|+.+|+++. ||||+.+++++++.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34568888999999999999999665 8999999765433      257899999999998 999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC----CCceEEcccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----DFIAKVADAG  222 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~----~~~~kl~DfG  222 (302)
                      +|||+|.||.|.+.+...      .+++..+..++.|++.++.|||+  .+++||||||+|+|+..    ++.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999998432      38999999999999999999999  77999999999999953    3589999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      ++.....   .......+||+.|+|||++...+|+..+||||+||++|.|++|.+||....
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            9998765   234567899999999999999999999999999999999999999998654

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=281.20  Aligned_cols=215  Identities=29%  Similarity=0.474  Sum_probs=188.7

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCC
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~  156 (302)
                      |.++..||+|+||.||++.++ .|+.+|+|..+-. ..+++..|+.+|..++.|++|++||.+.....+|+|||||..|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            445678999999999999865 5999999987644 56789999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 022118          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  236 (302)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~  236 (302)
                      ..+.++    ..+..+.+.++..+.+..++||+|||.  .+-||||||..|||++.+|.+||+|||.|-.+.++  ....
T Consensus       115 iSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~--~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR  186 (502)
T KOG0574|consen  115 ISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHD--LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR  186 (502)
T ss_pred             HHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHH--HHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence            999984    356789999999999999999999998  45899999999999999999999999999776543  3345


Q ss_pred             ccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhHHHHHHHH
Q 022118          237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDLVELMIKC  297 (302)
Q Consensus       237 ~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l~~~~~~~  297 (302)
                      .+..||+.|||||++..-.|+.++||||+|++..||.-|++||...++                   .=+.++-+++++|
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            678899999999999999999999999999999999999999985431                   2246778999999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      +-+.
T Consensus       267 LiK~  270 (502)
T KOG0574|consen  267 LIKK  270 (502)
T ss_pred             hcCC
Confidence            8653

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=277.54  Aligned_cols=218  Identities=29%  Similarity=0.466  Sum_probs=182.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      .+|+..+.||+|+||.||++...++..+|+|.....  ....+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            357788999999999999999877778999986543  345788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|.+++..    ....+++..+..++.|++.|++|||+  .+++||||||+||++++++.+||+|||+++........ 
T Consensus        84 ~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          84 GCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            999998842    23367899999999999999999998  67999999999999999999999999999866432211 


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~  296 (302)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....                 ...+.++.+++.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            1112223456999999999999999999999999999999 899986432                 2346789999999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||..+
T Consensus       237 cl~~~  241 (256)
T cd05059         237 CWHEK  241 (256)
T ss_pred             HhcCC
Confidence            99754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.1e-40  Score=299.69  Aligned_cols=200  Identities=25%  Similarity=0.342  Sum_probs=161.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeC--------Cee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN--------NLQ  145 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~  145 (302)
                      ...+|+..+.||+|+||.||+|... ++..||+|+..... ....+|+.+++.++||||+++++++...        ...
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            3467999999999999999999865 57899999865432 3345799999999999999999887432        245


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLR  224 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla  224 (302)
                      ++||||+++ +|.+++.... .....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            789999985 5655552211 234568889999999999999999998  6799999999999998664 7999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      +.+....   ......+|+.|+|||++.+. .|+.++|||||||++|||++|.+||...
T Consensus       219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8764322   12234678889999988764 6899999999999999999999999753

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.7e-40  Score=313.20  Aligned_cols=223  Identities=22%  Similarity=0.258  Sum_probs=182.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||+|... ++..||+|+.....      .+++.+|++++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999865 58899999865321      346889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCc------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          150 EYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ||+++|+|.+++.....      ......++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999988843211      112345667788999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCC----------------CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---
Q 022118          224 RNFLGRTDV----------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---  284 (302)
Q Consensus       224 a~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---  284 (302)
                      ++.......                ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....   
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            986621100                0011234689999999999999999999999999999999999999964321   


Q ss_pred             ----------------CChhhHHHHHHHHhhcc
Q 022118          285 ----------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ----------------~~~~~l~~~~~~~~~~~  301 (302)
                                      ..+..+.+++.+|+..+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~D  272 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVD  272 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCC
Confidence                            23456788889998765

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-39  Score=294.12  Aligned_cols=215  Identities=20%  Similarity=0.241  Sum_probs=179.9

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc---CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ...+|++.+.||+|+||.||++...   .+..|++|.....  ....+|++++++++||||+++++++...+..+++||+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            3457999999999999999999753   3578999987543  3456899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +. ++|.+++     .....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||+++......
T Consensus       168 ~~-~~l~~~l-----~~~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        168 YK-CDLFTYV-----DRSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             cC-CCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            86 5777777     234568899999999999999999998  679999999999999999999999999998765433


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhh
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG  299 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~  299 (302)
                      .........||..|+|||++.+..|+.++|||||||++|||++|+.||...........+..+.+|++
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~  307 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ  307 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence            33233356789999999999999999999999999999999999999987665555555555555554

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-39  Score=280.03  Aligned_cols=209  Identities=22%  Similarity=0.337  Sum_probs=174.5

Q ss_pred             eeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||+|+||.||++... ++..+|+|......      ......|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 58899999764321      23456799999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            8887432   23457888889999999999999998  679999999999999999999999999987654321   112


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------CCChhhHHHHHHH
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------PDSSQDLVELMIK  296 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------~~~~~~l~~~~~~  296 (302)
                      ...++..|+|||++.+..++.++||||+||++|||++|+.||....                     ...+.++.+++.+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL  232 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence            3457888999999999899999999999999999999999996431                     1235667888999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||.++
T Consensus       233 ~L~~~  237 (277)
T cd05607         233 FLAKK  237 (277)
T ss_pred             HhccC
Confidence            98765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-40  Score=283.20  Aligned_cols=215  Identities=33%  Similarity=0.555  Sum_probs=176.5

Q ss_pred             CCeeeeCCCeeEEEEEEc-----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           82 KNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .+.||.|.||.||+|.+.     .+..|++|......    .+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999976     25689999875432    356889999999999999999999999888899999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.+||+|||++........
T Consensus        84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            999999999432   24678999999999999999999999  6799999999999999999999999999987633222


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~  294 (302)
                      .........+..|+|||.+....++.++||||||+++|||++ |+.||...                 +...+..+.+++
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            222333456677999999999999999999999999999999 78898743                 234578899999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       239 ~~C~~~~  245 (259)
T PF07714_consen  239 QQCWSHD  245 (259)
T ss_dssp             HHHT-SS
T ss_pred             HHHcCCC
Confidence            9999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=280.78  Aligned_cols=225  Identities=26%  Similarity=0.399  Sum_probs=186.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      ..++|++.+.||+|+||.||++....      +..+++|......    ...+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            44578889999999999999998542      3679999865433    2357889999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcC-----CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                      .+++|||+++|+|.+++......     ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEEC
Confidence            99999999999999998543221     12346788999999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC----------------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL----------------  282 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~----------------  282 (302)
                      |||+++...............++..|+|||...+..++.++|||||||++||+++ |+.||...                
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD  241 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence            9999987654433222334456778999999988889999999999999999998 99998532                


Q ss_pred             -CCCChhhHHHHHHHHhhcc
Q 022118          283 -SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -~~~~~~~l~~~~~~~~~~~  301 (302)
                       +...+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~li~~~l~~~  261 (277)
T cd05032         242 LPENCPDKLLELMRMCWQYN  261 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCC
Confidence             3445688899999999865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.1e-40  Score=290.57  Aligned_cols=226  Identities=24%  Similarity=0.396  Sum_probs=181.1

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeC
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~  142 (302)
                      ++..+|++.+.||+|+||.||+|...      ++..||+|......    .+.+.+|+.++.++ +||||++++++|...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34457889999999999999999632      24689999865432    23567899999999 899999999988754


Q ss_pred             -CeeeEEEeccCCCCccccccCCCcC------------------------------------------------------
Q 022118          143 -NLQFLIYEYIPNGSVSIHLYGPSQV------------------------------------------------------  167 (302)
Q Consensus       143 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------  167 (302)
                       ...+++|||+++++|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             5678999999999999887432110                                                      


Q ss_pred             --CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccc
Q 022118          168 --SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF  245 (302)
Q Consensus       168 --~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~  245 (302)
                        ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              01367889999999999999999998  67999999999999999999999999999876433222222334556779


Q ss_pred             cchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------------CCChhhHHHHHHHHhhcc
Q 022118          246 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       246 ~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------------~~~~~~l~~~~~~~~~~~  301 (302)
                      +|||++.+..++.++|||||||++|||++ |..||....                  .....++.+++.+||..+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~  316 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN  316 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence            99999999999999999999999999998 999986422                  123567899999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=277.05  Aligned_cols=220  Identities=28%  Similarity=0.484  Sum_probs=183.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|+..+.||+|+||.||+|....    ...+++|..+...    ..++.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568889999999999999998642    4579999865432    3467889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|||+++++|.+++..    ....+++..+..++.|++.|++|||+  ++|+|+||||+||++++++.++|+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999843    23468899999999999999999998  67999999999999999999999999999877


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~  289 (302)
                      .............++..|+|||...+..++.++||||||+++|||++ |..||...                 +...+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSA  236 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            52221111222345667999999998999999999999999999998 99998532                 2344678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       237 l~~li~~cl~~~  248 (266)
T cd05033         237 LYQLMLDCWQKD  248 (266)
T ss_pred             HHHHHHHHcCCC
Confidence            899999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-39  Score=292.72  Aligned_cols=196  Identities=24%  Similarity=0.365  Sum_probs=164.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----eee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  146 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  146 (302)
                      +|+..+.||+|+||.||++... ++..||+|+....     ..+++.+|+++++.++||||+++++++..++     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 6889999986542     2346789999999999999999999998776     789


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+. ++|...+.     ....+++..+..++.|++.||.|||+  .+++||||||+|||+++++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999997 57776662     34568899999999999999999998  6799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ...... .......++..|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            543221 122334577889999998874 4799999999999999999999999643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.2e-39  Score=279.46  Aligned_cols=218  Identities=30%  Similarity=0.455  Sum_probs=177.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+|+..+.||+|+||+||+|... ++.    .+++|......    ..++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999864 333    47888765332    2356678888999999999999998764 45789


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ++||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999842    23467899999999999999999998  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQD  289 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~  289 (302)
                      .............++..|+|||...+..++.++||||||+++|||++ |+.||....                 .....+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            44332222334456678999999998899999999999999999998 999987532                 123457


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       240 ~~~li~~c~~~~  251 (279)
T cd05111         240 VYMVMVKCWMID  251 (279)
T ss_pred             HHHHHHHHcCCC
Confidence            788899999765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-39  Score=280.95  Aligned_cols=216  Identities=23%  Similarity=0.345  Sum_probs=180.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      +|+..+.||+|+||.||++... +++.+|+|......      ...+.+|+.++++++|+||+.+++.+.+.+..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677789999999999999865 58899999754321      2346789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999887432   23458889999999999999999998  67999999999999999999999999998765322


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l  290 (302)
                      .   ......++..|+|||.+.+..++.++|||||||++|||++|+.||....                    ...+.++
T Consensus       156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd05630         156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA  232 (285)
T ss_pred             c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHH
Confidence            1   1123467889999999999999999999999999999999999997432                    1244567


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       233 ~~li~~~l~~~  243 (285)
T cd05630         233 RSLCKMLLCKD  243 (285)
T ss_pred             HHHHHHHhhcC
Confidence            88888888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-39  Score=294.27  Aligned_cols=228  Identities=25%  Similarity=0.400  Sum_probs=184.5

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCC-CCceeeEEeEEe
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQ  140 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~  140 (302)
                      +....++|.+.+.||+|+||.||+|.+.      .+..||+|++....    .+.+.+|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3445556778899999999999999853      24679999876432    235788999999997 999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc------------------------------------------------------
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ------------------------------------------------------  166 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  166 (302)
                      .++..++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999998854211                                                      


Q ss_pred             ---------------------------------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 022118          167 ---------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  207 (302)
Q Consensus       167 ---------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~N  207 (302)
                                                             .....+++..+..++.|++.||+|||+  ++++||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcce
Confidence                                                   011346777889999999999999998  679999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC---
Q 022118          208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS---  283 (302)
Q Consensus       208 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~---  283 (302)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...+   
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986543222111223346778999999998899999999999999999998 888986432   


Q ss_pred             ---------------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------------~~~~~~l~~~~~~~~~~~  301 (302)
                                     ...+.++.+++.+||.++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~  382 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEK  382 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence                           234578889999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-39  Score=281.47  Aligned_cols=223  Identities=28%  Similarity=0.506  Sum_probs=184.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+|...+.||+|+||.||++...      ++..+++|.......   +.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777899999999999999742      345688888765443   468899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          148 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      ||||+++++|.+++.....           .....+++..++.++.|++.|++|||+  ++++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcE
Confidence            9999999999999854221           123458899999999999999999998  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------  283 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------  283 (302)
                      +|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....            
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  242 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR  242 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence            9999999976544332222333456778999999999999999999999999999998 999985322            


Q ss_pred             -----CCChhhHHHHHHHHhhcc
Q 022118          284 -----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----~~~~~~l~~~~~~~~~~~  301 (302)
                           ...+.++.+++.+||.++
T Consensus       243 ~~~~~~~~~~~~~~li~~~l~~~  265 (291)
T cd05094         243 VLERPRVCPKEVYDIMLGCWQRE  265 (291)
T ss_pred             CCCCCccCCHHHHHHHHHHcccC
Confidence                 234567899999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-39  Score=278.91  Aligned_cols=220  Identities=31%  Similarity=0.533  Sum_probs=187.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ...+|+..+.||+|+||.||+|...++..+++|......   ...+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            345688889999999999999998888999999866543   35688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||+  ++++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999998532   23567899999999999999999998  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      ..  .....++..|+|||...+..++.++||||||+++|+|++ |+.||...+                 ...++.+.++
T Consensus       159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence            22  123345667999999998899999999999999999998 899986432                 2445778999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       237 i~~~l~~~  244 (261)
T cd05148         237 MLECWAAE  244 (261)
T ss_pred             HHHHcCCC
Confidence            99999765

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-39  Score=281.53  Aligned_cols=222  Identities=29%  Similarity=0.401  Sum_probs=182.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      +|++.+.||+|+||.||+|...      ++..||+|.......    ..+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4666788999999999999853      246899998764432    457789999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCC-----------cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          148 IYEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      ++||+++++|.+++....           ......+++..+..++.|++.||.|||+  .+++||||||+||++++++.+
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCCce
Confidence            999999999998874211           1112457888899999999999999998  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-------------  282 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-------------  282 (302)
                      ||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||...             
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ  243 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999887654332222233345678999999988889999999999999999998 88887642             


Q ss_pred             ----CCCChhhHHHHHHHHhhcc
Q 022118          283 ----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----~~~~~~~l~~~~~~~~~~~  301 (302)
                          +.+.+..+.+++.+||.++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~  266 (283)
T cd05091         244 VLPCPDDCPAWVYTLMLECWNEF  266 (283)
T ss_pred             cCCCCCCCCHHHHHHHHHHhCCC
Confidence                2356678899999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=303.65  Aligned_cols=215  Identities=30%  Similarity=0.495  Sum_probs=186.3

Q ss_pred             CcCCeeeeCCCeeEEEEEE-cCC----cEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           80 SDKNLIGEGKFGEVYKGLL-QDG----MLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ...++||+|+||+||+|.+ .++    .+||+|.+..    +...++++|.-.|.+++|||+++++|+|..+. ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3458999999999999984 333    4788887433    23567999999999999999999999999876 789999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |++.|.|.++++.    .+..+.....+.+..||++||.|||+  +++|||||..+|||+.+-.++||+|||+++.+..+
T Consensus       778 ~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999943    46678888999999999999999998  78999999999999999999999999999998765


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                      ...-.......++.|||-|.+....|+.++|||||||++||++| |..||++.                 ++.++.|+..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~  931 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYM  931 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHH
Confidence            54444455566778999999999999999999999999999998 88999854                 4677889999


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      .|.+||..|
T Consensus       932 ~mvkCwmid  940 (1177)
T KOG1025|consen  932 VMVKCWMID  940 (1177)
T ss_pred             HHHHHhccC
Confidence            999999865

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.3e-39  Score=274.27  Aligned_cols=213  Identities=29%  Similarity=0.469  Sum_probs=176.0

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      +.||+|+||.||+|... ++..+|+|......    ...+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999864 68889999755332    34688999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++..    ....+++..++.++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++............
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            998832    23457889999999999999999998  679999999999999999999999999987654322111111


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHHHhh
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~~~~  299 (302)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||....                 ...+..+.+++.+||.
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence            2233456999999998899999999999999999998 888886322                 2335788899999997


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      .+
T Consensus       235 ~~  236 (252)
T cd05084         235 YD  236 (252)
T ss_pred             CC
Confidence            65

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.9e-39  Score=279.72  Aligned_cols=222  Identities=27%  Similarity=0.422  Sum_probs=180.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      +|++.+.||+|+||.||+|....      ...+++|......    ..++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778999999999999998531      2468888765433    2457889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCc-------------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          148 IYEYIPNGSVSIHLYGPSQ-------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      ++||+++|+|.+++.....                   .....+++..++.++.|++.||.|||+  .+++||||||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~ni  158 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNV  158 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhheE
Confidence            9999999999988753211                   112357889999999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----  283 (302)
                      |+++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||....    
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999976543222212223345667999999988899999999999999999998 999987432    


Q ss_pred             -------------CCChhhHHHHHHHHhhcc
Q 022118          284 -------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -------------~~~~~~l~~~~~~~~~~~  301 (302)
                                   ...+.++.+++.+||..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~  269 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQE  269 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence                         234568889999999765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-39  Score=276.61  Aligned_cols=220  Identities=26%  Similarity=0.409  Sum_probs=176.3

Q ss_pred             CcCCeeeeCCCeeEEEEEEcC-C--cEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC------Cee
Q 022118           80 SDKNLIGEGKFGEVYKGLLQD-G--MLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQ  145 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~  145 (302)
                      .+.+.||+|+||.||+|...+ +  ..+|+|..+..     ..+.+.+|+++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999998654 3  26899976533     134578899999999999999999987532      246


Q ss_pred             eEEEeccCCCCccccccCCC-cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      +++|||+++|+|.+++.... ......+++.....++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            89999999999988874221 1233457899999999999999999998  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDS  286 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~  286 (302)
                      +................+..|++||...+..++.++||||||+++|||++ |+.||...                 +...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC  239 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            87654332222233345677999999999999999999999999999999 88898642                 2334


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +..+.+++.+||.++
T Consensus       240 ~~~~~~li~~~l~~~  254 (272)
T cd05075         240 LDGLYSLMSSCWLLN  254 (272)
T ss_pred             CHHHHHHHHHHcCCC
Confidence            567899999999765

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-39  Score=279.23  Aligned_cols=224  Identities=26%  Similarity=0.395  Sum_probs=181.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||.||+|...      .+..|++|......    ...+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456888899999999999999864      35679999765433    23588899999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCc--CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVAD  220 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~---~~kl~D  220 (302)
                      +++|||+++++|.+++.....  .....+++..+..++.||+.|++|||+  ++++||||||+||+++.++   .+||+|
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEecc
Confidence            999999999999998854321  122368899999999999999999998  6799999999999998654   699999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC----------------
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----------------  283 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----------------  283 (302)
                      ||+++................+..|+|||...+..++.++|||||||++|||++ |+.||+...                
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~  242 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP  242 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999987643322222222233567999999998899999999999999999997 999987532                


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...+..+.+++++||..+
T Consensus       243 ~~~~~~~~~~~i~~cl~~~  261 (277)
T cd05036         243 PKGCPGPVYRIMTDCWQHT  261 (277)
T ss_pred             CCCCCHHHHHHHHHHcCCC
Confidence             234567889999999764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.7e-39  Score=281.61  Aligned_cols=227  Identities=28%  Similarity=0.466  Sum_probs=185.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      .+..++|+..+.||+|+||.||++....      ...+|+|.......    .++.+|+++++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3455678888999999999999998542      36799998654322    3477899999999 89999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      ++..+++|||+++|+|..++.....           .....+++..++.++.|++.||+|||+  ++|+||||||+||++
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~  165 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEE
Confidence            9999999999999999988843210           234568899999999999999999998  679999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------
Q 022118          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------  283 (302)
Q Consensus       211 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------  283 (302)
                      ++++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||...+      
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332222222334567999999998999999999999999999997 888886432      


Q ss_pred             -----------CCChhhHHHHHHHHhhcc
Q 022118          284 -----------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----------~~~~~~l~~~~~~~~~~~  301 (302)
                                 ...+.++.+++.+||.++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~  274 (293)
T cd05053         246 LLKEGYRMEKPQNCTQELYHLMRDCWHEV  274 (293)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccC
Confidence                       234578899999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-39  Score=278.82  Aligned_cols=219  Identities=28%  Similarity=0.464  Sum_probs=178.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|+..+.||+|+||+||+|... ++.    .||+|......    ...+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            457888899999999999999843 343    58999765432    34577899999999999999999998754 568


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||+|||+  ++++||||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999988842    23468899999999999999999998  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ..............++..|+|||...+..++.++|||||||++|||++ |..||....                 ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI  238 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCH
Confidence            643222111222344567999999999999999999999999999998 899987432                 23456


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       239 ~~~~li~~~l~~d  251 (279)
T cd05109         239 DVYMIMVKCWMID  251 (279)
T ss_pred             HHHHHHHHHcCCC
Confidence            7889999999865

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.1e-39  Score=279.67  Aligned_cols=215  Identities=20%  Similarity=0.327  Sum_probs=180.8

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      |+..+.||+|+||+||++... +++.+|+|......      ...+.+|+++++.++|+||+.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999864 58899999764321      23467899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998887432   23468999999999999999999998  679999999999999999999999999987653221


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLV  291 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~  291 (302)
                         ......++..|+|||.+.+..++.++|+|||||++|||++|+.||....                    ...+.++.
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK  233 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence               1223467889999999998999999999999999999999999997532                    23456678


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||..+
T Consensus       234 ~li~~~l~~~  243 (285)
T cd05632         234 SICKMLLTKD  243 (285)
T ss_pred             HHHHHHccCC
Confidence            8888888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=275.67  Aligned_cols=218  Identities=26%  Similarity=0.386  Sum_probs=182.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ++|+..+.||+|++|.||++... ++..+++|......        .+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999864 58899999754221        2357889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ++||+++++|.+++..     ...+++..+..++.|++.|+.|||+  .+++||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999988832     3457788889999999999999998  67999999999999999999999999999765


Q ss_pred             CCCCCCCC-CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChh
Q 022118          228 GRTDVAGP-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQ  288 (302)
Q Consensus       228 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~  288 (302)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||....                  ...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP  234 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCH
Confidence            43221111 133457778999999999899999999999999999999999986421                  23467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||.++
T Consensus       235 ~~~~li~~~l~~~  247 (263)
T cd06625         235 DARNFLRRTFVEN  247 (263)
T ss_pred             HHHHHHHHHhhcC
Confidence            8889999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=300.41  Aligned_cols=197  Identities=28%  Similarity=0.455  Sum_probs=169.4

Q ss_pred             CCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCC------eeeE
Q 022118           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFL  147 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l  147 (302)
                      +...+.||+|+||.||++++ .+|..||||....    ...+.+-+|+++|++++|||||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34457899999999999994 5699999997544    45677889999999999999999999866543      4589


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCC--ceEEccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDF--IAKVADAGL  223 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~--~~~--~~kl~DfGl  223 (302)
                      +||||.+|||...|..+  .+...+++.+.+.+..+++.||.|||+  ++||||||||.||++-  .+|  ..||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999655  356789999999999999999999998  7799999999999983  334  469999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      |+.+.++.   .-....||+.|++||+... ..|+..+|.|||||++||+.||..||...
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99887654   3456789999999999995 78899999999999999999999999754

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-39  Score=276.81  Aligned_cols=198  Identities=26%  Similarity=0.339  Sum_probs=159.6

Q ss_pred             CeeeeCCCeeEEEEEEcC---CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||+|...+   ...+++|......    ...+.+|++.++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   4578888754332    235778999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+++...........++.....++.|++.|++|||+  .+|+||||||+|||+++++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999865433233445677888999999999999998  6799999999999999999999999999876433222222


Q ss_pred             CccccCcccccchhhhcc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 022118          236 SSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSL  282 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dvws~Gvil~el~~-g~~p~~~~  282 (302)
                      .....++..|+|||+...       ..++.++|||||||++|||++ |..||...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            233345667999998753       356789999999999999999 78888643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.1e-39  Score=280.76  Aligned_cols=224  Identities=29%  Similarity=0.472  Sum_probs=183.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-----------------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  134 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~  134 (302)
                      .++|++.+.||+|+||.||++....                 +..+|+|......    .+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999987542                 2458999865443    346788999999999999999


Q ss_pred             EEeEEeeCCeeeEEEeccCCCCccccccCCCcC------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       135 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      +++++..++..+++|||+++++|.+++......      ....+++..++.++.|++.||+|||+  .+++||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence            999999999999999999999999988543211      12368899999999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh--CCCCCCCCC---
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLS---  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~--g~~p~~~~~---  283 (302)
                      ++++++.++|+|||+++...............++..|+|||...+..++.++|||||||++|||++  |..||...+   
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999986644333333334456678999999988889999999999999999998  667775432   


Q ss_pred             ---------------------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                           ...+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  280 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRD  280 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccC
Confidence                                 122468999999999765

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-39  Score=283.68  Aligned_cols=225  Identities=28%  Similarity=0.443  Sum_probs=182.5

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      ...+|.+.+.||+|+||.||++...        +...+|+|......    ...+.+|+++++++ +||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3457888999999999999999742        23579999876432    23577899999999 79999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      .+..|+||||+++|+|.+++.....           .....+++.+++.++.|++.||+|||+  .+++||||||+||++
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill  173 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLV  173 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEE
Confidence            9999999999999999999854321           123458889999999999999999998  679999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------
Q 022118          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------  283 (302)
Q Consensus       211 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------  283 (302)
                      +.++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||...+      
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999876643222222222334567999999998899999999999999999998 888876422      


Q ss_pred             -----------CCChhhHHHHHHHHhhcc
Q 022118          284 -----------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----------~~~~~~l~~~~~~~~~~~  301 (302)
                                 ...+.++.+++.+||..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~  282 (307)
T cd05098         254 LLKEGHRMDKPSNCTNELYMMMRDCWHAV  282 (307)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcccC
Confidence                       234578889999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.5e-39  Score=275.44  Aligned_cols=219  Identities=30%  Similarity=0.507  Sum_probs=182.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ..+|++.+.||+|+||.||+|...+...+|+|.....  ..+.+.+|++++++++||||+++++.+.+ +..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            4568889999999999999998877677999987643  34578899999999999999999998754 56799999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||.++........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999998432   23457889999999999999999998  67999999999999999999999999999876543321


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                      . .....++..|+|||...+..++.++||||||+++|||++ |+.||....                 ...+.++.+++.
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (262)
T cd05071         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  237 (262)
T ss_pred             c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            1 223345667999999988899999999999999999999 888886432                 234577899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       238 ~~l~~~  243 (262)
T cd05071         238 QCWRKE  243 (262)
T ss_pred             HHccCC
Confidence            999765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=296.58  Aligned_cols=211  Identities=27%  Similarity=0.441  Sum_probs=177.1

Q ss_pred             CcCCeeeeCCCeeEEEEEEc-CCcEEE---EEe--c--CCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCe--eeEEE
Q 022118           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVA---IKK--R--PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL--QFLIY  149 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~-~~~~va---vK~--~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lv~  149 (302)
                      +...+||+|+|-+||+|.+. +|..||   +|.  +  .+...++|..|+.+|+.|+||||+++|+.|.+..+  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34578999999999999865 366665   332  2  23334789999999999999999999999987765  78899


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~kl~DfGla~~~~  228 (302)
                      |.+..|+|..|+.+     -...+...+..+++||++||.|||++.++|||||||++||||+ ..|.|||+|+|||..+.
T Consensus       123 EL~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999999843     4556778899999999999999999999999999999999997 45899999999998865


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQD  289 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~  289 (302)
                      ...    .....|||.|||||+.. ..|++.+||||||++++||+|+..||.....                   -..++
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe  272 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE  272 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence            432    33478999999999988 8999999999999999999999999996431                   12367


Q ss_pred             HHHHHHHHhhc
Q 022118          290 LVELMIKCMGK  300 (302)
Q Consensus       290 l~~~~~~~~~~  300 (302)
                      +.++|.+|+-.
T Consensus       273 vr~fIekCl~~  283 (632)
T KOG0584|consen  273 VREFIEKCLAT  283 (632)
T ss_pred             HHHHHHHHhcC
Confidence            78889998754

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.6e-39  Score=279.13  Aligned_cols=225  Identities=24%  Similarity=0.396  Sum_probs=182.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      ...+|++.+.||+|+||.||+|...      .+..||+|......    ...+.+|+.+++.++||||+++++.+...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999999743      24579999765433    2357789999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCc-----CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                      .+++|||+++|+|.+++.....     ......+...+..++.|++.||.|||+  ++++||||||+||++++++.++|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999854221     112445677888999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC---------------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS---------------  283 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~---------------  283 (302)
                      |||+++...............++..|+|||...+..++.++|+|||||++|||++ |..||....               
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD  241 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999986544332222223345667999999998899999999999999999999 788886421               


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+..+.+++.+|+..+
T Consensus       242 ~~~~~~~~~~~li~~~l~~~  261 (288)
T cd05061         242 QPDNCPERVTDLMRMCWQFN  261 (288)
T ss_pred             CCCCCCHHHHHHHHHHcCCC
Confidence              233577899999999765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.5e-39  Score=279.77  Aligned_cols=224  Identities=27%  Similarity=0.426  Sum_probs=181.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-----------------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-----------------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  134 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~  134 (302)
                      .++|++.+.||+|+||.||++...                 ++..+|+|......    ..++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457899999999999999998532                 23468999865432    346889999999999999999


Q ss_pred             EEeEEeeCCeeeEEEeccCCCCccccccCCCcC------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       135 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      +++++...+..+++|||+++++|.+++......      ....+++..+..++.|++.|++|||+  .+++||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheE
Confidence            999999999999999999999999888543211      12347788899999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh--CCCCCCCCC---
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLS---  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~--g~~p~~~~~---  283 (302)
                      |+++++.++|+|||+++.+.............++..|++||...+..++.++|||||||++|||++  |..||...+   
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322111222334667999999888899999999999999999998  778875321   


Q ss_pred             ---------------------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                           ...+..+.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  280 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRN  280 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCC
Confidence                                 234577889999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-38  Score=272.52  Aligned_cols=211  Identities=26%  Similarity=0.456  Sum_probs=173.1

Q ss_pred             eeeeCCCeeEEEEEEc---CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCC
Q 022118           84 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~  156 (302)
                      .||+|+||.||+|...   ++..||+|......    .+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999754   35579999765443    2457899999999999999999998864 56799999999999


Q ss_pred             ccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC-CC
Q 022118          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-GP  235 (302)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~  235 (302)
                      |.+++..    ....+++..++.++.|++.||+|||+  ++++||||||+||+++.++.+||+|||+++........ ..
T Consensus        81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9988842    24568899999999999999999998  67999999999999999999999999999865433211 11


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHHH
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIKC  297 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~~  297 (302)
                      .....++..|+|||...+..++.++|||||||++||+++ |..||....                 ...+.++.+++.+|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            122233567999999988889999999999999999996 999996432                 23467899999999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |..+
T Consensus       235 ~~~~  238 (257)
T cd05115         235 WIYK  238 (257)
T ss_pred             cCCC
Confidence            9764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=274.82  Aligned_cols=221  Identities=26%  Similarity=0.435  Sum_probs=179.0

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCe-----
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  144 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----  144 (302)
                      |.+.+.||+|+||.||+|....    +..+|+|......     ...+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998542    3679999765322     2457889999999999999999998876554     


Q ss_pred             -eeEEEeccCCCCccccccCCCc-CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          145 -QFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       145 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                       .+++|||+++|+|..++..... .....+++..+..++.|++.||.|||+  .+++||||||+||++++++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCcc
Confidence             6899999999999888744321 123568889999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------C
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------P  284 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~  284 (302)
                      +++................+..|+|||...+..++.++|||||||++|||++ |..||....                 .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            9987644332222223344667999999988899999999999999999999 888886432                 2


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+.++.+++++||..+
T Consensus       239 ~~~~~~~~li~~~l~~~  255 (273)
T cd05035         239 DCLDELYDLMYSCWRAD  255 (273)
T ss_pred             CCCHHHHHHHHHHcCCC
Confidence            34578899999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-39  Score=282.32  Aligned_cols=226  Identities=26%  Similarity=0.453  Sum_probs=184.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEe
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~  140 (302)
                      +...+|.+.+.||+|+||.||++...        ++..+|+|......    ...+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44567888899999999999999731        24579999865432    34678999999999 8999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nil  209 (302)
                      ..+..+++|||+++|+|.+++.....           .....+++..+..++.|++.||.|||+  ++++||||||+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEE
Confidence            99999999999999999999854321           123457888899999999999999998  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----
Q 022118          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----  283 (302)
Q Consensus       210 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----  283 (302)
                      +++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||...+     
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            99999999999999987654333222333345667999999998899999999999999999998 788876432     


Q ss_pred             ------------CCChhhHHHHHHHHhhcc
Q 022118          284 ------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------------~~~~~~l~~~~~~~~~~~  301 (302)
                                  ...+.++.+++.+||.++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  279 (304)
T cd05101         250 KLLKEGHRMDKPANCTNELYMMMRDCWHAI  279 (304)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccC
Confidence                        234568889999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6e-39  Score=277.82  Aligned_cols=224  Identities=29%  Similarity=0.498  Sum_probs=183.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|...+.||+|+||.||++...      ++..+++|......   ...+.+|+++++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            356777899999999999999632      35678888766543   346889999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCc----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          147 LIYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      ++|||+++++|.+++.....          .....+++..+..++.|++.|++|||+  .+++||||||+|||+++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCE
Confidence            99999999999998854321          112457889999999999999999998  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------  283 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------  283 (302)
                      ||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |++||....            
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            9999999876543222122223334677999999999999999999999999999998 999985421            


Q ss_pred             -----CCChhhHHHHHHHHhhcc
Q 022118          284 -----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----~~~~~~l~~~~~~~~~~~  301 (302)
                           ...+..+.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~  264 (280)
T cd05092         242 ELERPRTCPPEVYAIMQGCWQRE  264 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCC
Confidence                 234577899999999765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-41  Score=297.06  Aligned_cols=211  Identities=31%  Similarity=0.452  Sum_probs=179.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCCh------HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .|+.++.||.|+||.||.|+. .+...||||++.-...      ++++.|+..|.+++|||++.+.|+|-.+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466778999999999999995 4678999998653322      357789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ||- |+-.|.+.    .-+..+.+..+..|+.+.+.||+|||+  .+.||||||..|||+++.|.|||+|||.|.+..  
T Consensus       107 YCl-GSAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--  177 (948)
T KOG0577|consen  107 YCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--  177 (948)
T ss_pred             HHh-ccHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhcC--
Confidence            995 56666663    235677888999999999999999999  559999999999999999999999999997654  


Q ss_pred             CCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhh
Q 022118          231 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQD  289 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~  289 (302)
                          +...++||++|||||++.   .+.|+-++||||+|++..||.-.++|+.+++                  ++=+..
T Consensus       178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~  253 (948)
T KOG0577|consen  178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY  253 (948)
T ss_pred             ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence                356789999999999876   4689999999999999999999999988654                  122456


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++-.|+.+.
T Consensus       254 F~~Fvd~CLqKi  265 (948)
T KOG0577|consen  254 FRNFVDSCLQKI  265 (948)
T ss_pred             HHHHHHHHHhhC
Confidence            688888898763

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.8e-39  Score=275.82  Aligned_cols=220  Identities=28%  Similarity=0.475  Sum_probs=183.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..+|+..+.||+|+||.||+|... ++..+++|......  ...+.+|+++++.++||||+++++++..++..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            345777899999999999999865 47889999865443  356889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++..++.++.|++.||+|||+  ++++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999988432   23567889999999999999999998  6799999999999999999999999999987654322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~  294 (302)
                      .. ......+..|+|||...+..++.++|||||||++|||++ |..||...                 +...+.++.+++
T Consensus       160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         160 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             ec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            11 112233556999999999999999999999999999998 89898632                 223457889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       239 ~~cl~~~  245 (263)
T cd05052         239 RACWQWN  245 (263)
T ss_pred             HHHccCC
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.7e-39  Score=281.87  Aligned_cols=196  Identities=24%  Similarity=0.356  Sum_probs=164.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||.||+|... ++..+|+|.....    ....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999865 5788999975432    234577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++ +|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 77777632    23457888899999999999999998  679999999999999999999999999997653322


Q ss_pred             CCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  207 (309)
T cd07872         159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG  207 (309)
T ss_pred             c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  1223356788999998865 4689999999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.2e-39  Score=273.85  Aligned_cols=220  Identities=29%  Similarity=0.501  Sum_probs=183.5

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||.||+|...++..+|+|......  ..++.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            456788899999999999999998888999999865433  467899999999999999999999864 45689999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          83 ENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999988432   23467888999999999999999998  6799999999999999999999999999977653222


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      .. .....++..|+|||......++.++||||||+++|||++ |+.||....                 ...+.++.+++
T Consensus       158 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         158 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             cc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11 122335567999999998899999999999999999999 999996432                 22346799999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       237 ~~~l~~~  243 (260)
T cd05067         237 RLCWKEK  243 (260)
T ss_pred             HHHccCC
Confidence            9999765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8e-39  Score=273.93  Aligned_cols=219  Identities=28%  Similarity=0.505  Sum_probs=182.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .++|++.+.||+|+||.||++...++..+|+|.....  ..+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            3468888999999999999999888888999976543  3467889999999999999999999875 456799999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +++|.+++...   ....+++..+..++.|++.||+|||+  ++++||||||+||++++++.++|+|||++.........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999988432   23457899999999999999999998  67999999999999999999999999999876443221


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                      . .....++..|+|||...+..++.++|+||||+++|||++ |+.||....                 .+.+..+.+++.
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML  237 (260)
T ss_pred             c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            1 122234567999999988889999999999999999999 889986432                 234567889999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       238 ~~l~~~  243 (260)
T cd05070         238 QCWKKD  243 (260)
T ss_pred             HHcccC
Confidence            999765

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-38  Score=273.95  Aligned_cols=215  Identities=27%  Similarity=0.358  Sum_probs=171.4

Q ss_pred             CeeeeCCCeeEEEEEEcC---CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||+|...+   +..+++|......    ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   4578999765432    235788999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+++...........++..+..++.|++.|++|||+  .+++||||||+||+++.++++||+|||+++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            99999854322223455677788899999999999998  6799999999999999999999999999976544332222


Q ss_pred             CccccCcccccchhhhccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCC----------------------C
Q 022118          236 SSQVTADEIFLASEVKEFR-------RFSEKSDVYSFGVFLLELVS-GREASSSLSP----------------------D  285 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~-------~~~~~~Dvws~Gvil~el~~-g~~p~~~~~~----------------------~  285 (302)
                      .....++..|+|||++.+.       .++.++|+||||+++|||++ |+.||.....                      .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            3334567789999988642       35789999999999999996 9999864321                      2


Q ss_pred             ChhhHHHHHHHHhh
Q 022118          286 SSQDLVELMIKCMG  299 (302)
Q Consensus       286 ~~~~l~~~~~~~~~  299 (302)
                      .++.+.++|.+||.
T Consensus       239 ~~~~~~~l~~~c~~  252 (269)
T cd05087         239 LSDRWYEVMQFCWL  252 (269)
T ss_pred             CChHHHHHHHHHhc
Confidence            34566788899983

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.6e-39  Score=281.08  Aligned_cols=227  Identities=28%  Similarity=0.464  Sum_probs=183.3

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC  139 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~  139 (302)
                      .....+|.+.+.||+|+||.||++...        ....+|+|......    ...+.+|+++++++ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            344567888999999999999999742        24568999765432    23577899999999 699999999999


Q ss_pred             eeCCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          140 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      ...+..+++|||+++|+|.+++.....           .....+++..+..++.|++.||.|||+  ++++||||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Ni  165 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNV  165 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeE
Confidence            999999999999999999998854211           123468899999999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----  283 (302)
                      ++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...+    
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987654322222222334457999999998899999999999999999999 888886432    


Q ss_pred             -------------CCChhhHHHHHHHHhhcc
Q 022118          284 -------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -------------~~~~~~l~~~~~~~~~~~  301 (302)
                                   ...+.++.+++.+||..+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  276 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYMLMRECWHAV  276 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence                         233567889999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-38  Score=272.06  Aligned_cols=210  Identities=25%  Similarity=0.427  Sum_probs=173.5

Q ss_pred             eeeeCCCeeEEEEEEc---CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           84 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      .||+|+||.||+|.+.   ++..+|+|..+...     .+.+.+|+.+++.++||||+++++++.. +..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999643   46789999865332     3467889999999999999999998864 4668999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC-C
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-G  234 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~  234 (302)
                      +|.+++.     ....+++..+..++.|++.|++|||+  ++++||||||+||++++++.+||+|||+++........ .
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999883     23467889999999999999999998  67999999999999999999999999999876543221 1


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~~  296 (302)
                      ......++..|+|||.+....++.++|+|||||++|||++ |+.||...                 +...+.++.++|.+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL  233 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            1122234567999999988889999999999999999998 99999742                 23457889999999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||..+
T Consensus       234 ~~~~~  238 (257)
T cd05116         234 CWTYG  238 (257)
T ss_pred             HhccC
Confidence            99764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.3e-39  Score=278.26  Aligned_cols=224  Identities=29%  Similarity=0.459  Sum_probs=184.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|+..+.||+|+||.||++...      ++..+|+|......    ...+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999853      46789999866443    24578899999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCc-----------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQ-----------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      +++|||+++|+|.+++.....                 .....+++..++.++.|++.||+|||+  ++++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~ni  161 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNC  161 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHhhe
Confidence            999999999999999853211                 112357888899999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----  282 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----  282 (302)
                      ++++++.++|+|||+++................+..|+|||...+..++.++|||||||++|||++ |..||...     
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999876543332222223344567999999998999999999999999999998 88888532     


Q ss_pred             ------------CCCChhhHHHHHHHHhhcc
Q 022118          283 ------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                  +...+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  272 (288)
T cd05050         242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKL  272 (288)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence                        2344678999999999764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=270.92  Aligned_cols=196  Identities=24%  Similarity=0.334  Sum_probs=170.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEe-----cCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~-----~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .+.|++.++||+|.|+.|+++.+ .+|+.+|+|.     +.....+++.+|+++.+.|+||||+++.+...+.+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            34577778999999999999875 4577777664     45556788999999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~---~~~~~kl~DfGla~~  226 (302)
                      |+++|++|..-+     ..+..+++..+-...+||+.+|.|+|.  ++|||||+||+|+++.   +.--+||+|||+|..
T Consensus        90 e~m~G~dl~~eI-----V~R~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDI-----VAREFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999997666     234667788888899999999999998  7899999999999994   445789999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++..   .......||+.|||||++...+|+..+|||+.||+||-|+.|.+||..
T Consensus       163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            8722   234567899999999999999999999999999999999999999986

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-38  Score=272.75  Aligned_cols=217  Identities=27%  Similarity=0.455  Sum_probs=182.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +|+..+.||+|+||.||+|...++..+|+|......         ...+.+|++++++++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467789999999999999998888999999754321         13478899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      +||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+++|+||+|+||++++++.++|+|||+++...
T Consensus        81 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999883     23457888889999999999999998  679999999999999999999999999987653


Q ss_pred             CCCC----CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CC
Q 022118          229 RTDV----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PD  285 (302)
Q Consensus       229 ~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~  285 (302)
                      ....    ........++..|+|||...+..++.++|+||||+++|||++|+.||....                   ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS  233 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCC
Confidence            2111    111233457888999999998899999999999999999999999996422                   22


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++++||.++
T Consensus       234 ~~~~~~~~i~~~l~~~  249 (265)
T cd06631         234 FSAAAIDFVTSCLTRD  249 (265)
T ss_pred             CCHHHHHHHHHHhcCC
Confidence            3567889999999764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-39  Score=279.99  Aligned_cols=224  Identities=27%  Similarity=0.439  Sum_probs=180.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC---------------CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD---------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLL  136 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~  136 (302)
                      .++|++.+.||+|+||.||++....               ...||+|......    ...+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4578899999999999999987532               2358999865432    24588899999999999999999


Q ss_pred             eEEeeCCeeeEEEeccCCCCccccccCCCc-------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 022118          137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (302)
Q Consensus       137 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nil  209 (302)
                      +++...+..++||||+++++|.+++.....       .....+++..++.++.|++.||+|||+  .+++||||||+||+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEE
Confidence            999999999999999999999988843210       111346888999999999999999998  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh--CCCCCCCC-----
Q 022118          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSL-----  282 (302)
Q Consensus       210 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~--g~~p~~~~-----  282 (302)
                      +++++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++  |..||...     
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976543322222223345678999999998899999999999999999998  66777532     


Q ss_pred             -------------------CCCChhhHHHHHHHHhhcc
Q 022118          283 -------------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -------------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                         ++..+..+.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  279 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD  279 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCC
Confidence                               1223467899999999865

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.7e-39  Score=287.66  Aligned_cols=195  Identities=24%  Similarity=0.350  Sum_probs=163.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----  143 (302)
                      ..++|+..+.||+|+||.||++... ++..+|+|.....     ....+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3468999999999999999999864 5889999986432     2346788999999999999999999986543     


Q ss_pred             -eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          144 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       144 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                       ..|+||||+++ +|...+       ...++...+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVI-------HMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHH-------hccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEecCC
Confidence             46999999976 454444       1246778888999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      +++......   ......+|..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            997643221   123446788899999999999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.8e-39  Score=275.64  Aligned_cols=220  Identities=25%  Similarity=0.370  Sum_probs=182.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||.||+|... ++..+|+|.....      ....+.+|++++++++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47888999999999999999854 6889999964321      1245788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.... .....+++..+..++.|++.||+|||+  ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988774321 123457888899999999999999998  6799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQD  289 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~  289 (302)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....                    ...+.+
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            221  1123457778999999998889999999999999999999999985321                    133467


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       237 ~~~li~~cl~~~  248 (267)
T cd08228         237 LRELVSMCIYPD  248 (267)
T ss_pred             HHHHHHHHCCCC
Confidence            899999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-38  Score=275.92  Aligned_cols=209  Identities=24%  Similarity=0.367  Sum_probs=177.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +|+..+.||+|+||.||++.. .++..+|+|......    ...+.+|++++++++||||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999985 468889999764332    245788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|..+.         .+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999886432         35677888999999999999998  67999999999999999999999999999765432  


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------------CCCh
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------------PDSS  287 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------------~~~~  287 (302)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....                         ...+
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS  226 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence              1233467888999999999999999999999999999999999986421                         1234


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||.++
T Consensus       227 ~~~~~li~~~l~~~  240 (279)
T cd06619         227 EKFVHFITQCMRKQ  240 (279)
T ss_pred             HHHHHHHHHHhhCC
Confidence            57889999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-38  Score=269.38  Aligned_cols=212  Identities=30%  Similarity=0.510  Sum_probs=177.8

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCcc
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (302)
                      ++||+|+||.||++...++..+|+|.......    ..+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988888999998655432    35788999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 022118          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  238 (302)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  238 (302)
                      +++..    ....+++..+..++.|++.||.|+|+  ++++||||||+||++++++.+||+|||++......... ....
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~  153 (250)
T cd05085          81 SFLRK----KKDELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL  153 (250)
T ss_pred             HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence            88732    23457889999999999999999998  67999999999999999999999999998765432211 1122


Q ss_pred             ccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHHHHhhc
Q 022118          239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       239 ~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~~~~~~  300 (302)
                      ..++..|+|||......++.++||||||+++||+++ |..||...                 +...+.++.+++.+||..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccc
Confidence            234567999999998889999999999999999998 99998642                 123457889999999976


Q ss_pred             c
Q 022118          301 E  301 (302)
Q Consensus       301 ~  301 (302)
                      +
T Consensus       234 ~  234 (250)
T cd05085         234 K  234 (250)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-38  Score=273.37  Aligned_cols=217  Identities=22%  Similarity=0.306  Sum_probs=180.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..+|++.+.||+|+||.||+|.. .++..+|+|.....   ....+.+|+.++++++||||+++++.+...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45789999999999999999996 45788999976533   234577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.     ....+++..+..++.|++.|++|||+  .+|+||||||+||++++++.+||+|||+++......
T Consensus        88 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999998873     23467889999999999999999998  679999999999999999999999999998764321


Q ss_pred             CCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------------------CCh
Q 022118          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSP---------------------DSS  287 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---------------------~~~  287 (302)
                      .  ......++..|+|||.+.   ...++.++|+|||||++|||++|+.||....+                     ..+
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS  238 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence            1  123345778899999874   34578899999999999999999999853210                     124


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      ..+.+++.+||..+
T Consensus       239 ~~~~~li~~~l~~~  252 (267)
T cd06646         239 STFHNFVKISLTKN  252 (267)
T ss_pred             HHHHHHHHHHhhCC
Confidence            57889999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=313.96  Aligned_cols=206  Identities=26%  Similarity=0.321  Sum_probs=181.1

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEe
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQ  140 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~  140 (302)
                      ...++.....+|+++++||+|+||.|.+++++ +++.+|+|++.      ...+.-|+.|-++|..-+.+.|+.+...|+
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            45667778889999999999999999999965 58899999754      344566889999999999999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      +++++|+||||++||||..++.     .-..+++..+.++...|+.||.-||+  .|+|||||||+|||+|..|++||+|
T Consensus       146 D~~~LYlVMdY~pGGDlltLlS-----k~~~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLS-----KFDRLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             CccceEEEEecccCchHHHHHh-----hcCCChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999982     23378999999999999999999999  6699999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ||.+-.+..++.. .....+|||-|.+||++..     +.|++.+|+||+||++|||++|..||..
T Consensus       219 FGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  219 FGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             chhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            9999887654433 3556789999999998763     5689999999999999999999999973

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=275.93  Aligned_cols=215  Identities=31%  Similarity=0.457  Sum_probs=176.3

Q ss_pred             CCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeE
Q 022118           79 FSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  147 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  147 (302)
                      |+..+.||+|+||+||++..     .++..+|+|.....    ....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47889999999999988653     35778999986543    235678999999999999999999988754  35789


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|||+++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLP------KHKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHH------HcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999998883      2358999999999999999999998  67999999999999999999999999999866


Q ss_pred             CCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------
Q 022118          228 GRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------  283 (302)
Q Consensus       228 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------  283 (302)
                      ...... .......++..|+|||...+..++.++||||||+++|||++|..||...+                       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            432211 11122345567999999988889999999999999999999999975422                       


Q ss_pred             ---------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------~~~~~~l~~~~~~~~~~~  301 (302)
                               ...+..+.+++.+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~  264 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETE  264 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence                     123468889999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.8e-39  Score=280.16  Aligned_cols=224  Identities=25%  Similarity=0.386  Sum_probs=183.2

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      ....++|...+.||+|+||.||++...      ++..+|+|......    .+.+.+|+++++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            344567888999999999999999742      24579999765432    24578899999999 79999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      .+..+++|||+++|+|.+++...   ....+++.++..++.|++.|++|||+  ++++|+||||+|||++.++.++++||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999988432   12337899999999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------  283 (302)
                      |+++...............++..|+|||.+.+..++.++||||+||++|||++ |..||...+                 
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  265 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ  265 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence            99986643321111222345677999999999999999999999999999998 999986432                 


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...+.++.+++.+||.++
T Consensus       266 ~~~~~~~~~~li~~cl~~~  284 (302)
T cd05055         266 PEHAPAEIYDIMKTCWDAD  284 (302)
T ss_pred             CCCCCHHHHHHHHHHcCCC
Confidence             123567889999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=287.50  Aligned_cols=208  Identities=21%  Similarity=0.279  Sum_probs=170.1

Q ss_pred             eeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC---CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        85 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ||+|+||+||+|... ++..+|+|.....      .......|..++...   +||||+++++.+.+++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 5889999986432      122345566666554   799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|..++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~  151 (330)
T cd05586          81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K  151 (330)
T ss_pred             ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence            99988873     34568899999999999999999998  679999999999999999999999999987542221  1


Q ss_pred             CCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~~~  296 (302)
                      ......||..|+|||.+.+. .++.++|||||||++|||++|+.||....                 ...+.++.+++.+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  231 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG  231 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            23345688999999998754 58999999999999999999999986532                 1235667788888


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||.++
T Consensus       232 ~L~~~  236 (330)
T cd05586         232 LLNRN  236 (330)
T ss_pred             HcCCC
Confidence            88764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-38  Score=276.08  Aligned_cols=225  Identities=26%  Similarity=0.451  Sum_probs=183.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC-----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee-CCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~  144 (302)
                      ..++|++.+.||+|+||.||+|....     +..|++|......    ...+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678889999999999999999765     6789999765432    2457889999999999999999998876 467


Q ss_pred             eeEEEeccCCCCccccccCCCcC---CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      .++++||+++++|.+++......   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEECCC
Confidence            79999999999999988543211   12568899999999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------  283 (302)
                      |+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||....                 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  241 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP  241 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence            99986643322211223345667999999999999999999999999999999 999986421                 


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~li~~~l~~~  259 (280)
T cd05043         242 INCPDELFAVMACCWALD  259 (280)
T ss_pred             CcCCHHHHHHHHHHcCCC
Confidence            233577899999999764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=317.14  Aligned_cols=188  Identities=30%  Similarity=0.537  Sum_probs=159.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      ..+...+.||+|+||.||+|.. .++..||+|+...... ....|++.+++++||||++++|+|.+++..|+||||+++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            4577788999999999999996 4688999998754332 2246789999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-CCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      +|.+++.        .+++..+..++.|++.|++|||.. .++|+||||||+||+++.++..++. ||.+.....     
T Consensus       769 ~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        769 NLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             cHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999982        378899999999999999999953 3689999999999999999988876 665543211     


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                       .....++..|+|||+..+..|+.++|||||||++|||++|+.||+
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence             122357788999999999999999999999999999999999985

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-38  Score=271.71  Aligned_cols=217  Identities=27%  Similarity=0.414  Sum_probs=183.6

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|++|.||++... ++..+++|....     .....+.+|++++++++||||+++++.+.+.+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999865 588899997542     2345688899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999988532   23567889999999999999999998  679999999999999999999999999988765432


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      ..  .....++..|+|||+..+..++.++|+||||+++|||++|+.||....                 ...+.++.+++
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd08529         156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI  233 (256)
T ss_pred             ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence            21  223457788999999999999999999999999999999999987432                 13356789999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       234 ~~~l~~~  240 (256)
T cd08529         234 DQCLTKD  240 (256)
T ss_pred             HHHccCC
Confidence            9999653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-38  Score=282.54  Aligned_cols=228  Identities=27%  Similarity=0.451  Sum_probs=184.3

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeE
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGY  138 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~  138 (302)
                      +.+...+|++.+.||+|+||.||++...        ++..+|+|......    .+.+.+|+++++++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3445567889999999999999999742        12368999765432    34678899999999 89999999999


Q ss_pred             EeeCCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 022118          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  207 (302)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~N  207 (302)
                      +...+..+++|||+++|+|.+++.....           .....+++..+..++.|++.||+|||+  ++++||||||+|
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~N  164 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARN  164 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccce
Confidence            9999999999999999999998854211           123467889999999999999999998  679999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC---
Q 022118          208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS---  283 (302)
Q Consensus       208 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~---  283 (302)
                      |+++.++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||...+   
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999987654332222223334567999999999999999999999999999998 888886432   


Q ss_pred             --------------CCChhhHHHHHHHHhhcc
Q 022118          284 --------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------------~~~~~~l~~~~~~~~~~~  301 (302)
                                    ...+.++.+++.+||..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  276 (334)
T cd05100         245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAV  276 (334)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence                          233567889999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-38  Score=276.96  Aligned_cols=213  Identities=24%  Similarity=0.347  Sum_probs=183.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||.||++... +++.+|+|....      ...+.+.+|++++++++||||+++++++...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999865 588999997543      22356788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLR-----KSGRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999998883     33568889999999999999999998  6799999999999999999999999999887543


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~  293 (302)
                      .     .....++..|+|||...+..++.++|+||||+++|+|++|+.||....                ...+..+.++
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHH
Confidence            2     234467788999999988888999999999999999999999986432                2335678889


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       229 i~~~l~~~  236 (290)
T cd05580         229 IRNLLQVD  236 (290)
T ss_pred             HHHHccCC
Confidence            99998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.9e-39  Score=285.01  Aligned_cols=226  Identities=24%  Similarity=0.382  Sum_probs=179.6

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEE------cCCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeC
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~  142 (302)
                      +..++|++.+.||+|+||.||+|..      .+++.||+|......    ...+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456789999999999999999973      246789999875432    23577899999999 789999999988755


Q ss_pred             -CeeeEEEeccCCCCccccccCCCcC------------------------------------------------------
Q 022118          143 -NLQFLIYEYIPNGSVSIHLYGPSQV------------------------------------------------------  167 (302)
Q Consensus       143 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------  167 (302)
                       ...+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             4578999999999999887532100                                                      


Q ss_pred             --------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccc
Q 022118          168 --------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV  239 (302)
Q Consensus       168 --------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~  239 (302)
                              ....+++..+..++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||+++..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    01246788889999999999999998  67999999999999999999999999999865432221122233


Q ss_pred             cCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------------CCChhhHHHHHHHHhhc
Q 022118          240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLVELMIKCMGK  300 (302)
Q Consensus       240 ~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------------~~~~~~l~~~~~~~~~~  300 (302)
                      .++..|+|||...+..++.++||||||+++|||++ |..||....                  ...++++.+++.+||..
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            45567999999998899999999999999999997 899986432                  11345788999999976


Q ss_pred             c
Q 022118          301 E  301 (302)
Q Consensus       301 ~  301 (302)
                      +
T Consensus       322 ~  322 (343)
T cd05103         322 E  322 (343)
T ss_pred             C
Confidence            5

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=292.05  Aligned_cols=209  Identities=24%  Similarity=0.324  Sum_probs=176.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC--hHHHHHHHHHhccCC-C-----CceeeEEeEEeeCCeeeEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-H-----RNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~lv  148 (302)
                      +|++.+.||+|+||.|.+|.. .+++.||||.++...  ..+-..|+.+|..++ |     -|+|+++++|...+..|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            678899999999999999985 469999999876544  345667999999886 4     4899999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC--CceEEcccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNF  226 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~--~~~kl~DfGla~~  226 (302)
                      +|.+. -+|.+++..   .....++...+..++.||+.||.+||+  .+|||+||||+||||.+-  ..+||+|||.|..
T Consensus       267 fELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  267 FELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99985 589999943   345678999999999999999999998  679999999999999644  3899999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      .+...     ..+.-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+   ++..+++..|..-+|.
T Consensus       341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG---~ne~DQl~~I~e~lG~  406 (586)
T KOG0667|consen  341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG---DNEYDQLARIIEVLGL  406 (586)
T ss_pred             cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC---CCHHHHHHHHHHHhCC
Confidence            65432     256677789999999999999999999999999999999877765   4456777777776653

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-38  Score=278.24  Aligned_cols=194  Identities=22%  Similarity=0.298  Sum_probs=167.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||.||++... ++..+++|......    ..++.+|++++++++||||+++++.+..++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 57788888765332    24578899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++..     ...+++..+..++.|++.||.|||+. .+++||||||+|||+++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999832     35578888999999999999999972 46999999999999999999999999998765322 


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                         ......++..|+|||...+..++.++|+||||+++|||++|+.||.
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence               1234567888999999988889999999999999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-38  Score=275.69  Aligned_cols=219  Identities=30%  Similarity=0.451  Sum_probs=179.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      ..|++.+.||+|+||.||++..     .++..+|+|......    ...+.+|+.+++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999974     247789999865432    34688899999999999999999998875  567


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||+|||+  ++++||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999998832    22357899999999999999999998  789999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC-----------------------
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS-----------------------  281 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~-----------------------  281 (302)
                      ........ .......++..|+|||...+..++.++|||||||++|||++++.|+..                       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76443211 112234566779999999988999999999999999999998765321                       


Q ss_pred             ---------CCCCChhhHHHHHHHHhhcc
Q 022118          282 ---------LSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 ---------~~~~~~~~l~~~~~~~~~~~  301 (302)
                               .+...+.++.+++.+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~  266 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQ  266 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence                     12334578899999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-38  Score=278.81  Aligned_cols=221  Identities=28%  Similarity=0.502  Sum_probs=178.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc--EEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM--LVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|++.+.||+|+||.||+|... ++.  .+++|......    ...+.+|++++.++ +||||+++++++...+..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457888899999999999999864 343  46777655332    23577899999999 89999999999999999999


Q ss_pred             EEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          148 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      +|||+++++|.+++.....           .....+++..++.++.|++.|++|||+  ++++||||||+|||+++++.+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCCCcE
Confidence            9999999999998854321           112467899999999999999999998  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------  283 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------  283 (302)
                      ||+|||+++......   .......+..|+|||...+..++.++|||||||++|||++ |..||....            
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            999999986432111   1112234567999999988889999999999999999998 999986421            


Q ss_pred             -----CCChhhHHHHHHHHhhcc
Q 022118          284 -----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----~~~~~~l~~~~~~~~~~~  301 (302)
                           ...+.++.+++.+||..+
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~  263 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREK  263 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCC
Confidence                 123567889999999765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=271.31  Aligned_cols=222  Identities=29%  Similarity=0.552  Sum_probs=186.3

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +..++|++.+.||+|+||.||++...++..+++|.....  ..+++.+|+.++++++||||+++++++......+++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            345678899999999999999999887888999986543  346789999999999999999999999998899999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||+  ++++|+||||+||++++++.+||+|||+++......
T Consensus        83 ~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999998432   23468899999999999999999998  679999999999999999999999999998765322


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      .. .......+..|+|||.+.+..++.++|+||+|+++|||++ |+.||....                 ...+.++.++
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            11 1112234457999999998889999999999999999998 999986432                 2335678899


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       237 i~~~l~~~  244 (261)
T cd05034         237 MLQCWDKD  244 (261)
T ss_pred             HHHHcccC
Confidence            99999765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-38  Score=272.53  Aligned_cols=220  Identities=28%  Similarity=0.437  Sum_probs=181.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccC-CCCceeeEEeEEeeC------Ce
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN------NL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~~  144 (302)
                      +.+.|+..+.||+|+||.||+|... ++..+|+|.....  ....+.+|+.+++++ +||||+++++++...      +.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            3456788899999999999999865 5788999986433  345688899999988 799999999998753      45


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|++|||+++++|.+++...   ....+++..+..++.|++.|++|||+  .+|+||||||+||++++++.+||+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            78999999999999988432   23467889999999999999999998  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------  283 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------  283 (302)
                      +......  .......++..|+|||++.     +..|+.++|||||||++|||++|+.||....                
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            8654321  2234456788899999886     3468889999999999999999999986321                


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+.++.+++.+||..+
T Consensus       237 ~~~~~~~~~~~li~~~l~~~  256 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKN  256 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCC
Confidence              234578899999999764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.1e-38  Score=271.34  Aligned_cols=218  Identities=28%  Similarity=0.467  Sum_probs=180.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      .+|++.+.||+|++|.||++....+..+++|.....  ..+.+.+|++++++++|||++++++++. .+..+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            457888999999999999999877777999976543  3356889999999999999999999875 4567999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++.++|+|||+++........ 
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          85 GSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            9999988432   23457888999999999999999998  67999999999999999999999999999876443221 


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~  296 (302)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....                 ...+..+.+++.+
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL  238 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence            1122345667999999998899999999999999999999 899986532                 2345678899999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||.++
T Consensus       239 ~l~~~  243 (260)
T cd05069         239 CWKKD  243 (260)
T ss_pred             HccCC
Confidence            99865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.9e-38  Score=272.44  Aligned_cols=196  Identities=22%  Similarity=0.331  Sum_probs=166.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|+..+.||+|+||.||++... +++.+|+|+....     ..+.+.+|+.++++++||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999976 5889999975322     23457889999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|..++.     ....+++..+..++.|++.||+|||+  .+++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999988877652     23458899999999999999999998  67999999999999999999999999999876443


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~  203 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG  203 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            21  1123346778999999876 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=295.33  Aligned_cols=215  Identities=28%  Similarity=0.432  Sum_probs=185.1

Q ss_pred             CcCCeeeeCCCeeEEEEEEcC--C--cEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           80 SDKNLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ...++||+|.||.|++|.+..  |  ..||||++...    ...+|++|+.+|.+|+|||+++|||+..+ ....||||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            345889999999999998653  3  46999986543    34689999999999999999999999987 567899999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      ++.|+|.+.|++   ..+..|.......++.||+.||.||.+  +++|||||..+|+|+-...+||||||||.+-++..+
T Consensus       192 aplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999965   245677888889999999999999998  789999999999999999999999999999887543


Q ss_pred             -CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHH
Q 022118          232 -VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       232 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                       .+.......-+..|.|||.+....++.+||||+|||++|||+| |+.||.+.                 +..|++++++
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~  346 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ  346 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence             2223344556677999999999999999999999999999999 78899854                 3578999999


Q ss_pred             HHHHHhhc
Q 022118          293 LMIKCMGK  300 (302)
Q Consensus       293 ~~~~~~~~  300 (302)
                      .|.+||.-
T Consensus       347 imk~cWah  354 (1039)
T KOG0199|consen  347 IMKNCWAH  354 (1039)
T ss_pred             HHHHhccC
Confidence            99999964

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=273.05  Aligned_cols=219  Identities=29%  Similarity=0.463  Sum_probs=180.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-C----cEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-G----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..+|+..+.||+|+||.||+|...+ +    ..+|+|......    ...+.+|+.++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3567888999999999999998543 3    258899765443    2467889999999999999999999987 7789


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ++|||+++|+|.+++..    ....+++..+..++.|++.|++|||+  .+++||||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999999843    23458899999999999999999998  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ..............++..|+|||......++.++|+||||+++||+++ |+.||...+                 ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI  238 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence            653322111222234567999999988899999999999999999998 999997533                 22456


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       239 ~~~~~~~~~l~~~  251 (279)
T cd05057         239 DVYMVLVKCWMID  251 (279)
T ss_pred             HHHHHHHHHcCCC
Confidence            7888999999765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-38  Score=269.77  Aligned_cols=217  Identities=27%  Similarity=0.480  Sum_probs=180.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------------hHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------------TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      +|.....||+|++|.||+|... ++..+|+|......            .+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999864 57889999654221            1347789999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .+++|||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+++||||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHH-----hccCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999883     23457888889999999999999998  67999999999999999999999999999


Q ss_pred             cccCCCCCC----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------
Q 022118          225 NFLGRTDVA----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------  283 (302)
Q Consensus       225 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------  283 (302)
                      +........    .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....                 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP  233 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC
Confidence            876532111    11123457788999999998899999999999999999999999997421                 


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++++||.++
T Consensus       234 ~~~~~~~~~li~~~l~~~  251 (267)
T cd06628         234 SNISSEAIDFLEKTFEID  251 (267)
T ss_pred             cccCHHHHHHHHHHccCC
Confidence            234677899999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.6e-38  Score=271.01  Aligned_cols=219  Identities=28%  Similarity=0.485  Sum_probs=180.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .+|++.+.||+|+||.||+|...    ++..+|+|..+...    .+.+.+|+.++++++||||+++++++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853    23479999865433    24678899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++..    ....+++.++..++.|++.|++|||+  .+++||||||+||+++.++.++++|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999842    23457889999999999999999998  679999999999999999999999999998765


Q ss_pred             CCCCCC-CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhh
Q 022118          229 RTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQD  289 (302)
Q Consensus       229 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~  289 (302)
                      ...... ......++..|++||...+..++.++|+||||+++||+++ |+.||....                 ...+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA  237 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence            422111 1112233457999999998899999999999999999886 999986432                 233568


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||.++
T Consensus       238 ~~~li~~~l~~~  249 (267)
T cd05066         238 LHQLMLDCWQKD  249 (267)
T ss_pred             HHHHHHHHcccC
Confidence            899999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.5e-38  Score=273.80  Aligned_cols=195  Identities=24%  Similarity=0.341  Sum_probs=160.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccC---CCCceeeEEeEEeeC-----C
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQEN-----N  143 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----~  143 (302)
                      +|++.+.||+|+||+||+|... +++.+|+|.....     ......+|+++++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 5889999975432     123456777777655   799999999988643     4


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..+++|||+++ +|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            57999999984 787777321   23458899999999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++......   ......++..|+|||.+.+..++.++||||+||++|||++|++||..
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~  209 (288)
T cd07863         155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  209 (288)
T ss_pred             cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence            98664322   12234578889999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.6e-38  Score=269.94  Aligned_cols=221  Identities=25%  Similarity=0.481  Sum_probs=183.8

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +...+|++.+.||+|+||.||++...++..+++|......  .+.+.+|++++++++|+||+++++.+.. ...+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3456788899999999999999998777889999765433  4568899999999999999999999887 778999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999998432   23457788899999999999999998  679999999999999999999999999997664322


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      .. ......++..|+|||.+....++.++|+|||||++|++++ |+.||....                 ...+.++.++
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            21 1222334567999999998889999999999999999999 999987532                 2234678899


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.++
T Consensus       236 i~~~l~~~  243 (260)
T cd05073         236 MMRCWKNR  243 (260)
T ss_pred             HHHHcccC
Confidence            99999764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.4e-38  Score=275.40  Aligned_cols=220  Identities=29%  Similarity=0.485  Sum_probs=178.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC-C--cEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD-G--MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|..+...    .+.+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998654 3  347888765422    24678899999999 799999999999999999999


Q ss_pred             EeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          149 YEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      |||+++++|.+++.....           .....+++..+..++.|++.|++|||+  .+++||||||+|||+++++.+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEE
Confidence            999999999998854211           012357889999999999999999998  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-------------
Q 022118          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-------------  283 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-------------  283 (302)
                      |+|||++......   ........+..|+|||......++.++|||||||++|||++ |+.||....             
T Consensus       160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999998643211   01111223456999999998899999999999999999997 999986432             


Q ss_pred             ----CCChhhHHHHHHHHhhcc
Q 022118          284 ----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----~~~~~~l~~~~~~~~~~~  301 (302)
                          ...+.++.+++.+||..+
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~  258 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDR  258 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCC
Confidence                234577889999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-38  Score=271.50  Aligned_cols=219  Identities=28%  Similarity=0.502  Sum_probs=179.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC-C---cEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|++.+.||+|+||.||+|.... +   ..+++|......    ..++..|+.+++.++||||+++++++.+++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357778999999999999998643 3   369999866432    34688999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++..    ....+++..+..++.|++.|++|||+  .+++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999988842    23467889999999999999999998  679999999999999999999999999987654


Q ss_pred             CCCCCCCC-cc--ccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCCh
Q 022118          229 RTDVAGPS-SQ--VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSS  287 (302)
Q Consensus       229 ~~~~~~~~-~~--~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~  287 (302)
                      ........ ..  ...+..|+|||...+..++.++|||||||++||+++ |..||....                 .+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  237 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCP  237 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCC
Confidence            32211111 11  112456999999999999999999999999999886 999986431                 2445


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      ..+.+++.+||.++
T Consensus       238 ~~~~~li~~~l~~~  251 (269)
T cd05065         238 TALHQLMLDCWQKD  251 (269)
T ss_pred             HHHHHHHHHHcCCC
Confidence            67889999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-38  Score=284.28  Aligned_cols=194  Identities=23%  Similarity=0.339  Sum_probs=163.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----  143 (302)
                      ..++|+..+.||+|+||.||++... .+..+|+|.....     ....+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999864 5788999986532     2345778999999999999999999886543     


Q ss_pred             -eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          144 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       144 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                       ..|++|||+++ ++...+       ...+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHH-------hhcCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCc
Confidence             46999999975 555554       1347788889999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +++..+...   ......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            998654322   12345678889999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.2e-38  Score=277.21  Aligned_cols=197  Identities=21%  Similarity=0.310  Sum_probs=158.3

Q ss_pred             CCeeeeCCCeeEEEEEEc---CCcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEee--CCeeeEEEeccCCC
Q 022118           82 KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNG  155 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~g  155 (302)
                      .+.||+|+||+||+|...   ++..+|+|...... ...+.+|++++++++||||+++++++..  +...+++|||+.+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            368999999999999864   46789999865433 4567899999999999999999999864  4567899999864 


Q ss_pred             CccccccCCC----cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEccccccccc
Q 022118          156 SVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFL  227 (302)
Q Consensus       156 ~L~~~l~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill----~~~~~~kl~DfGla~~~  227 (302)
                      +|.+++....    ......+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++..
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            6766653211    1122358889999999999999999998  679999999999999    45679999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          228 GRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..... ........+|..|+|||++.+. .|+.++||||+||++|||++|++||..
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            43221 1122345678899999998774 589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.5e-38  Score=275.24  Aligned_cols=216  Identities=21%  Similarity=0.371  Sum_probs=181.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..+|+..+.||+|+||.||++... ++..+++|......   .+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357888899999999999999854 57899999754332   35678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.      ...+++.++..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~------~~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999998873      2347888999999999999999998  679999999999999999999999999987653322


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVE  292 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~  292 (302)
                      .  ......++..|+|||...+..++.++|||||||++|+|++|+.||....                   ......+.+
T Consensus       171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (296)
T cd06654         171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (296)
T ss_pred             c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence            1  1223457788999999998889999999999999999999999986432                   122356788


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||.++
T Consensus       249 li~~~l~~~  257 (296)
T cd06654         249 FLNRCLDMD  257 (296)
T ss_pred             HHHHHCcCC
Confidence            999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-38  Score=269.24  Aligned_cols=216  Identities=31%  Similarity=0.503  Sum_probs=183.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|+..+.||+|+||.||++... ++.+|+|......  .+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            3457888999999999999999865 7889999876553  457889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++..+..++.|++.|+.|||+  .+++|+||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999988432   22368899999999999999999998  6799999999999999999999999999987633211


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                           ....+..|+|||.+....++.++||||||+++|||++ |+.||...+                 ...++++.+++
T Consensus       158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05039         158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence                 2234556999999988889999999999999999997 999986542                 23457889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      ++||..+
T Consensus       233 ~~~l~~~  239 (256)
T cd05039         233 KDCWELD  239 (256)
T ss_pred             HHHhccC
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=306.99  Aligned_cols=224  Identities=21%  Similarity=0.350  Sum_probs=180.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      ....+|++.+.||+|+||+||++... ++..+|+|.+...     ....+..|+.+++.++||||+++++++...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999965 4678889875432     234688999999999999999999988643  568


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC-----CCceecCCCCCCeeeCC--------
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-----PRVVHKDFKTANVLVDE--------  212 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----~~ivHrdlkp~Nill~~--------  212 (302)
                      |+||||+++|+|.+++.... .....+++..++.++.||+.||.|||+.+     ++||||||||+|||++.        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999998884321 12356899999999999999999999842     35999999999999964        


Q ss_pred             ---------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          213 ---------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       213 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                               .+.+||+|||+++.......   .....+|+.|+|||++.+  ..++.++|||||||+||||++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     23589999999987643221   234568899999999864  4589999999999999999999999974


Q ss_pred             CC-----------------CCChhhHHHHHHHHhhcc
Q 022118          282 LS-----------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 ~~-----------------~~~~~~l~~~~~~~~~~~  301 (302)
                      ..                 ...+.++.++|.+||..+
T Consensus       246 ~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~d  282 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLS  282 (1021)
T ss_pred             CCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCC
Confidence            22                 123567899999999764

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.8e-38  Score=269.23  Aligned_cols=220  Identities=25%  Similarity=0.414  Sum_probs=184.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||.||+|... ++..+++|....      ...+.+.+|++++++++|+||+++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            47888999999999999999976 688999996532      12456889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|..++.... .....+++..+..++.+++.|+.|||+  .+++|+||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999998874321 224557889999999999999999998  6799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------C-CChhh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------P-DSSQD  289 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~-~~~~~  289 (302)
                      ...  ......++..|+|||...+..++.++|+|||||++|+|++|+.||....                   . ..+.+
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            221  1223457778999999998899999999999999999999999985321                   1 33457


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       237 ~~~~i~~cl~~~  248 (267)
T cd08224         237 LRDLVSRCINPD  248 (267)
T ss_pred             HHHHHHHHcCCC
Confidence            889999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=283.24  Aligned_cols=198  Identities=22%  Similarity=0.261  Sum_probs=173.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      -|...+.||+|-|+.|-+|++ -+|..||||.+++..     +..+..|++-|+-++|||||++|.+..+...+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            466678999999999999984 579999999876554     34578999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-CCCCceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill-~~~~~~kl~DfGla~~~~~~  230 (302)
                      -++|+|.+|+.+.    +..+.+.....++.||+.|+.|+|+  ..+|||||||+||.+ .+-|.|||+|||++..+.+.
T Consensus        99 GD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999543    4568888999999999999999999  569999999999865 77899999999999876553


Q ss_pred             CCCCCCccccCcccccchhhhccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSP  284 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dvws~Gvil~el~~g~~p~~~~~~  284 (302)
                      .   ...+.+|+..|-|||++.+..|+ +++||||||||||.|++|++||+..++
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND  224 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND  224 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence            3   24567899999999999999997 579999999999999999999997553

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-38  Score=271.84  Aligned_cols=220  Identities=30%  Similarity=0.450  Sum_probs=177.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-----CCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      ..+|++.+.||+|+||.||++...     ++..+++|.......   +.+.+|++++++++||||+++++++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            346888899999999999999742     477899998765443   3678999999999999999999987543  467


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+||+|||+++
T Consensus        83 ~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            899999999999999832    23457889999999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCCC-CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------------
Q 022118          226 FLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------------  282 (302)
Q Consensus       226 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------------  282 (302)
                      ......... ......++..|+|||...+..++.++|||||||++|||++|..|+...                      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            764322111 111222345699999999889999999999999999999987664321                      


Q ss_pred             -----------CCCChhhHHHHHHHHhhcc
Q 022118          283 -----------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----------~~~~~~~l~~~~~~~~~~~  301 (302)
                                 +...+.++.+++.+||..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  266 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNND  266 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCC
Confidence                       1223467899999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-38  Score=267.00  Aligned_cols=217  Identities=34%  Similarity=0.529  Sum_probs=182.2

Q ss_pred             CeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||++....    +..+++|......    .+.+.+|++.++.++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    7789999865443    35688999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcC----CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          155 GSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       155 g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ++|.+++......    ....+++..+..++.|++.||+|||+  ++++|+||||+||++++++.+||+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999998432110    13678999999999999999999998  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                      ..........++..|+|||......++.++||||+|+++|||++ |..||...                 +...+.++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE  238 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence            32222334456778999999988899999999999999999999 69998753                 2344578899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       239 li~~~l~~~  247 (262)
T cd00192         239 LMLSCWQLD  247 (262)
T ss_pred             HHHHHccCC
Confidence            999999765

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.7e-38  Score=273.26  Aligned_cols=219  Identities=24%  Similarity=0.357  Sum_probs=181.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ..+.|++.+.||+|+||.||++.... +..+++|.......   +.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            34568889999999999999999754 78899998665443   457789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|..++..    ....+++..+..++.|++.|+.|||+  .+++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          90 FCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             cCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            9999999877632    23457889999999999999999998  67999999999999999999999999998754322


Q ss_pred             CCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDS  286 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~  286 (302)
                      .  .......++..|+|||.+.     ...++.++|||||||++|||++|+.||....                   ...
T Consensus       164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T cd06644         164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW  241 (292)
T ss_pred             c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCccc
Confidence            1  1123445777899999874     3457889999999999999999999986432                   122


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       242 ~~~~~~li~~~l~~~  256 (292)
T cd06644         242 SMEFRDFLKTALDKH  256 (292)
T ss_pred             CHHHHHHHHHHhcCC
Confidence            357889999999764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.4e-38  Score=268.49  Aligned_cols=217  Identities=20%  Similarity=0.324  Sum_probs=182.6

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +|++.+.||+|+||.||++... ++..+++|.....    ..+.+.+|+.+++.++||||+++++.+..++..|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999865 5888999975322    2356788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++.....++.|++.||.|||+  .+++|+||||+||++++++.++++|||+++.......
T Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999998887421   23457888899999999999999998  6799999999999999999999999999976643221


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                        ......++..|+|||+..+..++.++|+||||+++|+|++|+.||...+                 ...+.++.+++.
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (255)
T cd08219         156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK  233 (255)
T ss_pred             --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence              1233567888999999998899999999999999999999999997532                 223467788999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       234 ~~l~~~  239 (255)
T cd08219         234 QMFKRN  239 (255)
T ss_pred             HHHhCC
Confidence            999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=285.16  Aligned_cols=193  Identities=24%  Similarity=0.363  Sum_probs=169.9

Q ss_pred             CCeeeeCCCeeEEEEEEc-CCcEEEEEecC-----CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      .++||+|.||+||-|.++ +|+.||||.++     ......+++|+.||.+++||.||.+...|++++.+++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            388999999999999854 69999999644     444567899999999999999999999999999999999999765


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcccccccccCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl~DfGla~~~~~~~~  232 (302)
                      -|+..|    .....++++.....+..||+.||.|||.  ++|+|+||||+|||+.+.   -++||||||+|+++++...
T Consensus       649 MLEMIL----SsEkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  649 MLEMIL----SSEKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             HHHHHH----HhhcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            555555    2356788999999999999999999999  669999999999999543   4899999999999987654


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      .   ...+||+.|+|||++.+..|+..-|+||.|||+|--++|..||....
T Consensus       723 R---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  723 R---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             h---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence            3   45789999999999999999999999999999999999999998654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-39  Score=266.03  Aligned_cols=217  Identities=21%  Similarity=0.352  Sum_probs=182.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-------Ch----HHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-------PT----QEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~----~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      ..+.|...+.||+|..+.|.++..+ ++...|+|++.-.       ..    +.-.+|+.+++++ .||||+.+.+++++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456788899999999999988754 5778888864211       11    2346799999998 69999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      +...++|+|.|+.|.|.|+|     .+...+++....++++|+..|++|||.  +.||||||||+|||+|++..+||+||
T Consensus        95 ~sF~FlVFdl~prGELFDyL-----ts~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYL-----TSKVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHh-----hhheeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999     567889999999999999999999999  56999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------  283 (302)
                      |++..+.+..   .....+||+.|+|||.+.      ...|+..+|+||+|||+|.|+.|.+||-...            
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            9999886543   245679999999999865      3578999999999999999999999986211            


Q ss_pred             --------CCChhhHHHHHHHHhhcc
Q 022118          284 --------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------~~~~~~l~~~~~~~~~~~  301 (302)
                              ++-+.+..+++.+|+.-|
T Consensus       245 yqF~speWadis~~~KdLIsrlLqVd  270 (411)
T KOG0599|consen  245 YQFRSPEWADISATVKDLISRLLQVD  270 (411)
T ss_pred             cccCCcchhhccccHHHHHHHHHeeC
Confidence                    345667788888887644

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.3e-38  Score=270.99  Aligned_cols=197  Identities=27%  Similarity=0.391  Sum_probs=164.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|++|.||+|... ++..+|+|.....     ....+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999965 5889999975422     235678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      ++ ++|.+++...  .....+++..+..++.|++.||+|||+  .+++|+||||+||++++++.+||+|||++...+...
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 5787777432  123568899999999999999999998  679999999999999999999999999997654321


Q ss_pred             CCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  ......++..|+|||.+.+ ..++.++|||||||++|||++|++||..
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1  1122345778999998765 4578999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.4e-38  Score=267.79  Aligned_cols=218  Identities=29%  Similarity=0.457  Sum_probs=185.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .++|+..+.||+|+||.||++...+ +..+++|...... .+.+.+|++++++++||||+++++.+......|+++||++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            3578889999999999999999765 7889999865443 5678899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +++|.+++..    ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        82 ~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          82 AGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999998832    24567899999999999999999998  6799999999999999999999999999987654321 


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVELM  294 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~~  294 (302)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....                   ...+.++.+++
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence             1233456778999999999999999999999999999999999986432                   11235788999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       234 ~~~l~~~  240 (256)
T cd06612         234 KKCLVKD  240 (256)
T ss_pred             HHHHhcC
Confidence            9999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-38  Score=288.73  Aligned_cols=195  Identities=18%  Similarity=0.179  Sum_probs=166.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ...|.+.+.||+|+||.||++.... ++.||+|...   ...+.+|++++++++||||+++++++...+..+++||++. 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            3468889999999999999999754 7889999643   2345789999999999999999999999999999999995 


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|..++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       244 ~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        244 SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            688777732    23468999999999999999999998  679999999999999999999999999998764322222


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            2234568999999999999999999999999999999999887654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.4e-38  Score=266.98  Aligned_cols=215  Identities=31%  Similarity=0.459  Sum_probs=178.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEe-eCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~~~  153 (302)
                      ..+|++.+.||+|+||.||++... +..+++|...... .+.+.+|+.++++++|+|++++++++. ..+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            346888899999999999999765 7788999765433 456889999999999999999999765 4466899999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +++|.+++...   ....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          84 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999988432   23457889999999999999999998  679999999999999999999999999987643321  


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                         .....+..|+|||...+..++.++|||||||++|||++ |+.||....                 +..+..+.+++.
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence               12234456999999999899999999999999999998 999986422                 234577899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       234 ~~l~~~  239 (256)
T cd05082         234 QCWHLD  239 (256)
T ss_pred             HHhcCC
Confidence            999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-38  Score=271.75  Aligned_cols=216  Identities=23%  Similarity=0.330  Sum_probs=179.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ++|+..+.||+|+||.||+|... ++..+|+|..+...   ...+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            35677788999999999999864 58889999765432   235778999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++.     ....+++.++..++.|++.|+.|||+  .+++|+||||+||+++.++.+||+|||++....... 
T Consensus        89 ~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          89 GGGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999999873     34568899999999999999999998  679999999999999999999999999987654321 


Q ss_pred             CCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------------------CChh
Q 022118          233 AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSP---------------------DSSQ  288 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---------------------~~~~  288 (302)
                       .......++..|+|||.+.   ...++.++|+|||||++|||++|+.||....+                     ..+.
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence             1223456788899999874   45688999999999999999999999853211                     1234


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      .+.+++.+|+..+
T Consensus       240 ~~~~li~~~l~~~  252 (267)
T cd06645         240 SFHHFVKMALTKN  252 (267)
T ss_pred             HHHHHHHHHccCC
Confidence            5778999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.1e-38  Score=268.79  Aligned_cols=220  Identities=28%  Similarity=0.503  Sum_probs=180.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-C---cEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|+..+.||+|+||.||+|.... +   ..+++|......    .+.+.+|++++++++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3467788999999999999998642 3   379999865442    3457889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|||+++++|.+++..    ....+++..+..++.|++.|++|||+  .+++||||||+||++++++.+|++|||++...
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999988832    23567889999999999999999998  67999999999999999999999999998766


Q ss_pred             CCCCCCC-CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          228 GRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       228 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ....... .......+..|+|||.+.+..++.++|||||||++|||++ |+.||....                 .+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  237 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPS  237 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence            4322111 1112223456999999998899999999999999999997 999985321                 23467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       238 ~~~~li~~c~~~~  250 (268)
T cd05063         238 AVYQLMLQCWQQD  250 (268)
T ss_pred             HHHHHHHHHcCCC
Confidence            8889999999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.8e-38  Score=274.41  Aligned_cols=196  Identities=23%  Similarity=0.353  Sum_probs=164.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||.||++... ++..||+|.....    ....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999865 5788999975422    234577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      ++ ++|..++..    ....+++..+..++.|++.||+|||+  .+++|+||||+||++++++.+||+|||++.......
T Consensus        86 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 588777732    23457888999999999999999998  679999999999999999999999999997654322


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  ......++..|+|||.+.+. .++.++|||||||++|||++|++||..
T Consensus       159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  12233457789999987654 578899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.2e-38  Score=273.69  Aligned_cols=215  Identities=22%  Similarity=0.388  Sum_probs=182.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .+|+..+.||.|++|.||++.. .+++.+++|.....   ..+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999985 46889999975432   2456788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|..++.      ...+++.++..++.|++.|++|||+  .+++|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999998872      2357899999999999999999998  6799999999999999999999999999876543321


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                      .  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....                   ...+..+.++
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence            1  223457778999999998889999999999999999999999986421                   2234678899


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       249 i~~~l~~d  256 (296)
T cd06655         249 LNRCLEMD  256 (296)
T ss_pred             HHHHhhcC
Confidence            99999765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=282.16  Aligned_cols=193  Identities=23%  Similarity=0.354  Sum_probs=163.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC------
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------  142 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------  142 (302)
                      ..++|+..+.||+|+||+||++... ++..||+|......     ...+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3467999999999999999999864 57899999865432     24567899999999999999999987643      


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      ...|+++|++ +++|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+||++++++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEcCCc
Confidence            3458999987 678877662      3468899999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99865432     233467888999999877 5689999999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.3e-38  Score=270.85  Aligned_cols=215  Identities=26%  Similarity=0.394  Sum_probs=178.9

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      |++.+.||+|+||.||++.... +..+++|......   .+.+.+|+++++.++||||+++++.+...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5667889999999999999654 7788888865443   34578899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|..++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.......  .
T Consensus        87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            999887632    23468899999999999999999998  679999999999999999999999999987653321  1


Q ss_pred             CCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhH
Q 022118          235 PSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDL  290 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l  290 (302)
                      ......++..|+|||.+.     +..++.++|||||||++|||++|++||....                   ...+.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            223446788899999874     4457889999999999999999999987432                   1234678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||.++
T Consensus       239 ~~li~~~l~~~  249 (282)
T cd06643         239 KDFLKKCLEKN  249 (282)
T ss_pred             HHHHHHHccCC
Confidence            99999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.5e-38  Score=277.81  Aligned_cols=196  Identities=18%  Similarity=0.179  Sum_probs=160.8

Q ss_pred             cCCeeeeC--CCeeEEEEEE-cCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           81 DKNLIGEG--KFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        81 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++||+|  +|++||++.. .++..||+|..+...     ...+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  6889999985 468999999875432     234667999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999988432   22457889999999999999999998  6799999999999999999999999987543321111


Q ss_pred             -----CCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          233 -----AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       233 -----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                           ........++..|+|||++.+  ..|+.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                 111223345667999999876  4689999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-38  Score=283.28  Aligned_cols=193  Identities=22%  Similarity=0.341  Sum_probs=163.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC------C
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~  143 (302)
                      .++|+..+.||+|+||.||++... .+..+|+|+....     ....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467999999999999999999865 5788999986532     234678899999999999999999987643      3


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+||||+++ +|...+       ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHH-------HhcCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            56999999975 565555       1346788889999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++..+...   ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            98654322   12334678889999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.3e-38  Score=268.21  Aligned_cols=207  Identities=22%  Similarity=0.398  Sum_probs=168.1

Q ss_pred             CeeeeCCCeeEEEEEEcC-------------CcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           83 NLIGEGKFGEVYKGLLQD-------------GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      +.||+|+||.||+|...+             ...+++|.......   ..+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997432             23588887654332   35778899999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-------eEEc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-------AKVA  219 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~-------~kl~  219 (302)
                      ++|||+++|+|..++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999888732    23458889999999999999999998  67999999999999987664       8999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHH-hCCCCCCCCC--------------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELV-SGREASSSLS--------------  283 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~-~g~~p~~~~~--------------  283 (302)
                      |||++.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||....              
T Consensus       155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  228 (262)
T cd05077         155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML  228 (262)
T ss_pred             CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccC
Confidence            9999865432      12234667799999886 467899999999999999997 5888886432              


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       .....++.+++.+||..+
T Consensus       229 ~~~~~~~~~~li~~cl~~d  247 (262)
T cd05077         229 VTPSCKELADLMTHCMNYD  247 (262)
T ss_pred             CCCChHHHHHHHHHHcCCC
Confidence             123467889999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-38  Score=267.31  Aligned_cols=217  Identities=20%  Similarity=0.343  Sum_probs=183.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||.+... ++..+++|....     ....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999999999854 578899997442     2235688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999999988432   23567889999999999999999998  679999999999999999999999999998764433


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      .  ......++..|+|||...+..++.++|+||||+++|||++|+.||....                 ...+.++.+++
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV  233 (256)
T ss_pred             c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence            1  2234567888999999988889999999999999999999999986422                 22356789999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||.++
T Consensus       234 ~~~l~~~  240 (256)
T cd08221         234 HSLLQQD  240 (256)
T ss_pred             HHHcccC
Confidence            9999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-38  Score=270.33  Aligned_cols=214  Identities=30%  Similarity=0.471  Sum_probs=180.3

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCChHH-----HHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQE-----FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-----~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      |+..+.||+|+||+||++.... ++.+|+|.........     ..+|+.++++++||||+++++++...+..+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999765 6689999876665432     245899999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++.++|+|||.+.....  .
T Consensus        81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~  151 (260)
T PF00069_consen   81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N  151 (260)
T ss_dssp             TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred             cccccccccc-----cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc--c
Confidence            9999999883     45677899999999999999999999  6799999999999999999999999999875411  1


Q ss_pred             CCCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------CCChh
Q 022118          233 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------PDSSQ  288 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------~~~~~  288 (302)
                      ........++..|+|||... +..++.++||||+|+++|+|++|+.||....                       .....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE  231 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence            22234556788899999998 7889999999999999999999999998752                       01136


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      .+.+++.+|+..+
T Consensus       232 ~l~~li~~~l~~~  244 (260)
T PF00069_consen  232 ELRDLIKKMLSKD  244 (260)
T ss_dssp             HHHHHHHHHSSSS
T ss_pred             HHHHHHHHHccCC
Confidence            7777888887654

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.8e-38  Score=273.57  Aligned_cols=216  Identities=22%  Similarity=0.372  Sum_probs=182.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..+|+..+.||+|+||.||++.. .++..||+|.....   ..+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788999999999999999986 46889999976432   234578899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.      +..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVT------ETCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999998873      2456888899999999999999998  679999999999999999999999999987654322


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVE  292 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~  292 (302)
                      .  ......++..|+|||...+..++.++|+|||||++|+|++|+.||....                   ...+..+.+
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T cd06656         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD  247 (297)
T ss_pred             c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence            1  1233457788999999999899999999999999999999999996422                   122355788


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||.++
T Consensus       248 li~~~l~~~  256 (297)
T cd06656         248 FLNRCLEMD  256 (297)
T ss_pred             HHHHHccCC
Confidence            999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=264.97  Aligned_cols=213  Identities=29%  Similarity=0.517  Sum_probs=177.5

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCcc
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (302)
                      +.||+|+||.||++...++..+++|......    ...+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            4699999999999997778999999865433    346889999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 022118          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  238 (302)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  238 (302)
                      +++..    ....+++..+..++.+++.|+.|||+  ++++||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRK----KKNRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            98843    23457888899999999999999998  6799999999999999999999999999986543222211122


Q ss_pred             ccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHHHhhc
Q 022118          239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIKCMGK  300 (302)
Q Consensus       239 ~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~~~~~  300 (302)
                      ...+..|+|||.+.+..++.++|+|||||++|||++ |..||....                 ...+.++.+++.+||..
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            234566999999988899999999999999999999 888886432                 23357889999999976


Q ss_pred             c
Q 022118          301 E  301 (302)
Q Consensus       301 ~  301 (302)
                      +
T Consensus       235 ~  235 (251)
T cd05041         235 D  235 (251)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.5e-38  Score=273.62  Aligned_cols=218  Identities=20%  Similarity=0.237  Sum_probs=180.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||.||++... ++..|++|......      ...+.+|+++++.++||||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999865 47889999765432      245778999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++.     ....+++..+..++.|++.|+.|||+  .+++||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLK-----NIGALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999983     23457888899999999999999998  6799999999999999999999999999874211


Q ss_pred             CC-------------CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------
Q 022118          230 TD-------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------  283 (302)
Q Consensus       230 ~~-------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------  283 (302)
                      ..             .........++..|+|||.+.+..++.++|+|||||++|||++|+.||.+..             
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  233 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            00             0001112356778999999988899999999999999999999999987432             


Q ss_pred             ------CCChhhHHHHHHHHhhcc
Q 022118          284 ------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------~~~~~~l~~~~~~~~~~~  301 (302)
                            ...+.++.+++.+||.++
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~  257 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQN  257 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccC
Confidence                  123567899999999765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=271.92  Aligned_cols=218  Identities=23%  Similarity=0.350  Sum_probs=181.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|++.+.||+|+||.||++... ++..+++|......   .+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            346888899999999999999864 57899999865443   24578899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999988732    23468899999999999999999998  679999999999999999999999999987653322


Q ss_pred             CCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCCh
Q 022118          232 VAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSS  287 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~  287 (302)
                      .  ......++..|++||.+.     ...++.++|+||||+++|||++|+.||....                   ...+
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (280)
T cd06611         158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS  235 (280)
T ss_pred             c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence            1  123345788899999875     3457789999999999999999999986432                   1234


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       236 ~~~~~li~~~l~~~  249 (280)
T cd06611         236 SSFNDFLKSCLVKD  249 (280)
T ss_pred             HHHHHHHHHHhccC
Confidence            67899999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-37  Score=266.17  Aligned_cols=218  Identities=31%  Similarity=0.509  Sum_probs=182.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      .+|+..+.||+|+||.||++...++..+++|.....  ....+.+|++++++++||||+++++++......+++|||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            467778999999999999998877788999986543  245788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|.+++..    ....+++..+..++.|++.|++|||+  .+++|+||||+||+++.++.+||+|||+++........ 
T Consensus        84 ~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          84 GCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            999988842    23457888899999999999999998  67999999999999999999999999998766433221 


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~~  296 (302)
                      .......+..|+|||...+..++.++||||||+++|||++ |+.||...                 +...+..+.+++.+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH  236 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            1122234567999999998899999999999999999998 99998632                 12346778999999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||..+
T Consensus       237 ~l~~~  241 (256)
T cd05112         237 CWKER  241 (256)
T ss_pred             HcccC
Confidence            99764

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-38  Score=269.53  Aligned_cols=215  Identities=28%  Similarity=0.395  Sum_probs=183.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||.|++|.||+|... ++..+++|......    ...+.+|+++++.++||||+++.+.+.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35778899999999999999965 58899999865332    34578899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++..      ..+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.++|+|||+++.+....
T Consensus        81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            999999988832      278899999999999999999998  679999999999999999999999999998775432


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CC-ChhhHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PD-SSQDLVEL  293 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~-~~~~l~~~  293 (302)
                        .......++..|+|||...+..++.++||||||+++|||++|+.||....                 .. .+.++.++
T Consensus       153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence              12234467778999999998889999999999999999999999986422                 11 45678999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       231 l~~~l~~~  238 (274)
T cd06609         231 VSLCLNKD  238 (274)
T ss_pred             HHHHhhCC
Confidence            99999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4e-38  Score=270.45  Aligned_cols=220  Identities=25%  Similarity=0.390  Sum_probs=183.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .+|++.+.||+|+||.||++.. .++..+++|.....      ...++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3677889999999999999995 46889999965432      2246788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999998874321 134568899999999999999999998  6799999999999999999999999999876643


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQD  289 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~  289 (302)
                      ...  ......++..|+|||...+..++.++|+||||+++|||++|..||....                    ...+.+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            221  1223457788999999998899999999999999999999999985321                    123467


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       237 ~~~li~~~l~~~  248 (267)
T cd08229         237 LRQLVNMCINPD  248 (267)
T ss_pred             HHHHHHHhcCCC
Confidence            889999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-38  Score=273.73  Aligned_cols=216  Identities=21%  Similarity=0.304  Sum_probs=181.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|+..+.||+|+||+||++... ++..+|+|.....    ....+.+|+++++.++||||+++++.+...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            356778899999999999999865 5788999864322    24568899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++.     ....+++..+..++.+++.|+.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYK-----KGGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999988873     234578899999999999999999963 46999999999999999999999999998654221


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------------------------
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--------------------------  284 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~--------------------------  284 (302)
                          ......++..|+|||.+.+..++.++|+|||||++|||++|+.||.....                          
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL  233 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence                12234678889999999888999999999999999999999999974322                          


Q ss_pred             ---CChhhHHHHHHHHhhcc
Q 022118          285 ---DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ---~~~~~l~~~~~~~~~~~  301 (302)
                         ..+.++.+++.+||.++
T Consensus       234 ~~~~~~~~~~~li~~~l~~d  253 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKD  253 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCC
Confidence               13456788899999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=265.03  Aligned_cols=211  Identities=29%  Similarity=0.453  Sum_probs=173.1

Q ss_pred             CeeeeCCCeeEEEEEEcC----CcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|.+..    +..+|+|.......    +++.+|+.+++.++||||+++++++.. +..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997432    26899998664432    467889999999999999999998764 567999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++..     ...+++..+..++.|++.|++|||+  .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999999842     3367899999999999999999998  679999999999999999999999999998764432211


Q ss_pred             -CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHH
Q 022118          235 -PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMI  295 (302)
Q Consensus       235 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~  295 (302)
                       ......++..|+|||...+..++.++||||||+++|||++ |+.||...                 +...+..+.+++.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence             1112223457999999999999999999999999999998 99998643                 2234567889999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       233 ~cl~~~  238 (257)
T cd05060         233 SCWKYR  238 (257)
T ss_pred             HHhcCC
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.7e-38  Score=274.36  Aligned_cols=219  Identities=30%  Similarity=0.490  Sum_probs=177.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|+..+.||+|+||.||++... ++.    .+|+|......    ...+.+|+.+++.++||||+++++++..+ ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            456788899999999999999853 343    57888765433    23578899999999999999999998764 467


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +++||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccccc
Confidence            99999999999988842    23457888899999999999999998  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+                 ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI  238 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            643322212223345667999999999999999999999999999997 899986532                 23456


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       239 ~~~~li~~c~~~~  251 (303)
T cd05110         239 DVYMVMVKCWMID  251 (303)
T ss_pred             HHHHHHHHHcCCC
Confidence            7888999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.4e-38  Score=269.91  Aligned_cols=217  Identities=30%  Similarity=0.508  Sum_probs=177.0

Q ss_pred             CeeeeCCCeeEEEEEEcC-------CcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +.||+|+||.||+|...+       +..+++|.....    ....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998542       257888875432    345688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcC--CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-----ceEEcccccc
Q 022118          152 IPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-----IAKVADAGLR  224 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-----~~kl~DfGla  224 (302)
                      +++++|.+++......  ....+++.++..++.|++.|++|||+  .+++|+||||+||+++.++     .++++|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999998543211  23457889999999999999999998  6799999999999999877     8999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDS  286 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~  286 (302)
                      +................+..|+|||.+.+..++.++|||||||++|||++ |+.||...                 +...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            86644332222223345667999999999999999999999999999998 99998632                 2244


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||.++
T Consensus       239 ~~~~~~li~~~l~~~  253 (269)
T cd05044         239 PDKIYQLMTNCWAQD  253 (269)
T ss_pred             hHHHHHHHHHHcCCC
Confidence            577899999999765

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-37  Score=265.80  Aligned_cols=213  Identities=28%  Similarity=0.433  Sum_probs=176.5

Q ss_pred             CeeeeCCCeeEEEEEEcC--C--cEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|++|.||+|.+.+  +  ..+|+|.......    +.+.+|+.++++++||||+++++.+.. +..+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  3689998665443    467889999999999999999999988 888999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  233 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~-~  233 (302)
                      ++|.+++....   ...+++..+..++.|++.||+|||+  ++++|+||||+||+++.++.+||+|||+++....... .
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999985321   1467899999999999999999998  6799999999999999999999999999987654221 1


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------------CCCChhhHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------------SPDSSQDLVELM  294 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------------~~~~~~~l~~~~  294 (302)
                      .......++..|+|||...+..++.++|||||||++|||++ |+.||...                  +...+.++.+++
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence            11223456678999999999999999999999999999998 99998532                  123357888999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       235 ~~~l~~~  241 (257)
T cd05040         235 LQCWAHN  241 (257)
T ss_pred             HHHCCCC
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=298.84  Aligned_cols=229  Identities=30%  Similarity=0.453  Sum_probs=188.9

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc----C----CcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEe
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ----D----GMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLG  137 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~  137 (302)
                      .+++..++..+.+.||+|.||.|++|...    .    ...||||..+...    .+.+..|+++|+.+ +||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            44555556666779999999999999732    1    3579999765433    35688999999988 7999999999


Q ss_pred             EEeeCCeeeEEEeccCCCCccccccCCC---------cCCCc--ccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 022118          138 YCQENNLQFLIYEYIPNGSVSIHLYGPS---------QVSRQ--KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA  206 (302)
Q Consensus       138 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~  206 (302)
                      +|..++..++|+||+..|+|.++|+..+         .....  .++....+.++.||+.|++||++  .++|||||..+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaR  447 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAAR  447 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhh
Confidence            9999999999999999999999997654         11122  38999999999999999999998  67999999999


Q ss_pred             CeeeCCCCceEEcccccccccCCCCCCC-CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC--
Q 022118          207 NVLVDEDFIAKVADAGLRNFLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL--  282 (302)
Q Consensus       207 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~--  282 (302)
                      |||++++..+||+|||+|+...+.+... ......-+..|||||.+....|+.+||||||||+|||++| |..||.+.  
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999765544332 1121125667999999999999999999999999999999 88898852  


Q ss_pred             ----------------CCCChhhHHHHHHHHhhcc
Q 022118          283 ----------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                      |..+.+++.++|+.||+.+
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~  562 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNAD  562 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCC
Confidence                            3466889999999999654

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.3e-38  Score=266.42  Aligned_cols=213  Identities=32%  Similarity=0.521  Sum_probs=177.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      ++|++.+.||+|+||.||++.. ++..+|+|..... ..+.+.+|+.++++++||||+++++++..+ ..+++|||++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            4688899999999999999874 5778999986544 345788999999999999999999998765 479999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+++...   ....+++..+..++.|++.|+.|||+  .+++||||||+||+++.++.+||+|||+++.....     
T Consensus        84 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          84 NLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999998432   23457888999999999999999998  77999999999999999999999999998764321     


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHHHH
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMIKC  297 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~~~  297 (302)
                      ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||....                 ...+..+.+++.+|
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence            112233456999999998899999999999999999998 999986432                 23356788999999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |..+
T Consensus       234 l~~~  237 (254)
T cd05083         234 WETE  237 (254)
T ss_pred             cCCC
Confidence            9865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-37  Score=268.79  Aligned_cols=215  Identities=27%  Similarity=0.420  Sum_probs=181.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..|+..+.||.|+||.||+|... ++..+|+|..+...    ...+.+|+.++++++||||+++++.+.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999865 58899999765332    24578899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.      ...+++..+..++.|++.|++|||+  .+++|+||+|+||++++++.++++|||++.......
T Consensus        84 ~~~~~L~~~i~------~~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998873      2357888889999999999999998  679999999999999999999999999997764322


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      .  ......++..|+|||.+.+..++.++|+|||||++|||++|..||....                 ...+.++.+++
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHH
Confidence            1  1233456778999999988889999999999999999999999986432                 12346788999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||.++
T Consensus       234 ~~~l~~~  240 (277)
T cd06640         234 DACLNKD  240 (277)
T ss_pred             HHHcccC
Confidence            9999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.1e-37  Score=265.24  Aligned_cols=213  Identities=28%  Similarity=0.481  Sum_probs=169.0

Q ss_pred             CeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee-CCeeeEEEeccC
Q 022118           83 NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIP  153 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~  153 (302)
                      +.||+|+||.||+|...    +...+|+|......    .+.+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    23579999865332    3467789999999999999999998764 456799999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|.+++..    ......+..+..++.|++.|++|||+  .+++||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999843    22345677788899999999999998  67999999999999999999999999999765432211


Q ss_pred             --CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhC-CCCCCCC-----------------CCCChhhHHHH
Q 022118          234 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSL-----------------SPDSSQDLVEL  293 (302)
Q Consensus       234 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g-~~p~~~~-----------------~~~~~~~l~~~  293 (302)
                        .......++..|+|||...+..++.++|||||||++|||++| .+||...                 +...+..+.++
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence              111233456679999999888999999999999999999995 5555421                 12235678999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       235 i~~cl~~~  242 (262)
T cd05058         235 MLSCWHPK  242 (262)
T ss_pred             HHHHcCCC
Confidence            99999765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=269.14  Aligned_cols=206  Identities=20%  Similarity=0.360  Sum_probs=166.0

Q ss_pred             eeeeCCCeeEEEEEEcC-------------------------CcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeE
Q 022118           84 LIGEGKFGEVYKGLLQD-------------------------GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTL  135 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l  135 (302)
                      .||+|+||.||+|....                         ...|++|.......   ..+.+|..+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999987421                         13588887754433   357788999999999999999


Q ss_pred             EeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-
Q 022118          136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-  214 (302)
Q Consensus       136 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-  214 (302)
                      ++++.+++..++||||+++|+|..++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++.+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999888842    24567888999999999999999998  6799999999999997643 


Q ss_pred             ------ceEEcccccccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHH-hCCCCCCCCC---
Q 022118          215 ------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELV-SGREASSSLS---  283 (302)
Q Consensus       215 ------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~-~g~~p~~~~~---  283 (302)
                            .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....   
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  4899999987643221      12245667999998865 56899999999999999984 6899986432   


Q ss_pred             ------------CCChhhHHHHHHHHhhcc
Q 022118          284 ------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------------~~~~~~l~~~~~~~~~~~  301 (302)
                                  .....++.+++.+||..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  259 (274)
T cd05076         230 KERFYEKKHRLPEPSCKELATLISQCLTYE  259 (274)
T ss_pred             HHHHHHhccCCCCCCChHHHHHHHHHcccC
Confidence                        222357899999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=267.68  Aligned_cols=214  Identities=29%  Similarity=0.514  Sum_probs=172.4

Q ss_pred             CeeeeCCCeeEEEEEEcC-Cc--EEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQD-GM--LVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|...+ +.  .+++|......    .+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998654 33  57888765422    34678899999999 899999999999999999999999999


Q ss_pred             CCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          155 GSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       155 g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      |+|.+++.....           .....+++..+..++.|++.|++|||+  ++++||||||+||++++++.+|++|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCC
Confidence            999998853221           112357889999999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PD  285 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~  285 (302)
                      ++.....   ........+..|+|||......++.++|||||||++|||++ |..||...+                 ..
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN  235 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence            8632211   11112233556999999988899999999999999999997 999985321                 22


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       236 ~~~~~~~li~~~l~~~  251 (270)
T cd05047         236 CDDEVYDLMRQCWREK  251 (270)
T ss_pred             CCHHHHHHHHHHcccC
Confidence            3467889999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=266.89  Aligned_cols=218  Identities=27%  Similarity=0.373  Sum_probs=182.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|+..+.||+|+||.||++... ++..+++|.....   ..+.+.+|++++++++||||+++++++...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888899999999999999865 4778999975433   345688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++..    ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999988732    22568889999999999999999998  679999999999999999999999999987654321


Q ss_pred             CCCCCccccCcccccchhhhccC---CCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------CCCh
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLS---------------------PDSS  287 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------~~~~  287 (302)
                      .  ......++..|+|||...+.   .++.++|+||||+++|||++|+.||....                     ...+
T Consensus       156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            1  12334577789999998877   88999999999999999999999987432                     1113


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       234 ~~~~~li~~~l~~~  247 (262)
T cd06613         234 PVFHDFIKKCLTKD  247 (262)
T ss_pred             HHHHHHHHHHcCCC
Confidence            56789999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.9e-38  Score=272.21  Aligned_cols=214  Identities=30%  Similarity=0.426  Sum_probs=179.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .|+..+.||+|+||.||+|... ++..||+|..+...    .+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3555678999999999999864 57889999865332    245789999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++|+||+|+||++++++.++++|||++..+.....
T Consensus        85 ~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLK------PGPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999998872      2457888999999999999999998  6799999999999999999999999999976643221


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                        ......++..|+|||...+..++.++|+|||||++|||++|+.||....                 ...+.++.+++.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence              1223456778999999999899999999999999999999999986432                 123467899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       235 ~~l~~~  240 (277)
T cd06642         235 ACLNKD  240 (277)
T ss_pred             HHccCC
Confidence            999764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-37  Score=265.31  Aligned_cols=221  Identities=25%  Similarity=0.360  Sum_probs=185.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|++.+.||.|+||+||+|... ++..+++|.....    ..+.+.+|++.++.++|+||+++++.+...+..+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 5788999986533    235688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++....  ....+++..+..++.|++.|++|||+  .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999984321  12467889999999999999999998  679999999999999999999999999987765433


Q ss_pred             CC--CCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC----------------------CC
Q 022118          232 VA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSP----------------------DS  286 (302)
Q Consensus       232 ~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~----------------------~~  286 (302)
                      ..  .......++..|++||.+... .++.++|+|||||++|||++|+.||...+.                      ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence            22  123445678889999998877 789999999999999999999999975431                      22


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||.++
T Consensus       237 ~~~~~~li~~~l~~~  251 (267)
T cd06610         237 SKSFRKMISLCLQKD  251 (267)
T ss_pred             cHHHHHHHHHHcCCC
Confidence            467789999999765

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-37  Score=268.26  Aligned_cols=222  Identities=28%  Similarity=0.443  Sum_probs=181.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ++|+..+.||+|+||.||+|...      +...+++|......    .+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999854      24578999765433    346889999999999999999999999989999


Q ss_pred             EEEeccCCCCccccccCCCcC----CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      +||||+++|+|.+++......    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++++|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999998533211    12268999999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------------C
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------------S  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------------~  283 (302)
                      +++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...                  +
T Consensus       163 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         163 LSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             cccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            98754322211 1223345667999999988888999999999999999999 78888532                  2


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+..+.+++.+||..+
T Consensus       242 ~~~~~~l~~~i~~~l~~~  259 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVN  259 (275)
T ss_pred             CCCCHHHHHHHHHHcCCC
Confidence            345678899999999765

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.3e-38  Score=291.22  Aligned_cols=199  Identities=18%  Similarity=0.269  Sum_probs=161.0

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccCC------CCceeeEEeEEeeC-
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQ------HRNLVTLLGYCQEN-  142 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l~------H~nIv~l~~~~~~~-  142 (302)
                      .....+|++.+.||+|+||+||+|... ++..||+|.+...  .......|+.++..++      |++++++++++..+ 
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            344578999999999999999999865 5788999987532  2334566777776664      45689999988765 


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC--------
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF--------  214 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~--------  214 (302)
                      +..++|||++ +++|.+++.     ....+++..+..++.||+.||+|||+. .+||||||||+|||++.++        
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIM-----KHGPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccc
Confidence            4678999988 677887773     235688899999999999999999972 3799999999999998765        


Q ss_pred             --------ceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          215 --------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       215 --------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                              .+||+|||++.....     ......+|..|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                    499999998754221     2334578999999999999999999999999999999999999997644

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-37  Score=265.85  Aligned_cols=206  Identities=25%  Similarity=0.436  Sum_probs=169.1

Q ss_pred             CeeeeCCCeeEEEEEEcC-C----------cEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           83 NLIGEGKFGEVYKGLLQD-G----------MLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +.||+|+||.||+|...+ +          ..+++|......  ...+.+|+.+++.++||||+++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            468999999999998654 2          257778654333  4678899999999999999999999988 7789999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-------ceEEcccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-------IAKVADAG  222 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-------~~kl~DfG  222 (302)
                      ||+++|+|.+++...    ...+++..+..++.|++.||+|||+  ++|+||||||+||+++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999998432    2267888999999999999999998  6799999999999999887       79999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccC--CCCCccchhhHHHHHHHHHh-CCCCCCCCC---------------C
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVS-GREASSSLS---------------P  284 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dvws~Gvil~el~~-g~~p~~~~~---------------~  284 (302)
                      ++.....      .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||....               .
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  227 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM  227 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence            9986543      1223345569999998876  78999999999999999999 577775441               1


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ....++.+++.+||..+
T Consensus       228 ~~~~~~~~li~~~l~~~  244 (259)
T cd05037         228 PDCAELANLINQCWTYD  244 (259)
T ss_pred             CCchHHHHHHHHHhccC
Confidence            22368889999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8e-38  Score=271.30  Aligned_cols=227  Identities=25%  Similarity=0.390  Sum_probs=182.8

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccC-CCCceeeEEeEEe-----
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASI-QHRNLVTLLGYCQ-----  140 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l-~H~nIv~l~~~~~-----  140 (302)
                      +.+....++|++.+.||+|+||.||++... ++..+|+|......  ...+.+|+.+++++ +||||+++++++.     
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            344456778999999999999999999864 47889999765432  35678899999999 7999999999884     


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      ..+..+++|||+++++|.+++.... .....+++..+..++.|++.|+.|||+  .+++||||||+||++++++.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCCCCEEEcc
Confidence            3456799999999999988774321 124567888899999999999999998  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSP-----------  284 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-----------  284 (302)
                      ||+++.......  ......++..|+|||.+..     ..++.++||||+||++|||++|+.||.....           
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  245 (286)
T cd06638         168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP  245 (286)
T ss_pred             CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence            999887643221  1233467888999998753     4578999999999999999999999864321           


Q ss_pred             --------CChhhHHHHHHHHhhcc
Q 022118          285 --------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 --------~~~~~l~~~~~~~~~~~  301 (302)
                              ..+.++.+++.+||..+
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~  270 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKD  270 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCC
Confidence                    12356899999999764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-37  Score=266.69  Aligned_cols=216  Identities=23%  Similarity=0.330  Sum_probs=175.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----C---hHHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----P---TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      .+|+..+.||+|+||.||.+... ++..|++|.....     .   .+.+.+|+.++++++||||+++++++.++  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999865 4889999975311     1   23577899999999999999999988764  467


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      +++|||+++++|.+++.     ....+++.....++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999998883     23457788889999999999999998  679999999999999999999999999987


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCC
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDS  286 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~  286 (302)
                      ........ .......++..|+|||...+..++.++|||||||++|||++|+.||...+                  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV  234 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhh
Confidence            65432111 11233457788999999998889999999999999999999999986421                  122


Q ss_pred             hhhHHHHHHHHhh
Q 022118          287 SQDLVELMIKCMG  299 (302)
Q Consensus       287 ~~~l~~~~~~~~~  299 (302)
                      .....+++.+|+.
T Consensus       235 ~~~~~~~i~~~l~  247 (265)
T cd06652         235 SDHCRDFLKRIFV  247 (265)
T ss_pred             CHHHHHHHHHHhc
Confidence            3456677777774

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-37  Score=264.23  Aligned_cols=214  Identities=28%  Similarity=0.464  Sum_probs=180.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +|+..+.||+|+||.||+|... ++..+++|.....        ..+.+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999976 6889999974322        234678899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      +||+++++|.+++..     ...+++..+..++.|++.|++|||+  .+++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999988832     3457888899999999999999998  679999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQD  289 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~  289 (302)
                      ...   ......++..|++||...... ++.++|+||||+++|+|++|+.||....                  .....+
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDE  230 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHH
Confidence            322   123455778899999988776 8999999999999999999999986432                  223467


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       231 ~~~li~~~l~~~  242 (258)
T cd06632         231 AKDFILKCLQRD  242 (258)
T ss_pred             HHHHHHHHhhcC
Confidence            888999999765

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.9e-37  Score=266.86  Aligned_cols=218  Identities=29%  Similarity=0.492  Sum_probs=178.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..+|.+.+.||+|+||.||+|...+    ...+++|......    .+.+.+|+.++++++||||+++++++.. +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3457788999999999999998543    2468999765433    3468899999999999999999998875 45789


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999843    23457899999999999999999998  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQD  289 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~  289 (302)
                      ....... .....++..|+|||.+....++.++||||||+++||+++ |..||....                 +..+..
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (270)
T cd05056         158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  236 (270)
T ss_pred             cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence            4432211 122334567999999988899999999999999999986 999986432                 344678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       237 ~~~li~~~l~~~  248 (270)
T cd05056         237 LYSLMTKCWAYD  248 (270)
T ss_pred             HHHHHHHHcCCC
Confidence            899999999765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9e-38  Score=270.73  Aligned_cols=194  Identities=24%  Similarity=0.350  Sum_probs=162.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||+|... +|..+++|..+..     ....+.+|++++++++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999965 5889999975432     234577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++ +|.+++..    ....+++..+..++.||+.||.|||+  .+++||||||+||+++.++.+||+|||+++..+...
T Consensus        81 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            974 77766632    23458899999999999999999998  679999999999999999999999999998654322


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      .  ......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.
T Consensus       154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            1  12233567789999988764 47899999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-37  Score=265.41  Aligned_cols=217  Identities=27%  Similarity=0.425  Sum_probs=179.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-------------hHHHHHHHHHhccCCCCceeeEEeEEeeCC
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-------------TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~  143 (302)
                      +|...+.||+|+||.||+|... ++..+|+|......             .+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3667789999999999999854 58899999653210             134678999999999999999999999999


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..++||||+++++|.+++..     ...+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.++++|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999998843     2567888899999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCC--CCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      ++...............++..|+|||......  ++.++|+||||+++||+++|..||....                  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP  234 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence            97654322222233456778899999987654  7899999999999999999999986421                  


Q ss_pred             ----CCChhhHHHHHHHHhhcc
Q 022118          284 ----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----~~~~~~l~~~~~~~~~~~  301 (302)
                          ...+.++.+++.+||.++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~  256 (272)
T cd06629         235 PDVSMNLSPVALDFLNACFTIN  256 (272)
T ss_pred             ccccccCCHHHHHHHHHHhcCC
Confidence                122467889999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-38  Score=279.18  Aligned_cols=222  Identities=19%  Similarity=0.275  Sum_probs=180.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEec-----CCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR-----PGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~  146 (302)
                      .+....|++.+.||+||.+.||++...+.+.+|+|+.     +......+.+|+..|.+| .|.+|+++++|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            3455679999999999999999999888888888863     334456789999999999 5999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      |||||= .-||..+|...    ........+..++.|++.++.++|.  .||||.||||.|+|+-+ |.+||+|||+|+.
T Consensus       437 mvmE~G-d~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a  508 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDFGIANA  508 (677)
T ss_pred             EEeecc-cccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence            999975 45888888432    1222223778899999999999999  67999999999999865 7899999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCC-----------CCCccchhhHHHHHHHHHhCCCCCCCCC------------
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRR-----------FSEKSDVYSFGVFLLELVSGREASSSLS------------  283 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~Dvws~Gvil~el~~g~~p~~~~~------------  283 (302)
                      +..+...-....-+||+.||+||.+....           .+++|||||+|||||+|++|++||....            
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P  588 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP  588 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence            87655544455568999999999886443           4578999999999999999999998422            


Q ss_pred             -------CCCh-hhHHHHHHHHhhccC
Q 022118          284 -------PDSS-QDLVELMIKCMGKER  302 (302)
Q Consensus       284 -------~~~~-~~l~~~~~~~~~~~~  302 (302)
                             .... .++++.|..|+..++
T Consensus       589 ~~~Iefp~~~~~~~li~~mK~CL~rdP  615 (677)
T KOG0596|consen  589 NHEIEFPDIPENDELIDVMKCCLARDP  615 (677)
T ss_pred             CccccccCCCCchHHHHHHHHHHhcCc
Confidence                   1222 338999999998764

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-37  Score=270.54  Aligned_cols=217  Identities=24%  Similarity=0.353  Sum_probs=178.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +|++.+.||+|+||.||++... ++..+|+|......    ...+.+|++++++++||||+++++.+..++..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5788899999999999999975 68899999754322    346889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|..++...  .....+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          82 DAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             CCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999998887432  1134688999999999999999999962 479999999999999999999999999987653321 


Q ss_pred             CCCCccccCcccccchhhhccC------CCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDS  286 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~  286 (302)
                         .....++..|+|||.+.+.      .++.++|+|||||++|||++|+.||....                    ++.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence               2234567789999988543      35889999999999999999999985321                    233


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       235 ~~~~~~li~~~l~~~  249 (286)
T cd06622         235 SDDAQDFVAKCLNKI  249 (286)
T ss_pred             CHHHHHHHHHHcccC
Confidence            467788899998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-37  Score=269.15  Aligned_cols=225  Identities=28%  Similarity=0.431  Sum_probs=182.0

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccC-CCCceeeEEeEEee----
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQE----  141 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----  141 (302)
                      .++....+.|++.+.||+|+||.||+|... ++..+|+|.....  ....+..|+.+++++ +||||+++++++..    
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            344445678899999999999999999964 5788999976443  334678899999888 79999999999853    


Q ss_pred             --CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          142 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       142 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                        .+..+++|||+++|+|.+++...   ....+++..+..++.|++.|++|||+  .+++|+||+|+||++++++.++|+
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEe
Confidence              35679999999999999888432   23457788888999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------  283 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------  283 (302)
                      |||++.......  .......++..|+|||.+.     ...++.++|+|||||++|||++|+.||....           
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  241 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  241 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence            999987653221  1233456788899999875     3568889999999999999999999996421           


Q ss_pred             -------CCChhhHHHHHHHHhhcc
Q 022118          284 -------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -------~~~~~~l~~~~~~~~~~~  301 (302)
                             ...+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~  266 (282)
T cd06636         242 PPPKLKSKKWSKKFIDFIEGCLVKN  266 (282)
T ss_pred             CCCCCcccccCHHHHHHHHHHhCCC
Confidence                   124568899999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=289.23  Aligned_cols=213  Identities=27%  Similarity=0.454  Sum_probs=177.4

Q ss_pred             CeeeeCCCeeEEEEEEcC-CcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCcc
Q 022118           83 NLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (302)
                      -+||+|.||+||-|+..+ ...+|||.++....   +-+..|+.+.++++|.|||+++|.+.+++..-+.||-.+||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            479999999999999654 56799998765543   45789999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCCCCCCCCCc
Q 022118          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      +.|+..  ...-+-.+.++-.+.+||++||.|||+  +.|||||||-+|||++. .|.+||+|||.++++..  ....+.
T Consensus       661 sLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  661 SLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            999431  222223678888999999999999999  67999999999999975 58999999999988743  333456


Q ss_pred             cccCcccccchhhhccC--CCCCccchhhHHHHHHHHHhCCCCCCCCC---------------C----CChhhHHHHHHH
Q 022118          238 QVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLS---------------P----DSSQDLVELMIK  296 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~--~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------~----~~~~~l~~~~~~  296 (302)
                      +++||..|||||++..+  +|+.++|||||||++.||.||++||-.+.               +    .-+.+-..++.+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            78999999999999865  58999999999999999999999997431               2    223444678888


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      |+-++
T Consensus       815 cFepd  819 (1226)
T KOG4279|consen  815 CFEPD  819 (1226)
T ss_pred             HcCCC
Confidence            88765

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.3e-38  Score=267.98  Aligned_cols=214  Identities=21%  Similarity=0.304  Sum_probs=183.5

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      +|+..+.||.|+||.||++... ++..+++|....      ...+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999975 588899997543      234568899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|..++.     ....+++..+..++.|++.||.|||+  ++++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLS-----QKVKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999998883     23578889999999999999999998  67999999999999999999999999998766443


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDLV  291 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l~  291 (302)
                      .   ......++..|+|||...+..++.++|+||||+++|+|++|+.||.....                   ..+.++.
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI  230 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHH
Confidence            2   12334567789999999988899999999999999999999999986441                   2357888


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++++||..+
T Consensus       231 ~~i~~~l~~~  240 (258)
T cd05578         231 DAINKLLERD  240 (258)
T ss_pred             HHHHHHccCC
Confidence            9999998765

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.1e-38  Score=271.54  Aligned_cols=195  Identities=22%  Similarity=0.384  Sum_probs=165.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|+..+.||+|+||.||++... +++.+|+|.....     ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999975 4889999975432     23457889999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|..+..     ....+++..++.++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999988877652     23457899999999999999999998  67999999999999999999999999998875432


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ..  ......++..|+|||...+ ..++.++||||||+++|||++|++||.
T Consensus       154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~  202 (286)
T cd07846         154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence            21  1223456788999998875 457889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-37  Score=270.98  Aligned_cols=196  Identities=21%  Similarity=0.318  Sum_probs=157.5

Q ss_pred             CeeeeCCCeeEEEEEEc---CCcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEee--CCeeeEEEeccCCCC
Q 022118           83 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGS  156 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~g~  156 (302)
                      ..||+|+||.||+|...   ++..+|+|...... ...+.+|++++++++||||+++++++..  +...+++|||+++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence            57999999999999865   35689999865443 3467899999999999999999999854  4567999999875 6


Q ss_pred             ccccccCCC----cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEcccccccccC
Q 022118          157 VSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       157 L~~~l~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill----~~~~~~kl~DfGla~~~~  228 (302)
                      |.+++....    ......+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++...
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            666553211    1123457888999999999999999998  679999999999999    566899999999998765


Q ss_pred             CCCCC-CCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          229 RTDVA-GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       229 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..... .......+|..|+|||.+.+. .++.++|||||||++|||++|++||..
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            43221 122345678889999998764 579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4e-37  Score=264.71  Aligned_cols=214  Identities=25%  Similarity=0.329  Sum_probs=165.7

Q ss_pred             CeeeeCCCeeEEEEEEcCC---cEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           83 NLIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.||+|+||.||++...++   ..+++|.....    ..+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3599999999999975432   34667754432    2356889999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+++..... .....++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999854321 12345677788899999999999998  6799999999999999999999999999865322222222


Q ss_pred             CccccCcccccchhhhcc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCC----------------------CC
Q 022118          236 SSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLS----------------------PD  285 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----------------------~~  285 (302)
                      .....++..|+|||+...       ..++.++|||||||++|||++ |..||....                      ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            234457788999998753       245789999999999999997 567775322                      12


Q ss_pred             ChhhHHHHHHHHhh
Q 022118          286 SSQDLVELMIKCMG  299 (302)
Q Consensus       286 ~~~~l~~~~~~~~~  299 (302)
                      ....+.+++++||.
T Consensus       238 ~~~~~~~l~~~c~~  251 (268)
T cd05086         238 YSERWYEVLQFCWL  251 (268)
T ss_pred             CcHHHHHHHHHHhh
Confidence            24556778888884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-37  Score=264.87  Aligned_cols=219  Identities=25%  Similarity=0.412  Sum_probs=177.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++.+.....||+|+||.||+|... ++..+++|......   .+.+.+|+.+++.++|+||+++++++..++..++++|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            3444555578999999999999855 57789999765543   3467899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCccc--CHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEccccccccc
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKL--EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFL  227 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~~  227 (302)
                      |+++++|.+++...    ...+  +...+..++.|++.|++|||+  .+|+||||||+||+++. ++.++|+|||++...
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          86 QVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             cCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999988432    1223  677888899999999999998  67999999999999976 679999999998765


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCC--CCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDS  286 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~  286 (302)
                      .....  ......++..|+|||...+..  ++.++|+||||+++|+|++|+.||....                   ...
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL  237 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence            43221  122345778899999986543  7889999999999999999999986421                   123


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      .+++.+++++||..+
T Consensus       238 ~~~~~~li~~~l~~~  252 (268)
T cd06624         238 SAEAKNFILRCFEPD  252 (268)
T ss_pred             CHHHHHHHHHHcCCC
Confidence            457888999999764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-37  Score=268.22  Aligned_cols=219  Identities=30%  Similarity=0.453  Sum_probs=180.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee--CCee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~  145 (302)
                      ..|+..+.||+|+||.||++...     ++..+|+|......    ...+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     36789999865443    3468899999999999999999999887  5578


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      +++|||+++++|.+++..    ....+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            999999999999999843    23358899999999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------  283 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------  283 (302)
                      ........ .......++..|++||...+..++.++||||||+++|||++|+.|+....                     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76532211 11122344556999999988899999999999999999999999876432                     


Q ss_pred             -----------CCChhhHHHHHHHHhhcc
Q 022118          284 -----------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----------~~~~~~l~~~~~~~~~~~  301 (302)
                                 ...+.++.+++.+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~  266 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAE  266 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccC
Confidence                       122457889999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-38  Score=282.10  Aligned_cols=199  Identities=25%  Similarity=0.334  Sum_probs=175.1

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .....|.+.+.||+|.|++|.++++. ++..||+|.+++..     .+.+.+|+++|+.++|||||+++.+...+..+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567888999999999999999965 58899999866543     3457899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+.+|.+++++.+.     ....+..+..++.|+++|++|||+  +.|||||||++|+|++.+..+||+|||++..+
T Consensus       133 V~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccceee
Confidence            99999999999999543     344457778899999999999999  66999999999999999999999999999887


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ..   .....+.+|++.|.|||+..+..| .+++|+||+|++||-|++|.+||++.
T Consensus       206 ~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  206 DY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             cc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence            53   234567789999999999999988 47899999999999999999999953

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.9e-37  Score=263.77  Aligned_cols=199  Identities=26%  Similarity=0.358  Sum_probs=166.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--------ChHHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      .+|+..+.||+|+||.||++... ++..+++|.....        ....+.+|+.+++.++||||+++++.+...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999864 5889999975422        123577899999999999999999988753  567


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++++||+++++|.+++.     ....+++...+.++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLK-----AYGALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999998883     23457888889999999999999998  679999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ....... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            6533211 11122345778899999999888999999999999999999999999743

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=267.49  Aligned_cols=197  Identities=25%  Similarity=0.364  Sum_probs=164.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|++|.||++... ++..+|+|.....    ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999965 5789999975432    224567899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.+||+|||+++......
T Consensus        85 ~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            985 88887742    22367889999999999999999998  679999999999999999999999999987543221


Q ss_pred             CCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ..  .....++..|+|||...+ ..++.++||||+|+++|||++|+.||...
T Consensus       158 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         158 KT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             cc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  122245678999998865 45889999999999999999999999643

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=272.56  Aligned_cols=220  Identities=24%  Similarity=0.278  Sum_probs=182.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|+..+.||+|+||.||++.... +..+|+|......      .+.+.+|+++++.++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            367888999999999999999764 8899999765432      235788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+.+++|.+++..   .....+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999998842   123568889999999999999999998  6799999999999999999999999999865432


Q ss_pred             CCCC---------------------------CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          230 TDVA---------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       230 ~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ....                           .......++..|+|||+..+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1100                           0112345788899999999989999999999999999999999999643


Q ss_pred             C----------------C--CChhhHHHHHHHHhhcc
Q 022118          283 S----------------P--DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ~----------------~--~~~~~l~~~~~~~~~~~  301 (302)
                      .                .  ..+.++.+++.+||..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  272 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKD  272 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCC
Confidence            2                1  13577899999999764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=264.03  Aligned_cols=217  Identities=23%  Similarity=0.330  Sum_probs=178.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--------ChHHHHHHHHHhccCCCCceeeEEeEEeeC--Cee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  145 (302)
                      .+|++.+.||+|+||.||++... ++..+++|.....        ....+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999864 5889999975321        123578899999999999999999998764  457


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++++||+++++|.+++.     ....+++.....++.|++.|+.|||+  .+++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK-----AYGALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999998883     23457788899999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------------CCCC
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------------SPDS  286 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------------~~~~  286 (302)
                      ........ .......++..|+|||.+.+..++.++|+|||||++|||++|+.||...                  +...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~  234 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV  234 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCccc
Confidence            65321111 1122345788899999999888999999999999999999999999642                  2234


Q ss_pred             hhhHHHHHHHHhhc
Q 022118          287 SQDLVELMIKCMGK  300 (302)
Q Consensus       287 ~~~l~~~~~~~~~~  300 (302)
                      .+.+.+++.+||..
T Consensus       235 ~~~~~~~i~~~l~~  248 (264)
T cd06653         235 SDACRDFLKQIFVE  248 (264)
T ss_pred             CHHHHHHHHHHhcC
Confidence            56788888888864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.8e-37  Score=264.12  Aligned_cols=214  Identities=29%  Similarity=0.436  Sum_probs=180.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      -|+..+.||+|+||.||+|... ++..+|+|......    ...+.+|+..+++++||||+++++.+..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667889999999999999864 57899999765332    245788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|..++.      ...+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        85 ~~~~l~~~i~------~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999998873      2457889999999999999999998  6799999999999999999999999999876543221


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                        ......++..|+|||...+..++.++|+|||||++|+|++|..||....                 ...+.++.+++.
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE  234 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence              1223456778999999988888999999999999999999999986432                 123567899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       235 ~~l~~~  240 (277)
T cd06641         235 ACLNKE  240 (277)
T ss_pred             HHccCC
Confidence            999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-37  Score=274.90  Aligned_cols=194  Identities=18%  Similarity=0.255  Sum_probs=164.1

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ....+|++.+.||+|+||.||+|... ++..||+|.....   ....|+.++++++||||+++++++...+..++||||+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            34567999999999999999999965 4678999975433   2356999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      . ++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       140 ~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        140 S-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             C-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            5 577777732    34568899999999999999999998  679999999999999999999999999987533211 


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                        ......+|..|+|||++.+..|+.++|||||||++|||+++..|+.
T Consensus       212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence              1234568889999999999999999999999999999998665553

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.5e-37  Score=269.08  Aligned_cols=227  Identities=28%  Similarity=0.426  Sum_probs=182.3

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccC-CCCceeeEEeEEeeCC--
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQENN--  143 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~--  143 (302)
                      +++....++|++.+.||+|+||.||++... ++..+|+|.....  ....+.+|+.+++++ +|||++++++++...+  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            333345778999999999999999999864 5788999986543  245677899999988 8999999999987543  


Q ss_pred             ---eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          144 ---LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       144 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                         ..++||||+++++|.+++.... .....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEee
Confidence               5799999999999998874321 123567889999999999999999998  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSP-----------  284 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-----------  284 (302)
                      ||++.........  .....++..|+|||.+...     .++.++|||||||++|||++|+.||.....           
T Consensus       172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  249 (291)
T cd06639         172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP  249 (291)
T ss_pred             cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence            9998876432221  2234577889999987643     368899999999999999999999865321           


Q ss_pred             --------CChhhHHHHHHHHhhcc
Q 022118          285 --------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 --------~~~~~l~~~~~~~~~~~  301 (302)
                              .....+.+++.+||.++
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~~  274 (291)
T cd06639         250 PPTLLHPEKWCRSFNHFISQCLIKD  274 (291)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhcC
Confidence                    12345788999999764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.1e-37  Score=263.92  Aligned_cols=221  Identities=24%  Similarity=0.424  Sum_probs=176.7

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      |.+.+.||+|+||.||+|...    ++..+|+|......     .+++.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999853    36789999765432     345788999999999999999999886542      


Q ss_pred             eeeEEEeccCCCCccccccCCCc-CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      ..++++||+++|+|.+++..... .....+++.....++.|++.|++|||+  ++|+||||||+||+++.++.+|++|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECccc
Confidence            23788999999999887643221 122357888899999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------C
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------P  284 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~  284 (302)
                      +++...............++..|++||...+..++.++|||||||++|||++ |++||....                 .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            9987644332222333445667999999998899999999999999999999 888876432                 2


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+.++.+++.+||..+
T Consensus       239 ~~~~~~~~l~~~~l~~~  255 (273)
T cd05074         239 DCLEDVYELMCQCWSPE  255 (273)
T ss_pred             CCCHHHHHHHHHHcCCC
Confidence            34578899999999754

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.5e-37  Score=260.42  Aligned_cols=217  Identities=31%  Similarity=0.533  Sum_probs=180.6

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +++.+.||+|+||.||++...+     +..+|+|......    .+.+..|++.+..++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999998654     3789999876544    346889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++...   ....+++..+..++.|++.|++|||+  .+++|+||||+||++++++.++|+|||+++....
T Consensus        81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999888432   11228999999999999999999998  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLV  291 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~  291 (302)
                      ....... ...++..|+|||...+..++.++|+||+|+++|||++ |++||....                 ...+.++.
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY  234 (258)
T ss_pred             ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence            4222211 2236678999999988889999999999999999998 788886322                 23467888


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+|+..+
T Consensus       235 ~~i~~~l~~~  244 (258)
T smart00219      235 KLMLQCWAED  244 (258)
T ss_pred             HHHHHHCcCC
Confidence            8999998865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-37  Score=264.53  Aligned_cols=217  Identities=23%  Similarity=0.374  Sum_probs=180.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC---------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      +|+..+.||+|++|.||++.. .++..+|+|......         .+.+.+|+..+++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999985 468899999765322         3467889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNF  226 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~  226 (302)
                      |+||+++++|.+++..     ...+++..+..++.|++.||+|||+  .+++|+||+|+||+++.++ .+||+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999998832     3457888999999999999999998  6799999999999998776 699999999877


Q ss_pred             cCCCCCC--CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------
Q 022118          227 LGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------  283 (302)
Q Consensus       227 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------  283 (302)
                      .......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....                     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP  233 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence            6543211  11223457788999999988889999999999999999999999996432                     


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...++++.+++.+|+..+
T Consensus       234 ~~~~~~~~~~i~~~l~~~  251 (268)
T cd06630         234 EHLSPGLRDVTLRCLELQ  251 (268)
T ss_pred             hhhCHHHHHHHHHHcCCC
Confidence            123467788888998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.1e-37  Score=265.89  Aligned_cols=209  Identities=24%  Similarity=0.327  Sum_probs=175.6

Q ss_pred             eeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||+|+||+||++... ++..+++|.....      ....+.+|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 5889999976432      233467899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++...   ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            9888532   22468899999999999999999998  679999999999999999999999999987654311   122


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHHHHHHHH
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLVELMIKC  297 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~~~~~~~  297 (302)
                      ...++..|+|||...+..++.++|+||||+++|+|++|+.||....                    ...++++.+++.+|
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL  232 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHH
Confidence            3456677999999988889999999999999999999999996432                    23456789999999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |..+
T Consensus       233 l~~~  236 (277)
T cd05577         233 LQKD  236 (277)
T ss_pred             ccCC
Confidence            9765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.1e-37  Score=269.09  Aligned_cols=219  Identities=15%  Similarity=0.150  Sum_probs=163.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCCh----H----------HHHHHHHHhccCCCCceeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----Q----------EFIDEVCFLASIQHRNLVTLL  136 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~----------~~~~E~~~l~~l~H~nIv~l~  136 (302)
                      ..++|++.+.||+|+||+||+|...+    +..+++|.......    +          ....+...+..++|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34679999999999999999998654    34566664321111    0          112233455677999999999


Q ss_pred             eEEeeCC----eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 022118          137 GYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (302)
Q Consensus       137 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~  212 (302)
                      +.+....    ..++++|++.. ++.+.+..     ....++..+..++.|++.||+|||+  .+|+||||||+|||++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDG  161 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcC
Confidence            9876554    33678887643 44444411     1234677788999999999999998  67999999999999999


Q ss_pred             CCceEEcccccccccCCCCC-----CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----
Q 022118          213 DFIAKVADAGLRNFLGRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----  283 (302)
Q Consensus       213 ~~~~kl~DfGla~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----  283 (302)
                      ++.++|+|||+++.......     ........||+.|+|||...+..++.++|||||||++|||++|+.||....    
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999987643211     111233468999999999999999999999999999999999999997552    


Q ss_pred             --------------------CCChhhHHHHHHHHhhcc
Q 022118          284 --------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                          ..+++.+.+++..||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLS  279 (294)
T ss_pred             HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCC
Confidence                                234566788888888654

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-37  Score=266.78  Aligned_cols=219  Identities=22%  Similarity=0.316  Sum_probs=175.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHH-hccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|++.+.||+|+||.||++... ++..||+|..+...    ..++..|+.. ++.++||||+++++++..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999865 58999999865432    2345566665 566799999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |++ |+|.+++..... ....+++..++.++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 677766643221 235689999999999999999999982 27999999999999999999999999999865432


Q ss_pred             CCCCCCccccCcccccchhhhcc----CCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCCh
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSS  287 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~  287 (302)
                      .   ......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||....                   ...+
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS  234 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence            1   1122356778999998865    457889999999999999999999986321                   1235


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||.++
T Consensus       235 ~~l~~li~~~l~~~  248 (283)
T cd06617         235 PEFQDFVNKCLKKN  248 (283)
T ss_pred             HHHHHHHHHHccCC
Confidence            67899999999765

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=269.64  Aligned_cols=203  Identities=25%  Similarity=0.350  Sum_probs=166.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc---CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeC--Ceee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF  146 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~  146 (302)
                      +|+..+.||+|+||.||+|...   ++..+|+|.....      ..+.+.+|+.++++++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999964   4789999986542      235678899999999999999999999988  7889


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC----CCceEEcccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----DFIAKVADAG  222 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~----~~~~kl~DfG  222 (302)
                      +||||+++ +|.+.+..........+++..+..++.|++.||+|||+  .+|+||||||+||+++.    ++.+||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999975 56655533222223478889999999999999999998  67999999999999999    9999999999


Q ss_pred             cccccCCCCC-CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          223 LRNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       223 la~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +++....... ........++..|+|||...+. .++.++|||||||++|||++|++||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            9987644322 1122344567889999987764 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-37  Score=264.58  Aligned_cols=214  Identities=26%  Similarity=0.406  Sum_probs=179.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC----ChHHHHHHHHHhccCC---CCceeeEEeEEeeCCeeeEEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .|+..+.||+|+||.||+|.. .++..+++|.....    ...++.+|+.+++.++   |||++++++++...+..+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 46889999976432    2356788999998886   999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++.      ...+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMK------AGPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHH------ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999998873      2367889999999999999999998  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC------------------CChhhH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSP------------------DSSQDL  290 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~------------------~~~~~l  290 (302)
                      ...  ......++..|+|||...+ ..++.++|+|||||++|+|++|+.||.....                  ..+.++
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06917         154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLL  231 (277)
T ss_pred             Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHH
Confidence            331  1233467788999998765 4578999999999999999999999964321                  135678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       232 ~~~i~~~l~~~  242 (277)
T cd06917         232 REFVAACLDEE  242 (277)
T ss_pred             HHHHHHHcCCC
Confidence            99999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.5e-37  Score=266.85  Aligned_cols=197  Identities=22%  Similarity=0.337  Sum_probs=163.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|...+.||+|+||.||+|... ++..+++|......    ...+.+|+++++.++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467889999999999999999864 58899999764322    2357789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+. +++.+++..    ....+.+..+..++.|++.||+|||+  .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            996 567666532    22456778888999999999999998  67999999999999999999999999998765332


Q ss_pred             CCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ...  .....++..|+|||...+. .++.++|||||||++|||++|+.||..
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            211  2233467789999998754 578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.3e-37  Score=261.45  Aligned_cols=217  Identities=23%  Similarity=0.342  Sum_probs=179.5

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee-CCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e  150 (302)
                      +|++.+.||+|++|.||++... ++..+++|.....     ..+.+.+|++++++++|||++++.+.+.. ++..+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999865 4788999975432     23457889999999999999999998764 446799999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++...   ....+++.++..++.|++.|++|||+  .+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999888431   23457899999999999999999998  67999999999999999999999999999866432


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      .  .......++..|+|||...+..++.++|+||||+++|||++|+.||...+                 ...+..+.++
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL  233 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHH
Confidence            2  12234457788999999999999999999999999999999999987432                 1234668888


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       234 i~~~l~~~  241 (257)
T cd08223         234 IATMLSKR  241 (257)
T ss_pred             HHHHhccC
Confidence            89998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=288.21  Aligned_cols=202  Identities=15%  Similarity=0.203  Sum_probs=158.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC--CcEEEEE------------------ecCC--CChHHHHHHHHHhccCCCCce
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIK------------------KRPG--APTQEFIDEVCFLASIQHRNL  132 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~--~~~~~~~~E~~~l~~l~H~nI  132 (302)
                      ...+|++.+.||+|+||+||++..+.  +...+.|                  ....  .....+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987432  2111111                  1111  112457899999999999999


Q ss_pred             eeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 022118          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (302)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~  212 (302)
                      +++++++...+..|+++|++. ++|..++...............+..++.|++.||.|||+  ++||||||||+|||++.
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECC
Confidence            999999999999999999985 466666543221112233456677899999999999998  67999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       213 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ++.+||+|||+++.+..... .......||..|+|||++.+..|+.++|||||||++|||++|+.|+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            99999999999987654322 12234578999999999999999999999999999999999986543

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.2e-37  Score=262.46  Aligned_cols=212  Identities=21%  Similarity=0.226  Sum_probs=171.8

Q ss_pred             HhcCCCcCCee--eeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEe
Q 022118           75 ATKNFSDKNLI--GEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        75 ~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ..++|++.+.+  |+|+||.||++... ++..+++|..........  |+.....+ +||||+++++.+..++..++|||
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            34566666666  99999999999854 578899998654432222  22222212 79999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGR  229 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~  229 (302)
                      |+++++|.+++.     ....+++..+..++.|++.|+.|||+  .+++||||||+||+++.++ .++|+|||+++..+.
T Consensus        90 ~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         90 YIKDGDLFDLLK-----KEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             cCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999883     23378999999999999999999998  6799999999999999988 999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------------------CChhh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--------------------DSSQD  289 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~--------------------~~~~~  289 (302)
                      .      ....++..|+|||.+.+..++.++||||||+++|||++|+.||.....                    ..++.
T Consensus       163 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T PHA03390        163 P------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN  236 (267)
T ss_pred             C------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence            2      223567789999999999999999999999999999999999974321                    24567


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+..+
T Consensus       237 ~~~li~~~l~~~  248 (267)
T PHA03390        237 ANDFVQSMLKYN  248 (267)
T ss_pred             HHHHHHHHhccC
Confidence            788888888654

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=266.69  Aligned_cols=196  Identities=25%  Similarity=0.367  Sum_probs=167.5

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||+|... ++..+++|.....     ..+.+.+|++++++++|+||+++++.+..++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888899999999999999866 4789999975432     245688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      ++++++..+..     ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99877765552     23457889999999999999999998  679999999999999999999999999988765433


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      . .......++..|+|||+..+. .++.++||||||+++|+|++|++||..
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2 122334567889999999888 889999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-37  Score=270.32  Aligned_cols=212  Identities=22%  Similarity=0.333  Sum_probs=178.1

Q ss_pred             CcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC---CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      .....||+|+||.||++... ++..+++|....   ...+.+.+|+.+++.++||||+++++.+..++..+++|||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33457999999999999864 588999997542   23456789999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|..++.      ...+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++........  .
T Consensus       104 ~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         104 ALTDIVS------QTRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            9988762      3457889999999999999999998  6799999999999999999999999999876543221  1


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHHHHH
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVELMIK  296 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~~~~  296 (302)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||....                   ...+.++.+++.+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            233567888999999998899999999999999999999999985322                   1234678899999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||..+
T Consensus       254 ~l~~~  258 (297)
T cd06659         254 MLTRE  258 (297)
T ss_pred             HhcCC
Confidence            98765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.4e-37  Score=265.10  Aligned_cols=207  Identities=23%  Similarity=0.318  Sum_probs=167.5

Q ss_pred             eeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHH---hccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           84 LIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCF---LASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~---l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .||+|+||.||++... ++..+|+|......      ...+.+|..+   +...+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 58899999754321      1223444433   334579999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|.+++.     ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLS-----QHGVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999988873     23468999999999999999999998  679999999999999999999999999987553321  


Q ss_pred             CCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          234 GPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        .....++..|+|||... +..++.++|+||+||++|||++|+.||....                   +..+.++.++
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSL  229 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHH
Confidence              22346788899999886 4568999999999999999999999996432                   2335677888


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+..+
T Consensus       230 i~~~l~~~  237 (279)
T cd05633         230 LEGLLQRD  237 (279)
T ss_pred             HHHHhcCC
Confidence            88998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.9e-37  Score=267.50  Aligned_cols=194  Identities=25%  Similarity=0.350  Sum_probs=163.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +|+..+.||+|+||.||+|... ++..+++|......        ...+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677889999999999999965 58899999865432        23467899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+ +++|.+++...    ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 89999988421    2368899999999999999999998  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ....  ......++..|+|||.+.+ ..++.++|+|||||++|||++|.+||.
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~  204 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence            4321  1122345677999998864 467899999999999999999987775

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=257.11  Aligned_cols=228  Identities=22%  Similarity=0.287  Sum_probs=183.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeC-----C
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----N  143 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~  143 (302)
                      .+..++|++.+.||+|+|+.||++. ..++..+|+|++.-.   ..+..++|++..++++|||+++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3567889999999999999999998 567889999985433   345678999999999999999999987543     3


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|++++|...|+|.+.+...+ .....+++.+++.++.++++||++||+..+++.||||||.|||+++.+.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            4799999999999999985432 345678999999999999999999999666699999999999999999999999999


Q ss_pred             ccccCCC---CCC----CCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------
Q 022118          224 RNFLGRT---DVA----GPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSL-----------  282 (302)
Q Consensus       224 a~~~~~~---~~~----~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------  282 (302)
                      +....-.   ...    ........|..|.|||.+.   +...++++|||||||+||+|+.|..||...           
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            8654210   000    0011123455699999876   445689999999999999999999999831           


Q ss_pred             ---------CCCChhhHHHHHHHHhhcc
Q 022118          283 ---------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---------~~~~~~~l~~~~~~~~~~~  301 (302)
                               .+..++.+.+++..|+..|
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvd  283 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVD  283 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCC
Confidence                     1345788899999998765

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-37  Score=265.00  Aligned_cols=207  Identities=23%  Similarity=0.380  Sum_probs=168.0

Q ss_pred             CeeeeCCCeeEEEEEEcC--------CcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +.||+|+||.||+|....        ...+++|......   .+.+.+|..+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998532        2347778765433   24678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--------eEEccccc
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------AKVADAGL  223 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~--------~kl~DfGl  223 (302)
                      +++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            999999999843    23367888999999999999999998  77999999999999987765        69999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCC-CCCCCCC---------------CCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGR-EASSSLS---------------PDS  286 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~-~p~~~~~---------------~~~  286 (302)
                      +.....      .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+....               ...
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPK  228 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCC
Confidence            865432      2234566779999998864 5799999999999999999995 5554322               223


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      ..++.+++.+||..+
T Consensus       229 ~~~~~~li~~~l~~~  243 (258)
T cd05078         229 WTELANLINQCMDYE  243 (258)
T ss_pred             cHHHHHHHHHHhccC
Confidence            467889999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-36  Score=261.05  Aligned_cols=217  Identities=26%  Similarity=0.409  Sum_probs=181.5

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||++... ++..+++|.....     ....+.+|++++++++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 6888999975433     234678999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.     ....+++..+..++.|++.|++|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHh-----hcCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999883     23457788889999999999999998  679999999999999999999999999998765433


Q ss_pred             CCCC--CccccCcccccchhhhccCC---CCCccchhhHHHHHHHHHhCCCCCCCCC------------------C--CC
Q 022118          232 VAGP--SSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLS------------------P--DS  286 (302)
Q Consensus       232 ~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~--~~  286 (302)
                      ....  .....++..|+|||.+.+..   ++.++||||||+++||+++|+.||....                  .  ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence            2111  12345677899999988766   8899999999999999999999996431                  1  11


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +..+.+++.+||..+
T Consensus       234 ~~~~~~li~~~l~~~  248 (264)
T cd06626         234 SPEGKDFLDRCLESD  248 (264)
T ss_pred             CHHHHHHHHHHccCC
Confidence            567789999999765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=275.13  Aligned_cols=219  Identities=23%  Similarity=0.327  Sum_probs=179.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEe--cCCCC--------hHHHHHHHHHhccCCCCceeeEEeEEee-CCe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKK--RPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~--~~~~~--------~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~  144 (302)
                      .+|-.+.+||+|+|+.||+|.. ...+.||+|.  +.+.-        .+...+|.+|.+.|+||.||++|+++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3455678999999999999984 4578899996  22211        1235689999999999999999999974 467


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADA  221 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~---~~~~~kl~Df  221 (302)
                      .+-|+|||+|.+|.-+|.     .....++.++.+|+.||+.||.||.+..++|||-||||.|||+.   ..|.+||+||
T Consensus       543 FCTVLEYceGNDLDFYLK-----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK-----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHH-----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            789999999999999983     34567889999999999999999999889999999999999994   4589999999


Q ss_pred             ccccccCCCCCC-----CCCccccCcccccchhhhccC----CCCCccchhhHHHHHHHHHhCCCCCCCCC---------
Q 022118          222 GLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSGREASSSLS---------  283 (302)
Q Consensus       222 Gla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------  283 (302)
                      |+++++.+++..     ..++...||.+|++||.+--.    ..+.|+||||+|||+|++++|+.||....         
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            999999765443     234677899999999987543    46889999999999999999999997421         


Q ss_pred             -------------CCChhhHHHHHHHHhhc
Q 022118          284 -------------PDSSQDLVELMIKCMGK  300 (302)
Q Consensus       284 -------------~~~~~~l~~~~~~~~~~  300 (302)
                                   +-.+.+-.++|++|+..
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaY  727 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRRCLAY  727 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHHHHHh
Confidence                         23356678899999865

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.8e-37  Score=260.81  Aligned_cols=217  Identities=24%  Similarity=0.364  Sum_probs=181.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.+|++... ++..+++|....     ....++.+|+.++++++||||+++.+++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999854 578899997532     2234688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999887421   22357888899999999999999998  679999999999999999999999999997654322


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~~l~~~~  294 (302)
                      ..  .....++..|+|||...+..++.++|+|||||++|+|++|+.||...                 +...+.++.+++
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08218         156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV  233 (256)
T ss_pred             hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence            11  12335677899999999888999999999999999999999998632                 223456789999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||.++
T Consensus       234 ~~~l~~~  240 (256)
T cd08218         234 SQLFKRN  240 (256)
T ss_pred             HHHhhCC
Confidence            9999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.3e-37  Score=269.58  Aligned_cols=210  Identities=20%  Similarity=0.339  Sum_probs=175.8

Q ss_pred             CCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ...||+|+||.||++... ++..+|+|......   .+.+.+|+..++.++||||+++++.+...+..+++|||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            467999999999999864 58899999865433   34578899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++.      ...+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||++........  ...
T Consensus       107 ~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         107 TDIVT------HTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             HHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            88872      2357888999999999999999998  6799999999999999999999999999876543221  123


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhHHHHHHHHh
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDLVELMIKCM  298 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l~~~~~~~~  298 (302)
                      ...++..|+|||...+..++.++|+||||+++|||++|+.||.....                   ..+..+.+++.+||
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            34578889999999988999999999999999999999999864321                   12455677888888


Q ss_pred             hcc
Q 022118          299 GKE  301 (302)
Q Consensus       299 ~~~  301 (302)
                      ..+
T Consensus       257 ~~~  259 (292)
T cd06658         257 VRE  259 (292)
T ss_pred             cCC
Confidence            654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.4e-37  Score=266.53  Aligned_cols=215  Identities=23%  Similarity=0.392  Sum_probs=181.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .+|+..+.||+|+||.||++... ++..+++|.....   ..+.+.+|+.++++++||||+++++.+...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999854 5788999975432   2346788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++.      +..+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999998883      2356788899999999999999998  6799999999999999999999999999876543322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l~~~  293 (302)
                        ......++..|++||.+.+..++.++|+||||+++|++++|+.||.....                   ..+..+.++
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  248 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence              12234577889999999888899999999999999999999999974321                   113458899


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +++||..+
T Consensus       249 i~~~l~~~  256 (293)
T cd06647         249 LNRCLEMD  256 (293)
T ss_pred             HHHHccCC
Confidence            99999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.1e-37  Score=261.70  Aligned_cols=207  Identities=19%  Similarity=0.266  Sum_probs=175.9

Q ss_pred             eeeCCCeeEEEEEEcC-CcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQD-GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||.|+||.||++.... +..+++|.....      ..+.+.+|+.+++.++||||+++++.+.+++..+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999754 889999975432      234688899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++..     ...++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||+++......   ...
T Consensus        81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            999832     3457888999999999999999998  779999999999999999999999999998764432   122


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHHHHHHHH
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLVELMIKC  297 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~~~~~~~  297 (302)
                      ...++..|++||.+.+..++.++|+||+|+++|+|++|..||....                    ...+.++.+++.+|
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  230 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL  230 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence            3456778999999988889999999999999999999999997544                    12246778899999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |..+
T Consensus       231 l~~~  234 (262)
T cd05572         231 LRRN  234 (262)
T ss_pred             ccCC
Confidence            8765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.6e-37  Score=265.99  Aligned_cols=200  Identities=26%  Similarity=0.358  Sum_probs=163.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCe-----
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNL-----  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~-----  144 (302)
                      ++|+..+.||+|+||.||+|... ++..||+|.....     ....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999965 5889999975432     2346788999999995 6999999999987665     


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGL  223 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGl  223 (302)
                      .|++|||+++ +|..++..........+++..+..++.||+.||.|||+  ++++||||||+||+++. ++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            7999999985 78877754322224568999999999999999999998  67999999999999998 89999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++.......  ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||..
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            876533211  1122345677999998765 4578999999999999999999999854

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=268.47  Aligned_cols=210  Identities=23%  Similarity=0.320  Sum_probs=175.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh------HHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      +...+|..+.+||+|+||+|.++..+ +...+|||.+++...      +--..|-++|.-- +-|.++++...+++.+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            45668889999999999999999854 577899997655432      2224566666554 578999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||+.||+|--++     ..-.++.+..+..++.+|+-||-|||+  ++||.||||.+|||+|.+|++||+|||+++
T Consensus       426 yFVMEyvnGGDLMyhi-----QQ~GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHI-----QQVGKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeEEEEecCchhhhHH-----HHhcccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999998887     334667788889999999999999998  789999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHH
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMI  295 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~  295 (302)
                      ..--.  ..++.+.+||+-|+|||++...+|+.++|+|||||+||||+.|++||++.+   ..++.+.|.
T Consensus       499 Eni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~  563 (683)
T KOG0696|consen  499 ENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIM  563 (683)
T ss_pred             ccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHH
Confidence            54222  224567899999999999999999999999999999999999999998744   455555544

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.3e-37  Score=267.58  Aligned_cols=212  Identities=31%  Similarity=0.414  Sum_probs=175.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..|+..+.||+|+||.||+|... ++..|++|......      .+++.+|+++++.++||||+++.+++..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999865 58899999754221      235788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||++ |++.+++..    ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 466555521    23458899999999999999999998  6799999999999999999999999999876532


Q ss_pred             CCCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQ  288 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~  288 (302)
                      .      ....++..|+|||.+.   ...++.++||||||+++|||++|+.||....                  ...+.
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD  241 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCH
Confidence            2      2345677899999874   4568899999999999999999999986422                  12345


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||.++
T Consensus       242 ~~~~li~~~l~~~  254 (307)
T cd06607         242 YFRNFVDSCLQKI  254 (307)
T ss_pred             HHHHHHHHHhcCC
Confidence            7899999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-36  Score=259.33  Aligned_cols=217  Identities=24%  Similarity=0.333  Sum_probs=184.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|++|.||++... ++..+++|......    ...+.+|+..+.+++||||+++++++..++..+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999976 48899999865443    46788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++..     ...+++..++.++.|++.|++|||+. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999832     36688999999999999999999971 459999999999999999999999999988764332


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CC-ChhhH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PD-SSQDL  290 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~-~~~~l  290 (302)
                      ..  .....++..|+|||...+..++.++|+||||+++|||++|+.||....                    .. .+..+
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF  232 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            21  123456778999999998889999999999999999999999996552                    11 35678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++++||..+
T Consensus       233 ~~li~~~l~~~  243 (264)
T cd06623         233 RDFISACLQKD  243 (264)
T ss_pred             HHHHHHHccCC
Confidence            99999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.5e-37  Score=264.67  Aligned_cols=196  Identities=26%  Similarity=0.338  Sum_probs=166.6

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|++.+.||+|+||.||+|... ++..+++|......     ...+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999965 58899999755332     35688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      + +++|.+++..    ....+++..+..++.|++.||+|||+  .+++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRD----EERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 9999988743    23568899999999999999999998  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      . .......++..|+|||.+.+. .++.++||||+|+++|||++|++||..
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            1 112334678889999988654 468999999999999999999888753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.5e-37  Score=262.26  Aligned_cols=219  Identities=21%  Similarity=0.373  Sum_probs=180.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcC--CcEEEEEecCCC-------------ChHHHHHHHHHhcc-CCCCceeeEEeEEee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGA-------------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQE  141 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~-------------~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~  141 (302)
                      +|++.+.||+|+||.||++....  +..+|+|.....             ...++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999654  678999964321             12346778888764 799999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      .+..+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+. .+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988873221 1245688899999999999999999962 57999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      |++.......   ......++..|++||...+..++.++|+||||+++|||++|+.||....                  
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE  235 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc
Confidence            9998754432   2234567788999999998889999999999999999999999986421                  


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++.+||..+
T Consensus       236 ~~~~~~l~~li~~cl~~~  253 (269)
T cd08528         236 GMYSEDVTDVITSCLTPD  253 (269)
T ss_pred             ccCCHHHHHHHHHHCCCC
Confidence            134578999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-36  Score=263.74  Aligned_cols=219  Identities=26%  Similarity=0.410  Sum_probs=185.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..+.|+..+.||+|++|.||++... ++..+++|......  .+.+.+|++.++.++|+||+++++.+...+..++++||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4456788899999999999999976 58889999876544  56788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++...    ...+++..+..++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          97 MDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999998432    1378899999999999999999998  779999999999999999999999999987654321


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDLVE  292 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l~~  292 (302)
                      .  ......++..|++||.+.+..++.++|+|||||++|+|++|+.||....+                   ..+.++.+
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD  248 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence            1  12233467789999999988899999999999999999999999875321                   13467889


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       249 li~~~l~~~  257 (286)
T cd06614         249 FLNKCLVKD  257 (286)
T ss_pred             HHHHHhccC
Confidence            999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.8e-38  Score=261.77  Aligned_cols=221  Identities=23%  Similarity=0.321  Sum_probs=178.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-----CcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee-CCe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~  144 (302)
                      ...|+....||+|.||.||+|...+     ...+|+|+++..     ......+|+.+++.++||||+.+..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3468889999999999999996332     236899987655     23557899999999999999999999877 778


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC----CceEEcc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVAD  220 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~----~~~kl~D  220 (302)
                      +++++||.+. ||...++-.+......++...+.++..||+.|+.|||+  +-|+||||||+|||+..+    |.|||+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeEeec
Confidence            8999999976 67767755544455688999999999999999999999  569999999999999877    8999999


Q ss_pred             cccccccCCCCC-CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCC------ChhhHHH
Q 022118          221 AGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVE  292 (302)
Q Consensus       221 fGla~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~------~~~~l~~  292 (302)
                      ||+++.+...-. .......+.|.+|.|||.+.+. .|+.+.||||.|||+.||++-++-|.....+      ...+.++
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999998865422 2244567789999999999876 5899999999999999999999888764321      2234455


Q ss_pred             HHHHHhh
Q 022118          293 LMIKCMG  299 (302)
Q Consensus       293 ~~~~~~~  299 (302)
                      .|...+|
T Consensus       260 rIf~vLG  266 (438)
T KOG0666|consen  260 RIFEVLG  266 (438)
T ss_pred             HHHHHcC
Confidence            5554444

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=271.53  Aligned_cols=197  Identities=24%  Similarity=0.373  Sum_probs=162.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----ee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~  145 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|.....    ...++.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            357899999999999999999854 6889999986532    2345778999999999999999999876543     47


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+++||+++ +|...+      ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~~-~l~~~~------~~~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLI------KTQHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999974 776665      23468889999999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ........ .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            76432211 12233467888999998654 5689999999999999999999999853

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-36  Score=261.20  Aligned_cols=207  Identities=22%  Similarity=0.311  Sum_probs=168.2

Q ss_pred             eeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh------HHHHHHH---HHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           84 LIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV---CFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~---~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .||+|+||.||++... +++.||+|.......      ..+..|.   ..++...||||+.+.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999997543221      1233343   34455689999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|..++.     ....+++..+..++.|++.|++|||+  .+++||||||+||++++++.+||+|||++.......  
T Consensus        81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999988873     33568999999999999999999998  679999999999999999999999999987653221  


Q ss_pred             CCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||....                   ...+.++.++
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  229 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHH
Confidence              2234678889999998754 68999999999999999999999996431                   1235677888


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.++
T Consensus       230 i~~~l~~~  237 (278)
T cd05606         230 LEGLLQRD  237 (278)
T ss_pred             HHHHhhcC
Confidence            88888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-36  Score=264.31  Aligned_cols=216  Identities=24%  Similarity=0.313  Sum_probs=177.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE----cCCcEEEEEecCCC-------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      +|++.+.||+|+||.||++..    .++..+|+|.....       ..+.+.+|+.+++.+ +|+||+.+++.+..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477789999999999999985    36788999976532       224577899999999 699999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999883     23457788889999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccC--CCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      ........ ......++..|+|||.....  .++.++||||||+++|+|++|+.||....                    
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  232 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC
Confidence            75432211 12234577889999998753  46889999999999999999999986321                    


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+..+.+++++||..+
T Consensus       233 ~~~~~~~~~ll~~~l~~~  250 (290)
T cd05613         233 QEMSALAKDIIQRLLMKD  250 (290)
T ss_pred             ccCCHHHHHHHHHHhcCC
Confidence            123456788889998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-36  Score=255.93  Aligned_cols=217  Identities=30%  Similarity=0.465  Sum_probs=185.4

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeEEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIY  149 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~  149 (302)
                      +|...+.||+|++|.||+|... ++..+++|......     .+.+.+|++.+++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999976 68899999865444     46688999999999999999999999988  8899999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++..     ...+++..+..++.|++.|++|||+  .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999998832     3378899999999999999999998  6799999999999999999999999999987655


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDL  290 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l  290 (302)
                      ...........++..|++||......++.++||||||+++|+|++|+.||....                   ...+..+
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHH
Confidence            432212334567788999999988889999999999999999999999986542                   2335678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+|+..+
T Consensus       234 ~~~i~~~l~~~  244 (260)
T cd06606         234 KDFLRKCLRRD  244 (260)
T ss_pred             HHHHHHhCcCC
Confidence            99999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-36  Score=263.79  Aligned_cols=196  Identities=28%  Similarity=0.413  Sum_probs=164.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||.|++|.||+|... ++..+++|.....     ....+.+|++++++++||||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999865 5889999976432     224688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +. ++|..++...   ....+++..+..++.|++.||+|||+  .+++|+||+|+||++++++.+||+|||+++..+...
T Consensus        81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5788777432   23568899999999999999999998  679999999999999999999999999987654322


Q ss_pred             CCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  ......++..|+|||...+.. ++.++||||||+++|||+||+.||..
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1  112234567899999877654 58899999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-36  Score=270.50  Aligned_cols=197  Identities=23%  Similarity=0.349  Sum_probs=164.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee----CCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~  146 (302)
                      .+|+..+.||+|+||.||++... ++..|++|+....     ....+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888999999999999999854 5889999975432     23457789999999999999999998763    34679


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+. ++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.+||+|||+++.
T Consensus        85 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIH-----SDQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999996 58888873     23458899999999999999999998  6799999999999999999999999999977


Q ss_pred             cCCCCCC--CCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          227 LGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       227 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .......  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            6433221  11223467888999998765 4689999999999999999999999954

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=259.93  Aligned_cols=222  Identities=29%  Similarity=0.440  Sum_probs=181.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccC-CCCceeeEEeEEeeCC------e
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASI-QHRNLVTLLGYCQENN------L  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------~  144 (302)
                      ..++|+..+.||+|+||.||+|... ++..+++|......  .+.+.+|+.+++++ +||||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4578999999999999999999975 57889999865433  35688999999998 7999999999997654      4


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .+++|||+++++|.+++.... .....+++..+..++.|++.||+|||+  .+++|+||+|+||++++++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            799999999999998874321 124568899999999999999999998  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------------
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSP---------------  284 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---------------  284 (302)
                      .......  .......++..|+|||.+..     ..++.++||||||+++|+|++|+.||.....               
T Consensus       161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            7654322  12233457788999998753     3477899999999999999999999974321               


Q ss_pred             ----CChhhHHHHHHHHhhcc
Q 022118          285 ----DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ----~~~~~l~~~~~~~~~~~  301 (302)
                          ..++++.+++++||..+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~d  259 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKN  259 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcC
Confidence                13457889999999764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-36  Score=262.06  Aligned_cols=198  Identities=26%  Similarity=0.331  Sum_probs=166.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e  150 (302)
                      +|+..+.||.|++|.||++... ++..+|+|......    ..++.+|++++++++||||+++++++...  +..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5777899999999999999975 57889999765332    34688999999999999999999998654  46799999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++.... .....++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            999999988764221 134567888899999999999999998  67999999999999999999999999998765332


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .    .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            1    12345677799999999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.3e-36  Score=258.62  Aligned_cols=221  Identities=23%  Similarity=0.361  Sum_probs=181.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee--CCeeeEEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIY  149 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~  149 (302)
                      +|+..+.||.|+||.||++... ++..+++|.....     ..+++.+|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999854 5788999975432     23457789999999999999999998764  34579999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC---CCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ||+++++|.+++.... .....+++..++.++.|++.||.|||..   +.+++|+||+|+||++++++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999998884321 2245688999999999999999999922   26799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChhh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~~  289 (302)
                      .......  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...                 +...+.+
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd08217         160 LGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE  237 (265)
T ss_pred             ccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHH
Confidence            6543321  22345788899999999888999999999999999999999998743                 2234577


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+..+
T Consensus       238 ~~~l~~~~l~~~  249 (265)
T cd08217         238 LNEVIKSMLNVD  249 (265)
T ss_pred             HHHHHHHHccCC
Confidence            889999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-36  Score=256.76  Aligned_cols=216  Identities=24%  Similarity=0.409  Sum_probs=181.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||++... ++..+++|.....     ....+.+|+++++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 5788999975432     234688899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGla~~~~~~  230 (302)
                      +++++|.+++...   ....+++..+..++.+++.|++|||+  ++++|+||+|+||+++++ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999998432   23457889999999999999999998  679999999999999855 46899999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      .   ......++..|+|||...+..++.++||||||+++|+|++|+.||....                 ...+.++.++
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  232 (256)
T cd08220         156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQL  232 (256)
T ss_pred             c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHH
Confidence            2   1223457778999999998889999999999999999999999986421                 2345778999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.++
T Consensus       233 i~~~l~~~  240 (256)
T cd08220         233 ILSMLNLD  240 (256)
T ss_pred             HHHHccCC
Confidence            99999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.5e-36  Score=261.50  Aligned_cols=197  Identities=25%  Similarity=0.360  Sum_probs=161.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|+..+.||+|++|.||+|... +++.+++|.....     ....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999865 5889999975432     23467889999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR  229 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~~~~  229 (302)
                      |++ ++|.+++...   ....+++..+..++.|++.||+|||+  ++++||||+|+||++++ ++.+||+|||++...+.
T Consensus        82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 4777666321   22345778888999999999999998  67999999999999985 56799999999976543


Q ss_pred             CCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ...  ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            211  11223457789999988664 578999999999999999999999853

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-36  Score=263.88  Aligned_cols=196  Identities=26%  Similarity=0.385  Sum_probs=163.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  148 (302)
                      ++|+..+.||+|+||.||+|... ++..+++|..+...     ...+.+|+.++++++||||+++++++...  +..|++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999976 57889999754322     23467899999999999999999999877  889999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++ +|.+++..    ....+++..+..++.|++.||+|||+  .+++|+||||+||++++++.+||+|||+++...
T Consensus        85 ~e~~~~-~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 88877732    22368899999999999999999998  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ....  ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||..
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4321  12233467789999988754 468899999999999999999998863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-36  Score=261.30  Aligned_cols=213  Identities=21%  Similarity=0.340  Sum_probs=178.4

Q ss_pred             CCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      |...+.||+|++|.||++.. .++..+++|.....   ..+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457899999999999985 46788999975432   234578899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|.+++..      ..+++..+..++.|++.|++|||+  .+++||||+|+||+++.++.++|+|||++........  
T Consensus       101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            999988832      457888999999999999999998  6799999999999999999999999998875543211  


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVELMI  295 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~~~  295 (302)
                      ......++..|+|||...+..++.++|||||||++|||++|+.||....                   ...+..+.++++
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence            1223457788999999988889999999999999999999999985421                   113467899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       251 ~~l~~~  256 (285)
T cd06648         251 RMLVRD  256 (285)
T ss_pred             HHcccC
Confidence            999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.5e-36  Score=252.88  Aligned_cols=215  Identities=29%  Similarity=0.448  Sum_probs=184.4

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      +|+..+.||+|++|.||++... ++..+++|+.....   .+.+.+|++.+++++|||++++++.+..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999975 58889999865543   4568899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +++|.+++...    ...+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999888432    2568899999999999999999998  6799999999999999999999999999887654321 


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCC--hhhHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDS--SQDLVELM  294 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~--~~~l~~~~  294 (302)
                        .....++..|++||...+..++.++|+||||+++|+|++|+.||....                 ...  +..+.+++
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  231 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL  231 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHH
Confidence              234567778999999998889999999999999999999999997551                 111  56789999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       232 ~~~l~~~  238 (253)
T cd05122         232 KKCLQKN  238 (253)
T ss_pred             HHHccCC
Confidence            9999765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.9e-36  Score=259.25  Aligned_cols=198  Identities=27%  Similarity=0.404  Sum_probs=165.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +|+..+.||.|++|.||+|... ++..+|+|.....    ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999975 5889999975432    2346778999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++ +|.+++....  ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.++++|||+++.......
T Consensus        81 ~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 7877764321  23468999999999999999999998  6799999999999999999999999999976543211


Q ss_pred             CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                        ......++..|++||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              12233457789999988654 5788999999999999999999998643

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-36  Score=260.42  Aligned_cols=215  Identities=25%  Similarity=0.338  Sum_probs=180.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +|+..+.||+|+||.||++... ++..+++|......    ..++.+|++++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999976 58889999755432    346789999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...    ...+++..+..++.|++.|++|||+. .+++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999988432    25678889999999999999999972 4699999999999999999999999999876533211


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------CC-Chhh
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------PD-SSQD  289 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------~~-~~~~  289 (302)
                          ....++..|+|||...+..++.++||||||+++|+|++|+.||....                      .. .+.+
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD  232 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence                11567778999999999999999999999999999999999986431                      01 3456


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       233 ~~~li~~~l~~~  244 (265)
T cd06605         233 FQDFVNLCLIKD  244 (265)
T ss_pred             HHHHHHHHcCCC
Confidence            888999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=251.78  Aligned_cols=217  Identities=20%  Similarity=0.333  Sum_probs=173.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++.+.+..||.|+.|.|+++++. +|...|||......    .++++..++++.+- +.|.||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34455678999999999999965 48899999865443    34566677766544 58999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      .|.. -++.++.    .....+++.-+-.+...+++||.||.+. ++|+|||+||+|||+|+.|.+|+||||++-++-+.
T Consensus       172 lMs~-C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  172 LMST-CAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHH-HHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeecc
Confidence            8742 2222331    2345578888888999999999999985 78999999999999999999999999999877654


Q ss_pred             CCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCCh
Q 022118          231 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSS  287 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~  287 (302)
                      ...   +...|-+.|||||.+.   ...|+.++||||||+.++||.||+.||....                    ...+
T Consensus       246 kAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  246 KAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             ccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence            322   2334566799999886   3479999999999999999999999998622                    2357


Q ss_pred             hhHHHHHHHHhhccC
Q 022118          288 QDLVELMIKCMGKER  302 (302)
Q Consensus       288 ~~l~~~~~~~~~~~~  302 (302)
                      +++.+++..|+.+|.
T Consensus       323 p~F~~fv~~CL~kd~  337 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDH  337 (391)
T ss_pred             HHHHHHHHHHhhcCc
Confidence            899999999998873

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-36  Score=256.94  Aligned_cols=217  Identities=25%  Similarity=0.409  Sum_probs=181.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||++... ++..+|+|....     ...+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999965 478899997543     2345678999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~~  230 (302)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||+  .+++|+||||+||++++++ .+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999988432   23357889999999999999999998  6799999999999998886 5699999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVEL  293 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~  293 (302)
                      ..  ......++..|+|||...+..++.++|+||||+++|||++|+.||....                 +..+.++.++
T Consensus       156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (257)
T cd08225         156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL  233 (257)
T ss_pred             cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHH
Confidence            21  1223457788999999988889999999999999999999999987431                 2335678999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       234 i~~~l~~~  241 (257)
T cd08225         234 ISQLFKVS  241 (257)
T ss_pred             HHHHhccC
Confidence            99999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=252.06  Aligned_cols=215  Identities=30%  Similarity=0.489  Sum_probs=183.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|++|.||++... ++..+++|......     .+.+.+|++++++++|||++++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999865 57889999765443     34678999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.     ....+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999998883     23568899999999999999999998  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      ..  .....++..|+|||...+..++.++||||+|+++|+|++|+.||....                 ...+..+.+++
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  231 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFL  231 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            21  233457788999999988888999999999999999999999986422                 23456888999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+|+..+
T Consensus       232 ~~~l~~~  238 (254)
T cd06627         232 MQCFQKD  238 (254)
T ss_pred             HHHHhCC
Confidence            9999765

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.5e-36  Score=268.31  Aligned_cols=194  Identities=23%  Similarity=0.360  Sum_probs=163.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----  143 (302)
                      ..++|+..+.||+|+||.||++... ++..+|+|.....     ....+.+|+.++++++||||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3567999999999999999999865 6889999986532     2345778999999999999999999886443     


Q ss_pred             -eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          144 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       144 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                       ..|+||||+++ +|.+.+.       ..++...+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence             46999999964 7776662       127888889999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            9987643221   2234567789999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-36  Score=267.43  Aligned_cols=196  Identities=22%  Similarity=0.337  Sum_probs=163.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC-----Ce
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  144 (302)
                      .++|.+.+.||+|+||+||++... ++..||+|.....     ....+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            356888999999999999999854 5889999975432     234577899999999999999999988654     34


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+++||+. ++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 67877773     23568899999999999999999998  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            8664322  11233456778999998765 4689999999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=255.12  Aligned_cols=206  Identities=21%  Similarity=0.257  Sum_probs=170.1

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh------HHHHHHHHHh-ccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFL-ASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|... +++.+|+|.......      ..+..|..++ ...+|||++++++.+...+..|++|||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999864 588999998654321      2234454444 455899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.+||+|||+++....     
T Consensus        82 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999883     23457889999999999999999998  6799999999999999999999999999875432     


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLVELM  294 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~~~~  294 (302)
                       .....++..|++||...+..++.++||||||+++|||++|..||....                    ...++++.+++
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  228 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI  228 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence             223356777999999988889999999999999999999999986421                    12357888999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       229 ~~~l~~~  235 (260)
T cd05611         229 NRLLCMD  235 (260)
T ss_pred             HHHccCC
Confidence            9998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-36  Score=259.22  Aligned_cols=210  Identities=24%  Similarity=0.314  Sum_probs=175.8

Q ss_pred             eeeCCCeeEEEEEEcC-CcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||+|+||.||++.... +..+++|......      ...+.+|++++++++||||+++++.+...+..|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 8899999865432      34578899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-----  232 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~-----  232 (302)
                      .+++..     ...+++..+..++.|++.||+|||+  .+++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            988832     2367889999999999999999998  6799999999999999999999999999876433211     


Q ss_pred             -CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCC--hhhHHHH
Q 022118          233 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDS--SQDLVEL  293 (302)
Q Consensus       233 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~--~~~l~~~  293 (302)
                       ........++..|++||......++.++||||||+++||+++|+.||....                ...  +..+.++
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence             112233456778999999988889999999999999999999999986432                111  5778999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +++||..+
T Consensus       234 i~~~l~~~  241 (265)
T cd05579         234 ISKLLVPD  241 (265)
T ss_pred             HHHHhcCC
Confidence            99999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=281.25  Aligned_cols=215  Identities=23%  Similarity=0.368  Sum_probs=178.8

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      |+++..||.|+||+||+|..++ +...|.|.+....   .++++-|++||..++||+||++++.|..++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4566789999999999998665 4455666654433   45678899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |-....+..    -...+.+.++..++.|++.||.|||+  ++|||||||..|||++-+|.++|+|||.+......  ..
T Consensus       114 GAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q  185 (1187)
T KOG0579|consen  114 GAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ  185 (1187)
T ss_pred             chHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence            988877642    35678999999999999999999999  67999999999999999999999999987543322  22


Q ss_pred             CCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhH
Q 022118          235 PSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDL  290 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l  290 (302)
                      ....+.||++|||||+..     ..+|+.++||||||++|.||.-+.+|....+                   ..=+..+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            345678999999999764     5689999999999999999999999987543                   1224567


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+|+-++
T Consensus       266 ~DfLk~cL~Kn  276 (1187)
T KOG0579|consen  266 SDFLKRCLVKN  276 (1187)
T ss_pred             HHHHHHHHhcC
Confidence            88899998765

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.9e-36  Score=261.20  Aligned_cols=199  Identities=22%  Similarity=0.349  Sum_probs=161.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      .++|+..+.||+|+||.||++... ++..+|+|.....     ....+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346888999999999999999865 5889999975322     1234578999999999999999999987654      


Q ss_pred             --eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          144 --LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       144 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                        ..++||||+.+ +|.+.+..    ....+++.++..++.|++.||+|||+  .+++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCcEEECcC
Confidence              34999999974 77766632    23468899999999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCC--CCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          222 GLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       222 Gla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999766432211  112234567789999988664 478899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-37  Score=276.35  Aligned_cols=204  Identities=24%  Similarity=0.287  Sum_probs=170.4

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ....+-|..++.||-|+||.|.+++..+ ...+|.|.+.+..      ......|.+||...+.+.||+||.-|++.+++
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            3445567778999999999999998544 6678888654433      23467899999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||++|||+-.+|     .....|.+..+..++.++..|+++.|.  .|+|||||||+|||||.+|++||+||||+.
T Consensus       705 YFVMdYIPGGDmMSLL-----IrmgIFeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLL-----IRMGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EEEEeccCCccHHHHH-----HHhccCHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeeccccc
Confidence            9999999999999888     345678888889999999999999998  669999999999999999999999999974


Q ss_pred             cc---------CCCCC-------------------------------CCCCccccCcccccchhhhccCCCCCccchhhH
Q 022118          226 FL---------GRTDV-------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  265 (302)
Q Consensus       226 ~~---------~~~~~-------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~  265 (302)
                      -+         +..+.                               .......+||+.|+|||++....|+..+|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            32         11000                               000123578999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 022118          266 GVFLLELVSGREASSSLS  283 (302)
Q Consensus       266 Gvil~el~~g~~p~~~~~  283 (302)
                      |||||||+.|+.||....
T Consensus       858 gvil~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADT  875 (1034)
T ss_pred             hHHHHHHhhCCCCccCCC
Confidence            999999999999998654

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=259.50  Aligned_cols=194  Identities=27%  Similarity=0.391  Sum_probs=162.4

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      |+..+.||.|++|.||+|... ++..+++|+....     ....+.+|++.++.++|||++++++++.+.+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999865 6889999975432     2356788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      + ++|.+++...   ....+++..+..++.|++.||+|||+  ++++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 6888887322   12468899999999999999999998  6799999999999999999999999999976543211


Q ss_pred             CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                        ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||.
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  201 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP  201 (283)
T ss_pred             --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              11222457789999987654 57899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-36  Score=261.92  Aligned_cols=197  Identities=25%  Similarity=0.369  Sum_probs=162.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  147 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|......     .....+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457889999999999999999965 58899999754221     23456899999999999999999998765  56799


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++ +|.+++..    ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999974 77777632    23568899999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .....  ......++..|+|||.+.+ ..++.++||||+||++|||++|++||..
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            54321  1122234677999998865 4578999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=243.88  Aligned_cols=205  Identities=20%  Similarity=0.285  Sum_probs=163.8

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC----hHHHHHHHHHh-ccCCCCceeeEEeEEeeCCee
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFL-ASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      +++..+++.....||+|++|.|-+-++ .+|+..|+|++....    .++.++|+++. +....|.+|.+||........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            455566666678899999999988885 569999999865433    34577888875 455899999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++.||.|+- +|..+-... -......++.-+-+|+..+++||.|||+. ..+||||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M~t-Sldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999964 555443211 12456778888899999999999999985 569999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcc----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .+.++-.   .+-..|-..|||||.+..    ..|+-+|||||||+.+.||.+++.||++-
T Consensus       198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            7754321   111234445999998763    37999999999999999999999999864

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=254.17  Aligned_cols=198  Identities=19%  Similarity=0.272  Sum_probs=165.5

Q ss_pred             hcCCCcC-CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeC----CeeeEE
Q 022118           76 TKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQEN----NLQFLI  148 (302)
Q Consensus        76 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~~~lv  148 (302)
                      +++|++. ++||-|-.|+|..+..+ +++.+|+|.+..  .+..++|+++.-.. .|||||.+++++.+.    ..+.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            4556543 78999999999999854 688999998754  34456899886555 799999999998653    566899


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN  225 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~  225 (302)
                      ||.++||.|.+.+..   .....+++.++..|..||+.|+.|||+.  +|.||||||+|+|...   +-.+||+|||+|+
T Consensus       138 mE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  138 MECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEeccccccc
Confidence            999999999998843   3456799999999999999999999995  4999999999999954   4578999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      .-.+   .....+.+-|++|.|||++...+|+..+|+||+||++|-|++|.+||-+.+
T Consensus       213 ~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h  267 (400)
T KOG0604|consen  213 ETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_pred             ccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence            7543   233456678999999999999999999999999999999999999998654

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3e-36  Score=261.79  Aligned_cols=219  Identities=21%  Similarity=0.306  Sum_probs=173.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||++... ++..+|+|.....    ....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999865 5789999976533    2345788999999996 99999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +.. ++.++...........+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            864 444332110011235688999999999999999999973 479999999999999999999999999997654322


Q ss_pred             CCCCCccccCcccccchhhhccC---CCCCccchhhHHHHHHHHHhCCCCCCCCC------------------C----CC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLS------------------P----DS  286 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~----~~  286 (302)
                      .   .....++..|+|||.+...   .++.++|||||||++|||++|+.||....                  .    ..
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         163 A---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             c---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            1   1223567789999998776   68999999999999999999999986321                  0    13


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||.++
T Consensus       240 ~~~l~~li~~~l~~~  254 (288)
T cd06616         240 SPSFVNFINLCLIKD  254 (288)
T ss_pred             CHHHHHHHHHHccCC
Confidence            456889999999765

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9e-36  Score=265.56  Aligned_cols=199  Identities=23%  Similarity=0.372  Sum_probs=165.3

Q ss_pred             HHHHHHHhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        69 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      .+++....++|+..+.||+|+||.||++.. .++..||+|+.....     .+.+.+|++++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345556678899999999999999999985 468899999865422     34577899999999999999999988643


Q ss_pred             ------CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          143 ------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       143 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                            +..|++++++ +++|.+++.      ...+++..+..++.|++.||+|||+  .+++||||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEcCCCCE
Confidence                  3467888876 778877762      2458889999999999999999998  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ||+|||+++.....     .....++..|+|||...+ ..++.++|||||||++|||++|+.||..
T Consensus       160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999998764321     223456778999998866 5688999999999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-35  Score=259.43  Aligned_cols=199  Identities=26%  Similarity=0.364  Sum_probs=163.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----  143 (302)
                      ..++|++.+.||+|+||.||+|... ++..||+|.....     ....+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567889999999999999999975 4788999976432     2245678999999999999999999987655     


Q ss_pred             -----eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 022118          144 -----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       144 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                           ..++++||+++ ++...+..    ....+++..+..++.|++.||+|||+  .+|+|+||||+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEEe
Confidence                 68999999986 56555522    23468899999999999999999998  67999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||..
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999987644321 11122345667999998765 4578999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4e-36  Score=259.45  Aligned_cols=218  Identities=22%  Similarity=0.321  Sum_probs=184.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|+..+.||+|+||.||++... ++..+++|.....      ....+.+|.+++++++ ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999865 6889999976542      2345778999999998 99999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999883     23478999999999999999999998  679999999999999999999999999987764


Q ss_pred             CCCCC------------------CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------
Q 022118          229 RTDVA------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------  283 (302)
Q Consensus       229 ~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------  283 (302)
                      .....                  .......++..|+|||......++.++|+||||+++|++++|+.||....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK  233 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            43211                  12233456788999999988889999999999999999999999997432       


Q ss_pred             ---------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------~~~~~~l~~~~~~~~~~~  301 (302)
                               ...++.+.+++++||..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~li~~~l~~~  260 (280)
T cd05581         234 ILKLEYSFPPNFPPDAKDLIEKLLVLD  260 (280)
T ss_pred             HHhcCCCCCCccCHHHHHHHHHHhcCC
Confidence                     233567889999999765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-35  Score=259.07  Aligned_cols=209  Identities=21%  Similarity=0.361  Sum_probs=175.6

Q ss_pred             CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCcc
Q 022118           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (302)
                      ..||+|+||.||++... ++..+|+|......   ...+.+|+.+++.++||||+++++.+...+..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999864 68899999864322   345788999999999999999999999999999999999999998


Q ss_pred             ccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 022118          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  238 (302)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~  238 (302)
                      +++.      ...+++.....++.|++.|++|||+  .+++|+||+|+||++++++.++|+|||++........  ....
T Consensus       106 ~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         106 DIVT------HTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            8762      2357888999999999999999998  6799999999999999999999999999876543221  1233


Q ss_pred             ccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHHHHHHhh
Q 022118          239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       239 ~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~~~~~~~  299 (302)
                      ..++..|++||...+..++.++|+||+|+++|||++|..||....                   ...+.++.+++.+||.
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence            457788999999988889999999999999999999999986432                   1234667888999987


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      ++
T Consensus       256 ~~  257 (292)
T cd06657         256 RD  257 (292)
T ss_pred             CC
Confidence            65

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.9e-36  Score=264.20  Aligned_cols=197  Identities=23%  Similarity=0.329  Sum_probs=161.5

Q ss_pred             cCCC-cCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh-----------------HHHHHHHHHhccCCCCceeeEEe
Q 022118           77 KNFS-DKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT-----------------QEFIDEVCFLASIQHRNLVTLLG  137 (302)
Q Consensus        77 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~H~nIv~l~~  137 (302)
                      ++|. ..+.||+|+||+||+|... +++.+|+|.......                 ..+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3577999999999999865 588999997543221                 14678999999999999999999


Q ss_pred             EEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       138 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      ++...+..+++|||++ |+|.+++.     ....+++.....++.|++.||+|||+  .+++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEE
Confidence            9999999999999997 58888872     34568889999999999999999998  6799999999999999999999


Q ss_pred             EcccccccccCCCCC------------CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          218 VADAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       218 l~DfGla~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |+|||+++..+....            ........++..|+|||.+.+. .++.++|+|||||++|||++|++||..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999977652111            1111223456789999988764 468999999999999999999999864

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.6e-36  Score=266.01  Aligned_cols=197  Identities=26%  Similarity=0.408  Sum_probs=162.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccC-CCCceeeEEeEEeeC--Ceee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN--NLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~~  146 (302)
                      .++|+..+.||+|+||.||+|... ++..+|+|+...     .....+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456888899999999999999965 578899997532     1234567899999999 999999999998754  3579


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||++ ++|..++.      ...+++.....++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 lv~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIR------ANILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 58887772      1267788888999999999999998  6799999999999999999999999999987


Q ss_pred             cCCCCCC---CCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          227 LGRTDVA---GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       227 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            6433221   12234567888999998754 4578899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-35  Score=256.42  Aligned_cols=192  Identities=23%  Similarity=0.282  Sum_probs=158.1

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCC-CCceeeEEeEEeeC--CeeeEEEe
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYE  150 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e  150 (302)
                      |++.+.||+|+||.||++... ++..+|+|......    .....+|+..+.++. ||||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999854 58889999765421    223457888898885 99999999999987  88899999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |++ ++|.+.+..    ....+++..+..++.|++.||.|||+  .+++||||+|+||++++ +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 477777632    23468899999999999999999998  67999999999999999 99999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..   .....++..|+|||.... ..++.++|||||||++|||++|..||..
T Consensus       153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            21   123456778999997644 4578899999999999999999999964

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=254.60  Aligned_cols=194  Identities=22%  Similarity=0.367  Sum_probs=165.5

Q ss_pred             CeeeeCCCeeEEEEE-EcCCcEEEEEecCCC---ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           83 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      +.||+|+|+.|--+. ..++..+|||.+++.   .+.+..+|++++... .|+||+.+++||+++...|||||-+.||.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            689999999999887 678999999976554   467899999999998 599999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcccccccccCCCCC--
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLGRTDV--  232 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl~DfGla~~~~~~~~--  232 (302)
                      ..++     ..+..+++.++.++..+|+.||.|||.  +||.||||||+|||..+-   .-+|||||.++.-+.....  
T Consensus       164 LshI-----~~~~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  164 LSHI-----QKRKHFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHH-----HHhhhccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9998     356778999999999999999999998  789999999999998543   4689999999765532211  


Q ss_pred             ---CCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          233 ---AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       233 ---~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                         .....+.+|+..|||||+..     ...|+.++|.||||||||-|++|.+||.+..
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence               11223557888899999764     3468999999999999999999999998754

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-35  Score=259.74  Aligned_cols=211  Identities=30%  Similarity=0.396  Sum_probs=173.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .|+..+.||+|+||.||++... ++..+|+|......      ...+.+|++++++++|||++++++++..++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667789999999999999864 57899999764321      2357789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++ +|.+.+..    ....+++..+..++.|++.|+.|||+  .+++||||+|+||+++.++.+||+|||++..... 
T Consensus       106 ~~~g-~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         106 YCLG-SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             CCCC-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            9974 67666532    23457889999999999999999998  6799999999999999999999999999875432 


Q ss_pred             CCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhh
Q 022118          231 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQD  289 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~  289 (302)
                           .....++..|+|||.+.   ...++.++|||||||++|||++|+.||....                  ...+..
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY  252 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence                 22345777899999874   4568899999999999999999999985421                  123456


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       253 l~~li~~~l~~~  264 (317)
T cd06635         253 FRNFVDSCLQKI  264 (317)
T ss_pred             HHHHHHHHccCC
Confidence            889999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=257.49  Aligned_cols=195  Identities=26%  Similarity=0.384  Sum_probs=163.1

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeEEEe
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIYE  150 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e  150 (302)
                      |++.+.||+|+||.||+|... ++..+++|.....     ....+.+|+++++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999976 4788999986543     234578899999999999999999999988  88999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++ +|..++..    ....+++..++.++.|++.||+|||+  .+++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 78777732    22468899999999999999999998  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            211 1222345677999997764 4678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-35  Score=257.51  Aligned_cols=216  Identities=24%  Similarity=0.305  Sum_probs=176.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCC-------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      +|+..+.||+|++|.||++...    ++..+|+|.....       ..+.+.+|+.++.++ +||||+++.+.+...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677889999999999998742    4678999975432       224577899999999 699999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHh-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999998883     23457888999999999999999998  679999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCC--CCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      ........ ......++..|++||...+..  .+.++|+||||+++|||++|..||....                    
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP  232 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC
Confidence            65433211 122345778899999987655  7889999999999999999999985321                    


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++.+||..+
T Consensus       233 ~~~~~~l~~li~~~l~~~  250 (288)
T cd05583         233 KTMSAEARDFIQKLLEKD  250 (288)
T ss_pred             cccCHHHHHHHHHHhcCC
Confidence            123467788899998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.5e-35  Score=250.13  Aligned_cols=219  Identities=23%  Similarity=0.369  Sum_probs=185.4

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|+..+.||+|+||.||++... ++..+++|.....     ....+.+|++.++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777899999999999999965 5889999986543     335678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.... .....+++..+..++.+++.|+.|||+  .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999998884321 123678999999999999999999998  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      .  ......++..|+|||...+..++.++|+||+|+++|+|++|+.||....                 ...+.++.+++
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            1  1233467788999999998899999999999999999999999986542                 23457889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      ++||..+
T Consensus       236 ~~~l~~~  242 (258)
T cd08215         236 SSLLQKD  242 (258)
T ss_pred             HHHcCCC
Confidence            9999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=259.86  Aligned_cols=224  Identities=22%  Similarity=0.306  Sum_probs=173.1

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhc-cCCCCceeeEEeEEeeCCeeeE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLA-SIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      +...+.+.+..||+|+||+|++-.++ .|+..|||++....    .++++.|.+... .=+.||||++||.+..++..|+
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            33445566788999999999999865 58999999865433    356888887654 4478999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      .||.|+- +|..+-...-......+++.-...+....+.||.||-+. ..|||||+||+|||+|..|.+||||||++-.+
T Consensus       141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9999963 443222111112356778888888888999999999984 67999999999999999999999999998766


Q ss_pred             CCCCCCCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------  283 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------  283 (302)
                      .++-.   .+...|-..|||||.+..  ..|+-+|||||||++|||+.||+.||..-.                      
T Consensus       219 v~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~  295 (361)
T KOG1006|consen  219 VDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE  295 (361)
T ss_pred             HHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence            44211   122345555999998864  359999999999999999999999998421                      


Q ss_pred             -CCChhhHHHHHHHHhhccC
Q 022118          284 -PDSSQDLVELMIKCMGKER  302 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~~  302 (302)
                       -..+..+..++.-|+-++|
T Consensus       296 ~~~~s~~~~~fintCl~Kd~  315 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDR  315 (361)
T ss_pred             ccccCHHHHHHHHHHhhccc
Confidence             1245677888888888775

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=296.90  Aligned_cols=217  Identities=24%  Similarity=0.392  Sum_probs=178.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +++....||.|.||.||.|.. .+|...|+|.+...     ..+.+.+|..++..++|||+|++||+-...+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            455668899999999999984 56888999964322     234577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      |++|+|.+.+.     -....++.-...+..|++.|++|||+  .|||||||||+||+++.+|.+|++|||.|..+....
T Consensus      1316 C~~GsLa~ll~-----~gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLE-----HGRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHH-----hcchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999882     22334555556678899999999999  679999999999999999999999999998876542


Q ss_pred             --CCCCCccccCcccccchhhhccCC---CCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChh
Q 022118          232 --VAGPSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQ  288 (302)
Q Consensus       232 --~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~  288 (302)
                        ..+......||+.|||||++.+..   ...+.||||+||+..||+||+.||..++                  ..-++
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence              223345678999999999998754   4568999999999999999999998654                  12234


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      +=.+++.+|+..|
T Consensus      1469 ~g~dFle~Cl~~d 1481 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQD 1481 (1509)
T ss_pred             hHHHHHHHHHhcC
Confidence            4478888898765

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=256.80  Aligned_cols=194  Identities=26%  Similarity=0.396  Sum_probs=164.3

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      |+..+.||+|++|.||++... ++..+++|......     ...+.+|++++++++||||+++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999865 58889999765432     346788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++ +|..++..    ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 77777632    23568889999999999999999998  679999999999999999999999999998765433 


Q ss_pred             CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                       .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence             112223567789999998876 789999999999999999999999853

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-35  Score=261.46  Aligned_cols=194  Identities=22%  Similarity=0.278  Sum_probs=157.1

Q ss_pred             CeeeeC--CCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEG--KFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ..||+|  +||+||++... +++.||+|......     .+.+.+|+.+++.++||||+++++++..++..+++|||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  89999999864 68999999865322     24578899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC--
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--  232 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~--  232 (302)
                      ++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.++++||+.+........  
T Consensus        84 ~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999887432   23457888889999999999999998  6799999999999999999999999986543321111  


Q ss_pred             ---CCCCccccCcccccchhhhccC--CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          233 ---AGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       233 ---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                         ........++..|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence               1111122345569999998763  578999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-35  Score=257.08  Aligned_cols=218  Identities=20%  Similarity=0.319  Sum_probs=174.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..++|+..+.||+|+||.||++...+ +..+|+|......    ...+..|+.++.+. .||||+++++++.+....|++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            44678889999999999999999765 8899999865432    23456677766666 599999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+. +++.+.+..    ....+++..+..++.|++.|++|||+. ++|+||||+|+||++++++.+||+|||++..+.
T Consensus        93 ~e~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 466655522    234688889999999999999999962 479999999999999999999999999987664


Q ss_pred             CCCCCCCCccccCcccccchhhhccCC----CCCccchhhHHHHHHHHHhCCCCCCCCC--------------------C
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLS--------------------P  284 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~  284 (302)
                      ....   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||....                    .
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE  243 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence            3221   12234667799999987554    7889999999999999999999997521                    0


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+.++.+++.+||..+
T Consensus       244 ~~~~~l~~li~~~l~~~  260 (296)
T cd06618         244 GFSPDFCSFVDLCLTKD  260 (296)
T ss_pred             CCCHHHHHHHHHHccCC
Confidence            13567899999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.2e-35  Score=259.43  Aligned_cols=193  Identities=24%  Similarity=0.351  Sum_probs=162.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEee-CCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~l  147 (302)
                      .+++|+..+.||+|+||.||++... ++..+|+|+...     ...+.+.+|+++++.++||||+++.+++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            5678999999999999999999855 688999997532     223567889999999999999999999876 457899


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ++||+ +++|..++.      ...++......++.|++.||+|||+  .+++||||+|+||++++++.++|+|||++...
T Consensus        88 v~e~~-~~~L~~~~~------~~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          88 VTELL-GTDLHRLLT------SRPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             Eeehh-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            99998 568877762      2456778888999999999999998  67999999999999999999999999998754


Q ss_pred             CCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ...     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            321     223356778999998765 5789999999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-35  Score=261.91  Aligned_cols=191  Identities=23%  Similarity=0.369  Sum_probs=159.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      ..+|...+.||+|+||.||+|... ++..+|+|.....     ....+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            367888999999999999999864 6889999976432     2245778999999999999999999987553      


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..++++||+.. +|..+.       ...+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            45899999864 565443       2357888899999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            8764321     223456778999999876 4688999999999999999999999974

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.7e-35  Score=255.84  Aligned_cols=210  Identities=29%  Similarity=0.398  Sum_probs=172.5

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      |...+.||+|+||+||+|... ++..+++|......      ...+.+|+++++.++|||++++++++.+.+..|++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999864 57889999764321      23577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +. |++.+++..    ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.+||+|||++.....  
T Consensus       103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 566666632    23457889999999999999999998  6799999999999999999999999999864322  


Q ss_pred             CCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhhH
Q 022118          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQDL  290 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~l  290 (302)
                          .....++..|+|||.+.   ...++.++|||||||++|||++|..||....                  ...+..+
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF  249 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence                22345778899999974   4568889999999999999999999986432                  1223568


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||.++
T Consensus       250 ~~li~~~l~~~  260 (313)
T cd06633         250 RGFVDYCLQKI  260 (313)
T ss_pred             HHHHHHHccCC
Confidence            89999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=261.89  Aligned_cols=196  Identities=24%  Similarity=0.370  Sum_probs=166.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----eee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  146 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  146 (302)
                      +|++.+.||+|+||.||++... ++..+++|.....     ..+.+.+|+++++.++||||+++.+++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999965 4889999976543     2356889999999999999999999998775     789


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ++|||++ ++|.+++.     ....+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIK-----SPQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999998 47877773     23478899999999999999999998  6799999999999999999999999999987


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          227 LGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ...... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~  209 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG  209 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence            654321 0112334577889999999887 789999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=253.32  Aligned_cols=194  Identities=27%  Similarity=0.394  Sum_probs=160.5

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC-----hHHHHHHHHHhccC---CCCceeeEEeEEeeCCe-----
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-----TQEFIDEVCFLASI---QHRNLVTLLGYCQENNL-----  144 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~-----  144 (302)
                      |++.+.||+|+||.||++.... +..+|+|......     ...+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999764 8899999865321     23456777766555   69999999999998876     


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .+++|||+++ +|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.+||+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999974 788777321   22358899999999999999999998  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ........   .....++..|+|||...+..++.++|+|||||++|||++|++||..
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~  208 (287)
T cd07838         155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG  208 (287)
T ss_pred             eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence            77643321   1223467789999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.9e-35  Score=256.84  Aligned_cols=211  Identities=29%  Similarity=0.419  Sum_probs=172.7

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---C---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---P---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .|+..+.||+|+||.||+|... ++..+++|.....   .   ..++.+|+++++.++|+|++++.+++..++..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999965 5788999975421   1   2357789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+. |++.+.+..    ....+++..+..++.|++.|+.|||+  .+++||||+|+||+++.++.++|+|||++..... 
T Consensus        96 ~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          96 YCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             ccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            997 577666532    23457888999999999999999998  6799999999999999999999999999876532 


Q ss_pred             CCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChhh
Q 022118          231 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQD  289 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~~  289 (302)
                           .....++..|+|||.+.   ...++.++|||||||++|||++|+.||....                  ...+..
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY  242 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence                 22345677899999874   3567889999999999999999999985421                  134456


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       243 ~~~li~~cl~~~  254 (308)
T cd06634         243 FRNFVDSCLQKI  254 (308)
T ss_pred             HHHHHHHHhhCC
Confidence            788999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-35  Score=261.28  Aligned_cols=193  Identities=23%  Similarity=0.367  Sum_probs=162.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----  143 (302)
                      ...+|+..+.||+|+||.||++... ++..||+|.....     ....+.+|+++++.++||||+++++++...+     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3567999999999999999999854 6889999976432     1245778999999999999999999987654     


Q ss_pred             -eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          144 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       144 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                       ..++||||+ +++|..++.      ...+++..+..++.|++.||+|||+  .+|+||||||+||++++++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence             348999998 678877762      3467889999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++......     .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||..
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99765332     123356778999998876 4588999999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-35  Score=257.20  Aligned_cols=199  Identities=25%  Similarity=0.365  Sum_probs=160.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      .++|++.+.||+|+||.||+|... ++..+++|.....     ....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467899999999999999999965 5788999975322     2235678999999999999999999875443      


Q ss_pred             --eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          144 --LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       144 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                        ..+++|||+.+ ++...+..    ....+++..+..++.|++.||+|||+  .+++|+||||+||++++++.+||+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcC
Confidence              45999999875 56555522    24568999999999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCCC---------CCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          222 GLRNFLGRTDVAG---------PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       222 Gla~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |+++.........         ......++..|+|||.+.+. .++.++|||||||++|||++|++||..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            9997654322111         11223467789999987654 588999999999999999999999863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=252.85  Aligned_cols=230  Identities=25%  Similarity=0.385  Sum_probs=191.1

Q ss_pred             HHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeE
Q 022118           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGY  138 (302)
Q Consensus        69 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~  138 (302)
                      .+++.+...+++...++.+|.||.||.|.+.      +.+.|.+|..+...    ...++.|...+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3456666677888889999999999999543      33456666543322    3457889999999999999999999


Q ss_pred             EeeC-CeeeEEEeccCCCCccccccC---CCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC
Q 022118          139 CQEN-NLQFLIYEYIPNGSVSIHLYG---PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  214 (302)
Q Consensus       139 ~~~~-~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~  214 (302)
                      +.+. ...+.++.++.-|+|+.||..   ......+.++..+...++.|++.|++|||+  .++||.||..+|++||+..
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhhe
Confidence            8765 456888999999999999951   122345667788889999999999999998  6799999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------
Q 022118          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------  282 (302)
Q Consensus       215 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------  282 (302)
                      .+||+|=.+++.+-+.++.........+..||+||.+.+..|+..+|||||||+||||+| |+.||...           
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            999999999998877777665555667788999999999999999999999999999998 88998753           


Q ss_pred             ------CCCChhhHHHHHHHHhhc
Q 022118          283 ------SPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       283 ------~~~~~~~l~~~~~~~~~~  300 (302)
                            |-++++++...|.-||..
T Consensus       514 GyRlaQP~NCPDeLf~vMacCWal  537 (563)
T KOG1024|consen  514 GYRLAQPFNCPDELFTVMACCWAL  537 (563)
T ss_pred             cceecCCCCCcHHHHHHHHHHHhc
Confidence                  458899999999999964

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-35  Score=251.42  Aligned_cols=217  Identities=26%  Similarity=0.407  Sum_probs=182.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +|++.+.||+|+||.||++... ++..+++|.....     ....+.+|++++++++||||+++.+.+......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777899999999999999854 5788999975532     234577899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++.... .....+++..+..++.|++.||+|||+  .+++|+||+|+||++++++.+|++|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999998874321 123567889999999999999999998  67999999999999999999999999999876543 


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CCChhhHHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                         ......++..|++||...+..++.++|+||+|+++|||++|+.||....                 ...+.++.+++
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI  233 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence               1223456778999999999899999999999999999999999987432                 22346788999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+|+..+
T Consensus       234 ~~~l~~~  240 (256)
T cd08530         234 RSMLQVK  240 (256)
T ss_pred             HHHcCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.2e-35  Score=258.52  Aligned_cols=189  Identities=19%  Similarity=0.181  Sum_probs=153.2

Q ss_pred             CCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCcccccc
Q 022118           89 KFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY  162 (302)
Q Consensus        89 ~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  162 (302)
                      ++|.||.+... ++..+|+|+....     ....+.+|+++++.++||||+++++++...+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            34445555432 5889999985432     23468899999999999999999999999999999999999999999884


Q ss_pred             CCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-----CCCCc
Q 022118          163 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-----AGPSS  237 (302)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~-----~~~~~  237 (302)
                      ..   ....+++.....++.|++.||+|||+  .+|+||||||+||+++.++.+|++|||.+........     .....
T Consensus        92 ~~---~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          92 TH---FPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             Hh---cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            32   23457888899999999999999998  6799999999999999999999999998865532111     11123


Q ss_pred             cccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          238 QVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ...++..|+|||.+..  ..|+.++|+|||||++|||++|+.||...
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            3456678999999876  35889999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.7e-36  Score=283.17  Aligned_cols=194  Identities=25%  Similarity=0.389  Sum_probs=154.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      =.++|+..+.||+|+||.||+++.+ ||+.+|||+++-..    .....+|+..+++|+|||||+++..|.+..      
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4567888899999999999999965 79999999876543    235788999999999999999998652210      


Q ss_pred             --------------------------------------------------------------------------------
Q 022118          144 --------------------------------------------------------------------------------  143 (302)
Q Consensus       144 --------------------------------------------------------------------------------  143 (302)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHH
Q 022118          144 ---------------------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH  190 (302)
Q Consensus       144 ---------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  190 (302)
                                                       .+|+-||||+.-++.+++...    ...-.....++++++|++||.|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHHH
Confidence                                             136778888877777666321    1111356788999999999999


Q ss_pred             hhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC------C----------CCCCCCCccccCcccccchhhhccC
Q 022118          191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG------R----------TDVAGPSSQVTADEIFLASEVKEFR  254 (302)
Q Consensus       191 LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~------~----------~~~~~~~~~~~~~~~~~aPE~~~~~  254 (302)
                      +|+  .|||||||||.||++|++..|||+|||+|+...      +          ....+..+...||..|+|||++.+.
T Consensus       713 IH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  713 IHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999  679999999999999999999999999998721      0          0111233456899999999998865


Q ss_pred             C---CCCccchhhHHHHHHHHHh
Q 022118          255 R---FSEKSDVYSFGVFLLELVS  274 (302)
Q Consensus       255 ~---~~~~~Dvws~Gvil~el~~  274 (302)
                      .   |+.|+|+||+|++++||+.
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc
Confidence            5   9999999999999999997

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.2e-35  Score=257.71  Aligned_cols=196  Identities=25%  Similarity=0.312  Sum_probs=159.6

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-C--CcEEEEEecCCC-----ChHHHHHHHHHhccC-CCCceeeEEeEEeeC----Ce
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-D--GMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN----NL  144 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~  144 (302)
                      +|+..+.||+|+||.||++... .  +..+|+|.....     ..+.+.+|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999964 3  678999976532     234678899999999 599999999976432    45


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+++||+. ++|.+++.     ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            688999986 58887773     34568899999999999999999998  67999999999999999999999999999


Q ss_pred             cccCCCCCC--CCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +........  .......++..|+|||...+ ..++.++|+||+||++|+|++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            866432211  11233467888999998765 5689999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.9e-35  Score=260.53  Aligned_cols=196  Identities=21%  Similarity=0.344  Sum_probs=159.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeC----------
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN----------  142 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----------  142 (302)
                      .+|+..+.||.|+||.||+|... ++..|++|.....   ..+.+.+|++++++++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999865 5889999975433   335578899999999999999999876544          


Q ss_pred             ----CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceE
Q 022118          143 ----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAK  217 (302)
Q Consensus       143 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~k  217 (302)
                          ...+++|||++ ++|.+++.      ...+++..+..++.|++.||+|||+  .+++||||||+||+++. ++.+|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE------QGPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceEE
Confidence                35789999997 58877762      3457889999999999999999998  67999999999999974 56789


Q ss_pred             EcccccccccCCCCC-CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          218 VADAGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       218 l~DfGla~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++|||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999976543211 111223356778999997654 5678899999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-36  Score=229.63  Aligned_cols=209  Identities=24%  Similarity=0.371  Sum_probs=168.3

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC-----CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      |...+.||+|.||+||+|+.. +++.||+|+..     .......++|+.+++.++|.|||+++++...++.+.+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            444578999999999999954 58899999732     233456889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      +. +|..+..    ..+..++...+.+++.|+++||.|+|+  .++.|||+||+|.|++.+|+.|++|||+++-++-+..
T Consensus        84 dq-dlkkyfd----slng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   84 DQ-DLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hH-HHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            75 6776652    345678888999999999999999999  5599999999999999999999999999998764321


Q ss_pred             CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCChhhHHHHHHHHhh
Q 022118          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELMIKCMG  299 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~-g~~p~~~~~~~~~~~l~~~~~~~~~  299 (302)
                        ..+....|.+|.+|.++-+. -|+++.|+||.||++.|+.. |++.|++   .+-.+....|-+.+|
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg---~dvddqlkrif~~lg  220 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLG  220 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC---CcHHHHHHHHHHHhC
Confidence              12345678889999988775 58999999999999999998 4544443   223444444444433

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=252.49  Aligned_cols=193  Identities=26%  Similarity=0.379  Sum_probs=161.6

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      |++.+.||+|++|.||+|... ++..+++|+.....    .....+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999976 47889999865432    223467899999998 999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                       +|+|.+++...   ....+++..+..++.|++.+|.|||+  ++++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             78888877332   12467899999999999999999998  6799999999999999999999999999976543221


Q ss_pred             CCCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                         .....++..|+|||... ...++.++|+||||+++|||++|++||.
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~  200 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP  200 (283)
T ss_pred             ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence               22345677899999875 4457899999999999999999999985

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=245.93  Aligned_cols=208  Identities=25%  Similarity=0.342  Sum_probs=176.2

Q ss_pred             eeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        85 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      ||+|+||.||++... ++..+++|......      ...+.+|+++++.++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 48899999755432      23678899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~  237 (302)
                      .+++.     ....+++.....++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLS-----KEGRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            99883     23467899999999999999999998  679999999999999999999999999987764432  1123


Q ss_pred             cccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHHHHHHHhhcc
Q 022118          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~~~~~~~~~~  301 (302)
                      ...++..|++||...+...+.++|+||||+++||+++|+.||...+                ...+.++.+++++||..+
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCC
Confidence            4456778999999988888999999999999999999999996432                233567899999998754

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=266.53  Aligned_cols=200  Identities=17%  Similarity=0.247  Sum_probs=175.0

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCC-cEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ...++++.+..||-|+||.|=++..+.. ..+|+|.+++.      ..+....|-.+|...+.|.||++|-.|.++..+|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            3445677788899999999999886543 34777754432      2345778999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ++||-|-||.|-..|     ..+..++..+...++..+++|++|||+  ++||.|||||+|+++|.+|-+||-|||+|+.
T Consensus       497 mLmEaClGGElWTiL-----rdRg~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  497 MLMEACLGGELWTIL-----RDRGSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhHHhhcCchhhhhh-----hhcCCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999998888     346778888889999999999999999  6799999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      ++...   .+.+++||+.|.|||++.+...+.++|.||||+++|||++|++||++.+
T Consensus       570 i~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  570 IGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             hccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence            86543   4567899999999999999999999999999999999999999999754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.8e-35  Score=245.49  Aligned_cols=200  Identities=18%  Similarity=0.194  Sum_probs=164.8

Q ss_pred             CCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCc
Q 022118           88 GKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ  166 (302)
Q Consensus        88 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  166 (302)
                      |.+|.||++... +++.+|+|......  ...+|...+....||||+++++++.+.+..+++|||+++|+|.+++..   
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH---
Confidence            889999999965 57899999876543  334555555566799999999999999999999999999999988832   


Q ss_pred             CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccccc
Q 022118          167 VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL  246 (302)
Q Consensus       167 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~  246 (302)
                        ...+++..+..++.|++.||+|||+  ++++||||||+||+++.++.++++|||++.......     ....++..|+
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~  149 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC  149 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence              3458899999999999999999998  679999999999999999999999999886654321     1223456699


Q ss_pred             chhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------CCChhhHHHHHHHHhhcc
Q 022118          247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       247 aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------~~~~~~l~~~~~~~~~~~  301 (302)
                      |||...+..++.++|+||+|+++|||++|+.|+...+            ...+.++.+++.+|+.++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  216 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFN  216 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCC
Confidence            9999988889999999999999999999998765322            223567788999999765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=270.33  Aligned_cols=227  Identities=27%  Similarity=0.434  Sum_probs=189.0

Q ss_pred             HHHHHHHhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC--ChHHHHHHHHHhccC-CCCceeeEEeEEee---
Q 022118           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQE---  141 (302)
Q Consensus        69 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~---  141 (302)
                      ++.+...+..|++.++||.|.+|.||++.. .+++..|+|.....  ..++...|.++++.. +|||++.++|++..   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            344445667789999999999999999984 45788888875544  445677788888877 79999999999863   


Q ss_pred             --CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          142 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       142 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                        ++.+|||||||.+|+..+++.+..   ...+.|..+..|+..++.|+.|||.  +.++|||+|=.|||+++++.||++
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEEEe
Confidence              468899999999999999996653   6788999999999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC----------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSP----------  284 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~----------  284 (302)
                      |||.+..+..  ..+...+..||+.|||||++.-     ..|+.++|+||||++..||.-|.+|+-.+++          
T Consensus       166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            9999987643  3445677899999999998863     3578899999999999999999999865431          


Q ss_pred             ---------CChhhHHHHHHHHhhccC
Q 022118          285 ---------DSSQDLVELMIKCMGKER  302 (302)
Q Consensus       285 ---------~~~~~l~~~~~~~~~~~~  302 (302)
                               .=.+++.++|..|+-++.
T Consensus       244 PPPkLkrp~kWs~~FndFIs~cL~Kd~  270 (953)
T KOG0587|consen  244 PPPKLKRPKKWSKKFNDFISTCLVKDY  270 (953)
T ss_pred             CCccccchhhHHHHHHHHHHHHHhhcc
Confidence                     224667889999988763

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=246.05  Aligned_cols=199  Identities=22%  Similarity=0.308  Sum_probs=171.8

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh------HHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      +..++|..+++||+|+|++|.++++. +.+.+|+|..++...      +=.+.|-.++... +||.+|.+..+|+++..+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            45568899999999999999999954 578899997543321      2245566666555 799999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++|.||.+||+|.-++     ....++++..+..+..+|+.||.|||+  .|||.||||.+|+|+|..|++|++|+|+++
T Consensus       327 ffvieyv~ggdlmfhm-----qrqrklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEEecCcceeeeh-----hhhhcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchhh
Confidence            9999999999998887     356788999999999999999999999  789999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .--.+  ...+++.+||+.|.|||.+.+..|..++|+|++||+++||+.|+.||+-
T Consensus       400 e~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  400 EGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             cCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            63222  2346778999999999999999999999999999999999999999984

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-34  Score=247.61  Aligned_cols=218  Identities=20%  Similarity=0.289  Sum_probs=174.2

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecC--------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +|.+.+.||+|+||.||++.... +..+++|..+        .....++..|+.++++++||||+++++++.+.+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998643 3334343322        11223466789999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++.... .....+++..++.++.|++.|+.|||+  .+++|+||+|+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999988874321 234578899999999999999999998  67999999999999975 569999999987764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChhhHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQDLV  291 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~~l~  291 (302)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||...                 +...+.++.
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN  234 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence            3221  122345677899999998888999999999999999999999998632                 223456888


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      ++|.+||..+
T Consensus       235 ~li~~~l~~~  244 (260)
T cd08222         235 SIMQSMLNKD  244 (260)
T ss_pred             HHHHHHhcCC
Confidence            9999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=258.25  Aligned_cols=193  Identities=23%  Similarity=0.385  Sum_probs=162.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCe----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL----  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----  144 (302)
                      ..++|+..+.||+|++|.||+|... ++..+|+|.....     ....+.+|+.++++++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567889999999999999999975 5788999986532     22456789999999999999999998876554    


Q ss_pred             --eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          145 --QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       145 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                        .++|+||+ +++|.+++.      ...+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK------CQKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcccc
Confidence              79999998 568888773      2468899999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++......     .....++..|+|||...+ ..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99865432     233456778999998865 3678999999999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=247.83  Aligned_cols=194  Identities=27%  Similarity=0.399  Sum_probs=163.9

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      |+..+.||+|.+|.||+|... +++.+++|.....     ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999966 4889999976543     2345778999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      + ++|.+++...    ...+++..+..++.|++.||+|||+  .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 5898888421    1468899999999999999999998  6799999999999999999999999999887643221


Q ss_pred             CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                        .......+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence              12223456679999998776 789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=261.11  Aligned_cols=196  Identities=21%  Similarity=0.309  Sum_probs=164.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ...|+....+|.|+|+.|-.+.. .+++..++|.+... ..+..+|+.++... +||||+++.+.+.+....|+|||++.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            55688888899999999999985 45788999987765 33345677666554 89999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-CCCCceEEcccccccccCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill-~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++.+.+.+..     ...+. ..+..++.+|+.|+.|||+  +|+|||||||+|||+ ++.++++|+|||.++...+.  
T Consensus       400 g~ell~ri~~-----~~~~~-~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  400 GGELLRRIRS-----KPEFC-SEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             ccHHHHHHHh-----cchhH-HHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9998877732     23333 6677899999999999999  789999999999999 68999999999999876543  


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD  285 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~  285 (302)
                         ....+-|..|.|||+.....|++++||||||++||+|++|+.||..-+.+
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence               23445677899999999999999999999999999999999999876643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.1e-34  Score=272.06  Aligned_cols=142  Identities=27%  Similarity=0.314  Sum_probs=126.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|.+.+.||+|+||+||+|... ++..||+|.+....      ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 58899999865432      256788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ||+++++|.+++..     ...+++..++.++.||+.||.|||.  .+||||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998832     3457788899999999999999998  679999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-36  Score=241.58  Aligned_cols=213  Identities=22%  Similarity=0.381  Sum_probs=171.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEec-----CCCChHHHHHHHHHhccCCCCceeeEEeEEeeC--------
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN--------  142 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------  142 (302)
                      +.|+-..+||+|.||.||+|+.+ +++.||+|+.     +..-....++|++++..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            44666788999999999999955 5778899862     223345578999999999999999999988532        


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      ...|+|+++|+. ||.-.|.    ....+++..++..++.++..||.|+|+  ..|+|||+||+|+||+.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceEEeeccc
Confidence            246999999975 6766662    334788999999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCC--CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhh
Q 022118          223 LRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG  299 (302)
Q Consensus       223 la~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~  299 (302)
                      +++.+.....  .......+.|..|.+||.+.+. .|+++.|||..||++.||.+|.+-++.   +..+..+.+|...+|
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg---nteqqql~~Is~LcG  246 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG---NTEQQQLHLISQLCG  246 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC---ChHHHHHHHHHHHhc
Confidence            9987654322  2223345668899999998875 689999999999999999999988765   335566667766554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=240.37  Aligned_cols=211  Identities=25%  Similarity=0.405  Sum_probs=175.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-----eee
Q 022118           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  146 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  146 (302)
                      +.+..+.||-|+||.||.+.. ++|+.|++|++...     ..+++.+|+.++..++|.|++..++..+-.+     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455678899999999999985 46899999986643     3467899999999999999999999877654     458


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +++|.+.. ||...+     .+.+.++...++-+..||++||.|||+  .+|.||||||.|.|++++...||||||+++.
T Consensus       134 V~TELmQS-DLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQS-DLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHh-hhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecccccccc
Confidence            89999864 787777     456778888999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      -...+ .......+.|.+|.|||.+.+. .|+...||||.|||+.|++..+..|+...   +-+..++|.+.+|.
T Consensus       206 ee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~---PiqQL~lItdLLGT  276 (449)
T KOG0664|consen  206 WDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG---PIEQLQMIIDLLGT  276 (449)
T ss_pred             cchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC---hHHHHHHHHHHhCC
Confidence            54432 2234455678899999999876 58999999999999999999999988654   45666777666653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=251.04  Aligned_cols=195  Identities=22%  Similarity=0.365  Sum_probs=167.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCCh--HH---------HHHHHHHhccCC---CCceeeEEeEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT--QE---------FIDEVCFLASIQ---HRNLVTLLGYCQ  140 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~---------~~~E~~~l~~l~---H~nIv~l~~~~~  140 (302)
                      ..+|+..+.+|.|+||.|++|.++. ...|++|.+.+...  +.         .-.|+.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3468889999999999999999765 45688886544331  11         235999999997   999999999999


Q ss_pred             eCCeeeEEEecc-CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          141 ENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       141 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                      ++++.||+||-. ++-+|.+++     ...+.+++.++..|++|++.|+++||+  .+|||||||-+||.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEe
Confidence            999999999975 456888888     456788999999999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |||.+.....    ++-...+||..|.|||++.+..| +..-|||++|++||.+++..-||-+
T Consensus       713 dfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999876432    34566789999999999999999 4568999999999999999999864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=238.75  Aligned_cols=213  Identities=22%  Similarity=0.287  Sum_probs=176.3

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccCC-C-C----ceeeEEeEEeeCCe
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-H-R----NLVTLLGYCQENNL  144 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-H-~----nIv~l~~~~~~~~~  144 (302)
                      ...++|++..++|+|.||.|-.+... .+..||+|.++..  ..+.-+-|++++.++. + |    -++.+.+||.-.+.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            34678999999999999999999854 4788999976543  3455677999999883 2 2    37888899999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC------------
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE------------  212 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~------------  212 (302)
                      .++|+|.+ |-++.++|..   .+...++..++..++.|++++++|||+  .+++|-||||+|||+.+            
T Consensus       166 iCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             eEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEEeccCCc
Confidence            99999987 5589999943   355778999999999999999999999  67999999999999832            


Q ss_pred             --------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022118          213 --------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP  284 (302)
Q Consensus       213 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~  284 (302)
                              +..+|+.|||.|....+.     ....+.|..|.|||++.+-+++.++||||+||||+|+.+|...|+.-+ 
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-  313 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-  313 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-
Confidence                    346899999999864332     256778899999999999999999999999999999999999988644 


Q ss_pred             CChhhHHHHHHHHhhc
Q 022118          285 DSSQDLVELMIKCMGK  300 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~  300 (302)
                        ..+.+..|++++|+
T Consensus       314 --n~EHLaMMerIlGp  327 (415)
T KOG0671|consen  314 --NLEHLAMMERILGP  327 (415)
T ss_pred             --cHHHHHHHHHhhCC
Confidence              33445888888875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=2e-31  Score=222.37  Aligned_cols=195  Identities=31%  Similarity=0.450  Sum_probs=166.9

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      |...+.||+|++|.||++...+ +..+++|.....    ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4566889999999999999765 889999987654    34578899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcc-cCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      +++|.+++...     .. +++.....++.+++.++.+||+  .+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999888422     22 7888999999999999999998  6799999999999999999999999999887654321


Q ss_pred             CCCCccccCcccccchhhh-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                       .......++..|++||.. ....++.++|+||||++++||++|+.||..
T Consensus       154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             112334566779999998 677788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=1.9e-31  Score=224.61  Aligned_cols=203  Identities=29%  Similarity=0.401  Sum_probs=172.7

Q ss_pred             CCeeEEEEEEcC-CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCccccccC
Q 022118           89 KFGEVYKGLLQD-GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  163 (302)
Q Consensus        89 ~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  163 (302)
                      +||.||++.... +..+++|......    .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 8899999865443    46788999999999999999999999999999999999999999988832


Q ss_pred             CCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcc
Q 022118          164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE  243 (302)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~  243 (302)
                           ...+++..+..++.+++.++.|||+  .+++|+||+|+||++++++.++++|||.+.......   ......++.
T Consensus        81 -----~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 -----RGRLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             -----ccCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence                 2227889999999999999999998  679999999999999999999999999998765432   123345667


Q ss_pred             cccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------------C---ChhhHHHHHHHHhhcc
Q 022118          244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-----------------D---SSQDLVELMIKCMGKE  301 (302)
Q Consensus       244 ~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-----------------~---~~~~l~~~~~~~~~~~  301 (302)
                      .|++||...+..++.++|+||||+++|++++|..||.....                 .   .+.++.+++.+||..+
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  228 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD  228 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence            79999999988899999999999999999999999976110                 0   5578899999999754

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=8.3e-32  Score=247.31  Aligned_cols=204  Identities=22%  Similarity=0.308  Sum_probs=151.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEE-----------------cCCcEEEEEecCCCC---hHH--------------HHH
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLL-----------------QDGMLVAIKKRPGAP---TQE--------------FID  119 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~---~~~--------------~~~  119 (302)
                      ...++|++.++||+|+||+||+|..                 .++..||+|++....   .++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3567899999999999999999963                 234679999864321   112              234


Q ss_pred             HHHHhccCCCCce-----eeEEeEEee--------CCeeeEEEeccCCCCccccccCCCc-------------------C
Q 022118          120 EVCFLASIQHRNL-----VTLLGYCQE--------NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------V  167 (302)
Q Consensus       120 E~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~  167 (302)
                      |+.++.+++|.|+     ++++++|..        .+..++||||+++++|.+++.....                   .
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777766554     677777753        3567999999999999998854211                   0


Q ss_pred             CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccc
Q 022118          168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA  247 (302)
Q Consensus       168 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~a  247 (302)
                      ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....... ........++.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            12345677888999999999999998  6799999999999999999999999999976543211 11222344678999


Q ss_pred             hhhhccCC--------------------CC--CccchhhHHHHHHHHHhCCC-CCC
Q 022118          248 SEVKEFRR--------------------FS--EKSDVYSFGVFLLELVSGRE-ASS  280 (302)
Q Consensus       248 PE~~~~~~--------------------~~--~~~Dvws~Gvil~el~~g~~-p~~  280 (302)
                      ||.+....                    |+  .+.||||+||++|||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            99875432                    22  34799999999999999985 654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=7.3e-33  Score=220.84  Aligned_cols=211  Identities=21%  Similarity=0.312  Sum_probs=174.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCCChHHHHHHHHHhccCC-CCceeeEEeEEeeCC--eeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENN--LQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv~e~  151 (302)
                      .++|++.+.+|+|.++.||.|. ..+++++++|.+++...+.+.+|+.++.+|. ||||+++++...++.  ...|++||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            4578889999999999999998 4567899999999999999999999999997 999999999988664  45799999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGla~~~~~~  230 (302)
                      .++-++...-        +.++...+.....+++.||.|+|+  .||+|||+||.|+++|.. ...+|+|+|+|....+.
T Consensus       117 v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  117 VNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9988876443        566777888999999999999999  679999999999999865 58899999999876543


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhcc
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~~  301 (302)
                      ..   -+-.+.+..|..||.+-. ..|+-+-|+|||||++..|+..+.||....+  ..++.-.|.+.+|.+
T Consensus       187 ~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  187 KE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVKIAKVLGTD  253 (338)
T ss_pred             ce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHHHHHHHHHhChH
Confidence            32   223456677889997654 5688999999999999999999999975554  345555566666643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.6e-31  Score=250.77  Aligned_cols=202  Identities=20%  Similarity=0.203  Sum_probs=140.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-C----CcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeE------EeeCC
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-D----GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGY------CQENN  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~~~~  143 (302)
                      ..++|+..+.||+|+||.||+|... +    +..||+|+.......+...+.. ++...+.++..+...      ....+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhhchhhHHHHHHhhhcccccccCC
Confidence            5678999999999999999999965 3    6889999865433222211111 122222222222221      24556


Q ss_pred             eeeEEEeccCCCCccccccCCCcC---------------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQV---------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      ..++|+||+++++|.+++......               .........+..++.|++.||+|||+  ++|+||||||+||
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRDLKP~NI  286 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRDVKPQNI  286 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCcCCHHHE
Confidence            789999999999998887432100               00111234456799999999999998  6799999999999


Q ss_pred             eeCC-CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccC----------------------CCCCccchhhH
Q 022118          209 LVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----------------------RFSEKSDVYSF  265 (302)
Q Consensus       209 ll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Dvws~  265 (302)
                      |+++ ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9985 58999999999986543221 123445678899999965432                      23456799999


Q ss_pred             HHHHHHHHhCCCCCC
Q 022118          266 GVFLLELVSGREASS  280 (302)
Q Consensus       266 Gvil~el~~g~~p~~  280 (302)
                      ||+||||+++..|++
T Consensus       366 GviL~el~~~~~~~~  380 (566)
T PLN03225        366 GLIFLQMAFPNLRSD  380 (566)
T ss_pred             HHHHHHHHhCcCCCc
Confidence            999999999876654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-32  Score=247.85  Aligned_cols=199  Identities=25%  Similarity=0.339  Sum_probs=162.6

Q ss_pred             CCCcCCeeeeCCCee-EEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           78 NFSDKNLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      -|...+.+|.|+.|+ ||+|.+. ++.||||++-........+|+..++.- +|||||++++.-.++...|++.|.|.. 
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            355567899999986 6888875 689999998877777788999998776 799999999999999999999999965 


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---C--CceEEcccccccccCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---D--FIAKVADAGLRNFLGRT  230 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~--~~~kl~DfGla~~~~~~  230 (302)
                      +|.+++.... .......-........|++.||+|||+  .+||||||||.||||+.   +  ..++|+|||+++.+...
T Consensus       588 sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            8999986531 111111113446788999999999999  56999999999999975   3  47899999999988543


Q ss_pred             C-CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhC-CCCCCC
Q 022118          231 D-VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSS  281 (302)
Q Consensus       231 ~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g-~~p~~~  281 (302)
                      . .........||.+|+|||++....-+.++||+|+||++|..++| ..||..
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence            2 22335677899999999999999888899999999999999986 899974

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-31  Score=214.38  Aligned_cols=194  Identities=18%  Similarity=0.366  Sum_probs=154.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC--hHHHHHHHHHhccC-CCCceeeEEeE-EeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--TQEFIDEVCFLASI-QHRNLVTLLGY-CQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lv~e  150 (302)
                      .+.|.+.+.||+|.||.+-+++++. .+.+++|..+...  ..+|.+|...--.| .|.||+.-|++ |++.+..++++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            3468888999999999999999764 6789999876543  45788988776666 58999987765 677788889999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-C-CCCceEEcccccccccC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-D-EDFIAKVADAGLRNFLG  228 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill-~-~~~~~kl~DfGla~~~~  228 (302)
                      |++.|+|.+-+      ....+.+.....++.|+++|+.|+|+  +++||||||.+|||+ + +...+|+||||+.+..+
T Consensus       103 ~aP~gdL~snv------~~~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNV------EAAGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhc------CcccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999998766      33567778889999999999999999  669999999999999 3 44589999999987655


Q ss_pred             CCCCCCCCccccCcccccchhhhcc---C--CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEF---R--RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~--~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ....     ...-+..|-+||....   .  ..++.+|+|.||+++|.++||.+||+..
T Consensus       175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka  228 (378)
T KOG1345|consen  175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA  228 (378)
T ss_pred             ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence            4321     1222334788886553   2  2468899999999999999999999954

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=216.16  Aligned_cols=192  Identities=24%  Similarity=0.336  Sum_probs=157.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCC------e
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN------L  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  144 (302)
                      .+|..+..+|.|.- .|.-+... .++.||+|+...     ...++..+|...+..++|+||++++.++.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666777888877 55555432 478899997432     23356678999999999999999999987443      5


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+|||||. ++|...+.       -.++=.++.++..|++.|+.|||+  .+|+||||||+||++..++.+||.|||+|
T Consensus        96 ~y~v~e~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchhh
Confidence            699999996 47776652       345557788999999999999999  78999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      +..+.+   ...+.+..|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.
T Consensus       166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence            875443   2456678899999999999999999999999999999999999988753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2.2e-28  Score=200.98  Aligned_cols=194  Identities=35%  Similarity=0.519  Sum_probs=165.7

Q ss_pred             eeeCCCeeEEEEEEcC-CcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCccc
Q 022118           85 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (302)
Q Consensus        85 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (302)
                      ||+|.+|.||++.... +..+++|.......    +.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 88999998776654    678999999999999999999999999999999999999999999


Q ss_pred             cccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCCCCCCCCCcc
Q 022118          160 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQ  238 (302)
Q Consensus       160 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~  238 (302)
                      ++...    ...+++..+..++.+++.++.+||+  .+++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKEN----EGKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            88321    1467889999999999999999998  67999999999999999 89999999999876544321  1223


Q ss_pred             ccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhcc
Q 022118          239 VTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       239 ~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~~  301 (302)
                      ..+...|++||..... .++.++|+|++|+++++|               ..+.+++.+|+..+
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------~~~~~~l~~~l~~~  201 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------PELKDLIRKMLQKD  201 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------HHHHHHHHHHhhCC
Confidence            4466679999998877 788999999999999999               57788888888644

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=8.4e-31  Score=230.31  Aligned_cols=216  Identities=23%  Similarity=0.277  Sum_probs=178.2

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCCh--HHHHHHHHHhccCC------CCceeeEEeEEeeCC
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT--QEFIDEVCFLASIQ------HRNLVTLLGYCQENN  143 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~E~~~l~~l~------H~nIv~l~~~~~~~~  143 (302)
                      .+...+|.+....|+|-|++|..|.... |+.||||.+.....  +.=+.|+++|++|+      --|.++|+-.|...+
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            3455678888999999999999998654 78999998654332  34578999999995      347999999999999


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAG  222 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfG  222 (302)
                      .+|||+|-+. -+|...|.+..  .+..|....+..++.|+..||..|-.  .+|+|.||||+|||+++.. .+||||||
T Consensus       508 HLClVFE~Ls-lNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcceeeeccCc
Confidence            9999999874 57888885543  35678888999999999999999998  5699999999999998765 67999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhc
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK  300 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~~  300 (302)
                      .|...++...    +.+..+..|.|||++.+-+|+...|+||+||+||||.||+..|++..   ..+++.+++.|-|+
T Consensus       583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T---NN~MLrl~me~KGk  653 (752)
T KOG0670|consen  583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT---NNQMLRLFMELKGK  653 (752)
T ss_pred             cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC---cHHHHHHHHHhcCC
Confidence            9987765442    23344556999999999999999999999999999999999998765   35777888777654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-29  Score=227.11  Aligned_cols=196  Identities=23%  Similarity=0.336  Sum_probs=166.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..+|+..+.+|.|.||.||+++. .++...|+|..+   ....+-...|+-+++..+||||+.++|-+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45788899999999999999995 457888888644   33445567899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      |.+|+|.+.-+     -...+++.++...++..+.|++|||+  .+=+|||||=.|||+++.|.+|++|||.+-.++..-
T Consensus        94 cgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999998763     34678888999999999999999998  568999999999999999999999999987665432


Q ss_pred             CCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                        .......||++|||||+..   ...|..++|+|++|+...|+---++|-.
T Consensus       167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf  216 (829)
T KOG0576|consen  167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF  216 (829)
T ss_pred             --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence              2245678999999999754   4579999999999999999877666643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-28  Score=210.13  Aligned_cols=131  Identities=22%  Similarity=0.314  Sum_probs=108.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC--hHHHHHHHHHhccCC-----C---CceeeEEeEEeeC-
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----H---RNLVTLLGYCQEN-  142 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~~-  142 (302)
                      ...+|-+.++||.|-|++||++.. ...+.||+|..+.+.  ++..+.|+++|+.++     |   .+||+|++.|... 
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            446788899999999999999985 457889999876543  566789999998873     3   3699999999754 


Q ss_pred             ---CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          143 ---NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       143 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                         ..++||+|++ |.+|..++..   ..-+.++...+..|++|++.||.|||+. .+|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence               4679999998 5567666633   3456788999999999999999999986 689999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=5.1e-28  Score=208.27  Aligned_cols=205  Identities=23%  Similarity=0.289  Sum_probs=167.3

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCC-CChHHHHHHHHHhccC-CCCceeeEEeEEeeCC
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~  143 (302)
                      +..+...+.|...+.||.|.|++||++...    ....||+|.+.. ....+..+|++.|..+ -+.||+++.+++..++
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            344556778999999999999999999843    467899998654 4567899999999998 5999999999999999


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG  222 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfG  222 (302)
                      ...+|+||++..+..++.        ..++...+..++..+..||.++|.  +|||||||||+|+|.+.. +.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEech
Confidence            999999999988887776        345678889999999999999999  789999999999999854 566899999


Q ss_pred             cccccCC----------------C------------------CCC--------CCCccccCcccccchhhhccCC-CCCc
Q 022118          223 LRNFLGR----------------T------------------DVA--------GPSSQVTADEIFLASEVKEFRR-FSEK  259 (302)
Q Consensus       223 la~~~~~----------------~------------------~~~--------~~~~~~~~~~~~~aPE~~~~~~-~~~~  259 (302)
                      +|.....                .                  ...        .......||++|.|||++...+ .+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9862100                0                  000        0011235899999999998765 5889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCCC
Q 022118          260 SDVYSFGVFLLELVSGREASSSLSP  284 (302)
Q Consensus       260 ~Dvws~Gvil~el~~g~~p~~~~~~  284 (302)
                      +||||.|||+.-+++++.||-..++
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~d  283 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKD  283 (418)
T ss_pred             cceeeccceeehhhccccccccCcc
Confidence            9999999999999999999986553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.5e-27  Score=209.26  Aligned_cols=163  Identities=18%  Similarity=0.216  Sum_probs=125.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc--CCcEEEEEecCCC--------ChHHHHHHHHHhccCCCCceee-EEeEEeeC
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVT-LLGYCQEN  142 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~  142 (302)
                      ....+|...+.||+|+||+||+|...  ++..+|+|+....        ....+.+|++++++++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34567999999999999999999864  4677899975422        1345889999999999999985 5442    


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeeeCCCCceEEccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADA  221 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdl-kp~Nill~~~~~~kl~Df  221 (302)
                      +..|+||||+++++|....      ...      ...++.+++.+|.|||+  .+|+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~------~~~------~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR------PHG------DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC------ccc------hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            4579999999999986221      001      13567899999999998  77999999 999999999999999999


Q ss_pred             ccccccCCCCCCCC------CccccCcccccchhhhccC
Q 022118          222 GLRNFLGRTDVAGP------SSQVTADEIFLASEVKEFR  254 (302)
Q Consensus       222 Gla~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~  254 (302)
                      |+|+...+......      .....++..|++||.+...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99997755432111      1244567778999987643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.9e-27  Score=232.96  Aligned_cols=170  Identities=16%  Similarity=0.147  Sum_probs=124.7

Q ss_pred             ccCCC-CceeeEEeEE-------eeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCC
Q 022118          125 ASIQH-RNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP  196 (302)
Q Consensus       125 ~~l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~  196 (302)
                      +.++| +||.++++++       ......+.++||+ +++|.+++..    ....+++.+++.++.||+.||+|||+  +
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~   99 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS--Q   99 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh--C
Confidence            35566 6888888887       2334567788987 5699999842    23558999999999999999999998  7


Q ss_pred             CceecCCCCCCeeeCC-------------------CCceEEcccccccccCCCC---------CCC-----CCccccCcc
Q 022118          197 RVVHKDFKTANVLVDE-------------------DFIAKVADAGLRNFLGRTD---------VAG-----PSSQVTADE  243 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~-------------------~~~~kl~DfGla~~~~~~~---------~~~-----~~~~~~~~~  243 (302)
                      +|+||||||+|||++.                   ++.+|++|||+++......         ...     ......+|+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            7999999999999954                   4456667777765432100         000     011235788


Q ss_pred             cccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------C---CChhhHHHHHHHHhhcc
Q 022118          244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------P---DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       244 ~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------~---~~~~~l~~~~~~~~~~~  301 (302)
                      .|+|||++.+..|+.++|||||||+||||++|.+|+....            +   .......+++.+||.++
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~  252 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPE  252 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCC
Confidence            8999999999999999999999999999999998876321            1   11234566777777654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-27  Score=187.87  Aligned_cols=211  Identities=18%  Similarity=0.251  Sum_probs=174.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCC-ChHHHHHHHHHhccCCC-CceeeEEeEEeeCCeeeEEEec
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ....|.+++.||+|+||.+|.|. ..+|..||+|..... .-..+..|..+.+.|+| ..|..+..+..+...-.+|||.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            45679999999999999999998 567999999985544 34567889999988875 6788888888888888999998


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcccccccccC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLG  228 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl~DfGla~~~~  228 (302)
                      + |-+|++..    +.++..++..+++.++-|++.-++|+|.  +++|||||||+|+|+.-+   ..+.++|||+|+..-
T Consensus        93 L-GPsLEdLf----nfC~R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   93 L-GPSLEDLF----NFCSRRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             c-CccHHHHH----HHHhhhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            7 67888887    4578889999999999999999999998  679999999999999644   467899999998764


Q ss_pred             CCCC-----CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHH
Q 022118          229 RTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~  292 (302)
                      +...     .......+||..|.+-....+...+.+.|+-|+|.+|...--|..||++..+.+...-.+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE  234 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE  234 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence            3221     233456789999999888888888899999999999999999999999887654443333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=5.7e-26  Score=190.43  Aligned_cols=211  Identities=18%  Similarity=0.279  Sum_probs=177.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEE-EcCCcEEEEEecCCCC-hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .-.|.+.+.||+|+||..+.|. .-+++.||||..+..+ ..++..|.+..+.| ..++|...|.+..+...-.||+|.+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            4478999999999999999998 5678999999866544 46788899888888 4689999999988888888999987


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-----CceEEccccccccc
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAGLRNFL  227 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-----~~~kl~DfGla~~~  227 (302)
                       |-+|+|+.    ..+..+|+..++..+|.|++.-++|+|+  +..|.|||||+|+||..-     ..+.+.|||+|+..
T Consensus       107 -GPSLEDLF----D~CgR~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  107 -GPSLEDLF----DLCGRRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             -CcCHHHHH----HHhcCcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence             67888877    4678899999999999999999999999  569999999999999643     36889999999987


Q ss_pred             CCCCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHH
Q 022118          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  293 (302)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~  293 (302)
                      -++...     .......||..||+-....+..-+.+.|+-|+|-++...+-|.+||+++..+...+-.+.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            654432     233457899999999999999999999999999999999999999999876554444443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-25  Score=196.32  Aligned_cols=201  Identities=21%  Similarity=0.221  Sum_probs=163.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCC--cEEEEEecCCCC---hHHHHHHHHHhccCCC----CceeeEEeEE-eeCCeeeE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDG--MLVAIKKRPGAP---TQEFIDEVCFLASIQH----RNLVTLLGYC-QENNLQFL  147 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~---~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l  147 (302)
                      +|.+.+.||+|+||.||.+.....  ..+|+|......   ...+..|..++..+..    +++..+++.. ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996653  478888644321   2267788888888863    6899999999 47778899


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-----CceEEcccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAG  222 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-----~~~kl~DfG  222 (302)
                      ||+.+ |-+|.++....   ....++..+...++.|++.+|+++|+  .|++||||||+|+++...     ..+.+.|||
T Consensus        99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99987 77888876322   25789999999999999999999998  779999999999999754     469999999


Q ss_pred             ccc--ccCCCCC-----CCC-CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022118          223 LRN--FLGRTDV-----AGP-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP  284 (302)
Q Consensus       223 la~--~~~~~~~-----~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~  284 (302)
                      +++  .......     ... .....||..|.++++..+...+.+.|+||++.++.|++.|..||.....
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            998  3221111     111 2345699999999999999999999999999999999999999987653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=5.7e-24  Score=186.01  Aligned_cols=199  Identities=30%  Similarity=0.421  Sum_probs=164.8

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC------ChHHHHHHHHHhccCCCC-ceeeEEeEEeeCCeeeEEEec
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      |...+.||.|+||.||++...  ..+++|.....      ....+.+|..++..+.|+ +|+++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999977  67788864332      245688999999999988 799999999877778999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~~  230 (302)
                      +.++++.+++......  ..+.......+..|++.++.|+|+  .+++|||+||+|++++..+ .++++|||+++.....
T Consensus        80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666321110  367888999999999999999999  6699999999999999988 7999999999865543


Q ss_pred             CCCC----CCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          231 DVAG----PSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       231 ~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      ....    ......++..|++||...+   ..++...|+||+|++++++++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3221    2456788999999999988   578899999999999999999999976544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=2e-24  Score=175.80  Aligned_cols=136  Identities=19%  Similarity=0.140  Sum_probs=104.9

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh------------HHH-----------------HHHHHHhccCCCCce
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT------------QEF-----------------IDEVCFLASIQHRNL  132 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------~~~-----------------~~E~~~l~~l~H~nI  132 (302)
                      ...||+|+||.||+|...+|+.||+|.......            .+|                 .+|.+.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999987899999997543211            112                 348899999987776


Q ss_pred             eeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHh-hcCCCCceecCCCCCCeeeC
Q 022118          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDFKTANVLVD  211 (302)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~ivHrdlkp~Nill~  211 (302)
                      .....+..  ...++||||++++++.....     ....++......++.|++.+|.|+ |+  .+|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE
Confidence            44333222  22389999999887754431     234678888999999999999999 66  6799999999999998


Q ss_pred             CCCceEEccccccccc
Q 022118          212 EDFIAKVADAGLRNFL  227 (302)
Q Consensus       212 ~~~~~kl~DfGla~~~  227 (302)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=4.4e-24  Score=171.99  Aligned_cols=106  Identities=25%  Similarity=0.324  Sum_probs=91.4

Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++..    ....+++.+++.++.|++.||.|||+  .+      ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeecccc---
Confidence            678888732    24568999999999999999999998  34      999999999999999  99988754321   


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                          ..+++.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence                2577889999999999999999999999999999999999964

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.1e-23  Score=167.82  Aligned_cols=185  Identities=19%  Similarity=0.102  Sum_probs=136.6

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh--H-----HHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEecc
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--Q-----EFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~-----~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +...|++|+||+||.+.. .+.+++.+.......  .     .+.+|+++|++++ |++|++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997766 577787776554443  2     4678999999995 5889999886    4469999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeeeCCCCceEEcccccccccCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdl-kp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +|.+|...+      ...      ...+..|++.++.++|+  .||+|||| ||+|||++.++.++|+|||++....+..
T Consensus        81 ~G~~L~~~~------~~~------~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRP------PRG------DLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhh------hhh------hHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            998886433      011      13467899999999999  67999999 7999999999999999999998654322


Q ss_pred             CC----C-C------CccccCcccccchhhhccC-CCC-CccchhhHHHHHHHHHhCCCCCCCCCC
Q 022118          232 VA----G-P------SSQVTADEIFLASEVKEFR-RFS-EKSDVYSFGVFLLELVSGREASSSLSP  284 (302)
Q Consensus       232 ~~----~-~------~~~~~~~~~~~aPE~~~~~-~~~-~~~Dvws~Gvil~el~~g~~p~~~~~~  284 (302)
                      ..    . .      ......++.+++|+-.... ..+ ...++++-|.-+|.++|++.|.-+...
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10    0 0      0112245557777643322 333 467999999999999999999776543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=4.7e-24  Score=176.07  Aligned_cols=169  Identities=13%  Similarity=0.132  Sum_probs=129.9

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hH----H------HHHHHHHhccCCCCceeeEEeEEe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQ----E------FIDEVCFLASIQHRNLVTLLGYCQ  140 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~----~------~~~E~~~l~~l~H~nIv~l~~~~~  140 (302)
                      ....++|+..+++|.|+||.||+... ++..+|+|.+.+..  .+    .      +.+|+..+.++.||+|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34578899999999999999999766 56689999865332  11    1      578899999999999999999866


Q ss_pred             eC--------CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 022118          141 EN--------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (302)
Q Consensus       141 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~  212 (302)
                      ..        +..+++|||++|.+|.+...         ++.    ....+++.++..+|+  .+++|||++|+|+++++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeC
Confidence            43        35789999999999976631         122    245589999999998  67999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHH
Q 022118          213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL  272 (302)
Q Consensus       213 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el  272 (302)
                      ++ ++|+|||..+......              ..........|+.++|+||||+++.-.
T Consensus       171 ~g-i~liDfg~~~~~~e~~--------------a~d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRK--------------AKDRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CC-EEEEECCCcccccchh--------------hHHHHHHHhHhcccccccceeEeehHH
Confidence            88 9999999876432111              011134445677899999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.5e-23  Score=168.90  Aligned_cols=139  Identities=18%  Similarity=0.135  Sum_probs=107.9

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh-----------------------------HHHHHHHHHhccCCCCce
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----------------------------QEFIDEVCFLASIQHRNL  132 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~E~~~l~~l~H~nI  132 (302)
                      ...||+|+||.||+|...+|+.||+|.......                             ..+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999977899999997543210                             113578899999999987


Q ss_pred             eeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 022118          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (302)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~  212 (302)
                      .....+....  .++||||++++++.....     ....++......++.|++.++.++|+. .+|+||||||+||+++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-
Confidence            5544443332  489999999886543321     224566778899999999999999972 4699999999999999 


Q ss_pred             CCceEEcccccccccCC
Q 022118          213 DFIAKVADAGLRNFLGR  229 (302)
Q Consensus       213 ~~~~kl~DfGla~~~~~  229 (302)
                      ++.++|+|||++..+..
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            89999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=9.8e-24  Score=172.85  Aligned_cols=208  Identities=24%  Similarity=0.396  Sum_probs=163.2

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEe-----cCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-----~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      ...+|.+.-.|..|+|+++.+.. +.|.     .......+|..|.-.++.+.||||+.++|.|..+.++.++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            34567788889999999875443 3333     22334457888988999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc--ccccccccCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA--DAGLRNFLGRTDVA  233 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~--DfGla~~~~~~~~~  233 (302)
                      +|...|+..   .....+-.++.+++.++++|++|||++.+-|.---|....+++|++.+++|+  |--++         
T Consensus       273 slynvlhe~---t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---------  340 (448)
T KOG0195|consen  273 SLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---------  340 (448)
T ss_pred             HHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---------
Confidence            999999653   3455677888999999999999999986555556789999999999988875  22221         


Q ss_pred             CCCccccCcccccchhhhccCCCC---CccchhhHHHHHHHHHhCCCCCCCC------------------CCCChhhHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFS---EKSDVYSFGVFLLELVSGREASSSL------------------SPDSSQDLVE  292 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~---~~~Dvws~Gvil~el~~g~~p~~~~------------------~~~~~~~l~~  292 (302)
                      .........+.||+||.++..+-+   ..+|+|||.+++||+.|...||...                  ++..+..+-+
T Consensus       341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k  420 (448)
T KOG0195|consen  341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK  420 (448)
T ss_pred             eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence            112223445679999999877654   4689999999999999999999854                  3455677888


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      +|.-|++.|
T Consensus       421 lm~icmned  429 (448)
T KOG0195|consen  421 LMNICMNED  429 (448)
T ss_pred             HHHHHhcCC
Confidence            888898776

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.3e-24  Score=192.24  Aligned_cols=183  Identities=25%  Similarity=0.304  Sum_probs=152.5

Q ss_pred             eeeeCCCeeEEEEEE----cCCcEEEEEecCCCC-----hHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEeccC
Q 022118           84 LIGEGKFGEVYKGLL----QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ++|+|.||.|++++.    ..+..+|.|...+..     +.....|..++...+ ||.++++...++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999998752    235566766433221     123445777787786 9999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|...+     .....+.+.........++.+++++|+  .+|+|||+|++||+++.+|++++.|||+++..-+....
T Consensus        81 gg~lft~l-----~~~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRL-----SKEVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhcc-----ccCCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            99999888     345677888888888999999999999  66999999999999999999999999999876443221


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                            +||..|||||++.  .....+|+||||++++||++|-.||..
T Consensus       154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                  7899999999987  678899999999999999999999986

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=2.3e-22  Score=165.37  Aligned_cols=134  Identities=19%  Similarity=0.255  Sum_probs=102.1

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC---ChHHHHHHHHHhccC-----CCCceeeEEeEEeeCC---eee-
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-----QHRNLVTLLGYCQENN---LQF-  146 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~~-  146 (302)
                      +...+.||+|+||.||. ...++.. ++|.....   ..+.+.+|+.+++.+     +||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467899999999996 3233444 68875433   456789999999999     6799999999999874   334 


Q ss_pred             EEEec--cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHH-HHhhcCCCCceecCCCCCCeeeCC----CCceEEc
Q 022118          147 LIYEY--IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL-AHLHSLSPRVVHKDFKTANVLVDE----DFIAKVA  219 (302)
Q Consensus       147 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~LH~~~~~ivHrdlkp~Nill~~----~~~~kl~  219 (302)
                      +|+||  +++|+|.+++..      ..+++.  ..++.+++.++ +|||+  ++|+||||||+|||++.    ++.++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  668999999932      234444  35677888777 99998  67999999999999974    3489999


Q ss_pred             ccccc
Q 022118          220 DAGLR  224 (302)
Q Consensus       220 DfGla  224 (302)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.7e-23  Score=194.17  Aligned_cols=196  Identities=24%  Similarity=0.304  Sum_probs=152.4

Q ss_pred             CcCCeeeeCCCeeEEEEEEcC-CcEEEEEec-----CCCChH----HHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           80 SDKNLIGEGKFGEVYKGLLQD-GMLVAIKKR-----PGAPTQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~-----~~~~~~----~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .....+|.|++|.|+...... ....+.|..     +.....    .+..|..+-..++|||++.....+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            346889999999777776332 222333321     111111    2456777888899999988877777766666669


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++ ||..++.     ....+...++-.++.|++.|+.|+|+  .|+.|||+||+|++++.+|.+||+|||.+.....
T Consensus       401 E~~~~-Dlf~~~~-----~~~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM-----SNGKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHh-----cccccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 9998883     23467777888899999999999999  6799999999999999999999999999876543


Q ss_pred             CCCC--CCCccccCcccccchhhhccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          230 TDVA--GPSSQVTADEIFLASEVKEFRRFSE-KSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       230 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +...  .......|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~  529 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK  529 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence            3222  3345667888899999999999987 5899999999999999999998644

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=8.9e-21  Score=159.48  Aligned_cols=140  Identities=18%  Similarity=0.137  Sum_probs=108.6

Q ss_pred             CCCcCCeeeeCCCeeEEEEE--EcCCcEEEEEecCCCCh---------------------------HHHHHHHHHhccCC
Q 022118           78 NFSDKNLIGEGKFGEVYKGL--LQDGMLVAIKKRPGAPT---------------------------QEFIDEVCFLASIQ  128 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~---------------------------~~~~~E~~~l~~l~  128 (302)
                      .|.+.+.||+|+||.||+|.  ..+|..||+|.......                           ..+.+|.+.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  56799999997543210                           12467999999887


Q ss_pred             CC--ceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCC
Q 022118          129 HR--NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKT  205 (302)
Q Consensus       129 H~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-ivHrdlkp  205 (302)
                      +.  .+.+++++    ...++||||+++++|.....     ............++.|++.++.+||+  .+ ++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCCh
Confidence            53  34455543    23489999999988876542     22334555667899999999999998  77 99999999


Q ss_pred             CCeeeCCCCceEEcccccccccCC
Q 022118          206 ANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       206 ~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      +||+++ ++.++|+|||.+...+.
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCC
Confidence            999999 88999999999876543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.3e-21  Score=186.20  Aligned_cols=201  Identities=19%  Similarity=0.255  Sum_probs=158.2

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCC---CCceeeEEeEEeeCCeee
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~  146 (302)
                      .+..+....|.+.+.||+|+||.||+|...+|+.||+|..++....+|.-=.+++.+|+   -+.|..+.....-.+.-+
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            34455666788889999999999999998889999999987777665544444555555   233444555555667778


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-------CCCceEEc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------EDFIAKVA  219 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-------~~~~~kl~  219 (302)
                      +|+||.+.|+|.+++.     .....++..+..+..|++.-+++||.  .+|||+||||+|+||.       ...-++|+
T Consensus       771 lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCcccceEEE
Confidence            9999999999999993     55677888899999999999999999  6799999999999993       23468999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCC
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE  277 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~  277 (302)
                      |||-+-.+.--.....-.....|..+-.+|+..|..++.+.|-|.+.-+++-|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9998854422111112234567778899999999999999999999999999999973

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=4.2e-20  Score=153.21  Aligned_cols=131  Identities=21%  Similarity=0.293  Sum_probs=109.5

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +.||+|++|.||+|.. .+..+++|......           ...+.+|++++..++|++|.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 56778888643221           12467899999999999988887777777888999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ++|++|.+.+...        .. ....++.+++.+|.++|+  .+++|+|++|+|||++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887321        11 677899999999999998  6799999999999999 78999999999875

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=2.9e-20  Score=167.71  Aligned_cols=153  Identities=28%  Similarity=0.426  Sum_probs=126.5

Q ss_pred             hccCCCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 022118          124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (302)
Q Consensus       124 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdl  203 (302)
                      |+.+.|.|+.+++|.+.+++..+.|.+||..|+|.+.+..    ....+++.....+.++|+.||+|||+. +-..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNS-PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcC-cceeeeee
Confidence            4678999999999999999999999999999999999953    356788888999999999999999983 33399999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCC-------CCCccchhhHHHHHHHHHhCC
Q 022118          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-------FSEKSDVYSFGVFLLELVSGR  276 (302)
Q Consensus       204 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Dvws~Gvil~el~~g~  276 (302)
                      +++|+++|..+.+|++|||+.....+...............|.|||.+.+..       .+.+.|+||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999999999999999987764311111112223445699999988742       356799999999999999999


Q ss_pred             CCCCC
Q 022118          277 EASSS  281 (302)
Q Consensus       277 ~p~~~  281 (302)
                      .||+.
T Consensus       156 ~~~~~  160 (484)
T KOG1023|consen  156 GPFDL  160 (484)
T ss_pred             Ccccc
Confidence            99985

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.3e-19  Score=148.87  Aligned_cols=141  Identities=21%  Similarity=0.124  Sum_probs=108.2

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-------------------------hHHHHHHHHHhc
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------------TQEFIDEVCFLA  125 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~  125 (302)
                      ++......|...+.||+|+||.||++...++..+|+|......                         ......|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3333444477889999999999999998889999999643211                         112567888888


Q ss_pred             cCCCC--ceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 022118          126 SIQHR--NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (302)
Q Consensus       126 ~l~H~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdl  203 (302)
                      .+.|+  .+...++    .+..+++|||+++++|.....     .      .....++.+++.++.++|+  .+++||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----~------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-----L------EDPEEVLDEILEEIVKAYK--HGIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-----c------ccHHHHHHHHHHHHHHHHH--CCCCcCCC
Confidence            88777  4444444    244589999999999875531     0      2345688899999999998  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccC
Q 022118          204 KTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       204 kp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ||+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=8.3e-20  Score=150.10  Aligned_cols=128  Identities=22%  Similarity=0.308  Sum_probs=103.1

Q ss_pred             eeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           84 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .||+|+||.||++.. ++..+++|......           ..++.+|++++..++|+++.....++..++..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 46788888743211           134668999999999887666555666677779999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|++|.+.+...     ..       .++.+++.+|.++|+  .+++|+|++|+||+++ ++.+++.|||+++..
T Consensus        80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998776211     10       688999999999998  6799999999999999 899999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=1.1e-19  Score=170.79  Aligned_cols=134  Identities=23%  Similarity=0.283  Sum_probs=108.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEe-cCCC----------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGA----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ..|...+.||+|+||+||++.+.... +++|+ ....          ..+++.+|+++++.++|++++....++..++..
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456789999999999999875443 33332 1110          123578899999999999999988888887788


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++++|.+++.             ....++.+++.+|.|||+  .+++|||+||+|||+ +++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999988772             346788999999999998  679999999999999 67899999999997


Q ss_pred             cc
Q 022118          226 FL  227 (302)
Q Consensus       226 ~~  227 (302)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=5.3e-20  Score=174.52  Aligned_cols=168  Identities=22%  Similarity=0.257  Sum_probs=122.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ...+|+.++++..|+||.||.++++. .+.+|+|..+....  +++   ++.....|.+|                    
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--lRn---ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--LRN---ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccchh--hhc---cccccCCccee--------------------
Confidence            45678899999999999999998764 56677743321111  111   22233344443                    


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC---
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---  230 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~---  230 (302)
                       ||-...+..     ...++.        +.+.+++|||+  .+|+|||+||+|.+|+.-|++|++|||+++.....   
T Consensus       136 -gDc~tllk~-----~g~lPv--------dmvla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 -GDCATLLKN-----IGPLPV--------DMVLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             -chhhhhccc-----CCCCcc--------hhhHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence             444444422     122222        22679999998  67999999999999999999999999998654221   


Q ss_pred             ----------CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          231 ----------DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       231 ----------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                                .......+.+||+.|.|||++....|...+|+|++|+|+||.+-|..||.+..
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt  262 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  262 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence                      11223456789999999999999999999999999999999999999998763

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=2e-19  Score=152.92  Aligned_cols=196  Identities=21%  Similarity=0.254  Sum_probs=123.5

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcC-CcEEEEEec--CCCC----hHHHHHHHHHhccCCC----------CceeeEEeEEe-
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKR--PGAP----TQEFIDEVCFLASIQH----------RNLVTLLGYCQ-  140 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~--~~~~----~~~~~~E~~~l~~l~H----------~nIv~l~~~~~-  140 (302)
                      +...+.||.|+++.||.+.+.. ++.+|+|..  ....    .+++.+|.-....+.+          -.++.-++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            3446789999999999999764 899999962  2221    2345555544433322          12222222221 


Q ss_pred             --------eCC--------eeeEEEeccCCCCccccccCCCc--CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 022118          141 --------ENN--------LQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD  202 (302)
Q Consensus       141 --------~~~--------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrd  202 (302)
                              ...        +.+++|+-+ .+||.+.+.....  .....+....++.+..|+++.+++||+  .|+||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlVHgd  170 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS--YGLVHGD  170 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEEST
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh--cceEecc
Confidence                    111        235677766 4577766521110  112334455556777899999999999  6799999


Q ss_pred             CCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc--------CCCCCccchhhHHHHHHHHHh
Q 022118          203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--------RRFSEKSDVYSFGVFLLELVS  274 (302)
Q Consensus       203 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dvws~Gvil~el~~  274 (302)
                      |+|+|++++.+|.+.|+||+.....+.....     ...+..|.+||....        ..++.+.|.|++|+++|.|.|
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999987765542211     233456899997644        257889999999999999999


Q ss_pred             CCCCCCCC
Q 022118          275 GREASSSL  282 (302)
Q Consensus       275 g~~p~~~~  282 (302)
                      |+.||...
T Consensus       246 ~~lPf~~~  253 (288)
T PF14531_consen  246 GRLPFGLS  253 (288)
T ss_dssp             SS-STCCC
T ss_pred             ccCCCCCC
Confidence            99999854

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=1e-19  Score=173.02  Aligned_cols=193  Identities=19%  Similarity=0.206  Sum_probs=145.0

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecC----CCChHHHH---HHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP----GAPTQEFI---DEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~----~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++...+.||++.|=+|.+|.+.+|. |++|.+-    ......+.   .|++ ....+|||.+.+.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4666789999999999999998887 7777532    22333333   3444 556689999999888888888899999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc--C
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--G  228 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~--~  228 (302)
                      |.. .+|.|.+     ..++-+...+.+-|+.|++.|+.-+|.  .+|+|+|||.+|||++.=.=+.|+||..-+-.  .
T Consensus       102 yvk-hnLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVK-HNLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHh-hhhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            985 4888888     456667777888899999999999999  67999999999999998777889999865421  1


Q ss_pred             CCCC---CCCCccccCcccccchhhhccC----------C-CCCccchhhHHHHHHHHHh-CCCCCC
Q 022118          229 RTDV---AGPSSQVTADEIFLASEVKEFR----------R-FSEKSDVYSFGVFLLELVS-GREASS  280 (302)
Q Consensus       229 ~~~~---~~~~~~~~~~~~~~aPE~~~~~----------~-~~~~~Dvws~Gvil~el~~-g~~p~~  280 (302)
                      +++.   ...-.+..--.+|.|||.+-..          . .+++.||||+||++.||++ |++||.
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            1111   1001112233469999976431          1 5678999999999999998 688876

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=3.1e-17  Score=128.03  Aligned_cols=133  Identities=23%  Similarity=0.274  Sum_probs=111.0

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-hHHHHHHHHHhccCCC--CceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      +.+.||+|.++.||++...+ ..+++|...... ...+.+|...++.++|  +++++++++....+..+++|||++++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            35779999999999999765 678999865543 3578899999999976  5899999998888889999999998776


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC-CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ..+            +......++.+++.+++++|... .+++|+|++|+||++++.+.+++.|||.++.
T Consensus        81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            532            44556778899999999999842 3699999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=8.4e-19  Score=155.93  Aligned_cols=124  Identities=20%  Similarity=0.335  Sum_probs=105.3

Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+.|++|..++|.+++....  .....++...+.++.|++.|+.|     ++.+|||+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhh
Confidence            4689999999999999996543  34455677888999999999999     3589999999999999999999999999


Q ss_pred             ccccCCCC----CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh
Q 022118          224 RNFLGRTD----VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS  274 (302)
Q Consensus       224 a~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~  274 (302)
                      ........    .........||..||+||.+.+..|+.++||||||++|+|+++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            87654433    1222345679999999999999999999999999999999998

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=3.3e-17  Score=138.06  Aligned_cols=132  Identities=16%  Similarity=0.126  Sum_probs=100.7

Q ss_pred             CCeee-eCCCeeEEEEEEcCCcEEEEEecCC----------------CChHHHHHHHHHhccCCCCce--eeEEeEEeeC
Q 022118           82 KNLIG-EGKFGEVYKGLLQDGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNL--VTLLGYCQEN  142 (302)
Q Consensus        82 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~  142 (302)
                      ...|| .|+.|+||.+... +..+++|....                ....++.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8899999999875 56788886432                122457789999999988775  6777765443


Q ss_pred             Ce----eeEEEeccCC-CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          143 NL----QFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       143 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      ..    .++||||+++ .+|.+++..      ..++..    .+.+++.++.+||+  .||+||||||+|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEE
Confidence            22    2599999997 688877622      223332    35689999999999  7799999999999999999999


Q ss_pred             Ecccccccc
Q 022118          218 VADAGLRNF  226 (302)
Q Consensus       218 l~DfGla~~  226 (302)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=1.5e-17  Score=135.21  Aligned_cols=134  Identities=22%  Similarity=0.222  Sum_probs=94.6

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh-----HHH----------------------HHHHHHhccCCCC--ce
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----QEF----------------------IDEVCFLASIQHR--NL  132 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~E~~~l~~l~H~--nI  132 (302)
                      .+.||+|+||+||+|...+++.||+|.......     ...                      ..|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988899999997543211     111                      2445555555333  24


Q ss_pred             eeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 022118          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (302)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~  212 (302)
                      .+.++.    ...+++|||++++++......     ..... .....++.+++.++.++|.. .+|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~-----~~~~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK-----DVRLL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhh-----hhhhc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-
Confidence            444443    235899999999654322111     01111 55678899999999999972 5699999999999999 


Q ss_pred             CCceEEccccccccc
Q 022118          213 DFIAKVADAGLRNFL  227 (302)
Q Consensus       213 ~~~~kl~DfGla~~~  227 (302)
                      ++.++++|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=6.5e-17  Score=139.36  Aligned_cols=165  Identities=18%  Similarity=0.260  Sum_probs=119.1

Q ss_pred             CCCceeeEEeEEeeC---------------------------CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHH
Q 022118          128 QHRNLVTLLGYCQEN---------------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI  180 (302)
Q Consensus       128 ~H~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~  180 (302)
                      +|||||++.++|.++                           ...|+||.-.+. +|..++.      ....+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~------~~~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW------TRHRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh------cCCCchHHHHHH
Confidence            599999999988542                           235788876653 7777772      344556667778


Q ss_pred             HHHHHHHHHHhhcCCCCceecCCCCCCeee--CCCC--ceEEcccccccccCC----CCCCCCCccccCcccccchhhhc
Q 022118          181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDF--IAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASEVKE  252 (302)
Q Consensus       181 ~~~i~~~l~~LH~~~~~ivHrdlkp~Nill--~~~~--~~kl~DfGla~~~~~----~~~~~~~~~~~~~~~~~aPE~~~  252 (302)
                      ..|+++|+.|||.  +|+.|||+|.+|||+  |+|+  ..-++|||.+---..    -.+....-...|.-..||||+..
T Consensus       347 laQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  347 LAQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999  679999999999998  4444  567999997632111    01111122334666789999876


Q ss_pred             cCCC------CCccchhhHHHHHHHHHhCCCCCCC------------------CCCCChhhHHHHHHHHhhcc
Q 022118          253 FRRF------SEKSDVYSFGVFLLELVSGREASSS------------------LSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       253 ~~~~------~~~~Dvws~Gvil~el~~g~~p~~~------------------~~~~~~~~l~~~~~~~~~~~  301 (302)
                      ..+-      -.|+|.|+.|.+.||++...-||-+                  +++..++.+.+++..-++.|
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~  497 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRD  497 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCC
Confidence            4421      2589999999999999999999875                  23455677778877777654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=9.4e-18  Score=157.85  Aligned_cols=203  Identities=20%  Similarity=0.213  Sum_probs=159.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC--CcEEEEEecCCCC--h---HHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAP--T---QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~---~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l  147 (302)
                      ...|.+.+.||+|+|+.|-......  ...+|.|......  .   .....|..+-..+. |+|++.+++...+++..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456677889999999998887533  4566777544332  1   22334666667776 9999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeeCCCC-ceEEccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRN  225 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~  225 (302)
                      .+||.+++++.+.+..   ......+......+..|+..++.|+| .  .++.|||+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999999877721   11113445556778899999999999 6  7799999999999999999 99999999998


Q ss_pred             ccCC-CCCCCCCccccC-cccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          226 FLGR-TDVAGPSSQVTA-DEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       226 ~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      .... .+.........| +..|+|||...+..| .+..|+||.|+++.-+++|..||....
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            7766 444444455567 888999999988654 678999999999999999999998544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.64  E-value=8.6e-16  Score=140.25  Aligned_cols=138  Identities=19%  Similarity=0.159  Sum_probs=94.7

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHH-------------------------------------------HHH
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE-------------------------------------------FID  119 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------~~~  119 (302)
                      +.||.|++|.||+|+..+|+.||||...+...+.                                           +.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            6799999999999999999999999865543222                                           223


Q ss_pred             HHHHhccC----CCCceeeEEeEE-eeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHH-HHHHhhc
Q 022118          120 EVCFLASI----QHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK-GLAHLHS  193 (302)
Q Consensus       120 E~~~l~~l----~H~nIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~LH~  193 (302)
                      |...+.++    +|.+-+.+-..+ ......++||||++|++|.+.....    ....+   ...++.+++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCCC---HHHHHHHHHHHHHHHHHh
Confidence            43333333    222222222222 2234568999999999998775211    11111   2345555555 4678887


Q ss_pred             CCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       194 ~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                        .|++|+|++|.||++++++.++++|||++..+.+
T Consensus       276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              6799999999999999999999999999977643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=1.8e-14  Score=133.39  Aligned_cols=144  Identities=14%  Similarity=0.083  Sum_probs=90.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCChH---------------------------------------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ---------------------------------------  115 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---------------------------------------  115 (302)
                      ..+|+. +.||+|++|.||+|+..+ |+.||||...+...+                                       
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999887 999999976543211                                       


Q ss_pred             ----HHHHHHHHhccC----CCCceeeEEeEEe-eCCeeeEEEeccCCCCccccccCCC-cCCCcccCHHHHHHHHHHHH
Q 022118          116 ----EFIDEVCFLASI----QHRNLVTLLGYCQ-ENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAA  185 (302)
Q Consensus       116 ----~~~~E~~~l~~l----~H~nIv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~~i~  185 (302)
                          ++.+|...+.++    .+.+.+.+-.++. -....++||||++|+.+.+.-.-.. ......+....+..++.|+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                122333333332    2333333222222 1344579999999999976421000 00111233333334444443


Q ss_pred             HHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccccccccCC
Q 022118          186 KGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAGLRNFLGR  229 (302)
Q Consensus       186 ~~l~~LH~~~~~ivHrdlkp~Nill~~~~----~~kl~DfGla~~~~~  229 (302)
                             .  .|++|+|++|.||+++.++    .+++.|||++..+.+
T Consensus       278 -------~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------R--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------h--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   3  5699999999999999888    999999999876643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.6e-13  Score=108.41  Aligned_cols=127  Identities=17%  Similarity=0.082  Sum_probs=93.5

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hHHHHHHHHHhccCCCCce-eeEEeEEeeCCeeeEEEeccCCCCccc
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVSI  159 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (302)
                      +.++.|.++.||++... +..+++|......  ...+.+|..+++.+.+.++ .+++++..  ...++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence            56889999999999865 6789999865443  3456789999988865444 45555433  34589999999988753


Q ss_pred             cccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC---CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          160 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       160 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ..          .   .......+++.+++.||+..   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            21          0   01235678999999999842   1259999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=6.5e-13  Score=121.98  Aligned_cols=164  Identities=20%  Similarity=0.180  Sum_probs=117.4

Q ss_pred             EcCCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCH
Q 022118           98 LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF  174 (302)
Q Consensus        98 ~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  174 (302)
                      ..++.+|.+...+...   .....+-++.|+.++||||+++++.++.++..|+|+|-+.  -|..++.        .+..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk--------~l~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK--------ELGK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH--------HhHH
Confidence            4456666666544333   3456678899999999999999999999999999999874  4555552        1224


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccC
Q 022118          175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR  254 (302)
Q Consensus       175 ~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  254 (302)
                      .....-+.||+.||.|||+. .+++|++|.-+.|+++..|..||++|.++........  .......-..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            45566778999999999964 6799999999999999999999999998764332211  01111111224555543222


Q ss_pred             CCCCccchhhHHHHHHHHHhCC
Q 022118          255 RFSEKSDVYSFGVFLLELVSGR  276 (302)
Q Consensus       255 ~~~~~~Dvws~Gvil~el~~g~  276 (302)
                      .  -..|.|-||+++||++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  2459999999999999993

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=1.4e-13  Score=116.31  Aligned_cols=155  Identities=21%  Similarity=0.275  Sum_probs=117.6

Q ss_pred             HhccCCCCceeeEEeEEeeCC-----eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022118          123 FLASIQHRNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR  197 (302)
Q Consensus       123 ~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~  197 (302)
                      .+-.+.|.||+++..|+.+..     ...+++||+..|++..+|...+. +...+....-.+++.||..||.|||+..+.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            334456999999999987543     45889999999999999965543 455677777789999999999999999999


Q ss_pred             ceecCCCCCCeeeCCCCceEEcccccccccC--CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhC
Q 022118          198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG  275 (302)
Q Consensus       198 ivHrdlkp~Nill~~~~~~kl~DfGla~~~~--~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g  275 (302)
                      |+|+++.++.+++..+|.+|+.---......  .........-..+-++|.+||.-.....+..+|||+||.+..||..|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999999986322111100  00001112223445668999987777788899999999999999998


Q ss_pred             CCC
Q 022118          276 REA  278 (302)
Q Consensus       276 ~~p  278 (302)
                      ..-
T Consensus       279 Eiq  281 (458)
T KOG1266|consen  279 EIQ  281 (458)
T ss_pred             eec
Confidence            754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=5.7e-12  Score=102.10  Aligned_cols=133  Identities=17%  Similarity=0.074  Sum_probs=93.8

Q ss_pred             CeeeeCCCeeEEEEEEcC-------CcEEEEEecCC--------------C----------C-hHHH----HHHHHHhcc
Q 022118           83 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPG--------------A----------P-TQEF----IDEVCFLAS  126 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~--------------~----------~-~~~~----~~E~~~l~~  126 (302)
                      ..||.|.-+.||.|...+       +..+|+|....              .          . ...+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998543       47899994110              0          0 1122    378888888


Q ss_pred             CC--CCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHh-hcCCCCceecCC
Q 022118          127 IQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDF  203 (302)
Q Consensus       127 l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~ivHrdl  203 (302)
                      +.  .-++...+++    ..-++||||+.++.+....     .....++......+..+++.+|..+ |+  .++||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-----LKDAKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-----hhccccCHHHHHHHHHHHHHHHHHHHHh--CCeecCCC
Confidence            84  3566677664    4458999999775443221     1122334455667788999999999 77  67999999


Q ss_pred             CCCCeeeCCCCceEEccccccccc
Q 022118          204 KTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       204 kp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ++.||+++ ++.+.|+|||-+-..
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 467999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=6.4e-13  Score=120.65  Aligned_cols=199  Identities=24%  Similarity=0.266  Sum_probs=153.2

Q ss_pred             HHhcCCCcCCeeee--CCCeeEEEEEE---cCCcEEEEEecCC-----CChHHHHHHHHHhccC-CCCceeeEEeEEeeC
Q 022118           74 LATKNFSDKNLIGE--GKFGEVYKGLL---QDGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (302)
Q Consensus        74 ~~~~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~  142 (302)
                      .....+.....+|.  |.+|.||.+..   .++..+|+|+-+.     ....+=.+|....+++ .|+|.++.+..+...
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            34455677788999  99999999986   3577889886221     2233445777777777 599999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHH----HHHHhhcCCCCceecCCCCCCeeeCCC-CceE
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK----GLAHLHSLSPRVVHKDFKTANVLVDED-FIAK  217 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~k  217 (302)
                      +..|+-+|+|. .+|..+....    ...++....+....+...    |+.++|.  ..++|-|+||+|+++.++ ...+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccceee
Confidence            99999999986 6777776432    233555666677777777    9999998  679999999999999999 8899


Q ss_pred             EcccccccccCCCCCCCC---CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          218 VADAGLRNFLGRTDVAGP---SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ++|||+...++.......   .....+...|++||... ..++..+|+||+|.+..+-.+|..++.
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            999999988876543221   12225667799999865 567889999999999999988765543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=2.3e-11  Score=101.24  Aligned_cols=138  Identities=22%  Similarity=0.351  Sum_probs=104.8

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCC----ChHHHHHHHHHhccCCC--CceeeEEeEEeeCC---eeeEEEeccC
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQH--RNLVTLLGYCQENN---LQFLIYEYIP  153 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~---~~~lv~e~~~  153 (302)
                      +.|+.|..+.||++...+|..+++|.....    ....+.+|.++++.+.+  .++.+++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999998876688999975543    24568899999998865  45677777776543   5689999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---------------------------------------  194 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---------------------------------------  194 (302)
                      |.++...+.      ...++......++.+++..|..||+.                                       
T Consensus        84 G~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLL------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            988876541      12355566667777777777777742                                       


Q ss_pred             ---------------CCCceecCCCCCCeeeCC--CCceEEcccccccc
Q 022118          195 ---------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNF  226 (302)
Q Consensus       195 ---------------~~~ivHrdlkp~Nill~~--~~~~kl~DfGla~~  226 (302)
                                     ...++|+|+.|.||+++.  ++.+.|.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           134799999999999998  67789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=1.8e-11  Score=96.34  Aligned_cols=128  Identities=21%  Similarity=0.292  Sum_probs=95.8

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecC-CCC----------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRP-GAP----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ..+++|+-+.+|.+.+. |..+++|... +.-          ..+-.+|..++.+++--.|...+=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999764 4447777532 211          12456799999888655555555556677777899999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      .+|-.|.+.+...            ...++..+-.-+.-||.  .+|||+||.++|+.++.+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888321            13466677778889998  7899999999999998766 89999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=1.9e-12  Score=117.61  Aligned_cols=194  Identities=24%  Similarity=0.313  Sum_probs=146.7

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc--CCcEEEEEecCCCCh---HH--HHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAPT---QE--FIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~--~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      ....+|..+..||.|.|+.|+....+  ++..+++|.......   ++  -..|+-+...+ .|.++++++..+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888899999999999988744  477888886433221   11  23455555555 589999998888888888


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLR  224 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGla  224 (302)
                      |+-.|||+++++....     .....+++...+++..|++.++.++|+  +.++|+|+||+||++..+ +..++.|||.+
T Consensus       342 ~ip~e~~~~~s~~l~~-----~~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS-----VTSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cCchhhhcCcchhhhh-----HHHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccccccc
Confidence            8999999999987666     345667788889999999999999998  679999999999999886 78899999998


Q ss_pred             cccCCCCCCCCCccccCcccc-cchhhhccCCCCCccchhhHHHHHHHHHhCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA  278 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p  278 (302)
                      ..+.-..    ....-.+..| .+++......+..+.|++|||.-+.|..+|..-
T Consensus       415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cccceec----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            6532111    1111223334 366666677888999999999999999998643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.24  E-value=2.6e-12  Score=122.99  Aligned_cols=201  Identities=19%  Similarity=0.203  Sum_probs=140.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEe---cC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK---RP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~---~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ...+.+.+-+-+|.++.++.+.-. .+...+.|.   .+   ....+....+-.+.-.-+||.+++...-+......+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345566677889999999887633 232333332   11   11122223333444444567777766666666788999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ++|..+++|...|+...     ..+..-.......+..+.+|||.  ..++|||++|.|.+...+++.+++|||.....+
T Consensus       883 ~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccccccccc
Confidence            99999999998885432     23333334556678889999998  448999999999999999999999998433221


Q ss_pred             CC-------------------------CCC----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022118          229 RT-------------------------DVA----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS  279 (302)
Q Consensus       229 ~~-------------------------~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~  279 (302)
                      ..                         ...    .......+|+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            10                         000    1123456888999999999999999999999999999999999998


Q ss_pred             CCCC
Q 022118          280 SSLS  283 (302)
Q Consensus       280 ~~~~  283 (302)
                      ....
T Consensus      1036 na~t 1039 (1205)
T KOG0606|consen 1036 NAET 1039 (1205)
T ss_pred             CCcc
Confidence            8543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=8.3e-11  Score=92.31  Aligned_cols=140  Identities=19%  Similarity=0.225  Sum_probs=100.0

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCC-CC----------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-AP----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ....+.+|+-+.|+++.+. |+...||.... .-          ..+..+|.+.+.+++--.|..-.=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999875 67778885322 11          235678999998876545544444555666668999


Q ss_pred             eccCC-CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEccccccc
Q 022118          150 EYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRN  225 (302)
Q Consensus       150 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~---~~kl~DfGla~  225 (302)
                      ||.++ -++.+++.....  ....+ .....++..|-..+.-||.  ++|||+||..+||++..++   .+-+.|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d-~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESED-EGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--Ccccc-hhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 467777744322  12112 2225678888999999998  7799999999999996554   45899999986


Q ss_pred             c
Q 022118          226 F  226 (302)
Q Consensus       226 ~  226 (302)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=2.1e-09  Score=86.84  Aligned_cols=121  Identities=21%  Similarity=0.210  Sum_probs=77.4

Q ss_pred             eEEEEEEcCCcEEEEEecCC--------------CC---------------hHHHHHHHHHhccCCCC--ceeeEEeEEe
Q 022118           92 EVYKGLLQDGMLVAIKKRPG--------------AP---------------TQEFIDEVCFLASIQHR--NLVTLLGYCQ  140 (302)
Q Consensus        92 ~V~~~~~~~~~~vavK~~~~--------------~~---------------~~~~~~E~~~l~~l~H~--nIv~l~~~~~  140 (302)
                      .||.|...++..+|+|....              ..               .....+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999998999999994111              00               01246799999999755  567776552 


Q ss_pred             eCCeeeEEEeccC--CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHH-hhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          141 ENNLQFLIYEYIP--NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       141 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                         .-.+||||++  |..+....       ...++......++.+++..+.. +|.  .|+||+||.+.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-------~~~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-------DVDLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-------HCGGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHH-------hccccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEE
Confidence               2379999998  54443322       1111123345567777776665 466  679999999999999987 999


Q ss_pred             Ecccccccc
Q 022118          218 VADAGLRNF  226 (302)
Q Consensus       218 l~DfGla~~  226 (302)
                      ++|||.+..
T Consensus       147 iIDf~qav~  155 (188)
T PF01163_consen  147 IIDFGQAVD  155 (188)
T ss_dssp             E--GTTEEE
T ss_pred             EEecCccee
Confidence            999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=3.7e-09  Score=90.34  Aligned_cols=138  Identities=14%  Similarity=0.088  Sum_probs=94.3

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--------------hHHHHHHHHHhccCCCC--ceeeEEeEEee-----
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHR--NLVTLLGYCQE-----  141 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~H~--nIv~l~~~~~~-----  141 (302)
                      +.+-.-....|++... +|+.+.+|......              ...+.+|...+.++..-  ..+..+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4454444445666655 46789999643322              12467888888776322  23334444433     


Q ss_pred             CCeeeEEEeccCCC-CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-------C
Q 022118          142 NNLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------D  213 (302)
Q Consensus       142 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-------~  213 (302)
                      ....++|||++++- +|.+++...   .....+......++.+++..+.-||.  .||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCC
Confidence            23468999999875 788776321   12334456667899999999999999  77999999999999975       4


Q ss_pred             CceEEcccccccc
Q 022118          214 FIAKVADAGLRNF  226 (302)
Q Consensus       214 ~~~kl~DfGla~~  226 (302)
                      +.+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.88  E-value=1.3e-08  Score=85.03  Aligned_cols=128  Identities=21%  Similarity=0.152  Sum_probs=89.4

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcCCcEEEEEecC-------C-----------C-------ChHHHHHHHHHhccCCCC--c
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-------G-----------A-------PTQEFIDEVCFLASIQHR--N  131 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-------~-----------~-------~~~~~~~E~~~l~~l~H~--n  131 (302)
                      ..+...||-|.-+.||.|..++|.++|+|.-.       .           .       ++....+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34568999999999999999999999999410       0           0       012346799999988654  6


Q ss_pred             eeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 022118          132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (302)
Q Consensus       132 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~  211 (302)
                      |.+.+++    +...+||||.+|-.|...-     .  ..-...   .++..|+.-+.-.-.  .|+||+|+.+=||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~--~~en~~---~il~~il~~~~~~~~--~GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----L--DVENPD---EILDKILEEVRKAYR--RGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----C--cccCHH---HHHHHHHHHHHHHHH--cCccccCCchheEEEe
Confidence            7776665    4457999999986554221     0  111222   233344444433334  6799999999999999


Q ss_pred             CCCceEEcccc
Q 022118          212 EDFIAKVADAG  222 (302)
Q Consensus       212 ~~~~~kl~DfG  222 (302)
                      ++|.+.++||-
T Consensus       237 ~dg~~~vIDwP  247 (304)
T COG0478         237 EDGDIVVIDWP  247 (304)
T ss_pred             cCCCEEEEeCc
Confidence            99999999984

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.84  E-value=7.8e-08  Score=84.81  Aligned_cols=196  Identities=16%  Similarity=0.162  Sum_probs=123.3

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEE------eeC-CeeeEEEecc
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC------QEN-NLQFLIYEYI  152 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~------~~~-~~~~lv~e~~  152 (302)
                      ....||+|+-+.+|-.-.-.+  .+.|....-....-...++.|.+. .||-+..=+.|=      -+. ...-++|..+
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CCccccCCccceeeecchhhc--hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            357799999999995431111  233443322222222334444444 566443312221      111 2245667766


Q ss_pred             CCCCccccccC--CCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          153 PNGSVSIHLYG--PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       153 ~~g~L~~~l~~--~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      .+-.=-..+++  .++..-+...|...++.++.++.+.+-||+  .|.+-+|+.++|+|+++++.+.|.|-..-..... 
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n-  169 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN-  169 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceEEEEcccceeeccC-
Confidence            55321111222  123345678899999999999999999998  6699999999999999999999887543322211 


Q ss_pred             CCCCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhC-CCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSG-REASSSLS  283 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g-~~p~~~~~  283 (302)
                      +  ......+|...|.+||...-     -.-+..+|-|.+||++++++.| +.||++.+
T Consensus       170 g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         170 G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            1  11223467778999998662     2345679999999999999987 99998653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.81  E-value=4.3e-08  Score=88.31  Aligned_cols=169  Identities=19%  Similarity=0.245  Sum_probs=123.5

Q ss_pred             CCeeEEEEE-EcCCcEEEEEecCC---CChHHHHHHHHHhccCCCCceeeEEeEEee----CCeeeEEEeccCC-CCccc
Q 022118           89 KFGEVYKGL-LQDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIYEYIPN-GSVSI  159 (302)
Q Consensus        89 ~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  159 (302)
                      ...+.|++. ..+|..+++|++..   ........-++.++++.|+|||.+.+++..    +..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345678887 45788999998732   223233456789999999999999998873    3567899999885 45544


Q ss_pred             cccCCC----------cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          160 HLYGPS----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       160 ~l~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      .-....          .......++..++.++.|+..||.++|+  .|..-+-|.|.+|+++.+..++|+.-|.-..+..
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            332211          1234567889999999999999999999  6688899999999999888999988877655443


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA  278 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p  278 (302)
                      +.         +     +|  +   .--.+-|.=.||.++..|.||..-
T Consensus       446 d~---------~-----~~--l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP---------T-----EP--L---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC---------C-----cc--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            22         0     01  1   112356889999999999999654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.80  E-value=6.8e-10  Score=101.95  Aligned_cols=188  Identities=21%  Similarity=0.125  Sum_probs=138.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCCCCc-eeeEEeEEeeCCeeeEEEeccCCC-
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIPNG-  155 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~~~g-  155 (302)
                      .++....+++|+++++++.+....+....+.....  ....-++++|.+++||| .+..++-++.++..++.++|+.++ 
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            34445668899999999988543333335544332  33456889999999999 777778788888889999999887 


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +-....    ...+..+...+...+.+.-.++++++|+.  .=+|||    ||+..+ +..|..||+....+.+..   .
T Consensus       321 s~~~~~----~~se~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~  386 (829)
T KOG0576|consen  321 SSALEM----TVSEIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K  386 (829)
T ss_pred             cccccC----ChhhHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCccc---c
Confidence            222111    13344555556666777788899999983  248998    777665 778999999987765543   3


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .....+++.|+|||+.....++...|.||.|+-..++.-|-+|-.+
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            4566788899999999999999999999999988888888777553

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=2.7e-07  Score=75.21  Aligned_cols=136  Identities=11%  Similarity=-0.001  Sum_probs=96.5

Q ss_pred             eeeCCCeeEEEEEEcCCcEEEEEecC---------CCChHHHHHHHHHhccCCC--CceeeEEeEEeeCC----eeeEEE
Q 022118           85 IGEGKFGEVYKGLLQDGMLVAIKKRP---------GAPTQEFIDEVCFLASIQH--RNLVTLLGYCQENN----LQFLIY  149 (302)
Q Consensus        85 lg~G~~g~V~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~----~~~lv~  149 (302)
                      -|+|+-+-|+...... ..+-+|+..         +-....|.+|...+..+..  -++.+.........    ..+||+
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            4678888898877653 468888633         3355779999999888742  23555542222211    347999


Q ss_pred             eccCC-CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--eEEcccccccc
Q 022118          150 EYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~--~kl~DfGla~~  226 (302)
                      |-+++ -+|.+++...   .....+......+..+++..+.-||+  .|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            96653 4777776221   12344666677899999999999999  67999999999999986666  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=6.9e-08  Score=79.66  Aligned_cols=106  Identities=22%  Similarity=0.239  Sum_probs=79.1

Q ss_pred             hHHHHHHHHHhccCC--CCceeeEEeEEeeCC----eeeEEEeccCCC-CccccccCCCcCCCcccCHHHHHHHHHHHHH
Q 022118          114 TQEFIDEVCFLASIQ--HRNLVTLLGYCQENN----LQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAK  186 (302)
Q Consensus       114 ~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~  186 (302)
                      ..+..+|...+..+.  .-.+.+.+++.....    ..++|+|++++. +|.+++...     ...+......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence            345677887776663  233455556555432    348999999874 788877321     12455667789999999


Q ss_pred             HHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcccccccc
Q 022118          187 GLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNF  226 (302)
Q Consensus       187 ~l~~LH~~~~~ivHrdlkp~Nill~~~~---~~kl~DfGla~~  226 (302)
                      .+.-||+  .||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       130 ~i~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  130 LIAKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999  7799999999999998887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=1.1e-07  Score=88.11  Aligned_cols=141  Identities=19%  Similarity=0.184  Sum_probs=89.3

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHH-----------------------------------------
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE-----------------------------------------  116 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------------------  116 (302)
                      .|+. +.|+.++-|.||+|+..+|+.||||...+...+.                                         
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            3443 7899999999999999999999999643322211                                         


Q ss_pred             --HHHHHHHhccC-----CCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHH-H
Q 022118          117 --FIDEVCFLASI-----QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG-L  188 (302)
Q Consensus       117 --~~~E~~~l~~l-----~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~-l  188 (302)
                        +.+|...+.++     +.|++.--.=+++-.+...|+|||++|-.+.+....    .....+...+   +..++.+ +
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l----~~~g~d~k~i---a~~~~~~f~  278 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL----KSAGIDRKEL---AELLVRAFL  278 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH----HhcCCCHHHH---HHHHHHHHH
Confidence              23344444333     234333222233334556899999999888877421    1223332222   2222221 1


Q ss_pred             HHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       189 ~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ..+-.  .|+.|.|..|.||+++.+|.+-+.|||+...+.
T Consensus       279 ~q~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         279 RQLLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHh--cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            22222  459999999999999999999999999986654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=1e-06  Score=73.65  Aligned_cols=139  Identities=17%  Similarity=0.096  Sum_probs=83.4

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCCC--ceeeEEeEEeeCCeeeEEEeccCCCC-cc
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR--NLVTLLGYCQENNLQFLIYEYIPNGS-VS  158 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~~~~lv~e~~~~g~-L~  158 (302)
                      ..||+|..+.||+.   .+..+++|..... ......+|.++++.+..-  .+.+.+++...++...++||+++|.+ +.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            56899999999984   2445678876543 345678899999887533  34677777777777889999999864 11


Q ss_pred             ccccCC-----------------CcCC-CcccCHHHH-HHHHHH----------HHH-HHHHhh--cCCCCceecCCCCC
Q 022118          159 IHLYGP-----------------SQVS-RQKLEFKHR-LSIALG----------AAK-GLAHLH--SLSPRVVHKDFKTA  206 (302)
Q Consensus       159 ~~l~~~-----------------~~~~-~~~~~~~~~-~~~~~~----------i~~-~l~~LH--~~~~~ivHrdlkp~  206 (302)
                      ..+...                 .+.. ......... ..+..+          +.. ...+|.  .....++|+|+.|.
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~  163 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG  163 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence            111000                 0000 000010000 000000          000 112222  22245799999999


Q ss_pred             CeeeCCCCceEEccccccc
Q 022118          207 NVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       207 Nill~~~~~~kl~DfGla~  225 (302)
                      |+++++++ +.+.||+.+.
T Consensus       164 Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       164 NLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cEEEcCCC-cEEEechhcC
Confidence            99999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=2.5e-08  Score=92.65  Aligned_cols=93  Identities=26%  Similarity=0.281  Sum_probs=72.2

Q ss_pred             HHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC-CCCCC------CCccccCcccccchhhhccCC
Q 022118          183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAG------PSSQVTADEIFLASEVKEFRR  255 (302)
Q Consensus       183 ~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~-~~~~~------~~~~~~~~~~~~aPE~~~~~~  255 (302)
                      +++.|+.|+|.. .++||++|.|++|.++..+.+||+.|+++-.... ..+..      ..........|.|||.+.+..
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            344899999984 7899999999999999999999999998754432 11110      011122334699999999988


Q ss_pred             CCCccchhhHHHHHHHHHhCC
Q 022118          256 FSEKSDVYSFGVFLLELVSGR  276 (302)
Q Consensus       256 ~~~~~Dvws~Gvil~el~~g~  276 (302)
                      .++++|++|+||.+|.+..|.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~g  206 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGG  206 (700)
T ss_pred             ccccccceeeeeEEEEEecCC
Confidence            899999999999999999544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=2.3e-06  Score=72.47  Aligned_cols=139  Identities=19%  Similarity=0.188  Sum_probs=84.8

Q ss_pred             eeeCCC-eeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEeccCCCCcccccc
Q 022118           85 IGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY  162 (302)
Q Consensus        85 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  162 (302)
                      |-.|.. ..||+.... +..+.+|..+........+|+++++.+. +--+.+++++...++..++|||+++|.++.....
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~   84 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE   84 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence            445555 678988764 4678888876554456778888887773 4456678888777677899999999877753321


Q ss_pred             -------------------CCCcCCCcccCH--HHHHHH-----------------------HHHHHHHHHHhh--cCCC
Q 022118          163 -------------------GPSQVSRQKLEF--KHRLSI-----------------------ALGAAKGLAHLH--SLSP  196 (302)
Q Consensus       163 -------------------~~~~~~~~~~~~--~~~~~~-----------------------~~~i~~~l~~LH--~~~~  196 (302)
                                         .. ......+..  ......                       ..++...+....  ....
T Consensus        85 ~~~~~~~~~~l~~~l~~lH~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  163 (244)
T cd05150          85 ELEPERLVDALAEALRRLHAL-PVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL  163 (244)
T ss_pred             ccCHHHHHHHHHHHHHHHhcC-CcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence                               00 000001110  000000                       111111111111  0124


Q ss_pred             CceecCCCCCCeeeCCCCceEEccccccc
Q 022118          197 RVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      .++|+|+.|.||++++++.+.|.||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            58999999999999998888999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.41  E-value=4.4e-06  Score=82.85  Aligned_cols=77  Identities=17%  Similarity=0.336  Sum_probs=56.8

Q ss_pred             CCeeeeCCCeeEEEEEEcCC---cEEEEEecCCC----ChHHHHHHHHHhccCC-CCce--eeEEeEEeeC---CeeeEE
Q 022118           82 KNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNL--VTLLGYCQEN---NLQFLI  148 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~---~~~~lv  148 (302)
                      .+.++.|.++.+|+....++   ..+++|+.+..    ....+.+|.++++.+. |+++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788899999999876553   35777775432    2346889999999985 6654  7888888765   467999


Q ss_pred             EeccCCCCcc
Q 022118          149 YEYIPNGSVS  158 (302)
Q Consensus       149 ~e~~~~g~L~  158 (302)
                      |||++|..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999986543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.5e-06  Score=80.36  Aligned_cols=136  Identities=17%  Similarity=0.164  Sum_probs=86.8

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCChH----------------------------------------HHHHHHH
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------------------------------------EFIDEVC  122 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~E~~  122 (302)
                      +.||.-+.|.||+|+.++|+.||||...+.-.+                                        +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            679999999999999999999999964332221                                        1333433


Q ss_pred             Hhc----cCCCCc------eeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhh
Q 022118          123 FLA----SIQHRN------LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH  192 (302)
Q Consensus       123 ~l~----~l~H~n------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  192 (302)
                      -..    .+.|-+      |.+++-.+.  ....|+||||+|..+.+...    ..+..++...+..-+.+...-+-+- 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~----i~~~gi~~~~i~~~l~~~~~~qIf~-  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDA----IDKRGISPHDILNKLVEAYLEQIFK-  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHH----HHHcCCCHHHHHHHHHHHHHHHHHh-
Confidence            222    234555      444433332  34589999999988776642    1233344443333222222222222 


Q ss_pred             cCCCCceecCCCCCCeeeCC----CCceEEcccccccccC
Q 022118          193 SLSPRVVHKDFKTANVLVDE----DFIAKVADAGLRNFLG  228 (302)
Q Consensus       193 ~~~~~ivHrdlkp~Nill~~----~~~~kl~DfGla~~~~  228 (302)
                         .|++|+|=.|.||++++    ++.+.+-|||+...+.
T Consensus       320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               46999999999999984    6789999999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=4.9e-06  Score=68.25  Aligned_cols=136  Identities=15%  Similarity=0.138  Sum_probs=85.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh--HH----------HHHHHHHhccCCC---CceeeEEeE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--QE----------FIDEVCFLASIQH---RNLVTLLGY  138 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~----------~~~E~~~l~~l~H---~nIv~l~~~  138 (302)
                      +...+|...+++......-|.+-.. ++..+++|.......  ++          ..+++..+.+++.   -....++-+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4566788777787766666665554 367888886544332  11          1223333333322   222222222


Q ss_pred             Ee-----eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 022118          139 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (302)
Q Consensus       139 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~  213 (302)
                      ..     -....+++|||++|..|.+..         .++.    .++..+..++.-+|+  .|+.|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEECC
Confidence            22     223446899999998876553         1111    244567788999999  679999999999999865


Q ss_pred             CceEEcccccccc
Q 022118          214 FIAKVADAGLRNF  226 (302)
Q Consensus       214 ~~~kl~DfGla~~  226 (302)
                      + +++.||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            5 89999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=2.4e-06  Score=71.35  Aligned_cols=76  Identities=18%  Similarity=0.284  Sum_probs=55.1

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCC--CceeeEEeEEee---CCeeeEEEeccCCCC
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH--RNLVTLLGYCQE---NNLQFLIYEYIPNGS  156 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~---~~~~~lv~e~~~~g~  156 (302)
                      +.++.|..+.||+....+ ..+++|..... ....+.+|..+++.+..  ..+.+++.+...   ....+++|+++++..
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            568999999999999887 58899987655 44567788888877742  235667665433   335689999999987


Q ss_pred             ccc
Q 022118          157 VSI  159 (302)
Q Consensus       157 L~~  159 (302)
                      +..
T Consensus        82 ~~~   84 (239)
T PF01636_consen   82 LDD   84 (239)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.34  E-value=6.1e-06  Score=68.56  Aligned_cols=134  Identities=19%  Similarity=0.221  Sum_probs=88.0

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh----------------------HH-----HHHHHHHhccCC--CCcee
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----------------------QE-----FIDEVCFLASIQ--HRNLV  133 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~-----~~~E~~~l~~l~--H~nIv  133 (302)
                      ..|+.|.-+.||+|...++..+|+|.......                      .+     ..+|..-|+++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            45667888899999988899999996432211                      11     134666666652  33444


Q ss_pred             eEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 022118          134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (302)
Q Consensus       134 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~  213 (302)
                      +-+++..    -.|||||+.......-     ..+...+.......+..++++.+.-|-.. .++||+||..=|||+. +
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP-----~LkDv~~e~~e~~~~~~~~v~~~~~l~~~-a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAP-----RLKDVPLELEEAEGLYEDVVEYMRRLYKE-AGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCC-----CcccCCcCchhHHHHHHHHHHHHHHHHHh-cCcccccchhhheEEE-C
Confidence            4444432    2699999865421111     11223333335666777888888877763 5799999999999999 8


Q ss_pred             CceEEccccccccc
Q 022118          214 FIAKVADAGLRNFL  227 (302)
Q Consensus       214 ~~~kl~DfGla~~~  227 (302)
                      +.+.|+|||=|-..
T Consensus       203 ~~p~iID~~QaV~~  216 (268)
T COG1718         203 GEPYIIDVSQAVTI  216 (268)
T ss_pred             CeEEEEECcccccc
Confidence            89999999976543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.32  E-value=1.5e-05  Score=64.58  Aligned_cols=103  Identities=23%  Similarity=0.183  Sum_probs=79.0

Q ss_pred             HHHHHhccCCC-CceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCC-
Q 022118          119 DEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-  196 (302)
Q Consensus       119 ~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-  196 (302)
                      .|.-++..+++ +++.+++|+|-.    ++++||...+++...-...  ..-...+|..+..+|.++++.+.++++... 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            57788888876 699999999943    6899999877653210000  011345799999999999999999997422 


Q ss_pred             CceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      .+.-.|++|+|+-+++++.+|+.|...+-..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            2666999999999999999999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.12  E-value=4.7e-05  Score=62.08  Aligned_cols=126  Identities=17%  Similarity=0.192  Sum_probs=81.2

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-------------------hHHHHHHHHHhccCC------CCceeeE
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------TQEFIDEVCFLASIQ------HRNLVTL  135 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~------H~nIv~l  135 (302)
                      ....||+|+.=.||.  ++++....||......                   ..+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346799999988884  4444556666544433                   455667766555444      8899999


Q ss_pred             EeEEeeCCeeeEEEeccCC--C----CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 022118          136 LGYCQENNLQFLIYEYIPN--G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (302)
Q Consensus       136 ~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nil  209 (302)
                      +|+.+++-..-+|+|....  |    +|.+++      ....++. ....   .+-.-..||-+  .+|+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l------~~~~~~~-~~~~---~L~~f~~~l~~--~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL------KEGGLTE-ELRQ---ALDEFKRYLLD--HHIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH------HcCCccH-HHHH---HHHHHHHHHHH--cCCeecCCCcccEE
Confidence            9999999888888887643  2    344554      1223333 2222   23333456665  56999999999999


Q ss_pred             eCCC--C--ceEEcc
Q 022118          210 VDED--F--IAKVAD  220 (302)
Q Consensus       210 l~~~--~--~~kl~D  220 (302)
                      +...  +  .+.|.|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532  2  455555

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=3.4e-05  Score=64.95  Aligned_cols=73  Identities=11%  Similarity=0.218  Sum_probs=45.1

Q ss_pred             CeeeeCCCe-eEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCCC---ceeeEEeEEeeC---CeeeEEEeccCC
Q 022118           83 NLIGEGKFG-EVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQEN---NLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~---~~~~lv~e~~~~  154 (302)
                      +.++.|+.. .||+.    +..+++|..... ....+.+|.+.+..+...   .+.+.++.....   +..+++|++++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            456766665 48875    234667765443 344688899888776421   344455544332   234889999999


Q ss_pred             CCccc
Q 022118          155 GSVSI  159 (302)
Q Consensus       155 g~L~~  159 (302)
                      .++..
T Consensus        79 ~~l~~   83 (235)
T cd05155          79 ETATA   83 (235)
T ss_pred             CCCCc
Confidence            77753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=0.00011  Score=64.24  Aligned_cols=77  Identities=16%  Similarity=0.100  Sum_probs=57.3

Q ss_pred             CcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCC---CceeeEEeEEee---CCeeeEEEecc
Q 022118           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH---RNLVTLLGYCQE---NNLQFLIYEYI  152 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~---~~~~~lv~e~~  152 (302)
                      ...+.||.|..+.||.....++. +.+|..+.. ....+.+|.+.++.+.-   -.+.++++++..   .+..++|||++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            33577999999999998766554 566665442 45678899999887742   467888887754   36679999999


Q ss_pred             CCCCc
Q 022118          153 PNGSV  157 (302)
Q Consensus       153 ~~g~L  157 (302)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.90  E-value=0.00016  Score=63.04  Aligned_cols=144  Identities=17%  Similarity=0.092  Sum_probs=84.8

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCCCC--ceeeEEeE------EeeCCeeeEEEeccC
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIP  153 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~------~~~~~~~~lv~e~~~  153 (302)
                      .+.+..|....+|+....+ ..+++|............|.+++..+.+.  .+.+.+..      ....+..+++++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~   97 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA   97 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence            4567778778999887544 46888887655556677788888777432  24444432      123456689999999


Q ss_pred             CCCcccc----c----------cCCCcC------CCcccCHHHHH----------HHHHHHHHHHHHhhc-----CCCCc
Q 022118          154 NGSVSIH----L----------YGPSQV------SRQKLEFKHRL----------SIALGAAKGLAHLHS-----LSPRV  198 (302)
Q Consensus       154 ~g~L~~~----l----------~~~~~~------~~~~~~~~~~~----------~~~~~i~~~l~~LH~-----~~~~i  198 (302)
                      |..+...    .          +.....      ......|....          .....+...+.++.+     ...++
T Consensus        98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l  177 (296)
T cd05153          98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV  177 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence            8776431    0          000000      00011111110          011112233344332     22469


Q ss_pred             eecCCCCCCeeeCCCCceEEcccccccc
Q 022118          199 VHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       199 vHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +|+|+.|.|+++++++.+.|.||+.+..
T Consensus       178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         178 IHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CccCcCcccEEEeCCceEEEeehhhhcC
Confidence            9999999999999988789999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.89  E-value=0.00023  Score=64.33  Aligned_cols=72  Identities=17%  Similarity=0.155  Sum_probs=52.8

Q ss_pred             CCeeeeCCCeeEEEEEEcCC-cEEEEEecC----------CCChHHHHHHHHHhccCC---CCceeeEEeEEeeCCeeeE
Q 022118           82 KNLIGEGKFGEVYKGLLQDG-MLVAIKKRP----------GAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~----------~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+.||.|.+..||++...+| +.++||...          +...++...|.+.|..+.   -.++.+++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            36799999999999998876 489999632          123456777888887652   356778887743  45689


Q ss_pred             EEeccCCC
Q 022118          148 IYEYIPNG  155 (302)
Q Consensus       148 v~e~~~~g  155 (302)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>PRK05231 homoserine kinase; Provisional

Probab=97.88  E-value=0.00032  Score=61.85  Aligned_cols=144  Identities=14%  Similarity=0.063  Sum_probs=77.3

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCCC--CceeeEEe------EEeeCCeeeEEEeccC
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLG------YCQENNLQFLIYEYIP  153 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~------~~~~~~~~~lv~e~~~  153 (302)
                      .+.++.|....+|+....++ .+++|.......+....|...+..|..  -.+.+.+.      +....+..++++||++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~  105 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE  105 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence            35566777788999876655 578887653334444555555555421  11333332      1123456789999999


Q ss_pred             CCCcccc----c----------cCCCcC------CCcccCH-HHHHH------------HH-HHHHHHHHHhhc-----C
Q 022118          154 NGSVSIH----L----------YGPSQV------SRQKLEF-KHRLS------------IA-LGAAKGLAHLHS-----L  194 (302)
Q Consensus       154 ~g~L~~~----l----------~~~~~~------~~~~~~~-~~~~~------------~~-~~i~~~l~~LH~-----~  194 (302)
                      |..+...    .          +.....      ....+.+ .....            .. ..+...++.+..     .
T Consensus       106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  185 (319)
T PRK05231        106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL  185 (319)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence            8754211    0          000000      0001111 11100            11 111112223221     2


Q ss_pred             CCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       195 ~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ..++||+|+.|.||+++.+...-|.||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            35799999999999999776668999998753

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.86  E-value=0.00012  Score=62.43  Aligned_cols=135  Identities=14%  Similarity=0.119  Sum_probs=74.9

Q ss_pred             eeeCCCeeEEEEEEcCCcEEEEEecCCCCh---HHHHHHHHHhccCCCCce-eeEEeEEeeCCeeeEEEeccCCCCcccc
Q 022118           85 IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVSIH  160 (302)
Q Consensus        85 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~~~  160 (302)
                      +..|-.+.+|+... ++..+++|.......   -+..+|.++++.+....+ .+++....    .++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            44577788998873 456778886443221   135678888887753222 34444332    3689999998766432


Q ss_pred             -----------------ccCCCcCCCcccCHHH-HHHHHHHH---------HHHHHHhhc------CCCCceecCCCCCC
Q 022118          161 -----------------LYGPSQVSRQKLEFKH-RLSIALGA---------AKGLAHLHS------LSPRVVHKDFKTAN  207 (302)
Q Consensus       161 -----------------l~~~~~~~~~~~~~~~-~~~~~~~i---------~~~l~~LH~------~~~~ivHrdlkp~N  207 (302)
                                       ++... .....++... ......++         ...+..+-.      ....++|+|+.|.|
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQP-RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                             01110 0111122111 11111111         111111111      01358999999999


Q ss_pred             eeeCCCCceEEcccccccc
Q 022118          208 VLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       208 ill~~~~~~kl~DfGla~~  226 (302)
                      |++++++ +.+.||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.83  E-value=0.00012  Score=57.74  Aligned_cols=128  Identities=23%  Similarity=0.252  Sum_probs=83.8

Q ss_pred             CcCCeeeeCCCeeEEEEEEcCCcEEEEEe-cCCCChHHHHHHHHHhccCCCCceee-EEeEEeeCCeeeEEEeccCCCCc
Q 022118           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVT-LLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      +..+.|++|.+|.||++.+.. ..+|+|. ...+.+..+..|.+++..+.-.++.. ++.|..+    ++.|||.+|-.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L   99 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC-ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence            345789999999999999874 4778876 45556778999999999887666654 4444332    455999998777


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCC-CC-CeeeCCCCceEEccccccccc
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK-TA-NVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlk-p~-Nill~~~~~~kl~DfGla~~~  227 (302)
                      .+.-..        .+..++    ..+++. +|.-+. .||-|..|. |. ||++. ++.+.|+||..|+..
T Consensus       100 ~~~~~~--------~~rk~l----~~vlE~-a~~LD~-~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIG--------GDRKHL----LRVLEK-AYKLDR-LGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhc--------ccHHHH----HHHHHH-HHHHHH-hccchhhhcCCceeEEec-CCcEEEEEccchhhc
Confidence            654311        122222    233333 232221 567787775 34 55554 458999999988743

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.78  E-value=3.4e-06  Score=85.02  Aligned_cols=161  Identities=13%  Similarity=0.058  Sum_probs=115.4

Q ss_pred             HHHHHHHhccCCCCceeeEEeEEee--CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC
Q 022118          117 FIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL  194 (302)
Q Consensus       117 ~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  194 (302)
                      ...|.+-.+...|+++...+.-...  +...+..++|+.+|++.+.+.+... ..+.+...-+.....+.+.+..-.|+.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhc
Confidence            4456666677789998876665443  3445899999999999998855432 233333333333333435666666653


Q ss_pred             ---CCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHH
Q 022118          195 ---SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLE  271 (302)
Q Consensus       195 ---~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~e  271 (302)
                         +.--+|+++|+-|.+|..+..+|++++|+.++..+..  .......+++.|+.|+....-.++.++|+|..|+-+|+
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence               2337999999999999999999999999998433221  12234456778999999988899999999999999999


Q ss_pred             HHhCCCCCC
Q 022118          272 LVSGREASS  280 (302)
Q Consensus       272 l~~g~~p~~  280 (302)
                      ..-|..+|-
T Consensus      1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred             HhcccHHHH
Confidence            988876654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.77  E-value=0.00025  Score=59.55  Aligned_cols=72  Identities=18%  Similarity=0.151  Sum_probs=46.3

Q ss_pred             CeeeeCCCeeEEEEEEcC--CcEEEEEecCCCCh--HHHHHHHHHhccCCC-CceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           83 NLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAPT--QEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~--~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      +.|..|-...+|+....+  +..+++|.......  ....+|..+++.+.. .-..++++...  +  .++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence            456677788999988664  56788887554322  123468888887743 33444544332  2  489999998766


Q ss_pred             c
Q 022118          158 S  158 (302)
Q Consensus       158 ~  158 (302)
                      .
T Consensus        80 ~   80 (235)
T cd05157          80 E   80 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.75  E-value=0.00064  Score=59.64  Aligned_cols=143  Identities=17%  Similarity=0.069  Sum_probs=81.1

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCC--CceeeEEeEE------eeCCeeeEEEecc
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH--RNLVTLLGYC------QENNLQFLIYEYI  152 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H--~nIv~l~~~~------~~~~~~~lv~e~~  152 (302)
                      .+.++.|....+|+....++ .+++|..... .......|.+++..|..  -++.+++...      ...+..++++||+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            46677777789998876555 5667865432 24455667777766632  2244444421      1235568999999


Q ss_pred             CCCCccccc--------------cCCCcC---CC-c---ccCHHHHH------------HHHHHHHHHHHHhhc-----C
Q 022118          153 PNGSVSIHL--------------YGPSQV---SR-Q---KLEFKHRL------------SIALGAAKGLAHLHS-----L  194 (302)
Q Consensus       153 ~~g~L~~~l--------------~~~~~~---~~-~---~~~~~~~~------------~~~~~i~~~l~~LH~-----~  194 (302)
                      +|..+....              +.....   .. .   .-.|....            .....+...++++..     .
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            986543110              100000   00 0   00111100            001122334544532     2


Q ss_pred             CCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       195 ~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ..+++|+|+.+.|+++++++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3579999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.64  E-value=0.00064  Score=55.27  Aligned_cols=122  Identities=21%  Similarity=0.324  Sum_probs=84.9

Q ss_pred             cCCCcCCeeeeCCC-eeEEEEEEcCCcEEEEEecC---------------C---------CChHHHHHHHHHhccCC---
Q 022118           77 KNFSDKNLIGEGKF-GEVYKGLLQDGMLVAIKKRP---------------G---------APTQEFIDEVCFLASIQ---  128 (302)
Q Consensus        77 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~---------------~---------~~~~~~~~E~~~l~~l~---  128 (302)
                      .+++..+.||.|.- |.||+++.. |+.+|+|...               .         .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 999999986 6799999710               0         01123678888877774   


Q ss_pred             CCce--eeEEeEEeeCC------------------eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHH
Q 022118          129 HRNL--VTLLGYCQENN------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL  188 (302)
Q Consensus       129 H~nI--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l  188 (302)
                      +.++  ++.+||..-..                  ...+|-||.+...              .+.    ..-+.++.+-+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl  177 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDL  177 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHH
Confidence            4566  89999874221                  1135666554321              112    22345777888


Q ss_pred             HHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       189 ~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      ..+|.  .||+-+|+++.|..     .-||+|||.+
T Consensus       178 ~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence            89998  67999999999984     2389999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.61  E-value=0.00014  Score=72.13  Aligned_cols=171  Identities=23%  Similarity=0.245  Sum_probs=116.8

Q ss_pred             HHHHHHhccCCCCceeeEEeEEeeCCe----eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhc
Q 022118          118 IDEVCFLASIQHRNLVTLLGYCQENNL----QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS  193 (302)
Q Consensus       118 ~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  193 (302)
                      .-|.+.+.++.|+|++.++.|-.+...    ..+..|||..-++...+     ......+..+.+.+..++.+|+.|+|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-----q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-----QSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-----hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            346677888999999999998765432    23456788888887777     334566778888899999999999998


Q ss_pred             CCCCceecCCCCC---CeeeCCCCceEEc--ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCc--cchhhHH
Q 022118          194 LSPRVVHKDFKTA---NVLVDEDFIAKVA--DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK--SDVYSFG  266 (302)
Q Consensus       194 ~~~~ivHrdlkp~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~Dvws~G  266 (302)
                      .  ...|.-+..+   +.-.+.++.+.++  ||+..+........   .....+..+.++|......++.+  .|+|.+|
T Consensus       305 ~--~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 L--SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             h--ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence            4  3555444444   4444566777777  99888766543322   12233445788888877776654  7999999


Q ss_pred             HHHHHHHhCCCCCCC-------CCCCChhhHHHHHHHHh
Q 022118          267 VFLLELVSGREASSS-------LSPDSSQDLVELMIKCM  298 (302)
Q Consensus       267 vil~el~~g~~p~~~-------~~~~~~~~l~~~~~~~~  298 (302)
                      .....+..|..+-..       ++..+.....+...+|.
T Consensus       380 ll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~  418 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCL  418 (1351)
T ss_pred             HHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhc
Confidence            999999998754331       22222224555666665

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.41  E-value=0.0011  Score=57.14  Aligned_cols=30  Identities=27%  Similarity=0.376  Sum_probs=25.2

Q ss_pred             CceecCCCCCCeeeCCCCc-eEEcccccccc
Q 022118          197 RVVHKDFKTANVLVDEDFI-AKVADAGLRNF  226 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~~~~-~kl~DfGla~~  226 (302)
                      .++|+|+.|.|+++++++. .-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997554 57999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.29  E-value=0.0016  Score=56.93  Aligned_cols=72  Identities=26%  Similarity=0.265  Sum_probs=44.9

Q ss_pred             eeeeCCCeeEEEEEEcC-------CcEEEEEecCCCC--hHHHHHHHHHhccCCCCc-eeeEEeEEeeCCeeeEEEeccC
Q 022118           84 LIGEGKFGEVYKGLLQD-------GMLVAIKKRPGAP--TQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .+..|-...+|+....+       +..+++|......  ..+..+|.+++..+.... ..++++.+. +   .+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence            45556666888887654       4678888755432  234567888887774222 334555543 2   36899998


Q ss_pred             CCCccc
Q 022118          154 NGSVSI  159 (302)
Q Consensus       154 ~g~L~~  159 (302)
                      |..+..
T Consensus        81 G~~l~~   86 (302)
T cd05156          81 SRTLTT   86 (302)
T ss_pred             CCcCCH
Confidence            877643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.27  E-value=0.00026  Score=61.31  Aligned_cols=128  Identities=17%  Similarity=0.136  Sum_probs=86.9

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEe--cC---------------CCC--------hHHHHHHHHHhccCC-CC-
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK--RP---------------GAP--------TQEFIDEVCFLASIQ-HR-  130 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~--~~---------------~~~--------~~~~~~E~~~l~~l~-H~-  130 (302)
                      -+.+.+.||-|.-+.+|.+...+|.+.++|.  +-               ...        +-...+|...|+.|. |- 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            3567899999999999999999999999883  00               000        012346888888773 32 


Q ss_pred             ceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       131 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      -|.+.+++    +..++|||++.+-.|...-        ...+..++   ...+..-+--|..  .|+||+|..-=||++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~--------~v~d~~~l---y~~lm~~Iv~la~--~GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVR--------HVEDPPTL---YDDLMGLIVRLAN--HGLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeee--------ecCChHHH---HHHHHHHHHHHHH--cCceecccchheeEE
Confidence            34444444    4458999999988775332        11222222   2233333344554  679999999999999


Q ss_pred             CCCCceEEcccc
Q 022118          211 DEDFIAKVADAG  222 (302)
Q Consensus       211 ~~~~~~kl~DfG  222 (302)
                      ++++.+.++||-
T Consensus       236 ~dd~~i~vIDFP  247 (465)
T KOG2268|consen  236 KDDDKIVVIDFP  247 (465)
T ss_pred             ecCCCEEEeech
Confidence            999999999995

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.25  E-value=0.0015  Score=56.59  Aligned_cols=74  Identities=18%  Similarity=0.270  Sum_probs=49.8

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC---CCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      ..+.++-|....+|+.. .++..+.+|.........|..|.+-|+.|   .--.+.+.+++....+..||+|||++.+
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            34678888888899877 56788999987766667788888777766   3456889999988888889999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.18  E-value=0.0055  Score=53.62  Aligned_cols=30  Identities=27%  Similarity=0.435  Sum_probs=27.6

Q ss_pred             CceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          197 RVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      .++|+|+.+.|++++.++.+-+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            589999999999999999899999999864

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.16  E-value=0.0073  Score=54.64  Aligned_cols=70  Identities=14%  Similarity=0.188  Sum_probs=49.1

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecC------CC----ChHHHHHHHHHhccCC---CCceeeEEeEEeeCCeeeEE
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRP------GA----PTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~------~~----~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .+.||.|....||+.... +..++||...      +.    ...+-..|.+.|+.+.   ..++.+++.++.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            467899999999998864 4568898643      11    3344455666665542   3578889988884  35789


Q ss_pred             EeccCC
Q 022118          149 YEYIPN  154 (302)
Q Consensus       149 ~e~~~~  154 (302)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.67  E-value=0.02  Score=51.02  Aligned_cols=69  Identities=13%  Similarity=0.184  Sum_probs=45.1

Q ss_pred             eeeeCCCeeEEEEEEcCC-cEEEEEec-------C---CCChHHHHHHHHHhccCC--CC-ceeeEEeEEeeCCeeeEEE
Q 022118           84 LIGEGKFGEVYKGLLQDG-MLVAIKKR-------P---GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~~~-~~vavK~~-------~---~~~~~~~~~E~~~l~~l~--H~-nIv~l~~~~~~~~~~~lv~  149 (302)
                      .||.|....||++...++ ..++||..       .   +...++..-|.+.|+...  -| .+.+++.+  +++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997654 57999941       1   223345566777776542  23 45566554  334456899


Q ss_pred             eccCC
Q 022118          150 EYIPN  154 (302)
Q Consensus       150 e~~~~  154 (302)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.61  E-value=0.044  Score=47.94  Aligned_cols=29  Identities=21%  Similarity=0.276  Sum_probs=25.3

Q ss_pred             CCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       196 ~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      .+++|+|+.+.||+++. +.+.+.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 668899999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.42  E-value=0.031  Score=49.65  Aligned_cols=136  Identities=18%  Similarity=0.164  Sum_probs=87.7

Q ss_pred             CcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-------------------------ChHH--H--HHHHHHhccCCCC
Q 022118           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------------------------PTQE--F--IDEVCFLASIQHR  130 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------------------------~~~~--~--~~E~~~l~~l~H~  130 (302)
                      .+...|..|.-+.||-+...+|..+|||.++..                         +++.  .  ..|++-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            344678889999999999999999999953211                         1111  1  3466667666543


Q ss_pred             ceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       131 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      .|.-.--...  ....|||+++.......-.     .....++...+..+-.+++.-|.-|.+. .+.||.||.-=|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPK-----LKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcc-----cccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheE
Confidence            3322111111  1237999998643322111     2345566666777778888888888764 579999999999988


Q ss_pred             CCCCceEEcccccc
Q 022118          211 DEDFIAKVADAGLR  224 (302)
Q Consensus       211 ~~~~~~kl~DfGla  224 (302)
                      .+ |.+.|+|.+=+
T Consensus       299 hd-G~lyiIDVSQS  311 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQS  311 (520)
T ss_pred             EC-CEEEEEEcccc
Confidence            54 67788887644

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.41  E-value=0.06  Score=44.73  Aligned_cols=68  Identities=18%  Similarity=0.316  Sum_probs=50.7

Q ss_pred             eeEEEEE-EcC-CcEEEEEecCCCChHHHHHHHHHhccC---CCCceeeEEeEEeeCCeeeEEEeccCCCCcc
Q 022118           91 GEVYKGL-LQD-GMLVAIKKRPGAPTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (302)
Q Consensus        91 g~V~~~~-~~~-~~~vavK~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (302)
                      |.|..|. ..+ ..++-+|+-.......|..|+.-|..+   +--++.+.+.+..+.+..|+||||++-|.+.
T Consensus        27 G~inea~~v~dg~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceeEeecCCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3454443 223 467889988877778888887666554   4467888999999999999999999876654

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.31  E-value=0.0065  Score=44.99  Aligned_cols=34  Identities=32%  Similarity=0.379  Sum_probs=21.4

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 022118            4 TLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVS   37 (302)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   37 (302)
                      +-+++++|++|+++.+++++++++||.+|++++.
T Consensus        62 s~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~   95 (122)
T PF01102_consen   62 SEPAIIGIIFGVMAGVIGIILLISYCIRRLRKKS   95 (122)
T ss_dssp             S-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred             cccceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence            4456777777777766666677777776666554

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.93  E-value=0.029  Score=49.67  Aligned_cols=72  Identities=18%  Similarity=0.186  Sum_probs=53.7

Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      ...|++|++. |+.+..         ...-.+.+...++.+.+.-+.-+.. .-+.=|||+.-.||||+ +|.+.|+||-
T Consensus       299 ~y~yl~~kdh-gt~is~---------ik~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPISI---------IKADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceeee---------eecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEee
Confidence            3456777764 445431         2234577888888887776666655 35689999999999999 9999999999


Q ss_pred             cccc
Q 022118          223 LRNF  226 (302)
Q Consensus       223 la~~  226 (302)
                      +++.
T Consensus       367 lsRl  370 (488)
T COG5072         367 LSRL  370 (488)
T ss_pred             eeec
Confidence            9984

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.92  E-value=0.075  Score=46.63  Aligned_cols=31  Identities=19%  Similarity=0.189  Sum_probs=27.8

Q ss_pred             CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       196 ~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      .+++|+|+.+.|+++++++.+.+.||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4699999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=95.89  E-value=0.12  Score=46.07  Aligned_cols=140  Identities=15%  Similarity=0.152  Sum_probs=75.3

Q ss_pred             CeeeeCCCeeEEEEEEcC-----CcEEEEEecCCCChH--HHHHHHHHhccCCCCce-eeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ..+-.|-...+|+....+     +..+++|........  +-.+|..+++.+..-++ .++++.+.. +   .|.||+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            344446677889887432     357888876543221  12568888777743222 344555432 2   57999987


Q ss_pred             CCcccc-c----------------cCCCcCCCc-ccCHHHHHHHHHH-----------------HHHHHHH----hhc--
Q 022118          155 GSVSIH-L----------------YGPSQVSRQ-KLEFKHRLSIALG-----------------AAKGLAH----LHS--  193 (302)
Q Consensus       155 g~L~~~-l----------------~~~~~~~~~-~~~~~~~~~~~~~-----------------i~~~l~~----LH~--  193 (302)
                      .++... +                +........ ...+.++..+..+                 +...+..    +..  
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421 1                111000011 1112222222211                 1111111    111  


Q ss_pred             CCCCceecCCCCCCeeeCC-CCceEEcccccccc
Q 022118          194 LSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNF  226 (302)
Q Consensus       194 ~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~  226 (302)
                      ....++|+|+++.||++++ ++.+.+.||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1235899999999999976 47899999998764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.62  E-value=0.12  Score=45.70  Aligned_cols=141  Identities=18%  Similarity=0.209  Sum_probs=80.9

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCC-C--Cc---eeeEEeEE----eeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQ-H--RN---LVTLLGYC----QENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~-H--~n---Iv~l~~~~----~~~~~~~lv~e~  151 (302)
                      ..|.+ .-..+|+....++.. ++|..... ...+...|...+..+. +  +=   +.++-|-.    ..+...+-+.+|
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccccc-ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            33444 456788888877776 88887664 5566777888877662 1  11   23332221    111266788999


Q ss_pred             cCCCCccc-ccc------------------CCC--cC-CCcccCHHH----H---------HHHHHHHHHHHHHhhcC--
Q 022118          152 IPNGSVSI-HLY------------------GPS--QV-SRQKLEFKH----R---------LSIALGAAKGLAHLHSL--  194 (302)
Q Consensus       152 ~~~g~L~~-~l~------------------~~~--~~-~~~~~~~~~----~---------~~~~~~i~~~l~~LH~~--  194 (302)
                      ++|..+.. ...                  +-.  +. ......|..    .         .....++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988773 110                  000  00 111122220    0         11223334444444431  


Q ss_pred             ----CCC--ceecCCCCCCeeeCCCCc-eEEccccccc
Q 022118          195 ----SPR--VVHKDFKTANVLVDEDFI-AKVADAGLRN  225 (302)
Q Consensus       195 ----~~~--ivHrdlkp~Nill~~~~~-~kl~DfGla~  225 (302)
                          +.+  +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                123  899999999999998884 8999999764

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.44  E-value=0.069  Score=48.25  Aligned_cols=71  Identities=14%  Similarity=0.147  Sum_probs=46.9

Q ss_pred             CCeeeeCCCeeEEEEEEcC-CcEEEEEecC---------CCChHHHHHHHHHhccCC--CC-ceeeEEeEEeeCCeeeEE
Q 022118           82 KNLIGEGKFGEVYKGLLQD-GMLVAIKKRP---------GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~---------~~~~~~~~~E~~~l~~l~--H~-nIv~l~~~~~~~~~~~lv  148 (302)
                      .+.||.|.-.-||++...+ +..++||...         +...++..-|.+.|+...  -| .+.+++.+-  +....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence            4679999999999999753 5678998411         223455666777776552  23 566666553  3445688


Q ss_pred             EeccCC
Q 022118          149 YEYIPN  154 (302)
Q Consensus       149 ~e~~~~  154 (302)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998853

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.36  E-value=0.043  Score=49.41  Aligned_cols=122  Identities=20%  Similarity=0.151  Sum_probs=69.3

Q ss_pred             CeeeeCCCeeEEEEEEc----------------CCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEE------
Q 022118           83 NLIGEGKFGEVYKGLLQ----------------DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC------  139 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~----------------~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~------  139 (302)
                      ..||.|+-+.||+|..+                ..+.+|+|...+...+.+.....+|... +-+|++.-..|.      
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v  274 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV  274 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence            67999999999998632                1246999987666655555444444332 111222111111      


Q ss_pred             ---------------------------e-------------eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHH
Q 022118          140 ---------------------------Q-------------ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS  179 (302)
Q Consensus       140 ---------------------------~-------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  179 (302)
                                                 .             -.....++-+|..|-++..++..      ...++.....
T Consensus       275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~------~~~pe~l~kk  348 (565)
T KOG1236|consen  275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKW------KSQPEALVKK  348 (565)
T ss_pred             HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhc------ccChHHHHHH
Confidence                                       0             00122456677777777777632      2223334444


Q ss_pred             HHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 022118          180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (302)
Q Consensus       180 ~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~  211 (302)
                      ++.--+.|+.-+--. .+++|.|+.|.||++-
T Consensus       349 va~lg~~AllkMl~v-DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  349 VAKLGVNALLKMLIV-DNFVHADLHPGNVLIR  379 (565)
T ss_pred             HHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence            554444555433322 3599999999999994

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.22  E-value=0.55  Score=41.55  Aligned_cols=70  Identities=16%  Similarity=0.170  Sum_probs=43.0

Q ss_pred             CCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCC--CceeeE---Ee--EEeeCCeeeEEEeccCCCCc
Q 022118           88 GKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQH--RNLVTL---LG--YCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        88 G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H--~nIv~l---~~--~~~~~~~~~lv~e~~~~g~L  157 (302)
                      +.-..||+....++..+++|.....  .......|.+.+..|..  -.++..   -|  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            3456799988877888999976533  34556678777765521  112221   11  12234566789999987653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.04  E-value=0.2  Score=44.46  Aligned_cols=30  Identities=17%  Similarity=0.286  Sum_probs=25.8

Q ss_pred             CceecCCCCCCeeeCC-CCceEEcccccccc
Q 022118          197 RVVHKDFKTANVLVDE-DFIAKVADAGLRNF  226 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~-~~~~kl~DfGla~~  226 (302)
                      -.+|.|+-+.||++++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            3799999999999974 57899999998754

>COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis]

Probab=94.80  E-value=0.32  Score=40.29  Aligned_cols=127  Identities=21%  Similarity=0.224  Sum_probs=84.2

Q ss_pred             eeeeCCC-eeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC-----CCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           84 LIGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-----QHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        84 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      .+..|.. +.||+-.-...--+-+|.........+..|.+.++=+     ..|.|   .++-.+.+..||+|+-++|.++
T Consensus        25 ~v~~geS~~~v~rl~a~~r~g~~~k~~~~~~~a~L~~Ea~RlrWla~~~l~~P~V---~~~~~~~~~~wLl~salpG~~~  101 (266)
T COG3231          25 RVTEGESGAGVFRLFADSRPGLYLKIASSGPAAELEGEAARLRWLAGQGLGCPRV---LGLEDDADQAWLLMSALPGEDA  101 (266)
T ss_pred             eeeccCCCCeEEEEeccCCCceEEEEecCcchhhhhhHHHHHHHhcccCCCCCce---EeeccCcchhHHhhhhcCCCcc
Confidence            4555544 4577655444445677777777778888898877644     34544   4455557778999999999876


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS------------------------------------------  195 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------------------------------------  195 (302)
                      ...-        ..++.+   ..+--++.+|..||++.                                          
T Consensus       102 s~~~--------~~~~p~---r~v~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~E  170 (266)
T COG3231         102 SHPR--------YALDPK---RAVPLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEE  170 (266)
T ss_pred             cchh--------hcCCHH---HHHHHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHH
Confidence            5322        223333   23445677788888642                                          


Q ss_pred             --------------CCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          196 --------------PRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       196 --------------~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                                    .-+.|+|-..-|++++...---.+|+|-.
T Consensus       171 l~d~L~~~rp~~edLVv~HGDACLPN~i~d~~rf~GfIDlGrl  213 (266)
T COG3231         171 LFDELEARRPAVEDLVVTHGDACLPNFILDGWRFSGFIDLGRL  213 (266)
T ss_pred             HHHHHHhcCCchhhceeecCcccCcceEecCCceEEeeecCcc
Confidence                          13789999999999998866667777743

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.67  E-value=0.0095  Score=44.40  Aligned_cols=44  Identities=18%  Similarity=0.268  Sum_probs=39.0

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhcc
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS  126 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~  126 (302)
                      +.|+.|+.|.||+|++.+|+.||||...+...+.+..++.+|+.
T Consensus        17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEADLRILRR   60 (119)
T ss_pred             chhhheehhhheeeeecccchhhhhhcchHHHHHHHHHHHHHHH
Confidence            67999999999999999999999999888888888878777764

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK06148 hypothetical protein; Provisional

Probab=94.60  E-value=0.65  Score=47.62  Aligned_cols=142  Identities=18%  Similarity=0.197  Sum_probs=76.2

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-hHHHHHHHHHhccC-------CCCceeeEE-e----EEee-CC--eee
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASI-------QHRNLVTLL-G----YCQE-NN--LQF  146 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l-------~H~nIv~l~-~----~~~~-~~--~~~  146 (302)
                      +.|+ |..-.+|+....++..+++|...... ......|...+..|       .-|.+++-. |    .... ++  ..+
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v  109 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL  109 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence            4454 45577898887778889999876443 33444555555444       223333321 1    1111 22  346


Q ss_pred             EEEeccCCCCcccccc---------------------CCCcC-CCcccCHH-----------------HHHHHHHHHHHH
Q 022118          147 LIYEYIPNGSVSIHLY---------------------GPSQV-SRQKLEFK-----------------HRLSIALGAAKG  187 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~---------------------~~~~~-~~~~~~~~-----------------~~~~~~~~i~~~  187 (302)
                      -+++|++|..+.....                     .-... ....+.|.                 ....++.++...
T Consensus       110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~  189 (1013)
T PRK06148        110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR  189 (1013)
T ss_pred             EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence            6899999877654110                     00000 01111111                 111222222222


Q ss_pred             HH-----HhhcCCCCceecCCCCCCeeeCCCC--ce-EEccccccc
Q 022118          188 LA-----HLHSLSPRVVHKDFKTANVLVDEDF--IA-KVADAGLRN  225 (302)
Q Consensus       188 l~-----~LH~~~~~ivHrdlkp~Nill~~~~--~~-kl~DfGla~  225 (302)
                      ..     .+.+...++||.|+.+.|||++.++  .+ -|.|||-+.
T Consensus       190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            21     2333335699999999999999875  45 499999764

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.37  E-value=0.056  Score=47.30  Aligned_cols=53  Identities=25%  Similarity=0.248  Sum_probs=35.2

Q ss_pred             HHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCCeee-CCC-----------------CceEEccccccccc
Q 022118          175 KHRLSIALGAAKGLAHLHSL--SPRVVHKDFKTANVLV-DED-----------------FIAKVADAGLRNFL  227 (302)
Q Consensus       175 ~~~~~~~~~i~~~l~~LH~~--~~~ivHrdlkp~Nill-~~~-----------------~~~kl~DfGla~~~  227 (302)
                      .-+..+..|++.-.-.+.+.  ...++|-||||+|||+ |++                 -.++|.||.+++..
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  351 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA  351 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence            44567778887665444332  2359999999999998 222                 23567788777643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	302
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-31
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-29
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/226 (35%), Positives = 124/226 (54%), Gaps = 7/226 (3%)
Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-- 115
           E+ + + +RF + EL +A+ NF +KN++G G FG+VYKG L DG LVA+K+     TQ  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 129
Query: 174 FKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
           +  R  I                P+++H+D K AN+L+DE+F A V D GL   +   D 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
               + V      +A E     + SEK+DV+ +GV LLEL++G+ A
Sbjct: 190 HVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  130 bits (327), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 81/226 (35%), Positives = 124/226 (54%), Gaps = 7/226 (3%)
Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK----RPGAP 113
           E+ + + +RF + EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+    R    
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 114 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 79  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 137
Query: 174 FKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
           +  R  I                P+++H+D K AN+L+DE+F A V D GL   +   D 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
               + V      +A E     + SEK+DV+ +GV LLEL++G+ A
Sbjct: 198 HVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 242

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 81/219 (36%), Positives = 120/219 (54%), Gaps = 6/219 (2%)
Query: 63  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 119
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG S +    + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           I                 ++H+D K+ N+L+DE+F+ K+ D G+       D       V
Sbjct: 144 ICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
                ++  E     R +EKSDVYSFGV L E++  R A
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/222 (37%), Positives = 124/222 (55%), Gaps = 12/222 (5%)
Query: 63  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 119
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG S +    + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR---NFLGRTDVAGPS 236
           I                 ++H+D K+ N+L+DE+F+ K+ D G+      LG+T +    
Sbjct: 144 ICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX--- 198
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
             V     ++  E     R +EKSDVYSFGV L E++  R A
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 111/238 (46%), Gaps = 19/238 (7%)
Query: 54  NVGIELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIK 107
           N  +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 108 KRPGAPT-------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 160
           K             Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 161 LYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVAD 220
           L          L +  R  I                  +H+D K+AN+L+DE F AK++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISD 176
Query: 221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
            GL     +       S++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 54  NVGIELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIK 107
           N  +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 108 KRPGAPT-------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 160
           K             Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 161 LYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVAD 220
           L          L +  R  I                  +H+D K+AN+L+DE F AK++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISD 176
Query: 221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
            GL     +        ++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 67  FQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT------ 114
           F   EL   T NF ++      N +GEG FG VYKG + +   VA+KK            
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 115 -QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
            Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   L          L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLS 125
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           +  R  I                  +H+D K+AN+L+DE F AK++D GL     +    
Sbjct: 126 WHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
               ++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 102/225 (45%), Gaps = 19/225 (8%)
Query: 67  FQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT------ 114
           F   EL   T NF ++      N  GEG FG VYKG + +   VA+KK            
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 115 -QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
            Q+F  E+   A  QH NLV LLG+  + +   L+Y Y PNGS+   L          L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPPLS 122
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           +  R  I                  +H+D K+AN+L+DE F AK++D GL     +    
Sbjct: 123 WHXRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
              S++     + A E       + KSD+YSFGV LLE+++G  A
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 224

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
           +++ +   + + K  IG G FG V++     G  VA+K             EF+ EV  +
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 125 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 181
             ++H N+V  +G   Q  NL  ++ EY+  GS+   +H  G    +R++L+ + RLS+ 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMA 143
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                         P +VH++ K+ N+LVD+ +  KV D GL      T ++  S+  T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  ++A EV      +EKSDVYSFGV L EL +
Sbjct: 204 E--WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 11/223 (4%)
Query: 56  GIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGA 112
           G++L         M++  +   + + K+ +G G++GEVY G+ +   + VA+K  K    
Sbjct: 11  GVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM 70
Query: 113 PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL 172
             +EF+ E   +  I+H NLV LLG C      +++ EY+P G++  +L    + +R+  
Sbjct: 71  EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL---RECNRE-- 125
Query: 173 EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 231
           E    + +                  +H+D    N LV E+ + KVAD GL R   G T 
Sbjct: 126 EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY 185
Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A   ++      + A E   +  FS KSDV++FGV L E+ +
Sbjct: 186 TAHAGAKFPIK--WTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 125
           +++  +   + + K+ +G G+FGEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEI 244
                        +H+D    N LV E+ + KVAD GL R   G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-- 175
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 125
           +++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEI 244
                        +H+D    N LV E+ + KVAD GL R   G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-- 175
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
           +++ +   + + K  IG G FG V++     G  VA+K             EF+ EV  +
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 125 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 181
             ++H N+V  +G   Q  NL  ++ EY+  GS+   +H  G    +R++L+ + RLS+ 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMA 143
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                         P +VH+D K+ N+LVD+ +  KV D GL        +    +  T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  ++A EV      +EKSDVYSFGV L EL +
Sbjct: 204 E--WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 129
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLAY 187
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLAS 126
           ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 186
           I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +      
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQI 125
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIF 245
                       +H+D    N LV E+ + KVAD GL   + G T  A   ++      +
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--W 183
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A E   + +FS KSDV++FGV L E+ +
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 125
           +++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEI 244
                        +H+D    N LV E+ + KVAD GL R   G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-- 175
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 186
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLAS 126
           ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 186
           I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +      
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQI 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
                       +H+D    N LV E+ + KVAD GL R   G T  A   ++      +
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--W 178
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A E   + +FS KSDV++FGV L E+ +
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 186
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLAS 126
           ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 186
           I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +      
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQI 125
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
                       +H+D    N LV E+ + KVAD GL R   G T  A   ++      +
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--W 183
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A E   + +FS KSDV++FGV L E+ +
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 129
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--WTAPESLAY 187
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 186
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 186
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 130
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 188
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 66  RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVC 122
           +++ME   +  K+      +G G++GEVY+G+ +   + VA+K  K      +EF+ E  
Sbjct: 12  KWEMERTDITMKH-----KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA 66
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            +  I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +  
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYM 121
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 241
                           +H+D    N LV E+ + KVAD GL R   G T  A   ++   
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              + A E   + +FS KSDV++FGV L E+ +
Sbjct: 182 K--WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 130
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--WTAPESLAY 188
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   + +FS
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 203
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 186
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLE 133
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 191
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLAS 126
           ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 186
           I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +      
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQI 124
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
                       +H+D    N LV E+ + KVAD GL R   G T  A   ++      +
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--W 182
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A E   + +FS KSDV++FGV L E+ +
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 133
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 191
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LLG C      ++I E++  G++  +L    + +RQ  E    + +              
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLE 130
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +H+D    N LV E+ + KVAD GL R   G T  A   ++      + A E   +
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 188
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +FS KSDV++FGV L E+ +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 75  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 187 VWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 78  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 190 VWSFGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 75  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 187 VWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 73  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 185 VWSFGVLMWEVFS 197

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 66  RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVC 122
           +++ME   +  K+      +G G++GEVY+G+ +   + VA+K  K      +EF+ E  
Sbjct: 214 KWEMERTDITMKH-----KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA 268
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            +  I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +  
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYM 323
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTA 241
                           +H++    N LV E+ + KVAD GL   + G T  A   ++   
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              + A E   + +FS KSDV++FGV L E+ +
Sbjct: 384 K--WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 66  RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVC 122
           +++ME   +  K+      +G G++GEVY+G+ +   + VA+K  K      +EF+ E  
Sbjct: 253 KWEMERTDITMKH-----KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA 307
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            +  I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +  
Sbjct: 308 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYM 362
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTA 241
                           +H++    N LV E+ + KVAD GL   + G T  A   ++   
Sbjct: 363 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 422
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              + A E   + +FS KSDV++FGV L E+ +
Sbjct: 423 K--WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V I K    PT    Q F +EV  L   +H N++  +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           ++NL  ++ ++    S+  HL+       Q+ +F+    I                 ++H
Sbjct: 103 KDNLA-IVTQWCEGSSLYKHLH------VQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + E    K+ D GL     R   +    Q T   +++A EV   ++   FS
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 258 EKSDVYSFGVFLLELVSG 275
            +SDVYS+G+ L EL++G
Sbjct: 216 FQSDVYSYGIVLYELMTG 233

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L+ E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 76  APICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 188 VWSFGVLMWEVFS 200

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           +  L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 79  KPQLA-IVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS--IIH 131
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 258 EKSDVYSFGVFLLELVSGR 276
            +SDVY+FG+ L EL++G+
Sbjct: 192 FQSDVYAFGIVLYELMTGQ 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           +  L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 91  KPQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 143
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 258 EKSDVYSFGVFLLELVSGR 276
            +SDVY+FG+ L EL++G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  K       +FI+E   +  + H  LV L G C E 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 95  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 262 VYSFGVFLLELVS 274
           V+SFGV + E+ S
Sbjct: 207 VWSFGVLMWEVFS 219

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
              L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 91  APQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 143
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 258 EKSDVYSFGVFLLELVSGR 276
            +SDVY+FG+ L EL++G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 78  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQ 128
           N   K  +GEG FG+V+          QD +LVA+K    A     ++F  E   L ++Q
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQV----SRQKLEFKHRLSIXX 182
           H ++V   G C E +   +++EY+ +G ++  +  +GP  V         E      +  
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D  T N LV E+ + K+ D G+   +  TD           
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++  E   +R+F+ +SDV+S GV L E+ +
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  I+H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 83  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 132
            ++G G FG VYKG+ + +G    + VAIK       P A   EF+DE   +AS+ H +L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHL 102
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           V LLG C    +Q L+ + +P+G +         V   K     +L +            
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLL------EYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLA 247
               R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMA 210
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   +R+F+ +SDV+S+GV + EL++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 185
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 140 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 198 MPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 185
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 185
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 146 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 204 MPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETG---KYLRLPQLVDMSAQIASGMAYVERM--NYVHRD 136
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L       
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 143 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
              ++I EY+  GS+   L    G   +  + ++F  +++                   +
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA--------EGMAYIERKNYI 132
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 253
           H+D + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINF 185
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             F+ KSDV+SFG+ L E+V+
Sbjct: 186 GCFTIKSDVWSFGILLYEIVT 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           ++G G FG VYKG+ + +G    + VAIK       P A   EF+DE   +AS+ H +LV
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHLV 80
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            LLG C    +Q L+ + +P+G +         V   K     +L +             
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLL------EYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLAS 248
              R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A 
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMAL 188
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E   +R+F+ +SDV+S+GV + EL++
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 79  PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 132
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 191 VWSFGILLTELTT 203

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 82  KNLIGEGKFGEVYKG------LLQDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 132
           K  +GEG FG+V+          +D MLVA+K  K P  A  ++F  E   L ++QH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP-------SQVSRQKLEFKHRLSIXXX 183
           V   G C + +   +++EY+ +G ++  +  +GP        Q  + K E      +   
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                          VH+D  T N LV  + + K+ D G+   +  TD            
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 118
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 80
Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 81  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 135
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 136 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 239 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 118
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 22  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 79
Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 80  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 134
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 135 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 239 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 75  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 82  KNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNL 132
           + +IG G+FGEVYKG+L+       + VAIK      T+    +F+ E   +    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXX 191
           + L G   +     +I EY+ NG++   L       R+K  EF     +           
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-------REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEV 250
                  VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A E 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             +R+F+  SDV+SFG+ + E+++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 388
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 447 VWSFGILLTELTT 459

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 77  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVCEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 76  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 128
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 189 SFQSDVYAFGIVLYELMTGQ 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETG---KYLRLPQLVDMSAQIASGMAYVERM--NYVHRD 136
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 101/233 (43%), Gaps = 24/233 (10%)
Query: 46  EPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVA 105
           +P V  G     +   R      M+EL L          IG+G+FG+V  G  + G  VA
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLL-------QTIGKGEFGDVMLGDYR-GNKVA 220
Query: 106 IKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYG 163
           +K  +  A  Q F+ E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L  
Sbjct: 221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR- 279
Query: 164 PSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
               SR +        +                  VH+D    NVLV ED +AKV+D GL
Sbjct: 280 ----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 224 RNFLGRTDVAG--PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                 T   G  P         + A E    ++FS KSDV+SFG+ L E+ S
Sbjct: 336 TKEASSTQDTGKLPVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVGEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 131
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 131
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            +  ++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 76  PIX-IVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 129
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 188 VWSFGILLTELTT 200

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFID 119
            RR   ++  +     +    IG G FG VYKG     + V +     APT    Q F +
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKN 81
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    + 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLID 136
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q+
Sbjct: 137 IARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 194
Query: 240 TADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           +   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 140
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 193
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 194 TIKSDVWSFGILLTEIVT 211

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D   AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 86  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 139
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 192
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 193 TIKSDVWSFGILLTEIVT 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 89  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 142
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 195
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 196 TIKSDVWSFGILLTEIVT 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 140
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 193
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 194 TIKSDVWSFGILLTEIVT 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
               L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TAPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 81
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 82  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 135
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 188
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 189 TIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 118
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 15  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 72
Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 73  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 127
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 128 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 239 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 90  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 143
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 196
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 197 TIKSDVWSFGILLTEIVT 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 90
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 91  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 144
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 198 TIKSDVWSFGILLTEIVT 215

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 83  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 136
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 189
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 190 TIKSDVWSFGILLTEIVT 207

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 253 PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 363 SDVWSFGILLTELTT 377

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 76  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 129
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 183 TIKSDVWSFGILLTEIVT 200

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VAIK  +PG  + E F++E   +  ++H  LV L     E 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEE 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L        + L+  + + +                  +H+D
Sbjct: 77  PI-YIVTEYMNKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRD 130
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            ++AN+LV    I K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L ELV+
Sbjct: 189 VWSFGILLTELVT 201

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDE 120
           R      M+EL L          IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E
Sbjct: 13  RSGWALNMKELKLL-------QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE 64
Query: 121 VCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
              +  ++H NLV LLG   +E    +++ EY+  GS+  +L      SR +        
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCL 119
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSS 237
           +                  VH+D    NVLV ED +AKV+D GL      T   G  P  
Sbjct: 120 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 179
Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                  + A E    ++FS KSDV+SFG+ L E+ S
Sbjct: 180 -------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  G +   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVMEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  G +   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQEN 142
           IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   +E 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
              +++ EY+  GS+  +L      SR +        +                  VH+D
Sbjct: 73  GGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSSQVTADEIFLASEVKEFRRFSEKS 260
               NVLV ED +AKV+D GL      T   G  P         + A E    ++FS KS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKFSTKS 180
Query: 261 DVYSFGVFLLELVS 274
           DV+SFG+ L E+ S
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L     + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 143 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
              ++I E++  GS+   L    G   +  + ++F  +++                   +
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA--------EGMAYIERKNYI 131
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 253
           H+D + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINF 184
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             F+ KS+V+SFG+ L E+V+
Sbjct: 185 GCFTIKSNVWSFGILLYEIVT 205

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 19/204 (9%)
Query: 82  KNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G  GEV  G L    Q  + VAIK      T+    +F+ E   +    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G      L  ++ EY+ NGS+   L           +F     +             
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL------RTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
                VH+D    NVLVD + + KV+D GL   L   D    +   T  +I   + A E 
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             FR FS  SDV+SFGV + E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H++
Sbjct: 77  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRN 130
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 184 TIKSDVWSFGILLTEIVT 201

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 19/204 (9%)
Query: 82  KNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G  GEV  G L    Q  + VAIK      T+    +F+ E   +    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G      L  ++ EY+ NGS+   L           +F     +             
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL------RTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
                VH+D    NVLVD + + KV+D GL   L   D    +   T  +I   + A E 
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             FR FS  SDV+SFGV + E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++TLLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 92  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV++  + KV+D GL R  L   + +   S+      +   EV  + +FS
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR--WSPPEVLMYSKFS 199
Query: 258 EKSDVYSFGVFLLELVS 274
            KSD+++FGV + E+ S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 141 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 77  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFS 257
           +H+D    N LV++  + KV+D GL  ++   D    SS+ +   + +   EV  + +FS
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 258 EKSDVYSFGVFLLELVS 274
            KSD+++FGV + E+ S
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 145 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 202
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 203 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 149 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 206
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 207 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 148 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 205
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 206 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 197 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+ GEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DAEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+E     + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 76  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 125
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 181
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 182 FSSKSDIWAFGVLMWEIYS 200

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 77  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 182
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           + PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV L E+ +
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 92  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 197
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 83  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 188
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 189 FSSKSDIWAFGVLMWEIYS 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 72  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 177
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 178 FSSKSDIWAFGVLMWEIYS 196

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   ++    +I E++ NGS+       S + +   +F     +             
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 151
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADEI---FLASE 249
                VH+D    N+LV+ + + KV+D GL  FL   D + P+ +     +I   + A E
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             ++R+F+  SDV+S+G+ + E++S
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 31/238 (13%)
Query: 61  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRP 110
           I + ++ +++E+SL+   F ++  +GE +FG+VYKG L      +    VAIK    K  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 111 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--------Y 162
           G   +EF  E    A +QH N+V LLG   ++    +I+ Y  +G +   L         
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 163 GPSQVSR------QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 216
           G +   R      +  +F H ++                  VVHKD  T NVLV +    
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVA-----QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184
Query: 217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           K++D GL   +   D             ++A E   + +FS  SD++S+GV L E+ S
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQEN 142
           IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   +E 
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 78
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
              +++ EY+  GS+  +L      SR +        +                  VH+D
Sbjct: 79  GGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
               NVLV ED +AKV+D GL      T D      + TA E    +       FS KSD
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAA------FSTKSD 187
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L E+ S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 150 TYQLARGMEYLASQ--KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 208 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 155 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 213 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 152 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 210 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 50/225 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 134 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 177
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 134
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 229
             +                + +H+D    N+LV E+++AK+AD GL        +  +GR
Sbjct: 135 --LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 192
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             V            ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 193 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 50/225 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 134 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 177
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 144
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 229
             +                + +H+D    N+LV E+++AK+AD GL        +  +GR
Sbjct: 145 --LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             V            ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 203 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 209 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE- 116
           +S +  + ++ +   +  ++   +  +G G+FGEV+         VA+K  +PG+ + E 
Sbjct: 164 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 223
Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F+ E   + ++QH  LV L     +  + ++I E++  GS+ +      + S+Q L    
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL-LDFLKSDEGSKQPLP--- 278
Query: 177 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           +L I                  +H+D + AN+LV    + K+AD GL     +  +    
Sbjct: 279 KL-IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK--- 334
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                   + A E   F  F+ KSDV+SFG+ L+E+V+
Sbjct: 335 --------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + ++AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE- 116
           +S +  + ++ +   +  ++   +  +G G+FGEV+         VA+K  +PG+ + E 
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 229
Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F+ E   + ++QH  LV L     +  + ++I E++  GS+ +      + S+Q L    
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL-LDFLKSDEGSKQPLP--- 284
Query: 177 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           +L I                  +H+D + AN+LV    + K+AD GL   +         
Sbjct: 285 KL-IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI-------ED 336
Query: 237 SQVTADE------IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++ TA E       + A E   F  F+ KSDV+SFG+ L+E+V+
Sbjct: 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D  LVA+K      P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +    +++ E +  G     L    +    +L  K  L +                  +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E  + K++D G+      G    +G   QV     + A E   + R+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK--WTAPEALNYGRYS 293
Query: 258 EKSDVYSFGVFLLELVS 274
            +SDV+SFG+ L E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEF 117
           +++E+SL+   F ++  +GE +FG+VYKG L      +    VAIK    K  G   +EF
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--------YGPSQVSR 169
             E    A +QH N+V LLG   ++    +I+ Y  +G +   L         G +   R
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 170 ------QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                 +  +F H ++                  VVHKD  T NVLV +    K++D GL
Sbjct: 120 TVKSALEPPDFVHLVA-----QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +   D             ++A E   + +FS  SD++S+GV L E+ S
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 41/214 (19%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV +G L+        VAIK   G  T+    EF+ E   +   +H N++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 136 LGYCQENNLQFLIYEYIPNGSVS------------IHLYGPSQVSRQKLEFKHRLSIXXX 183
            G    +    ++ E++ NG++             I L G  +     + +   +S    
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---- 138
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                          VH+D    N+LV+ + + KV+D GL  FL         +     +
Sbjct: 139 --------------YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 244 I---FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           I   + A E   FR+F+  SD +S+G+ + E++S
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 30  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 89
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 143
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 35/227 (15%)
Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FID 119
           ++A     E L L  K       +G G+FGEV+         VA+K  +PG+ + E F+ 
Sbjct: 7   KDAWEIPRESLKLEKK-------LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA 59
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKH 176
           E   + ++QH  LV L     +  + ++I E++  GS+   L    G  Q   + ++F  
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 118
Query: 177 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           +++                   +H+D + AN+LV    + K+AD GL   +         
Sbjct: 119 QIA--------EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE-------D 163
Query: 237 SQVTADE------IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GR 276
           ++ TA E       + A E   F  F+ KSDV+SFG+ L+E+V+ GR
Sbjct: 164 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV +G L+        VAIK   G  T+    EF+ E   +   +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS------------IHLYGPSQVSRQKLEFKHRLSIX 181
            L G    +    ++ E++ NG++             I L G  +     + +   +S  
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 136
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                            VH+D    N+LV+ + + KV+D GL  FL         +    
Sbjct: 137 ----------------YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 242 DEI---FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            +I   + A E   FR+F+  SD +S+G+ + E++S
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 126
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 109 GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 84  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 85  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D  LVA+K      P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +    +++ E +  G     L    +    +L  K  L +                  +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E  + K++D G+      G    +G   QV     + A E   + R+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--WTAPEALNYGRYS 293
Query: 258 EKSDVYSFGVFLLELVS 274
            +SDV+SFG+ L E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 77  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I  Y   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 82  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 83  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 40  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 99
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 153
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 154 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G   ++    ++ EY+ NGS+   L       +   +F     +               
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL------KKNDGQFTVIQLVGMLRGISAGMKYLSD 142
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 254
              VH+D    N+L++ + + KV+D GL   L     A  +++     I + A E   FR
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 255 RFSEKSDVYSFGVFLLELVS 274
           +F+  SDV+S+G+ + E+VS
Sbjct: 203 KFTSASDVWSYGIVMWEVVS 222

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   ++    +I E++ NGS+       S + +   +F     +             
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADEI---FLASE 249
                VH+     N+LV+ + + KV+D GL  FL   D + P+ +     +I   + A E
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             ++R+F+  SDV+S+G+ + E++S
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 50/225 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 134 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 177
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 141
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 229
             +                + +H++    N+LV E+++AK+AD GL        +  +GR
Sbjct: 142 --LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 199
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             V            ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 200 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I  Y   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++A E    R ++ +SDV+SFGV + E+ +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 34/206 (16%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +GEG +G VYK + ++ G +VAIK+ P  +  QE I E+  +      ++V   G   +N
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 143 NLQFLIYEYIPNGSVS--IHLYGPS----------QVSRQKLEFKHRLSIXXXXXXXXXX 190
              +++ EY   GSVS  I L   +          Q + + LE+ H +            
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM------------ 144
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                 R +H+D K  N+L++ +  AK+AD G+   L  TD     + V     ++A EV
Sbjct: 145 ------RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEV 196
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
            +   ++  +D++S G+  +E+  G+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VA+K  K       EF  E   +  + H  LV   G C + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 143 NLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
              +++ EYI NG +  +L  +G      Q LE  + +                  + +H
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC--------EGMAFLESHQFIH 127
Query: 201 KDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           +D    N LVD D   KV+D G+ R  L    V+   ++      + A EV  + ++S K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--WSAPEVFHYFKYSSK 185
Query: 260 SDVYSFGVFLLELVS 274
           SDV++FG+ + E+ S
Sbjct: 186 SDVWAFGILMWEVFS 200

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L    Q   ++++  H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYL----QAHAERID--HIKLLQYTSQICKGMEYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++        +S+      ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEVYK---GLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI E++P GS+  +L       + K    H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEFLPYGSLREYL------QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 67  FQMEELSLATKNFSDK---------NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP 113
           F  E+ + A + F+ +          +IG G+FGEV  G L+      + VAIK      
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 114 T----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           T    ++F+ E   +    H N++ L G   +     +I EY+ NGS+   L       +
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL------RK 123
Query: 170 QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
               F     +                  VH+D    N+LV+ + + KV+D G+   L  
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 230 TDVAGPSSQVTADEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              A  +++     I + A E   +R+F+  SDV+S+G+ + E++S
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 79  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H++  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +FS  SDV+SFGV L EL +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T    ++F+ E   +    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   +     +I EY+ NGS+   L       +    F     +             
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFL------RKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 252
                VH+D    N+LV+ + + KV+D G+   L     A  +++     I + A E   
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
           +R+F+  SDV+S+G+ + E++S
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T    ++F+ E   +    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   +     +I EY+ NGS+   L       +    F     +             
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFL------RKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 252
                VH+D    N+LV+ + + KV+D G+   L     A  +++     I + A E   
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
           +R+F+  SDV+S+G+ + E++S
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMS 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 81  DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLL 136
           D+ ++G+G +G VY G  L + + +AIK+ P      +Q   +E+     ++H+N+V  L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G   EN    +  E +P GS+S  L   +GP + + Q + F  +  +             
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---- 141
Query: 194 XXPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-- 250
              ++VH+D K  NVL++    + K++D G    L   +    +   T    ++A E+  
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIID 196
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
           K  R + + +D++S G  ++E+ +G+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 74
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 127
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 83  NLIGEGKFGEVYKGL-LQDG-------MLVAIKKRPGAPT-QEFIDEVCFLASIQHRNLV 133
            ++G G FG V+KG+ + +G        +  I+ + G  + Q   D +  + S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            LLG C  ++LQ L+ +Y+P GS+  H      V + +     +L +             
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDH------VRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +VH++    NVL+      +VAD G+ + L   D     S+      ++A E   F
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +++ +SDV+S+GV + EL++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 71
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDY------VREHKDNIGSQYLLNWC 124
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 83  NLIGEGKFGEVYKGL-LQDG-------MLVAIKKRPGAPT-QEFIDEVCFLASIQHRNLV 133
            ++G G FG V+KG+ + +G        +  I+ + G  + Q   D +  + S+ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            LLG C  ++LQ L+ +Y+P GS+  H      V + +     +L +             
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDH------VRQHRGALGPQLLLNWGVQIAKGMYYL 149
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +VH++    NVL+      +VAD G+ + L   D     S+      ++A E   F
Sbjct: 150 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +++ +SDV+S+GV + EL++
Sbjct: 210 GKYTHQSDVWSYGVTVWELMT 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 85  IGEGKFGEVYK----GLL--QDGMLVAIK---KRPGAPTQ-EFIDEVCFLASIQHRNLVT 134
           IGEG FG V++    GLL  +   +VA+K   +   A  Q +F  E   +A   + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 135 LLGYCQENNLQFLIYEYIPNGSV-----SIHLYGPSQVSRQKLEFKHRLS---------- 179
           LLG C       L++EY+  G +     S+  +    +S   L  + R+S          
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 180 --IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
             +                + VH+D  T N LV E+ + K+AD GL   +   D      
Sbjct: 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234
Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                  ++  E   + R++ +SDV+++GV L E+ S
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 71
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 124
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 80  SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTL 135
            D+ ++G+G +G VY G  L + + +AIK+ P      +Q   +E+     ++H+N+V  
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           LG   EN    +  E +P GS+S  L   +GP + + Q + F  +  +            
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 193 XXXPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
               ++VH+D K  NVL++    + K++D G    L   +    +   T    ++A E+ 
Sbjct: 128 ----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEII 181
Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGR 276
            K  R + + +D++S G  ++E+ +G+
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 158
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 217
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 76
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 129
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 130 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 126
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 135
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 194
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 80
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 133
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 134 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 133
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 192
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 67
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 120
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 121 VQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 64
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 117
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 132
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 191
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDY------VREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 127
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 186
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + E   +R+F+  SDV+S+G+ L E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 95
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 148
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 149 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV      K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           ++G G FG VYKG+ + DG    + VAIK       P A  +E +DE   +A +    + 
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYVS 82
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            LLG C  + +Q L+ + +P G +  H+    + +R +L  +  L+              
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHV----RENRGRLGSQDLLNWCMQIAKGMSYLED 137
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVK 251
              R+VH+D    NVLV      K+ D GL   L    T+      +V    + L S ++
Sbjct: 138 V--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
             RRF+ +SDV+S+GV + EL++
Sbjct: 196 --RRFTHQSDVWSYGVTVWELMT 216

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 510
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 569
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 114
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 115 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 167
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 121
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 174
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVC 122
           +  +A ++     ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E  
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 66  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 118
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 176
Query: 243 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVC 122
           +  +A ++     ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E  
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 78  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 130
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 131 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 188
Query: 243 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTXLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTELCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RTDVAGPSSQVTADE 243
                     RV+H+D K  N+L+      K+AD G         RTD+ G     T D 
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD- 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 172 -YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 116
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 117 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 169
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 84  LIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTL 135
           ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E   + ++ H ++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
           +G  +E    ++I E  P G +  +L       R K   K    +               
Sbjct: 75  IGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 254
              VH+D    N+LV      K+ D GL  ++   D    S  VT   I +++ E   FR
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPIKWMSPESINFR 185
Query: 255 RFSEKSDVYSFGVFLLELVS 274
           RF+  SDV+ F V + E++S
Sbjct: 186 RFTTASDVWMFAVCMWEILS 205

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 31/243 (12%)
Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGL 97
           S P   P   +  +    E+++ Q      A ++F     +G+GKFG VY       K +
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 98  LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 157
           L   +L   +        +   EV   + ++H N++ L GY  +    +LI EY P G+V
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 158 SIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 216
              L        QKL +F  + +                 RV+H+D K  N+L+      
Sbjct: 122 YREL--------QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 173
Query: 217 KVADAGLRNFLGRTDVAGPSSQVT---ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
           K+AD G         V  PSS+ T       +L  E+ E R   EK D++S GV   E +
Sbjct: 174 KIADFGW-------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 226
Query: 274 SGR 276
            G+
Sbjct: 227 VGK 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RTDVAGPSSQVTADE 243
                     RV+H+D K  N+L+      K+AD G         RTD+ G     T D 
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD- 172
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 173 -YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLXGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 77  KNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH 129
           ++F     +G+GKFG VY       K +L   +L   +        +   EV   + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N++ L GY  +    +LI EY P G+V   L   S+   Q+       +          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR-------TATYITELANA 124
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADEIFL 246
                  RV+H+D K  N+L+  +   K+AD G         V  PSS+ T       +L
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-------SVHAPSSRRTTLCGTLDYL 177
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             E+ E R   EK D++S GV   E + G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 134
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 187
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK------KRPGAP--TQEFIDEVCFL 124
           L    F    ++G G FG VYKGL + +G  V I       +   +P   +E +DE   +
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXX 184
           AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +    
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWCV 158
Query: 185 XXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
                       R+VH+D    NVLV      K+ D GL   LG  +    +        
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 510
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV      K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 569
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDDLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E  E R   EK D++S GV   E + G+
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 121
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 234
                         P +VH+D ++ N+ +   DE+    AKVAD GL  ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            + Q  A E   A E      ++EK+D YSF + L  +++G
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTG 224

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 119
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 172
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDTLCGTL 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  ++   +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 243
                     +V+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 118 ANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 31/243 (12%)
Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGL 97
           S P   P   +  +    E+++ Q      A ++F     +G+GKFG VY       K +
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 98  LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 157
           L   +L   +        +   EV   + ++H N++ L GY  +    +LI EY P G+V
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 158 SIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 216
              L        QKL +F  + +                 RV+H+D K  N+L+      
Sbjct: 122 YREL--------QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 173
Query: 217 KVADAGLRNFLGRTDVAGPSSQ---VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
           K+AD G         V  PSS+   +     +L  E+ E R   EK D++S GV   E +
Sbjct: 174 KIADFGW-------SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 226
Query: 274 SGR 276
            G+
Sbjct: 227 VGK 229

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 153
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+ L +  D     +       ++A E  +
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT 233

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 74
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 127
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 77  KNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH 129
           ++F     +G+GKFG VY       K +L   +L   +        +   EV   + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N++ L GY  +    +LI EY P G+V   L   S+   Q+       +          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR-------TATYITELANA 124
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADEIFL 246
                  RV+H+D K  N+L+  +   K+AD G         V  PSS+   +     +L
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-------SVHAPSSRRDTLCGTLDYL 177
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             E+ E R   EK D++S GV   E + G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 253 FRRFSEKSDVYSFGVFLLEL 272
            R +  K+DV+S G+ L+E+
Sbjct: 215 -RPYDYKADVWSLGITLIEM 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 106/264 (40%), Gaps = 20/264 (7%)
Query: 25  LSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQ-MEELSLATKNF--SD 81
           L   C     S S   + GS     Q    V I+LS       Q ++ + +   +     
Sbjct: 34  LDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHF 93
Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 133
             +IG G FG VY G L D     +  A+K            +F+ E   +    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           +LLG C +      ++  Y+ +G +   +   +     K      L +            
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 211
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEV 250
               + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E 
Sbjct: 212 ----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
            + ++F+ KSDV+SFGV L EL++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+A+ G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-------SVHAPSSRRTTLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 25/201 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVK 251
           +++H+D K  N+L   D   K+AD G+     R    R    G +    A E+ +    K
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG-TPYWMAPEVVMCETSK 213
Query: 252 EFRRFSEKSDVYSFGVFLLEL 272
           + R +  K+DV+S G+ L+E+
Sbjct: 214 D-RPYDYKADVWSLGITLIEM 233

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 24/239 (10%)
Query: 43  GSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG 101
           G   P  QP          ++A R  M   +LA  NF  +  IG G+F EVY+   L DG
Sbjct: 10  GPPVPQFQP----------QKALRPDMGYNTLA--NFRIEKKIGRGQFSEVYRAACLLDG 57
Query: 102 MLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 155
           + VA+KK             + I E+  L  + H N++       E+N   ++ E    G
Sbjct: 58  VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 156 SVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFI 215
            +S  +       +QK     R                   RV+H+D K ANV +    +
Sbjct: 118 DLSRMI---KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV 174
Query: 216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            K+ D GL  F      A  S  +     +++ E      ++ KSD++S G  L E+ +
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G            PSS+ T      
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SCHAPSSRRTTLSGTL 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 253 FRRFSEKSDVYSFGVFLLEL 272
            R +  K+DV+S G+ L+E+
Sbjct: 215 -RPYDYKADVWSLGITLIEM 233

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 119
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+A+ G         V  PSS+ T      
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-------SVHAPSSRRTTLCGTL 172
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VAIK   K    PT  Q+   EV  +  + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +LI EY   G V  +L    ++  ++   K R  +           
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-- 130
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 248
                R+VH+D K  N+L+D D   K+AD G  N     G+ D    S    A E+F   
Sbjct: 131 -----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 186 KYD-----GPEVDVWSLGVILYTLVSG 207

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 151
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G         ++ E++ NG++   L       +   +F     +             
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFL------RKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
                VH+D    N+LV+ + + KV+D GL   +   D        T  +I   + A E 
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI--EDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
            ++R+F+  SDV+S+G+ + E++S
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 121
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 234
                         P +VH+D ++ N+ +   DE+    AKVAD G   ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLG 188
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            + Q  A E   A E      ++EK+D YSF + L  +++G
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTG 224

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VAIK   K    PT  Q+   EV  +  + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +LI EY   G V  +L    ++  ++   K R  +           
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-- 133
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 248
                R+VH+D K  N+L+D D   K+AD G  N     G+ D    +    A E+F   
Sbjct: 134 -----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 189 KYD-----GPEVDVWSLGVILYTLVSG 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 153
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 144
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 145 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT 224

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 150
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 170
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 171 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMT 250

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 157
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 158 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMT 237

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 121
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 234
                         P +VH+D ++ N+ +   DE+    AKVAD  L  ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLG 188
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            + Q  A E   A E      ++EK+D YSF + L  +++G
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTG 224

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           K    + ++G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G C   N   L+ EY   GS+   L+G   +        H +S                
Sbjct: 67  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA--AHAMSWCLQCSQGVAYLHSMQ 122
Query: 196 PR-VVHKDFKTANVL-VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           P+ ++H+D K  N+L V    + K+ D G        D+    +       ++A EV E 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 254 RRFSEKSDVYSFGVFLLELVSGRE 277
             +SEK DV+S+G+ L E+++ R+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 150
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 151
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 147
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 149
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMT 229

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 171
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 172 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++F+ KSDV+SFGV L EL++
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMT 251

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           K    + ++G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G C   N   L+ EY   GS+   L+G   +        H +S                
Sbjct: 68  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA--AHAMSWCLQCSQGVAYLHSMQ 123
Query: 196 PR-VVHKDFKTANVL-VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           P+ ++H+D K  N+L V    + K+ D G        D+    +       ++A EV E 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 178
Query: 254 RRFSEKSDVYSFGVFLLELVSGRE 277
             +SEK DV+S+G+ L E+++ R+
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRK 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 85  IGEGKFGEVYKGLL---QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +G G FG V +G+    +  + VAIK        A T+E + E   +  + +  +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ---VSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
            CQ   L  L+ E    G +   L G  +   VS    E  H++S+              
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEK------ 129
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEF 253
               VH+D    NVL+     AK++D GL   LG  D    +       + + A E   F
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
           R+FS +SDV+S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 118
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 127
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ-- 115
           A  F  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +   
Sbjct: 3   ADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 62
Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEME 118
Query: 174 FKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 226
               L+       I                + VH+D    N +V EDF  K+ D G+   
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 84  LIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID-------EVCFLASIQHRNLVTLL 136
           +IG G FG+VY+     G  VA+K     P ++          E    A ++H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 137 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
           G C +E NL  L+ E+   G ++  L G     R   +     ++               
Sbjct: 73  GVCLKEPNL-CLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 196 PRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           P ++H+D K++N+L+ +          I K+ D GL     RT     +        ++A
Sbjct: 128 P-IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA----WMA 182
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     FS+ SDV+S+GV L EL++G
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 120
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 80  SDKNLIGEGKFGEVYKG----LLQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 131
           SD+ +IG+G FG VY G      Q+ +  AIK           + F+ E   +  + H N
Sbjct: 25  SDR-VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           ++ L+G       L  ++  Y+ +G +   +  P +    K      L +          
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEI-FLAS 248
                 + VH+D    N ++DE F  KVAD GL R+ L R   +    +     + + A 
Sbjct: 144 ------KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E  +  RF+ KSDV+SFGV L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAP 113
           S   A  +  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 114 TQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           +     EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLR 117
Query: 170 QKLEFKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 222
            ++E    L+       I                + VH+D    N +V EDF  K+ D G
Sbjct: 118 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +   +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 178 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 155
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 216 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 126
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 28/248 (11%)
Query: 42  TGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNL-IGEGKFGEVYKGLL-- 98
           T   +P   P      E    +    + ++L L   N    ++ +G G FG V +G+   
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359
Query: 99  -QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 153
            +  + VAIK        A T+E + E   +  + +  +V L+G CQ   L  L+ E   
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAG 418
Query: 154 NGSVSIHLYGPSQVSRQKL------EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTAN 207
            G +   L G     R+++      E  H++S+                  VH++    N
Sbjct: 419 GGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK--------NFVHRNLAARN 466
Query: 208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSDVYSFG 266
           VL+     AK++D GL   LG  D    +       + + A E   FR+FS +SDV+S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526
Query: 267 VFLLELVS 274
           V + E +S
Sbjct: 527 VTMWEALS 534

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 126
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHR 177
           E   +      ++V LLG   +     +I E +  G +  +L    P+  +   L     
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-PPS 126
Query: 178 LS--IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
           LS  I                + VH+D    N +V EDF  K+ D G+   +  TD    
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 85  IGEGKFGEVYKGLLQDGML---VAIKKRPGAPTQE------FIDEVCFLASIQHRNLVTL 135
           +G G    VY  L +D +L   VAIK     P ++      F  EV   + + H+N+V++
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 136 LGYCQENNLQFLIYEYI--PNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           +   +E++  +L+ EYI  P  S  I  +GP  V    + F +++               
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD-TAINFTNQI--------LDGIKHA 127
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              R+VH+D K  N+L+D +   K+ D G+   L  T +   ++ V     + + E  + 
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKG 186
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
               E +D+YS G+ L E++ G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVG 208

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 133
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHR 177
           E   +      ++V LLG   +     +I E +  G +  +L    P+  +   L     
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-PPS 136
Query: 178 LS--IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
           LS  I                + VH+D    N +V EDF  K+ D G+   +  TD    
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 84  LIGEGKFGEVYKGLL--QDG--MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           ++GEG+FG V +G L  +DG  + VA+K            +EF+ E   +    H N++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 135 LLGYCQENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIXXX 183
           LLG C E + Q      +I  ++  G +  +L       GP  +  Q L  K  + I   
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKFMVDIALG 159
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                          +H+D    N ++ +D    VAD GL   +   D            
Sbjct: 160 MEYLSNR------NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ KSDV++FGV + E+ +
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G+G FG+VYK   ++ G L A   I+ +     +++I E+  LA+  H  +V LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 141 ENNLQFLIYEYIPNGSVSIHLY----GPSQ-----VSRQKLEFKHRLSIXXXXXXXXXXX 191
            +   +++ E+ P G+V   +     G ++     V RQ LE  + L             
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 134
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTADEIFL 246
                R++H+D K  NVL+  +   ++AD G     L+    R    G +    A E+ +
Sbjct: 135 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-TPYWMAPEVVM 190
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLEL 272
              +K+   +  K+D++S G+ L+E+
Sbjct: 191 CETMKD-TPYDYKADIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G+G FG+VYK   ++ G L A   I+ +     +++I E+  LA+  H  +V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 141 ENNLQFLIYEYIPNGSVSIHLY----GPSQ-----VSRQKLEFKHRLSIXXXXXXXXXXX 191
            +   +++ E+ P G+V   +     G ++     V RQ LE  + L             
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 126
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTADEIFL 246
                R++H+D K  NVL+  +   ++AD G     L+    R    G +    A E+ +
Sbjct: 127 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-TPYWMAPEVVM 182
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLEL 272
              +K+   +  K+D++S G+ L+E+
Sbjct: 183 CETMKD-TPYDYKADIWSLGITLIEM 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C  A + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +G VYK     G +VA+K+        G P+   I E+  L  + H N+V+L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
                   L++E++      +     ++   Q  + K  L                  R+
Sbjct: 88  IHSERCLTLVFEFMEKDLKKV--LDENKTGLQDSQIKIYL-----YQLLRGVAHCHQHRI 140
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 254
           +H+D K  N+L++ D   K+AD GL    G    +     VT    A ++ + S     +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----K 195
Query: 255 RFSEKSDVYSFGVFLLELVSGR 276
           ++S   D++S G    E+++G+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +G VYK     G +VA+K+        G P+   I E+  L  + H N+V+L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
                   L++E++      +     ++   Q  + K  L                  R+
Sbjct: 88  IHSERCLTLVFEFMEKDLKKV--LDENKTGLQDSQIKIYL-----YQLLRGVAHCHQHRI 140
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 254
           +H+D K  N+L++ D   K+AD GL    G    +     VT    A ++ + S     +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----K 195
Query: 255 RFSEKSDVYSFGVFLLELVSGR 276
           ++S   D++S G    E+++G+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 120
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N  V EDF  K+ D G+   +  TD 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++         
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                   ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 169 YLHSH--NMIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 220
Query: 250 V---KEFRRFSEKSDVYSFGVFLLELV 273
           V    +  ++  K DV+S G+  +EL 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 21/212 (9%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLAS 126
            L   N+     IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 62
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 186
           + H N+V L    +     +L+ EY   G V  +L     +  ++   K R  +      
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADE 243
                      +VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E
Sbjct: 123 HQKF-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +F   +         + DV+S GV L  LVSG
Sbjct: 176 LFQGKKYD-----GPEVDVWSLGVILYTLVSG 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 131
           N+  +  IG+G F +V     +  G  VA+K   K    PT  Q+   EV  +  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +L+ EY   G V  +L    ++  ++   K R  +           
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY- 134
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 248
                 +VH+D K  N+L+D D   K+AD G  N      + D    S    A E+F   
Sbjct: 135 ------IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 189 KYD-----GPEVDVWSLGVILYTLVSG 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 27/245 (11%)
Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 108
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 109 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 161
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 162 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 209
            GP  +          L             I                ++VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 270 LELVS 274
            E+V+
Sbjct: 243 WEIVT 247

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQ 128
           + + + +  L+GEG +G V K   +D G +VAIKK   +   + +      E+  L  ++
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXX 188
           H NLV LL  C++    +L++E++ +  +      P+ +  Q ++ K+   I        
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCH 141
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---- 244
                    ++H+D K  N+LV +  + K+ D G      RT +A P  +V  DE+    
Sbjct: 142 SH------NIIHRDIKPENILVSQSGVVKLCDFG----FART-LAAP-GEVYDDEVATRW 189
Query: 245 -----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                 L  +VK    + +  DV++ G  + E+  G
Sbjct: 190 YRAPELLVGDVK----YGKAVDVWAIGCLVTEMFMG 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++         
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                   ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 130 YLHSH--NMIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181
Query: 250 V---KEFRRFSEKSDVYSFGVFLLELV 273
           V    +  ++  K DV+S G+  +EL 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 27/245 (11%)
Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 108
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 109 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 161
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 162 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 209
            GP  +          L             I                ++VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 270 LELVS 274
            E+V+
Sbjct: 243 WEIVT 247

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 63
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 119
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 120 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 162 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLS 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 68
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 124
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 125 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 167 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGX-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 68
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 124
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 125 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 167 YTHEVVTLWYRAPEILLGX-----KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVTL 135
           +GEG FG+V    Y     + G  VA+K  +P +      D   E+  L ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 136 LGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            G C E+  N   LI E++P+GS+  +L      ++ K+  K +L               
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEVK 251
              + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E  
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
              +F   SDV+SFGV L EL++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVTL 135
           +GEG FG+V    Y     + G  VA+K  +P +      D   E+  L ++ H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 136 LGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            G C E+  N   LI E++P+GS+  +L      ++ K+  K +L               
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEVK 251
              + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E  
Sbjct: 133 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
              +F   SDV+SFGV L EL++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VA++     +   +  Q+   EV  +  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +L+ EY   G V  +L    ++  ++   K R  +           
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF- 133
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLAS 248
                 +VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   
Sbjct: 134 ------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGK 187
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 188 KYD-----GPEVDVWSLGVILYTLVSG 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +L+ EY   G V  +L    ++  ++   K R  +           
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF- 133
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLAS 248
                 +VH+D K  N+L+D D   K+AD G  N   F  + D    +    A E+F   
Sbjct: 134 ------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 188 KYD-----GPEVDVWSLGVILYTLVSG 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 65
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 121
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 122 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 163
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 164 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 62
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 118
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 119 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 123
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 183 HAEPVDVWSCGIVLTAMLAG 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 95/245 (38%), Gaps = 27/245 (11%)
Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 108
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 109 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 161
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 162 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 209
            GP  +          L             I                 +VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL 182
Query: 210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 270 LELVS 274
            E+V+
Sbjct: 243 WEIVT 247

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEV---YKGLLQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV      + ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 84  LIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 139
           ++G+G FG+  K   ++   V + K   R    TQ  F+ EV  +  ++H N++  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            ++     I EYI  G+    L G  +    +  +  R+S                  ++
Sbjct: 77  YKDKRLNFITEYIKGGT----LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--NII 130
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFL--------GRTDVAGPSSQ----VTADEIFLA 247
           H+D  + N LV E+    VAD GL   +        G   +  P  +    V  +  ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELV 273
            E+   R + EK DV+SFG+ L E++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 129
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 130 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
                   RN V  +   ++ +  F+  EY  NG++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 232
                           ++H+D K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 273
            G S  +T+     +++A+EV +    ++EK D+YS G+   E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VA++     +   +  Q+   EV  +  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +L+ EY   G V  +L    ++  ++   K R  +           
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF- 133
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLAS 248
                 +VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   
Sbjct: 134 ------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGK 187
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 188 KYD-----GPEVDVWSLGVILYTLVSG 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 14  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 72
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 73  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 130
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 131 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENXYKAQTHGKWPVKWYA 182
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 136 LGYCQEN---NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C++    +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 99  KGCCEDAGAASLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 149
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAGPSSQVTADEI 244
                 +H+D    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV-------F 202
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 8   LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 66
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 67  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 124
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 125 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 176
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 177 PECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 142 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 199
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 14  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 72
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 73  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 130
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 131 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 182
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 20  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 79  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 136
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 137 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 188
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 10  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 69  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 127 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 178
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+ K        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+ K        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 30  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 89  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 146
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 147 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 198
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 30  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 89  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 146
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 147 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 198
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 28  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 86
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 87  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 145 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 196
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 372 LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 430
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 431 YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 488
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 489 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 540
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 541 PECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 373 LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 431
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 432 YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 489
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 490 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 541
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 542 PECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 82  KGCCEDQGEKSLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 132
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H++    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 133 LHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 185
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 82  KGCCEDQGEKSLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 132
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H++    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 133 LHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 185
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEV---YKGLLQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG  GEV      + ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQDGM-LVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+  + IG+G FGEVYKG+      +VAIK    +      ++   E+  L+      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +    +    R  +             
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSE---- 135
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              R +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 191 SAYDFKADIWSLGITAIELAKG 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 139
           L+G G +G+VYKG  ++ G L AIK     G   +E   E+  L     HRN+ T  G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 140 QENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            + N        +L+ E+   GSV+  L   ++ +  K E+   +               
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYIC----REILRGLSHL 145
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 250
              +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV   
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 203
Query: 251 --KEFRRFSEKSDVYSFGVFLLELVSG 275
                  +  KSD++S G+  +E+  G
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 144 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 201
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 202 SLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 80/200 (40%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV     + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    +   ++   K R  +                 +
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    +    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQ 128
           E SL   N     LIG G++G VYKG L D   VA+K    A  Q FI+E  +  +  ++
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLME 65
Query: 129 HRNLVTLL----GYCQENNLQF-LIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 181
           H N+   +        +  +++ L+ EY PNGS+   + L+    VS  +L       + 
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGL- 124
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                         P + H+D  + NVLV  D    ++D GL   L    +  P  +  A
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 242 --DEI----FLASEV-------KEFRRFSEKSDVYSFGVFLLEL 272
              E+    ++A EV       ++     ++ D+Y+ G+   E+
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 79/205 (38%), Gaps = 30/205 (14%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +GEVYK +       VAIK+        G P    I EV  L  +QHRN++ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIELKS 100
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 197
               N+   LI+EY  N         P    R    F ++L                  R
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL--------INGVNFCHSRR 152
Query: 198 VVHKDFKTANVLV-----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
            +H+D K  N+L+      E  + K+ D GL    G      P  Q T + I L     E
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-----PIRQFTHEIITLWYRPPE 207
Query: 253 F----RRFSEKSDVYSFGVFLLELV 273
                R +S   D++S      E++
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 85  IGEGKFGE-VYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG FG+ +     +DG    IK     +      +E   EV  LA+++H N+V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIXXXXXXXXXXXXXXXPR 197
            +EN   +++ +Y   G +        +++ QK + F+    +                +
Sbjct: 92  FEENGSLYIVMDYCEGGDLF------KRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           ++H+D K+ N+ + +D   ++ D G+   L  T     +        +L+ E+ E + ++
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYN 203
Query: 258 EKSDVYSFGVFLLELVSGREA 278
            KSD+++ G  L EL + + A
Sbjct: 204 NKSDIWALGCVLYELCTLKHA 224

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 129
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 130 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
                   RN V  +   ++ +  F+  EY  N ++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 232
                           ++H+D K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 273
            G S  +T+     +++A+EV +    ++EK D+YS G+   E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-----RPGAPTQEFIDEVCFLASIQ 128
           ++  F     +G G +  VYKGL +  G+ VA+K+       G P+   I E+  +  ++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELK 61
Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIXXXXXXX 187
           H N+V L       N   L++E++ N    +  Y  S+ V       +  L         
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----AD 242
                    +++H+D K  N+L+++    K+ D GL    G   V   SS+V      A 
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAP 177
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++ + S     R +S   D++S G  L E+++G+
Sbjct: 178 DVLMGS-----RTYSTSIDIWSCGCILAEMITGK 206

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 38/234 (16%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQV 167
           E+  ++ + QH N+V LLG C       +I EY   G +   L           Y PS  
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 168 SRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL---- 223
             ++L  +  L                    +H+D    NVL+    +AK+ D GL    
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 216
Query: 224 ---RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 217 MNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 263

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 36/206 (17%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNLVTLLGYCQ 140
           IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXXXXXXXXXX 190
             +  +++ EY+  GS    V+       Q++       Q LEF H              
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-------------- 133
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASE 249
                 +V+H+D K+ N+L+  D   K+ D G   F  + T      S++     ++A E
Sbjct: 134 ----SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSEMVGTPYWMAPE 186
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V   + +  K D++S G+  +E++ G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 131 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             FS +SDV+SFGV L EL +
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT 209

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 73  SLAT------KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFID 119
           SLAT      ++F   NL+G+G F  VY+   +  G+ VAIK             Q   +
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHR 177
           EV     ++H +++ L  Y +++N  +L+ E   NG ++ +L    +     +   F H+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           +                   ++H+D   +N+L+  +   K+AD GL      T +  P  
Sbjct: 121 IITGMLYLHSHG--------ILHRDLTLSNLLLTRNMNIKIADFGL-----ATQLKMPHE 167
Query: 238 Q---VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +   +     +++ E+        +SDV+S G     L+ GR
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH++    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 146 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 203
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 204 SLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH++    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 138
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 134 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             FS +SDV+SFGV L EL +
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 135 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             FS +SDV+SFGV L EL +
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 36/206 (17%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNLVTLLGYCQ 140
           IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXXXXXXXXXX 190
             +  +++ EY+  GS    V+       Q++       Q LEF H              
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-------------- 133
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASE 249
                 +V+H+D K+ N+L+  D   K+ D G   F  + T      S +     ++A E
Sbjct: 134 ----SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V   + +  K D++S G+  +E++ G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 36/206 (17%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNLVTLLGYCQ 140
           IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXXXXXXXXXX 190
             +  +++ EY+  GS    V+       Q++       Q LEF H              
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-------------- 133
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASE 249
                 +V+H+D K+ N+L+  D   K+ D G   F  + T      S +     ++A E
Sbjct: 134 ----SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSXMVGTPYWMAPE 186
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V   + +  K D++S G+  +E++ G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGLL-QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 143
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 199 SAYDSKADIWSLGITAIELARG 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 36/206 (17%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNLVTLLGYCQ 140
           IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+V  L    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXXXXXXXXXX 190
             +  +++ EY+  GS    V+       Q++       Q LEF H              
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-------------- 134
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASE 249
                 +V+H+D K+ N+L+  D   K+ D G   F  + T      S +     ++A E
Sbjct: 135 ----SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSXMVGTPYWMAPE 187
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V   + +  K D++S G+  +E++ G
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             FS +SDV+SFGV L EL +
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 109 RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSV-SIHLYGPS 165
           +P  P ++   E+  L  + H N+V L+    + N    ++++E +  G V  +    P 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 166 QVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN 225
              + +  F+  +                  +++H+D K +N+LV ED   K+AD G+ N
Sbjct: 135 SEDQARFYFQDLIK---------GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 226 FLGRTDVAGPSSQVTADEIFLASE-VKEFRR-FSEKS-DVYSFGVFLLELVSGR 276
               +D     S       F+A E + E R+ FS K+ DV++ GV L   V G+
Sbjct: 186 EFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLSIXXX 183
            LLG C +     + I E+   G++S +L         Y P  + +  L  +H +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        + +H+D    N+L+ E  + K+ D GL   + +              
Sbjct: 157 VAKGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+SFGV L E+ S
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  T       +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 49/223 (21%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID--------EVCFLAS 126
            K +   + +GEG+F  VYK   ++   +VAIKK       E  D        E+  L  
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 127 IQHRNLVTLL-GYCQENNLQFLIYEY--------IPNGSVSI---HLYGPSQVSRQKLEF 174
           + H N++ LL  +  ++N+  L++++        I + S+ +   H+     ++ Q LE+
Sbjct: 69  LSHPNIIGLLDAFGHKSNIS-LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 175 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
            H+  I                  +H+D K  N+L+DE+ + K+AD GL    G  + A 
Sbjct: 128 LHQHWI------------------LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 235 PSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
               VT    A E+   +     R +    D+++ G  L EL+
Sbjct: 170 XHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELL 207

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQE---FIDEVCFLASIQHRNLVTL 135
           +G G +GEV   L +D +  A      IKK     T      +DEV  L  + H N++ L
Sbjct: 29  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
             + ++    +L+ E    G +   +     + RQK  F    +                
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEI-----ILRQK--FSEVDAAVIMKQVLSGTTYLHK 139
Query: 196 PRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
             +VH+D K  N+L++    D + K+ D GL       +V G   +      ++A EV  
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTAYYIAPEVLR 196
Query: 253 FRRFSEKSDVYSFGVFLLELVSG 275
            +++ EK DV+S GV L  L+ G
Sbjct: 197 -KKYDEKCDVWSCGVILYILLCG 218

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 134 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPS---QVSRQKLEFKHRLSIXXXXXXXXX 189
              G   + +  ++I EY+  GS + +   GP    Q++    E    L           
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE----- 139
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A E
Sbjct: 140 -------KKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPE 190
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V +   +  K+D++S G+  +EL  G
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 90
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----LE 173
           E+  ++ + QH N+V LLG C       +I EY   G +   L   ++    K     LE
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNF 226
            +  L                    +H+D    NVL+    +AK+ D GL        N+
Sbjct: 151 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 208
Query: 227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 209 IVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----LE 173
           E+  ++ + QH N+V LLG C       +I EY   G +   L   ++    K     LE
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNF 226
            +  L                    +H+D    NVL+    +AK+ D GL        N+
Sbjct: 159 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 216
Query: 227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 217 IVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 257

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQE---FIDEVCFLASIQHRNLVTL 135
           +G G +GEV   L +D +  A      IKK     T      +DEV  L  + H N++ L
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
             + ++    +L+ E    G +   +     + RQK  F    +                
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEI-----ILRQK--FSEVDAAVIMKQVLSGTTYLHK 122
Query: 196 PRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
             +VH+D K  N+L++    D + K+ D GL       +V G   +      ++A EV  
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 179
Query: 253 FRRFSEKSDVYSFGVFLLELVSG 275
            +++ EK DV+S GV L  L+ G
Sbjct: 180 -KKYDEKCDVWSCGVILYILLCG 201

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQ-----DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  + G   Q    +  E+  L ++ H ++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E ++Q L+ EY+P GS+  +L        Q L F  ++              
Sbjct: 77  KGCCEDQGEKSVQ-LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--------EGMAY 127
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H+     NVL+D D + K+ D GL          +  R D   P         
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 180
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  + G   Q    +  E+  L ++ H ++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E ++Q L+ EY+P GS+  +L        Q L F  ++              
Sbjct: 76  KGCCEDQGEKSVQ-LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--------EGMAY 126
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H+     NVL+D D + K+ D GL          +  R D   P         
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 179
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 205 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 214 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 41/232 (17%)
Query: 77  KNFSDKNLIGEGKFGEVYK----GLLQDG--MLVAIK----KRPGAPTQEFIDEVCFLAS 126
           +N     ++G G FG+V      G+ + G  + VA+K    K   +  +  + E+  +  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 127 I-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQV---SRQKLEFKH 176
           +  H N+V LLG C  +   +LI+EY   G +  +L      +   ++   ++++LE + 
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 177 RLSIXX-------XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL------ 223
            L++                         VH+D    NVLV    + K+ D GL      
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 224 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             N++ R +   P   +  + +F          ++ KSDV+S+G+ L E+ S
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI-------YTIKSDVWSYGILLWEIFS 269

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 36/206 (17%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNLVTLLGYCQ 140
           IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+V  L    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXXXXXXXXXX 190
             +  +++ EY+  GS    V+       Q++       Q LEF H              
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-------------- 134
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASE 249
                 +V+H++ K+ N+L+  D   K+ D G   F  + T      S +     ++A E
Sbjct: 135 ----SNQVIHRNIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPE 187
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V   + +  K D++S G+  +E++ G
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 205 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 190
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 251 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 88  GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQE-NNL 144
           G+FG V+K  L +   VA+K  P    Q +  E    ++  ++H NL+  +   +  +NL
Sbjct: 26  GRFGCVWKAQLMND-FVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNL 84
Query: 145 Q---FLIYEYIPNGSVSIHLYGPSQVSRQKL----EFKHRLSIXXXXXXXXXXXXXXXPR 197
           +   +LI  +   GS++ +L G + ++  +L    E   R                  P 
Sbjct: 85  EVELWLITAFHDKGSLTDYLKG-NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 143
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE----F 253
           + H+DFK+ NVL+  D  A +AD GL          G +        ++A EV E    F
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 203
Query: 254 RRFS-EKSDVYSFGVFLLELVS 274
           +R +  + D+Y+ G+ L ELVS
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVS 225

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 41/239 (17%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV-------SIHLYGPSQVSRQK 171
           E+  ++ + QH N+V LLG C       +I EY   G +       +  + GPS    Q 
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 172 LE---------FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 222
            E          + R  +                  +H+D    NVL+    +AK+ D G
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 223 L-------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L        N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 255

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 26/202 (12%)
Query: 85  IGEGKFGEVYKGLLQDG-MLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +G+GKFG VY    +    +VA+K       ++ G   Q    E+   A + H N++ L 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ-LRREIEIQAHLHHPNILRLY 89
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            Y  +    +LI EY P G     LY   Q S     F  + +                 
Sbjct: 90  NYFYDRRRIYLILEYAPRGE----LYKELQKS---CTFDEQRTATIMEELADALMYCHGK 142
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNF---LGRTDVAGPSSQVTADEIFLASEVKEF 253
           +V+H+D K  N+L+      K+AD G       L R  + G     T D  +L  E+ E 
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCG-----TLD--YLPPEMIEG 195
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
           R  +EK D++  GV   EL+ G
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVG 217

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF---- 174
           E+  ++ + QH N+V LLG C       +I EY   G +   L   S+V      F    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 175 ---KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 224
                R  +                  +H+D    NVL+    +AK+ D GL        
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF---- 174
           E+  ++ + QH N+V LLG C       +I EY   G +   L   S+V      F    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 175 ---KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 224
                R  +                  +H+D    NVL+    +AK+ D GL        
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    R ++ +SDV+SFGV L E+ S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    R ++ +SDV+SFGV L E+ S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    R ++ +SDV+SFGV L E+ S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/204 (20%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 131
           +L T +F   +LI     G  Y   +L+  ++V +K+      +   DE   L+ + H  
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-----VEHTNDERLMLSIVTHPF 67
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           ++ + G  Q+    F+I +YI  G +   L       R+   F + ++            
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVCLALE 120
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 ++++D K  N+L+D++   K+ D G   +     V   +  +     ++A EV 
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVV 175
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             + +++  D +SFG+ + E+++G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVC 122
           ++ L  ++F    ++G+G FG+V+    K   Q   + A+KK       +     +++  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
              + +H  L  +    Q     F + EY+  G +  H+    +    +  F     I  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVT 240
                          +V++D K  N+L+D+D   K+AD G+   N LG       +++  
Sbjct: 132 LQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFC 180
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               ++A E+   ++++   D +SFGV L E++ G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLL-----G 137
           IG+G++GEV+ G  + G  VA+K         +  E     ++  +H N++  +     G
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 197
                 L +LI +Y  NGS+  +L   +  ++  L+  +                   P 
Sbjct: 104 TGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTD-VAGPSSQVTADEIFLASEV----- 250
           + H+D K+ N+LV ++    +AD GL   F+  T+ V  P +     + ++  EV     
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 251 --KEFRRFSEKSDVYSFGVFLLELV 273
               F+ +   +D+YSFG+ L E+ 
Sbjct: 223 NRNHFQSYI-MADMYSFGLILWEVA 246

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
           + H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/233 (19%), Positives = 99/233 (42%), Gaps = 20/233 (8%)
Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKR------- 109
           L I +  + ++E++ +  + F+   ++G+G+FG V +  L  +DG  V +  +       
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64
Query: 110 PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFLIYEYIPNGSVSIHLYG 163
             +  +EF+ E   +    H ++  L+G    +       +  +I  ++ +G +   L  
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 164 PSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
            S++         +  +                  +H+D    N ++ ED    VAD GL
Sbjct: 125 -SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 224 --RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             + + G     G +S++     +LA E      ++  SDV++FGV + E+++
Sbjct: 184 SRKIYSGDYYRQGCASKLPVK--WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
           + H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 139 CQENNLQFLIYEYIPNGS---VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
                   L++E++       + +   G   V+ +    +    I               
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------- 119
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-- 253
            RV+H+D K  N+L++ +   K+AD GL    G      P  + T + + L     +   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYTHEVVTLWYRAPDVLM 173
Query: 254 --RRFSEKSDVYSFGVFLLELVSG 275
             +++S   D++S G    E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 139 CQENNLQFLIYEYIPNGS---VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
                   L++E++       + +   G   V+ +    +    I               
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------- 119
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-- 253
            RV+H+D K  N+L++ +   K+AD GL    G      P  + T + + L     +   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYTHEVVTLWYRAPDVLM 173
Query: 254 --RRFSEKSDVYSFGVFLLELVSG 275
             +++S   D++S G    E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHLY-----------GPSQVSRQKLEFKHRLSIX 181
            LLG C +     + I E+   G++S +L             P  + +  L  +H +   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAG 234
                          + +H+D    N+L+ E  + K+ D GL        +++ + D   
Sbjct: 157 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           P   +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 215 PLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF          ++ +SDV+S+G+FL EL S
Sbjct: 211 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFS 242

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 169 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF          ++ +SDV+S+G+FL EL S
Sbjct: 229 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFS 260

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    R ++ +SDV+SFGV L E+ S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 167 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF          ++ +SDV+S+G+FL EL S
Sbjct: 227 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFS 258

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 139 CQENNLQFLIYEYIPNGS---VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
                   L++E++       + +   G   V+ +    +    I               
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------- 119
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVK 251
            RV+H+D K  N+L++ +   K+AD GL    G          VT    A ++ + S   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS--- 175
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             +++S   D++S G    E+V+G
Sbjct: 176 --KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 135
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 136 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 193
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 194 INMKHFESF-KRADIYAMGLVFWEIA 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVC 122
           ++ L  ++F    ++G+G FG+V+    K   Q   + A+KK       +     +++  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
              + +H  L  +    Q     F + EY+  G +  H+    +    +  F     I  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQ 238
                          +V++D K  N+L+D+D   K+AD G+   N LG  +T+    +  
Sbjct: 131 LQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD 183
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A EI L       ++++   D +SFGV L E++ G+
Sbjct: 184 YIAPEILLG------QKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF          ++ +SDV+S+G+FL EL S
Sbjct: 234 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFS 265

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              +  + IF          ++ +SDV+S+G+FL EL S
Sbjct: 234 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFS 265

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 130
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 131 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 188
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 189 INMKHFESF-KRADIYAMGLVFWEIA 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF--AWCAPESL 186
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 190
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 147
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 148 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 147
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 148 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHLYG----------PSQVSRQKLEFKHRLSIXX 182
            LLG C +     + I E+   G++S +L            P  + +  L  +H +    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 156 QVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    R ++ +SDV+SFGV L E+ S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 186
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 133 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 190
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 191 INMKHFESF-KRADIYAMGLVFWEIA 215

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 196
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 96  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 155
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 156 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 213
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 214 INMKHFESF-KRADIYAMGLVFWEIA 238

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 186
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF--AWCAPESL 196
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 139
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 140 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 197
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 198 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 190
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCA 206
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 187
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 188 INMKHFESF-KRADIYAMGLVFWEIA 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 226
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 227 INMKHFESF-KRADIYAMGLVFWEIA 251

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 164
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 165 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 222
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 223 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 154
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 155 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 212
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 213 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 174
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 175 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 232
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 233 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVT--ADEIFLASEVKE-FR 254
           +H+D K  N+L+ ED   ++AD G+  FL    D+     + T      ++A EV E  R
Sbjct: 138 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 197
Query: 255 RFSEKSDVYSFGVFLLELVSG 275
            +  K+D++SFG+  +EL +G
Sbjct: 198 GYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVT--ADEIFLASEVKE-FR 254
           +H+D K  N+L+ ED   ++AD G+  FL    D+     + T      ++A EV E  R
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 255 RFSEKSDVYSFGVFLLELVSG 275
            +  K+D++SFG+  +EL +G
Sbjct: 203 GYDFKADIWSFGITAIELATG 223

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 188
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 189 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 165
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 166 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 224 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQ----EFIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   ++    +F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 139 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 197 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               V+H+D K ANV +D     K+ D GL   L   +    + +      +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKEFVGTPYYMSPEQMNR 190
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRN 131
           K F  K  +G G F EV     +  G L A+K  P    +       +E+  L  I+H N
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHEN 81
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE---FKHRLSI 180
           +V L    +  N  +L+ + +  G      V    Y     S   RQ L+   + HR+ I
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSS 237
                             VH+D K  N+L    DE+    ++D GL    G+ DV   + 
Sbjct: 142 ------------------VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC 183
Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                  ++A EV   + +S+  D +S GV    L+ G
Sbjct: 184 GTPG---YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/239 (20%), Positives = 94/239 (39%), Gaps = 23/239 (9%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF------IDEV 121
           +E   +    F    ++G+G FGEV    ++  G + A KK      ++       ++E 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             L  +  R +V+L    +  +   L+   +  G +  H+Y   Q       F    ++ 
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-----FPEARAVF 290
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                          R+V++D K  N+L+D+    +++D GL        V  P  Q   
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIK 343
Query: 242 DEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELMIK 296
             +    ++A EV +  R++   D ++ G  L E+++G+              VE ++K
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 130
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQ------VTAD 242
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q        A 
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 243 EIFLASEVK-EFRRFSEKSDVYSFGVFLLEL 272
             + A EV     ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID 119
           +M +      +F     +G+GKFG VY     Q+  ++A+K       ++ G   Q    
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRR 64
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+   + ++H N++ +  Y  +    +L+ E+ P G +   L    +   Q+       S
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------S 117
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS--- 236
                            +V+H+D K  N+L+      K+AD G         V  PS   
Sbjct: 118 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRR 170
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             +     +L  E+ E +   EK D++  GV   E + G
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/243 (20%), Positives = 98/243 (40%), Gaps = 24/243 (9%)
Query: 66  RFQMEELSLATKN-FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF------ 117
           +++  E    TKN F    ++G+G FGEV    ++  G + A KK      ++       
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L  +  R +V+L    +  +   L+   +  G +  H+Y   Q       F   
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-----FPEA 286
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
            ++                R+V++D K  N+L+D+    +++D GL        V  P  
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEG 339
Query: 238 QVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVEL 293
           Q     +    ++A EV +  R++   D ++ G  L E+++G+              VE 
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
Query: 294 MIK 296
           ++K
Sbjct: 400 LVK 402

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 130
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQ------VTAD 242
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q        A 
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 243 EIFLASEVK-EFRRFSEKSDVYSFGVFLLEL 272
             + A EV     ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 77/201 (38%), Gaps = 22/201 (10%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLGY 138
           IGEG +G V+K   +D G +VAIKK   +     I      E+  L  ++H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +      L++EY  +  +        ++ R +      L                    
Sbjct: 71  FRRKRRLHLVFEYCDHTVL-------HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF----R 254
           +H+D K  N+L+ +  + K+ D G    L      GPS     +         E      
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLL-----TGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 255 RFSEKSDVYSFGVFLLELVSG 275
           ++    DV++ G    EL+SG
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG 199

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 130
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQVT-------- 240
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q +        
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
               A E+ L S      ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSA-----KYSRAMDVWSCGCILAEL 216

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID 119
           +M +      +F     +G+GKFG VY     Q+  ++A+K       ++ G   Q    
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRR 63
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+   + ++H N++ +  Y  +    +L+ E+ P G +   L    +   Q+       S
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------S 116
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS--- 236
                            +V+H+D K  N+L+      K+AD G         V  PS   
Sbjct: 117 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRR 169
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             +     +L  E+ E +   EK D++  GV   E + G
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G +  
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 353 PG----FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 43/273 (15%)
Query: 31  YRNRSVSRTSETGSSEPSVQ---------PGRNVGIELSIREARRFQMEELSLATKNFSD 81
           + N SV+R++      P            P +  G     RE +R   E+   A +   D
Sbjct: 86  FENMSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVD 145
Query: 82  KN----------LIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASI 127
                        IGEG  G V    ++  G LVA+KK   R     +   +EV  +   
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           QH N+V +       +  +++ E++  G+    V+       Q++   L     LS+   
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA 265
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTAD 242
                         V+H+D K+ ++L+  D   K++D G   F  +     P  + +   
Sbjct: 266 QG------------VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGT 310
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             ++A E+     +  + D++S G+ ++E+V G
Sbjct: 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 14/84 (16%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAGPSSQVTADEIFLASEVKE 252
           VVH+D K  NVL+D    AK+AD GL N +      RT    P+        + A EV  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVIS 183
Query: 253 FRRFS-EKSDVYSFGVFLLELVSG 275
            R ++  + D++S GV L  L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 139 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 197 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               V+H+D K ANV +D     K+ D GL   L   D +   + V     +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFV-GTPYYMSPEQMNR 190
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 139 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 197 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               V+H+D K ANV +D     K+ D GL   L   D +   + V     +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFV-GTPYYMSPEQMNR 190
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 55/218 (25%)
Query: 85  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +  VYKG   L D  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 67
Query: 138 YCQENNLQFLIYEYIPNG---------------SVSIHLYGPSQVSRQKLEFKHRLSIXX 182
                    L++EY+                  +V + L+   Q+ R  L + HR     
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF---QLLR-GLAYCHR----- 118
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
                         +V+H+D K  N+L++E    K+AD GL            +  VT  
Sbjct: 119 -------------QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +I L S       +S + D++  G    E+ +GR
Sbjct: 166 YRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGP-SQVSRQKLEFKHRLSIXXXXX 185
            LLG C +     + I E+   G++S +L      + P   + +  L  +H +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQ 238
                      + +H+D    N+L+ E  + K+ D GL        +++ + D   P   
Sbjct: 155 KGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 213 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVA----IKKRPGAPTQEFIDEVCFLASIQHRNLV 133
           NF  K  + E   GE++KG  Q   +V     ++      +++F +E   L    H N++
Sbjct: 13  NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 134 TLLGYCQENNLQF--LIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
            +LG CQ        LI  ++P GS+   L+ G + V  Q    K  L +          
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM----ARGMAF 126
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASE 249
                P +      + +V++DED  A+++ A ++ +F     +  P+    A E      
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA--WVAPEALQKKP 184
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
               RR    +D++SF V L ELV+
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVT 206

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 140
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 196
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 197 YGPEVDIWSLGIMVIEMVDG 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 129
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 130 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
                   RN V      ++ +  F+  EY  N ++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 232
                           ++H++ K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 273
            G S  +T+      ++A+EV +    ++EK D YS G+   E +
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 34/244 (13%)
Query: 51  PGRNVGIELSIREARRFQMEELSLATKNFSDKN----------LIGEGKFGEVYKGLLQD 100
           P +  G     RE +R   E+   A +   D             IGEG  G V    ++ 
Sbjct: 38  PEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRS 97
Query: 101 -GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS 156
            G LVA+KK   R     +   +EV  +   QH N+V +       +  +++ E++  G+
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 157 ----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDE 212
               V+       Q++   L     LS+                 V+H+D K+ ++L+  
Sbjct: 158 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG------------VIHRDIKSDSILLTH 205
Query: 213 DFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLE 271
           D   K++D G   F  +     P  + +     ++A E+     +  + D++S G+ ++E
Sbjct: 206 DGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 272 LVSG 275
           +V G
Sbjct: 263 MVDG 266

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 145
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 201
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 202 YGPEVDIWSLGIMVIEMVDG 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 147
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 203
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 204 YGPEVDIWSLGIMVIEMVDG 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVTL- 135
           K  +G G FG V + + QD G  VAIK  ++  +P   + +  E+  +  + H N+V+  
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 136 -----LGYCQENNLQFLIYEYIPNGSVSIHLY----------GP-----SQVSRQKLEFK 175
                L     N+L  L  EY   G +  +L           GP     S +S   L + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS-SALRYL 137
Query: 176 HRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV 232
           H                    R++H+D K  N+++    +  I K+ D G    L + ++
Sbjct: 138 HE------------------NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++      +LA E+ E ++++   D +SFG    E ++G
Sbjct: 180 C---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVTL- 135
           K  +G G FG V + + QD G  VAIK  ++  +P   + +  E+  +  + H N+V+  
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 136 -----LGYCQENNLQFLIYEYIPNGSVSIHLY----------GP-----SQVSRQKLEFK 175
                L     N+L  L  EY   G +  +L           GP     S +S   L + 
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS-SALRYL 138
Query: 176 HRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV 232
           H                    R++H+D K  N+++    +  I K+ D G    L + ++
Sbjct: 139 HE------------------NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++      +LA E+ E ++++   D +SFG    E ++G
Sbjct: 181 C---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 136
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 192
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLG---YC 139
           +G+G++GEV++GL   G  VA+K       Q +  E     ++  +H N++  +      
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 140 QENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLE--FKHRLSIXXXXXXXXXXX----X 192
           + ++ Q +LI  Y  +GS+   L       RQ LE     RL++                
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFL------QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLR--NFLGRTDVAGPSSQVTADEIFLASEV 250
              P + H+DFK+ NVLV  +    +AD GL   +  G   +   ++     + ++A EV
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 251 KE-------FRRFSEKSDVYSFGVFLLEL 272
            +       F  + + +D+++FG+ L E+
Sbjct: 189 LDEQIRTDCFESY-KWTDIWAFGLVLWEI 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGP-SQVSRQKLEFKHRLSIXXXXX 185
            LLG C +     + I E+   G++S +L      + P   + +  L  +H   I     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL--IXYSFQ 152
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQ 238
                      + +H+D    N+L+ E  + K+ D GL        +++ + D   P   
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 213 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ DAGL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S GV + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S GV + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 70  EELSLATKNFSD----KNLIGEGKFGE----VYKGLLQDGMLVAIKKRPGAPTQEFIDEV 121
           E L   +  FSD    K  IG G + E    V+K    +  +  I K    P++E   E+
Sbjct: 16  ENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EI 73
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             L   QH N++TL     +    +L+ E +  G +        ++ RQK  F  R +  
Sbjct: 74  -LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL------DKILRQKF-FSEREASF 125
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVL-VDEDF---IAKVADAGLRNFLGRTDVAGPSS 237
                           VVH+D K +N+L VDE       ++ D G    L   +    + 
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             TA+  F+A EV + + + E  D++S G+ L  +++G
Sbjct: 186 CYTAN--FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 14/85 (16%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E+ + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 219 KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIF---- 274
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
               + +S KSDV+S+GV L E+ S
Sbjct: 275 ---DKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 19/163 (11%)
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  +  ++H  LV L    Q+    F++ + +  G +  HL       +Q + FK    
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-------QQNVHFKEETV 117
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                            R++H+D K  N+L+DE     + D  +   L R       +Q+
Sbjct: 118 KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR------ETQI 171
Query: 240 TA---DEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGR 276
           T     + ++A E+   R+   +S   D +S GV   EL+ GR
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 14/84 (16%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAGPSSQVTADEIFLASEVKE 252
           VVH+D K  NVL+D    AK+AD GL N +      R     P+        + A EV  
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPN--------YAAPEVIS 188
Query: 253 FRRFS-EKSDVYSFGVFLLELVSG 275
            R ++  + D++S GV L  L+ G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 26  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 138
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 195 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 14/84 (16%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAGPSSQVTADEIFLASEVKE 252
           VVH+D K  NVL+D    AK+AD GL N +      R     P+        + A EV  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPN--------YAAPEVIS 183
Query: 253 FRRFS-EKSDVYSFGVFLLELVSG 275
            R ++  + D++S GV L  L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 88  GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQENNL- 144
           G+FG V+K  L +   VA+K  P    Q + +E  V  L  ++H N++  +G  +     
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93
Query: 145 ---QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS--IXXXXXXXXXXXXXXXPRVV 199
               +LI  +   GS+S  L        +       ++  +               P + 
Sbjct: 94  DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE----FRR 255
           H+D K+ NVL+  +  A +AD GL         AG +        ++A EV E    F+R
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213
Query: 256 FS-EKSDVYSFGVFLLELVS 274
            +  + D+Y+ G+ L EL S
Sbjct: 214 DAFLRIDMYAMGLVLWELAS 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 236
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 79  FSD----KNLIGEGKFGE----VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR 130
           FSD    K  IG G + E    V+K    +  +  I K    P++E   E+  L   QH 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EI-LLRYGQHP 81
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++TL     +    +L+ E +  G +        ++ RQK  F  R +           
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELL------DKILRQKF-FSEREASFVLHTIGKTV 134
Query: 191 XXXXXPRVVHKDFKTANVL-VDEDF---IAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
                  VVH+D K +N+L VDE       ++ D G    L   +    +   TA+  F+
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN--FV 192
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           A EV + + + E  D++S G+ L  +++G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 132 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
            +T L  C Q  +  + + EY+  G +  H+    QV R    FK   ++          
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR----FKEPHAVFYAAEIAIGL 134
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                  ++++D K  NV++D +   K+AD G+        V       T D  ++A E+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD--YIAPEI 192
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++ + +  D ++FGV L E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+L+      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 236
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 132 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
            +T L  C Q  +  + + EY+  G +  H+    QV R    FK   ++          
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR----FKEPHAVFYAAEIAIGL 455
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                  ++++D K  NV++D +   K+AD G+        V       T D  ++A E+
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD--YIAPEI 513
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++ + +  D ++FGV L E+++G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 115 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
           +E  +E+  L S+ H N++ L    ++    +L+ E+   G +   +     ++R K + 
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDE 145
Query: 175 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLGRTD 231
               +I                 +VH+D K  N+L++        K+ D GL +F  + D
Sbjct: 146 CDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-D 202
Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                   TA   ++A EV + ++++EK DV+S GV +  L+ G
Sbjct: 203 YKLRDRLGTA--YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGY 138
           L+GEG + +V   + LQ+G   A+K   K+ G        EV  L   Q ++N++ L+ +
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +++   +L++E +  GS+  H      + +QK  F  R +                  +
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAH------IQKQK-HFNEREASRVVRDVAAALDFLHTKGI 132
Query: 199 VHKDFKTANVLVDED---FIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------FLA 247
            H+D K  N+L +        K+ D  L + +   +   P   +T  E+        ++A
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTP---ITTPELTTPCGSAEYMA 189
Query: 248 SEVKEF-----RRFSEKSDVYSFGVFLLELVSG 275
            EV E        + ++ D++S GV L  ++SG
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 132
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 189 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 236
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 34/175 (19%)
Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSR- 169
           F  E    A++ H  +V +    +       L +++ EY+   ++   +H  GP    R 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 170 --------QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADA 221
                   Q L F H+  I                  +H+D K AN+++      KV D 
Sbjct: 119 IEVIADACQALNFSHQNGI------------------IHRDVKPANIMISATNAVKVMDF 160
Query: 222 GL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           G+ R      +    ++ V     +L+ E         +SDVYS G  L E+++G
Sbjct: 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 244
                     ++H+D K +N++V  D   K+ D G    L RT  AG S  +T + +   
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPEVVTRY 190
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           + A EV     + E  D++S G  + E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 43  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 102
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 155
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 212 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 44  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 103
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 156
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 213 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           IG G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 18/88 (20%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAGP---SSQVTADEIFLAS 248
           ++VH+D K  N+L+D++   K+AD GL N +      +T    P   + +V   +++   
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EV          DV+S G+ L  ++ GR
Sbjct: 188 EV----------DVWSCGIVLYVMLVGR 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 194
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/165 (21%), Positives = 69/165 (41%), Gaps = 32/165 (19%)
Query: 124 LASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
           LA +     +T L  C Q  +  + + EY+  G +  H+    QV +    FK   ++  
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGK----FKEPQAVFY 125
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTD 231
                          ++++D K  NV++D +   K+AD G+           R F G  D
Sbjct: 126 AAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                        ++A E+  ++ + +  D +++GV L E+++G+
Sbjct: 186 -------------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEV-------YKGLLQ 99
           P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 44  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 103
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 104 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 162
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +   F     +                  +H+D K  N+L+D+    K+A
Sbjct: 163 NLMSNYDVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLA 215
Query: 220 DAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++ 
Sbjct: 216 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 273
Query: 275 G 275
           G
Sbjct: 274 G 274

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEV-------YKGLLQ 99
           P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 44  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 103
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 104 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 162
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +   F     +                  +H+D K  N+L+D+    K+A
Sbjct: 163 NLMSNYDVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLA 215
Query: 220 DAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++ 
Sbjct: 216 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 273
Query: 275 G 275
           G
Sbjct: 274 G 274

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 92/249 (36%), Gaps = 49/249 (19%)
Query: 57  IELSIREARRFQ---------MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGM---LV 104
           + LS+  AR F          ++E  +  +      LIG+G+FG+VY G     +   L+
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLI 63
Query: 105 AIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI---------YEYIPNG 155
            I++      + F  EV      +H N+V  +G C       +I         Y  + + 
Sbjct: 64  DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 156 SVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFI 215
            + + +    Q++++ ++    L                   ++HKD K+ NV  D   +
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHAKG---------------ILHKDLKSKNVFYDNGKV 168
Query: 216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR------------FSEKSDVY 263
             + D GL +  G         ++     +L     E  R            FS+ SDV+
Sbjct: 169 V-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 264 SFGVFLLEL 272
           + G    EL
Sbjct: 228 ALGTIWYEL 236

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 55/225 (24%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 131
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAG 234
                            ++VH+D K  N+L+DE    K+AD GL N +      +T    
Sbjct: 132 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 175
Query: 235 P---SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           P   + +V + +++   EV          DV+S GV L  ++  R
Sbjct: 176 PNYAAPEVISGKLYAGPEV----------DVWSCGVILYVMLCRR 210

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEV-------YKGLLQ 99
           P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 39  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 98
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 157
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +   F     +                  +H+D K  N+L+D+    K+A
Sbjct: 158 NLMSNYDVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLA 210
Query: 220 DAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++ 
Sbjct: 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 268
Query: 275 G 275
           G
Sbjct: 269 G 269

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 107 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 154
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 155 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 55/225 (24%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 130
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAG 234
                            ++VH+D K  N+L+DE    K+AD GL N +      +T    
Sbjct: 131 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 174
Query: 235 P---SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           P   + +V + +++   EV          DV+S GV L  ++  R
Sbjct: 175 PNYAAPEVISGKLYAGPEV----------DVWSCGVILYVMLCRR 209

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 268
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
               R ++ +SDV+SFGV L E+ S
Sbjct: 269 ---DRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 100 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 202
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 266
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
               R ++ +SDV+SFGV L E+ S
Sbjct: 267 ---DRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 87  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 189
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 85  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 187
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGL---CRHTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 109 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 211
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 55/225 (24%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 121
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAG 234
                            ++VH+D K  N+L+DE    K+AD GL N +      +T    
Sbjct: 122 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 165
Query: 235 P---SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           P   + +V + +++   EV          DV+S GV L  ++  R
Sbjct: 166 PNYAAPEVISGKLYAGPEV----------DVWSCGVILYVMLCRR 200

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/240 (20%), Positives = 103/240 (42%), Gaps = 20/240 (8%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   L+  E    ++  L +  +++    +IG G FGEV        + +  
Sbjct: 45  PALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYA 104
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 105 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-V 163
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +  +F     +                 ++H+D K  N+L+D+    K+A
Sbjct: 164 NLMSNYDVPEKWAKFYTAEVVLALDAIHSMG-------LIHRDVKPDNMLLDKHGHLKLA 216
Query: 220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSG 275
           D G    +  T +    + V   + +++ EV + +     +  + D +S GVFL E++ G
Sbjct: 217 DFGTCMKMDETGMVHCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 86  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 188
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    + G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 138 YCQE-----NNLQFLIY------EYIPNGSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +  IY      E+   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 88  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 190
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 100 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 202
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    + G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 83
Query: 138 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 142
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 143 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 170

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 86  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 188
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 273
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
               R ++ +SDV+SFGV L E+ S
Sbjct: 274 ---DRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGXVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 22/208 (10%)
Query: 77  KNFSDKNLIGEGKFGEVY--KGLLQDGM--LVAIKKRPGAPTQEFIDEVCFLASIQHRNL 132
           K F    ++G G F EV+  K  L   +  L  IKK P        +E+  L  I+H N+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           VTL    +     +L+ + +  G +   I   G        L  +  LS           
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG-- 126
Query: 191 XXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                  +VH+D K  N+L    +E+    + D G    L + +  G  S       ++A
Sbjct: 127 -------IVHRDLKPENLLYLTPEENSKIMITDFG----LSKMEQNGIMSTACGTPGYVA 175
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV   + +S+  D +S GV    L+ G
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 95  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 197
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    + G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 138 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 108 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 210
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 112 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 214
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 31/96 (32%)
Query: 197 RVVHKDFKTANVLVDE----------------DFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           +++H+D K +N+L+D                 D IAK  DAG R ++    +   +S+  
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR-- 203
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                        + +  +SDV+S G+ L EL +GR
Sbjct: 204 -------------QGYDVRSDVWSLGITLYELATGR 226

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 275
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
               R ++ +SDV+SFGV L E+ S
Sbjct: 276 ---DRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 55/225 (24%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 125
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAG 234
                            ++VH+D K  N+L+DE    K+AD GL N +      +T    
Sbjct: 126 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 169
Query: 235 P---SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           P   + +V + +++   EV          DV+S GV L  ++  R
Sbjct: 170 PNYAAPEVISGKLYAGPEV----------DVWSCGVILYVMLCRR 204

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/78 (28%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           ++++D K  N+L+DE+   K+ D GL       D    +        ++A EV   R  +
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 258 EKSDVYSFGVFLLELVSG 275
           + +D +SFGV + E+++G
Sbjct: 205 QSADWWSFGVLMFEMLTG 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 18/78 (23%), Positives = 40/78 (51%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           ++H+D K  N+L++ED   ++ D G    L        ++       +++ E+   +  S
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 258 EKSDVYSFGVFLLELVSG 275
           + SD+++ G  + +LV+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 83
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 138
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP---FVVTRYYRA 195
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 41/81 (50%), Gaps = 4/81 (4%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRR 255
           RV+H+D K  N+ ++ED   K+ D GL     + +  G   +V      ++A EV   + 
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 256 FSEKSDVYSFGVFLLELVSGR 276
            S + DV+S G  +  L+ G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +IG+G F  V + + ++ G   A+K          PG  T++   E      ++H ++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX- 193
           LL     + + ++++E++    +   +     V R    F +  ++              
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 194 -XXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                ++H+D K  NVL+   +     K+ D G+   LG + +       T    F+A E
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPH--FMAPE 203
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V +   + +  DV+  GV L  L+SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    + G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 138 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/78 (28%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           ++++D K  N+L+DE+   K+ D GL       D    +        ++A EV   R  +
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 258 EKSDVYSFGVFLLELVSG 275
           + +D +SFGV + E+++G
Sbjct: 206 QSADWWSFGVLMFEMLTG 223

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	302
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-85
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-81
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-52
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-47
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-43
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-22
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-17
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-17
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-17
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-05
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-12
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-11
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-09
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  256 bits (657), Expect = 8e-85
 Identities = 95/272 (34%), Positives = 148/272 (54%), Gaps = 17/272 (6%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
             +  T S   ++     V  E     + R  + +L  AT NF  K LIG G FG+VYKG
Sbjct: 4   KYSKATNSINDALSSSYLVPFE-----SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58

Query: 97  LLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 153
           +L+DG  VA+K+R    +Q   EF  E+  L+  +H +LV+L+G+C E N   LIY+Y+ 
Sbjct: 59  VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 213
           NG++  HLYG        + ++ RL I +GAA+GL +LH+    ++H+D K+ N+L+DE+
Sbjct: 119 NGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDEN 175

Query: 214 FIAKVADAGL-RNF--LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLL 270
           F+ K+ D G+ +    L +T +   S+ V     ++  E     R +EKSDVYSFGV L 
Sbjct: 176 FVPKITDFGISKKGTELDQTHL---STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 271 ELVSGREASSSLSPDSSQDLVELMIKCMGKER 302
           E++  R A     P    +L E  ++     +
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  248 bits (635), Expect = 2e-81
 Identities = 96/250 (38%), Positives = 145/250 (58%), Gaps = 25/250 (10%)

Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-- 115
           E+ + + +RF + EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+     TQ  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 129

Query: 174 FKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--- 229
           +  R  IALG+A+GLA+LH    P+++H+D K AN+L+DE+F A V D GL   +     
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 230 ---TDVAGPSSQVTADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--SSSL 282
              T V G     T       +A E     + SEK+DV+ +GV LLEL++G+ A   + L
Sbjct: 190 HVTTAVRG-----T----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 283 SPDSSQDLVE 292
           + D    L++
Sbjct: 241 ANDDDVMLLD 250

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  230 bits (589), Expect = 1e-74
 Identities = 84/255 (32%), Positives = 121/255 (47%), Gaps = 33/255 (12%)

Query: 57  IELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRP 110
           +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+KK  
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63

Query: 111 GAPT-------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG 163
                      Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                   L +  R  IA GAA G+  LH      +H+D K+AN+L+DE F AK++D GL
Sbjct: 124 LD--GTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGL 179

Query: 224 RNFLGRTDVAGPSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 277
                +      +S++       A E             + KSD+YSFGV LLE+++G  
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-------EITPKSDIYSFGVVLLEIITGLP 232

Query: 278 ASSSLSPDSSQDLVE 292
           A         Q L++
Sbjct: 233 AVDEHREP--QLLLD 245

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  187 bits (476), Expect = 1e-57
 Identities = 61/246 (24%), Positives = 95/246 (38%), Gaps = 28/246 (11%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFL 124
              E L   +       +   G+FG V+K  L     VA+K  P    Q + +E  V  L
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 125 ASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
             ++H N++  +G  +         +LI  +   GS+S  L          + +     I
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHI 126

Query: 181 ALGAAKGLAHLHS--------LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 231
           A   A+GLA+LH           P + H+D K+ NVL+  +  A +AD GL   F     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 232 VAGPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 286
                 QV      A E+ L   +   R    + D+Y+ G+ L EL S   A+     + 
Sbjct: 187 AGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 287 SQDLVE 292
                E
Sbjct: 246 MLPFEE 251

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  172 bits (438), Expect = 2e-52
 Identities = 58/255 (22%), Positives = 104/255 (40%), Gaps = 40/255 (15%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 123
            ++L+  TK       + E   GE++KG  Q G  + +K  +    +    ++F +E   
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 124 LASIQHRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           L    H N++ +LG CQ         I  ++P GS+   L+  +      ++    +  A
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFA 117

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
           L  A+G+A LH+L P +      + +V++DED  A+++ A ++           +    A
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-APAWVA 176

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----------------- 284
            E     + K        +D++SF V L ELV+     + LS                  
Sbjct: 177 PEAL---QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233

Query: 285 -DSSQDLVELMIKCM 298
              S  + +LM  CM
Sbjct: 234 PGISPHVSKLMKICM 248

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  171 bits (436), Expect = 8e-52
 Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 41/251 (16%)

Query: 78  NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 129
            + D   K  IG G FG V++     G  VA+K             EF+ EV  +  ++H
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N+V  +G   +     ++ EY+  GS+   L+     +R++L+ + RLS+A   AKG+ 
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMN 151

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEI 244
           +LH+ +P +VH++ K+ N+LVD+ +  KV D GL       FL     AG     T    
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG-----TP--E 204

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE--------------ASSSLSPDSSQD- 289
           ++A EV      +EKSDVYSFGV L EL + ++                     +  ++ 
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264

Query: 290 ---LVELMIKC 297
              +  ++  C
Sbjct: 265 NPQVAAIIEGC 275

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  167 bits (424), Expect = 8e-50
 Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 34/242 (14%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFL 124
               E SL   N     LIG G++G VYKG L D   VA+K    A  Q FI+E  +  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61

Query: 125 ASIQHRNLVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
             ++H N+   +   +           L+ EY PNGS+  +L      S    ++     
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCR 115

Query: 180 IALGAAKGLAHLHS-------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
           +A    +GLA+LH+         P + H+D  + NVLV  D    ++D GL   L    +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 233 AGPSSQVTAD------------EIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 279
             P  +  A             E+   A  +++     ++ D+Y+ G+   E+       
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 280 SS 281
             
Sbjct: 236 FP 237

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  164 bits (416), Expect = 4e-49
 Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 46/259 (17%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 123
             ++++  +       IG G FG VYKG       VA+K     APT    Q F +EV  
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           L   +H N++  +GY     L  ++ ++    S+  HL      S  K E K  + IA  
Sbjct: 74  LRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQ 128

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
            A+G+ +LH+    ++H+D K+ N+ + ED   K+ D GL     R   +    Q++   
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 244 IFLASEV---KEFRRFSEKSDVYSFGVFLLELVSG----------------------REA 278
           +++A EV   ++   +S +SDVY+FG+ L EL++G                         
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246

Query: 279 SSSLSPDSSQDLVELMIKC 297
            S +  +  + +  LM +C
Sbjct: 247 LSKVRSNCPKRMKRLMAEC 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  162 bits (412), Expect = 2e-48
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 42/243 (17%)

Query: 56  GIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------ 108
           G E            E+    +       IG+G FG V+KG L++D  +VAIK       
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 109 ----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP 164
                     QEF  EV  ++++ H N+V L G         ++ E++P G +   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK 115

Query: 165 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVA 219
           +      +++  +L + L  A G+ ++ + +P +VH+D ++ N+ +          AKVA
Sbjct: 116 AH----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171

Query: 220 DAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G    L +  V   S  +      A E   A E      ++EK+D YSF + L  +++
Sbjct: 172 DFG----LSQQSVHSVSGLLGNFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILT 223

Query: 275 GRE 277
           G  
Sbjct: 224 GEG 226

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  159 bits (403), Expect = 6e-47
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
           +G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L G C    
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV 74

Query: 144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKD 202
              L+ EY   GS+   L+G   +        H +S  L  ++G+A+LHS+ P+ ++H+D
Sbjct: 75  --CLVMEYAEGGSLYNVLHGAEPLP--YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 203 FKTANVLVDEDF-IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
            K  N+L+     + K+ D G    +         S       ++A EV E   +SEK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA-----AWMAPEVFEGSNYSEKCD 185

Query: 262 VYSFGVFLLELVSGRE 277
           V+S+G+ L E+++ R+
Sbjct: 186 VFSWGIILWEVITRRK 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  156 bits (397), Expect = 4e-46
 Identities = 56/252 (22%), Positives = 102/252 (40%), Gaps = 43/252 (17%)

Query: 82  KNLIGEGKFGEVYKGLL-QDGMLVAIKK--RPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 137
             ++G+G FG+  K    + G ++ +K+  R    TQ  F+ EV  +  ++H N++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 138 YC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
              ++  L   I EYI  G++   +    +    +  +  R+S A   A G+A+LHS++ 
Sbjct: 75  VLYKDKRL-NFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-------- 248
            ++H+D  + N LV E+    VAD GL   +          +                  
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 249 ----EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------------D 285
               E+   R + EK DV+SFG+ L E++    A     P                   +
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 286 SSQDLVELMIKC 297
                  + ++C
Sbjct: 248 CPPSFFPITVRC 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  153 bits (390), Expect = 2e-45
 Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 58/266 (21%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------QEFIDEV 121
             EL+L          IG G FG+VY+     G  VA+K  R           +    E 
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
              A ++H N++ L G C +     L+ E+   G ++  L      S +++     ++ A
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWA 111

Query: 182 LGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDV 232
           +  A+G+ +LH  +   ++H+D K++N+L+ +          I K+ D GL     RT  
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171

Query: 233 ---AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----- 284
              AG  +       ++A EV     FS+ SDV+S+GV L EL++G      +       
Sbjct: 172 MSAAGAYA-------WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224

Query: 285 -------------DSSQDLVELMIKC 297
                           +   +LM  C
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDC 250

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  152 bits (385), Expect = 3e-44
 Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 47/258 (18%)

Query: 78  NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 129
            F       LIG+G+FG+VY G       VAI+            + F  EV      +H
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N+V  +G C       +I       ++   +       +  L+      IA    KG+ 
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMG 144

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD------- 242
           +LH  +  ++HKD K+ NV  D   +  + D GL +  G         ++          
Sbjct: 145 YLH--AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201

Query: 243 --EIF---LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------- 284
             EI         ++   FS+ SDV++ G    EL +      +                
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261

Query: 285 -----DSSQDLVELMIKC 297
                   +++ ++++ C
Sbjct: 262 NLSQIGMGKEISDILLFC 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  150 bits (381), Expect = 2e-43
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 27/222 (12%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 140
             IG+G+FGEV++G  + G  VA+K       + +  E  +     ++H N++  +    
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 141 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS--- 193
           ++N      +L+ +Y  +GS+  +L      +R  +  +  + +AL  A GLAHLH    
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 194 ---LSPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 242
                P + H+D K+ N+LV ++    +AD GL    +    T    P+ +V      A 
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
           E+   S   +     +++D+Y+ G+   E+            
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  149 bits (377), Expect = 3e-43
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 27/222 (12%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 140
             +G+G++GEV++G  Q G  VA+K       + +  E  +     ++H N++  +    
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 141 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 195
            +       +LI  Y   GS+  +L          L+    L I L  A GLAHLH    
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 196 -----PRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 242
                P + H+D K+ N+LV ++    +AD GL    +        G + +V      A 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
           E+   +   +     ++ D+++FG+ L E+     ++  +  
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  148 bits (375), Expect = 1e-42
 Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 140
             IG+G++GEV+ G  + G  VA+K         +  E  +     ++H N++  +    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 141 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 195
           +        +LI +Y  NGS+  +L          L+ K  L +A  +  GL HLH+   
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 196 -----PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA--GPSSQV-----TAD 242
                P + H+D K+ N+LV ++    +AD GL   F+  T+     P+++V        
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
           E+   S  +   +    +D+YSFG+ L E+     +   +  
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (359), Expect = 3e-40
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 36/263 (13%)

Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-----Q 99
           +  ++     +G     R+  +F+   L            +G+G FG V           
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDN 68

Query: 100 DGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPN 154
            G +VA+KK +        +F  E+  L S+QH N+V   G C     +   LI EY+P 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128

Query: 155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 214
           GS+  +L    Q  +++++    L       KG+ +L +   R +H+D  T N+LV+ + 
Sbjct: 129 GSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENEN 182

Query: 215 IAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LASEVKEFRRFSEKSDVYSFGV 267
             K+ D GL +      +           E     IF  A E     +FS  SDV+SFGV
Sbjct: 183 RVKIGDFGLTKVLPQDKEYY------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236

Query: 268 FLLELVSGREASSSLSPDSSQDL 290
            L EL +  E S S   +  + +
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMI 259

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (348), Expect = 3e-39
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 33/207 (15%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 139
              IG G+FG V+ G   +   VAIK  R GA + ++FI+E   +  + H  LV L G C
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            E     L+ E++ +G +S +L    +  R     +  L + L   +G+A+L      V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVI 126

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS----------- 248
           H+D    N LV E+ + KV+D G+             ++   D+ + +S           
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGM-------------TRFVLDDQYTSSTGTKFPVKWAS 173

Query: 249 -EVKEFRRFSEKSDVYSFGVFLLELVS 274
            EV  F R+S KSDV+SFGV + E+ S
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (350), Expect = 7e-39
 Identities = 69/260 (26%), Positives = 113/260 (43%), Gaps = 51/260 (19%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDE 120
            E             +G G FG VYKGL         + VAIK+ R     +   E +DE
Sbjct: 15  TEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
              +AS+ + ++  LLG C  + +Q LI + +P G +  ++    +  +  +  ++ L+ 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNW 122

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
            +  AKG+ +L     R+VH+D    NVLV      K+ D GL   LG  +      +  
Sbjct: 123 CVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYH 175

Query: 241 ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS-- 283
           A+   +     A E    R ++ +SDV+S+GV + EL++            E SS L   
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

Query: 284 ------PDSSQDLVELMIKC 297
                 P  + D+  +M KC
Sbjct: 236 ERLPQPPICTIDVYMIMRKC 255

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (347), Expect = 8e-39
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 29/223 (13%)

Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLL 136
           +G+G FG V            G +VA+KK +        +F  E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 137 GYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           G C     +   LI EY+P GS+  +L    Q  +++++    L       KG+ +L + 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LA 247
             R +H+D  T N+LV+ +   K+ D GL +      +           E     IF  A
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF------KVKEPGESPIFWYA 185

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 290
            E     +FS  SDV+SFGV L EL +  E S S   +  + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (346), Expect = 9e-39
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 19/200 (9%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 139
              +G G+FG V  G  +    VAIK  + G+ +  EFI+E   + ++ H  LV L G C
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    F+I EY+ NG +  +L    +  R + + +  L +     + + +L S   + +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK--QFL 142

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 254
           H+D    N LV++  + KV+D GL R  L     +   S+     +  E+ +      + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM------YS 196

Query: 255 RFSEKSDVYSFGVFLLELVS 274
           +FS KSD+++FGV + E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  135 bits (342), Expect = 2e-38
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 33/204 (16%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VA+K  + G+ +  EF  E   +  + H  LV   G C + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              +++ EYI NG +  +L    +   + LE    L +     +G+A L S   + +H+D
Sbjct: 76  YPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRD 129

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 250
               N LVD D   KV+D G+             ++   D+ +++S            EV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGM-------------TRYVLDDQYVSSVGTKFPVKWSAPEV 176

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             + ++S KSDV++FG+ + E+ S
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFS 200

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (343), Expect = 4e-38
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G  VA+K  +P +      +   E+  L ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 136 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G C E+      LI E++P+GS+  +L      ++ K+  K +L  A+   KG+ +L S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 252
              + VH+D    NVLV+ +   K+ D GL   +                +F  A E   
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
             +F   SDV+SFGV L EL++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  138 bits (350), Expect = 9e-38
 Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 139
           + +G G++GEVY+G+ +   + VA+K  +      E F+ E   +  I+H NLV LLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
                 ++I E++  G++  +L    + +RQ++     L +A   +  + +L       +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFI 340

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 258
           H++    N LV E+ + KVAD GL R   G T  A   ++      + A E   + +FS 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFSI 398

Query: 259 KSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVELMIKC 297
           KSDV++FGV L E+ +            +    L             + + ELM  C
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  136 bits (345), Expect = 3e-37
 Identities = 73/279 (26%), Positives = 114/279 (40%), Gaps = 52/279 (18%)

Query: 46  EPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVA 105
           +P V  G     +   R      M+EL L          IG+G+FG+V  G  + G  VA
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVA 220

Query: 106 IKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYG 163
           +K  +  A  Q F+ E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L  
Sbjct: 221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                R  L     L  +L   + + +L       VH+D    NVLV ED +AKV+D GL
Sbjct: 281 RG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 224 -RNFLGRTDVAGPSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-- 274
            +      + +            TA E          ++FS KSDV+SFG+ L E+ S  
Sbjct: 336 TK------EASSTQDTGKLPVKWTAPEALR------EKKFSTKSDVWSFGILLWEIYSFG 383

Query: 275 --------GREASSSLS--------PDSSQDLVELMIKC 297
                    ++    +               + ++M  C
Sbjct: 384 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (338), Expect = 3e-37
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 36/232 (15%)

Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP 113
           + ++   F+   L   ++       +G+G FG V            G LVA+K+ +   P
Sbjct: 13  ACQDPTIFEERHLKYISQ-------LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65

Query: 114 TQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR 169
            Q  +F  E+  L ++    +V   G       Q   L+ EY+P+G +   L    Q  R
Sbjct: 66  DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHR 121

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 228
            +L+    L  +    KG+ +L S   R VH+D    N+LV+ +   K+AD GL +    
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 229 RTDVAGPSSQVTADE-----IF-LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             D           E     IF  A E      FS +SDV+SFGV L EL +
Sbjct: 180 DKDYY------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (335), Expect = 3e-37
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 33/204 (16%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  + G+ +   F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I EY+ NGS+   L  PS     KL     L +A   A+G+A +       +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 250
            + AN+LV +    K+AD GL             +++  D  + A             E 
Sbjct: 135 LRAANILVSDTLSCKIADFGL-------------ARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             +  F+ KSDV+SFG+ L E+V+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  135 bits (341), Expect = 3e-37
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D  LVA+K  R   P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +  G     L    +    +L  K  L +   AA G+ +L S     +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESK--CCI 235

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 256
           H+D    N LV E  + K++D G+            ++     ++   + A E   + R+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRY 292

Query: 257 SEKSDVYSFGVFLLELVS-GRE 277
           S +SDV+SFG+ L E  S G  
Sbjct: 293 SSESDVWSFGILLWETFSLGAS 314

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (344), Expect = 5e-37
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 33/206 (16%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQ 140
             +G G+FGEV+         VA+K  +PG+ + + F+ E   + ++QH  LV L     
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           +  + ++I E++  GS+   L         K      +  +   A+G+A +       +H
Sbjct: 254 KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR--NYIH 307

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 248
           +D + AN+LV    + K+AD GL             ++V  D  + A             
Sbjct: 308 RDLRAANILVSASLVCKIADFGL-------------ARVIEDNEYTAREGAKFPIKWTAP 354

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E   F  F+ KSDV+SFG+ L+E+V+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVT 380

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  132 bits (334), Expect = 5e-37
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 27/202 (13%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC- 139
              IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           +E    +++ EY+  GS+  +L       R  L     L  +L   + + +L       V
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 139

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASEVKE 252
           H+D    NVLV ED +AKV+D GL +      + +            TA E         
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR------ 187

Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
            ++FS KSDV+SFG+ L E+ S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (334), Expect = 5e-37
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 45/253 (17%)

Query: 82  KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVT 134
              +G G FG V +G+ +     + VAIK  + G     T+E + E   +  + +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L+G CQ   L  L+ E    G +   L       R+++   +   +    + G+ +L   
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 247
               VH+D    NVL+     AK++D GL   LG  D    A  + +      A E    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN- 186

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQD 289
                FR+FS +SDV+S+GV + E +S          G E  + +         P+   +
Sbjct: 187 -----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241

Query: 290 LVELMIKCMGKER 302
           L  LM  C   + 
Sbjct: 242 LYALMSDCWIYKW 254

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (334), Expect = 6e-37
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 33/208 (15%)

Query: 82  KNLIGEGKFGEVYKGLLQDG-MLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  +      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
           C      ++I E++  G++  +L    + +RQ++     L +A   +  + +L       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NF 132

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---------- 248
           +H+D    N LV E+ + KVAD GL             S++   + + A           
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGL-------------SRLMTGDTYTAHAGAKFPIKWT 179

Query: 249 --EVKEFRRFSEKSDVYSFGVFLLELVS 274
             E   + +FS KSDV++FGV L E+ +
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  134 bits (340), Expect = 1e-36
 Identities = 68/247 (27%), Positives = 110/247 (44%), Gaps = 51/247 (20%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 140
             +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           E  + +++ EY+  GS+   L G +    + L     + +A   A G+A++  +    VH
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 303

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 248
           +D + AN+LV E+ + KVAD GL             +++  D  + A             
Sbjct: 304 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 350

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDL 290
           E   + RF+ KSDV+SFG+ L EL +           RE    +         P+  + L
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410

Query: 291 VELMIKC 297
            +LM +C
Sbjct: 411 HDLMCQC 417

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (333), Expect = 2e-36
 Identities = 68/267 (25%), Positives = 112/267 (41%), Gaps = 53/267 (19%)

Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGML-----VAIKK-RPGAPTQ-- 115
           AR F+  EL            +G G FG V+KG+           V IK     +  Q  
Sbjct: 7   ARIFKETELRKLKV-------LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59

Query: 116 -EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
               D +  + S+ H ++V LLG C  ++LQ L+ +Y+P GS+  H+    +  R  L  
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV----RQHRGALGP 114

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
           +  L+  +  AKG+ +L      +VH++    NVL+      +VAD G+ + L   D   
Sbjct: 115 QLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172

Query: 235 PSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS----------GREA 278
             S+        A E         F +++ +SDV+S+GV + EL++            E 
Sbjct: 173 LYSEAKTPIKWMALESIH------FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

Query: 279 SSSLS--------PDSSQDLVELMIKC 297
              L            + D+  +M+KC
Sbjct: 227 PDLLEKGERLAQPQICTIDVYMVMVKC 253

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (333), Expect = 2e-36
 Identities = 68/245 (27%), Positives = 113/245 (46%), Gaps = 44/245 (17%)

Query: 85  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +G G FG VYKGL         + VAIK+ R     +   E +DE   +AS+ + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C  + +Q LI + +P G +  ++    +  +  +  ++ L+  +  AKG+ +L    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEV 250
            R+VH+D    NVLV      K+ D GL   LG  +      +  A+   +     A E 
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALES 190

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVE 292
              R ++ +SDV+S+GV + EL++            E SS L         P  + D+  
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250

Query: 293 LMIKC 297
           +M+KC
Sbjct: 251 IMVKC 255

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (333), Expect = 2e-36
 Identities = 70/251 (27%), Positives = 105/251 (41%), Gaps = 45/251 (17%)

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLL 136
           IG G  GEV  G L+      + VAIK  + G   ++   F+ E   +    H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G      L  ++ EY+ NGS+   L    +    +      + +  G   G+ +L  L  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 249
             VH+D    NVLVD + + KV+D GL R      D A  ++        TA E      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--- 227

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLV 291
              FR FS  SDV+SFGV + E+++           R+  SS+               L 
Sbjct: 228 ---FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284

Query: 292 ELMIKCMGKER 302
           +LM+ C  K+R
Sbjct: 285 QLMLDCWHKDR 295

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (330), Expect = 2e-36
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 49/249 (19%)

Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L G      ++ ++ E  P GS+   L    +  +           A+  A+G+ +L S 
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYLESK 140

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 247
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     A E    
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK- 197

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS---------PDSSQ 288
                 R FS  SD + FGV L E+ +          G +    +           D  Q
Sbjct: 198 -----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252

Query: 289 DLVELMIKC 297
           D+  +M++C
Sbjct: 253 DIYNVMVQC 261

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  135 bits (341), Expect = 3e-36
 Identities = 68/247 (27%), Positives = 110/247 (44%), Gaps = 51/247 (20%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 140
             +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           E  + +++ EY+  GS+   L G +    + L     + +A   A G+A++  +    VH
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 386

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 248
           +D + AN+LV E+ + KVAD GL             +++  D  + A             
Sbjct: 387 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 433

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDL 290
           E   + RF+ KSDV+SFG+ L EL +           RE    +         P+  + L
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 493

Query: 291 VELMIKC 297
            +LM +C
Sbjct: 494 HDLMCQC 500

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (332), Expect = 3e-36
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 34/246 (13%)

Query: 85  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTL 135
           IG G+FGEVYKG+L+       + VAIK  + G   ++   F+ E   +    H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
            G   +     +I EY+ NG++   L    +    +      + +  G A G+ +L ++ 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 254
              VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A E   +R
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 255 RFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVELMIK 296
           +F+  SDV+SFG+ + E+++            E   +++         D    + +LM++
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 285

Query: 297 CMGKER 302
           C  +ER
Sbjct: 286 CWQQER 291

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  129 bits (326), Expect = 2e-35
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 32/208 (15%)

Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  +  A       +  E+  L ++ H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 136 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G C++       L+ EY+P GS+  +L       R  +     L  A    +G+A+LH+
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-L 246
                +H+D    NVL+D D + K+ D GL +      +           E     +F  
Sbjct: 153 Q--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVREDGDSPVFWY 204

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           A E  +  +F   SDV+SFGV L EL++
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLT 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  127 bits (322), Expect = 3e-35
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)

Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLV 133
             +IG+G FG VY G   D     +  AIK        Q+   F+ E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            L+G       L  ++  Y+ +G +   +    +  ++    K  +S  L  A+G+ +L 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LAS 248
               + VH+D    N ++DE F  KVAD GL   +   +         A         A 
Sbjct: 142 EQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA--RLPVKWTAL 197

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E  +  RF+ KSDV+SFGV L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  127 bits (321), Expect = 4e-35
 Identities = 60/260 (23%), Positives = 102/260 (39%), Gaps = 51/260 (19%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQ----EFIDEV 121
           + L+L  K       +G G FG V KG  Q       VA+K  +  A       E + E 
Sbjct: 16  KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +  + +  +V ++G C+  +   L+ E    G ++ +L     V  + +     + + 
Sbjct: 70  NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELV 123

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              + G+ +L       VH+D    NVL+     AK++D GL   L   +     +   A
Sbjct: 124 HQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKA 176

Query: 242 DEI------FLASEVKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS-- 283
                    + A E   + +FS KSDV+SFGV + E  S          G E ++ L   
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236

Query: 284 ------PDSSQDLVELMIKC 297
                     +++ +LM  C
Sbjct: 237 ERMGCPAGCPREMYDLMNLC 256

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (320), Expect = 5e-35
 Identities = 58/244 (23%), Positives = 104/244 (42%), Gaps = 44/244 (18%)

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 136
           +GEG FGEVY+G+  +     + VA+K  +         +F+ E   + ++ H ++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G  +E    ++I E  P G +  +L    + ++  L+    +  +L   K +A+L S+  
Sbjct: 80  GIIEEEPT-WIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 251
             VH+D    N+LV      K+ D GL  ++   D      +++     + E        
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN----- 187

Query: 252 EFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVEL 293
            FRRF+  SDV+ F V + E++S           ++    L               L  L
Sbjct: 188 -FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 246

Query: 294 MIKC 297
           M +C
Sbjct: 247 MTRC 250

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  127 bits (321), Expect = 6e-35
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 82  KNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNL 132
           K  +GEG FG+V+          +D MLVA+K  +       ++F  E   L ++QH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 133 VTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 181
           V   G C + +   +++EY+ +G              I + G  + ++ +L     L IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV 239
              A G+ +L S     VH+D  T N LV  + + K+ D G+   +  TD    G  + +
Sbjct: 140 SQIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 240 ----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                  E  +      +R+F+ +SDV+SFGV L E+ +
Sbjct: 198 PIRWMPPESIM------YRKFTTESDVWSFGVILWEIFT 230

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (324), Expect = 8e-35
 Identities = 70/264 (26%), Positives = 107/264 (40%), Gaps = 26/264 (9%)

Query: 28  FCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSI---REARRFQMEELSLATKNFSDKNL 84
            C     S S   + GS     Q    V I+LS       +  Q   +  ++       +
Sbjct: 37  ICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV 96

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLL 136
           IG G FG VY G L D     +  A+K         E   F+ E   +    H N+++LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 137 GYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           G C  +     ++  Y+ +G +   +    +        K  +   L  AKG+  L S  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFLASK- 211

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEV 250
            + VH+D    N ++DE F  KVAD GL   +   +     S        L     A E 
Sbjct: 212 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---FDSVHNKTGAKLPVKWMALES 267

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
            + ++F+ KSDV+SFGV L EL++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  126 bits (318), Expect = 9e-35
 Identities = 63/244 (25%), Positives = 101/244 (41%), Gaps = 44/244 (18%)

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK  +         +F+ E   +    H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G   EN + ++I E    G +   L    QV +  L+    +  A   +  LA+L S   
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESK-- 135

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 251
           R VH+D    NVLV  +   K+ D GL  ++  +        ++     A E        
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN----- 190

Query: 252 EFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVEL 293
            FRRF+  SDV+ FGV + E++             +    +         P+    L  L
Sbjct: 191 -FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 249

Query: 294 MIKC 297
           M KC
Sbjct: 250 MTKC 253

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (319), Expect = 1e-34
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 23/206 (11%)

Query: 83  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
            +IG G FG VY G L D     +  A+K         E   F+ E   +    H N+++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 135 LLGYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           LLG C  +     ++  Y+ +G +   +    +        K  +   L  AKG+ +L S
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 248
              + VH+D    N ++DE F  KVAD GL   +   +     S        L     A 
Sbjct: 147 K--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMAL 201

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E  + ++F+ KSDV+SFGV L EL++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  128 bits (323), Expect = 1e-34
 Identities = 60/251 (23%), Positives = 109/251 (43%), Gaps = 45/251 (17%)

Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 136
           +G G+FGEV  G L+      + VAIK  + G   +   +F+ E   +    H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G   ++    ++ EY+ NGS+   L    +    +      + +  G A G+ +L  +  
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 249
             VH+D    N+L++ + + KV+D GL R      + A  +         T+ E      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--- 223

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLV 291
              +R+F+  SDV+S+G+ L E++S           ++   ++          D    L 
Sbjct: 224 ---YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280

Query: 292 ELMIKCMGKER 302
           +LM+ C  K+R
Sbjct: 281 QLMLDCWQKDR 291

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  125 bits (317), Expect = 2e-34
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 35/220 (15%)

Query: 82  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRN 131
              +GE +FG+VYKG L           VAIK  +  A      EF  E    A +QH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSI 180
           +V LLG   ++    +I+ Y  +G              +      +  +  LE    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQ 238
               A G+ +L S    VVHKD  T NVLV +    K++D GL   +   D      +S 
Sbjct: 134 VAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 239 V----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +     A E  +      + +FS  SD++S+GV L E+ S
Sbjct: 192 LPIRWMAPEAIM------YGKFSIDSDIWSYGVVLWEVFS 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (328), Expect = 3e-34
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 43/249 (17%)

Query: 85  IGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTLLG 137
           +G G FG V +G+ +     + VAIK  + G     T+E + E   +  + +  +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            CQ   L  L+ E    G +   L       R+++   +   +    + G+ +L      
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--N 456

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEVK 251
            VH++    NVL+     AK++D GL   LG  D     S  TA         + A E  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECI 511

Query: 252 EFRRFSEKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVEL 293
            FR+FS +SDV+S+GV + E +S          G E  + +         P+   +L  L
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 571

Query: 294 MIKCMGKER 302
           M  C   + 
Sbjct: 572 MSDCWIYKW 580

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (316), Expect = 6e-34
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+     +       MLVA+K  +  + +   +F  E   L  +QH+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 136 LGYCQENNLQFLIYEYIPNGS----------VSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            G C E     +++EY+ +G            +  L G   V+   L     L++A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV---- 239
            G+ +L  L    VH+D  T N LV +  + K+ D G+   +  TD    G  + +    
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              E  L      +R+F+ +SDV+SFGV L E+ +
Sbjct: 227 MPPESIL------YRKFTTESDVWSFGVVLWEIFT 255

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (314), Expect = 8e-34
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 50/226 (22%)

Query: 85  IGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +            M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 134 TLLGYCQENNLQFLIYEYIPNGS-------------VSIHLYGPSQVSRQKLEFKHRLSI 180
            LLG C       +I EY   G               S       +     L+ +  LS 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           +   AKG+A L S     +H+D    N+L+    I K+ D GL            +  + 
Sbjct: 151 SYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGL------------ARDIK 196

Query: 241 ADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS 274
            D  ++        VK           ++ +SDV+S+G+FL EL S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (324), Expect = 1e-33
 Identities = 73/298 (24%), Positives = 116/298 (38%), Gaps = 54/298 (18%)

Query: 31  YRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKF 90
            R+ +VS +     +E   +        +        Q E + L          IGEG+F
Sbjct: 354 VRSHTVSVSETDDYAEIIDEEDTY---TMPSTRDYEIQRERIELGRC-------IGEGQF 403

Query: 91  GEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQEN 142
           G+V++G+        M VAIK  +         +F+ E   +    H ++V L+G   EN
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I E    G +   L    QV +  L+    +  A   +  LA+L S   R VH+D
Sbjct: 464 PV-WIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLESK--RFVHRD 516

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVKEFRRFS 257
               NVLV  +   K+ D GL  ++  +          A +  L     A E   FRRF+
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFT 570

Query: 258 EKSDVYSFGVFLLELVS----------GREASSSLS--------PDSSQDLVELMIKC 297
             SDV+ FGV + E++             +    +         P+    L  LM KC
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 628

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (313), Expect = 1e-33
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 34/217 (15%)

Query: 82  KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++     M  AIK+ +  A   +   F  E+  L  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 134 TLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIAL 182
            LLG C+     +L  EY P+G+            +   +  +  +   L  +  L  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 241
             A+G+ +L     + +H+D    N+LV E+++AK+AD GL R      +V         
Sbjct: 150 DVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKT 199

Query: 242 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                   +A E   +  ++  SDV+S+GV L E+VS
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  123 bits (310), Expect = 4e-33
 Identities = 62/287 (21%), Positives = 104/287 (36%), Gaps = 58/287 (20%)

Query: 20  GIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNF 79
           G+ +       Y+ R     S  G+S   + P      +L   E   F    L       
Sbjct: 1   GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQF----- 50

Query: 80  SDKNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 128
                +G G FG+V +            + VA+K  +  A   E    + E+  ++ + Q
Sbjct: 51  --GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLS 179
           H N+V LLG C       +I EY   G +   L              ++      +  L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
            +   A+G+A L S     +H+D    NVL+    +AK+ D GL            +  +
Sbjct: 169 FSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGL------------ARDI 214

Query: 240 TADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS 274
             D  ++        VK           ++ +SDV+S+G+ L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  122 bits (307), Expect = 8e-33
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIK--KRPGAPTQE---FIDEVCFLASIQHRNL 132
             ++GEG+FG V +G L+      + VA+K  K   +  +E   F+ E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 133 VTLLGYC-----QENNLQFLIYEYIPNGSVSIHL-YGPSQVSRQKLEFKHRLSIALGAAK 186
           + LLG C     Q      +I  ++  G +  +L Y   +   + +  +  L   +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV----T 240
           G+ +L +     +H+D    N ++ +D    VAD GL   +   D    G  +++     
Sbjct: 159 GMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           A E          R ++ KSDV++FGV + E+ +
Sbjct: 217 AIESLA------DRVYTSKSDVWAFGVTMWEIAT 244

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  121 bits (305), Expect = 2e-32
 Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 29/211 (13%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +G G FGEVY+G +         + VA+K        Q+   F+ E   ++   H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            +G   ++  +F++ E +  G +   L    P       L     L +A   A G  +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 193 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 243
                 +H+D    N L+       +AK+ D G+   + R      G  + +       E
Sbjct: 158 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            F+         F+ K+D +SFGV L E+ S
Sbjct: 216 AFM------EGIFTSKTDTWSFGVLLWEIFS 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  121 bits (305), Expect = 2e-32
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 29/211 (13%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G+ +          VAIK     A  +E   F++E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           LLG   +     +I E +  G +  +L        +            + +A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 243
           +L++   + VH+D    N +V EDF  K+ D G+   +  TD    G    +     + E
Sbjct: 153 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                       F+  SDV+SFGV L E+ +
Sbjct: 211 SLK------DGVFTTYSDVWSFGVVLWEIAT 235

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (304), Expect = 2e-32
 Identities = 49/238 (20%), Positives = 101/238 (42%), Gaps = 30/238 (12%)

Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAP 113
           L I +  + ++E++ +  + F+   ++G+G+FG V +  L+      + VA+K  +    
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64

Query: 114 T----QEFIDEVCFLASIQHRNLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYG 163
                +EF+ E   +    H ++  L+G            +  +I  ++ +G +   L  
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124

Query: 164 PS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
                +   L  +  +   +  A G+ +L S     +H+D    N ++ ED    VAD G
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFG 182

Query: 223 LRNFLGRTDV--AGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L   +   D    G +S++     A E            ++  SDV++FGV + E+++
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLA------DNLYTVHSDVWAFGVTMWEIMT 234

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (304), Expect = 4e-32
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 34/221 (15%)

Query: 82  KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 128
              +GEG FG+V                + VA+K  +  A  ++    + E+  +  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 177
           H+N++ LLG C ++   ++I EY   G+              + Y  ++V  +++ FK  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           +S     A+G+ +L S   + +H+D    NVLV E+ + K+AD GL   +   D      
Sbjct: 160 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213

Query: 238 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + T +       +A E    R ++ +SDV+SFGV + E+ +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (302), Expect = 4e-32
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)

Query: 85  IGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +              VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 134 TLLGYC-QENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 181
            LLG C +      +I E+   G+              +   P  + +  L  +H +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              AKG+  L S   + +H+D    N+L+ E  + K+ D GL   + +            
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKG 208

Query: 242 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D       +A E    R ++ +SDV+SFGV L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (302), Expect = 1e-31
 Identities = 66/261 (25%), Positives = 107/261 (40%), Gaps = 41/261 (15%)

Query: 42  TGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD- 100
           T +             EL          + L L          +GEG FG+V        
Sbjct: 41  TENLYFQGMLAGVSEYELPEDPRWELPRDRLVL-------GKPLGEGAFGQVVLAEAIGL 93

Query: 101 -------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI 148
                     VA+K  +  A  ++    I E+  +  I +H+N++ LLG C ++   ++I
Sbjct: 94  DKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153

Query: 149 YEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            EY   G+              + Y PS    ++L  K  +S A   A+G+ +L S   +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--K 211

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVKEF 253
            +H+D    NVLV ED + K+AD GL   +   D      + T +       +A E    
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFD 267

Query: 254 RRFSEKSDVYSFGVFLLELVS 274
           R ++ +SDV+SFGV L E+ +
Sbjct: 268 RIYTHQSDVWSFGVLLWEIFT 288

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  118 bits (298), Expect = 1e-31
 Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 45/226 (19%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +GEG+FG+V K              VA+K  +  A   E    + E   L  + H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 135 LLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKLEFK 175
           L G C ++    LI EY   GS                    S +         + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 176 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VA 233
             +S A   ++G+ +L  +  ++VH+D    N+LV E    K++D GL   +   D  V 
Sbjct: 151 DLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 234 GPSSQV----TADE-IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               ++     A E +F          ++ +SDV+SFGV L E+V+
Sbjct: 209 RSQGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVT 247

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (301), Expect = 2e-31
 Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 29/211 (13%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +G G FGEVY+G +         + VA+K        Q+   F+ E   ++   H+N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            +G   ++  +F++ E +  G +   L    P       L     L +A   A G  +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 193 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 243
                 +H+D    N L+       +AK+ D G+   + R      G  + +       E
Sbjct: 199 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            F+         F+ K+D +SFGV L E+ S
Sbjct: 257 AFM------EGIFTSKTDTWSFGVLLWEIFS 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  119 bits (300), Expect = 2e-31
 Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 46/282 (16%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDK--------- 82
             R V+ ++E+ SS  S  P   +   LS        +  +S        K         
Sbjct: 26  LRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTP-MLAGVSEYELPEDPKWEFPRDKLT 84

Query: 83  --NLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI- 127
               +GEG FG+V                + VA+K  +  A  ++    + E+  +  I 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKH 176
           +H+N++ LLG C ++   ++I EY   G+              + Y  ++V  +++ FK 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
            +S     A+G+ +L S   + +H+D    NVLV E+ + K+AD GL   +   D     
Sbjct: 205 LVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259

Query: 237 SQVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            + T +       +A E    R ++ +SDV+SFGV + E+ +
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (298), Expect = 3e-31
 Identities = 54/234 (23%), Positives = 86/234 (36%), Gaps = 55/234 (23%)

Query: 82  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHR 130
             ++G G FG+V              + VA+K  +  A + E    + E+  +  +  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGS------------------VSIHLYGPSQVSRQKL 172
           N+V LLG C  +   +LI+EY   G                            +     L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 173 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
            F+  L  A   AKG+  L       VH+D    NVLV    + K+ D GL         
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGL--------- 218

Query: 233 AGPSSQVTADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS 274
              +  + +D  ++        VK           ++ KSDV+S+G+ L E+ S
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  117 bits (295), Expect = 3e-31
 Identities = 47/260 (18%), Positives = 96/260 (36%), Gaps = 60/260 (23%)

Query: 85  IGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLV 133
           +G+G F +++KG+ ++           V +K            F +    ++ + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G C   +   L+ E++  GS+  +L    + ++  +    +L +A   A  +  L  
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 194 LSPRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
               ++H +    N+L+  +           K++D G+            S  V   +I 
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------------SITVLPKDIL 177

Query: 246 ------LASE-VKEFRRFSEKSDVYSFGVFLLELVS-GR---------------EASSSL 282
                 +  E ++  +  +  +D +SFG  L E+ S G                E    L
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237

Query: 283 SPDSSQDLVELMIKCMGKER 302
               + +L  L+  CM  E 
Sbjct: 238 PAPKAAELANLINNCMDYEP 257

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  118 bits (297), Expect = 3e-31
 Identities = 60/229 (26%), Positives = 90/229 (39%), Gaps = 45/229 (19%)

Query: 82  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRN 131
              IGEG FG V++             +VA+K  +  A       F  E   +A   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKL 172
           +V LLG C       L++EY+  G                            S      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 173 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 231
               +L IA   A G+A+L     + VH+D  T N LV E+ + K+AD GL RN +   D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRN-IYSAD 228

Query: 232 --VAGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
              A  +  +       E         + R++ +SDV+++GV L E+ S
Sbjct: 229 YYKADGNDAIPIRWMPPESIF------YNRYTTESDVWAYGVVLWEIFS 271

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  107 bits (270), Expect = 9e-28
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 37/212 (17%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
            IG G F  VYKGL  +  + VA       K   +  Q F +E   L  +QH N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 138 Y----CQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 185
                 +      L+ E + +G++   +  +            RQ L+            
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK------------ 140

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
            GL  LH+ +P ++H+D K  N+ +       K+ D GL      +     +   T +  
Sbjct: 141 -GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPE-- 195

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           F+A E+ E  ++ E  DVY+FG+ +LE+ +  
Sbjct: 196 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSE 226

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  108 bits (271), Expect = 1e-27
 Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 35/261 (13%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIE-LSIREARRFQMEELSLATKNFSDKNLIGEGKF 90
              S+++T  +GS++           E + + E  +    E        + +  +G G F
Sbjct: 12  SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSF 71

Query: 91  GEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 149
           GEV++    Q G   A+KK      +   +E+   A +    +V L G  +E     +  
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFM 129

Query: 150 EYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 201
           E +  GS+   I   G            Q LE             GL +LH+   R++H 
Sbjct: 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------------GLEYLHTR--RILHG 174

Query: 202 DFKTANVLVDED-FIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           D K  NVL+  D   A + D G       + LG++ + G     T  E  +A EV   + 
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT--ETHMAPEVVMGKP 232

Query: 256 FSEKSDVYSFGVFLLELVSGR 276
              K D++S    +L +++G 
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (269), Expect = 2e-27
 Identities = 52/261 (19%), Positives = 104/261 (39%), Gaps = 38/261 (14%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT---QEFIDEVCFLASI-Q 128
           T  F +   IG G+FG V+K +   DG + AIK+  +P A +   Q  + EV   A + Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H ++V       E++   +  EY   GS++      +       +      + L   +GL
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLA-DAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-------GPSSQVTA 241
            ++HS+   +VH D K +N+ +    I   A          ++         G  +++++
Sbjct: 129 RYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 242 DEIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSS------------- 281
            ++       LA+EV +E      K+D+++  + ++          +             
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246

Query: 282 -LSPDSSQDLVELMIKCMGKE 301
            +    SQ+  EL+   +  +
Sbjct: 247 RIPQVLSQEFTELLKVMIHPD 267

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (263), Expect = 2e-26
 Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 21/233 (9%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI 118
           RE   FQ   + +  K++     +GEG F  V     L DG   A+K+        +E  
Sbjct: 14  RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73

Query: 119 D-EVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             E        H N++ L+ YC          +L+  +   G++   +    +     L 
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLT 132

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
               L + LG  +GL  +H+      H+D K  N+L+ ++    + D G  N        
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 234 GPSSQVTADEI-------FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
              +    D         + A E+   +      E++DV+S G  L  ++ G 
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  103 bits (258), Expect = 7e-26
 Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 49/302 (16%)

Query: 22  IFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSD 81
           ++F S    ++ +    +    +SE    PG +       R    FQ        ++F  
Sbjct: 18  LYFQSM---HQLQPRRVSFRGEASETLQSPGYD-----PSRPESFFQ--------QSFQR 61

Query: 82  KNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQE---FIDEVCFLASI-QHRNLVT 134
            + +G G +GEV+K    +DG L A+K    P    ++    + EV     + QH   V 
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L    +E  + +L  E     S+  H     +     L               LAHLHS 
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
              +VH D K AN+ +      K+ D GL   LG         Q   D  ++A E+ +  
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPRYMAPELLQ-G 230

Query: 255 RFSEKSDVYSFGVFLLELVSGREA---------------SSSLSPDSSQDLVELMIKCMG 299
            +   +DV+S G+ +LE+    E                    +   S +L  +++  + 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290

Query: 300 KE 301
            +
Sbjct: 291 PD 292

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  103 bits (258), Expect = 9e-26
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT----QEFIDEVCFLASIQH 129
            NF  +  IG G+F EVY+   L DG+ VA+KK             + I E+  L  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKG 187
            N++       E+N   ++ E    G +S  +       +QK     R      +     
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIF 245
           L H+HS   RV+H+D K ANV +    + K+ D GL R F  +T  A   S V T    +
Sbjct: 149 LEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTP--YY 202

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++ E      ++ KSD++S G  L E+ + +
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  102 bits (256), Expect = 3e-25
 Identities = 54/250 (21%), Positives = 105/250 (42%), Gaps = 34/250 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           + +     IGEG FG+       +DG    IK+           +E   EV  LA+++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V      +EN   +++ +Y   G +   +   +       +    L   +     L H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIFLAS 248
           +H    +++H+D K+ N+ + +D   ++ D G+ R      ++A   + + T    +L+ 
Sbjct: 141 VHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTP--YYLSP 194

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR---EASS--------------SLSPDSSQDLV 291
           E+ E + ++ KSD+++ G  L EL + +   EA S               +S   S DL 
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254

Query: 292 ELMIKCMGKE 301
            L+ +   + 
Sbjct: 255 SLVSQLFKRN 264

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 99.4 bits (248), Expect = 2e-24
 Identities = 46/267 (17%), Positives = 86/267 (32%), Gaps = 46/267 (17%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 131
            +F     +G G FG V++     D    AIK+          ++ + EV  LA ++H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 132 LVTLLGYCQENNLQ------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           +V       E N              ++  +     ++   +    + + ++ E    L 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLH 122

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           I L  A+ +  LHS    ++H+D K +N+    D + KV D GL   + + +        
Sbjct: 123 IFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 240 TADEIFLAS----------EVKEFRRFSEKSDVYSFGVFLLELVSGREASS--------- 280
                              E      +S K D++S G+ L EL+                
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240

Query: 281 ------SLSPDSSQDLVELMIKCMGKE 301
                  L          ++   +   
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPS 267

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 98.5 bits (246), Expect = 3e-24
 Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 40/255 (15%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +F +  LIG G FG+V+K     DG    IK+      ++   EV  LA + H N+V  
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHY 69

Query: 136 LGYCQENNLQ----------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
            G     +                  F+  E+   G++   +    +   +KL+    L 
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALE 126

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           +     KG+ ++HS   +++++D K +N+ + +    K+ D GL   L        +   
Sbjct: 127 LFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182

Query: 240 -TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR----EASS--------SLSPDS 286
            T    +++ E    + + ++ D+Y+ G+ L EL+       E S          +S   
Sbjct: 183 GTLR--YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF 240

Query: 287 SQDLVELMIKCMGKE 301
            +    L+ K + K+
Sbjct: 241 DKKEKTLLQKLLSKK 255

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.4 bits (243), Expect = 8e-24
 Identities = 48/215 (22%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 131
            K ++    IG+G  G VY  + +  G  VAI++   +     +  I+E+  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           +V  L  Y   + L +++ EY+  GS++        V+   ++     ++     + L  
Sbjct: 79  IVNYLDSYLVGDEL-WVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEF 131

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 244
           LHS   +V+H+D K+ N+L+  D   K+ D G              +Q+T ++       
Sbjct: 132 LHSN--QVIHRDIKSDNILLGMDGSVKLTDFGF------------CAQITPEQSKRSTMV 177

Query: 245 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++A EV   + +  K D++S G+  +E++ G
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.4 bits (243), Expect = 9e-24
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHR 130
            + F+    IG+G FGEV+KG+  +   +VAIK       ++ I+    E+  L+     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 131 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            +    G Y ++  L ++I EY+  GS    L  P       L+     +I     KGL 
Sbjct: 81  YVTKYYGSYLKDTKL-WIIMEYLGGGSAL-DLLEP-----GPLDETQIATILREILKGLD 133

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGLRNFLGR--TDVAGPSSQVTADE 243
           +LHS   + +H+D K ANVL+ E    K+AD      L +   +  T V  P        
Sbjct: 134 YLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP-------- 183

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            ++A EV +   +  K+D++S G+  +EL  G
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 96.7 bits (241), Expect = 2e-23
 Identities = 55/280 (19%), Positives = 90/280 (32%), Gaps = 50/280 (17%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEF 117
           R+   F  + + L       + ++ EG F  VY+   +  G   A+K          +  
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 118 IDEVCFLASIQ-HRNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           I EVCF+  +  H N+V                  +FL+   +  G +   L      SR
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESR 130

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L     L I     + + H+H   P ++H+D K  N+L+      K+ D G    +  
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI-- 188

Query: 230 TDVAGPSSQVTADEIFLASEVKE---------------FRRF--SEKSDVYSFGVFLLEL 272
                P    +A    L  E                  +  F   EK D+++ G  L  L
Sbjct: 189 --SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 273 VSGR---EASSSL-----------SPDSSQDLVELMIKCM 298
              +   E  + L                     L I+ M
Sbjct: 247 CFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL-IRAM 285

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.4 bits (238), Expect = 4e-23
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 35/214 (16%)

Query: 81  DKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           D+ ++G+G +G VY G  L + + +AIK   +R    +Q   +E+     ++H+N+V  L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 137 GYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVS--------RQKLEFKHRLSIALGAA 185
           G   EN    +  E +P GS+S      +GP + +        +Q LE            
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE------------ 133

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
            GL +LH    ++VH+D K  NVL++    + K++D G    L   +    +   T    
Sbjct: 134 -GLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL--Q 188

Query: 245 FLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++A E+  K  R + + +D++S G  ++E+ +G+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 95.5 bits (238), Expect = 4e-23
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 131
            + +     +G+G FG+VYK    + G L A K    +     +++I E+  LA+  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           +V LLG Y  +  L +++ E+ P G+V   +        + L       +     + L  
Sbjct: 78  IVKLLGAYYHDGKL-WIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNF 132

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLG-RTDVAGPSSQVT----A 241
           LHS   R++H+D K  NVL+  +   ++AD G        L  R    G     T    A
Sbjct: 133 LHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-----TPYWMA 185

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
            E+ +   +K+   +  K+D++S G+ L+E+         L+P
Sbjct: 186 PEVVMCETMKD-TPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.1 bits (237), Expect = 8e-23
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 38/237 (16%)

Query: 58  ELSIREARRFQMEELSLA------TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP 110
            + +R   R Q+++L          + F     +GEG +G VYK +  + G +VAIK+ P
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63

Query: 111 GAP-TQEFIDEVCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
                QE I E+  +      ++V   G Y +  +L +++ EY   GSVS  +    ++ 
Sbjct: 64  VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVS-DII---RLR 118

Query: 169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 228
            + L      +I     KGL +LH +  R +H+D K  N+L++ +  AK+AD     F  
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLAD-----F-- 169

Query: 229 RTDVAGPSSQVTADEI----------FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                G + Q+T              ++A EV +   ++  +D++S G+  +E+  G
Sbjct: 170 -----GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 36/215 (16%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 131
                    IGEG  G V        G  VA+K    R     +   +EV  +   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           +V +   Y     L +++ E++  G+++        VS+ +L  +   ++     + LA+
Sbjct: 104 VVEMYKSYLVGEEL-WVLMEFLQGGALT------DIVSQVRLNEEQIATVCEAVLQALAY 156

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 244
           LH+    V+H+D K+ ++L+  D   K++D G              +Q++ D        
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGF------------CAQISKDVPKRKSLV 202

Query: 245 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++A EV     ++ + D++S G+ ++E+V G
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 24/221 (10%)

Query: 73  SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 127
           S+   ++  + +IG G    V           VAIK+    +      E + E+  ++  
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 128 QHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALG 183
            H N+V+    +  ++ L +L+ + +  GSV     H+    +     L+     +I   
Sbjct: 71  HHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTAD 242
             +GL +LH      +H+D K  N+L+ ED   ++AD G+  FL    D+     + T  
Sbjct: 130 VLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-- 185

Query: 243 EIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 276
             F      +A EV ++ R +  K+D++SFG+  +EL +G 
Sbjct: 186 --FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 93.1 bits (232), Expect = 2e-22
 Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 28/235 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           +++     IG G +G   K     DG ++  K+        A  Q  + EV  L  ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 131 NLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAK 186
           N+V        + N   +++ EY   G ++  +   ++ ++++        L +      
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 187 GLAHLHS---LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQV-TA 241
            L   H        V+H+D K ANV +D     K+ D GL   L      A   + V T 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTP 180

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
              +++ E      ++EKSD++S G  L EL +         P ++    EL  K
Sbjct: 181 --YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGK 227

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 93.1 bits (232), Expect = 3e-22
 Identities = 57/257 (22%), Positives = 106/257 (41%), Gaps = 56/257 (21%)

Query: 84  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 134
            +G G    VY    +D +L   VAIK    P    +E +     EV   + + H+N+V+
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 135 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           ++   +E++  +L+ EYI   ++S  I  +GP       L     ++       G+ H H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGIKHAH 128

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---- 248
            +  R+VH+D K  N+L+D +   K+ D G+         A   + +T     L +    
Sbjct: 129 DM--RIVHRDIKPQNILIDSNKTLKIFDFGIA-------KALSETSLTQTNHVLGTVQYF 179

Query: 249 --EVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------EASSSLSPD 285
             E  +     E +D+YS G+ L E++ G                        ++ +  D
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 286 SSQDLVELMIKCMGKER 302
             Q L  ++++   K++
Sbjct: 240 IPQSLSNVILRATEKDK 256

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 94.6 bits (235), Expect = 3e-22
 Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 34/244 (13%)

Query: 63  EARRFQMEELSLATKNFSDKNLIGEG--KFGEVYKGL-LQDGMLVAIK-----KRPGAPT 114
                 M         +    +IG+G      V        G  V ++            
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70

Query: 115 QEFIDEVCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
                E+       H N+V     +  +N L +++  ++  GS    L            
Sbjct: 71  TFLQGELHVSKLFNHPNIVPYRATFIADNEL-WVVTSFMAYGSAK-DLI--------CTH 120

Query: 174 FKHRLS---IAL---GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----L 223
           F   ++   IA    G  K L ++H +    VH+  K +++L+  D    ++       +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178

Query: 224 RNFLGRTDVAGPSSQVTADEIF-LASEV--KEFRRFSEKSDVYSFGVFLLELVSGREASS 280
            +   R  V     + +   +  L+ EV  +  + +  KSD+YS G+   EL +G     
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

Query: 281 SLSP 284
            +  
Sbjct: 239 DMPA 242

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 93.0 bits (231), Expect = 1e-21
 Identities = 50/262 (19%), Positives = 97/262 (37%), Gaps = 28/262 (10%)

Query: 33  NRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGE 92
             S  + +     E       ++G +   + +     E +S+  + +S    IG G   +
Sbjct: 13  RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS-ANECISVKGRIYSILKQIGSGGSSK 71

Query: 93  VYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL--VTLLGYCQENNLQ 145
           V++ L +   + AIK     +        + +E+ +L  +Q  +   + L  Y   +   
Sbjct: 72  VFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131

Query: 146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 205
           +++ E   N  ++  L       ++ ++   R S      + +  +H     +VH D K 
Sbjct: 132 YMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKP 183

Query: 206 ANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADEIFL-----ASEVKEFR 254
           AN L+ +  + K+ D G+       T      SQV        E            K   
Sbjct: 184 ANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 255 RFSEKSDVYSFGVFLLELVSGR 276
           + S KSDV+S G  L  +  G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 1e-21
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 35/237 (14%)

Query: 63  EARRFQMEELSLA-----TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT 114
           ++    ++E+ L+        F    L+G G +G+VYKG  ++ G L AIK     G   
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE 64

Query: 115 QEFIDEVCFLASI-QHRNLVTLLG-YCQENNLQF-----LIYEYIPNGSVSIHLYGPSQV 167
           +E   E+  L     HRN+ T  G + ++N         L+ E+   GSV+  L   ++ 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTK- 122

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGL 223
               L+ +    I     +GL+HLH    +V+H+D K  NVL+ E+   K+ D    A L
Sbjct: 123 -GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 224 RNFLG-RTDVAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              +G R    G     T    A E+    E  +   +  KSD++S G+  +E+  G
Sbjct: 180 DRTVGRRNTFIG-----TPYWMAPEVIACDENPD-ATYDFKSDLWSLGITAIEMAEG 230

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 90.5 bits (225), Expect = 5e-21
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 27/218 (12%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           + +S    IG G   +V++ L +   + AIK     +        + +E+ +L  +Q  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 132 L--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
              + L  Y   +   +++ E   N  ++  L       ++ ++   R S      + + 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 122

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADE 243
            +H     +VH D K AN L+ +  + K+ D G+       T      SQV T      E
Sbjct: 123 TIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 244 IFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                       K   + S KSDV+S G  L  +  G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 90.6 bits (225), Expect = 5e-21
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 37/217 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 128
            K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           H N +   G Y +E+   +L+ EY    +  +      +V ++ L+     ++  GA +G
Sbjct: 113 HPNTIQYRGCYLREHTA-WLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQG 166

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-- 245
           LA+LHS    ++H+D K  N+L+ E  + K+ D     F       G +S +     F  
Sbjct: 167 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGD-----F-------GSASIMAPANSFVG 212

Query: 246 ----LASEV---KEFRRFSEKSDVYSFGVFLLELVSG 275
               +A EV    +  ++  K DV+S G+  +EL   
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.4 bits (224), Expect = 8e-21
 Identities = 36/227 (15%), Positives = 77/227 (33%), Gaps = 22/227 (9%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKG------LLQDGMLVAIKK-RPGAPTQEFI--DE 120
            E  L +K     +L+GEG F +VY+         ++     +K  +P  P + +I    
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           +  L        +         N   L+ E    G++   +        + +     +S 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--------V 232
           A+     +  +H     ++H D K  N ++   F+ +  +  L   L   D        +
Sbjct: 178 AMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 233 AGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +  TA      F   E+   + ++ + D +     +  ++ G 
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 89.3 bits (222), Expect = 9e-21
 Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 27/225 (12%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
           + +S+  + +S    IG G   +V++ L +   + AIK     +        + +E+ +L
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 80

Query: 125 ASIQHRNL--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
             +Q  +   + L  Y   +   +++ E   N  ++  L       ++ ++   R S   
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWK 134

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T 240
              + +  +H     +VH D K AN L+ +  + K+ D G+       T      SQV T
Sbjct: 135 NMLEAVHTIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 241 ----ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 E            K   + S KSDV+S G  L  +  G+
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 44/240 (18%), Positives = 88/240 (36%), Gaps = 40/240 (16%)

Query: 84  LIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLVTLLG 137
            I  G  G +Y       +G  V +K    +   E       E  FLA + H ++V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 138 YCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           + +  +     + +++ EY+   S+        +   QKL     ++  L     L++LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-------RSKGQKLPVAEAIAYLLEILPALSYLH 199

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVK 251
           S+   +V+ D K  N+++ E+ + K+ D G  + +     + G     T    F A E+ 
Sbjct: 200 SI--GLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLYG-----TPG--FQAPEIV 249

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR----------EASSSLSPDSSQDLVELMIKCMGKE 301
                +  +D+Y+ G  L  L                       +      L+ + +  +
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPD 308

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 27/276 (9%), Positives = 64/276 (23%), Gaps = 54/276 (19%)

Query: 37  SRTSETGSSEPSVQPGRNVGIE-LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYK 95
                   +           ++ L  +  R+ ++ E             +  G    V+ 
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEP------------LRVGDRSVVFL 80

Query: 96  GL-LQDGMLVAIK------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ--- 145
              ++     A+K      +   +  +   +     A +   +        +        
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 146 -----------------------FLIYEYIP-NGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
                                   L+      +  +         V R          + 
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-RTDVAGPSSQVT 240
               +  A+L S    +VH  F   N+ +  D    + D      +G R   +       
Sbjct: 201 AQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYA 258

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             E   AS       F+   + +  G+ +  +    
Sbjct: 259 PREFLNAST----ATFTHALNAWQLGLSIYRVWCLF 290

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 87.8 bits (218), Expect = 3e-20
 Identities = 52/255 (20%), Positives = 92/255 (36%), Gaps = 43/255 (16%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNL 132
             +F +  ++G+G FG+V K     D    AIK  +         + EV  LAS+ H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 133 VTLLGYCQENNLQ-------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           V       E                 F+  EY  NG++   +           +      
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYWR 120

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ 238
           +     + L+++HS    ++H+D K  N+ +DE    K+ D GL +N     D+    SQ
Sbjct: 121 LFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 239 VTADEIFLAS-----------EVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDS 286
                    +           EV +     +EK D+YS G+   E++            +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST 230

Query: 287 SQDLVELMIKCMGKE 301
             + V ++ K     
Sbjct: 231 GMERVNILKKLRSVS 245

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 85.7 bits (213), Expect = 1e-19
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 83  NLIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVT 134
             +G+GKFG VY     Q   ++A+K       ++ G   Q    EV   + ++H N++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L GY  +    +LI EY P G+V   L         K + +   +     A  L++ HS 
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHSK 128

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQVTADEIFLASEVK 251
             RV+H+D K  N+L+      K+AD G         RTD+ G     T D  +L  E+ 
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD--YLPPEMI 179

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR 276
           E R   EK D++S GV   E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 40/212 (18%)

Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+G F + ++        + A K        +P    +    E+    S+ H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 194
            G+ ++N+  F++ E     S+           R+ L E + R         G  +LH  
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 246
             RV+H+D K  N+ ++ED   K+ D GL            +++V  D            
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 206

Query: 247 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A EV   +  S + DV+S G  +  L+ G+
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 40/212 (18%)

Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+G F + ++        + A K        +P    +    E+    S+ H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 194
            G+ ++N+  F++ E     S+           R+ L E + R         G  +LH  
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 134

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 246
             RV+H+D K  N+ ++ED   K+ D GL            +++V  D            
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 180

Query: 247 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A EV   +  S + DV+S G  +  L+ G+
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.9 bits (211), Expect = 4e-19
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 60/268 (22%)

Query: 61  IREARRFQMEELSLATKNFSDK----NLIGEGKFGEVYKGLLQDGMLVAIKK------RP 110
           +           +L  +   +K      +GEG +G VYK     G +VA+K+        
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 111 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLY 162
           G P+   I E+  L  + H N+V+L+          L++E++              +   
Sbjct: 61  GIPSTA-IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ-- 117

Query: 163 GPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 219
             SQ+     Q L             +G+AH H    R++H+D K  N+L++ D   K+A
Sbjct: 118 -DSQIKIYLYQLL-------------RGVAHCHQH--RILHRDLKPQNLLINSDGALKLA 161

Query: 220 DAGL-RNFLGRTDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
           D GL R F          +   VT    A ++ + S     +++S   D++S G    E+
Sbjct: 162 DFGLARAF---GIPVRSYTHEVVTLWYRAPDVLMGS-----KKYSTSVDIWSIGCIFAEM 213

Query: 273 VSGREASSSLSP-DSSQDLVELMIKCMG 299
           ++G+     L P  +  D +  +   +G
Sbjct: 214 ITGK----PLFPGVTDDDQLPKIFSILG 237

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 50/237 (21%), Positives = 100/237 (42%), Gaps = 33/237 (13%)

Query: 58  ELSIREARRFQMEEL--------SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKK 108
           EL + E +R ++E           L   +F   + +G G  G V+K      G+++A K 
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65

Query: 109 RPGAPTQEFIDEVC----FLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYG 163
                     +++      L       +V   G +  +  +  +  E++  GS+   L  
Sbjct: 66  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKK 124

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG- 222
             ++  Q L       +++   KGL +L     +++H+D K +N+LV+     K+ D G 
Sbjct: 125 AGRIPEQILG-----KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 223 ---LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              L + +  + V   S        +++ E  +   +S +SD++S G+ L+E+  GR
Sbjct: 179 SGQLIDSMANSFVGTRS--------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 82.7 bits (204), Expect = 3e-18
 Identities = 31/286 (10%), Positives = 80/286 (27%), Gaps = 47/286 (16%)

Query: 34  RSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQME-ELSLATKNFSDKNLIGEGKFGE 92
             + + +   +SE       ++         + F++E EL    +      ++G+     
Sbjct: 29  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88

Query: 93  VYKGL-LQDGMLVAIK-----KRPGAPTQE--------------------------FIDE 120
             +    + G    +      +RP +   +                          FI  
Sbjct: 89  YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148

Query: 121 VCFLASIQHRNLVTLLGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
              +   Q + ++ +    +     +  FL      N      +      + + L    R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRT 230
           L + L   + LA LH     +VH   +  ++++D+     +                   
Sbjct: 209 LQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSR 266

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               P  ++ A    ++         +   D ++ G+ +  +    
Sbjct: 267 GFEPP--ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.8 bits (203), Expect = 3e-18
 Identities = 53/252 (21%), Positives = 98/252 (38%), Gaps = 62/252 (24%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           + +     IGEG +G V+K    +   +VA+K+        G P+   + E+C L  ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQV---SRQKLEFKHRL 178
           +N+V L      +    L++E+          + +  +    P  V     Q L      
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLL------ 111

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSS 237
                  KGL   HS    V+H+D K  N+L++ +   K+A+ GL R F        P  
Sbjct: 112 -------KGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAF------GIPVR 156

Query: 238 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSS 287
             +           ++   +     + +S   D++S G    EL +       L P +  
Sbjct: 157 CYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRP---LFPGNDV 208

Query: 288 QDLVELMIKCMG 299
            D ++ + + +G
Sbjct: 209 DDQLKRIFRLLG 220

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 82.2 bits (204), Expect = 4e-18
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 35/239 (14%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
            F     +G G +  VYKGL    G+ VA+K+       G P+   I E+  +  ++H N
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELKHEN 64

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V L       N   L++E++ N             + + LE            +GLA  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT----A 241
           H    +++H+D K  N+L+++    K+ D GL R F        P +      VT    A
Sbjct: 125 HEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAF------GIPVNTFSSEVVTLWYRA 176

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCMG 299
            ++ + S     R +S   D++S G  L E+++G+     L P  + ++ ++L+   MG
Sbjct: 177 PDVLMGS-----RTYSTSIDIWSCGCILAEMITGK----PLFPGTNDEEQLKLIFDIMG 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 45/304 (14%), Positives = 92/304 (30%), Gaps = 75/304 (24%)

Query: 35  SVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY 94
            +             + G   G          +++  L            +G G  G+VY
Sbjct: 13  GLVPRGSHMDGTAESREGTQFG---------PYRLRRL------------VGRGGMGDVY 51

Query: 95  KGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVTLLGYCQENNLQ 145
           +   +D +    VA+K      +    F      E      +Q  ++V +  + + +   
Sbjct: 52  EA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109

Query: 146 FLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF 203
           ++    I    ++  +   GP       L     ++I       L   H+      H+D 
Sbjct: 110 YVDMRLINGVDLAAMLRRQGP-------LAPPRAVAIVRQIGSALDAAHAA--GATHRDV 160

Query: 204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------EVKEFRRFS 257
           K  N+LV  D  A + D G+         A    ++T     + +      E       +
Sbjct: 161 KPENILVSADDFAYLVDFGIA-------SATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 258 EKSDVYSFGVFLLELVSGR-------------------EASSSLSPDSSQDLVELMIKCM 298
            ++D+Y+    L E ++G                       S++ P        ++ + M
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGM 273

Query: 299 GKER 302
            K  
Sbjct: 274 AKNP 277

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.9 bits (203), Expect = 5e-18
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 41/240 (17%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
            + +  L+GEG +G V K      G +VAIKK               + E+  L  ++H 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA-MREIKLLKQLRHE 84

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           NLV LL  C++    +L++E+     V   +    ++    L+++           G+  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT--------- 240
            HS    ++H+D K  N+LV +  + K+ D G  R        A P              
Sbjct: 140 CHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTL------AAPGEVYDDEVATRWYR 191

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCMG 299
           A E+ +        ++ +  DV++ G  + E+  G      L P DS  D +  ++ C+G
Sbjct: 192 APELLVGD-----VKYGKAVDVWAIGCLVTEMFMGE----PLFPGDSDIDQLYHIMMCLG 242

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 81.5 bits (202), Expect = 5e-18
 Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 43/234 (18%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAP-TQEFIDEVCFLASIQHRNLVTLL 136
           IGEG +G V+K      G +VAIKK       P        + E+  L  ++H NLV LL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
              +      L++EY  +      +       ++ +      SI     + +   H    
Sbjct: 69  EVFRRKRRLHLVFEYCDH-----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT---------ADEIFL 246
             +H+D K  N+L+ +  + K+ D G  R         GPS             + E+ +
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL------TGPSDYYDDEVATRWYRSPELLV 175

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCMG 299
                   ++    DV++ G    EL+SG      L P  S  D + L+ K +G
Sbjct: 176 GD-----TQYGPPVDVWAIGCVFAELLSGV----PLWPGKSDVDQLYLIRKTLG 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 81.5 bits (202), Expect = 5e-18
 Identities = 53/261 (20%), Positives = 95/261 (36%), Gaps = 59/261 (22%)

Query: 84  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 134
           ++G G   EV+    +D      VA+K  +   A    F      E    A++ H  +V 
Sbjct: 19  ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 135 LLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           +    +       L +++ EY+   ++   +H  GP       +  K  + +   A + L
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLA 247
              H     ++H+D K AN+++      KV D G+ R       +A   + VT     + 
Sbjct: 130 NFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIAR------AIADSGNSVTQTAAVIG 181

Query: 248 S------EVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSS 281
           +      E         +SDVYS G  L E+++G                        S+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241

Query: 282 LSPDSSQDLVELMIKCMGKER 302
                S DL  +++K + K  
Sbjct: 242 RHEGLSADLDAVVLKALAKNP 262

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.6 bits (200), Expect = 7e-18
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           + +     IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHS 60

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V L           L++E++        L     V    LE     S  L    G+A+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT---- 240
            H    RV+H+D K  N+L++ +   K+AD GL R F        P  +     VT    
Sbjct: 116 CHDR--RVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIVTLWYR 167

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           A ++ + S     +++S   D++S G    E+V+G 
Sbjct: 168 APDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.5 bits (202), Expect = 8e-18
 Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 57/229 (24%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF-------IDEVCFLASI 127
           K +   + +GEG+F  VYK        +VAIKK + G  ++         + E+  L  +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 128 QHRNLVTLLG-YCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQKLEFKHR 177
            H N++ LL  +  ++N+  L+++++           S+ L  PS +       L     
Sbjct: 70  SHPNIIGLLDAFGHKSNI-SLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTL----- 122

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGP- 235
                   +GL +LH     ++H+D K  N+L+DE+ + K+AD GL ++F        P 
Sbjct: 123 --------QGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPN 166

Query: 236 ---SSQV-T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              + QV T    A E+   +     R +    D+++ G  L EL+   
Sbjct: 167 RAYTHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRV 210

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 42/212 (19%)

Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+GKFG VY     Q+  ++A+K       ++ G   Q    E+   + ++H N++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 189
             Y  +    +L+ E+ P G     LY       ++L+   R      A      A  L 
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGE----LY-------KELQKHGRFDEQRSATFMEELADALH 128

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEI 244
           + H    +V+H+D K  N+L+      K+AD G         V  PS +      T D  
Sbjct: 129 YCHER--KVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRRRTMCGTLD-- 177

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +L  E+ E +   EK D++  GV   E + G 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 35/217 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLL 136
           +F  K+++G G  G +    + D   VA+K+           EV  L  S +H N++   
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSL 194
              ++   Q++  E                V ++         +++      GLAHLHSL
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEY-------VEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 195 SPRVVHKDFKTANVLVDE------------DF-IAKVADAGLRNFLGRTDVAGPSSQVTA 241
              +VH+D K  N+L+              DF + K    G  +F  R+ V G       
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG---- 191

Query: 242 DEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSG 275
              ++A E+         +   D++S G     ++S 
Sbjct: 192 ---WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 80.2 bits (198), Expect = 2e-17
 Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 24/226 (10%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 123
           M   S +   +   +++G+G    V++G   + G L AIK         P    + E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 124 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           L  + H+N+V L    +E   +   LI E+ P GS+   L  PS  +   L     L + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 237
                G+ HL      +VH++ K  N++     D   + K+ D G    L   +     S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 238 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                     +++          +++    D++S GV      +G 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 45/237 (18%), Positives = 92/237 (38%), Gaps = 32/237 (13%)

Query: 68  QMEELSLATKNFSD----KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCF 123
           ++  +    ++  +    + ++G G  G V       G  VA+K+         + E+  
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61

Query: 124 L-ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 180
           L  S  H N++        +   ++  E   N ++   +     S  + +  +  + +S+
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------------EDFIAKVADAGLRNFL 227
               A G+AHLHSL  +++H+D K  N+LV              E+    ++D GL   L
Sbjct: 121 LRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 228 GRTDVAGPSSQVT--------ADEIFLAS-EVKEFRRFSEKSDVYSFGVFLLELVSG 275
                +  ++           A E+   S  ++  RR +   D++S G     ++S 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 49/217 (22%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           L+G+G F  VY+   +  G+ VAIK        + G   +   +EV     ++H +++ L
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 189
             Y +++N  +L+ E   NG ++ +L      +R K       S             G+ 
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYL-----KNRVK-----PFSENEARHFMHQIITGML 126

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 246
           +LHS    ++H+D   +N+L+  +   K+AD GL            ++Q+          
Sbjct: 127 YLHSH--GILHRDLTLSNLLLTRNMNIKIADFGL------------ATQLKMPHEKHYTL 172

Query: 247 -------ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  + E+        +SDV+S G     L+ GR
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 32/292 (10%), Positives = 79/292 (27%), Gaps = 44/292 (15%)

Query: 26  SWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQME-ELSLATKNFSDKNL 84
                     + + +   +SE       ++         + F++E EL    +      +
Sbjct: 26  DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV 85

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDE--------------------- 120
           +G+       +    + G    +        P    I +                     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 121 -------VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-- 171
                     L     +  +  +   + +      +   P    ++  +G   +S     
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 172 --LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L    RL + L   + LA LH     +VH   +  ++++D+     +         G 
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGR 276
           + V+         E   A  +  F +      +   D ++ G+ +  +    
Sbjct: 264 SAVSPIGRGFAPPE-TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 34/297 (11%), Positives = 69/297 (23%), Gaps = 91/297 (30%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
            R S     +  + PG  +          R+++                G     + ++ 
Sbjct: 10  DRESSAPPDDVQLVPGARIA-------NGRYRLLIF------------HGGVPPLQFWQA 50

Query: 97  LLQDGML---VAIK------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 147
              D  L   VA+         P    QE +     L+ I    +  +L          +
Sbjct: 51  --LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108

Query: 148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN 207
           + E+I  GS+        +V+         +      A      H     V       + 
Sbjct: 109 VAEWIRGGSLQ-------EVADTSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSR 159

Query: 208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGV 267
           V V  D    +A                ++                     + D+   G 
Sbjct: 160 VRVSIDGDVVLAYPA---------TMPDANP--------------------QDDIRGIGA 190

Query: 268 FLLELVSGR-----------------------EASSSLSPDSSQDLVELMIKCMGKE 301
            L  L+  R                          + +  D    +  +  + +  +
Sbjct: 191 SLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 27/216 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNL 132
            +  K  +G G FG V + +    G  VAIK   +      +E    E+  +  + H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 133 VTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLS-IALGA 184
           V+             N+L  L  EY   G +  +L         K    +  LS I+   
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA- 133

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV-T 240
              L +LH    R++H+D K  N+++    +  I K+ D G    L + ++   +  V T
Sbjct: 134 ---LRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGT 186

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +LA E+ E ++++   D +SFG    E ++G 
Sbjct: 187 --LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 24/226 (10%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 123
           M   S +   +   +++G+G    V++G   + G L AIK         P    + E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 124 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           L  + H+N+V L    +E   +   LI E+ P GS+   L  PS  +   L     L + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 237
                G+ HL      +VH++ K  N++     D   + K+ D G    L   +     S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 238 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                     +++          +++    D++S GV      +G 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 79.5 bits (196), Expect = 5e-17
 Identities = 52/242 (21%), Positives = 97/242 (40%), Gaps = 35/242 (14%)

Query: 85  IGEGKFGEVYKGLLQD---GMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +G G +G VYK   +D       A+K+    G        E+  L  ++H N+++L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVF 87

Query: 140 QENNLQ--FLIYEYIPN---GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             +  +  +L+++Y  +     +  H    +     +L      S+      G+ +LH+ 
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146

Query: 195 SPRVVHKDFKTANVLVDEDF----IAKVADAGL-RNF--LGRTDVAGPSSQVT----ADE 243
              V+H+D K AN+LV  +       K+AD G  R F    +         VT    A E
Sbjct: 147 -NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS------GREASSSLSPDSSQDLVELMIKC 297
           + L +     R +++  D+++ G    EL++       R+     S     D ++ +   
Sbjct: 206 LLLGA-----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260

Query: 298 MG 299
           MG
Sbjct: 261 MG 262

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 51/224 (22%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           + +   + +GEG +  VYKG       LVA+K+       GAP    I EV  L  ++H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHA 60

Query: 131 NLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           N+VTL           L++EY+         +    I+      V   KL     L    
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIIN---MHNV---KLFLFQLL---- 110

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--- 238
              +GLA+ H    +V+H+D K  N+L++E    K+AD GL R        + P+     
Sbjct: 111 ---RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK------SIPTKTYDN 159

Query: 239 --VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             VT      +I L S       +S + D++  G    E+ +GR
Sbjct: 160 EVVTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGR 198

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 47/221 (21%), Positives = 88/221 (39%), Gaps = 23/221 (10%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----F 123
           +      ++  D   IG G +G V K +    G ++A+K+      ++   ++       
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           + S     +V   G        ++  E + + S          V    +  +    I L 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 239
             K L HL   + +++H+D K +N+L+D     K+ D G    L + + +T  AG     
Sbjct: 134 TVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-- 190

Query: 240 TADEIFLASEV----KEFRRFSEKSDVYSFGVFLLELVSGR 276
                ++A E        + +  +SDV+S G+ L EL +GR
Sbjct: 191 -----YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 40/217 (18%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAP-TQEFIDEVCFLASIQHRNLVTLL 136
           IG+G FGEV+K    + G  VA+KK      + G P T   + E+  L  ++H N+V L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLI 82

Query: 137 GYCQENNLQ--------FLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKG 187
             C+             +L++++        H L G       K        +      G
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCE------HDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF--LGRTDVAGPSSQV-T--- 240
           L ++H    +++H+D K ANVL+  D + K+AD GL R F     +     +++V T   
Sbjct: 137 LYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 241 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              E+ L       R +    D++  G  + E+ +  
Sbjct: 195 RPPELLLGE-----RDYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 63/282 (22%), Positives = 99/282 (35%), Gaps = 63/282 (22%)

Query: 50  QPGRNVGIELSIREARRFQMEELSLATK--NFSDKNLIGEGKFGEVYKGL-LQDGMLVAI 106
                  +E   +      +     AT    +     +GEG +GEVYK +       VAI
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 107 KK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP------- 153
           K+        G P    I EV  L  +QHRN++ L      N+   LI+EY         
Sbjct: 65  KRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM 123

Query: 154 NGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 210
           + +  +       +     Q +              G+   H  S R +H+D K  N+L+
Sbjct: 124 DKNPDVS---MRVIKSFLYQLI-------------NGVNFCH--SRRCLHRDLKPQNLLL 165

Query: 211 DEDFIA-----KVADAGL-RNFLGRTDVAGPSSQ--VT----ADEIFLASEVKEFRRFSE 258
                +     K+ D GL R F          +   +T      EI L S     R +S 
Sbjct: 166 SVSDASETPVLKIGDFGLARAF---GIPIRQFTHEIITLWYRPPEILLGS-----RHYST 217

Query: 259 KSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCMG 299
             D++S      E++        L P DS  D +  + + +G
Sbjct: 218 SVDIWSIACIWAEMLMKT----PLFPGDSEIDQLFKIFEVLG 255

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 75.5 bits (186), Expect = 9e-16
 Identities = 39/231 (16%), Positives = 80/231 (34%), Gaps = 59/231 (25%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIK----------KRPGAPTQEFID----------EVCFL 124
           + +GKF ++     +D    A+K          +       + I           E+  +
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
             I++   +T  G     +  ++IYEY+ N S+              L+  +   I +  
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-----EYFFVLDKNYTCFIPIQV 152

Query: 185 AK--------GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
            K          +++H+    + H+D K +N+L+D++   K++D G              
Sbjct: 153 IKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGE------------- 198

Query: 237 SQVTADEI---------FLASEVKEFRRF--SEKSDVYSFGVFLLELVSGR 276
           S+   D+          F+  E           K D++S G+ L  +    
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 26/207 (12%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----FLASIQHRNLVTLLG- 137
           +G G +G V K   +  G ++A+K+       +    +       + ++     VT  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
             +E ++ ++  E + + S+    Y       Q +       IA+   K L HLHS    
Sbjct: 75  LFREGDV-WICMELM-DTSLD-KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130

Query: 198 VVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEV--- 250
           V+H+D K +NVL++     K+ D G    L + + +   AG          ++A E    
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-------YMAPERINP 183

Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGR 276
               + +S KSD++S G+ ++EL   R
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 42/223 (18%), Positives = 91/223 (40%), Gaps = 30/223 (13%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFL 124
           +       +  +   +G G  G+V+K    + G ++A+K+   +  +E       ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 125 -ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
             S     +V   G +    ++ F+  E +   +  +       +     E      + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIP----ERILG-KMTV 131

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQ 238
              K L +L      V+H+D K +N+L+DE    K+ D G    L +   +   AG ++ 
Sbjct: 132 AIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA- 189

Query: 239 VTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGR 276
                 ++A E  +        +  ++DV+S G+ L+EL +G+
Sbjct: 190 ------YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 52/268 (19%), Positives = 94/268 (35%), Gaps = 47/268 (17%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDK----NLIGE 87
           + R      E G          +          +++  + + +   +  D       +G 
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167

Query: 88  GKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
           G FG V++      G   A   +     +  +    E+  ++ ++H  LV L    +++N
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 144 LQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
              +IYE++  G            +      +  RQ  +             GL H+H  
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------------GLCHMHEN 274

Query: 195 SPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLA 247
           +   VH D K  N++      + + K+ D GL   L          G     TA+  F A
Sbjct: 275 N--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTG-----TAE--FAA 324

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV E +     +D++S GV    L+SG
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 72.2 bits (178), Expect = 9e-15
 Identities = 63/256 (24%), Positives = 95/256 (37%), Gaps = 65/256 (25%)

Query: 78  NFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ- 128
            +     IGEG +G+V+K   L   G  VA+K+        G P    I EV  L  ++ 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLET 70

Query: 129 --HRNLVTLL------GYCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQK 171
             H N+V L          +E  L  L++E++          V         +     Q 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT 230
           L             +GL  LHS   RVVH+D K  N+LV      K+AD GL R +    
Sbjct: 130 L-------------RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIY---- 170

Query: 231 DVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
                 +   VT    A E+ L S       ++   D++S G    E+   +     L  
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRK----PLFR 220

Query: 285 -DSSQDLVELMIKCMG 299
             S  D +  ++  +G
Sbjct: 221 GSSDVDQLGKILDVIG 236

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 44/228 (19%)

Query: 72  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEV 121
           ++    + S+       +G G +GEV         +  AIK         +   + ++EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             L  + H N++ L  + ++    +L+ E    G     L+        ++  + + +  
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LF-------DEIIHRMKFNEV 136

Query: 182 LGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR--- 229
             A        G+ +LH  +  +VH+D K  N+L+   ++D + K+ D GL         
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194

Query: 230 -TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             +  G     TA   ++A EV   +++ EK DV+S GV L  L++G 
Sbjct: 195 MKERLG-----TAY--YIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 48/266 (18%), Positives = 89/266 (33%), Gaps = 55/266 (20%)

Query: 43  GSSEPSVQPGRNVG----------IELSIREARRFQMEELSLATKNFSDK----NLIGEG 88
           GS        +  G           +      +++  + + +   +  D       +G G
Sbjct: 3   GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62

Query: 89  KFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 144
            FG V++ +    G +     I            +E+  +  + H  L+ L    ++   
Sbjct: 63  AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122

Query: 145 QFLIYEYIPNG------SVSIHLYGPSQVS---RQKLEFKHRLSIALGAAKGLAHLHSLS 195
             LI E++  G      +   +    ++V    RQ  E             GL H+H   
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------------GLKHMHEH- 168

Query: 196 PRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASE 249
             +VH D K  N++    +    K+ D GL   L                TA+  F A E
Sbjct: 169 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-----TAE--FAAPE 220

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           + +       +D+++ GV    L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.4 bits (176), Expect = 2e-14
 Identities = 57/257 (22%), Positives = 90/257 (35%), Gaps = 65/257 (25%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASI 127
            +     IG G +G VYK      G  VA+K            G P    + EV  L  +
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST-VREVALLRRL 68

Query: 128 Q---HRNLVTLLGYCQENNLQ-----FLIYEYIPN------GSVSIHLYGPSQV---SRQ 170
           +   H N+V L+  C  +         L++E++                    +    RQ
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGR 229
            L             +GL  LH+    +VH+D K  N+LV      K+AD GL R +   
Sbjct: 129 FL-------------RGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIY--- 170

Query: 230 TDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 283
                  +   VT    A E+ L S       ++   D++S G    E+   +     L 
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRRK----PLF 219

Query: 284 P-DSSQDLVELMIKCMG 299
             +S  D +  +   +G
Sbjct: 220 CGNSEADQLGKIFDLIG 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 53/228 (23%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
             +++D  +IG G FG VY+  L D G LVAIKK          D      E+  +  + 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD 105

Query: 129 HRNLVTLLGYCQENNLQF------LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           H N+V L  +   +  +       L+ +Y+P       +Y   +V+R     K  L +  
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-----TVY---RVARHYSRAKQTLPVIY 157

Query: 183 G------AAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP 235
                    + LA++HS    + H+D K  N+L+D D  + K+ D G      +  V G 
Sbjct: 158 VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFG----SAKQLVRGE 211

Query: 236 SSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +     +    A E+   +       ++   DV+S G  L EL+ G+
Sbjct: 212 PNVSYICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQ 254

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 43/244 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            K +     +G G +G V   +  + G  VAIKK    P Q  I       E+  L  +Q
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81

Query: 129 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           H N++ LL         +     +L+  ++      +      ++   K   +    +  
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQ-----KIMGLKFSEEKIQYLVY 133

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
              KGL ++HS    VVH+D K  N+ V+ED   K+ D G    L R   A  +  V   
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTR 187

Query: 241 ---ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIK 296
              A E+ L+     +  +++  D++S G  + E+++G+    +L       D +  ++K
Sbjct: 188 WYRAPEVILS-----WMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQLTQILK 238

Query: 297 CMGK 300
             G 
Sbjct: 239 VTGV 242

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 46/225 (20%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 125
              F+++     ++G+G FGEV K          A+K           T   + EV  L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            + H N++ L    ++++  +++ E    G     L+        ++  + R S    AA
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LF-------DEIIKRKRFSEH-DAA 124

Query: 186 K-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TD 231
           +       G+ ++H     +VH+D K  N+L+   ++D   K+ D GL     +     D
Sbjct: 125 RIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             G     TA   ++A EV     + EK DV+S GV L  L+SG 
Sbjct: 183 RIG-----TAY--YIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 56/267 (20%), Positives = 94/267 (35%), Gaps = 49/267 (18%)

Query: 35  SVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSD------KNLIGEG 88
            V   ++     P      +            F    ++      +         ++G G
Sbjct: 41  EVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGG 100

Query: 89  KFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 144
           +FG+V+K      G+ +A   IK R     +E  +E+  +  + H NL+ L    +  N 
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160

Query: 145 QFLIYEYIPNGSV------SIHLYGPSQVS---RQKLEFKHRLSIALGAAKGLAHLHSLS 195
             L+ EY+  G +        +           +Q  E             G+ H+H + 
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------------GIRHMHQM- 206

Query: 196 PRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLAS 248
             ++H D K  N+L    D   I K+ D GL              G     T +  FLA 
Sbjct: 207 -YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFG-----TPE--FLAP 257

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           EV  +   S  +D++S GV    L+SG
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 44/249 (17%)

Query: 57  IELSIREARRF-----QMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAI 106
           I LS+   + F      +++ S+  K   D+      +G G  GEV      +    VAI
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165

Query: 107 K---KRPGAPTQE--------FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 155
           +   KR  A               E+  L  + H  ++ +  +    +  +++ E +  G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG 224

Query: 156 SV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--- 210
            +   +       V  ++L+              + +LH     ++H+D K  NVL+   
Sbjct: 225 ELFDKV-------VGNKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQ 275

Query: 211 DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFG 266
           +ED + K+ D G    LG       + G  + + A E+           ++   D +S G
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYL-APEVL---VSVGTAGYNRAVDCWSLG 331

Query: 267 VFLLELVSG 275
           V L   +SG
Sbjct: 332 VILFICLSG 340

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 70.7 bits (174), Expect = 3e-14
 Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 46/226 (20%)

Query: 73  SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFL 124
           S+ T N         ++G G F EV+       G L A+K   K P        +E+  L
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYG------PSQVSRQKLEFKH 176
             I+H N+VTL    +     +L+ + +  G +   I   G       S V +Q L    
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS--- 117

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR---T 230
                      + +LH     +VH+D K  N+L    +E+    + D GL         +
Sbjct: 118 ----------AVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165

Query: 231 DVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              G P         ++A EV   + +S+  D +S GV    L+ G
Sbjct: 166 TACGTPG--------YVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 70.5 bits (173), Expect = 5e-14
 Identities = 48/274 (17%), Positives = 101/274 (36%), Gaps = 47/274 (17%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDK----NLIGE 87
           R+      +    ++            L  +            A K F  K    ++IG 
Sbjct: 45  RDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGR 104

Query: 88  GKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID--------EVCFLASI-QHRNLVT 134
           G    V + +    G   A+K         + E ++        E   L  +  H +++T
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 135 LLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKL-E------FKHRLSIALGAA 185
           L+   + ++  FL+++ +  G +   +         +  L E       +  L       
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYL-------TEKVALSEKETRSIMRSLLE------ 211

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----TDVAGPSSQVTA 241
             ++ LH+    +VH+D K  N+L+D++   +++D G    L       ++ G    + A
Sbjct: 212 -AVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL-A 267

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EI   S  +    + ++ D+++ GV L  L++G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 39/220 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            K + +   IG G  G V           VAIKK    P Q          E+  +  + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119

Query: 129 HRNLVTLLG-YCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
           H+N+++LL  +  +  L+    +Y  +     ++      QV + +L+ +    +     
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLLYQML 174

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----- 240
            G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T     
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVT 226

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A E+ L         + E  D++S G  + E+V  +
Sbjct: 227 RYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRHK 260

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 69.6 bits (171), Expect = 6e-14
 Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 34/225 (15%)

Query: 75  ATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT---------QEF 117
           +T  F +      ++G G    V + +        A+K      G            +  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 118 IDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEF 174
           + EV  L  +  H N++ L    + N   FL+++ +  G +   +         +  L  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-------TEKVTLSE 123

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----T 230
           K    I     + +  LH L   +VH+D K  N+L+D+D   K+ D G    L       
Sbjct: 124 KETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +V G  S + A EI   S       + ++ D++S GV +  L++G
Sbjct: 182 EVCGTPSYL-APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 70.1 bits (172), Expect = 9e-14
 Identities = 58/244 (23%), Positives = 107/244 (43%), Gaps = 49/244 (20%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFID-EVCFLASIQHRNLVTLL 136
           +++  +IG G FG V++  L +   VAIKK         F + E+  +  ++H N+V L 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLK 98

Query: 137 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG------A 184
            +   N  +       L+ EY+P       +Y   + SR   + K  + + L        
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-----TVY---RASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQ---VT 240
            + LA++HS+   + H+D K  N+L+D    + K+ D G      +  +AG  +     +
Sbjct: 151 LRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFG----SAKILIAGEPNVSYICS 204

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMI 295
               A E+   +       ++   D++S G  + EL+ G+     L P +S  D +  +I
Sbjct: 205 RYYRAPELIFGA-----TNYTTNIDIWSTGCVMAELMQGQ----PLFPGESGIDQLVEII 255

Query: 296 KCMG 299
           K +G
Sbjct: 256 KVLG 259

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 69.9 bits (171), Expect = 9e-14
 Identities = 43/258 (16%), Positives = 79/258 (30%), Gaps = 62/258 (24%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID----EVC 122
                 K      IG+G +G V   +  Q   + AIK     +      + ++    EV 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 180
            +  + H N+  L    ++     L+ E    G +   ++++      +  ++       
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 181 ALG--------------------------AAK-------GLAHLHSLSPRVVHKDFKTAN 207
                                         +         L +LH+    + H+D K  N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPEN 198

Query: 208 VLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEV--KEFRRFSE 258
            L   ++ F  K+ D GL     + +                  F+A EV       +  
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLN---NGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 259 KSDVYSFGVFLLELVSGR 276
           K D +S GV L  L+ G 
Sbjct: 256 KCDAWSAGVLLHLLLMGA 273

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 45/229 (19%)

Query: 72  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----E 120
           +  +T  FSD+     ++G+G FGEV        G   A+K   +     +   +    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V  L  + H N++ L  + ++    +L+ E    G     L+        ++  + R S 
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LF-------DEIISRKRFSE 125

Query: 181 ALGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 229
              A        G+ ++H     +VH+D K  N+L+    +D   ++ D GL        
Sbjct: 126 VDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

Query: 230 --TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              D  G     TA   ++A EV     + EK DV+S GV L  L+SG 
Sbjct: 184 KMKDKIG-----TAY--YIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 6/200 (3%)

Query: 76  TKNFSDKNLIGE-GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 134
           TK      +I E  KFG +   L          K  GA  ++  D V  +     R L +
Sbjct: 96  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           +       +  F+  + +   S       P  + +  L  +H +  +   AKG+  L S 
Sbjct: 156 ITSSQSSASSGFVEEKSL---SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             + +H+D    N+L+ E  + K+ D GL   + +               ++A E    R
Sbjct: 213 --KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270

Query: 255 RFSEKSDVYSFGVFLLELVS 274
            ++ +SDV+SFGV L E+ S
Sbjct: 271 VYTIQSDVWSFGVLLWEIFS 290

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 47/216 (21%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 138
            +GEG +GEV   +       VA+K    +      E I  E+C    + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 191
            +E N+Q+L  EY   G +   +          +        F   ++       G+ +L
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 246
           H +   + H+D K  N+L+DE    K++D GL              +    E  L     
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169

Query: 247 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                A E+ + R F  E  DV+S G+ L  +++G 
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 53/249 (21%), Positives = 94/249 (37%), Gaps = 46/249 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQHRNL 132
              F  + + G+G FG V  G     GM VAIKK    P      +  +  LA + H N+
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 133 VTLL------GYCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG-- 183
           V L       G     ++   ++ EY+P+   ++H     +  R     +      L   
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPD---TLH-----RCCRNYYRRQVAPPPILIKV 133

Query: 184 ----AAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQ 238
                 + +  LH  S  V H+D K  NVLV+  D   K+ D G      +       + 
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNV 189

Query: 239 ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDL 290
               +    A E+   +     + ++   D++S G    E++ G      +   D+S   
Sbjct: 190 AYICSRYYRAPELIFGN-----QHYTTAVDIWSVGCIFAEMMLGE----PIFRGDNSAGQ 240

Query: 291 VELMIKCMG 299
           +  +++ +G
Sbjct: 241 LHEIVRVLG 249

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 45/223 (20%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            K + +   IG G  G V           VAIKK    P Q          E+  +  + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82

Query: 129 HRNLVTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           H+N++ LL  +  + +L+     +++ E +     ++      QV + +L+ +    +  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLC-----QVIQMELDHERMSYLLY 134

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
               G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPY 186

Query: 241 -------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  A E+ L         + E  D++S G  + E++ G 
Sbjct: 187 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKGG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 43/206 (20%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFG 91
           ++ S ++ + +GS +   Q  ++   + +    R     ++      +  ++LIG G +G
Sbjct: 11  QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYG 67

Query: 92  EVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG-YCQENN 143
            V +     +  +VAIKK      ++ ID      E+  L  + H ++V +L     ++ 
Sbjct: 68  HVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126

Query: 144 LQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            +F    ++ E               ++  +   L   H  ++      G+ ++HS    
Sbjct: 127 EKFDELYVVLEIAD---SDFK-----KLFRTPVYLTELHIKTLLYNLLVGVKYVHS--AG 176

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGL 223
           ++H+D K AN LV++D   KV D GL
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGL 202

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 67.6 bits (166), Expect = 3e-13
 Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 49/226 (21%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 125
           +  FSD       +G+G F  V + +    G+  A K     K      Q+   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGP---SQVSRQKLEFKHR 177
            +QH N+V L    QE +  +L+++ +  G      V+   Y     S   +Q LE    
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---- 116

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----T 230
                     +A+ HS    +VH++ K  N+L+    +    K+AD GL   +       
Sbjct: 117 ---------SIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165

Query: 231 DVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             AG P         +L+ EV +   +S+  D+++ GV L  L+ G
Sbjct: 166 GFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 67.3 bits (165), Expect = 4e-13
 Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 36/219 (16%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 125
              F+++     ++G+G FGEV K          A+K           T   + EV  L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 183
            + H N++ L    ++++  +++ E    G +   I       + R++        I   
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-------IKRKRFSEHDAARIIKQ 129

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPS 236
              G+ ++H  +  +VH+D K  N+L+   ++D   K+ D GL     +     D  G  
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG-- 185

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              TA   ++A EV     + EK DV+S GV L  L+SG
Sbjct: 186 ---TA--YYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 57/236 (24%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----------------KRPGAPT 114
                +       +G G +GEV            AIK                K      
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 115 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
           +E  +E+  L S+ H N++ L    ++    +L+ E+   G     L+       +++  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LF-------EQIIN 139

Query: 175 KHRLSIALGAAK-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLR 224
           +H+      AA        G+ +LH  +  +VH+D K  N+L+   +     K+ D GL 
Sbjct: 140 RHKFDEC-DAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS 196

Query: 225 NFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +F  +     D  G     TA   ++A EV + ++++EK DV+S GV +  L+ G 
Sbjct: 197 SFFSKDYKLRDRLG-----TAY--YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 47/216 (21%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 138
            +GEG +GEV   +       VA+K    +      E I  E+C    + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 191
            +E N+Q+L  EY   G +   +          +        F   ++       G+ +L
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 246
           H +   + H+D K  N+L+DE    K++D GL              +    E  L     
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169

Query: 247 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                A E+ + R F  E  DV+S G+ L  +++G 
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 66.5 bits (163), Expect = 9e-13
 Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 42/217 (19%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           L+GEG +G+V + L  +     A+K       +R          E+  L  ++H+N++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 136 ---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAA 185
              L   ++  + +++ EY   G   +       V  ++         F   +       
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDS----VPEKRFPVCQAHGYFCQLID------ 120

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP------SSQV 239
            GL +LHS    +VHKD K  N+L+      K++  G+   L              S   
Sbjct: 121 -GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              EI   + +  F  F  K D++S GV L  + +G 
Sbjct: 178 QPPEIA--NGLDTFSGF--KVDIWSAGVTLYNITTGL 210

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 48/233 (20%), Positives = 84/233 (36%), Gaps = 52/233 (22%)

Query: 73  SLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFI 118
           +   +   D       +G G+F  V K      G+  A K          R G   +E  
Sbjct: 4   TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63

Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQ 170
            EV  L  + H N++TL    +      LI E +  G               + +   +Q
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNF 226
            L+             G+ +LH+    + H D K  N+++          K+ D GL + 
Sbjct: 124 ILD-------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 227 LGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +       ++ G     T +  F+A E+  +     ++D++S GV    L+SG
Sbjct: 169 IEDGVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 31/168 (18%), Positives = 61/168 (36%), Gaps = 14/168 (8%)

Query: 115 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
                ++  +     +N V  L         ++  +     ++   +    + S +  E 
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN--RRCSLEDREH 163

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA 233
              L I +  A+ +  LHS    ++H+D K +N+    D + KV D GL        +  
Sbjct: 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 234 GPSSQVTADEIF---------LASEVKEFRRFSEKSDVYSFGVFLLEL 272
              + + A             ++ E      +S K D++S G+ L EL
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 19/109 (17%), Positives = 33/109 (30%), Gaps = 5/109 (4%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 131
            +F     +G G FG V++     D    AIK+          ++ + EV  LA ++H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           +V       E   +    E             P            ++  
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 56/244 (22%), Positives = 96/244 (39%), Gaps = 73/244 (29%)

Query: 82  KNLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID------------- 119
           K+ IG+G +G V       D    A+K        ++ G P +                 
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 120 --------EVCFLASIQHRNLVTL---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
                   E+  L  + H N+V L   L    E++L ++++E +  G V          +
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVM------EVPT 130

Query: 169 RQKLE-------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 221
            + L        F+  +        G+ +LH    +++H+D K +N+LV ED   K+AD 
Sbjct: 131 LKPLSEDQARFYFQDLIK-------GIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 222 GLRNFLGRTDV-----AG-PSSQVTADEIFLASEV--KEFRRFS-EKSDVYSFGVFLLEL 272
           G+ N    +D       G P+        F+A E   +  + FS +  DV++ GV L   
Sbjct: 182 GVSNEFKGSDALLSNTVGTPA--------FMAPESLSETRKIFSGKALDVWAMGVTLYCF 233

Query: 273 VSGR 276
           V G+
Sbjct: 234 VFGQ 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 49/236 (20%), Positives = 89/236 (37%), Gaps = 53/236 (22%)

Query: 72  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQE------- 116
           +S+  K   D+      +G G  GEV      +    VAIK   KR  A           
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 117 -FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLE 173
               E+  L  + H  ++ +  +    +  +++ E +  G +   +       V  ++L+
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV-------VGNKRLK 112

Query: 174 -------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGL 223
                  F   L         + +LH     ++H+D K  NVL+   +ED + K+ D G 
Sbjct: 113 EATCKLYFYQMLL-------AVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 224 RNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              LG       + G  + + A E+ ++        ++   D +S GV L   +SG
Sbjct: 164 SKILGETSLMRTLCGTPTYL-APEVLVS---VGTAGYNRAVDCWSLGVILFICLSG 215

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 52/230 (22%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 121
            +   D       +G G+F  V K      G+  A K          R G   +E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 173
             L  + H N++TL    +      LI E +  G               + +   +Q L+
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 229
                        G+ +LH+    + H D K  N+++          K+ D GL + +  
Sbjct: 127 -------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

Query: 230 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                ++ G     T +  F+A E+  +     ++D++S GV    L+SG
Sbjct: 172 GVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 46/231 (19%)

Query: 76  TKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 126
           +  F D     ++++GEG    V   + L      A+K   K+PG        EV  L  
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 127 IQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHR 177
            Q HRN++ L+ + +E +  +L++E +  GS+   IH          S V +        
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---- 122

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAG 234
                     L  LH+    + H+D K  N+L    ++    K+ D  L + +       
Sbjct: 123 ---------ALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 235 PSSQVTADEI-----FLASEV-----KEFRRFSEKSDVYSFGVFLLELVSG 275
           P S            ++A EV     +E   + ++ D++S GV L  L+SG
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 55/238 (23%)

Query: 71  ELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEF 117
           +++     F D      +IG+G F  V + +  + G   A+K          PG  T++ 
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG---------SVSIHLYG---PS 165
             E      ++H ++V LL     + + ++++E++            + +  +Y     S
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 166 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAG 222
              RQ LE              L + H     ++H+D K   VL+   +     K+   G
Sbjct: 134 HYMRQILE-------------ALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFG 178

Query: 223 LRNFLGR-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +   LG          G     T    F+A EV +   + +  DV+  GV L  L+SG
Sbjct: 179 VAIQLGESGLVAGGRVG-----TPH--FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 49/215 (22%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VAIK     +    + + +  EV  +  + H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 191
            +     +LI EY   G V  +L     V+  +++       F+  +S        + + 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVS-------AVQYC 130

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------- 244
           H    R+VH+D K  N+L+D D   K+AD G             S++ T           
Sbjct: 131 HQK--RIVHRDLKAENLLLDADMNIKIADFGF------------SNEFTVGGKLDAFCGA 176

Query: 245 --FLASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
             + A E+ + +++   + DV+S GV L  LVSG 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
              +++ + IGEG +G V       + + VAIKK   +P +          E+  L   +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR 83

Query: 129 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIAL 182
           H N++ +         ++    +++ + +      ++     ++ + Q L   H      
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLME---TDLY-----KLLKTQHLSNDHICYFLY 135

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 239
              +GL ++HS +  V+H+D K +N+L++     K+ D GL R      D  G  ++   
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 240 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           T    A EI L       + +++  D++S G  L E++S R
Sbjct: 194 TRWYRAPEIMLN-----SKGYTKSIDIWSVGCILAEMLSNR 229

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 49/233 (21%)

Query: 69  MEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFI 118
            E +  A+  FSD       +G+G F  V + +    G+  A K     K      Q+  
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76

Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYG---PSQVSRQ 170
            E      +QH N+V L    QE +  +L+++ +  G      V+   Y     S   +Q
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 227
            LE              +A+ HS    +VH++ K  N+L+    +    K+AD GL   +
Sbjct: 137 ILE-------------SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 228 GR----TDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                    AG P         +L+ EV +   +S+  D+++ GV L  L+ G
Sbjct: 182 NDSEAWHGFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 52/230 (22%), Positives = 85/230 (36%), Gaps = 52/230 (22%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 121
            +N  D       +G G+F  V K      G+  A K          R G   ++   EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 173
             L  IQH N++TL    +      LI E +  G               + +   +Q L 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 229
                        G+ +LHSL   + H D K  N+++          K+ D GL + +  
Sbjct: 126 -------------GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170

Query: 230 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                ++ G     T +  F+A E+  +     ++D++S GV    L+SG
Sbjct: 171 GNEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 64.1 bits (157), Expect = 5e-12
 Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 48/217 (22%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +G G+F  V K      G   A K          R G   +E   EV  L  I+H N++T
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 135 LLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLEFKHRLSIALGAAK 186
           L    +      LI E +  G               + +   +Q L+             
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD------------- 119

Query: 187 GLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 238
           G+ +LHS   R+ H D K  N+++      +   K+ D G+ + +       ++ G    
Sbjct: 120 GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG---- 173

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            T +  F+A E+  +     ++D++S GV    L+SG
Sbjct: 174 -TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.9 bits (156), Expect = 8e-12
 Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 42/227 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK--------RPGAPTQEFID------EV 121
              ++ +  I  G +G V  G+  +G+ VAIK+        R      +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 122 CFLASIQHRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
             L    H N++ L            +  +L+ E +        L       R  +  +H
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-----DLAQVIHDQRIVISPQH 135

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
                     GL  LH     VVH+D    N+L+ ++    + D      L R D A  +
Sbjct: 136 IQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFN----LAREDTADAN 189

Query: 237 SQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                      A E+ +      F+ F++  D++S G  + E+ + +
Sbjct: 190 KTHYVTHRWYRAPELVMQ-----FKGFTKLVDMWSAGCVMAEMFNRK 231

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 63.4 bits (155), Expect = 9e-12
 Identities = 46/217 (21%), Positives = 77/217 (35%), Gaps = 34/217 (15%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASI 127
             + +      N IG G +GEV   +     +  A K   K        F  E+  + S+
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            H N++ L    ++N   +L+ E    G +   +       V ++         I     
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-------VHKRVFRESDAARIMKDVL 116

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 238
             +A+ H L   V H+D K  N L      D   K+ D GL              G    
Sbjct: 117 SAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---- 170

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            T    +++ +V E   +  + D +S GV +  L+ G
Sbjct: 171 -TP--YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 63.4 bits (155), Expect = 9e-12
 Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 45/225 (20%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLAS 126
                D       +G G FG+V+       G+   IK     R   P ++   E+  L S
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEY---------IPNGSVSIHLYGPSQVSRQKLEFKHR 177
           + H N++ +    ++ +  +++ E          I +            V+      K  
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL---MKQM 133

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----T 230
           ++        LA+ HS    VVHKD K  N+L          K+ D GL          T
Sbjct: 134 MN-------ALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           + AG     TA  +++A EV + R  + K D++S GV +  L++G
Sbjct: 185 NAAG-----TA--LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 42/221 (19%), Positives = 74/221 (33%), Gaps = 44/221 (19%)

Query: 77  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 129
           K   +K      +G G+FG V++ +          K  K  G        E+  L   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKLEFKHRLSI 180
           RN++ L    +      +I+E+I          + +  L          Q  E       
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------- 113

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR----TDVAG 234
                  L  LHS +  + H D +  N++         K+ + G    L        +  
Sbjct: 114 ------ALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                  +  + A EV +    S  +D++S G  +  L+SG
Sbjct: 166 -----APE--YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 48/229 (20%), Positives = 85/229 (37%), Gaps = 48/229 (20%)

Query: 73  SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVC 122
           ++    F+++      +G+G F  V + + +  G   A       K      Q+   E  
Sbjct: 3   TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEF 174
               ++H N+V L     E    +LI++ +  G +   I           S   +Q LE 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE- 121

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 229
                        + H H +   VVH++ K  N+L+    +    K+AD GL   +    
Sbjct: 122 ------------AVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

Query: 230 ---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                 AG     T    +L+ EV     + +  D+++ GV L  L+ G
Sbjct: 168 QAWFGFAG-----TPG--YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 41/220 (18%), Positives = 79/220 (35%), Gaps = 52/220 (23%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID----EVCFLASIQHRNL 132
           +G G FG V+  +  +    V +K                 +     E+  L+ ++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK------ 186
           + +L   +      L+ E   +G   + L+         ++   RL   L +        
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG---LDLF-------AFIDRHPRLDEPLASYIFRQLVS 141

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPS 236
            + +L      ++H+D K  N+++ EDF  K+ D G   +L          G  +   P 
Sbjct: 142 AVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP- 198

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +V     +   E+          +++S GV L  LV   
Sbjct: 199 -EVLMGNPYRGPEL----------EMWSLGVTLYTLVFEE 227

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            + + + + +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 86

Query: 129 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 181
           H N++ LL         +E N  +L+   +      ++      + + QKL   H   + 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLN-----NIVKCQKLTDDHVQFLI 138

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 240
               +GL ++HS    ++H+D K +N+ V+ED   K+ D G    L R      +  V  
Sbjct: 139 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVAT 192

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A EI L      +  +++  D++S G  + EL++GR
Sbjct: 193 RWYRAPEIMLN-----WMHYNQTVDIWSVGCIMAELLTGR 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 45/229 (19%), Positives = 84/229 (36%), Gaps = 51/229 (22%)

Query: 76  TKNFSDK-----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
            +NF++        +G GKF  V + +    G   A K     +R      E + E+  L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 125 ASIQHR-NLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHLYGPSQVS---RQKLE 173
              +    ++ L    +  +   LI EY   G            +   + V    +Q LE
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG-- 228
                        G+ +LH     +VH D K  N+L+         K+ D G+   +G  
Sbjct: 143 -------------GVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187

Query: 229 --RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++ G     T +  +LA E+  +   +  +D+++ G+    L++ 
Sbjct: 188 CELREIMG-----TPE--YLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 51/270 (18%), Positives = 88/270 (32%), Gaps = 48/270 (17%)

Query: 30  LYRNRSVSRTSETGSSEPSVQPGRNV-GIELSIREARRFQMEELSLATKNFSDK----NL 84
           ++ +   S   + G+     Q   +V         +               SD     + 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE 60

Query: 85  IGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G G    VY+          A   +KK      +    E+  L  + H N++ L    +
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 141 ENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHRLSIALGAAKGLAHLH 192
                 L+ E +  G +   I   G       +   +Q LE              +A+LH
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------------AVAYLH 165

Query: 193 SLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIF 245
                +VH+D K  N+L      D   K+AD GL   +        V G     T    +
Sbjct: 166 EN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG-----TPG--Y 216

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            A E+     +  + D++S G+    L+ G
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 39/220 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
              + D   +G G +G V   +  + G  VAIKK    P Q  +       E+  L  ++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR 82

Query: 129 HRNLVTLLG--YCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 181
           H N++ LL      E    F    L+  ++      +      ++ + +KL       + 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMG---TDLG-----KLMKHEKLGEDRIQFLV 134

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 240
               KGL ++H+    ++H+D K  N+ V+ED   K+ D G    L R   +  +  V  
Sbjct: 135 YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVT 188

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A E+ L      + R+++  D++S G  + E+++G+
Sbjct: 189 RWYRAPEVILN-----WMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 47/245 (19%), Positives = 91/245 (37%), Gaps = 46/245 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
             N+  K+LIG G +G VY          VAIKK      ++ ID      E+  L  ++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLK 83

Query: 129 HRNLVTLLGYCQ-ENNLQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 181
              ++ L      ++ L+F    ++ E        +      ++  +   L  +H  +I 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIAD---SDLK-----KLFKTPIFLTEEHIKTIL 135

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 240
                G   +H     ++H+D K AN L+++D   KV D GL R      D    +    
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 241 ADEIFLASEVKE--------------------FRRFSEKSDVYSFGVFLLELVSGREASS 280
            +E    ++  +                       +++  D++S G    EL++  ++  
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 281 SLSPD 285
           +   +
Sbjct: 254 NDPTN 258

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 44/228 (19%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
           + +F  K+L+GEG +G V        G +VAIKK    P  + +       E+  L   +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFK 67

Query: 129 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQV-SRQKLEFKHRLSIAL 182
           H N++T+         +  N  ++I E +      +H     +V S Q L   H      
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQ---TDLH-----RVISTQMLSDDHIQYFIY 119

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSS 237
              + +  LH  +  V+H+D K +N+L++ +   KV D GL      +    ++  G  S
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 238 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +          A E+ L S      ++S   DV+S G  L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTS-----AKYSRAMDVWSCGCILAELFLRR 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.1 bits (149), Expect = 6e-11
 Identities = 45/241 (18%), Positives = 94/241 (39%), Gaps = 43/241 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQ-HRNL 132
             ++     +G GK+ EV++ + + +   V +K  +P    ++   E+  L +++   N+
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNI 93

Query: 133 VTLLG--YCQENNLQFLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           +TL        +    L++E++ N       LY       Q L             K L 
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNN--TDFKQLY-------QTLTDYDIRFYMYEILKALD 144

Query: 190 HLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVT-------- 240
           + HS+   ++H+D K  NV++D E    ++ D GL  F        P  +          
Sbjct: 145 YCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF------YHPGQEYNVRVASRYF 196

Query: 241 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELMIKCM 298
              E+ +     +++ +    D++S G  L  ++  +E          + D +  + K +
Sbjct: 197 KGPELLV-----DYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVL 248

Query: 299 G 299
           G
Sbjct: 249 G 249

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 8e-11
 Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
              + D   +G G  G V+  +       VAIKK       +         E+  +  + 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK---IVLTDPQSVKHALREIKIIRRLD 66

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP------SQVSR-QKLEFKHRLSIA 181
           H N+V +      +  Q            S+++         + V     L  +H     
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGL-RNFLGRTDVAGPSSQ- 238
               +GL ++HS +  V+H+D K AN+ ++ ED + K+ D GL R         G  S+ 
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 239 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            VT    +  + L+        +++  D+++ G    E+++G+
Sbjct: 185 LVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGK 222

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 60.8 bits (148), Expect = 9e-11
 Identities = 56/266 (21%), Positives = 92/266 (34%), Gaps = 48/266 (18%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
           S       S   V  G ++     +   +    +E       +    L+G G FG VY G
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 97  L-LQDGMLVAIK--------KRPGAPTQEFID-EVCFLASIQHR--NLVTLLGYCQENNL 144
           + + D + VAIK             P    +  EV  L  +      ++ LL + +  + 
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 145 QFLIYEYI-PNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHLHSLSP 196
             LI E   P   +   +       R  L+       F   L         + H H+   
Sbjct: 123 FVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLE-------AVRHCHNC-- 168

Query: 197 RVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGR---TDVAG-PSSQVTADEIFLASEVK 251
            V+H+D K  N+L+D +    K+ D G    L     TD  G           +   E  
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV--------YSPPEWI 220

Query: 252 EFRRFS-EKSDVYSFGVFLLELVSGR 276
            + R+    + V+S G+ L ++V G 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 59.9 bits (146), Expect = 1e-10
 Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 54/219 (24%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G G FG+V  G     G  VA+K       +      +    E+  L   +H +++ L
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL 76

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 188
                     F++ EY+  G +  ++         ++E       F+  LS        +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI-----CKHGRVEEMEARRLFQQILS-------AV 124

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 246
            + H     VVH+D K  NVL+D    AK+AD GL N +             +D  FL  
Sbjct: 125 DYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRT 169

Query: 247 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                   A EV   R ++  + D++S GV L  L+ G 
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 60/279 (21%), Positives = 95/279 (34%), Gaps = 49/279 (17%)

Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQD 100
               +   + V   L   E    +++E+ L   +F    +IG G F EV     K     
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---T 85

Query: 101 GMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEY 151
           G + A+K        KR       F +E   L +   R +  L  +  Q+ N  +L+ EY
Sbjct: 86  GQVYAMKIMNKWDMLKR--GEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142

Query: 152 IPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKT 205
              G +   L      S+        ++      I +     +  +H L    VH+D K 
Sbjct: 143 YVGGDLLTLL------SKFGERIPAEMARFYLAEIVM----AIDSVHRLG--YVHRDIKP 190

Query: 206 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-TAD----EIFLASEVKEFRRFSEKS 260
            N+L+D     ++AD G    L           V T D    EI  A             
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 261 -DVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM 298
            D ++ GVF  E+  G       +P  +    E   K +
Sbjct: 251 CDWWALGVFAYEMFYG------QTPFYADSTAETYGKIV 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 19/229 (8%)

Query: 60  SIREARRFQ---MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ 115
           S+   R  Q   +E   +    F D  ++G G FGEV+   ++  G L A KK      +
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224

Query: 116 EFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
           +             LA +  R +V+L  Y  +      L+   +  G +  H+Y   + +
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 228
               E +     A     GL HLH     ++++D K  NVL+D+D   +++D GL     
Sbjct: 284 PGFQEPRAIFYTA-QIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAV-EL 339

Query: 229 RTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +           T    F+A E+     +    D ++ GV L E+++ R
Sbjct: 340 KAGQTKTKGYAGTPG--FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 51/219 (23%), Positives = 75/219 (34%), Gaps = 46/219 (21%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID-EVCFL----ASIQH 129
           L+G+G FG V+ G  L D + VAIK                     EV  L    A   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--- 186
             ++ LL + +      L+ E          L+         +  K  L           
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLF-------DYITEKGPLGEGPSRCFFGQ 147

Query: 187 ---GLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGR---TDVAG-PSSQ 238
               + H HS    VVH+D K  N+L+D     AK+ D G    L     TD  G     
Sbjct: 148 VVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV-- 203

Query: 239 VTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                 +   E     ++    + V+S G+ L ++V G 
Sbjct: 204 ------YSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 52/218 (23%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----EVCFLASIQHRNLVTLL 136
            +G G FG+V  G     G  VA+K   R    + + +     E+  L   +H +++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLA 189
                 +  F++ EY+  G +  ++         +L+       F+  LS       G+ 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI-----CKNGRLDEKESRRLFQQILS-------GVD 130

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 246
           + H     VVH+D K  NVL+D    AK+AD GL N +             +D  FL   
Sbjct: 131 YCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRTS 175

Query: 247 -------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                  A EV   R ++  + D++S GV L  L+ G 
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 50/271 (18%), Positives = 94/271 (34%), Gaps = 64/271 (23%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV 133
           +K +S    +G G FG V +    + G   A+KK       +    E+  +  + H N++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK--NRELDIMKVLDHVNII 63

Query: 134 TLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK------------ 175
            L+      G  +    Q         G  +        V     + K            
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123

Query: 176 -HRLSIALGAAK-----------------GLAHLHSLSPRVVHKDFKTANVLVD-EDFIA 216
            H++  +   +                   +  +HSL   + H+D K  N+LV+ +D   
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSKDNTL 181

Query: 217 KVADAGLRNFLGRTDVAGPSSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           K+ D G      +  +    S     +    A E+ L +       ++   D++S G   
Sbjct: 182 KLCDFG----SAKKLIPSEPSVAYICSRFYRAPELMLGA-----TEYTPSIDLWSIGCVF 232

Query: 270 LELVSGREASSSLSP-DSSQDLVELMIKCMG 299
            EL+ G+     L   ++S D +  +I+ MG
Sbjct: 233 GELILGK----PLFSGETSIDQLVRIIQIMG 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 57/283 (20%)

Query: 44  SSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQ 99
            +   ++  +N+   L   +    +++++ L  ++F    +IG G FGEV     K    
Sbjct: 41  CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN--- 97

Query: 100 DGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 151
              + A+K        KR  A T  F +E   L +   + + TL    Q++N  +L+ +Y
Sbjct: 98  ADKVFAMKILNKWEMLKR--AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155

Query: 152 IPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKT 205
              G +   L      S+ +      ++      + +     +  +H L    VH+D K 
Sbjct: 156 YVGGDLLTLL------SKFEDRLPEEMARFYLAEMVI----AIDSVHQLH--YVHRDIKP 203

Query: 206 ANVLVDEDFIAKVADAGL-----RNFLGRTDVA-GPSSQVTAD----EIFLASEVKEFRR 255
            N+L+D +   ++AD G       +   ++ VA G     T D    EI  A E  +  R
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG-----TPDYISPEILQAMEGGK-GR 257

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM 298
           +  + D +S GV + E++ G       +P  ++ LVE   K M
Sbjct: 258 YGPECDWWSLGVCMYEMLYG------ETPFYAESLVETYGKIM 294

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 58/251 (23%), Positives = 109/251 (43%), Gaps = 36/251 (14%)

Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQD 100
             P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV     K     
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---T 93

Query: 101 GMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 152
             + A+K        KR  + +  F +E   +A      +V L    Q++   +++ EY+
Sbjct: 94  RKVYAMKLLSKFEMIKR--SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151

Query: 153 PNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAHLHSLSPRVVHKDFKTANVLV 210
           P G +   +      S   +  K  R   A +  A  L  +HS+    +H+D K  N+L+
Sbjct: 152 PGGDLVNLM------SNYDVPEKWARFYTAEVVLA--LDAIHSMG--FIHRDVKPDNMLL 201

Query: 211 DEDFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEV----KEFRRFSEKSDVYSF 265
           D+    K+AD G    + +  +    + V T D  +++ EV         +  + D +S 
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRECDWWSV 259

Query: 266 GVFLLELVSGR 276
           GVFL E++ G 
Sbjct: 260 GVFLYEMLVGD 270

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 49/230 (21%), Positives = 82/230 (35%), Gaps = 53/230 (23%)

Query: 74  LATKNFSD-------KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVC 122
           +    F            +GEG F    K +  +     A+K   KR  A TQ+   E+ 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57

Query: 123 FLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLE 173
            L   + H N+V L     +    FL+ E +  G +   I           S + R+ + 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR- 229
                         ++H+H +   VVH+D K  N+L    +++   K+ D G        
Sbjct: 118 -------------AVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 230 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                         T    + A E+     + E  D++S GV L  ++SG
Sbjct: 163 NQPLKTPCF-----TLH--YAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 42/232 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            + +     +G+G +G V+K +  + G +VA+KK      Q   D      E+  L  + 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELS 66

Query: 129 -HRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIALGA 184
            H N+V LL   + +N +  +L+++Y+      +H      V R   LE  H+  +    
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME---TDLH-----AVIRANILEPVHKQYVVYQL 118

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE 243
            K + +LHS    ++H+D K +N+L++ +   KVAD GL R+F+    V         + 
Sbjct: 119 IKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 244 IFLASEVKEF-------------------RRFSEKSDVYSFGVFLLELVSGR 276
                + +                      ++++  D++S G  L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 44/240 (18%)

Query: 60  SIREARRFQ---MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ 115
           SI   R  Q   +E   +    F    ++G+G FGEV    ++  G + A KK      +
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 116 EFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
           +   E         L  +  R +V+L  Y  +  +   L+   +  G +  H+Y      
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-----H 277

Query: 169 RQKLEFKHRLSIALGA--AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--- 223
             +  F    ++   A    GL  LH    R+V++D K  N+L+D+    +++D GL   
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVH 335

Query: 224 -------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  +  +G                ++A EV +  R++   D ++ G  L E+++G+
Sbjct: 336 VPEGQTIKGRVGTVG-------------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 58/220 (26%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID-----------EVCFLASIQHRN 131
            IG G FG            LVA+K         +I+           E+    S++H N
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVK---------YIERGAAIDENVQREIINHRSLRHPN 77

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGA 184
           +V             +I EY   G +   +      +  +         F+  LS     
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERI-----CNAGRFSEDEARFFFQQLLS----- 127

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA--KVADAGLRNF-----LGRTDVAGPSS 237
             G+++ HS+  ++ H+D K  N L+D       K+ D G           ++ V  P+ 
Sbjct: 128 --GVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 182

Query: 238 QVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                  ++A EV   + +  + +DV+S GV L  ++ G 
Sbjct: 183 -------YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 54.9 bits (133), Expect = 6e-09
 Identities = 49/249 (19%), Positives = 95/249 (38%), Gaps = 37/249 (14%)

Query: 43  GSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG 101
           G++        ++       + R+ + E       +F    ++GEG F  V     L   
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELATS 55

Query: 102 MLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 155
              AIK   KR      +      E   ++ + H   V L    Q++   +    Y  NG
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 115

Query: 156 SVSIHLYGPSQVSRQKLEFKHRLSIALG---AAK---GLAHLHSLSPRVVHKDFKTANVL 209
            +  ++        +K                A+    L +LH     ++H+D K  N+L
Sbjct: 116 ELLKYI--------RK---IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENIL 162

Query: 210 VDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGV 267
           ++ED   ++ D G  +     +  A  +S V TA   +++ E+   +   + SD+++ G 
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ--YVSPELLTEKSACKSSDLWALGC 220

Query: 268 FLLELVSGR 276
            + +LV+G 
Sbjct: 221 IIYQLVAGL 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 50/232 (21%)

Query: 69  MEELSLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDE 120
           +++L   +  F+D    K  IG G +    + +     M  A+K   K    PT+E I+ 
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEI 68

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKL 172
           +      QH N++TL     +    +++ E +  G +   I           S V     
Sbjct: 69  LLRY--GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126

Query: 173 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG 228
           +              + +LH+    VVH+D K +N+L           ++ D G    L 
Sbjct: 127 K-------------TVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 229 R-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                           TA+  F+A EV E + +    D++S GV L  +++G
Sbjct: 172 AENGLLMTPCY-----TAN--FVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 55/219 (25%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +GEG FG+V      +    VA+K       K+     +    E+ +L  ++H +++ L
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL 74

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 188
                      ++ EY   G +  ++     V ++++        F+  +         +
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYI-----VEKKRMTEDEGRRFFQQIIC-------AI 121

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 246
            + H    ++VH+D K  N+L+D++   K+AD GL N +              D  FL  
Sbjct: 122 EYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------------TDGNFLKT 166

Query: 247 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                   A EV   + ++  + DV+S G+ L  ++ GR
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.7 bits (128), Expect = 2e-08
 Identities = 35/194 (18%), Positives = 57/194 (29%), Gaps = 46/194 (23%)

Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-----------GAPTQEFIDEVC 122
           L T+       IGEG FGEV++ +  D   VAIK                  +E + E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 123 FL---------ASIQHRNLVTLLGY--CQENNLQFLIYEYI----PNGSVSIHL--YGPS 165
                         +    + L      Q +    L+  +       GS +     +   
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 166 QV----------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL 209
           Q+                  +        SI       LA   + S R  H+D    NVL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVL 194

Query: 210 VDEDFIAKVADAGL 223
           + +  + K+     
Sbjct: 195 LKKTSLKKLHYTLN 208

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 41/243 (16%), Positives = 81/243 (33%), Gaps = 55/243 (22%)

Query: 62  REARRFQMEELSLATKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGA 112
                   +         +D     K ++G G  G+V +    + G   A+K     P A
Sbjct: 9   SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68

Query: 113 PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGP-- 164
             +          +    ++V +L   +  +       +I E +  G +   I   G   
Sbjct: 69  RQEVDH----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124

Query: 165 ------SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFI 215
                 +++ R                  +  LHS +  + H+D K  N+L    ++D +
Sbjct: 125 FTEREAAEIMRDIGT-------------AIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169

Query: 216 AKVADAGLRNFLGR---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
            K+ D G      +             T    ++A EV    ++ +  D++S GV +  L
Sbjct: 170 LKLTDFGFAKETTQNALQTPCY-----TPY--YVAPEVLGPEKYDKSCDMWSLGVIMYIL 222

Query: 273 VSG 275
           + G
Sbjct: 223 LCG 225

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 34/236 (14%)

Query: 60  SIREARRFQMEELSLATK----NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT 114
           S +  R  Q + + L       +FS   +IG G FGEVY     D G + A+K       
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227

Query: 115 QEFIDEVCFLA---------SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGP 164
           +    E   L          +     +V +  Y     +    I + +  G +  HL   
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH 286

Query: 165 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL- 223
              S   + F +   I LG    L H+H+    VV++D K AN+L+DE    +++D GL 
Sbjct: 287 GVFSEADMRF-YAAEIILG----LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLA 339

Query: 224 -RNFLGRTDVAGPSSQV-TADEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 276
                 +       + V T    ++A EV ++   +   +D +S G  L +L+ G 
Sbjct: 340 CDFSKKKP-----HASVGTHG--YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 42/274 (15%), Positives = 89/274 (32%), Gaps = 63/274 (22%)

Query: 33  NRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGE 92
                  +      P+  P                Q+++ ++         ++G G  G+
Sbjct: 18  APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGK 77

Query: 93  VYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV-CFLASIQHRNLVTLLGYCQENNLQ-- 145
           V +    +     A+K     P     +   EV     + Q  ++V ++   +       
Sbjct: 78  VLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRK 132

Query: 146 --FLIYEYIPNGSV--SIHLYGP--------SQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              ++ E +  G +   I   G         S++ +   E              + +LHS
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE-------------AIQYLHS 179

Query: 194 LSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----- 245
           ++  + H+D K  N+L      + I K+ D G             + + T+         
Sbjct: 180 IN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------AKETTSHNSLTTPCY 225

Query: 246 ----LASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               +A EV    ++ +  D++S GV +  L+ G
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 48.8 bits (117), Expect = 9e-07
 Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 41/257 (15%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
           +  ++ GS + SV+       E  +++          L    F     +G G FG V   
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVM-- 58

Query: 97  LLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVTLLGYCQENNLQFL 147
           L++    G   A+K   K+     ++    ++E   L ++    LV L    ++N+  ++
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118

Query: 148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHK 201
           + EY+  G +  HL       R+   F    +      I L       +LHSL   ++++
Sbjct: 119 VMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVL----TFEYLHSLD--LIYR 165

Query: 202 DFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEK 259
           D K  N+L+D+    +V D G  +   GRT  + G     T +   LA E+   + +++ 
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPE--ALAPEIILSKGYNKA 218

Query: 260 SDVYSFGVFLLELVSGR 276
            D ++ GV + E+ +G 
Sbjct: 219 VDWWALGVLIYEMAAGY 235

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 70/290 (24%), Positives = 107/290 (36%), Gaps = 70/290 (24%)

Query: 33  NRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGE 92
            +  +   +  S  PS   G         +   R  M         F    L+G+G FG+
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-------EFEYLKLLGKGTFGK 163

Query: 93  VYKGLLQD-GMLVAIK---KRPGAPTQEFI---DEV-------CFLASIQHRNLVTLLGY 138
           V     +  G   A+K   K       E I   DEV         L + +H  L  L  Y
Sbjct: 164 VILVKEKATGRYYAMKILKK-------EVIVAKDEVAHTLTENRVLQNSRHPFLTALK-Y 215

Query: 139 C-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLHSLS 195
             Q ++    + EY   G +  HL      SR+++ F    +   GA     L +LHS  
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL------SRERV-FSEDRARFYGAEIVSALDYLHSEK 268

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEI 244
             VV++D K  N+++D+D   K+ D GL           + F G  +             
Sbjct: 269 -NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE------------- 314

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           +LA EV E   +    D +  GV + E++ GR       P  +QD  +L 
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLF 358

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 32/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 141
           IG G FG++Y G  +  G  VAIK         +   E      +Q    + T+     E
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
            +   ++ E          L GPS         +K   K  L +A      + ++HS + 
Sbjct: 77  GDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125

Query: 197 RVVHKDFKTANVLV 210
             +H+D K  N L+
Sbjct: 126 -FIHRDVKPDNFLM 138

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 55/274 (20%), Positives = 105/274 (38%), Gaps = 66/274 (24%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFG 91
           R +        G+  P  +    +    +     R ++        +F+   ++G+G FG
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLT-------DFNFLMVLGKGSFG 355

Query: 92  EV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLASIQHRNLVTLL 136
           +V     KG      L A+K       ++ +   D+V              +   L  L 
Sbjct: 356 KVMLSERKG---TDELYAVK----ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 137 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLHS 193
             C Q  +  + + EY+  G +  H+        Q   FK   ++   A  A GL  L S
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTAD 242
               ++++D K  NV++D +   K+AD G+           + F G  D           
Sbjct: 461 KG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD----------- 507

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++A E+  ++ + +  D ++FGV L E+++G+
Sbjct: 508 --YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 20/134 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV-TLLGYCQE 141
           IG G FGE+Y G  +Q    VAIK         + + E      +Q    +  +  +  E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
            +   L+ +          L GPS         +KL  K  L +A      +  +HS S 
Sbjct: 75  GDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123

Query: 197 RVVHKDFKTANVLV 210
             +H+D K  N L+
Sbjct: 124 -FLHRDIKPDNFLM 136

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 42/244 (17%), Positives = 88/244 (36%), Gaps = 37/244 (15%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
            +G G F  V+    + +   VA+K  +     T+   DE+  L  +   +         
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 141 ENNLQFLIYEYIPNGSVSIH------LYGPSQVSRQKLEFKHRLSIALGAA------KGL 188
            + L+ L +     G   +H      + G + ++  K      + +            GL
Sbjct: 86  NHILKLLDHFNH-KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 189 AHLHSLSPRVVHKDFKTANVLVDE------DFIAKVADAGLRNFLGR---TDVAGPSSQV 239
            ++H     ++H D K  NVL++           K+AD G   +        +   + + 
Sbjct: 145 DYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREY 201

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQDLVELMIK 296
            + E+ L +       +   +D++S    + EL++G    E     S     D +  +I+
Sbjct: 202 RSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 297 CMGK 300
            +G+
Sbjct: 256 LLGE 259

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 141
           IGEG FG +++G  L +   VAIK     +   +  DE      +     +  +  + QE
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
                L+ +          L GPS      +  +K   K     A      +  +H  S 
Sbjct: 78  GLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126

Query: 197 RVVHKDFKTANVLV 210
            +V++D K  N L+
Sbjct: 127 -LVYRDIKPDNFLI 139

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 43.4 bits (103), Expect = 4e-05
 Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 64/224 (28%)

Query: 84  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV-------CFLAS 126
           L+G+G FG+V     K     G   A+K   K       E I   DEV         L +
Sbjct: 12  LLGKGTFGKVILVREKA---TGRYYAMKILRK-------EVIIAKDEVAHTVTESRVLQN 61

Query: 127 IQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA- 184
            +H  L  L  Y  Q ++    + EY   G +  HL        ++  F    +   GA 
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFYGAE 113

Query: 185 -AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDV 232
               L +LHS    VV++D K  N+++D+D   K+ D GL           + F G  + 
Sbjct: 114 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE- 170

Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                       +LA EV E   +    D +  GV + E++ GR
Sbjct: 171 ------------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 54/251 (21%), Positives = 90/251 (35%), Gaps = 71/251 (28%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ------------ 128
           +IG+G FG+V K    +    VA+K  +      ++  +E+  L  ++            
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 129 ------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHR 177
                  RN   +   LL      NL    YE I  N      L    + +   L+    
Sbjct: 164 MLENFTFRNHICMTFELLSM----NL----YELIKKNKFQGFSLPLVRKFAHSILQ---- 211

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTDVAGP 235
                     L  LH    R++H D K  N+L+ +      KV D G   +  +      
Sbjct: 212 ---------CLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----V 256

Query: 236 SSQVT-----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQD 289
            + +      A E+ L +      R+    D++S G  L EL++G      L P +   D
Sbjct: 257 YTYIQSRFYRAPEVILGA------RYGMPIDMWSLGCILAELLTGY----PLLPGEDEGD 306

Query: 290 LVELMIKCMGK 300
            +  MI+ +G 
Sbjct: 307 QLACMIELLGM 317

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 52/255 (20%), Positives = 86/255 (33%), Gaps = 75/255 (29%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ----------- 128
           +LIG+G FG+V K     +   VAIK  K   A   +   EV  L  +            
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 129 -------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKH 176
                   RN   LV  +L Y    NL    Y+ +       + L    + ++Q      
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY----NL----YDLLRNTNFRGVSLNLTRKFAQQMCT--- 168

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAG 234
                      L  L +    ++H D K  N+L+   +    K+ D G            
Sbjct: 169 ----------ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG------------ 206

Query: 235 PSSQVTADEIFL--------ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-D 285
            SS      I+         + EV     +    D++S G  L+E+ +G      L    
Sbjct: 207 -SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGA 261

Query: 286 SSQDLVELMIKCMGK 300
           +  D +  +++ +G 
Sbjct: 262 NEVDQMNKIVEVLGI 276

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.3 bits (103), Expect = 5e-05
 Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 32/162 (19%)

Query: 78  NFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEF---IDEVCFLASI 127
           +F     +G G FG V+    +    +G   A+K   K      ++     DE   L+ +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IA 181
            H  ++ + G  Q+    F+I +YI  G +   L       R+   F + ++      + 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVC 116

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
           L     L +LHS    ++++D K  N+L+D++   K+ D G 
Sbjct: 117 L----ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGF 152

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 44/215 (20%)

Query: 84  LIGEGKFGEVYKGLLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVT 134
            IG+G FG+V   ++Q      + A+K   K+      E      E+  +  ++H  LV 
Sbjct: 22  AIGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 135 LLGYCQ-ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIA-LGAAKGLA 189
           L    Q E ++ F++ + +  G +  HL       +Q + FK    +L I  L  A  L 
Sbjct: 80  LWYSFQDEEDM-FMVVDLLLGGDLRYHL-------QQNVHFKEETVKLFICELVMA--LD 129

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--------A 241
           +L +   R++H+D K  N+L+DE     + D  +        +   +   T        A
Sbjct: 130 YLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNI-----AAMLPRETQITTMAGTKPYMA 182

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            E+F +   ++   +S   D +S GV   EL+ GR
Sbjct: 183 PEMFSS---RKGAGYSFAVDWWSLGVTAYELLRGR 214

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 42.6 bits (101), Expect = 9e-05
 Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 80/287 (27%)

Query: 41  ETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KG 96
           E  ++ P+  P  +  I L        +         +F    +IG+G FG+V     K 
Sbjct: 9   ELMNANPAPPPAPSQQINLGPSSNPHAKPS-------DFHFLKVIGKGSFGKVLLARHKA 61

Query: 97  LLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLASIQHRNLVTLLGYC-QE 141
              + +  A+K   K       + I    E           L +++H  LV L  +  Q 
Sbjct: 62  ---EEVFYAVKVLQK-------KAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQT 110

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIALGAAKGLAHLHSLSPRV 198
            +  + + +YI  G +  HL    Q  R  LE + R     IA      L +LHSL+  +
Sbjct: 111 ADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASA----LGYLHSLN--I 160

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLA 247
           V++D K  N+L+D      + D GL             F G  +             +LA
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-------------YLA 207

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
            EV   + +    D +  G  L E++ G      L P  S++  E+ 
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYG------LPPFYSRNTAEMY 248

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 30/135 (22%), Positives = 49/135 (36%), Gaps = 22/135 (16%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQ 140
           IG G FGE+  G  L     VAIK         Q    E  F   +     +  +  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-LHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
                 ++ E          L GPS      +  +    K  L IA+     + ++HS +
Sbjct: 76  CGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 196 PRVVHKDFKTANVLV 210
             ++++D K  N L+
Sbjct: 126 --LIYRDVKPENFLI 138

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 53/219 (24%)

Query: 84  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           ++G+G FG+V     K     G L A+K   K       + I   D+V            
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVLKK-------DVILQDDDVECTMTEKRILSL 79

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           +  H  L  L   C Q  +  F + E++  G +  H+        +   F    +    A
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFDEARARFYAA 131

Query: 185 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA----GPSS 237
                L  LH     ++++D K  NVL+D +   K+AD G+ +  +          G   
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG--- 186

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             T D  ++A E+ +   +    D ++ GV L E++ G 
Sbjct: 187 --TPD--YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 63/271 (23%), Positives = 106/271 (39%), Gaps = 76/271 (28%)

Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRP 110
           E++I    +   E+       F    ++G+G FG+V+            L A+K   K  
Sbjct: 7   EIAITHHVKEGHEKADP--SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-- 62

Query: 111 GAPTQEFI---DEV------CFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIH 160
                  +   D V        L  + H  +V L  Y  Q     +LI +++  G +   
Sbjct: 63  -----ATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTR 116

Query: 161 LYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 214
           L      S++ + F           +AL     L HLHSL   ++++D K  N+L+DE+ 
Sbjct: 117 L------SKEVM-FTEEDVKFYLAELALA----LDHLHSLG--IIYRDLKPENILLDEEG 163

Query: 215 IAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVY 263
             K+ D GL            +F G           T +  ++A EV   R  ++ +D +
Sbjct: 164 HIKLTDFGLSKESIDHEKKAYSFCG-----------TVE--YMAPEVVNRRGHTQSADWW 210

Query: 264 SFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           SFGV + E+++G        P   +D  E M
Sbjct: 211 SFGVLMFEMLTG------TLPFQGKDRKETM 235

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 65/225 (28%)

Query: 84  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           ++G+G FG+V     KG      L A+K   K       + +   D+V            
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKILKK-------DVVIQDDDVECTMVEKRVLAL 76

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
             +   L  L   C Q  +  + + EY+  G +  H+        Q   FK   ++   A
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAA 128

Query: 185 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTD 231
             A GL  L S    ++++D K  NV++D +   K+AD G+           + F G  D
Sbjct: 129 EIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                        ++A E+  ++ + +  D ++FGV L E+++G+
Sbjct: 187 -------------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 57/221 (25%)

Query: 84  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           ++G+G FG+V    +K         AIK   K       + +   D+V            
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKALKK-------DVVLMDDDVECTMVEKRVLSL 73

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIA 181
           + +H  L  +     Q     F + EY+  G +  H+    Q   +    +       I 
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEII 128

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVA----GP 235
           LG    L  LHS    +V++D K  N+L+D+D  I K+AD G+ +  +          G 
Sbjct: 129 LG----LQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCG- 180

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               T D  ++A E+   ++++   D +SFGV L E++ G+
Sbjct: 181 ----TPD--YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 57/266 (21%), Positives = 98/266 (36%), Gaps = 53/266 (19%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-- 94
           +        E  +     +        A +  +E       NF    ++G G +G+V+  
Sbjct: 21  TSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLV 73

Query: 95  --KGLLQDGMLVAIK---KRPGAPTQEFID----EVCFLASIQHRNLVTLLGYC-QENNL 144
                   G L A+K   K       +  +    E   L  I+    +  L Y  Q    
Sbjct: 74  RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133

Query: 145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRV 198
             LI +YI  G +  HL      S+++  F           I L     L HLH L   +
Sbjct: 134 LHLILDYINGGELFTHL------SQRER-FTEHEVQIYVGEIVLA----LEHLHKLG--I 180

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVA----GPSSQVTADEIFLASEV-K 251
           +++D K  N+L+D +    + D GL        T+ A    G     T +  ++A ++ +
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG-----TIE--YMAPDIVR 233

Query: 252 EFRRFSEKS-DVYSFGVFLLELVSGR 276
                 +K+ D +S GV + EL++G 
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGA 259

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 40.2 bits (95), Expect = 5e-04
 Identities = 43/222 (19%), Positives = 86/222 (38%), Gaps = 56/222 (25%)

Query: 84  LIGEGKFGEVY---KGLLQD-GMLVAIKKRPGAPTQEFIDEVC-------FLASIQHRNL 132
           ++G+G +G+V+   K    + G + A+K    A       +          L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 133 VTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAA 185
           V L+ Y  Q     +LI EY+  G + + L        ++  F    +      I++   
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-------REGIFMEDTACFYLAEISMA-- 133

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAG 234
             L HLH     ++++D K  N++++     K+ D GL             F G      
Sbjct: 134 --LGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG------ 183

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                T +  ++A E+      +   D +S G  + ++++G 
Sbjct: 184 -----TIE--YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 39.9 bits (94), Expect = 6e-04
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 55/220 (25%)

Query: 84  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           +IG G + +V     K       + A+K   K       E +   +++         F  
Sbjct: 16  VIGRGSYAKVLLVRLKK---TDRIYAMKVVKK-------ELVNDDEDIDWVQTEKHVFEQ 65

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIA 181
           +  H  LV L   C Q  +  F + EY+  G +  H+    Q  R+  E   R     I+
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEIS 120

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA----GPS 236
           L     L +LH     ++++D K  NVL+D +   K+ D G+ +  L   D      G  
Sbjct: 121 LA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG-- 172

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              T +  ++A E+     +    D ++ GV + E+++GR
Sbjct: 173 ---TPN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 39.6 bits (93), Expect = 6e-04
 Identities = 38/225 (16%), Positives = 77/225 (34%), Gaps = 54/225 (24%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV- 121
            Q+++ ++         ++G G  G+V +    +     A+K           +   EV 
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62

Query: 122 CFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGPSQVSRQKLEFK 175
               + Q  ++V ++   +          ++ E +  G +   I         R    F 
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFT 115

Query: 176 HR--LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRT 230
            R    I     + + +LHS++  + H+D K  N+L      + I K+ D G        
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                           A E     ++ +  D++S GV +  L+ G
Sbjct: 166 ---------------FAKETTG-EKYDKSCDMWSLGVIMYILLCG 194

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 39.6 bits (93), Expect = 8e-04
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 61/223 (27%)

Query: 84  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           +IG G + +V     K       + A++   K       E +   +++         F  
Sbjct: 59  VIGRGSYAKVLLVRLKK---TDRIYAMRVVKK-------ELVNDDEDIDWVQTEKHVFEQ 108

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----- 179
           +  H  LV L   C Q  +  F + EY+  G +  H+        ++ +     +     
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-------RQRKLPEEHARFYSA 160

Query: 180 -IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA---- 233
            I+L     L +LH     ++++D K  NVL+D +   K+ D G+ +  L   D      
Sbjct: 161 EISLA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 214

Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           G     T +  ++A E+     +    D ++ GV + E+++GR
Sbjct: 215 G-----TPN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 39.3 bits (92), Expect = 8e-04
 Identities = 28/172 (16%), Positives = 51/172 (29%), Gaps = 47/172 (27%)

Query: 85  IGEGKFGEVYKGL---------LQDGMLVAIK---------------KRPGAPTQEFIDE 120
                 G +Y+                  ++K               +R   P Q  +++
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ--VNK 107

Query: 121 VCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPS------QVSRQKLE 173
              L S     + T +G+   ++  +FL+              G S         +  L 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVSPKHVLS 157

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV--ADAGL 223
            +  L +A      L  LH      VH +    N+ VD +  ++V  A  G 
Sbjct: 158 ERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGF 207

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	302
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.9
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.59
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.12
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.88
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.61
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.46
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.4
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.24
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.13
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.0
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.87
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.11
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	95.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.54
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.11
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.73
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.68
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	94.23
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	94.08
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	93.72
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.27
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.14
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	91.92
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	91.77
2k1a_A	42	Integrin alpha-IIB; single-PASS transmembrane segm	89.4
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	85.84
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.21
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.27

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-58  Score=399.29  Aligned_cols=224  Identities=30%  Similarity=0.498  Sum_probs=191.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|.+.+.||+|+||+||+|++.      ++..||||.++....   ++|.+|+++|++++|||||+++|+|.+++..|
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            356778899999999999999863      467899998765543   46899999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCC--------cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 022118          147 LIYEYIPNGSVSIHLYGPS--------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                      +|||||++|+|.++|....        ......+++.+++.++.||+.||+|||+  ++||||||||+|||+++++.+||
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCcEEE
Confidence            9999999999999995432        1234579999999999999999999999  67999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC---------------
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL---------------  282 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~---------------  282 (302)
                      +|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||...               
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~  249 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  249 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999987655443333445568999999999999999999999999999999998 89999743               


Q ss_pred             --CCCChhhHHHHHHHHhhcc
Q 022118          283 --SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 --~~~~~~~l~~~~~~~~~~~  301 (302)
                        +...++++.++|.+||.++
T Consensus       250 ~~p~~~~~~~~~li~~cl~~d  270 (299)
T 4asz_A          250 QRPRTCPQEVYELMLGCWQRE  270 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCccchHHHHHHHHHHcCCC
Confidence              3467789999999999876

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.7e-58  Score=402.72  Aligned_cols=224  Identities=29%  Similarity=0.488  Sum_probs=184.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|...+.||+|+||+||+|++.      ++..||||.++....   ++|.+|+++|++++|||||+++|+|.+++..|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            345667789999999999999864      478899998765543   56899999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCc----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          147 LIYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      +|||||++|+|.+++.....          .....+++.+++.++.||+.||+|||+  ++||||||||+|||+++++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCCCcE
Confidence            99999999999999865422          123568999999999999999999999  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-------------  282 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-------------  282 (302)
                      ||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||...             
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999998765444444455679999999999999999999999999999999999 89999742             


Q ss_pred             ----CCCChhhHHHHHHHHhhcc
Q 022118          283 ----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----~~~~~~~l~~~~~~~~~~~  301 (302)
                          +...++++.++|.+||.++
T Consensus       278 ~~~~p~~~~~~~~~li~~cl~~d  300 (329)
T 4aoj_A          278 ELERPRACPPEVYAIMRGCWQRE  300 (329)
T ss_dssp             CCCCCTTCCHHHHHHHHHHCCSS
T ss_pred             CCCCcccccHHHHHHHHHHcCcC
Confidence                3467789999999999876

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-57  Score=396.97  Aligned_cols=223  Identities=30%  Similarity=0.403  Sum_probs=192.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .+++..+.||+|+||+||+|.+.      +++.||||.++..    ..++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34556789999999999999863      4678999986543    3467999999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~  215 (302)
                      +|||||++|+|.++|.....           .....+++..+..++.||+.||+|||+  ++||||||||+|||+++++.
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEECCCCC
Confidence            99999999999999954321           123568999999999999999999999  67999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------
Q 022118          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------  282 (302)
Q Consensus       216 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------  282 (302)
                      +||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||...            
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~  263 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR  263 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999998765444444556679999999999999999999999999999999998 89999743            


Q ss_pred             -----CCCChhhHHHHHHHHhhcc
Q 022118          283 -----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----~~~~~~~l~~~~~~~~~~~  301 (302)
                           +++++.++.++|.+||..+
T Consensus       264 ~~~~~p~~~~~~~~~li~~C~~~d  287 (308)
T 4gt4_A          264 QVLPCPDDCPAWVYALMIECWNEF  287 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCCCcccchHHHHHHHHHHcCCC
Confidence                 3567889999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-57  Score=394.07  Aligned_cols=218  Identities=18%  Similarity=0.245  Sum_probs=193.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|+.. +++.||+|.++      ....+.+.+|+++|++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999965 58999999754      334567899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++|+|.+++.     ....+++..+..++.||+.||+|||+  ++||||||||+|||+++++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999983     34678999999999999999999999  6799999999999999999999999999998765


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~~  293 (302)
                      ..........+||+.|||||++.+..|+.++||||+||++|||++|+.||...                +...+++..++
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl  264 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDL  264 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHH
Confidence            44444456678999999999999999999999999999999999999999743                23456778888


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.+|
T Consensus       265 i~~lL~~d  272 (311)
T 4aw0_A          265 VEKLLVLD  272 (311)
T ss_dssp             HHHHSCSS
T ss_pred             HHHHccCC
Confidence            88888765

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-56  Score=389.76  Aligned_cols=219  Identities=28%  Similarity=0.467  Sum_probs=180.7

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +..+++++.+.||+|+||+||+|.+..  .||||.++...     .++|.+|+++|++++|||||+++|++.+ +..|+|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            445678888999999999999998653  58999765322     2468899999999999999999998865 568999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ||||++|+|.++|..    ....+++.++..++.||+.||+|||+  ++||||||||+|||+++++.+||+|||+|+...
T Consensus       110 mEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          110 TQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999843    34568999999999999999999999  679999999999999999999999999998775


Q ss_pred             CCCCCCCCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------  283 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------  283 (302)
                      ............||+.|||||++.+   ..|+.++|||||||+||||+||+.||....                      
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            5443334456689999999999864   469999999999999999999999997432                      


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      .+.++++.++|.+||.++
T Consensus       264 ~~~~~~l~~li~~cl~~d  281 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKV  281 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSS
T ss_pred             ccchHHHHHHHHHHcCCC
Confidence            245678999999999876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-56  Score=392.66  Aligned_cols=215  Identities=20%  Similarity=0.354  Sum_probs=189.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +.|+..+.||+|+||+||+|... +|+.||+|+++   ....+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999975 58999999753   334567889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++.      ...+++..+..++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+|+.+.....
T Consensus       154 ~gg~L~~~l~------~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999883      3468999999999999999999999  6799999999999999999999999999987754322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|++||...+                   ...++++.++
T Consensus       226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence              2345689999999999999999999999999999999999999997532                   1235678899


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.+|
T Consensus       304 i~~~L~~d  311 (346)
T 4fih_A          304 LDRLLVRD  311 (346)
T ss_dssp             HHHHSCSS
T ss_pred             HHHHcCCC
Confidence            99999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-56  Score=395.08  Aligned_cols=218  Identities=23%  Similarity=0.353  Sum_probs=183.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|++.+.||+|+||+||+|+.. +++.||+|.+....     .+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999965 58999999864332     3468899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ||++|+|.+++..   .....+++..++.++.||+.||+|||+  ++||||||||+|||+++++.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999842   123457889999999999999999999  67999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChhhHHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQDLVEL  293 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~~l~~~  293 (302)
                      ..  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...                 +...+.++.++
T Consensus       179 ~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          179 VE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             cc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            11  123457999999999999999999999999999999999999999743                 23456788999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.+|
T Consensus       257 i~~~L~~d  264 (350)
T 4b9d_A          257 VSQLFKRN  264 (350)
T ss_dssp             HHHHTCSS
T ss_pred             HHHHccCC
Confidence            99999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.7e-56  Score=388.30  Aligned_cols=216  Identities=23%  Similarity=0.283  Sum_probs=184.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g  155 (302)
                      +.|+..+.||+|+||+||+|++. +|+.||+|.++....  ..+|+.++++++|||||++++++.+++..|+|||||++|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            45777788999999999999975 589999998754332  247999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCCCCC-
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTDVA-  233 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~~~~~-  233 (302)
                      +|.+++.     ....+++..+..++.||+.||+|||+  ++||||||||+|||++.+| .+||+|||+|+.+...... 
T Consensus       136 ~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999993     34568999999999999999999998  6799999999999999987 6999999999987543321 


Q ss_pred             --CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------CCCChhhHHH
Q 022118          234 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-------------------SPDSSQDLVE  292 (302)
Q Consensus       234 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------~~~~~~~l~~  292 (302)
                        ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...                   ++..++++.+
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  288 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ  288 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence              1233467999999999999999999999999999999999999999753                   2345678899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||.+|
T Consensus       289 li~~~L~~d  297 (336)
T 4g3f_A          289 AIQEGLRKE  297 (336)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHccCC
Confidence            999999876

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.3e-55  Score=394.45  Aligned_cols=215  Identities=20%  Similarity=0.354  Sum_probs=190.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +.|+..+.||+|+||+||+|... +|+.||+|.+.   ....+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 58999999753   334567899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++.      ...+++..+..++.||+.||+|||+  ++||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus       231 ~gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          231 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            9999999883      3468999999999999999999999  6799999999999999999999999999987754322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+                   ...+.++.++
T Consensus       303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence              2346789999999999999999999999999999999999999997532                   2346788999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.+|
T Consensus       381 i~~~L~~d  388 (423)
T 4fie_A          381 LDRLLVRD  388 (423)
T ss_dssp             HHHHSCSS
T ss_pred             HHHHcCCC
Confidence            99999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-56  Score=385.61  Aligned_cols=216  Identities=23%  Similarity=0.277  Sum_probs=182.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ++|++.+.||+|+||+||+|+..    +++.||+|.++..     ...++.+|+++|++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999853    4678999976432     23468899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||||+||+|.+++.     ....+++..+..++.|++.||+|||+  ++||||||||+|||+++++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999983     34578999999999999999999999  67999999999999999999999999999865


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHH
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLV  291 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~  291 (302)
                      ....  ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...                +...++++.
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~  254 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ  254 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            4322  2234568999999999999999999999999999999999999999853                244577889


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||.++
T Consensus       255 ~li~~~L~~d  264 (304)
T 3ubd_A          255 SLLRMLFKRN  264 (304)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHcccC
Confidence            9999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-55  Score=379.00  Aligned_cols=212  Identities=26%  Similarity=0.395  Sum_probs=178.7

Q ss_pred             CcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee----CCeeeEEE
Q 022118           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY  149 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~  149 (302)
                      +..+.||+|+||+||+|.+. ++..||+|.+...     ..+++.+|+++|++++|||||++++++.+    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45578999999999999965 5889999975432     23568899999999999999999999875    34579999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~kl~DfGla~~~~  228 (302)
                      |||++|+|.+++.     ....+++..+..++.||+.||+|||+.+++||||||||+|||++ .++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999993     34578999999999999999999998444599999999999997 47999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQD  289 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~  289 (302)
                      ..    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....                   ...+++
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence            22    2345689999999998865 69999999999999999999999997432                   123467


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||.++
T Consensus       259 ~~~li~~~L~~d  270 (290)
T 3fpq_A          259 VKEIIEGCIRQN  270 (290)
T ss_dssp             HHHHHHHHSCSS
T ss_pred             HHHHHHHHccCC
Confidence            899999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-55  Score=390.71  Aligned_cols=232  Identities=25%  Similarity=0.385  Sum_probs=195.2

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCCh----HHHHHHHHHhccCCC-CceeeEE
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASIQH-RNLVTLL  136 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~E~~~l~~l~H-~nIv~l~  136 (302)
                      ...++++..++|++.+.||+|+||+||+|.+..      ++.||+|.+.....    +.+.+|+++|++++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345666777889999999999999999998542      35799998765432    458899999999965 9999999


Q ss_pred             eEEeeC-CeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 022118          137 GYCQEN-NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  204 (302)
Q Consensus       137 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlk  204 (302)
                      |+|.++ +..++|||||++|+|.++|.....           .....+++..+..++.||+.||+|||+  ++|||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK  212 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLA  212 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccC
Confidence            999765 568999999999999999954321           123558999999999999999999999  679999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-
Q 022118          205 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-  282 (302)
Q Consensus       205 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-  282 (302)
                      |+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||... 
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999997755433333445678999999999999999999999999999999998 99999753 


Q ss_pred             -----------------CCCChhhHHHHHHHHhhcc
Q 022118          283 -----------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                       ++..++++.++|.+||.++
T Consensus       293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~d  328 (353)
T 4ase_A          293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  328 (353)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcC
Confidence                             2456788999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-54  Score=371.50  Aligned_cols=214  Identities=21%  Similarity=0.299  Sum_probs=174.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|... +++.||+|.+...      ...++.+|++++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999964 6899999975432      2456899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||| +|+|.+++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHH-----HSCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 679988883     34679999999999999999999999  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ..   .....+||+.|+|||++.+..| +.++||||+||++|||++|+.||...                +...++++.+
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  241 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG  241 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            32   2345689999999999998887 57999999999999999999999753                2345678888


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+|+.+|
T Consensus       242 li~~~L~~d  250 (275)
T 3hyh_A          242 LIKRMLIVN  250 (275)
T ss_dssp             HHHHHSCSS
T ss_pred             HHHHHccCC
Confidence            999998765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.2e-53  Score=369.51  Aligned_cols=197  Identities=25%  Similarity=0.415  Sum_probs=162.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHH--HHHHhccCCCCceeeEEeEEeeCC----eeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID--EVCFLASIQHRNLVTLLGYCQENN----LQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~e  150 (302)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||+++....+.+..  |+..+.+++|||||+++|++.+++    ..|+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            3566778999999999999987 58999999987666655554  455567889999999999998764    4699999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      ||++|+|.+++.      ...+++..+..++.|++.||+|||+.      .++||||||||+|||+++++++||+|||+|
T Consensus        82 y~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCCcHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999993      34688999999999999999999973      238999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCccccCcccccchhhhccC------CCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          225 NFLGRTDV--AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       225 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      +.......  ........||+.|||||++.+.      .|+.++|||||||+||||+||++||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            87654322  2223456799999999998764      36789999999999999999977653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-52  Score=364.41  Aligned_cols=218  Identities=22%  Similarity=0.328  Sum_probs=168.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCC--------
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN--------  143 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------  143 (302)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....    .+++.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999965 58999999764322    246889999999999999999999987654        


Q ss_pred             ----eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          144 ----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       144 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                          ..|+|||||++|+|.+++....  ......+..++.++.||+.||+|||+  ++||||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCCcEEEc
Confidence                3689999999999999995432  22345567788999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCCC----------CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------
Q 022118          220 DAGLRNFLGRTDVA----------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------  283 (302)
Q Consensus       220 DfGla~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------  283 (302)
                      |||+|+.+......          ......+||+.|||||++.+..|+.++|||||||++|||++   ||....      
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            99999887543221          11234579999999999999999999999999999999996   665311      


Q ss_pred             ------------CCChhhHHHHHHHHhhcc
Q 022118          284 ------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------------~~~~~~l~~~~~~~~~~~  301 (302)
                                  ....++..+++.+||.++
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~d  267 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPS  267 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSS
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence                        011234567888888765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=364.51  Aligned_cols=197  Identities=23%  Similarity=0.356  Sum_probs=168.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC------Ce
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------NL  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~  144 (302)
                      ++|++.+.||+|+||+||+|... +|+.||+|+++...     .+++.+|+++|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46899999999999999999965 68999999875432     24578999999999999999999998643      56


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      +|+|||||+ |+|.+++.     ....+++..+..++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEEeeccee
Confidence            799999996 67988883     35679999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCC--CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTD--VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +.+....  ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            8765432  22234567899999999998875 569999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-50  Score=377.84  Aligned_cols=215  Identities=22%  Similarity=0.307  Sum_probs=183.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHH---HHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFID---EVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~---E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|++.++||+|+||+||+|+.. +|+.||+|.+++      .......+   ++.+++.++|||||++++++++++.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999975 589999997642      22223333   46777889999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+|||||+||+|.+++.     ....+++..+..++.||+.||+|||+  ++||||||||+|||++.+|++||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~-----~~~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999993     34678999999999999999999998  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------CCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSL-------------------SPD  285 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------~~~  285 (302)
                      .+....    ....+||+.|||||++. +..|+.++||||+||++|||++|++||...                   +..
T Consensus       341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~  416 (689)
T 3v5w_A          341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS  416 (689)
T ss_dssp             ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTT
T ss_pred             ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCcc
Confidence            765432    34568999999999996 468999999999999999999999999642                   234


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+++..+++.+|+.++
T Consensus       417 ~S~~a~dLI~~lL~~d  432 (689)
T 3v5w_A          417 FSPELRSLLEGLLQRD  432 (689)
T ss_dssp             SCHHHHHHHHHHTCSC
T ss_pred             CCHHHHHHHHHHccCC
Confidence            4667888888888765

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.9e-50  Score=356.99  Aligned_cols=197  Identities=24%  Similarity=0.267  Sum_probs=168.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCC-CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..+.|++.+.||+|+||+||+|+.+    +++.||+|.+.. ....++.+|+++++.+ +||||+++++++.+++..|+|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            4578999999999999999999853    467899997644 3456788999999988 699999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEccccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFL  227 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGla~~~  227 (302)
                      ||||++|+|.+++        ..+++.++..++.|++.||+|||+  ++||||||||+|||++.+ +.+||+|||+|+..
T Consensus        99 mE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           99 MPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            9999999999888        247889999999999999999999  679999999999999876 79999999999865


Q ss_pred             CCCCC--------------------------CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          228 GRTDV--------------------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       228 ~~~~~--------------------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      .....                          .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43211                          0112345799999999999875 58999999999999999999999995


Q ss_pred             C
Q 022118          281 S  281 (302)
Q Consensus       281 ~  281 (302)
                      .
T Consensus       249 ~  249 (361)
T 4f9c_A          249 K  249 (361)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-48  Score=367.33  Aligned_cols=216  Identities=23%  Similarity=0.313  Sum_probs=187.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ++|++.+.||+|+||+||+|... +|+.||+|.+....   .+.+.+|+++|+.++|||||++++++.+++..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57899999999999999999965 58999999865443   345789999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC--CceEEcccccccccCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGRT  230 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~--~~~kl~DfGla~~~~~~  230 (302)
                      ++|+|.+++..    ....+++..+..++.||+.||+|||+  ++|+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       237 ~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999998832    23568999999999999999999999  679999999999999854  89999999999987543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l  290 (302)
                      .   .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....                    ...+++.
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            2   2345679999999999999999999999999999999999999997432                    1235677


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||.+|
T Consensus       388 ~dli~~~L~~d  398 (573)
T 3uto_A          388 KDFIRKLLLAD  398 (573)
T ss_dssp             HHHHHTTSCSS
T ss_pred             HHHHHHHccCC
Confidence            88888888765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-45  Score=323.35  Aligned_cols=211  Identities=40%  Similarity=0.686  Sum_probs=182.9

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      +..++....++|+..+.||+|+||.||+|...++..||+|......   .+.+.+|+++++.++||||+++++++...+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            3344445678999999999999999999998889999999865443   3568899999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999985432 223468999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +...............+|+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence            876543333334455688999999999999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-45  Score=325.83  Aligned_cols=217  Identities=23%  Similarity=0.275  Sum_probs=188.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||+||++... +++.||+|.+.      ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357888999999999999999975 58899999753      33456788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|..++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999998883     34568899999999999999999999  679999999999999999999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...+.++.+
T Consensus       157 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  234 (337)
T 1o6l_A          157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            221  1234567899999999999999999999999999999999999999743                2345678899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||.++
T Consensus       235 li~~lL~~d  243 (337)
T 1o6l_A          235 LLAGLLKKD  243 (337)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHhhcC
Confidence            999999765

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-45  Score=319.66  Aligned_cols=216  Identities=21%  Similarity=0.377  Sum_probs=188.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|+..+.||+|+||+||+|.. .++..||+|...   ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999985 468899999743   33456788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++|+|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999883      2358899999999999999999999  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVE  292 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~  292 (302)
                      .  ......+|+.|+|||.+.+..|+.++|||||||++|||++|+.||....                   ...+..+.+
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred             c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence            2  2345578999999999999999999999999999999999999996532                   234566889


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       249 li~~~l~~d  257 (297)
T 3fxz_A          249 FLNRCLEMD  257 (297)
T ss_dssp             HHHHHSCSS
T ss_pred             HHHHHccCC
Confidence            999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.3e-46  Score=327.24  Aligned_cols=215  Identities=41%  Similarity=0.689  Sum_probs=186.4

Q ss_pred             hhccCHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEE
Q 022118           64 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYC  139 (302)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~  139 (302)
                      ...+...++....++|+..+.||+|+||.||+|...++..||+|......    ...+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45677889999999999999999999999999998889999999865443    23688999999999999999999999


Q ss_pred             eeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-CCCceecCCCCCCeeeCCCCceEE
Q 022118          140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                      ..++..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. .++|+||||||+|||+++++.+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            99999999999999999999986432 2345689999999999999999999983 117999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      +|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            99999987654322 12234458999999999999999999999999999999999999995

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-45  Score=329.61  Aligned_cols=225  Identities=26%  Similarity=0.459  Sum_probs=190.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      ..++|++.+.||+|+||.||+|...        ++..||+|.......    +.+.+|+++++++ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3467888899999999999999852        346799998765433    4578999999999 89999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      .+..|+||||+++|+|.+++.....           .....+++..++.++.|++.||+|||+  .+|+||||||+|||+
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEEE
Confidence            9999999999999999999854321           123468899999999999999999999  679999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-------
Q 022118          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-------  282 (302)
Q Consensus       211 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-------  282 (302)
                      +.++.+||+|||+++...............+|+.|+|||++.+..|+.++|||||||++|||++ |+.||...       
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987765444334445567888999999999999999999999999999999 99999753       


Q ss_pred             ----------CCCChhhHHHHHHHHhhcc
Q 022118          283 ----------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----------~~~~~~~l~~~~~~~~~~~  301 (302)
                                +...+.++.+++.+||..+
T Consensus       317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~d  345 (370)
T 2psq_A          317 LLKEGHRMDKPANCTNELYMMMRDCWHAV  345 (370)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence                      2345668999999999865

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-45  Score=324.80  Aligned_cols=216  Identities=26%  Similarity=0.336  Sum_probs=187.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.....     ..+++.+|+++++.++||||+++++++.+++..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45799999999999999999997 56899999985432     2345789999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999883     34568899999999999999999999  6799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCC-CccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ..   ......||+.|+|||.+.+..++ .++||||+||++|||++|+.||...                +...+.++.+
T Consensus       167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  243 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN  243 (328)
T ss_dssp             SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            32   23456789999999999988875 7899999999999999999999753                2344678889


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       244 li~~~L~~d  252 (328)
T 3fe3_A          244 LLKRFLVLN  252 (328)
T ss_dssp             HHHHHCCSS
T ss_pred             HHHHHCCCC
Confidence            999998765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-45  Score=336.91  Aligned_cols=224  Identities=23%  Similarity=0.296  Sum_probs=188.0

Q ss_pred             HHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEee
Q 022118           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (302)
Q Consensus        69 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~  141 (302)
                      ..++....++|+..+.||+|+||+||++.... ++.||+|.+..      .....+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44555667889999999999999999999765 78899997542      233448899999999999999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      ++..|+||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+||||||||+|||++.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999843    24568999999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------  283 (302)
                      |+++........ ......||+.|+|||++.     ...|+.++|||||||++|||++|+.||....             
T Consensus       220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE  298 (437)
T ss_dssp             TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence            999876543221 123457999999999987     4578999999999999999999999997432             


Q ss_pred             --------CCChhhHHHHHHHHhh
Q 022118          284 --------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       284 --------~~~~~~l~~~~~~~~~  299 (302)
                              ...+++..+++++|+.
T Consensus       299 ~~~~p~~~~~~s~~~~dLi~~lL~  322 (437)
T 4aw2_A          299 RFQFPTQVTDVSENAKDLIRRLIC  322 (437)
T ss_dssp             HCCCCSSCCCSCHHHHHHHHTTSS
T ss_pred             cccCCcccccCCHHHHHHHHHHhc
Confidence                    1245667777777663

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-45  Score=330.64  Aligned_cols=218  Identities=21%  Similarity=0.303  Sum_probs=186.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|++.+.||+|+||+||+++.. +++.+|+|.+...      ..+.+.+|..++.++ +||||+++++++.+++..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            4567899999999999999999976 4788999975422      234578899999876 8999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|..++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999998883     34568999999999999999999999  6799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------------------
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------------------  282 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------------------  282 (302)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...                        
T Consensus       203 ~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  280 (396)
T 4dc2_A          203 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR  280 (396)
T ss_dssp             CCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred             cccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence            33221  2344567999999999999999999999999999999999999999532                        


Q ss_pred             -CCCChhhHHHHHHHHhhcc
Q 022118          283 -SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -~~~~~~~l~~~~~~~~~~~  301 (302)
                       +...+.++.+++.+||.++
T Consensus       281 ~p~~~s~~~~~li~~lL~~d  300 (396)
T 4dc2_A          281 IPRSLSVKAASVLKSFLNKD  300 (396)
T ss_dssp             CCTTSCHHHHHHHHHHTCSC
T ss_pred             CCCcCCHHHHHHHHHHhcCC
Confidence             2334567888999998765

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=330.97  Aligned_cols=226  Identities=14%  Similarity=0.128  Sum_probs=189.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEE------EcCCcEEEEEecCCCChHHHHHHHHHhccCC---CCceeeEEeEEeeCCe
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNL  144 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~  144 (302)
                      ...++|++.+.||+|+||+||+|.      ..++..||+|........++.+|.+++..++   |+||+++++++...+.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            445678888999999999999994      4468899999998888888999999888886   9999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----------C
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----------D  213 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-----------~  213 (302)
                      .|+||||+++|+|.+++..........+++..+..++.|++.||+|||+  .+||||||||+|||++.           +
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC------C
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcccccccc
Confidence            9999999999999999854333345679999999999999999999998  67999999999999998           8


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------
Q 022118          214 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---------  284 (302)
Q Consensus       214 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---------  284 (302)
                      +.+||+|||+++.+.............||..|+|||++.+..|+.++|||||||++|||++|+.||.....         
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  299 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF  299 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSCC
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechhc
Confidence            99999999999765432222223455789999999999999999999999999999999999999853211         


Q ss_pred             ---CChhhHHHHHHHHhhcc
Q 022118          285 ---DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ---~~~~~l~~~~~~~~~~~  301 (302)
                         ...+.+.+++.+|+..+
T Consensus       300 ~~~~~~~~~~~~~~~~l~~~  319 (365)
T 3e7e_A          300 RRLPHLDMWNEFFHVMLNIP  319 (365)
T ss_dssp             TTCSSHHHHHHHHHHHHCCC
T ss_pred             cccCcHHHHHHHHHHHcCCC
Confidence               22456677777777654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=327.72  Aligned_cols=219  Identities=21%  Similarity=0.305  Sum_probs=183.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      ...++|++.+.||+|+||+||+|+.. +++.||+|.+..      .....+.+|..+++.+ +||||+++++++.+++..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            45678999999999999999999975 588999997643      2345678899999888 799999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            99999999999998883     34568999999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQD  289 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~  289 (302)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....                ...+.+
T Consensus       173 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~  250 (353)
T 3txo_A          173 EGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED  250 (353)
T ss_dssp             CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence            543221  22345679999999999999999999999999999999999999997532                335677


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+.++
T Consensus       251 ~~~li~~lL~~d  262 (353)
T 3txo_A          251 ATGILKSFMTKN  262 (353)
T ss_dssp             HHHHHHHHTCSS
T ss_pred             HHHHHHHHhhhC
Confidence            888999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-45  Score=321.88  Aligned_cols=219  Identities=23%  Similarity=0.342  Sum_probs=187.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|++.+.||+|+||.||+|... +++.||+|......    .+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999976 68899999754322    3568899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999983     34568999999999999999999999  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l  290 (302)
                      ..........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....                   ..+.++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence            33333445678999999999988776 7789999999999999999999975432                   235677


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       239 ~~li~~~L~~d  249 (323)
T 3tki_A          239 LALLHKILVEN  249 (323)
T ss_dssp             HHHHHHHSCSS
T ss_pred             HHHHHHHccCC
Confidence            88999998765

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=316.01  Aligned_cols=220  Identities=25%  Similarity=0.443  Sum_probs=187.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|+..+.||+|+||+||++... ++..||+|......   .+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            456888899999999999999975 58899999765443   34688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999842    24568999999999999999999999  679999999999999999999999999998764432


Q ss_pred             CCC------------CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------
Q 022118          232 VAG------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------  282 (302)
Q Consensus       232 ~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------  282 (302)
                      ...            ......||+.|+|||.+.+..++.++||||||+++|||++|..||...                 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            211            111457899999999999999999999999999999999999998752                 


Q ss_pred             --CCCChhhHHHHHHHHhhcc
Q 022118          283 --SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 --~~~~~~~l~~~~~~~~~~~  301 (302)
                        +...+.++.+++.+||..+
T Consensus       243 ~~~~~~~~~l~~li~~~l~~d  263 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLD  263 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSS
T ss_pred             cCCCCCCHHHHHHHHHHccCC
Confidence              2455678999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.3e-45  Score=317.98  Aligned_cols=218  Identities=24%  Similarity=0.384  Sum_probs=182.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---C---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---P---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||++... ++..||+|.....   .   .+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            457899999999999999999965 5889999975321   1   24678999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999983     33568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------CCCh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------PDSS  287 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------~~~~  287 (302)
                      ..... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....                     .+.+
T Consensus       163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence            43221 2334568999999999999999999999999999999999999997532                     2346


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      +.+.+++.+|+.++
T Consensus       242 ~~l~~li~~~l~~d  255 (294)
T 4eqm_A          242 QSLSNVILRATEKD  255 (294)
T ss_dssp             HHHHHHHHHHSCSS
T ss_pred             HHHHHHHHHHhcCC
Confidence            77899999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6e-45  Score=323.03  Aligned_cols=220  Identities=24%  Similarity=0.360  Sum_probs=187.7

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~  144 (302)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|....      .....+..|..++..+ +||||+++++++.+++.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            356678999999999999999999975 588999997542      3445678899998876 99999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999983     33568899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChh
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQ  288 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~  288 (302)
                      +......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....                ...+.
T Consensus       166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  243 (345)
T 1xjd_A          166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK  243 (345)
T ss_dssp             BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCH
Confidence            8643221  12345678999999999999999999999999999999999999997532                23457


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||.++
T Consensus       244 ~~~~li~~lL~~d  256 (345)
T 1xjd_A          244 EAKDLLVKLFVRE  256 (345)
T ss_dssp             HHHHHHHHHSCSS
T ss_pred             HHHHHHHHHhcCC
Confidence            7889999998765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-45  Score=318.44  Aligned_cols=214  Identities=22%  Similarity=0.360  Sum_probs=187.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||++... +++.||+|....      ...+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            457888999999999999999975 588999997542      3455678899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999983     34568899999999999999999998  679999999999999999999999999998754


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ..     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...+.++.+
T Consensus       158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  232 (318)
T 1fot_A          158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD  232 (318)
T ss_dssp             SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            32     23457899999999999999999999999999999999999999642                2345678889


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+|+.++
T Consensus       233 li~~lL~~d  241 (318)
T 1fot_A          233 LLSRLITRD  241 (318)
T ss_dssp             HHHHHTCSC
T ss_pred             HHHHHhccC
Confidence            999998765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-44  Score=322.01  Aligned_cols=216  Identities=22%  Similarity=0.284  Sum_probs=186.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .+.|++.+.||+|+||.||++... ++..+|+|.+...         ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            456888999999999999999975 5889999975322         235789999999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA  221 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~----~~kl~Df  221 (302)
                      ++||||+++|+|.+++.     ....+++..+..++.||+.||.|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999983     34568999999999999999999999  6799999999999998777    7999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      |+++......   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||....                  
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  240 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE  240 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            9998765432   2334578999999999999999999999999999999999999997532                  


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+.++.+++.+|+.++
T Consensus       241 ~~~~~s~~~~~li~~~L~~d  260 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKE  260 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSS
T ss_pred             hccCCCHHHHHHHHHHCCCC
Confidence              233566888999998765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-45  Score=333.63  Aligned_cols=222  Identities=22%  Similarity=0.312  Sum_probs=188.0

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      .++....++|+..+.||+|+||+||++... ++..+|+|.+..      .....+.+|..+++.++||||+++++++.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455678999999999999999999976 488999997532      3344588999999999999999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      +..|+||||+++|+|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~------~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999999883      2458899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCC----CCCccchhhHHHHHHHHHhCCCCCCCCC---------------
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLS---------------  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------  283 (302)
                      +++........ ......||+.|+|||++.+..    |+.++|||||||++|||++|+.||....               
T Consensus       214 ~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          214 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL  292 (410)
T ss_dssp             TCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence            99876543221 123567999999999998765    8899999999999999999999997432               


Q ss_pred             -----CCChhhHHHHHHHHhhc
Q 022118          284 -----PDSSQDLVELMIKCMGK  300 (302)
Q Consensus       284 -----~~~~~~l~~~~~~~~~~  300 (302)
                           ...+.++.+++.+|+..
T Consensus       293 ~~p~~~~~s~~~~~li~~lL~~  314 (410)
T 3v8s_A          293 TFPDDNDISKEAKNLICAFLTD  314 (410)
T ss_dssp             CCCTTCCCCHHHHHHHHHHSSC
T ss_pred             cCCCcccccHHHHHHHHHHccC
Confidence                 13457788888888753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-45  Score=329.50  Aligned_cols=223  Identities=29%  Similarity=0.459  Sum_probs=189.7

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+..++|+..+.||+|+||.||+|... ++..||+|.......    +++.+|++++++++||||+++++++..++..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            344567888899999999999999976 688999998765432    357889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus       190 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            9999999999999842    23468899999999999999999999  67999999999999999999999999999875


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~  289 (302)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |+.||...                 +...+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA  343 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            44332222233345678999999999999999999999999999998 99999743                 2345678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.++|.+||..+
T Consensus       344 l~~li~~cl~~d  355 (377)
T 3cbl_A          344 VFRLMEQCWAYE  355 (377)
T ss_dssp             HHHHHHHHTCSS
T ss_pred             HHHHHHHHcCCC
Confidence            999999999865

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.7e-45  Score=321.89  Aligned_cols=217  Identities=21%  Similarity=0.302  Sum_probs=185.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|+..+.||+|+||.||+++.. +++.+|+|......      .+.+.+|..++.++ +||||+++++++.+++..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            356888999999999999999976 58899999864321      23477899999887 89999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999998883     33568999999999999999999999  67999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------------
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-------------------------  282 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------------  282 (302)
                      ....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                         
T Consensus       161 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  238 (345)
T 3a8x_A          161 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  238 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC
T ss_pred             cCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC
Confidence            3221  2234567899999999999999999999999999999999999999641                         


Q ss_pred             CCCChhhHHHHHHHHhhcc
Q 022118          283 SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ~~~~~~~l~~~~~~~~~~~  301 (302)
                      +...+.++.+++.+||.++
T Consensus       239 p~~~s~~~~~li~~lL~~d  257 (345)
T 3a8x_A          239 PRSLSVKAASVLKSFLNKD  257 (345)
T ss_dssp             CTTSCHHHHHHHHHHTCSS
T ss_pred             CCCCCHHHHHHHHHHhcCC
Confidence            2234567788899998765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-44  Score=321.46  Aligned_cols=219  Identities=22%  Similarity=0.302  Sum_probs=188.4

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCC------CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      ...++|+..+.||+|+||.||++.... ++.||+|....      ...+.+.+|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            456789999999999999999999764 78899997542      3456678999999888 899999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            99999999999999983     23568899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQD  289 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~  289 (302)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...+.+
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  247 (353)
T 2i0e_A          170 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE  247 (353)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence            643221  1234567899999999999999999999999999999999999999753                2345678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+.++
T Consensus       248 ~~~li~~lL~~d  259 (353)
T 2i0e_A          248 AVAICKGLMTKH  259 (353)
T ss_dssp             HHHHHHHHTCSC
T ss_pred             HHHHHHHHhhcC
Confidence            889999998865

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=324.80  Aligned_cols=216  Identities=22%  Similarity=0.318  Sum_probs=186.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||++... ++..||+|.+.      ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457888999999999999999965 47899999753      33456788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ-----QNVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999983     34568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------CCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSL-------------------SPDS  286 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------~~~~  286 (302)
                      ...   ......||+.|+|||++..   ..|+.++|||||||++|||++|+.||...                   +...
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~  243 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW  243 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTS
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcC
Confidence            432   2345679999999999874   45899999999999999999999999743                   2344


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||.++
T Consensus       244 s~~~~~li~~lL~~d  258 (384)
T 4fr4_A          244 SQEMVSLLKKLLEPN  258 (384)
T ss_dssp             CHHHHHHHHHHSCSS
T ss_pred             CHHHHHHHHHHhcCC
Confidence            577888999998765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-45  Score=321.42  Aligned_cols=201  Identities=28%  Similarity=0.370  Sum_probs=170.8

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChH--HHHHHHHHhccCCCCceeeEEeEEeeCCe----eeE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNL----QFL  147 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~l  147 (302)
                      +..++|++.+.||+|+||+||+|... +..||+|........  ...+|+.++++++||||+++++++.....    .++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            34567899999999999999999876 789999987654433  35568888999999999999999987543    699


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC--------CCCceecCCCCCCeeeCCCCceEEc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--------SPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                      ||||+++|+|.+++.      ...+++..+..++.|++.||+|||+.        +++|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999983      24589999999999999999999983        1179999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccC-----CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |||+++...............+|+.|+|||++.+.     .++.++|||||||++|||++|+.||..
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            99999877654443344456789999999999863     456788999999999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-44  Score=320.93  Aligned_cols=214  Identities=21%  Similarity=0.285  Sum_probs=188.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||.||++... ++..||+|....      ...+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357888999999999999999975 588999997532      3446788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999983     23568899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ..     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...+.++.+
T Consensus       193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  267 (350)
T 1rdq_E          193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD  267 (350)
T ss_dssp             SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHH
T ss_pred             CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            32     23457899999999999999999999999999999999999999743                2345678899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       268 li~~lL~~d  276 (350)
T 1rdq_E          268 LLRNLLQVD  276 (350)
T ss_dssp             HHHHHSCSC
T ss_pred             HHHHHhhcC
Confidence            999999765

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-44  Score=317.12  Aligned_cols=225  Identities=31%  Similarity=0.466  Sum_probs=181.1

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      +.+...+|++.+.||+|+||+||+|.. ++..||+|......     .+++.+|++++++++||||+++++++.+.+..+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            344567888999999999999999987 57889999865433     245789999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++...  .....+++..++.++.|++.||+|||+.+++|+||||||+|||++.++.+||+|||+++.
T Consensus       111 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEECCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEEecCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999998432  112348899999999999999999998322399999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------------CCCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------------SPDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------------~~~~~~  288 (302)
                      .....  .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...                  +...+.
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP  266 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            54322  1233457889999999999999999999999999999999999999753                  234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       267 ~l~~li~~~l~~d  279 (309)
T 3p86_A          267 QVAAIIEGCWTNE  279 (309)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHccCC
Confidence            8899999999865

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-44  Score=318.06  Aligned_cols=217  Identities=20%  Similarity=0.298  Sum_probs=179.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE----cCCcEEEEEecCCC-------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      .++|++.+.||+|+||.||+++.    .++..+|+|.....       ....+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999986    46889999986543       23457789999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999998883     33567889999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChh
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQ  288 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~  288 (302)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...                ++..+.
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  246 (327)
T 3a62_A          169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ  246 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred             cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence            76432221  223457899999999999999999999999999999999999999753                234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       247 ~~~~li~~~L~~d  259 (327)
T 3a62_A          247 EARDLLKKLLKRN  259 (327)
T ss_dssp             HHHHHHHHHSCSC
T ss_pred             HHHHHHHHHHhcC
Confidence            8889999998765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.1e-45  Score=325.75  Aligned_cols=218  Identities=23%  Similarity=0.302  Sum_probs=179.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHH-hccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|+..+.||+|+||.||+++.. ++..+|+|.+...      ....+.+|..+ ++.++||||+++++++.+.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3467999999999999999999976 4788999975432      23446677776 57789999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       116 lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999999999883     34568889999999999999999999  6799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhH
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDL  290 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l  290 (302)
                      .....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...+.++
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (373)
T 2r5t_A          189 NIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA  266 (373)
T ss_dssp             GBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHH
T ss_pred             cccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Confidence            43222  2344567999999999999999999999999999999999999999743                23456778


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+|+.++
T Consensus       267 ~~li~~lL~~d  277 (373)
T 2r5t_A          267 RHLLEGLLQKD  277 (373)
T ss_dssp             HHHHHHHTCSS
T ss_pred             HHHHHHHcccC
Confidence            89999998765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-43  Score=312.38  Aligned_cols=213  Identities=21%  Similarity=0.320  Sum_probs=184.4

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC---CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      |...+.||+|+||.||+|... +++.||+|....   ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            556678999999999999976 689999997543   3346688999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      ++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       127 ~~L~~~l~------~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  196 (321)
T 2c30_A          127 GALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  196 (321)
T ss_dssp             CBHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--
Confidence            99999883      3468999999999999999999999  6799999999999999999999999999987654321  


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVELMI  295 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~~~  295 (302)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....                   ...+.++.+++.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            2334578999999999999999999999999999999999999996432                   123567889999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       277 ~~l~~d  282 (321)
T 2c30_A          277 RMLVRD  282 (321)
T ss_dssp             HHSCSS
T ss_pred             HHccCC
Confidence            999765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=314.42  Aligned_cols=215  Identities=22%  Similarity=0.301  Sum_probs=185.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      +.|+..+.||+|+||.||++... ++..||+|.....         ..+.+.+|+.++++++||||+++++++.+++..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45888899999999999999975 5889999974322         2467899999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  222 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~----~~kl~DfG  222 (302)
                      +||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999983     34568899999999999999999999  6799999999999999887    89999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------  283 (302)
                      +++......   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....                   
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  240 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence            998765322   2234568999999999999999999999999999999999999996432                   


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...+..+.+++.+||..+
T Consensus       241 ~~~~~~~~~~li~~~L~~d  259 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKD  259 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSS
T ss_pred             cccCCHHHHHHHHHHccCC
Confidence             234567789999998765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=315.98  Aligned_cols=221  Identities=29%  Similarity=0.468  Sum_probs=185.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|++.+.||+|+||.||+|...    .+..||+|......    .+.+.+|+.++++++||||+++++++.+++..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3467888899999999999999974    35579999876543    245889999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       127 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999843    23568999999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCCh
Q 022118          227 LGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSS  287 (302)
Q Consensus       227 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~  287 (302)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...+
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            6543211 11223345778999999999999999999999999999999 99999643                 23457


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       281 ~~l~~li~~~l~~d  294 (325)
T 3kul_A          281 HALHQLMLDCWHKD  294 (325)
T ss_dssp             HHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHccCC
Confidence            78999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=330.30  Aligned_cols=225  Identities=20%  Similarity=0.259  Sum_probs=188.1

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEe
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQ  140 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~  140 (302)
                      ..++.....++|+..+.||+|+||+||+++.. +++.||+|.+...      ..+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556788999999999999999999975 6899999986432      2234788999999999999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      +++..|+||||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++++||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999832    23468899999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-------FRRFSEKSDVYSFGVFLLELVSGREASSSLS----------  283 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------  283 (302)
                      ||+++........ ......||+.|+|||++.       ...|+.++|||||||++|||++|+.||....          
T Consensus       206 FGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          206 FGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             CTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             chhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999876543221 123457999999999987       3568999999999999999999999997532          


Q ss_pred             -----------CCChhhHHHHHHHHhh
Q 022118          284 -----------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       284 -----------~~~~~~l~~~~~~~~~  299 (302)
                                 ...+.+..+++++|+.
T Consensus       285 ~~~~~~~p~~~~~~s~~~~dli~~lL~  311 (412)
T 2vd5_A          285 YKEHLSLPLVDEGVPEEARDFIQRLLC  311 (412)
T ss_dssp             HHHHCCCC----CCCHHHHHHHHTTSS
T ss_pred             cccCcCCCccccCCCHHHHHHHHHHcC
Confidence                       2345667777777775

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-44  Score=315.14  Aligned_cols=217  Identities=19%  Similarity=0.240  Sum_probs=186.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||.||++... ++..+|+|......  ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            357888999999999999999976 57889999876443  345789999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC--CCceEEcccccccccCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~--~~~~kl~DfGla~~~~~~  230 (302)
                      ++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.  ++.+||+|||+++.....
T Consensus        84 ~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999999832    23468999999999999999999999  67999999999999987  789999999999876442


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l  290 (302)
                      .   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....                    ...+.++
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            2   1234568899999999999889999999999999999999999997532                    1345677


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+|+..+
T Consensus       235 ~~li~~~L~~d  245 (321)
T 1tki_A          235 MDFVDRLLVKE  245 (321)
T ss_dssp             HHHHHTTSCSS
T ss_pred             HHHHHHHcCCC
Confidence            88888888765

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=308.73  Aligned_cols=216  Identities=25%  Similarity=0.381  Sum_probs=180.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----------------------------hHHHHHHHHHhc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------------------------TQEFIDEVCFLA  125 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~  125 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|......                             .+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467899999999999999999965 58899999754321                             246889999999


Q ss_pred             cCCCCceeeEEeEEee--CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 022118          126 SIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (302)
Q Consensus       126 ~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdl  203 (302)
                      +++||||+++++++.+  .+..++||||+++++|.+++      ....+++..+..++.|++.||+|||+  .+|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCC
Confidence            9999999999999987  56789999999999998765      23568999999999999999999999  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCC---CCCccchhhHHHHHHHHHhCCCCCC
Q 022118          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       204 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ||+|||++.++.+||+|||+++.......  ......+|+.|+|||.+.+..   ++.++|||||||++|||++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987654321  123456889999999988765   3778999999999999999999996


Q ss_pred             CCC------------------CCChhhHHHHHHHHhhcc
Q 022118          281 SLS------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       281 ~~~------------------~~~~~~l~~~~~~~~~~~  301 (302)
                      ...                  +..+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  280 (298)
T 2zv2_A          242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKN  280 (298)
T ss_dssp             CSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSC
T ss_pred             CccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcC
Confidence            421                  245678999999999876

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.4e-44  Score=308.80  Aligned_cols=196  Identities=26%  Similarity=0.358  Sum_probs=166.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||.||+|...++..+|+|+.....     .+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999999889999999864332     35688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++ +|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++..+...
T Consensus        82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            985 88887732    34568899999999999999999999  679999999999999999999999999998764322


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  12334678899999998764 589999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.7e-44  Score=318.98  Aligned_cols=216  Identities=21%  Similarity=0.297  Sum_probs=185.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .++|++.+.||+|+||.||++... ++..||+|......     .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999975 58899999864332     245789999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl~DfGla~~  226 (302)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.+   +.+||+|||+++.
T Consensus       108 e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999998883     34568899999999999999999999  679999999999999765   4699999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDS  286 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~  286 (302)
                      .....   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||....                    ...
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  257 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV  257 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence            65432   2234578999999999999999999999999999999999999996432                    123


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       258 ~~~~~~li~~~L~~d  272 (362)
T 2bdw_A          258 TPEAKSLIDSMLTVN  272 (362)
T ss_dssp             CHHHHHHHHHHSCSS
T ss_pred             CHHHHHHHHHHcCCC
Confidence            567889999999765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=326.79  Aligned_cols=217  Identities=19%  Similarity=0.243  Sum_probs=185.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .++|++.+.||+|+||.||++... ++..+|+|.+....     .+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            456889999999999999999864 68899999865433     245789999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~---~~~~~kl~DfGla~~  226 (302)
                      ||+++|+|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++   +++.+||+|||+++.
T Consensus        90 E~~~gg~L~~~i~-----~~~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999998883     34568999999999999999999999  6799999999999998   568899999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDS  286 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~  286 (302)
                      ......  ......||+.|+|||++.+..|+.++||||+||++|+|++|++||....                    +..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV  240 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence            654322  1234578999999999999999999999999999999999999996422                    244


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      ++++.+++.+|+..+
T Consensus       241 s~~~~~li~~~L~~d  255 (444)
T 3soa_A          241 TPEAKDLINKMLTIN  255 (444)
T ss_dssp             CHHHHHHHHHHSCSS
T ss_pred             CHHHHHHHHHHcCCC
Confidence            678899999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-44  Score=317.23  Aligned_cols=215  Identities=20%  Similarity=0.294  Sum_probs=185.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||+|.. .++..||+|...      ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35788999999999999999996 468899999753      23345788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+ +|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++++.+||+|||+++...
T Consensus        88 ~E~~-~g~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 678888873     34568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLV  291 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~  291 (302)
                      ....   .....||+.|+|||.+.+..+ ++++|||||||++|||++|+.||...                +...++++.
T Consensus       160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  236 (336)
T 3h4j_B          160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ  236 (336)
T ss_dssp             TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHH
T ss_pred             CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHH
Confidence            4322   234568999999999988876 68999999999999999999999743                233467889


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++++||..+
T Consensus       237 ~li~~~L~~d  246 (336)
T 3h4j_B          237 SLIRRMIVAD  246 (336)
T ss_dssp             HHHHTTSCSS
T ss_pred             HHHHHHcCCC
Confidence            9999999765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-44  Score=320.10  Aligned_cols=221  Identities=19%  Similarity=0.284  Sum_probs=186.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC--------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .+.|++.+.||+|+||+||+|... +++.||+|...        ....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356889999999999999999865 58999999743        224567899999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGL  223 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~---~kl~DfGl  223 (302)
                      +||||+++|+|.+.+.... .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988774321 123458899999999999999999999  67999999999999986654   99999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------C
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------P  284 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~  284 (302)
                      ++.......  ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||....                   .
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccc
Confidence            987754322  1234578999999999999999999999999999999999999996421                   2


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+.++.+++.+||..+
T Consensus       258 ~~s~~~~~li~~~L~~d  274 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLD  274 (351)
T ss_dssp             TSCHHHHHHHHHHTCSS
T ss_pred             cCCHHHHHHHHHHCCCC
Confidence            34567889999999765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=318.84  Aligned_cols=228  Identities=29%  Similarity=0.446  Sum_probs=191.2

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~  141 (302)
                      +....++|++.+.||+|+||.||+|...      ++..||+|......    .+.+.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678999999999999999999964      34789999876543    2457899999999999999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcC-------------------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD  202 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrd  202 (302)
                      .+..++||||+++|+|.+++......                   ....+++..++.++.|++.||.|||+  .+|+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~D  199 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRD  199 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCC
Confidence            99999999999999999998532110                   12568999999999999999999999  6799999


Q ss_pred             CCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 022118          203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSS  281 (302)
Q Consensus       203 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~  281 (302)
                      |||+|||++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987654433333445567888999999999999999999999999999999 9999964


Q ss_pred             C-----------------CCCChhhHHHHHHHHhhcc
Q 022118          282 L-----------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 ~-----------------~~~~~~~l~~~~~~~~~~~  301 (302)
                      .                 +...+.++.+++.+||..+
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  316 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL  316 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccC
Confidence            3                 2355678999999999865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=323.38  Aligned_cols=225  Identities=24%  Similarity=0.375  Sum_probs=189.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      ..++|++.+.||+|+||+||+|...      ++..||+|.+.....    .++.+|+.++++++||||+++++++.+.+.
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3467888999999999999999843      467899998764432    357889999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCc--CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVA  219 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~---~~kl~  219 (302)
                      .++||||+++|+|.+++.....  .....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++   .+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999854321  123468899999999999999999999  6799999999999999554   59999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC----------------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL----------------  282 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~----------------  282 (302)
                      |||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...                
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~  306 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  306 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999986644333334445667889999999999999999999999999999998 99999743                


Q ss_pred             -CCCChhhHHHHHHHHhhcc
Q 022118          283 -SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -~~~~~~~l~~~~~~~~~~~  301 (302)
                       +...+.++.+++.+||..+
T Consensus       307 ~~~~~~~~l~~li~~~l~~d  326 (367)
T 3l9p_A          307 PPKNCPGPVYRIMTQCWQHQ  326 (367)
T ss_dssp             CCTTCCHHHHHHHHHHTCSS
T ss_pred             CCccCCHHHHHHHHHHcCCC
Confidence             2345678999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-44  Score=321.27  Aligned_cols=221  Identities=27%  Similarity=0.475  Sum_probs=176.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ...+|++.+.||+|+||.||+|...    ++..||+|......    .+++.+|+.++++++||||+++++++.+++..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3467999999999999999999864    46789999876543    246889999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999843    23468899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCCh
Q 022118          227 LGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSS  287 (302)
Q Consensus       227 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~  287 (302)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            6543211 11222345678999999999999999999999999999998 99999642                 23556


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       277 ~~l~~li~~cl~~d  290 (373)
T 2qol_A          277 AALYQLMLDCWQKD  290 (373)
T ss_dssp             HHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHhCcC
Confidence            78999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-44  Score=315.53  Aligned_cols=219  Identities=21%  Similarity=0.315  Sum_probs=178.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCee---
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ---  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---  145 (302)
                      .++|++.+.||+|+||.||++.. .+++.||+|......      ...+.+|+.++++++||||+++++++...+..   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            45788999999999999999996 468899999865432      13578999999999999999999998866543   


Q ss_pred             -eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          146 -FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       146 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                       |+||||+++++|.+++.     ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             99999999999999983     34568899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          225 NFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      +........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....                    
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  243 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence            876543221 22334568999999999999999999999999999999999999997543                    


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++.+||.++
T Consensus       244 ~~~~~~l~~li~~~l~~d  261 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKN  261 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSS
T ss_pred             CCCCHHHHHHHHHHHhcC
Confidence            234677899999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.3e-44  Score=311.94  Aligned_cols=198  Identities=24%  Similarity=0.413  Sum_probs=169.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|++.+.||+|+||+||+|...++..||+|......     ...+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46789999999999999999999889999999865332     2467899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++ +|.+.+..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..+..
T Consensus       100 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9985 77777632    34558899999999999999999999  67999999999999999999999999999876532


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ..  ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            21  2234467889999999876 56899999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.9e-44  Score=306.38  Aligned_cols=220  Identities=30%  Similarity=0.461  Sum_probs=189.5

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|+..+.||+|+||.||++...++..||+|.....  ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            34578889999999999999999988899999986644  3567899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++..    ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++.......
T Consensus        88 ~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999999843    23568899999999999999999999  6799999999999999999999999999987644321


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~  294 (302)
                      . ......+|..|+|||.+.+..++.++||||+|+++|||++ |+.||....                 ...+.++.+++
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          162 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             H-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             c-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHH
Confidence            1 1233456778999999999999999999999999999999 999987432                 23467889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       241 ~~~l~~~  247 (269)
T 4hcu_A          241 NHCWRER  247 (269)
T ss_dssp             HHHTCSS
T ss_pred             HHHccCC
Confidence            9999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.2e-44  Score=314.77  Aligned_cols=219  Identities=17%  Similarity=0.212  Sum_probs=185.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC-CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.... ...+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            45788999999999999999996 4688999998643 3345688999999999 9999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-----eEEccccccccc
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFL  227 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~-----~kl~DfGla~~~  227 (302)
                       +++|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           88 -GPSLEDLFDL----CDRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             -CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence             9999999842    24578999999999999999999999  67999999999999998887     999999999876


Q ss_pred             CCCCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC----------------
Q 022118          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS----------------  286 (302)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~----------------  286 (302)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......                
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            543221     12345678999999999999999999999999999999999999998754321                


Q ss_pred             -------hhhHHHHHHHHhhcc
Q 022118          287 -------SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 -------~~~l~~~~~~~~~~~  301 (302)
                             .+++.+++.+||..+
T Consensus       241 ~~~~~~~~p~~~~li~~~l~~~  262 (330)
T 2izr_A          241 IEVLCENFPEMATYLRYVRRLD  262 (330)
T ss_dssp             HHHHTTTCHHHHHHHHHHHHCC
T ss_pred             HHHHhccChHHHHHHHHHHhCC
Confidence                   127788888888764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-43  Score=330.50  Aligned_cols=221  Identities=23%  Similarity=0.325  Sum_probs=189.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||.||+++.. +++.||+|.+..      ...+.+.+|.+++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888899999999999999975 589999997542      3345688999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++..... ....+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999998854321 24568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQ  288 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~  288 (302)
                      ....  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||....                    ...+.
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  418 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP  418 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence            4321  1234579999999999999999999999999999999999999997532                    33466


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+|+.++
T Consensus       419 ~~~~li~~lL~~d  431 (543)
T 3c4z_A          419 ASKDFCEALLQKD  431 (543)
T ss_dssp             HHHHHHHHHSCSS
T ss_pred             HHHHHHHHhccCC
Confidence            7888888888765

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-44  Score=322.23  Aligned_cols=232  Identities=25%  Similarity=0.380  Sum_probs=191.6

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEE
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLL  136 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~  136 (302)
                      ....+.+..++|++.+.||+|+||.||+|.+.      +++.||+|.......    +.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34555667788999999999999999999742      357899998765432    3588999999999 899999999


Q ss_pred             eEEeeCCe-eeEEEeccCCCCccccccCCCcC------------------------------------------------
Q 022118          137 GYCQENNL-QFLIYEYIPNGSVSIHLYGPSQV------------------------------------------------  167 (302)
Q Consensus       137 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------  167 (302)
                      +++.+.+. .++||||+++|+|.+++......                                                
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 89999999999999998643210                                                


Q ss_pred             -------------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          168 -------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       168 -------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                                   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                         01228899999999999999999999  679999999999999999999999999998765433322


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC------------------CCChhhHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS------------------PDSSQDLVELMI  295 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~------------------~~~~~~l~~~~~  295 (302)
                      ......+|..|+|||++.+..++.++|||||||++|||++ |+.||....                  ...++++.+++.
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML  330 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            3344567888999999999999999999999999999998 999997532                  345678999999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       331 ~~l~~d  336 (359)
T 3vhe_A          331 DCWHGE  336 (359)
T ss_dssp             HHTCSS
T ss_pred             HHccCC
Confidence            999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.8e-44  Score=329.42  Aligned_cols=223  Identities=25%  Similarity=0.472  Sum_probs=189.7

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +.+..++|+..+.||+|+||.||+|...++..||+|.....  ..+.+.+|+.+|++++||||+++++++. .+..++||
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            34456678888999999999999999988899999986643  4577999999999999999999999987 56789999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++...   ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus       262 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             eecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999999432   22357888999999999999999999  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLV  291 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~  291 (302)
                      .... ......+|..|+|||++....++.++|||||||++|||++ |+.||...                 +...+.++.
T Consensus       337 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  415 (454)
T 1qcf_A          337 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY  415 (454)
T ss_dssp             HHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             Ccee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2211 1223346778999999999999999999999999999999 99999743                 235578899


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      ++|.+||..+
T Consensus       416 ~li~~cl~~d  425 (454)
T 1qcf_A          416 NIMMRCWKNR  425 (454)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHccCC
Confidence            9999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=319.36  Aligned_cols=227  Identities=28%  Similarity=0.431  Sum_probs=192.5

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEEeEE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYC  139 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~~  139 (302)
                      .+..++|++.+.||+|+||.||+|...        ++..||+|.......    .++.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            345567888999999999999999852        235799998765433    4578999999999 999999999999


Q ss_pred             eeCCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          140 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      .+++..++||||+++|+|.+++.....           .....+++..++.++.|++.||+|||+  .+|+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceE
Confidence            999999999999999999999853321           123468999999999999999999999  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----  282 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----  282 (302)
                      |+++++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.||...     
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987765444344455567888999999999999999999999999999999 99999753     


Q ss_pred             ------------CCCChhhHHHHHHHHhhcc
Q 022118          283 ------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                  +...+.++.+++.+||..+
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  333 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAV  333 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSS
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence                        2355678999999999865

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-44  Score=310.77  Aligned_cols=221  Identities=27%  Similarity=0.456  Sum_probs=188.0

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +..++|+..+.||+|+||.||++...++..||+|.....  ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            345678889999999999999999988889999987654  456789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++......
T Consensus       101 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          101 MANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CTTCBHHHHHHC----GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999843    24568999999999999999999999  679999999999999999999999999998764422


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVEL  293 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~  293 (302)
                      .. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...++++.++
T Consensus       175 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  253 (283)
T 3gen_A          175 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI  253 (283)
T ss_dssp             HH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence            11 1233446778999999999999999999999999999998 99999742                 23456788999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       254 i~~~l~~~  261 (283)
T 3gen_A          254 MYSCWHEK  261 (283)
T ss_dssp             HHHTTCSS
T ss_pred             HHHHccCC
Confidence            99999865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.8e-44  Score=314.24  Aligned_cols=227  Identities=28%  Similarity=0.426  Sum_probs=190.9

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      .+..++|++.+.||+|+||.||+|...      ++..||+|.......    +.+.+|++++++++||||+++++++.+.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            345667888999999999999999852      347899998765432    4578899999999999999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCcC-------------------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdl  203 (302)
                      +..++||||+++|+|.+++......                   ....+++..++.++.|++.||.|||+  .+|+||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~di  176 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDL  176 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCccccc
Confidence            9999999999999999998532210                   12458899999999999999999999  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 022118          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  282 (302)
Q Consensus       204 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~  282 (302)
                      ||+||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987755433333445567788999999999999999999999999999999 99999753


Q ss_pred             C-----------------CCChhhHHHHHHHHhhcc
Q 022118          283 S-----------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ~-----------------~~~~~~l~~~~~~~~~~~  301 (302)
                      +                 ...+.++.+++.+||..+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  292 (314)
T 2ivs_A          257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQE  292 (314)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCC
Confidence            2                 345678899999999765

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7e-44  Score=309.94  Aligned_cols=217  Identities=25%  Similarity=0.416  Sum_probs=180.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhcc--CCCCceeeEEeEEeeC----CeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQEN----NLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~lv~  149 (302)
                      .++|++.+.||+|+||+||+|.. ++..||+|.........+.+|.+++..  ++||||+++++++...    +..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            46789999999999999999987 588999999877777777777777765  7999999999987643    4579999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhh--------cCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      ||+++|+|.+++.      ...+++..++.++.|++.||+|||        +  ++|+||||||+|||++.++.+||+||
T Consensus        86 e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           86 HYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             hhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999982      346899999999999999999999        6  67999999999999999999999999


Q ss_pred             ccccccCCCCCC--CCCccccCcccccchhhhccC------CCCCccchhhHHHHHHHHHhC----------CCCCCCCC
Q 022118          222 GLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REASSSLS  283 (302)
Q Consensus       222 Gla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dvws~Gvil~el~~g----------~~p~~~~~  283 (302)
                      |+++........  .......+|+.|+|||++.+.      .++.++|||||||++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999776443221  122345789999999999876      455789999999999999999          88885432


Q ss_pred             C----------------------------CChhhHHHHHHHHhhcc
Q 022118          284 P----------------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~----------------------------~~~~~l~~~~~~~~~~~  301 (302)
                      .                            ..+.++.+++.+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  283 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN  283 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSS
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcC
Confidence            1                            12256889999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.9e-44  Score=313.28  Aligned_cols=211  Identities=21%  Similarity=0.308  Sum_probs=165.7

Q ss_pred             CCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEeccCCCCccc
Q 022118           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (302)
                      .+.||+|+||.||++... +++.||+|.........+.+|+.+++.+. ||||+++++++.+++..|+||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            378999999999999975 58899999987777778899999999997 9999999999999999999999999999999


Q ss_pred             cccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcccccccccCCCCCCCCC
Q 022118          160 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNFLGRTDVAGPS  236 (302)
Q Consensus       160 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~---~~kl~DfGla~~~~~~~~~~~~  236 (302)
                      ++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++   .+||+|||+++.......  ..
T Consensus        96 ~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~  166 (325)
T 3kn6_A           96 RIK-----KKKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL  166 (325)
T ss_dssp             HHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence            983     34568999999999999999999999  6799999999999997665   899999999986543321  22


Q ss_pred             ccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------------------------CChhh
Q 022118          237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---------------------------DSSQD  289 (302)
Q Consensus       237 ~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---------------------------~~~~~  289 (302)
                      ....+|+.|+|||.+.+..|+.++|||||||++|||++|+.||.....                           ..+++
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence            345678899999999999999999999999999999999999975321                           24577


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+..+
T Consensus       247 ~~~li~~~L~~d  258 (325)
T 3kn6_A          247 AKDLIQGLLTVD  258 (325)
T ss_dssp             HHHHHHHHHCCC
T ss_pred             HHHHHHHHCCCC
Confidence            889999999765

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.8e-44  Score=327.54  Aligned_cols=219  Identities=22%  Similarity=0.266  Sum_probs=179.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|+..+.||+|+||.||++... ++..||+|.+..      .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3467899999999999999999965 588999997532      233567889999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999998883     345688999999999999999999961 46999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHH
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLV  291 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~  291 (302)
                      ....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...++++.
T Consensus       300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  377 (446)
T 4ejn_A          300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK  377 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence            3322  1234567899999999999999999999999999999999999999753                234567889


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||.++
T Consensus       378 ~li~~~L~~d  387 (446)
T 4ejn_A          378 SLLSGLLKKD  387 (446)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHcccC
Confidence            9999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6e-43  Score=305.11  Aligned_cols=213  Identities=38%  Similarity=0.585  Sum_probs=180.9

Q ss_pred             hhccCHHHHHHHhcCCCcC------CeeeeCCCeeEEEEEEcCCcEEEEEecCCC-------ChHHHHHHHHHhccCCCC
Q 022118           64 ARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHR  130 (302)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~H~  130 (302)
                      ...+...++...+++|...      +.||+|+||.||+|.. ++..||+|.....       ..+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3456777888888887766      8999999999999986 5788999975432       235688999999999999


Q ss_pred             ceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       131 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      ||+++++++.+.+..++||||+++++|.+++...  .....+++..+..++.|++.||.|||+  .+|+||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEE
Confidence            9999999999999999999999999999988532  123568899999999999999999999  679999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       211 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      +.++.+||+|||+++...............+++.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            9999999999999987654332222344568899999998865 5889999999999999999999999754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=318.18  Aligned_cols=217  Identities=21%  Similarity=0.302  Sum_probs=186.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|++.+.||+|+||.||+|... ++..+|+|......   ...+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357899999999999999999975 58899999865543   34578999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC--CCceEEcccccccccCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGR  229 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~--~~~~kl~DfGla~~~~~  229 (302)
                      +++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.  ++.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999998842    23468999999999999999999999  67999999999999974  57899999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQD  289 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~  289 (302)
                      ..   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....                    ...+.+
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            32   1234568999999999999999999999999999999999999997532                    234667


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       281 ~~~li~~~L~~d  292 (387)
T 1kob_A          281 AKDFIKNLLQKE  292 (387)
T ss_dssp             HHHHHHTTSCSS
T ss_pred             HHHHHHHHcCCC
Confidence            889999998765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.7e-43  Score=309.12  Aligned_cols=201  Identities=23%  Similarity=0.384  Sum_probs=157.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|.....    ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457899999999999999999865 5889999975422    34678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCc-CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          151 YIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |++ |+|.+++..... .....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            998 588888743211 123458899999999999999999999  6799999999999999999999999999987653


Q ss_pred             CCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ...  ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            221  22345678899999998764 689999999999999999999999964

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.2e-44  Score=316.54  Aligned_cols=228  Identities=22%  Similarity=0.413  Sum_probs=174.0

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEcC-C---cEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      ..+..++|++.+.||+|+||.||+|.... +   ..||+|.....     ..+++.+|++++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            33456789999999999999999998654 3   27999986543     235688999999999999999999999877


Q ss_pred             Cee------eEEEeccCCCCccccccCCCc-CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 022118          143 NLQ------FLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (302)
Q Consensus       143 ~~~------~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~  215 (302)
                      +..      +++|||+++|+|.+++..... .....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSC
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCCCC
Confidence            655      999999999999998843211 122368899999999999999999999  67999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------
Q 022118          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------  282 (302)
Q Consensus       216 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------  282 (302)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...            
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999987655443333445566788999999999999999999999999999999 99999743            


Q ss_pred             -----CCCChhhHHHHHHHHhhcc
Q 022118          283 -----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----~~~~~~~l~~~~~~~~~~~  301 (302)
                           +...+.++.+++.+||..+
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~d  279 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSAD  279 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             CCCCCCCccCHHHHHHHHHHccCC
Confidence                 2355678999999999865

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-43  Score=331.19  Aligned_cols=219  Identities=21%  Similarity=0.335  Sum_probs=188.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|+..+.||+|+||.||++... ++..||+|.+.      ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3466888999999999999999975 68999999753      2344568899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++...   ....+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus       262 VmEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999988532   23458999999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCCh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSS  287 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~  287 (302)
                      ....   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||....                    ...+
T Consensus       337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s  413 (576)
T 2acx_A          337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS  413 (576)
T ss_dssp             CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC
Confidence            5432   1234578999999999999999999999999999999999999997642                    2345


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+|+.++
T Consensus       414 ~~~~dLI~~lL~~d  427 (576)
T 2acx_A          414 PQARSLCSQLLCKD  427 (576)
T ss_dssp             HHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHhccCC
Confidence            67788888888765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-43  Score=316.87  Aligned_cols=216  Identities=20%  Similarity=0.235  Sum_probs=176.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC--CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||+||++... +++.||+|....  ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            457899999999999999999976 688999998653  33467889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--eEEcccccccccCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRNFLGRT  230 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~--~kl~DfGla~~~~~~  230 (302)
                      ++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.  +||+|||+++.....
T Consensus        99 ~~~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           99 SGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999998883     34568999999999999999999998  67999999999999987765  999999999754322


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCC----------------------CCh
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEK-SDVYSFGVFLLELVSGREASSSLSP----------------------DSS  287 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dvws~Gvil~el~~g~~p~~~~~~----------------------~~~  287 (302)
                      .   ......+|+.|+|||++.+..++.+ +|||||||++|||++|+.||.....                      ..+
T Consensus       172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            1   2334568999999999998888766 8999999999999999999975321                      245


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       249 ~~~~~li~~~L~~d  262 (361)
T 3uc3_A          249 PECCHLISRIFVAD  262 (361)
T ss_dssp             HHHHHHHHHHSCSC
T ss_pred             HHHHHHHHHHccCC
Confidence            78889999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-43  Score=303.66  Aligned_cols=220  Identities=26%  Similarity=0.435  Sum_probs=189.5

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||.||++...++..||+|.....  ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            45678889999999999999999888889999986543  4567899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++..    ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           86 SNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             TTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             CCCcHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999832    23458999999999999999999999  6799999999999999999999999999987654332


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~  294 (302)
                      .. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...++++.+++
T Consensus       160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          160 VS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             EE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             hc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence            21 223445677999999999999999999999999999999 99999742                 233467889999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       239 ~~~l~~~  245 (268)
T 3sxs_A          239 YSCWHEL  245 (268)
T ss_dssp             HHTTCSS
T ss_pred             HHHcCCC
Confidence            9999865

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-43  Score=324.01  Aligned_cols=217  Identities=31%  Similarity=0.462  Sum_probs=184.8

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCCCceeeEEeEEeeCC-eeeEEEec
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEY  151 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~  151 (302)
                      +..++|+..+.||+|+||.||+|... +..||+|..+.. ..+.+.+|+++|++++||||+++++++.+.+ ..++||||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            34567888899999999999999875 779999986543 4567999999999999999999999987765 78999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +++|+|.+++...   ....+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       269 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999432   22347889999999999999999999  67999999999999999999999999999864322 


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVEL  293 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~  293 (302)
                          .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...                 +...+.++.++
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence                122356778999999999999999999999999999998 99999753                 23556889999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      |.+||..+
T Consensus       419 i~~cl~~d  426 (450)
T 1k9a_A          419 MKNCWHLD  426 (450)
T ss_dssp             HHHHTCSS
T ss_pred             HHHHcCCC
Confidence            99999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4e-43  Score=304.31  Aligned_cols=194  Identities=23%  Similarity=0.350  Sum_probs=165.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|+..+.||+|+||+||+|... +++.||+|......     ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999975 58899999754222     3567899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++ ++.+.+.    .....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++..+..
T Consensus        82 ~~~~-~l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 4444442    234568999999999999999999999  67999999999999999999999999999876533


Q ss_pred             CCCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREAS  279 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~  279 (302)
                      ..  ......+|..|+|||.+.+.. ++.++|||||||++|||++|..||
T Consensus       155 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            22  233456788999999988765 899999999999999999998885

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.1e-44  Score=313.44  Aligned_cols=219  Identities=29%  Similarity=0.476  Sum_probs=180.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|+..+.||+|+||+||+|.+. ++.    +||+|....    ...+.+.+|+.++++++||||+++++++.+++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            456888999999999999999864 333    468887543    33467899999999999999999999998765 78


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999999842    24568899999999999999999999  6799999999999999999999999999988


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ..............+|..|+|||.+.+..++.++|||||||++|||++ |+.||...+                 ...+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            765444333444567888999999999999999999999999999999 999997532                 34567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       247 ~~~~li~~~l~~~  259 (327)
T 3poz_A          247 DVYMIMVKCWMID  259 (327)
T ss_dssp             HHHHHHHHHTCSC
T ss_pred             HHHHHHHHHcCCC
Confidence            7899999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.2e-44  Score=309.76  Aligned_cols=221  Identities=29%  Similarity=0.426  Sum_probs=181.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeC--Ce
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQEN--NL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~  144 (302)
                      ..++|++.+.||+|+||.||++++     .++..||+|.......   +.+.+|++++++++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            356788899999999999999984     2578999998765543   4578999999999999999999998654  45


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++||||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            7999999999999999842    23458999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC---------------------
Q 022118          225 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL---------------------  282 (302)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~---------------------  282 (302)
                      +....... ........++..|+|||.+.+..++.++||||||+++|||++|..||...                     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87654322 12233445777899999999999999999999999999999998887532                     


Q ss_pred             ------------CCCChhhHHHHHHHHhhcc
Q 022118          283 ------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                  +...+.++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  272 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNN  272 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCC
Confidence                        2345678999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-43  Score=312.51  Aligned_cols=219  Identities=29%  Similarity=0.440  Sum_probs=181.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|+..+.||+|+||.||+|... ++.    +|++|.....    ....+.+|+.++++++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            457888999999999999999864 333    4888865332    2346778999999999999999999986 45688


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999999843    23568888999999999999999999  6799999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ..............+|..|+|||.+.+..++.++|||||||++|||++ |+.||....                 ...+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI  244 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence            765444334455667888999999999999999999999999999999 999997532                 23456


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       245 ~~~~li~~~l~~d  257 (325)
T 3kex_A          245 DVYMVMVKCWMID  257 (325)
T ss_dssp             TTTHHHHHHTCSC
T ss_pred             HHHHHHHHHcCCC
Confidence            7888999999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-43  Score=318.59  Aligned_cols=203  Identities=18%  Similarity=0.192  Sum_probs=173.3

Q ss_pred             HhcCCCcCCeeeeC--CCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEG--KFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|++.+.||+|  +||.||+|... ++..||+|.+....     .+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34578999999999  99999999976 68999999854322     245778999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999998432   23568899999999999999999999  6799999999999999999999999999865


Q ss_pred             cCCCC-----CCCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          227 LGRTD-----VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       227 ~~~~~-----~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .....     .........+|..|+|||++.+  ..|+.++|||||||++|||++|+.||...
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            42211     1122334578889999999987  67999999999999999999999999753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.1e-44  Score=330.43  Aligned_cols=223  Identities=27%  Similarity=0.474  Sum_probs=191.3

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .+...+|+..+.||+|+||.||+|.+.. +..||+|.....  ..+.+.+|+.+|++++||||+++++++...+..++||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            3445678888999999999999999765 889999987643  4577999999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++|+|.+++...   ....+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus       296 E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          296 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999998432   34568899999999999999999999  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLV  291 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~  291 (302)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...                 +...+.++.
T Consensus       371 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          371 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             CCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             Ccee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            3222 1223446778999999999999999999999999999999 99999743                 235568899


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      ++|.+||..+
T Consensus       450 ~li~~cl~~d  459 (495)
T 1opk_A          450 ELMRACWQWN  459 (495)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHcCcC
Confidence            9999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-43  Score=322.62  Aligned_cols=216  Identities=23%  Similarity=0.322  Sum_probs=188.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|.+.+.||+|+||.||+|... +++.||+|....      .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457888999999999999999976 689999997642      2345788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999983     34568999999999999999999998  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLV  291 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~  291 (302)
                      ...   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....                ...+.++.
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  244 (476)
T 2y94_A          168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI  244 (476)
T ss_dssp             TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHH
T ss_pred             ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHH
Confidence            432   2334578999999999998876 679999999999999999999997532                23467889


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||..+
T Consensus       245 ~Li~~~L~~d  254 (476)
T 2y94_A          245 SLLKHMLQVD  254 (476)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHcCCC
Confidence            9999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-44  Score=315.55  Aligned_cols=218  Identities=21%  Similarity=0.322  Sum_probs=178.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCC--CceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~l  147 (302)
                      ..+.|++.+.||+|+||.||++...++..||+|......     .+.+.+|+.++++++|  |||+++++++..++..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            356788999999999999999998889999999754322     2457899999999976  999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||| +.+++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|||+++..
T Consensus        87 v~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 56789999983     34568899999999999999999999  6799999999999997 578999999999877


Q ss_pred             CCCCCCCCCccccCcccccchhhhcc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCC--------------
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSL--------------  282 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dvws~Gvil~el~~g~~p~~~~--------------  282 (302)
                      .............||+.|+|||++.+           ..++.++|||||||++|||++|+.||...              
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  237 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  237 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence            55433333345678999999999875           67899999999999999999999999742              


Q ss_pred             -----CCCChhhHHHHHHHHhhcc
Q 022118          283 -----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----~~~~~~~l~~~~~~~~~~~  301 (302)
                           +...+.++.+++.+||..+
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~d  261 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRD  261 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSS
T ss_pred             cccCCcccCCHHHHHHHHHHcCCC
Confidence                 2334467899999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-43  Score=325.82  Aligned_cols=222  Identities=30%  Similarity=0.511  Sum_probs=184.0

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .+..++|+..+.||+|+||.||+|....+..||+|.....  ..+.+.+|+++|++++||||+++++++.+ +..++|||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            3455678888999999999999999988888999987643  35679999999999999999999999876 67899999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++...   ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++.....
T Consensus       259 ~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999998421   23458899999999999999999999  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                      ... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||...                 +...+..+.+
T Consensus       334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            221 1233456778999999999999999999999999999999 99999743                 3456778999


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      +|.+||..+
T Consensus       413 li~~cl~~d  421 (452)
T 1fmk_A          413 LMCQCWRKE  421 (452)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHccCC
Confidence            999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=312.57  Aligned_cols=221  Identities=20%  Similarity=0.308  Sum_probs=179.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCC--------
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--------  143 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------  143 (302)
                      ++|++.+.||+|+||.||+|... ++..||+|+...    ...+.+.+|++++++++||||+++++++.+.+        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46888999999999999999976 689999998542    22456889999999999999999999986643        


Q ss_pred             -------------------------------------------------eeeEEEeccCCCCccccccCCCcCCCcccCH
Q 022118          144 -------------------------------------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF  174 (302)
Q Consensus       144 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  174 (302)
                                                                       ..++||||+++|+|.+++....  ......+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~  163 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREH  163 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchhh
Confidence                                                             2799999999999999985432  2344567


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC----------CCCccccCccc
Q 022118          175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA----------GPSSQVTADEI  244 (302)
Q Consensus       175 ~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~~~~~  244 (302)
                      ..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++........          .......+|+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7789999999999999998  67999999999999999999999999999877543211          12234578999


Q ss_pred             ccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------C---CCChhhHHHHHHHHhhcc
Q 022118          245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------S---PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       245 ~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------~---~~~~~~l~~~~~~~~~~~  301 (302)
                      |+|||.+.+..++.++|||||||++|||++|..|+...            +   ....+++.+++.+||..+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  313 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPS  313 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSS
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCC
Confidence            99999999999999999999999999999998776421            0   122356788999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.1e-44  Score=317.23  Aligned_cols=206  Identities=23%  Similarity=0.248  Sum_probs=175.9

Q ss_pred             hccCHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCC-----CCceeeEE
Q 022118           65 RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----HRNLVTLL  136 (302)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----H~nIv~l~  136 (302)
                      ..+..++.....++|++.+.||+|+||+||+|... ++..||+|......  ...+..|.++++.++     ||||++++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            34444444556778999999999999999999974 58899999876432  345678999998886     99999999


Q ss_pred             eEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC----
Q 022118          137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----  212 (302)
Q Consensus       137 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~----  212 (302)
                      +++...+..++||||+ +++|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.    
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCC
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEcccccc
Confidence            9999999999999999 89999988432   23458899999999999999999999  67999999999999975    


Q ss_pred             ---------------------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHH
Q 022118          213 ---------------------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLE  271 (302)
Q Consensus       213 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~e  271 (302)
                                           ++.+||+|||+++.....     .....+|+.|+|||++.+..|+.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 789999999999865432     234568899999999999999999999999999999


Q ss_pred             HHhCCCCCCC
Q 022118          272 LVSGREASSS  281 (302)
Q Consensus       272 l~~g~~p~~~  281 (302)
                      |++|+.||..
T Consensus       252 ll~g~~pf~~  261 (360)
T 3llt_A          252 LYTGSLLFRT  261 (360)
T ss_dssp             HHHSSCSCCC
T ss_pred             HHHCCCCCCC
Confidence            9999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=313.09  Aligned_cols=217  Identities=19%  Similarity=0.230  Sum_probs=171.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||.||+|... ++..||+|..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            3457889999999999999999976 4788999986543 3456788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccccCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGR  229 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~~~~~  229 (302)
                      ++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       131 ~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          131 TGGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CSCBHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999999883     34568899999999999999999999  67999999999999975   88999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------CCChh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------PDSSQ  288 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------~~~~~  288 (302)
                      ..   ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....                     +..+.
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            22   1234568899999999999999999999999999999999999996432                     23456


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+|+..+
T Consensus       281 ~~~~li~~~L~~d  293 (349)
T 2w4o_A          281 NAKDLVRKLIVLD  293 (349)
T ss_dssp             HHHHHHHTTSCSS
T ss_pred             HHHHHHHHHccCC
Confidence            7888999998765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-44  Score=315.54  Aligned_cols=228  Identities=25%  Similarity=0.379  Sum_probs=189.3

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCC----ChHHHHHHHHHhccC-CCCceeeEEeEEe
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~----~~~~~~~E~~~l~~l-~H~nIv~l~~~~~  140 (302)
                      +.+..++|+..+.||+|+||.||+|...      ++..||+|.....    ..+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3455678999999999999999999862      3568999986533    345688999999999 8999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcC------------------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQV------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD  202 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrd  202 (302)
                      ..+..++||||+++|+|.+++......                  ....+++..++.++.|++.||+|||+  .+|+|||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~D  197 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRD  197 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETT
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccCC
Confidence            999999999999999999998543211                  01347899999999999999999999  6799999


Q ss_pred             CCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 022118          203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSS  281 (302)
Q Consensus       203 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~  281 (302)
                      |||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987654332222334456778999999999999999999999999999998 9999975


Q ss_pred             CC------------------CCChhhHHHHHHHHhhcc
Q 022118          282 LS------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 ~~------------------~~~~~~l~~~~~~~~~~~  301 (302)
                      .+                  ...+.++.+++.+||..+
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  315 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD  315 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            43                  234678899999999865

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-43  Score=310.48  Aligned_cols=227  Identities=25%  Similarity=0.400  Sum_probs=190.2

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEE------cCCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      .+..++|+..+.||+|+||.||+|..      .++..||+|......    .+.+.+|+.+++++ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34556788999999999999999985      246789999876543    25688999999999 99999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCc-------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      ++..++||||+++|+|.+++.....             .....+++..++.++.|++.||.|||+  .+|+||||||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Ni  176 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNI  176 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceE
Confidence            9999999999999999999853221             112358999999999999999999999  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----  283 (302)
                      +++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+    
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987755433222334456778999999999999999999999999999999 999997543    


Q ss_pred             --------------CCChhhHHHHHHHHhhcc
Q 022118          284 --------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------------~~~~~~l~~~~~~~~~~~  301 (302)
                                    ...+.++.+++.+||..+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  288 (313)
T 1t46_A          257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD  288 (313)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHhccCCCCCCcccCCHHHHHHHHHHcCCC
Confidence                          334678899999999865

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=312.55  Aligned_cols=216  Identities=20%  Similarity=0.286  Sum_probs=186.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----------ChHHHHHHHHHhccCCCCceeeEEeEEeeCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~  143 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|.....           ....+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            457899999999999999999964 5889999975433           2335778999999999999999999999999


Q ss_pred             eeeEEEeccCCC-CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          144 LQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       144 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      ..++||||+.+| +|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH-----TCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999777 9988883     34568999999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCC----------CCCChhhHH
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSL----------SPDSSQDLV  291 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~----------~~~~~~~l~  291 (302)
                      +++......   ......+|+.|+|||.+.+..+ +.++|||||||++|||++|+.||...          +...+.++.
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHH
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHH
Confidence            998765432   2234568999999999988887 78999999999999999999999742          234567899


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||.++
T Consensus       253 ~li~~~L~~d  262 (335)
T 3dls_A          253 SLVSGLLQPV  262 (335)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHccCC
Confidence            9999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-42  Score=301.45  Aligned_cols=219  Identities=18%  Similarity=0.228  Sum_probs=187.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC-CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||.||+|.. .++..||+|.... ...+.+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            46789999999999999999996 5688999997643 3445688999999999 8999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-----eEEccccccccc
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFL  227 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~-----~kl~DfGla~~~  227 (302)
                       +++|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        89 -~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           89 -GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence             9999999842    23458999999999999999999998  67999999999999987776     999999999876


Q ss_pred             CCCCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC------------------
Q 022118          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------------  284 (302)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~------------------  284 (302)
                      ......     .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.....                  
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221     123456789999999999999999999999999999999999999986432                  


Q ss_pred             ------CChhhHHHHHHHHhhcc
Q 022118          285 ------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ------~~~~~l~~~~~~~~~~~  301 (302)
                            ..++++.+++.+||..+
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~d  264 (298)
T 1csn_A          242 LRELCAGFPEEFYKYMHYARNLA  264 (298)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCC
T ss_pred             HHHHHhhCcHHHHHHHHHHhcCC
Confidence                  34668889999999765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=308.70  Aligned_cols=199  Identities=24%  Similarity=0.384  Sum_probs=170.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCC--eeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv  148 (302)
                      .++|++.+.||+|+||+||+|.... ++.||+|....    ...+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3568889999999999999999764 88999998653    33466889999999999999999999998765  67999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEcccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLR  224 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill----~~~~~~kl~DfGla  224 (302)
                      |||+++++|.+++....  ....+++..++.++.|++.||+|||+  .+|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999985431  22348999999999999999999999  679999999999999    78889999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhc--------cCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKE--------FRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +.......   .....+|..|+|||++.        +..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            87654322   23456889999999986        57889999999999999999999999964

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-43  Score=318.22  Aligned_cols=199  Identities=25%  Similarity=0.387  Sum_probs=158.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCC-CCceeeEEeEEeeCC--ee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENN--LQ  145 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~  145 (302)
                      ..++|++.+.||+|+||.||+|... ++..||+|++....     .+++.+|+.+++++. ||||+++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4568999999999999999999865 58899999864321     245778999999997 999999999998654  67


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||++ ++|..++.      ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999998 58887773      2468889999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCC-------------------CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          226 FLGRTDV-------------------AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       226 ~~~~~~~-------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .......                   ........+|+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            7643110                   111234578999999999886 67899999999999999999999999653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-43  Score=304.50  Aligned_cols=197  Identities=23%  Similarity=0.332  Sum_probs=166.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|+..+.||+|+||+||+|... ++..||+|+.....     .+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999976 48899999764433     2457789999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~~~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDR-----YQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHh-----hhcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999988773     34568899999999999999999999  67999999999999999999999999999876532


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ..  ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            21  1234467888999999876 67899999999999999999999999653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-43  Score=317.46  Aligned_cols=217  Identities=21%  Similarity=0.322  Sum_probs=178.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCC--CCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..+|++.+.||+|+||.||++...++..||+|.+....     .+.+.+|+.++++++  ||||+++++++..++..|+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            34589999999999999999998889999999764322     246889999999996  59999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      || +.+++|.+++.     ....+++..+..++.||+.||.|||+  .+|+||||||+|||++ ++.+||+|||+++...
T Consensus       135 ~E-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 56889999883     23467888999999999999999998  6799999999999996 5899999999998775


Q ss_pred             CCCCCCCCccccCcccccchhhhcc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCC---------------
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSL---------------  282 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dvws~Gvil~el~~g~~p~~~~---------------  282 (302)
                      ............||+.|+|||++.+           ..|+.++|||||||++|||++|+.||...               
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  285 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  285 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence            4333223345679999999999875           46899999999999999999999999753               


Q ss_pred             ----CCCChhhHHHHHHHHhhcc
Q 022118          283 ----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----~~~~~~~l~~~~~~~~~~~  301 (302)
                          +...+.++.+++.+||..+
T Consensus       286 ~~~~~~~~~~~~~~li~~~L~~d  308 (390)
T 2zmd_A          286 EIEFPDIPEKDLQDVLKCCLKRD  308 (390)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSS
T ss_pred             cCCCCccchHHHHHHHHHHcccC
Confidence                1233567899999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-43  Score=315.03  Aligned_cols=220  Identities=16%  Similarity=0.206  Sum_probs=180.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCCh--------------HHHHHHHHHhccCCCCceee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT--------------QEFIDEVCFLASIQHRNLVT  134 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~--------------~~~~~E~~~l~~l~H~nIv~  134 (302)
                      ..++|++.+.||+|+||.||+|.+..      +..||+|.......              .....|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578999999999999999998754      46899998655432              12334556677889999999


Q ss_pred             EEeEEeeC----CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          135 LLGYCQEN----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       135 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                      +++++...    ...++||||+ +++|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEE
Confidence            99999875    4579999999 9999999832    33568999999999999999999999  679999999999999


Q ss_pred             C--CCCceEEcccccccccCCCCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          211 D--EDFIAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       211 ~--~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +  .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8  8899999999999876543221     11234558999999999999999999999999999999999999998421


Q ss_pred             ---------------------------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                                 ...+.++.+++.+||..+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  310 (364)
T 3op5_A          266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD  310 (364)
T ss_dssp             TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCC
T ss_pred             cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCC
Confidence                                       344678889999998765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.6e-43  Score=299.46  Aligned_cols=213  Identities=27%  Similarity=0.460  Sum_probs=175.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||.||+|... +..+|+|.....       ..+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            457888999999999999999975 788999975432       235688999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCC---ceecCCCCCCeeeCC--------CCceE
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR---VVHKDFKTANVLVDE--------DFIAK  217 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~---ivHrdlkp~Nill~~--------~~~~k  217 (302)
                      |||+++++|.+++.      ...+++..+..++.|++.||.|||+  .+   |+||||||+||+++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999998882      3568899999999999999999999  55   999999999999986        77899


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------
Q 022118          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------  283 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------  283 (302)
                      |+|||+++......    .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....              
T Consensus       157 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  232 (271)
T 3dtc_A          157 ITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA  232 (271)
T ss_dssp             ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred             EccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence            99999998654432    223468889999999999999999999999999999999999997532              


Q ss_pred             ----CCChhhHHHHHHHHhhcc
Q 022118          284 ----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----~~~~~~l~~~~~~~~~~~  301 (302)
                          ...+.++.+++.+||..+
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~  254 (271)
T 3dtc_A          233 LPIPSTCPEPFAKLMEDCWNPD  254 (271)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCCcccCHHHHHHHHHHhcCC
Confidence                345678999999999865

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-43  Score=311.48  Aligned_cols=228  Identities=21%  Similarity=0.224  Sum_probs=183.3

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC--------CCChHHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      +....++|++.+.||+|+||.||+|... ++..||+|...        ....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3345667999999999999999999965 57889999743        23346788999999999999999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCc-----------------------------------CCCcccCHHHHHHHHHHHHHH
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQ-----------------------------------VSRQKLEFKHRLSIALGAAKG  187 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------~~~~~~~~~~~~~~~~~i~~~  187 (302)
                      +..++||||+++|+|.+++.....                                   .....+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999988842110                                   012234677788999999999


Q ss_pred             HHHhhcCCCCceecCCCCCCeeeCCCC--ceEEcccccccccCCCCC--CCCCccccCcccccchhhhcc--CCCCCccc
Q 022118          188 LAHLHSLSPRVVHKDFKTANVLVDEDF--IAKVADAGLRNFLGRTDV--AGPSSQVTADEIFLASEVKEF--RRFSEKSD  261 (302)
Q Consensus       188 l~~LH~~~~~ivHrdlkp~Nill~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~--~~~~~~~D  261 (302)
                      |+|||+  .+|+||||||+|||++.++  .+||+|||+++.......  ........+|+.|+|||.+.+  ..++.++|
T Consensus       181 l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          181 LHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999  6799999999999998776  899999999987643221  112345578999999999875  67899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCC--------------------CChhhHHHHHHHHhhcc
Q 022118          262 VYSFGVFLLELVSGREASSSLSP--------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       262 vws~Gvil~el~~g~~p~~~~~~--------------------~~~~~l~~~~~~~~~~~  301 (302)
                      ||||||++|||++|+.||.....                    ..+.++.+++.+||..+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence            99999999999999999975321                    13568899999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.3e-43  Score=317.31  Aligned_cols=215  Identities=18%  Similarity=0.265  Sum_probs=173.7

Q ss_pred             cCCCcC-CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHh-ccCCCCceeeEEeEEee----CCeeeEEE
Q 022118           77 KNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLLGYCQE----NNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~lv~  149 (302)
                      ++|... +.||+|+||+||++... ++..||+|.+..  ...+.+|++++ +..+||||+++++++..    .+..|+||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~  138 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM  138 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence            345554 68999999999999975 588999998753  35677899887 45589999999999876    56789999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~~  226 (302)
                      ||+++|+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       139 E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          139 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             ECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999999999998432   23468999999999999999999999  67999999999999987   78999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------  283 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------  283 (302)
                      .....   ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||....                       
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  290 (400)
T 1nxk_A          214 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  290 (400)
T ss_dssp             CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred             cCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence            54322   2335578999999999999999999999999999999999999996432                       


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...+.++.+++.+||..+
T Consensus       291 ~~~~s~~~~~li~~~L~~d  309 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTE  309 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSS
T ss_pred             cccCCHHHHHHHHHHCCCC
Confidence             134567889999998765

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.3e-43  Score=310.62  Aligned_cols=212  Identities=30%  Similarity=0.435  Sum_probs=180.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      +.|+..+.||+|+||.||+|.. .++..||+|......      .+.+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999996 468899999864322      245789999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||++ |+|.+++.    .....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus       134 e~~~-g~l~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 57777663    124568899999999999999999999  6799999999999999999999999999986543


Q ss_pred             CCCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQ  288 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~  288 (302)
                            .....+|+.|+|||++.   ...++.++|||||||++|||++|+.||....                  ...+.
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE  280 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Confidence                  23456889999999985   5678999999999999999999999986432                  24467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      .+.+++.+||..+
T Consensus       281 ~l~~li~~~l~~d  293 (348)
T 1u5q_A          281 YFRNFVDSCLQKI  293 (348)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHcccC
Confidence            7899999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8e-43  Score=334.23  Aligned_cols=219  Identities=22%  Similarity=0.303  Sum_probs=188.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~  145 (302)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+.      ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34567899999999999999999965 57889999754      23445678899999887 799999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||+++|+|.+++.     ....+++..+..++.||+.||+|||+  .+||||||||+|||++.++++||+|||+++
T Consensus       418 ~lV~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEeCcCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999983     33568999999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQD  289 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~  289 (302)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...+.+
T Consensus       491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  568 (674)
T 3pfq_A          491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE  568 (674)
T ss_dssp             ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHH
T ss_pred             ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence            643222  2244567999999999999999999999999999999999999999853                2345678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+|+.++
T Consensus       569 ~~~li~~lL~~d  580 (674)
T 3pfq_A          569 AVAICKGLMTKH  580 (674)
T ss_dssp             HHHHHHHHSCSS
T ss_pred             HHHHHHHHccCC
Confidence            889999998765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.5e-43  Score=308.36  Aligned_cols=226  Identities=26%  Similarity=0.463  Sum_probs=189.0

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc--------CCcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEEeEEe
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~~~  140 (302)
                      +..++|++.+.||+|+||.||+|...        ++..||+|.......    +.+.+|+++++++ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34578889999999999999999863        467899998765432    4578999999999 8999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nil  209 (302)
                      ..+..++||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  .+|+||||||+||+
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL  189 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEE
Confidence            99999999999999999999854321           112358899999999999999999999  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------
Q 022118          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------  282 (302)
Q Consensus       210 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------  282 (302)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...      
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            99999999999999987765433333344566788999999999899999999999999999999 99999743      


Q ss_pred             -----------CCCChhhHHHHHHHHhhcc
Q 022118          283 -----------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----------~~~~~~~l~~~~~~~~~~~  301 (302)
                                 +...+.++.+++.+||..+
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  299 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAV  299 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCC
Confidence                       2345678899999999765

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-42  Score=297.95  Aligned_cols=219  Identities=23%  Similarity=0.339  Sum_probs=186.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|....    ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356888999999999999999976 588999997542    223568899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999983     34568899999999999999999999  67999999999999999999999999999876443


Q ss_pred             CCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l  290 (302)
                      ..........++..|+|||.+.+..+ +.++||||||+++|||++|+.||.....                   ..+.++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence            32223345678889999999987775 6789999999999999999999975432                   235678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       239 ~~li~~~l~~~  249 (276)
T 2yex_A          239 LALLHKILVEN  249 (276)
T ss_dssp             HHHHHHHSCSS
T ss_pred             HHHHHHHCCCC
Confidence            88999999765

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.9e-43  Score=305.96  Aligned_cols=216  Identities=22%  Similarity=0.289  Sum_probs=186.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||.||++... ++..||+|.....         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            346888999999999999999975 5889999974322         246789999999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA  221 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~----~~kl~Df  221 (302)
                      ++||||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHH-----TCSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999983     34568899999999999999999999  6799999999999999888    7999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      |+++......   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....                  
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  240 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE  240 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence            9998765432   2234568899999999999999999999999999999999999997532                  


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+..+.+++.+||..+
T Consensus       241 ~~~~~~~~~~~li~~~l~~d  260 (321)
T 2a2a_A          241 FFSHTSELAKDFIRKLLVKE  260 (321)
T ss_dssp             HHTTCCHHHHHHHHTTSCSS
T ss_pred             hhcccCHHHHHHHHHHcCCC
Confidence              234567888999998765

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.5e-43  Score=301.37  Aligned_cols=219  Identities=28%  Similarity=0.463  Sum_probs=173.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|++.+.||+|+||.||+|....    +..||+|......    .+.+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            45678889999999999999998643    4579999876543    245789999999999999999999984 56789


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999832    23468899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~  288 (302)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...                 +...+.
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            6543221 1233456778999999999999999999999999999997 99999743                 234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       245 ~l~~li~~~l~~~  257 (281)
T 1mp8_A          245 TLYSLMTKCWAYD  257 (281)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHccCC
Confidence            8899999999865

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.8e-43  Score=299.02  Aligned_cols=219  Identities=29%  Similarity=0.450  Sum_probs=188.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .++|+..+.||+|+||.||++...++..||+|.....  ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4578888999999999999999988889999986654  45678999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++........
T Consensus        87 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           87 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            9999999842    23567899999999999999999999  67999999999999999999999999999876432211


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~  295 (302)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...+.++.+++.
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence             1223456778999999999999999999999999999999 89998743                 2334678899999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       240 ~~l~~~  245 (267)
T 3t9t_A          240 HCWRER  245 (267)
T ss_dssp             HHTCSS
T ss_pred             HHccCC
Confidence            999765

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-43  Score=312.63  Aligned_cols=228  Identities=24%  Similarity=0.369  Sum_probs=189.2

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEe
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~  140 (302)
                      +....++|+..+.||+|+||.||+|....      ...||+|......    .+.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34456789999999999999999998643      2479999876543    34588999999999 8999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc---------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ---------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~  211 (302)
                      .++..++||||+++|+|.+++.....         .....+++..++.++.|++.||+|||+  .+|+||||||+|||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEEC
Confidence            99999999999999999999843211         013457899999999999999999999  6799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-------
Q 022118          212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-------  283 (302)
Q Consensus       212 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-------  283 (302)
                      .++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |..||....       
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999987654332222334456778999999999999999999999999999999 999997532       


Q ss_pred             -----------CCChhhHHHHHHHHhhcc
Q 022118          284 -----------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----------~~~~~~l~~~~~~~~~~~  301 (302)
                                 ...+.++.+++.+||..+
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~  307 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALE  307 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence                       234678899999999865

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-43  Score=313.51  Aligned_cols=216  Identities=21%  Similarity=0.331  Sum_probs=181.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .++|++.+.||+|+||.||++... +++.||+|.+.... ....+|++++.++ +||||+++++++.+++..|+||||++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            456889999999999999999975 58899999875443 2345788888877 79999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC----CceEEcccccccccCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGR  229 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~----~~~kl~DfGla~~~~~  229 (302)
                      +|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||+.++    +.+||+|||+++....
T Consensus       100 gg~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A          100 GGELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             SCBHHHHHH-----TCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999883     34568999999999999999999999  679999999999998433    3599999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------CCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------PDS  286 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------~~~  286 (302)
                      ..  .......+|+.|+|||++.+..|+.++|||||||++|||++|+.||...+                       ...
T Consensus       173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            32  12334578899999999998889999999999999999999999997532                       234


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+|+..+
T Consensus       251 s~~~~~li~~~L~~d  265 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVD  265 (342)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHCCCC
Confidence            567788899998765

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-42  Score=299.21  Aligned_cols=216  Identities=25%  Similarity=0.381  Sum_probs=183.5

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|++.+.||+|+||.||+|... ++..||+|....      .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467888999999999999999865 477899997532      234568899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||++...
T Consensus        87 v~e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999999998883     33568899999999999999999998  67999999999999999999999999998654


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHH
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLV  291 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~  291 (302)
                      ....    .....++..|+|||.+.+..++.++||||||+++|||++|+.||...                +...+.++.
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (279)
T 3fdn_A          160 PSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR  235 (279)
T ss_dssp             ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred             Cccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHH
Confidence            3322    23456788999999999999999999999999999999999999843                234567788


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||..+
T Consensus       236 ~li~~~l~~~  245 (279)
T 3fdn_A          236 DLISRLLKHN  245 (279)
T ss_dssp             HHHHHHCCSS
T ss_pred             HHHHHHhccC
Confidence            9999999765

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.1e-43  Score=320.59  Aligned_cols=191  Identities=23%  Similarity=0.361  Sum_probs=150.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC-----Ce
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  144 (302)
                      .++|++.+.||+|+||+||+|... ++..||+|++....     .+++.+|++++++++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            357999999999999999999865 58899999865432     24678999999999999999999999543     56


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||+. ++|.+++.     ....+++..+..++.||+.||.|||+  .+||||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFR-----TPVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999985 68888873     34568999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC-------------------------CCCccccCcccccchhhh-ccCCCCCccchhhHHHHHHHHHh
Q 022118          225 NFLGRTDVA-------------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVS  274 (302)
Q Consensus       225 ~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dvws~Gvil~el~~  274 (302)
                      +........                         .......||+.|+|||++ ....|+.++|||||||++|||++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            876432211                         122345789999999976 46679999999999999999999

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=307.61  Aligned_cols=219  Identities=29%  Similarity=0.468  Sum_probs=177.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCc----EEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|+..+.||+|+||.||+|... ++.    +|++|....    ...+.+.+|+.++++++||||+++++++..++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467899999999999999999864 333    467886532    34567899999999999999999999998765 78


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999998842    24568899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~  288 (302)
                      ..............+|..|+|||.+.+..|+.++|||||||++|||++ |+.||...+                 ...+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            755443333444567788999999999999999999999999999999 999997532                 34567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++++||..+
T Consensus       247 ~l~~li~~~l~~d  259 (327)
T 3lzb_A          247 DVYMIMRKCWMID  259 (327)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHcCCC
Confidence            8899999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=313.77  Aligned_cols=218  Identities=23%  Similarity=0.295  Sum_probs=182.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE----cCCcEEEEEecCC-------CChHHHHHHHHHhccC-CCCceeeEEeEEeeCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~  143 (302)
                      .++|++.+.||+|+||.||+++.    .++..||+|.+..       ...+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46789999999999999999997    3688999997643       2345677899999999 6999999999999999


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999983     23568899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSL-------------------  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------  282 (302)
                      ++........ ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...                   
T Consensus       206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  284 (355)
T 1vzo_A          206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  284 (355)
T ss_dssp             EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC
Confidence            9865432211 2234578999999999985  35789999999999999999999999632                   


Q ss_pred             -CCCChhhHHHHHHHHhhcc
Q 022118          283 -SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -~~~~~~~l~~~~~~~~~~~  301 (302)
                       +...+..+.+++.+||..+
T Consensus       285 ~~~~~~~~~~~li~~~L~~d  304 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKD  304 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSS
T ss_pred             CCcccCHHHHHHHHHHhhhC
Confidence             2334566788999999765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.1e-43  Score=301.71  Aligned_cols=219  Identities=30%  Similarity=0.491  Sum_probs=171.4

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +..++|++.+.||+|+||.||+|....  .+|+|......     .+.+.+|++++++++||||+++++++ ..+..++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            346679999999999999999998643  58999754332     24588999999999999999999965 45568999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999998842    34568899999999999999999999  679999999999999999999999999998665


Q ss_pred             CCCCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------  283 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------  283 (302)
                      ............+|+.|+|||.+.   +..++.++||||||+++|||++|+.||....                      
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence            433333334557899999999986   6678889999999999999999999997532                      


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++.+||..+
T Consensus       252 ~~~~~~l~~li~~~l~~~  269 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKK  269 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSS
T ss_pred             ccCCHHHHHHHHHHccCC
Confidence            245678999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=303.87  Aligned_cols=198  Identities=25%  Similarity=0.349  Sum_probs=166.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC--------CChHHHHHHHHHhccC---CCCceeeEEeEEeeC
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--------APTQEFIDEVCFLASI---QHRNLVTLLGYCQEN  142 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~  142 (302)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|....        .....+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 4688999997531        1234677888887766   499999999999876


Q ss_pred             C-----eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          143 N-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       143 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      .     ..+++|||++ ++|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEE
Confidence            5     4799999997 5999888432   23448999999999999999999999  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999998764322   23456789999999999999999999999999999999999999964

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=312.63  Aligned_cols=211  Identities=25%  Similarity=0.338  Sum_probs=176.0

Q ss_pred             CCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      .+.||+|+||.||+|... ++..||+|......   .+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            467999999999999865 58899999876543   35688999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee--CCCCceEEcccccccccCCCCCCCC
Q 022118          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill--~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      .+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            888832    23568899999999999999999999  679999999999999  6778999999999987654322   


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHHHHHH
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLVELMI  295 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~~~~~  295 (302)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....                    ...++++.+++.
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            233468999999999999999999999999999999999999997532                    234567888888


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +|+..+
T Consensus       325 ~~L~~d  330 (373)
T 2x4f_A          325 KLLIKE  330 (373)
T ss_dssp             TTSCSS
T ss_pred             HHcCCC
Confidence            888765

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=306.86  Aligned_cols=222  Identities=26%  Similarity=0.415  Sum_probs=181.3

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC--CCCceeeEEeEEeeC----Ceee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN----NLQF  146 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~~~~  146 (302)
                      ....++|++.+.||+|+||.||+|... +..||+|.........+.+|.+++...  +||||+++++++...    +..+
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            344568999999999999999999876 889999998766666677777776654  999999999999887    6789


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEcc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      +||||+++|+|.+++.      ...+++..++.++.|++.||+|||+.      .++|+||||||+|||++.++.+||+|
T Consensus       112 lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          112 LITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            9999999999999983      34688999999999999999999983      12799999999999999999999999


Q ss_pred             cccccccCCCCCC--CCCccccCcccccchhhhccCCCCCc------cchhhHHHHHHHHHhC----------CCCCCCC
Q 022118          221 AGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEK------SDVYSFGVFLLELVSG----------REASSSL  282 (302)
Q Consensus       221 fGla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~------~Dvws~Gvil~el~~g----------~~p~~~~  282 (302)
                      ||+++........  .......+|+.|+|||++.+..++.+      +|||||||++|||++|          +.||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999776443221  11234578999999999988877765      9999999999999999          7777543


Q ss_pred             CC----------------------------CChhhHHHHHHHHhhcc
Q 022118          283 SP----------------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ~~----------------------------~~~~~l~~~~~~~~~~~  301 (302)
                      ..                            ..+.++.+++.+||..+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  312 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN  312 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSS
T ss_pred             cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhC
Confidence            11                            22345889999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.6e-43  Score=300.81  Aligned_cols=222  Identities=28%  Similarity=0.498  Sum_probs=187.8

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .+..++|++.+.||+|+||.||+|...++..||+|.....  ..+.+.+|++++++++||||+++++++.. +..++|||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            3445678889999999999999999888889999986543  45678999999999999999999999874 56899999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||++++++.+||+|||+++.....
T Consensus        88 ~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999998421   12368899999999999999999999  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...+.++.+
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence            322 1223456778999999998899999999999999999999 99998643                 2345678899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       242 li~~~l~~~  250 (279)
T 1qpc_A          242 LMRLCWKER  250 (279)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHhccC
Confidence            999999765

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-43  Score=309.05  Aligned_cols=229  Identities=26%  Similarity=0.397  Sum_probs=190.5

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEe
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ  140 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~  140 (302)
                      ++....++|++.+.||+|+||.||+|...      ++..||+|.......    ..+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34455678999999999999999999854      367899998765432    35789999999999999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc-----CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~  215 (302)
                      +.+..++||||+++|+|.+++.....     .....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCCe
Confidence            99999999999999999999843211     112456889999999999999999999  67999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------
Q 022118          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------  282 (302)
Q Consensus       216 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------  282 (302)
                      +||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...            
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            99999999987654332222334456788999999999999999999999999999999 89998642            


Q ss_pred             -----CCCChhhHHHHHHHHhhcc
Q 022118          283 -----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----~~~~~~~l~~~~~~~~~~~  301 (302)
                           +...+.++.+++.+||..+
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~d  280 (322)
T 1p4o_A          257 GLLDKPDNCPDMLFELMRMCWQYN  280 (322)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCC
Confidence                 2455678899999999865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-42  Score=297.15  Aligned_cols=215  Identities=22%  Similarity=0.307  Sum_probs=184.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|++.+.||+|+||.||+|.... +..+|+|+..   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            3468889999999999999999764 6789999754   34457789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~~~~  228 (302)
                      +++++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999988873     34568899999999999999999999  679999999999999   788999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------------------CChh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--------------------DSSQ  288 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~--------------------~~~~  288 (302)
                      ...   ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||.....                    ..++
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence            432   22345688899999998754 89999999999999999999999975321                    3467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+|+..+
T Consensus       237 ~~~~li~~~l~~d  249 (277)
T 3f3z_A          237 QAESLIRRLLTKS  249 (277)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHccCC
Confidence            8899999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=332.36  Aligned_cols=211  Identities=28%  Similarity=0.469  Sum_probs=176.1

Q ss_pred             eeeeCCCeeEEEEEEc---CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCCCC
Q 022118           84 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (302)
Q Consensus        84 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~  156 (302)
                      .||+|+||.||+|.+.   ++..||+|..+..    ..+.+.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   4567999987543    34678999999999999999999999976 56899999999999


Q ss_pred             ccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-CCC
Q 022118          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGP  235 (302)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~  235 (302)
                      |.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus       422 L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999843    34568999999999999999999999  6799999999999999999999999999987654321 111


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHHHH
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMIKC  297 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~~~  297 (302)
                      .....+|..|+|||++.+..|+.++|||||||++|||++ |+.||...                 +...+.++.++|.+|
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  575 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC  575 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            223345678999999999999999999999999999998 99999753                 245678999999999


Q ss_pred             hhcc
Q 022118          298 MGKE  301 (302)
Q Consensus       298 ~~~~  301 (302)
                      |..+
T Consensus       576 l~~d  579 (613)
T 2ozo_A          576 WIYK  579 (613)
T ss_dssp             TCSS
T ss_pred             cCCC
Confidence            9875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=310.37  Aligned_cols=218  Identities=16%  Similarity=0.180  Sum_probs=177.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC--------------hHHHHHHHHHhccCCCCceeeEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNLVTLLG  137 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~  137 (302)
                      .++|++.+.||+|+||.||+|...    ++..+|+|......              ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467889999999999999999975    46789999765432              123567888899999999999999


Q ss_pred             EEee----CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 022118          138 YCQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (302)
Q Consensus       138 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~  213 (302)
                      ++..    .+..|+||||+ +++|.+++.     ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISG-----QNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCB-----GGGBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccC
Confidence            9988    67889999999 999999983     23478999999999999999999999  679999999999999887


Q ss_pred             C--ceEEcccccccccCCCCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---
Q 022118          214 F--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---  283 (302)
Q Consensus       214 ~--~~kl~DfGla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---  283 (302)
                      +  .+||+|||+++.+......     .......+|..|+|||++.+..++.++|||||||++|||++|+.||....   
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876433211     11244578999999999999999999999999999999999999995311   


Q ss_pred             ------------------------CCChhhHHHHHHHHhhcc
Q 022118          284 ------------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                              ...+.++.+++.+||..+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  309 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLA  309 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcC
Confidence                                    045668999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=296.78  Aligned_cols=218  Identities=23%  Similarity=0.364  Sum_probs=167.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||+|.. .++..||+|....      ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688899999999999999997 4688999997542      2346788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999998842    23568899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~  292 (302)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....                ...+.++.+
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD  241 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence            3221  1234567889999999999999999999999999999999999997432                234677899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       242 li~~~l~~d  250 (278)
T 3cok_A          242 LIHQLLRRN  250 (278)
T ss_dssp             HHHHHSCSS
T ss_pred             HHHHHcccC
Confidence            999999765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.4e-42  Score=297.52  Aligned_cols=216  Identities=28%  Similarity=0.453  Sum_probs=180.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh----------HHHHHHHHHhccCCCCceeeEEeEEeeCC
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----------QEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~  143 (302)
                      ..++|+..+.||+|+||.||+|... ++..||+|.......          +.+.+|++++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3467888999999999999999974 688999998643221          56889999999999999999999987665


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-----eEE
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKV  218 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~-----~kl  218 (302)
                        ++||||+++|+|.+++..    ....+++..++.++.|++.||+|||+.+++|+||||||+|||++.++.     +||
T Consensus        97 --~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             --eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence              799999999999888743    345689999999999999999999983222999999999999988776     999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------  283 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------  283 (302)
                      +|||+++....     ......+|+.|+|||.+.  ...++.++|||||||++|||++|+.||....             
T Consensus       171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            99999975433     233456888999999983  4567899999999999999999999997432             


Q ss_pred             -------CCChhhHHHHHHHHhhcc
Q 022118          284 -------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -------~~~~~~l~~~~~~~~~~~  301 (302)
                             ...++++.+++.+||..+
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~d  270 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGD  270 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCC
Confidence                   345677899999999865

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-43  Score=306.52  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=162.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChH----HHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||.||+|... ++..||+|........    .+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999976 6889999986543322    355799999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      ++ |+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 588877732    34568899999999999999999999  679999999999999999999999999998654322


Q ss_pred             CCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .  ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          155 K--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             c--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  2234467889999999876 56899999999999999999999999753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-42  Score=302.09  Aligned_cols=219  Identities=17%  Similarity=0.251  Sum_probs=176.9

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|++.+.||+|+||.||++... ++..||+|......      .+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3568999999999999999999975 58899999865332      2567899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999983     23568899999999999999999999  67999999999999999999999999999776


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-------------------CCCChh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-------------------SPDSSQ  288 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------~~~~~~  288 (302)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...                   ++..+.
T Consensus       185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred             cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence            543221 223456888999999999999999999999999999999999999742                   234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       264 ~l~~li~~~l~~d  276 (309)
T 2h34_A          264 AFDAVIARGMAKN  276 (309)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHhccCC
Confidence            7899999999865

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5e-43  Score=327.97  Aligned_cols=222  Identities=30%  Similarity=0.511  Sum_probs=188.7

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .+..++|++.+.||+|+||.||+|.+..+..||+|.+...  ..+.+.+|+++|++++||||+++++++.+ +..|+|||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3455678888999999999999999988888999986543  35679999999999999999999999876 67899999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++...   ....+++..++.++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||+++.....
T Consensus       342 ~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             hhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999998321   22458899999999999999999999  67999999999999999999999999999876532


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVE  292 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~  292 (302)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...                 +...+.++.+
T Consensus       417 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          417 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  495 (535)
T ss_dssp             HHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            211 1223346778999999999999999999999999999999 99999753                 2456778999


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      +|.+||..+
T Consensus       496 li~~cl~~d  504 (535)
T 2h8h_A          496 LMCQCWRKE  504 (535)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHcCCC
Confidence            999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=311.62  Aligned_cols=218  Identities=29%  Similarity=0.500  Sum_probs=170.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc--CC--cEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee-CCeeeEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ--DG--MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv  148 (302)
                      .|+..+.||+|+||.||+|...  ++  ..||+|......    .+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566789999999999999853  22  468999865432    3568899999999999999999998764 4678999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999843    33457888999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCC--CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChh
Q 022118          229 RTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       229 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~  288 (302)
                      .....  .......+|..|+|||.+.+..++.++|||||||++|||++ |.+||...                 +...+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~  323 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  323 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            43221  12233456778999999999999999999999999999999 67787643                 234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      .+.+++.+||..+
T Consensus       324 ~l~~li~~cl~~d  336 (373)
T 3c1x_A          324 PLYEVMLKCWHPK  336 (373)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHcCCC
Confidence            8999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.5e-42  Score=296.42  Aligned_cols=215  Identities=22%  Similarity=0.338  Sum_probs=186.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|...      ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            457888999999999999999976 47889999753      23346788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999998883     23468899999999999999999998  679999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ...    .....++..|+|||.+.+..++.++||||||+++|||++|+.||...                +...+.++.+
T Consensus       166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T 2vgo_A          166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD  241 (284)
T ss_dssp             SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred             ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence            321    23456888999999999999999999999999999999999999753                2345678899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+|+..+
T Consensus       242 li~~~l~~~  250 (284)
T 2vgo_A          242 LISKLLRYH  250 (284)
T ss_dssp             HHHHHSCSS
T ss_pred             HHHHHhhcC
Confidence            999999765

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.6e-44  Score=319.25  Aligned_cols=217  Identities=12%  Similarity=0.140  Sum_probs=173.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC------CChHHHHHHH---HHhccCCCCceeeEE-------eE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEV---CFLASIQHRNLVTLL-------GY  138 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~  138 (302)
                      .++|++.+.||+|+||.||+|.. .++..||+|.+..      ...+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35678889999999999999995 5689999998532      1235688999   556666899999998       66


Q ss_pred             EeeCCe-----------------eeEEEeccCCCCccccccCCCcC--CCcccCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 022118          139 CQENNL-----------------QFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV  199 (302)
Q Consensus       139 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~iv  199 (302)
                      +..++.                 .|++|||+ +|+|.+++......  ....+++..++.++.|++.||+|||+  .+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            665532                 78999999 68999998432111  12334458888899999999999999  6799


Q ss_pred             ecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccC-----------CCCCccchhhHHHH
Q 022118          200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----------RFSEKSDVYSFGVF  268 (302)
Q Consensus       200 Hrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Dvws~Gvi  268 (302)
                      ||||||+|||++.++.+||+|||+++..+..     .....| +.|+|||++.+.           .|+.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999864331     223456 789999999987           89999999999999


Q ss_pred             HHHHHhCCCCCCCCC------------CCChhhHHHHHHHHhhcc
Q 022118          269 LLELVSGREASSSLS------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       269 l~el~~g~~p~~~~~------------~~~~~~l~~~~~~~~~~~  301 (302)
                      +|||++|+.||....            ...++++.+++.+||..+
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  347 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP  347 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCC
Confidence            999999999997532            355788999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.5e-42  Score=305.23  Aligned_cols=217  Identities=21%  Similarity=0.316  Sum_probs=187.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|...+.||+|+||.||++...+ +..+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4678889999999999999999764 788999975432      235678899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999998873     34568899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|+.||...                +...+.++.+
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS  270 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence            3221  233456888999999999999999999999999999999999999753                2345677899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       271 li~~~l~~d  279 (335)
T 2owb_A          271 LIQKMLQTD  279 (335)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHccCC
Confidence            999999765

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-42  Score=309.55  Aligned_cols=209  Identities=20%  Similarity=0.292  Sum_probs=168.9

Q ss_pred             hhccCHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--------------hHHHHHHHHHhccCCC
Q 022118           64 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQH  129 (302)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~H  129 (302)
                      ..+....++....++|++.+.||+|+||.||+|...++..||+|+.....              .+.+.+|++++++++|
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   88 (362)
T 3pg1_A            9 AMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH   88 (362)
T ss_dssp             HHHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC
Confidence            33445567778889999999999999999999998889999999753211              1568899999999999


Q ss_pred             CceeeEEeEEeeC-----CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 022118          130 RNLVTLLGYCQEN-----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  204 (302)
Q Consensus       130 ~nIv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlk  204 (302)
                      |||+++++++...     ...|+||||++ |+|.+++..    ....+++..+..++.|++.||.|||+  .+|+|||||
T Consensus        89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlk  161 (362)
T 3pg1_A           89 PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLH  161 (362)
T ss_dssp             TTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCC
T ss_pred             cCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCC
Confidence            9999999998543     35799999998 577777742    34568999999999999999999999  679999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          205 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       205 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      |+|||++.++.+||+|||+++......   ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999997543322   2334568888999999887 67899999999999999999999999753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-42  Score=304.04  Aligned_cols=231  Identities=24%  Similarity=0.426  Sum_probs=178.7

Q ss_pred             HHHHHHHhcCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEE
Q 022118           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYC  139 (302)
Q Consensus        69 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~  139 (302)
                      ..++....++|++.+.||+|+||.||+|...    ++..||+|......     .+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3444556678899999999999999999854    34589999865432     24578999999999999999999999


Q ss_pred             eeCCe-----eeEEEeccCCCCccccccCCC-cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 022118          140 QENNL-----QFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (302)
Q Consensus       140 ~~~~~-----~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~  213 (302)
                      ...+.     .++||||+++|+|.+++.... ......+++..++.++.|++.||.|||+  .+|+||||||+||+++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCC
Confidence            87653     499999999999999884321 1234668999999999999999999998  679999999999999999


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC---------
Q 022118          214 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS---------  283 (302)
Q Consensus       214 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~---------  283 (302)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....         
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            9999999999987654433333344567788999999999999999999999999999999 889987532         


Q ss_pred             --------CCChhhHHHHHHHHhhcc
Q 022118          284 --------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------~~~~~~l~~~~~~~~~~~  301 (302)
                              ...+.++.+++.+||..+
T Consensus       264 ~~~~~~~~~~~~~~l~~li~~~l~~d  289 (313)
T 3brb_A          264 HGHRLKQPEDCLDELYEIMYSCWRTD  289 (313)
T ss_dssp             TTCCCCCBTTCCHHHHHHHHHTTCSS
T ss_pred             cCCCCCCCccccHHHHHHHHHHcCCC
Confidence                    344578899999999765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.1e-43  Score=305.26  Aligned_cols=232  Identities=25%  Similarity=0.386  Sum_probs=190.7

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEE------cCCcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEE
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLL  136 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~  136 (302)
                      ....+....++|++.+.||+|+||.||+|..      .++..||+|.......    ..+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445556678899999999999999999984      2467899998765432    3578999999999 799999999


Q ss_pred             eEEeeCC-eeeEEEeccCCCCccccccCCCcC-----------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 022118          137 GYCQENN-LQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  204 (302)
Q Consensus       137 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlk  204 (302)
                      +++...+ ..++||||+++|+|.+++......           ....+++..+..++.|++.||.|||+  .+|+|||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dik  175 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLA  175 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccCc
Confidence            9988765 489999999999999998543211           02237899999999999999999999  679999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022118          205 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS  283 (302)
Q Consensus       205 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~  283 (302)
                      |+||+++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999999999987654332222334557788999999999999999999999999999998 999997532


Q ss_pred             ------------------CCChhhHHHHHHHHhhcc
Q 022118          284 ------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                        ...+.++.+++.+||..+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  291 (316)
T 2xir_A          256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  291 (316)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCC
Confidence                              334678899999999865

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.5e-42  Score=303.23  Aligned_cols=192  Identities=20%  Similarity=0.298  Sum_probs=170.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCChHHHHHHHHHhccCC-CCceeeEEeEEee--CCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lv~e~  151 (302)
                      .++|++.+.||+|+||.||+|.. .++..||+|.......+.+.+|++++++++ ||||+++++++..  ....++||||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            35788999999999999999986 468899999998888889999999999997 9999999999988  5677999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~~  230 (302)
                      +++++|.+++        ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       115 ~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          115 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999998887        237888999999999999999999  6799999999999999776 8999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      .   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            2   2334568888999999887 678999999999999999999999994

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.6e-42  Score=314.34  Aligned_cols=196  Identities=21%  Similarity=0.323  Sum_probs=162.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC-----Ce
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  144 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|+.....     .+++.+|+.++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            457999999999999999999965 57899999875432     24678999999999999999999999876     56


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||++ |+|.+++.     ....+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK-----TPIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999987 58988883     34568999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC--------------------CCCccccCcccccchhhh-ccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022118          225 NFLGRTDVA--------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREAS  279 (302)
Q Consensus       225 ~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dvws~Gvil~el~~g~~p~  279 (302)
                      +........                    .......+|+.|+|||++ ....|+.++|||||||++|||++|..||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876543211                    123556789999999986 5667999999999999999999854443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-42  Score=301.62  Aligned_cols=218  Identities=22%  Similarity=0.311  Sum_probs=176.6

Q ss_pred             cCCCcC-CeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      +.|++. +.||+|+||.||+|... ++..||+|.....   ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457764 78999999999999854 6889999985432   356789999999885 79999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEccccccccc
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNFL  227 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~---~kl~DfGla~~~  227 (302)
                      |+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.   +||+|||+++..
T Consensus        92 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIH-----KRRHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999983     23568899999999999999999999  67999999999999988775   999999998765


Q ss_pred             CCCCC-----CCCCccccCcccccchhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------
Q 022118          228 GRTDV-----AGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------  284 (302)
Q Consensus       228 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------  284 (302)
                      .....     ........+|..|+|||.+.+     ..++.++|||||||++|||++|+.||.....             
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            43211     111223458999999999875     5689999999999999999999999975421             


Q ss_pred             ----------------------CChhhHHHHHHHHhhcc
Q 022118          285 ----------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ----------------------~~~~~l~~~~~~~~~~~  301 (302)
                                            ..+.++.+++.+|+..+
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  283 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD  283 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCC
Confidence                                  23457889999998765

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-42  Score=298.36  Aligned_cols=217  Identities=20%  Similarity=0.309  Sum_probs=186.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||.||++... ++..+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            456888999999999999999976 4788999975432      234678899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++...
T Consensus        94 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999998872     33568899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|+.||...                +...+..+.+
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS  244 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHH
Confidence            3221  223456888999999999999999999999999999999999999753                2344677899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       245 li~~~l~~~  253 (294)
T 2rku_A          245 LIQKMLQTD  253 (294)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHcccC
Confidence            999999765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-42  Score=296.99  Aligned_cols=216  Identities=21%  Similarity=0.295  Sum_probs=184.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|......     .+.+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467889999999999999999965 58899999754322     245788999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~---~kl~DfGla~~  226 (302)
                      ||+++++|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999988873     34568899999999999999999999  67999999999999976654   99999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDS  286 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~  286 (302)
                      ......   .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||....                    ...
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV  234 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc
Confidence            654322   234568889999999999999999999999999999999999986432                    244


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      ++++.+++.+||..+
T Consensus       235 ~~~~~~li~~~l~~d  249 (284)
T 3kk8_A          235 TPEAKSLIDSMLTVN  249 (284)
T ss_dssp             CHHHHHHHHHHSCSS
T ss_pred             CHHHHHHHHHHcccC
Confidence            678899999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-43  Score=321.65  Aligned_cols=194  Identities=23%  Similarity=0.334  Sum_probs=161.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      .++|+..+.||+|+||+||+|... +++.||+|++...     ..+++.+|+.+++.++||||+++++++...+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467899999999999999999865 5889999986532     2356789999999999999999999997553      


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+||||++++ |...+       ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~-------~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVI-------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHH-------hhcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            569999999865 55554       1247889999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++..+...   ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            98765422   234567899999999999999999999999999999999999999753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=300.79  Aligned_cols=216  Identities=29%  Similarity=0.452  Sum_probs=176.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      .++|++.+.||+|+||.||++... +..||+|...... .+.+.+|++++++++||||+++++++.+  ..++||||+++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            356788899999999999999875 6889999876544 4568999999999999999999998874  47999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC-CCceecCCCCCCeeeCCCCc-eEEcccccccccCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGRTDV  232 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-~~ivHrdlkp~Nill~~~~~-~kl~DfGla~~~~~~~~  232 (302)
                      |+|.+++....  ....++...++.++.|++.||+|||+.. ++|+||||||+|||++.++. +||+|||++......  
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           84 GSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             CBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999985431  2235788899999999999999999843 46999999999999988886 799999999765432  


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                         .....+|..|+|||.+.+..++.++||||||+++|||++|+.||....                   ...+..+.++
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL  236 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence               223458889999999999999999999999999999999999997432                   2446788999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       237 i~~~l~~d  244 (307)
T 2eva_A          237 MTRCWSKD  244 (307)
T ss_dssp             HHHHTCSS
T ss_pred             HHHHhcCC
Confidence            99999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-42  Score=304.81  Aligned_cols=198  Identities=24%  Similarity=0.369  Sum_probs=164.9

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--------hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ..++|+..+.||+|+||.||+|... +++.||+|......        ...+.+|+++++.++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4568999999999999999999965 58999999865321        24678999999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++ +|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999986 78777732    23467888899999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .......  ......+|+.|+|||.+.+. .++.++|||||||++|||++|.+||..
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            7654322  23345688999999998754 589999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.5e-42  Score=293.33  Aligned_cols=215  Identities=27%  Similarity=0.403  Sum_probs=181.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  148 (302)
                      .++|+..+.||+|+||.||+|... +..+|+|......     .+.+.+|+.++++++||||+++++++.++  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            457888999999999999999985 7889999865432     24588999999999999999999999887  778999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++...   ....+++..+..++.|++.||+|||+.+..++||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999999532   2335899999999999999999999833339999999999999999999999999875432


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCC---ccchhhHHHHHHHHHhCCCCCCCC------------------CCCCh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSE---KSDVYSFGVFLLELVSGREASSSL------------------SPDSS  287 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Dvws~Gvil~el~~g~~p~~~~------------------~~~~~  287 (302)
                             .....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||...                  +...+
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS  237 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence                   22346788899999998766554   799999999999999999999742                  23557


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       238 ~~~~~li~~~l~~~  251 (271)
T 3kmu_A          238 PHVSKLMKICMNED  251 (271)
T ss_dssp             HHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHcCCC
Confidence            78999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-42  Score=304.72  Aligned_cols=198  Identities=24%  Similarity=0.405  Sum_probs=165.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .++|+..+.||+|+||.||++.... +..||+|......     .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4578889999999999999999764 8899999754332     234678999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus       104 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999887762     34568899999999999999999999  6799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ...  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            321  12344678889999998875 7899999999999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.7e-42  Score=318.88  Aligned_cols=216  Identities=23%  Similarity=0.388  Sum_probs=183.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC----------------CChHHHHHHHHHhccCCCCceeeEEe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNLVTLLG  137 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~H~nIv~l~~  137 (302)
                      ..++|++.+.||+|+||+||+|... ++..+|+|....                ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3567999999999999999999975 478999997543                22456889999999999999999999


Q ss_pred             EEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---
Q 022118          138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---  214 (302)
Q Consensus       138 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~---  214 (302)
                      ++.+++..|+|||||++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999998883     34568999999999999999999999  6799999999999998776   


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------
Q 022118          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------  283 (302)
Q Consensus       215 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------  283 (302)
                      .+||+|||+++......   ......||+.|+|||++. ..|+.++||||+||++|+|++|+.||....           
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            69999999998765432   233456899999999987 469999999999999999999999998543           


Q ss_pred             ---------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------~~~~~~l~~~~~~~~~~~  301 (302)
                               ...+.++.+++.+|+..+
T Consensus       263 ~~~~~~~~~~~~s~~~~~li~~~L~~d  289 (504)
T 3q5i_A          263 KYYFDFNDWKNISDEAKELIKLMLTYD  289 (504)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred             CCCCCccccCCCCHHHHHHHHHHcCCC
Confidence                     234577889999998765

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-42  Score=305.77  Aligned_cols=198  Identities=24%  Similarity=0.338  Sum_probs=162.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..++|++.+.||+|+||+||+|... ++..||+|......     ...+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4567999999999999999999865 68899999875433     23467899999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-----CCCCceEEccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-----DEDFIAKVADAGL  223 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill-----~~~~~~kl~DfGl  223 (302)
                      |||++ |+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~-~~L~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAE-NDLKKYMD-----KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCS-EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCC-CCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99998 48888883     34568899999999999999999999  679999999999999     4556699999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++..+....  ......+|..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            987653221  22344678899999999875 4899999999999999999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.6e-42  Score=313.13  Aligned_cols=217  Identities=20%  Similarity=0.312  Sum_probs=174.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----------ChHHHHHHHHHhccCCCCceeeEEeEEee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~  141 (302)
                      ...++|.+.+.||+|+||.||+|... ++..||+|.+...           ....+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999865 5789999974321           12247899999999999999999999754


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEE
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKV  218 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl  218 (302)
                       +..|+||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.+   +.+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEE
Confidence             55799999999999998883     34568999999999999999999999  679999999999999654   46999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSP-----------  284 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-----------  284 (302)
                      +|||+++..+...   ......||+.|+|||++.+   ..|+.++|||||||++|||++|+.||.....           
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~  360 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  360 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence            9999998765432   2334578999999999853   6788899999999999999999999975321           


Q ss_pred             ----------CChhhHHHHHHHHhhcc
Q 022118          285 ----------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ----------~~~~~l~~~~~~~~~~~  301 (302)
                                ..+.++.+++.+||..+
T Consensus       361 ~~~~~~~~~~~~~~~~~~li~~~L~~d  387 (419)
T 3i6u_A          361 KYNFIPEVWAEVSEKALDLVKKLLVVD  387 (419)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred             CCCCCchhhcccCHHHHHHHHHHccCC
Confidence                      23567889999998765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.4e-42  Score=301.47  Aligned_cols=215  Identities=27%  Similarity=0.429  Sum_probs=182.0

Q ss_pred             CCcCCeeeeCCCeeEEEEEEc-----CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeC--CeeeE
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  147 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  147 (302)
                      |+..+.||+|+||+||++.+.     ++..||+|......    .+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998643     57899999876543    34578999999999999999999999884  57799


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++|+|.+++.      ...+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~------~~~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            999999999999983      2348899999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------------------
Q 022118          228 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------------------  282 (302)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------------------  282 (302)
                      ..... ........+|..|+|||.+.+..++.++||||||+++|||++|+.||...                        
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            54321 11233455778899999999999999999999999999999999998632                        


Q ss_pred             --------CCCChhhHHHHHHHHhhcc
Q 022118          283 --------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 --------~~~~~~~l~~~~~~~~~~~  301 (302)
                              +...+.++.+++.+||..+
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~d  291 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETE  291 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCC
Confidence                    2345678999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-41  Score=296.56  Aligned_cols=216  Identities=29%  Similarity=0.433  Sum_probs=187.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .+.|+..+.||+|+||.||+|... ++..||+|....    ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888899999999999999865 588999997543    234678999999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++.      ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++......
T Consensus       101 ~~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999883      3468899999999999999999999  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChhhHHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQDLVEL  293 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~~l~~~  293 (302)
                      ..  ......++..|+|||.+.+..++.++||||||+++|||++|+.||...                 +...+..+.++
T Consensus       173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF  250 (303)
T ss_dssp             BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred             cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence            22  233456888999999999999999999999999999999999999743                 23456778999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       251 i~~~l~~d  258 (303)
T 3a7i_A          251 VEACLNKE  258 (303)
T ss_dssp             HHHHCCSS
T ss_pred             HHHHcCCC
Confidence            99999765

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-42  Score=320.56  Aligned_cols=215  Identities=23%  Similarity=0.387  Sum_probs=184.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||.||++... ++..||+|.+..      .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            456888999999999999999976 689999997532      3356789999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRN  225 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~  225 (302)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHH-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999998883     34568899999999999999999999  679999999999999   567899999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PD  285 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~  285 (302)
                      ......   ......+|+.|+|||++.+ .|+.++||||+||++|+|++|++||....                    ..
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  253 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK  253 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGG
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccccc
Confidence            764422   2234568999999999876 69999999999999999999999997532                    12


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .++++.+++.+|+..+
T Consensus       254 ~s~~~~~li~~~L~~d  269 (484)
T 3nyv_A          254 VSESAKDLIRKMLTYV  269 (484)
T ss_dssp             SCHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHCCCC
Confidence            3567889999998765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-42  Score=318.58  Aligned_cols=215  Identities=23%  Similarity=0.394  Sum_probs=180.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .+.|+..+.||+|+||+||+|... ++..+|+|....     .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            346888999999999999999975 588999997542     33567899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~~  226 (302)
                      |||++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       116 e~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999988873     34568899999999999999999999  67999999999999976   45699999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDS  286 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~  286 (302)
                      .....   ......||+.|+|||++. ..|+.++||||+||++|+|++|+.||....                    ...
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  264 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV  264 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence            65432   233456899999999886 569999999999999999999999997532                    134


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       265 s~~~~~li~~~L~~d  279 (494)
T 3lij_A          265 SEGAKDLIKQMLQFD  279 (494)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHCCCC
Confidence            567889999998765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=301.76  Aligned_cols=215  Identities=25%  Similarity=0.325  Sum_probs=175.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|+..+.||+|+||+||+|... ++..||+|+.....     ..+...|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357889999999999999999976 68999999754322     12345566555444 899999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+ +++|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++..+
T Consensus       136 ~e~~-~~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA----WGASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 6688887732    23568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC---------------CCCChhhHHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL---------------SPDSSQDLVEL  293 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~---------------~~~~~~~l~~~  293 (302)
                      ...   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...               +...+.++.++
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHH
Confidence            432   2334568899999999876 7999999999999999999997665421               13456789999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       285 i~~~L~~d  292 (311)
T 3p1a_A          285 LVMMLEPD  292 (311)
T ss_dssp             HHHHSCSS
T ss_pred             HHHHcCCC
Confidence            99999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-42  Score=300.81  Aligned_cols=220  Identities=30%  Similarity=0.439  Sum_probs=184.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeC--Ce
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~  144 (302)
                      .+.|+..+.||+|+||.||+|.+     .++..||+|.....    ..+.+.+|++++++++||||+++++++..+  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34578889999999999999983     35789999986533    346788999999999999999999999877  66


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++||||+++|+|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccccc
Confidence            7999999999999999832    33568899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC----------------------
Q 022118          225 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS----------------------  281 (302)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~----------------------  281 (302)
                      +....... ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+..                      
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654322 1223345678889999999999999999999999999999999887531                      


Q ss_pred             ----------CCCCChhhHHHHHHHHhhcc
Q 022118          282 ----------LSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 ----------~~~~~~~~l~~~~~~~~~~~  301 (302)
                                .+...++++.+++.+||..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  283 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ  283 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCC
Confidence                      12355678999999999865

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-42  Score=302.59  Aligned_cols=220  Identities=28%  Similarity=0.497  Sum_probs=178.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      .++|+..+.||+|+||.||+|....     +..||+|......    ...+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4567778999999999999998543     2469999876543    235789999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999842    23568899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCCh
Q 022118          227 LGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSS  287 (302)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~  287 (302)
                      ...... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  276 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence            654321 111223345778999999999999999999999999999999 99999632                 23456


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       277 ~~l~~li~~~l~~~  290 (333)
T 1mqb_A          277 SAIYQLMMQCWQQE  290 (333)
T ss_dssp             HHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHcCCC
Confidence            78999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-42  Score=296.25  Aligned_cols=218  Identities=23%  Similarity=0.348  Sum_probs=179.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC----CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|++.+.||+|+||.||++... ++..+|+|...    ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888899999999999999965 58899999743    23456789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~~~~  228 (302)
                      +++|+|.+++.... .....+++..+..++.|++.||+|||+  .+|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999998874321 123568899999999999999999999  679999999999999   456889999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQD  289 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~  289 (302)
                      ...   ......+++.|+|||.+. ..++.++||||||+++|||++|+.||....                   ...+++
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            422   233456888999999886 568999999999999999999999997432                   124578


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       255 ~~~li~~~L~~d  266 (285)
T 3is5_A          255 AVDLLKQMLTKD  266 (285)
T ss_dssp             HHHHHHHHTCSC
T ss_pred             HHHHHHHHccCC
Confidence            899999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.4e-42  Score=305.34  Aligned_cols=217  Identities=21%  Similarity=0.365  Sum_probs=184.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----------hHHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      ...+|++.+.||+|+||.||+|... +|..||+|......           .+.+.+|+.+++++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3467888999999999999999975 68999999754332           34577899999998 89999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      .+..++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+||
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999883     34568899999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcc------CCCCCccchhhHHHHHHHHHhCCCCCCCCC------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLS------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------  283 (302)
                      |++..+....   ......+|+.|+|||++.+      ..++.++|||||||++|||++|+.||....            
T Consensus       245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          245 GFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            9998765432   2334578999999999864      368899999999999999999999996432            


Q ss_pred             --------CCChhhHHHHHHHHhhcc
Q 022118          284 --------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------~~~~~~l~~~~~~~~~~~  301 (302)
                              ...+.++.+++.+|+..+
T Consensus       322 ~~~~~~~~~~~~~~~~~li~~~L~~d  347 (365)
T 2y7j_A          322 YQFSSPEWDDRSSTVKDLISRLLQVD  347 (365)
T ss_dssp             CCCCHHHHSSSCHHHHHHHHHHSCSS
T ss_pred             CCCCCcccccCCHHHHHHHHHHcCCC
Confidence                    133456889999998765

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.6e-42  Score=296.04  Aligned_cols=215  Identities=22%  Similarity=0.302  Sum_probs=182.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ++|++.+.||+|+||.||++... ++..+|+|.....         ..+.+.+|+.++++++||||+++++++.+++..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999976 5889999974322         2467899999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  222 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~----~~kl~DfG  222 (302)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLA-----EKESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999983     34568899999999999999999999  6799999999999998877    89999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------  283 (302)
                      ++........   .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....                   
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY  234 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh
Confidence            9987644321   234468889999999999999999999999999999999999997532                   


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...+..+.+++.+||..+
T Consensus       235 ~~~~~~~~~~li~~~l~~d  253 (283)
T 3bhy_A          235 FSNTSELAKDFIRRLLVKD  253 (283)
T ss_dssp             HTTCCHHHHHHHHTTSCSS
T ss_pred             cccCCHHHHHHHHHHccCC
Confidence             233566888899998765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-42  Score=307.62  Aligned_cols=196  Identities=21%  Similarity=0.301  Sum_probs=170.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .++|+..+.||+|+||.||++... ++..||+|......    .+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            457889999999999999999976 58899999865432    3467899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999983     234688999999999999999999982 26999999999999999999999999998765332


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .    .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1    2345688899999999999999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.7e-42  Score=318.13  Aligned_cols=215  Identities=24%  Similarity=0.361  Sum_probs=183.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC-----CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      .++|++.+.||+|+||+||++... ++..||+|.+.     ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356888999999999999999975 68899999753     345667899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~---~~~~~kl~DfGla~~  226 (302)
                      ||+++|+|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++   .++.+||+|||+++.
T Consensus       101 e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999988883     34568999999999999999999999  6799999999999995   556899999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDS  286 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~  286 (302)
                      .....   ......||+.|+|||++.+ .|+.++||||+||++|+|++|++||....                    ...
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI  249 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence            64432   2334578999999999876 59999999999999999999999997532                    123


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       250 s~~~~~li~~~L~~d  264 (486)
T 3mwu_A          250 SDDAKDLIRKMLTFH  264 (486)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHcCCC
Confidence            567889999999765

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-42  Score=307.01  Aligned_cols=192  Identities=23%  Similarity=0.368  Sum_probs=161.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|+.....     .+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            457889999999999999999974 58999999874332     245789999999999999999999998763      


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+||||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            359999999 789988873      2468899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ++.....     .....+|..|+|||++.+ ..|+.++||||+||++|||++|+.||..
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            9875432     234578899999999887 6899999999999999999999999974

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=295.52  Aligned_cols=218  Identities=26%  Similarity=0.426  Sum_probs=180.1

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCee-eEE
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ-FLI  148 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lv  148 (302)
                      .|...+.||+|+||+||+|...+    +..+|+|.......    +.+.+|+.++++++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45556899999999999998532    23799998665432    4578999999999999999999999877665 999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+.+|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999843    34567889999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCC--CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCC-CCCC-----------------CCCChh
Q 022118          229 RTDV--AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSL-----------------SPDSSQ  288 (302)
Q Consensus       229 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p-~~~~-----------------~~~~~~  288 (302)
                      ....  ........+|..|+|||.+.+..++.++||||||+++|||++|..| |...                 +...+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD  255 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence            4321  2233445678899999999999999999999999999999996555 4321                 234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       256 ~l~~li~~~l~~~  268 (298)
T 3pls_A          256 SLYQVMQQCWEAD  268 (298)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHccCC
Confidence            8999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.4e-43  Score=301.75  Aligned_cols=223  Identities=28%  Similarity=0.484  Sum_probs=190.1

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ....++|+..+.||+|+||.||+|.... +..||+|......  .+.+.+|++++++++||||+++++++.+++..++||
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            3456678889999999999999999765 7889999866543  356889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++..   .....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           89 EFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             ECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999999999843   234568899999999999999999999  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLV  291 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~  291 (302)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....                 ...++++.
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          164 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  242 (288)
T ss_dssp             SSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             Cccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence            3221 1233456778999999999999999999999999999999 999987432                 34567889


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+|+..+
T Consensus       243 ~li~~~l~~d  252 (288)
T 3kfa_A          243 ELMRACWQWN  252 (288)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHhCCC
Confidence            9999999865

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-42  Score=295.86  Aligned_cols=218  Identities=28%  Similarity=0.460  Sum_probs=183.3

Q ss_pred             cCCCcCC-eeeeCCCeeEEEEEEc---CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|......    .+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999853   57789999876543    34588999999999999999999999 55668999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999999842    34568999999999999999999999  679999999999999999999999999998775


Q ss_pred             CCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhh
Q 022118          229 RTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~  289 (302)
                      .... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            4322 122333456788999999998899999999999999999998 99999743                 2455788


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       242 l~~li~~~l~~~  253 (287)
T 1u59_A          242 LYALMSDCWIYK  253 (287)
T ss_dssp             HHHHHHHTTCSS
T ss_pred             HHHHHHHHcCCC
Confidence            999999999765

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=306.76  Aligned_cols=199  Identities=28%  Similarity=0.392  Sum_probs=161.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHh--ccCCCCceeeEEeEEee-----CCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL--ASIQHRNLVTLLGYCQE-----NNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~H~nIv~l~~~~~~-----~~~~~l  147 (302)
                      ..++|++.+.||+|+||.||+|.. ++..||+|.........+..|.+++  ..++||||+++++.+..     ....++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            456788999999999999999976 5889999998766666666666654  45899999999986543     235689


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-------CCCceecCCCCCCeeeCCCCceEEcc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-------~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      ||||+++|+|.+++.      ....++..+..++.|++.||.|||+.       .++|+||||||+|||++.++.+||+|
T Consensus        90 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHh------hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            999999999999983      23447888999999999999999983       11799999999999999999999999


Q ss_pred             cccccccCCCCC------CCCCccccCcccccchhhhcc-------CCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          221 AGLRNFLGRTDV------AGPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       221 fGla~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.||.
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            999987654321      112234568999999999986       456778999999999999999977653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.3e-42  Score=309.12  Aligned_cols=202  Identities=23%  Similarity=0.327  Sum_probs=164.2

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeC---------
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN---------  142 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------  142 (302)
                      ....++|++.+.||+|+||+||+|.. .++..||+|+..... ....+|+++++.++||||+++++++...         
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            34567899999999999999999986 468999999764332 2234799999999999999999998543         


Q ss_pred             -----------------------------CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhc
Q 022118          143 -----------------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS  193 (302)
Q Consensus       143 -----------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  193 (302)
                                                   ...++||||++ |+|.+.+.... .....+++..+..++.|++.||.|||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                         33789999998 47766663211 234678899999999999999999998


Q ss_pred             CCCCceecCCCCCCeeeC-CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHH
Q 022118          194 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLE  271 (302)
Q Consensus       194 ~~~~ivHrdlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~e  271 (302)
                        .+|+||||||+|||++ +++.+||+|||+++......   ......+|..|+|||.+.+. .|+.++||||+||++||
T Consensus       160 --~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             --TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             --CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence              6799999999999997 68999999999998764432   23345678889999998775 48999999999999999


Q ss_pred             HHhCCCCCCCC
Q 022118          272 LVSGREASSSL  282 (302)
Q Consensus       272 l~~g~~p~~~~  282 (302)
                      |++|+.||...
T Consensus       235 ll~g~~pf~~~  245 (383)
T 3eb0_A          235 LILGKPLFSGE  245 (383)
T ss_dssp             HHHSSCSSCCS
T ss_pred             HHhCCCCCCCC
Confidence            99999999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.8e-42  Score=295.56  Aligned_cols=220  Identities=19%  Similarity=0.248  Sum_probs=180.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecC-CCChHHHHHHHHHhccCCCCceeeEEeEE-eeCCeeeEEEec
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEY  151 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e~  151 (302)
                      ..++|+..+.||+|+||.||+|.. .++..||+|... ....+.+.+|+++++.++|+|++..++.+ ...+..++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            346799999999999999999996 568899999743 33345688999999999988877766665 567788999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~~~~  228 (302)
                      + +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||+   ++++.+||+|||+++...
T Consensus        87 ~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           87 L-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             C-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             c-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9 9999998832    24568999999999999999999999  679999999999999   788999999999998765


Q ss_pred             CCCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          229 RTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       229 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      .....     .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....                    
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            43321     12345678999999999999999999999999999999999999998643                    


Q ss_pred             ----CCChhhHHHHHHHHhhcc
Q 022118          284 ----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----~~~~~~l~~~~~~~~~~~  301 (302)
                          ...+.++.+++.+||..+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~  261 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLR  261 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSC
T ss_pred             hhhhccCCHHHHHHHHHHHhcC
Confidence                223678899999999876

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.4e-42  Score=296.97  Aligned_cols=221  Identities=28%  Similarity=0.479  Sum_probs=180.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEe-eCCee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQ  145 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~  145 (302)
                      ...+|+..+.||+|+||.||+|...+    ...+|+|.......    +.+.+|+.++++++||||+++++++. .++..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            34568888999999999999998543    34689998665432    45789999999999999999999865 45677


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++|+|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+||++++++.+||+|||+++
T Consensus       103 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccccc
Confidence            999999999999999843    34567889999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCC--CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CC
Q 022118          226 FLGRTDV--AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PD  285 (302)
Q Consensus       226 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~  285 (302)
                      .......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....                 ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY  256 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence            7654322  122334457788999999999999999999999999999999 566665432                 33


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       257 ~~~~l~~li~~~l~~~  272 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPK  272 (298)
T ss_dssp             CCHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHcCCC
Confidence            4677999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.4e-42  Score=298.85  Aligned_cols=215  Identities=23%  Similarity=0.330  Sum_probs=184.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .++|++.+.||+|+||.||++... +++.||+|.....   ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356888999999999999999975 6889999986533   335688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~~~~  228 (302)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||++   +.++.+||+|||+++...
T Consensus        88 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999998883     23568899999999999999999999  679999999999999   788999999999987643


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQ  288 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~  288 (302)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....                    ...+.
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE  236 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence            21    2234568889999999999999999999999999999999999986421                    23467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+|+..+
T Consensus       237 ~~~~li~~~l~~d  249 (304)
T 2jam_A          237 SAKDFICHLLEKD  249 (304)
T ss_dssp             HHHHHHHHHHCSS
T ss_pred             HHHHHHHHHcCCC
Confidence            8899999999765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-42  Score=299.33  Aligned_cols=214  Identities=22%  Similarity=0.391  Sum_probs=179.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-C-------cEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-G-------MLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      .++|++.+.||+|+||+||+|.... +       ..||+|.....   ..+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4578888999999999999998543 3       47999986543   34568899999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--------e
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------A  216 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~--------~  216 (302)
                      .++||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999842    23448899999999999999999999  67999999999999988886        9


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCC-CCCCCC------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGR-EASSSL------------  282 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~-~p~~~~------------  282 (302)
                      ||+|||++.....      .....++..|+|||.+.+ ..++.++||||||+++|||++|. +||...            
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~  234 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR  234 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence            9999999865432      223456778999999987 67899999999999999999954 454432            


Q ss_pred             ---CCCChhhHHHHHHHHhhcc
Q 022118          283 ---SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---~~~~~~~l~~~~~~~~~~~  301 (302)
                         +...+.++.+++.+||..+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~d  256 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYE  256 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCC
Confidence               2345678899999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-42  Score=295.75  Aligned_cols=219  Identities=28%  Similarity=0.457  Sum_probs=180.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|++.+.||+|+||.||+|....    +..||+|......    .+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34678888999999999999998543    3469999876542    3568899999999999999999999875 4568


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        89 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            99999999999999832    23458899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~  288 (302)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...++
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP  241 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred             ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence            6543221 1233456778999999999999999999999999999998 99999632                 234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      .+.+++.+||..+
T Consensus       242 ~l~~li~~~l~~~  254 (281)
T 3cc6_A          242 VLYTLMTRCWDYD  254 (281)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHccCC
Confidence            7899999999765

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-41  Score=294.18  Aligned_cols=219  Identities=19%  Similarity=0.246  Sum_probs=183.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC-CChHHHHHHHHHhccCCCCceeeEEeEE-eeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.... ...+.+.+|+.+++.++|+|++..++++ ...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            46789999999999999999996 5689999997543 3446789999999999988866666655 5667789999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~~~~~  229 (302)
                       +++|.+++..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||+   ++++.+||+|||+++....
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           88 -GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence             8999998832    24568999999999999999999999  679999999999999   4889999999999987654


Q ss_pred             CCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------
Q 022118          230 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------  283 (302)
Q Consensus       230 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------  283 (302)
                      ....     .......+|..|+|||.+.+..++.++|||||||++|||++|+.||....                     
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            3321     12345678999999999999999999999999999999999999998642                     


Q ss_pred             ---CCChhhHHHHHHHHhhcc
Q 022118          284 ---PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---~~~~~~l~~~~~~~~~~~  301 (302)
                         ...++++.+++.+||..+
T Consensus       241 ~~~~~~~~~l~~li~~~l~~d  261 (296)
T 3uzp_A          241 VLCKGYPSEFATYLNFCRSLR  261 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSC
T ss_pred             HHHhhCCHHHHHHHHHHHhcC
Confidence               234678899999999865

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=297.32  Aligned_cols=219  Identities=27%  Similarity=0.431  Sum_probs=183.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||.||+|... ++..||+|.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            4567999999999999999999976 488999998653 34577899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++.    .....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++........
T Consensus       107 ~~~~L~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          107 GAGSVSDIIR----LRNKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             TTEEHHHHHH----HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999883    134568899999999999999999999  6799999999999999999999999999987654321


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||....                   ...+.++.++
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence              2334568889999999999999999999999999999999999997532                   1235678999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||..+
T Consensus       259 i~~~l~~d  266 (314)
T 3com_A          259 VKQCLVKS  266 (314)
T ss_dssp             HHHHTCSC
T ss_pred             HHHHccCC
Confidence            99999865

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.6e-42  Score=299.24  Aligned_cols=227  Identities=22%  Similarity=0.336  Sum_probs=171.1

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+..++|++.+.||+|+||.||++... ++..||+|.....    ..+++.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            455678999999999999999999854 6889999986533    34567899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCC---cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          148 IYEYIPNGSVSIHLYGPS---QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      ||||+++++|.+++....   ......+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999998884211   1124568899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCC---CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------
Q 022118          225 NFLGRTDV---AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------  283 (302)
Q Consensus       225 ~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------  283 (302)
                      ........   ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+                 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            76643221   112234568889999999876 578999999999999999999999997522                 


Q ss_pred             ---------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------~~~~~~l~~~~~~~~~~~  301 (302)
                               ...+.++.+++.+||..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~d  275 (303)
T 2vwi_A          249 TGVQDKEMLKKYGKSFRKMISLCLQKD  275 (303)
T ss_dssp             C-----CCCCCCCHHHHHHHHHHCCSS
T ss_pred             cccccchhhhhhhHHHHHHHHHHccCC
Confidence                     133467889999999765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.7e-42  Score=301.34  Aligned_cols=225  Identities=24%  Similarity=0.376  Sum_probs=183.5

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE------cCCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      ..++|++.+.||+|+||.||+|..      .++..||+|......    ..++.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            456899999999999999999983      246789999876443    2457889999999999999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCc--CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVA  219 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~  219 (302)
                      .++||||+++++|.+++.....  .....+++..++.++.|++.||.|||+  .+|+||||||+|||++.   +..+||+
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999854321  122458899999999999999999999  67999999999999984   4569999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC----------------
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL----------------  282 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~----------------  282 (302)
                      |||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...                
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  265 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  265 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            9999986654433333445567888999999999999999999999999999998 99999743                


Q ss_pred             -CCCChhhHHHHHHHHhhcc
Q 022118          283 -SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -~~~~~~~l~~~~~~~~~~~  301 (302)
                       +...+..+.+++.+||..+
T Consensus       266 ~~~~~~~~l~~li~~~l~~d  285 (327)
T 2yfx_A          266 PPKNCPGPVYRIMTQCWQHQ  285 (327)
T ss_dssp             CCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCCCCHHHHHHHHHHhcCC
Confidence             2345678899999999865

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.3e-42  Score=327.08  Aligned_cols=211  Identities=25%  Similarity=0.416  Sum_probs=175.6

Q ss_pred             CeeeeCCCeeEEEEEEc---CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||.||+|.+.   .+..||+|.++...     .+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   35789999865432     3578999999999999999999999964 557899999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  233 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~-~  233 (302)
                      |+|.+++.     ....+++..+..++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus       454 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999983     34568899999999999999999999  6799999999999999999999999999987754322 2


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~  295 (302)
                      .......+|..|+|||++.+..|+.++|||||||++|||++ |+.||...                 +...+.++.++|.
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22334456788999999999999999999999999999998 99999753                 3456788999999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       607 ~cl~~d  612 (635)
T 4fl3_A          607 LCWTYD  612 (635)
T ss_dssp             HHTCSS
T ss_pred             HHcCCC
Confidence            999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-41  Score=302.35  Aligned_cols=200  Identities=22%  Similarity=0.344  Sum_probs=168.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC-------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-------  142 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------  142 (302)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+....     ....+.+|+++++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35788999999999999999997 46899999975432     234678999999999999999999999874       


Q ss_pred             -CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          143 -NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       143 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                       +..++||||+++ +|.+.+..    ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence             467999999985 66666632    23568999999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCC--CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          222 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       222 Gla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      |+++.......  ........+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99987653221  222344568999999999876 45899999999999999999999999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-42  Score=299.62  Aligned_cols=219  Identities=25%  Similarity=0.406  Sum_probs=181.2

Q ss_pred             HhcCCCcCC-eeeeCCCeeEEEEEEc---CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           75 ATKNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        75 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      ..++|++.+ .||+|+||.||+|...   ++..||+|......     .+++.+|+++++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            345677777 9999999999999643   36789999865432     35688999999999999999999999 56778


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEECCTTEEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCCHHHHHH-----hCcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            99999999999999983     23558899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCC
Q 022118          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDS  286 (302)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~  286 (302)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC  245 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            7654322 111223446678999999998899999999999999999999 99999753                 2345


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       246 ~~~l~~li~~~l~~d  260 (291)
T 1xbb_A          246 PREMYDLMNLCWTYD  260 (291)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHcCCC
Confidence            678999999999865

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=293.51  Aligned_cols=220  Identities=22%  Similarity=0.282  Sum_probs=180.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-------CChHHHHHHHHHhccCCCCceeeEEeEEe--eCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-------APTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~  145 (302)
                      .++|++.+.||+|+||.||++... ++..+|+|....       .....+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            367999999999999999999964 588999998643       23456889999999999999999999984  45678


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||++++ |.+++..   .....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999877 5555532   234568899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCC--CCccchhhHHHHHHHHHhCCCCCCCC----------------CCCCh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRF--SEKSDVYSFGVFLLELVSGREASSSL----------------SPDSS  287 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~  287 (302)
                      ...............++..|+|||.+.+...  +.++||||||+++|||++|+.||...                +...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  237 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG  237 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence            7654333323345568899999999876543  77999999999999999999999753                23456


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      .++.+++.+||..+
T Consensus       238 ~~l~~li~~~l~~d  251 (305)
T 2wtk_C          238 PPLSDLLKGMLEYE  251 (305)
T ss_dssp             HHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHccCC
Confidence            78899999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-42  Score=301.83  Aligned_cols=221  Identities=28%  Similarity=0.394  Sum_probs=185.9

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEe--eCCe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQ--ENNL  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~  144 (302)
                      ..++|+..+.||+|+||.||++.+     .++..||+|.......   +.+.+|++++++++||||+++++++.  ..+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            345788899999999999999984     3578999998765543   35789999999999999999999987  4456


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++||||+++++|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccc
Confidence            8999999999999999832    23468999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC----------------------
Q 022118          225 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS----------------------  281 (302)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~----------------------  281 (302)
                      +....... ........+|..|+|||.+.+..++.++||||||+++|||++|+.||..                      
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654321 1123345678889999999999999999999999999999999998742                      


Q ss_pred             ----------CCCCChhhHHHHHHHHhhcc
Q 022118          282 ----------LSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 ----------~~~~~~~~l~~~~~~~~~~~  301 (302)
                                .+...++++.+++.+||..+
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  284 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPS  284 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCC
Confidence                      12345678999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=308.36  Aligned_cols=218  Identities=18%  Similarity=0.237  Sum_probs=183.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC---------CcEEEEEecCCCChHHHHHHHHHhccCCCCceee------------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT------------  134 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~------------  134 (302)
                      .++|++.+.||+|+||.||+|....         +..||+|.....  +.+.+|++++++++||||++            
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            4678999999999999999999763         788999987643  56889999999999999988            


Q ss_pred             ---EEeEEee-CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 022118          135 ---LLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (302)
Q Consensus       135 ---l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill  210 (302)
                         +++++.. .+..++||||+ +++|.+++...   ....+++..++.++.|++.||.|||+  .+|+||||||+|||+
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEE
Confidence               6777776 67889999999 99999998421   23678999999999999999999999  679999999999999


Q ss_pred             CCCC--ceEEcccccccccCCCCC-----CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          211 DEDF--IAKVADAGLRNFLGRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       211 ~~~~--~~kl~DfGla~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +.++  .+||+|||+++.......     ........+|+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  999999999987654321     112234578999999999999999999999999999999999999997542


Q ss_pred             C---------------------------CChhhHHHHHHHHhhcc
Q 022118          284 P---------------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~---------------------------~~~~~l~~~~~~~~~~~  301 (302)
                      .                           ..+.++.+++.+||..+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  317 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT  317 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred             cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence            1                           23678899999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-41  Score=303.05  Aligned_cols=198  Identities=23%  Similarity=0.344  Sum_probs=168.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCC-----ee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~  145 (302)
                      ..+|+..+.||+|+||.||+|... ++..||+|.......    +.+.+|++++++++||||+++++++....     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357899999999999999999965 578899998764332    45789999999999999999999997653     67


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      |+||||++ |+|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~-~~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999997 58888772      3458899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          226 FLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            7654322 222345678999999998654 45899999999999999999999999754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.9e-42  Score=303.64  Aligned_cols=222  Identities=24%  Similarity=0.405  Sum_probs=184.5

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhcc--CCCCceeeEEeEEeeCC----e
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----L  144 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~  144 (302)
                      ......++|++.+.||+|+||.||+|.. +++.||+|.........+.+|.+++..  ++||||+++++++...+    .
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3344567899999999999999999988 488999999887777788899988876  79999999999998876    7


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhh--------cCCCCceecCCCCCCeeeCCCCce
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      .++||||+++|+|.+++.      ...+++..++.++.|++.||.|||        +  .+|+||||||+|||++.++.+
T Consensus       115 ~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             EEEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEECTTSCE
T ss_pred             eEEEEeecCCCcHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEECCCCCE
Confidence            899999999999999983      246889999999999999999999        6  679999999999999999999


Q ss_pred             EEcccccccccCCCCCC--CCCccccCcccccchhhhccCC------CCCccchhhHHHHHHHHHhC----------CCC
Q 022118          217 KVADAGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFRR------FSEKSDVYSFGVFLLELVSG----------REA  278 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dvws~Gvil~el~~g----------~~p  278 (302)
                      ||+|||+++........  .......+|..|+|||.+.+..      ++.++|||||||++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999876543211  1234457889999999988653      33689999999999999999          778


Q ss_pred             CCCCCC----------------------------CChhhHHHHHHHHhhcc
Q 022118          279 SSSLSP----------------------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       279 ~~~~~~----------------------------~~~~~l~~~~~~~~~~~  301 (302)
                      |.....                            .....+.+++.+||..+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  317 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN  317 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred             ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence            864311                            11236788999999765

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-41  Score=293.85  Aligned_cols=215  Identities=26%  Similarity=0.398  Sum_probs=178.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee----CCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~  146 (302)
                      ..|++.+.||+|+||.||+|... ++..||+|.....     ..+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34677789999999999999865 5788999975422     23458899999999999999999999875    35579


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRN  225 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~kl~DfGla~  225 (302)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+.+.+|+||||||+|||++ +++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHH-----HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999983     23568899999999999999999998333399999999999997 78999999999997


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDS  286 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~  286 (302)
                      .....    ......+++.|+|||.+. ..++.++||||||+++|+|++|+.||....                   ...
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence            64332    223456888999999876 458999999999999999999999997532                   123


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      ++++.+++.+||..+
T Consensus       256 ~~~l~~li~~~l~~d  270 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQN  270 (290)
T ss_dssp             CHHHHHHHHHHSCSS
T ss_pred             CHHHHHHHHHHccCC
Confidence            467899999999865

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.7e-42  Score=305.05  Aligned_cols=193  Identities=24%  Similarity=0.387  Sum_probs=151.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC------C
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~  143 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|+.....     .+++.+|+++++.++||||+++++++...      +
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            367999999999999999999864 58899999875432     24678999999999999999999998754      4


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|++|||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            579999998 689988872      2568999999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++.....     .....+|..|+|||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9865432     234578899999999887 67899999999999999999999999753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.6e-42  Score=296.17  Aligned_cols=216  Identities=31%  Similarity=0.459  Sum_probs=177.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCCCceeeEEeEEeeC-CeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-NLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||.||++... +..||+|..... ..+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            4567889999999999999999875 789999987654 456789999999999999999999997654 4789999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+++.....  
T Consensus        98 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           98 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             TTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999998321   12337888999999999999999999  67999999999999999999999999998765432  


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~  294 (302)
                         .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...                 +...++.+.+++
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence               123356778999999999999999999999999999998 99999743                 234567899999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       248 ~~~l~~~  254 (278)
T 1byg_A          248 KNCWHLD  254 (278)
T ss_dssp             HHHTCSS
T ss_pred             HHHhcCC
Confidence            9999865

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=301.00  Aligned_cols=222  Identities=28%  Similarity=0.443  Sum_probs=179.9

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC--CCChHHHHHHHHHhccC-CCCceeeEEeEEee------C
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE------N  142 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------~  142 (302)
                      ....++|++.+.||+|+||.||+|... ++..||+|...  ......+.+|+.+++++ +||||+++++++..      .
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            345678999999999999999999974 68899999754  33456789999999998 89999999999987      4


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      +..++||||+++|+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEEeeCc
Confidence            6789999999999999998432   23568899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------  283 (302)
                      ++.......  .......++..|+|||.+.     +..++.++|||||||++|||++|+.||....              
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            998764322  1223456888999999987     5678999999999999999999999996432              


Q ss_pred             ----CCChhhHHHHHHHHhhcc
Q 022118          284 ----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----~~~~~~l~~~~~~~~~~~  301 (302)
                          ...+..+.+++.+||..+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~d  274 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKN  274 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSS
T ss_pred             cCCccccCHHHHHHHHHHhccC
Confidence                234678899999999765

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-41  Score=291.22  Aligned_cols=217  Identities=23%  Similarity=0.318  Sum_probs=179.1

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      ..++|++.+.||+|+||.||+|... +++.||+|....      ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3467889999999999999999976 688999997532      334578899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999983     23468899999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhH
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDL  290 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l  290 (302)
                      .....   .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...                +...+.++
T Consensus       162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l  238 (276)
T 2h6d_A          162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV  238 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHH
Confidence            54321   234467888999999988776 57999999999999999999999743                23346788


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       239 ~~li~~~l~~~  249 (276)
T 2h6d_A          239 ATLLMHMLQVD  249 (276)
T ss_dssp             HHHHHHHTCSS
T ss_pred             HHHHHHHccCC
Confidence            99999999765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.1e-42  Score=294.04  Aligned_cols=217  Identities=23%  Similarity=0.361  Sum_probs=185.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEee-------------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE-------------  141 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------------  141 (302)
                      ..+|+..+.||+|+||.||+|... +++.||+|...... +.+.+|++++++++||||+++++++..             
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            456888999999999999999976 68999999876443 567899999999999999999998864             


Q ss_pred             ---CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 022118          142 ---NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       142 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                         .+..++||||+++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEEcCCCCEEE
Confidence               34579999999999999998421   23568899999999999999999999  67999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC------------CCCCC
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS------------LSPDS  286 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~------------~~~~~  286 (302)
                      +|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++|..|+..            .+...
T Consensus       164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 2a19_B          164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF  240 (284)
T ss_dssp             CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTS
T ss_pred             Ccchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccccC
Confidence            9999998765432   22344688899999999999999999999999999999999988742            23455


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       241 ~~~~~~li~~~l~~d  255 (284)
T 2a19_B          241 DKKEKTLLQKLLSKK  255 (284)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHccCC
Confidence            678899999999765

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-41  Score=299.17  Aligned_cols=221  Identities=28%  Similarity=0.503  Sum_probs=182.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcE--EEEEecCC----CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGML--VAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|++.+.||+|+||.||+|... ++..  +++|....    ...+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            457888999999999999999864 4554  48887543    2345688999999999 99999999999999999999


Q ss_pred             EEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 022118          148 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~  216 (302)
                      ||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEEcCCCeE
Confidence            9999999999999854320           123468999999999999999999999  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-------------
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-------------  282 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-------------  282 (302)
                      ||+|||+++.....   .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...             
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            99999998753321   12233456778999999999899999999999999999998 99999643             


Q ss_pred             ----CCCChhhHHHHHHHHhhcc
Q 022118          283 ----SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ----~~~~~~~l~~~~~~~~~~~  301 (302)
                          +...+.++.+++.+||..+
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~d  281 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREK  281 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCC
Confidence                2344678899999999765

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.4e-42  Score=309.58  Aligned_cols=199  Identities=23%  Similarity=0.304  Sum_probs=162.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeCCe------eeEEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL------QFLIY  149 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lv~  149 (302)
                      ..+|+..+.||+|+||+||+|....+..+|+|+..... ....+|+++++.++||||+++++++...+.      .++||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            34688999999999999999998777779998754322 223479999999999999999999965443      78999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~kl~DfGla~~~~  228 (302)
                      ||++++.+......  ......+++..+..++.|++.||+|||+  .+|+||||||+|||++ .++.+||+|||+++...
T Consensus       118 e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          118 EYVPETVYRASRHY--AKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             ECCSEEHHHHHHHH--HHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCccHHHHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99987544332210  1134678899999999999999999999  6799999999999998 79999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ...   ......+|+.|+|||.+.+. .|+.++|||||||++|||++|+.||...
T Consensus       194 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          194 AGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             TTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            322   23345678899999998765 5899999999999999999999999753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=312.42  Aligned_cols=199  Identities=24%  Similarity=0.383  Sum_probs=170.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCC--eeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv  148 (302)
                      .++|++.+.||+|+||+||+|.... +..||+|.+..    ...+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            4568889999999999999999764 88999998653    33466889999999999999999999998765  67999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEcccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLR  224 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill----~~~~~~kl~DfGla  224 (302)
                      |||+++|+|.+++....  ....+++..++.++.|++.||+|||+  .+|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999984321  22348999999999999999999999  679999999999999    77888999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc--------CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF--------RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +.......   .....+|..|+|||++.+        ..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            87654322   234568899999999875        5678899999999999999999999964

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-41  Score=296.83  Aligned_cols=221  Identities=18%  Similarity=0.232  Sum_probs=183.1

Q ss_pred             HHHhcCCCcC-CeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccC-CCCceeeEEeEEeeCCe
Q 022118           73 SLATKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (302)
Q Consensus        73 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~  144 (302)
                      ....+.|.+. +.||+|+||.||+|... ++..||+|....     .....+.+|+.++..+ +||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3345566666 88999999999999976 588999997543     2346788999999998 56999999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADA  221 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~Df  221 (302)
                      .++||||+++|+|.+++..   .....+++..+..++.|++.||+|||+  .+|+||||||+|||++.   ++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999998843   234668999999999999999999999  67999999999999987   789999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      |+++.......   .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||....                  
T Consensus       179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  255 (327)
T 3lm5_A          179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE  255 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence            99987654321   234568899999999999999999999999999999999999996432                  


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+..+.+++.+||..+
T Consensus       256 ~~~~~~~~~~~li~~~L~~d  275 (327)
T 3lm5_A          256 TFSSVSQLATDFIQSLLVKN  275 (327)
T ss_dssp             TTTTSCHHHHHHHHHHSCSS
T ss_pred             hhcccCHHHHHHHHHHcCCC
Confidence              234567889999999765

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-41  Score=292.72  Aligned_cols=217  Identities=24%  Similarity=0.354  Sum_probs=181.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|.....     ...++.+|+..+..+ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456888999999999999999976 6899999975432     234678899999888 999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---------------
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---------------  213 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---------------  213 (302)
                      |||+++++|.+++.... .....+++..+..++.|++.||+|||+  .+|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999984321 112568899999999999999999999  679999999999999844               


Q ss_pred             ----CceEEcccccccccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC-------
Q 022118          214 ----FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS-------  281 (302)
Q Consensus       214 ----~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~-------  281 (302)
                          ..+||+|||++......      ....+|..|+|||.+.+. .++.++|||||||++|||++|.+|+..       
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence                47999999999876542      223588899999999876 567899999999999999999987642       


Q ss_pred             -------CCCCChhhHHHHHHHHhhcc
Q 022118          282 -------LSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 -------~~~~~~~~l~~~~~~~~~~~  301 (302)
                             .+...+.++.+++.+||..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~d  267 (289)
T 1x8b_A          241 RQGRLPRIPQVLSQEFTELLKVMIHPD  267 (289)
T ss_dssp             HTTCCCCCSSCCCHHHHHHHHHHTCSS
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHhCCC
Confidence                   23456788999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-41  Score=297.88  Aligned_cols=221  Identities=24%  Similarity=0.385  Sum_probs=174.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..+|++.+.||+|+||.||+|.. .++..||+|.....      ....+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688999999999999999996 46889999986532      134578999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++.... .....+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999998884221 124568899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQ  288 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~  288 (302)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++|+.||....                    ...+.
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            3221  1234467888999999999999999999999999999999999996421                    23467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       266 ~l~~li~~~l~~d  278 (310)
T 2wqm_A          266 ELRQLVNMCINPD  278 (310)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHcCCC
Confidence            8999999999765

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.4e-42  Score=311.13  Aligned_cols=199  Identities=27%  Similarity=0.350  Sum_probs=161.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeC------CeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv  148 (302)
                      ..+|+..+.||+|+||.||+|... ++..||+|+..... ....+|++++++++||||+++++++...      ...++|
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            346888999999999999999975 58999999865432 2345799999999999999999998542      235789


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEccccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFL  227 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-~~~kl~DfGla~~~  227 (302)
                      |||+++ +|...+... ......+++..+..++.||+.||+|||+  .+|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999986 454444211 1234678899999999999999999998  679999999999999965 67899999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ....   ......+|+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus       208 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          208 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             CTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            4322   22345788999999998765 7999999999999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-41  Score=301.24  Aligned_cols=220  Identities=18%  Similarity=0.243  Sum_probs=185.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC------h--------------HHHHHHHHHhccCCCCceeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------T--------------QEFIDEVCFLASIQHRNLVTL  135 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~--------------~~~~~E~~~l~~l~H~nIv~l  135 (302)
                      .++|++.+.||+|+||.||+|.. ++..||+|......      .              +.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999743211      1              778999999999999999999


Q ss_pred             EeEEeeCCeeeEEEeccCCCCccccccCC---CcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 022118          136 LGYCQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (302)
Q Consensus       136 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~  212 (302)
                      ++++.+++..++||||+++|+|.+++...   .......+++..+..++.|++.||.|||+ ..+|+||||||+||+++.
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcC
Confidence            99999999999999999999999983210   11125678999999999999999999997 246999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCC-------
Q 022118          213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSE-KSDVYSFGVFLLELVSGREASSSLS-------  283 (302)
Q Consensus       213 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dvws~Gvil~el~~g~~p~~~~~-------  283 (302)
                      ++.+||+|||++......    ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||....       
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999876443    23345688899999999887 6766 9999999999999999999997432       


Q ss_pred             -----------------------------CCChhhHHHHHHHHhhcc
Q 022118          284 -----------------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----------------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                                   ...+.++.+++.+||..+
T Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  310 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN  310 (348)
T ss_dssp             HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSS
T ss_pred             HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCC
Confidence                                         234678899999999765

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.2e-41  Score=308.84  Aligned_cols=195  Identities=22%  Similarity=0.275  Sum_probs=167.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh--HHHHHHHHHhccC------CCCceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT--QEFIDEVCFLASI------QHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..+|++.+.||+|+||.||+|... ++..||+|.......  ..+.+|+++++.+      +|+||+++++++...+..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            456899999999999999999865 488999998765432  4567788777665      6789999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--eEEcccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLR  224 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~--~kl~DfGla  224 (302)
                      +||||+. ++|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.  +||+|||++
T Consensus       176 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999996 5888887432   23458999999999999999999999  67999999999999999887  999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +.....     .....+|+.|+|||++.+..|+.++|||||||++|||++|++||..
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            765432     2345788999999999999999999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9e-42  Score=305.78  Aligned_cols=194  Identities=22%  Similarity=0.327  Sum_probs=158.3

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|......     .+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999865 58899999864322     245789999999999999999999998665      


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+||||+++ +|.+.+.       ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            67999999975 6776662       347889999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++..+...   ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus       174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            98764322   223457888999999999999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.9e-41  Score=292.30  Aligned_cols=217  Identities=23%  Similarity=0.343  Sum_probs=184.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------------hHHHHHHHHHhccCC-CCceeeEEeEEe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQ  140 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~-H~nIv~l~~~~~  140 (302)
                      ..++|+..+.||+|+||.||+|... +++.||+|......            .+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3467899999999999999999975 58899999864332            245778999999995 999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      .++..++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999983     34568899999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------  283 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------  283 (302)
                      ||++.......   ......++..|+|||.+.      ...++.++||||||+++|||++|+.||....           
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99998765432   223456888999999885      4568899999999999999999999986432           


Q ss_pred             ---------CCChhhHHHHHHHHhhcc
Q 022118          284 ---------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---------~~~~~~l~~~~~~~~~~~  301 (302)
                               ...+.++.+++.+||..+
T Consensus       245 ~~~~~~~~~~~~~~~l~~li~~~l~~d  271 (298)
T 1phk_A          245 NYQFGSPEWDDYSDTVKDLVSRFLVVQ  271 (298)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSS
T ss_pred             CcccCcccccccCHHHHHHHHHHccCC
Confidence                     134567899999999765

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-42  Score=308.24  Aligned_cols=212  Identities=10%  Similarity=0.030  Sum_probs=161.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHH---HHhccCCCCceeeEE-------eEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEV---CFLASIQHRNLVTLL-------GYC  139 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~---~~l~~l~H~nIv~l~-------~~~  139 (302)
                      .+|+..+.||+|+||.||+|... ++..||+|.+....      .+.+.+|+   ..++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            34888899999999999999965 68899999865533      23466774   55556 799988755       444


Q ss_pred             eeC-----------------CeeeEEEeccCCCCccccccCCCcCCCcccCHHHH------HHHHHHHHHHHHHhhcCCC
Q 022118          140 QEN-----------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR------LSIALGAAKGLAHLHSLSP  196 (302)
Q Consensus       140 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~------~~~~~~i~~~l~~LH~~~~  196 (302)
                      ..+                 ...|+||||++ |+|.+++...    ...+.+..+      ..++.|++.||+|||+  .
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--~  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQS--K  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHH--C
Confidence            433                 33799999999 8999998432    223344445      6778999999999999  6


Q ss_pred             CceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHh
Q 022118          197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVS  274 (302)
Q Consensus       197 ~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~  274 (302)
                      +|+||||||+|||++.++.+||+|||+++..+...     ....+|+.|+|||++.+  ..|+.++|||||||++|||++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            79999999999999999999999999998764321     13455688999999987  789999999999999999999


Q ss_pred             CCCCCCCCC-------------------------CCChhhHHHHHHHHhhcc
Q 022118          275 GREASSSLS-------------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       275 g~~p~~~~~-------------------------~~~~~~l~~~~~~~~~~~  301 (302)
                      |+.||....                         ...++++.+++.+||..+
T Consensus       289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred             CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence            999997551                         134678999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-41  Score=297.66  Aligned_cols=215  Identities=20%  Similarity=0.319  Sum_probs=178.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----------hHHHHHHHHHhccCCCCceeeEEeEEeeCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~  143 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|......           ...+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            456889999999999999999975 47899999764321           234789999999999999999999987665


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVAD  220 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~---~~kl~D  220 (302)
                       .|+||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++   .+||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             799999999999998883     34568899999999999999999999  6799999999999998765   499999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------------
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSP-------------  284 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------  284 (302)
                      ||+++.......   .....+|..|+|||.+.   ...++.++|||||||++|||++|+.||.....             
T Consensus       161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            999987643211   12346888999999974   56789999999999999999999999975321             


Q ss_pred             --------CChhhHHHHHHHHhhcc
Q 022118          285 --------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 --------~~~~~l~~~~~~~~~~~  301 (302)
                              ..+.++.+++.+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~~d  262 (322)
T 2ycf_A          238 NFIPEVWAEVSEKALDLVKKLLVVD  262 (322)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred             ccCchhhhhcCHHHHHHHHHHcccC
Confidence                    23567889999999765

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.5e-41  Score=289.35  Aligned_cols=219  Identities=25%  Similarity=0.412  Sum_probs=180.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .+|.....||+|+||.||+|... ++..||+|.....   ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555669999999999999964 5789999975433   3466889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~DfGla~~~~~~~  231 (302)
                      ++++|.+++...  .....+++..+..++.|++.||.|||+  .+++||||||+||+++. ++.+||+|||+++......
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          102 PGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             SEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999998432  123456788889999999999999999  67999999999999987 8999999999998764322


Q ss_pred             CCCCCccccCcccccchhhhccCC--CCCccchhhHHHHHHHHHhCCCCCCCC-------------------CCCChhhH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSL-------------------SPDSSQDL  290 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dvws~Gvil~el~~g~~p~~~~-------------------~~~~~~~l  290 (302)
                      .  ......++..|+|||.+.+..  ++.++||||||+++|||++|+.||...                   +...+.++
T Consensus       178 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 P--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             C--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence            1  123456888999999987654  889999999999999999999999532                   23456788


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       256 ~~li~~~l~~d  266 (295)
T 2clq_A          256 KAFILKCFEPD  266 (295)
T ss_dssp             HHHHHHTTCSS
T ss_pred             HHHHHHHccCC
Confidence            99999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.2e-41  Score=308.40  Aligned_cols=219  Identities=20%  Similarity=0.250  Sum_probs=185.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCC-CChHHHHHHHHHhccCCC-CceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||.||+|.. .++..||+|.... ....++.+|+++++.++| ++|..+..++...+..++||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            46799999999999999999996 4688999997543 334568899999999976 56667777777888889999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---~~~~~~kl~DfGla~~~~~  229 (302)
                       +++|.+++..    ....+++..++.++.||+.||+|||+  .+||||||||+|||+   +.++.+||+|||+++....
T Consensus        86 -g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           86 -GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence             8999999832    34568999999999999999999999  679999999999999   6889999999999987754


Q ss_pred             CCCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------------------
Q 022118          230 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS---------------------  283 (302)
Q Consensus       230 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~---------------------  283 (302)
                      ....     .......+|..|+|||.+.+..++.++|||||||++|||++|+.||....                     
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            3321     12335678999999999999999999999999999999999999998643                     


Q ss_pred             ---CCChhhHHHHHHHHhhcc
Q 022118          284 ---PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ---~~~~~~l~~~~~~~~~~~  301 (302)
                         ...+.++.+++.+||..+
T Consensus       239 ~l~~~~p~~l~~li~~cl~~d  259 (483)
T 3sv0_A          239 ALCRGYPTEFASYFHYCRSLR  259 (483)
T ss_dssp             HHHTTSCHHHHHHHHHHHTCC
T ss_pred             HHhcCCcHHHHHHHHHHhcCC
Confidence               244678899999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.3e-41  Score=300.78  Aligned_cols=192  Identities=23%  Similarity=0.374  Sum_probs=162.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCee----
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ----  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~----  145 (302)
                      .++|...+.||+|+||.||+|... ++..||+|......     .+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357888999999999999999865 58899999865432     24678999999999999999999999887665    


Q ss_pred             --eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          146 --FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       146 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                        ++||||++ ++|.+.+       ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-------GMEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 5777766       2348899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++.....     .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9865432     234567889999999887 78999999999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.3e-41  Score=299.17  Aligned_cols=208  Identities=24%  Similarity=0.281  Sum_probs=158.4

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC--CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCe--
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL--  144 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--  144 (302)
                      .......++|++.+.||+|+||.||+|... ++..||+|+..  ......+.+|++.++.++||||+++++++...+.  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            444566789999999999999999999975 58899999753  3334567788888899999999999999976443  


Q ss_pred             -----eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEE
Q 022118          145 -----QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKV  218 (302)
Q Consensus       145 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl  218 (302)
                           .++||||++++ |...+... ......+++..+..++.|++.||.|||.++.+|+||||||+|||++. ++.+||
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                 78999999874 43333111 02345678889999999999999999933378999999999999996 899999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      +|||+++......   ......+|+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            9999998765432   223456788999999986654 899999999999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-41  Score=299.08  Aligned_cols=198  Identities=26%  Similarity=0.383  Sum_probs=165.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeC-----Cee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~  145 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|.......    .++.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457888999999999999999975 588999998764432    3567899999999999999999998764     667


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||++ ++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIS------TQMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 58888772      2468899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCC--------CCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          226 FLGRTDVAG--------PSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       226 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      .........        ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            765322111        1223568999999998764 67899999999999999999999999653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.3e-42  Score=295.63  Aligned_cols=221  Identities=24%  Similarity=0.364  Sum_probs=182.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEee--CCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l  147 (302)
                      .++|++.+.||+|+||.||++... +++.||+|......     .+.+.+|+.++++++||||+++++++..  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            457888999999999999999975 58899999864332     3457899999999999999999998854  567899


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCC-----ceecCCCCCCeeeCCCCceEEcccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-----VVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-----ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      ||||+++++|.+++.... .....+++..++.++.|++.||+|||+  .+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999984321 123458999999999999999999998  55     9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------CC
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------PD  285 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------~~  285 (302)
                      +++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||....                 ..
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            9987643211  1123467888999999999999999999999999999999999997532                 34


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       240 ~~~~l~~li~~~l~~~  255 (279)
T 2w5a_A          240 YSDELNEIITRMLNLK  255 (279)
T ss_dssp             SCHHHHHHHHHHTCSS
T ss_pred             cCHHHHHHHHHHcCCC
Confidence            4678899999999865

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=298.89  Aligned_cols=221  Identities=29%  Similarity=0.426  Sum_probs=184.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE-----cCCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCC--e
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENN--L  144 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~  144 (302)
                      ..++|++.+.||+|+||.||++..     .++..||+|.......   +.+.+|++++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            355688899999999999999984     3588999998765433   46889999999999999999999987654  6


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++||||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            7999999999999999842    23458899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC---------------------
Q 022118          225 NFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL---------------------  282 (302)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~---------------------  282 (302)
                      +........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||...                     
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            876543221 1123345677899999999989999999999999999999998887521                     


Q ss_pred             ------------CCCChhhHHHHHHHHhhcc
Q 022118          283 ------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ------------~~~~~~~l~~~~~~~~~~~  301 (302)
                                  +...+.++.+++.+||..+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  303 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNN  303 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCC
Confidence                        2345678999999999765

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=306.88  Aligned_cols=201  Identities=21%  Similarity=0.308  Sum_probs=151.9

Q ss_pred             CCc-CCeeeeCCCeeEEEEEEc---CCcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEee--CCeeeEEEec
Q 022118           79 FSD-KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEY  151 (302)
Q Consensus        79 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~  151 (302)
                      |+. .++||+|+||+||+|...   ++..||+|.+.... ...+.+|+.++++++||||+++++++..  ....++||||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            544 468999999999999965   47889999876543 4578899999999999999999999954  6788999999


Q ss_pred             cCCCCccccccCCC----cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEccccc
Q 022118          152 IPNGSVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL  223 (302)
Q Consensus       152 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill----~~~~~~kl~DfGl  223 (302)
                      +++ +|.+++....    ......+++..++.++.||+.||.|||+  .+|+||||||+|||+    +.++.+||+|||+
T Consensus       102 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          102 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             CSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             CCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            975 7766663211    0122358899999999999999999999  679999999999999    6789999999999


Q ss_pred             ccccCCCCC-CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          224 RNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       224 a~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ++....... ........+|+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            987654221 1223456789999999999874 5899999999999999999999999643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-41  Score=294.93  Aligned_cols=219  Identities=24%  Similarity=0.359  Sum_probs=180.6

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ..++|++.+.||+|+||.||+|... ++..+|+|.....   ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467889999999999999999976 4889999976433   34678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CCTTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999988732    24568899999999999999999999  67999999999999999999999999997543221


Q ss_pred             CCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDS  286 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~  286 (302)
                      ..  ......++..|+|||.+.     +..++.++||||||+++|||++|+.||....                   ...
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (302)
T 2j7t_A          171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW  248 (302)
T ss_dssp             HH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred             cc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence            11  122346788899999983     6678999999999999999999999997532                   223


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       249 ~~~l~~li~~~l~~d  263 (302)
T 2j7t_A          249 SVEFRDFLKIALDKN  263 (302)
T ss_dssp             CHHHHHHHHHHSCSC
T ss_pred             CHHHHHHHHHHcccC
Confidence            467889999999765

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.2e-41  Score=290.89  Aligned_cols=220  Identities=23%  Similarity=0.297  Sum_probs=169.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChH----H-HHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ----E-FIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~-~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..++|+..+.||+|+||.||++... +++.||+|........    + +.++...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3567889999999999999999974 6889999987654321    2 33444557889999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||+++ +|.+++.... .....+++..+..++.|++.||+|||+  . +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 7776663211 134678999999999999999999998  5 7999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhh----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------C
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------P  284 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~  284 (302)
                      ....   ......+|+.|+|||.+    .+..++.++||||||+++|||++|+.||....                   .
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            4432   12334688889999996    56678999999999999999999999997421                   2


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+.++.+++.+||..+
T Consensus       238 ~~~~~~~~li~~~l~~~  254 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKN  254 (290)
T ss_dssp             TSCHHHHHHHHHHTCSS
T ss_pred             cCCHHHHHHHHHHhhcC
Confidence            45678999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.7e-42  Score=299.10  Aligned_cols=222  Identities=20%  Similarity=0.322  Sum_probs=179.3

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCC--CCceeeEEeEEeeCC
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ--HRNLVTLLGYCQENN  143 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~  143 (302)
                      .+....++|++.+.||+|+||.||++...++..||+|......     .+.+.+|++++++++  ||||+++++++..++
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            3444567799999999999999999998889999999864322     256789999999997  599999999999999


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..+++|| +.+++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++ +.+||+|||+
T Consensus       102 ~~~lv~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             EEEEEEe-cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999 56889999983     33567889999999999999999999  67999999999999964 8999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCC----------
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSL----------  282 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------  282 (302)
                      ++...............+++.|+|||.+.+           ..++.++||||||+++|||++|+.||...          
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            987654433223345568899999999875           47888999999999999999999999753          


Q ss_pred             ---------CCCChhhHHHHHHHHhhcc
Q 022118          283 ---------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---------~~~~~~~l~~~~~~~~~~~  301 (302)
                               +...+.++.+++.+||..+
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~d  280 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDVLKCCLKRD  280 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSS
T ss_pred             HhcccccCCcccchHHHHHHHHHHccCC
Confidence                     2234567899999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.9e-41  Score=293.36  Aligned_cols=198  Identities=26%  Similarity=0.370  Sum_probs=166.3

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEE--cCCcEEEEEecC-----CCChHHHHHHHHHhccC---CCCceeeEEeEEe----
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQ----  140 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~----  140 (302)
                      ..++|++.+.||+|+||.||+|..  .++..||+|...     ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346799999999999999999997  357889999743     22234567788777665   8999999999987    


Q ss_pred             -eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          141 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       141 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                       .....++||||++ |+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCEEEe
Confidence             4567799999998 6998888432   23458899999999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       220 DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |||+++......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            999998764322   12345678889999999999999999999999999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=293.23  Aligned_cols=198  Identities=22%  Similarity=0.358  Sum_probs=159.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEe-----------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQ-----------  140 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~-----------  140 (302)
                      .++|+..+.||+|+||.||+|.... ++.||+|......   .+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3578889999999999999999764 8899999865443   346789999999999999999999874           


Q ss_pred             ---eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCce
Q 022118          141 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIA  216 (302)
Q Consensus       141 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~  216 (302)
                         +.+..++||||++ |+|.+++.      ...+++..+..++.|++.||+|||+  .+|+||||||+||+++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE------QGPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh------cCCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCeE
Confidence               3467799999998 68988882      3467889999999999999999999  6799999999999997 56799


Q ss_pred             EEcccccccccCCCCC-CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          217 KVADAGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       217 kl~DfGla~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      ||+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            9999999987643221 222344567888999998865 67899999999999999999999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=295.70  Aligned_cols=190  Identities=24%  Similarity=0.382  Sum_probs=161.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCe------
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL------  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------  144 (302)
                      ++|...+.||+|+||.||+|... ++..||+|......     .+.+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999975 58899999865432     2457889999999999999999999987654      


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||++ ++|.+++       ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIM-------GLKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CEEEEECCS-EEGGGTT-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             EEEEecccc-CCHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence            399999997 5887776       2348899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      +.....     .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            865432     234567889999999887 6789999999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.1e-41  Score=319.84  Aligned_cols=221  Identities=29%  Similarity=0.467  Sum_probs=182.1

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  144 (302)
                      ....++|++.+.||+|+||.||+|.+..    +..||+|.......    +.+.+|+.++++++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3445678888999999999999998642    46799998664432    56889999999999999999999985 456


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .++||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCCC
Confidence            8999999999999999842    23468899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDS  286 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~  286 (302)
                      +........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...                 +...
T Consensus       539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  617 (656)
T 2j0j_A          539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  617 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred             eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            876543221 1233456778999999999999999999999999999997 99999742                 3455


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||..+
T Consensus       618 ~~~l~~li~~~l~~d  632 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYD  632 (656)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             cHHHHHHHHHHcCCC
Confidence            688999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=296.38  Aligned_cols=225  Identities=24%  Similarity=0.335  Sum_probs=182.2

Q ss_pred             CHHHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      ..+++.+..++|++.+.||+|+||.||+|....  .+|+|.....     ..+.+.+|+.++++++||||+++++++.++
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            334555667889999999999999999998764  4888875432     235577899999999999999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      +..+++|||+++++|.+++..    ....+++..+..++.|++.||+|||+  .+++||||||+||+++ ++.+||+|||
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             CceEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecC
Confidence            999999999999999999842    23468889999999999999999999  6799999999999998 6799999999


Q ss_pred             cccccCCCC---CCCCCccccCcccccchhhhcc---------CCCCCccchhhHHHHHHHHHhCCCCCCCCC-------
Q 022118          223 LRNFLGRTD---VAGPSSQVTADEIFLASEVKEF---------RRFSEKSDVYSFGVFLLELVSGREASSSLS-------  283 (302)
Q Consensus       223 la~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------  283 (302)
                      +++..+...   .........++..|+|||.+.+         ..++.++||||||+++|||++|+.||....       
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  254 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ  254 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            987654221   1122334458889999999874         457889999999999999999999997532       


Q ss_pred             -----------CCChhhHHHHHHHHhhcc
Q 022118          284 -----------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----------~~~~~~l~~~~~~~~~~~  301 (302)
                                 ...+.++.+++.+||..+
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~  283 (319)
T 2y4i_B          255 MGTGMKPNLSQIGMGKEISDILLFCWAFE  283 (319)
T ss_dssp             HHTTCCCCCCCSSCCTTHHHHHHHHHCSS
T ss_pred             hccCCCCCCCcCCCCHHHHHHHHHHhcCC
Confidence                       134678999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.9e-41  Score=302.32  Aligned_cols=197  Identities=21%  Similarity=0.287  Sum_probs=166.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCC--------CCceeeEEeEEe----
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ--------HRNLVTLLGYCQ----  140 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~--------H~nIv~l~~~~~----  140 (302)
                      .++|++.+.||+|+||+||+|... +++.||+|......  .+.+.+|+++++.++        ||||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            467999999999999999999865 58899999876543  356788999998885        888999999988    


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCC-----
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDF-----  214 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~ivHrdlkp~Nill~~~~-----  214 (302)
                      .....++||||+ +++|.+.+..   .....+++..+..++.||+.||.|||+  + +|+||||||+|||++.++     
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEeccchhhhh
Confidence            456789999999 4556555532   123568999999999999999999998  5 799999999999999775     


Q ss_pred             --------------------------------------------ceEEcccccccccCCCCCCCCCccccCcccccchhh
Q 022118          215 --------------------------------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV  250 (302)
Q Consensus       215 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~  250 (302)
                                                                  .+||+|||+++.....     .....+|..|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     234468899999999


Q ss_pred             hccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          251 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       251 ~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      +.+..|+.++|||||||++|||++|+.||....
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            999999999999999999999999999997543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=300.56  Aligned_cols=225  Identities=20%  Similarity=0.293  Sum_probs=167.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCC-CCceeeEEeEEe--------
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQ-HRNLVTLLGYCQ--------  140 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~-H~nIv~l~~~~~--------  140 (302)
                      ....+|++.+.||+|+||.||++... ++..||+|.+....   ...+.+|+.+++++. ||||+++++++.        
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            34567889999999999999999965 68899999764333   345789999999995 999999999994        


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                      .....+++|||++ |+|.+++...  .....+++..++.++.|++.||.|||+.+++|+||||||+|||++.++.+||+|
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence            3345799999996 6888887421  123568999999999999999999998323399999999999999999999999


Q ss_pred             cccccccCCCCCCC----------CCccccCcccccchhhh---ccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----
Q 022118          221 AGLRNFLGRTDVAG----------PSSQVTADEIFLASEVK---EFRRFSEKSDVYSFGVFLLELVSGREASSSL-----  282 (302)
Q Consensus       221 fGla~~~~~~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----  282 (302)
                      ||+++.........          ......+|+.|+|||++   .+..++.++|||||||++|||++|+.||...     
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99998765432111          11244588899999998   5667899999999999999999999998742     


Q ss_pred             ---------CCCChhhHHHHHHHHhhcc
Q 022118          283 ---------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---------~~~~~~~l~~~~~~~~~~~  301 (302)
                               ....+..+.+++.+||..+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~li~~~l~~~  289 (337)
T 3ll6_A          262 VNGKYSIPPHDTQYTVFHSLIRAMLQVN  289 (337)
T ss_dssp             ----CCCCTTCCSSGGGHHHHHHHSCSS
T ss_pred             hcCcccCCcccccchHHHHHHHHHccCC
Confidence                     1234567889999999865

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=296.73  Aligned_cols=225  Identities=22%  Similarity=0.295  Sum_probs=181.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEee----CCee
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQ  145 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~  145 (302)
                      +..++|++.+.||+|+||.||++.. .++..||+|.+....   .+.+.+|+++++.++||||+++++++..    .+..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            3456899999999999999999997 568999999764332   3567899999999999999999999873    3467


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            99999999999998884321 134668999999999999999999999  679999999999999999999999999987


Q ss_pred             ccCCCCCCC-------CCccccCcccccchhhhccCC---CCCccchhhHHHHHHHHHhCCCCCCC--------------
Q 022118          226 FLGRTDVAG-------PSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSS--------------  281 (302)
Q Consensus       226 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~---~~~~~Dvws~Gvil~el~~g~~p~~~--------------  281 (302)
                      .........       ......+|..|+|||.+.+..   ++.++||||||+++|||++|+.||..              
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            643211000       011234688899999987554   68999999999999999999999852              


Q ss_pred             -----CCCCChhhHHHHHHHHhhcc
Q 022118          282 -----LSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       282 -----~~~~~~~~l~~~~~~~~~~~  301 (302)
                           .....+.++.+++.+||..+
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~d  287 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVD  287 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcC
Confidence                 12345678999999999865

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-40  Score=294.23  Aligned_cols=196  Identities=22%  Similarity=0.306  Sum_probs=168.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-c-CCcEEEEEecCCCC--hHHHHHHHHHhccCCCC------ceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-Q-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHR------NLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||.||+|.. . ++..||+|......  .+.+.+|+++++.++|+      +++++++++...+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            45789999999999999999986 3 57899999876543  35678899988887655      599999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-------------
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------------  212 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-------------  212 (302)
                      ++||||+ +++|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 88998888421   22467899999999999999999999  67999999999999987             


Q ss_pred             ------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          213 ------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       213 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                            ++.+||+|||+++.....     .....+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                  678999999999865432     23456889999999999999999999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.9e-40  Score=285.57  Aligned_cols=216  Identities=23%  Similarity=0.348  Sum_probs=183.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC-----CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..++|++.+.||+|+||.||+|... +++.||+|...     ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999976 68899999743     23456789999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRN  225 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~---~~~kl~DfGla~  225 (302)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.+   +.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          100 GELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999988873     23468899999999999999999999  679999999999999754   479999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CC
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PD  285 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~  285 (302)
                      ......   ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||....                    ..
T Consensus       173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (287)
T 2wei_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT  248 (287)
T ss_dssp             TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred             eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence            764432   1233457888999999875 48999999999999999999999996432                    23


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       249 ~~~~~~~li~~~l~~d  264 (287)
T 2wei_A          249 ISDDAKDLIRKMLTFH  264 (287)
T ss_dssp             SCHHHHHHHHHHTCSS
T ss_pred             cCHHHHHHHHHHcccC
Confidence            4567899999999765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-40  Score=291.96  Aligned_cols=221  Identities=21%  Similarity=0.333  Sum_probs=163.2

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh----HHHHHHHH-HhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..++|+..+.||+|+||.||+|... +++.||+|.......    .++..|+. +++.++||||+++++++..++..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            4578889999999999999999975 688999998654432    24555665 67888999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||+++ +|.+++..........+++..+..++.|++.||.|||+  . +|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999985 77666632111235678899999999999999999998  5 7999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhh----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      ....   ......++..|+|||.+    .+..++.++||||||+++|||++|+.||....                    
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            4322   12234688889999998    46678999999999999999999999996421                    


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+.++.+++.+||..+
T Consensus       254 ~~~~~~~~l~~li~~~l~~d  273 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKD  273 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSS
T ss_pred             ccccCCHHHHHHHHHHhhCC
Confidence              134678999999999765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.6e-41  Score=296.91  Aligned_cols=220  Identities=23%  Similarity=0.343  Sum_probs=184.5

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCC--CCceeeEEeE
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGY  138 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~--H~nIv~l~~~  138 (302)
                      +.....++|++.+.||+|+||.||+|... ++..||+|.....         ....+.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            33445678999999999999999999864 5889999975322         2245678999999986  5999999999


Q ss_pred             EeeCCeeeEEEeccCC-CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCce
Q 022118          139 CQENNLQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIA  216 (302)
Q Consensus       139 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~  216 (302)
                      +..++..++||||+.+ ++|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++ +++.+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCE
Confidence            9999999999999986 89998883     34568899999999999999999999  6799999999999999 78999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCC----------CCCC
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSS----------LSPD  285 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~----------~~~~  285 (302)
                      ||+|||+++......    .....+|..|+|||.+.+..+ +.++||||||+++|||++|+.||..          .+..
T Consensus       190 kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  265 (320)
T 3a99_A          190 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR  265 (320)
T ss_dssp             EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSC
T ss_pred             EEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhccccccccc
Confidence            999999998765432    234568889999999987776 6789999999999999999999974          2345


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       266 ~~~~~~~li~~~l~~d  281 (320)
T 3a99_A          266 VSSECQHLIRWCLALR  281 (320)
T ss_dssp             CCHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHccCC
Confidence            6788999999999865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.1e-41  Score=290.51  Aligned_cols=219  Identities=29%  Similarity=0.423  Sum_probs=174.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc--CC--cEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ--DG--MLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||.||+|.+.  ++  ..||+|.....      ..+.+.+|++++++++||||+++++++..++ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            457888999999999999999853  23  36899976533      2356889999999999999999999998765 7


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        96 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHh----ccCCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            899999999999998842    23568899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------------CCC
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------------SPD  285 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------------~~~  285 (302)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...                  +..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  249 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence            76543221 12233456778999999999899999999999999999999 99999642                  234


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       250 ~~~~l~~li~~~l~~~  265 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHK  265 (291)
T ss_dssp             CCHHHHHHHHHHTCSS
T ss_pred             cCHHHHHHHHHHccCC
Confidence            5678999999999865

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.6e-41  Score=307.16  Aligned_cols=220  Identities=19%  Similarity=0.258  Sum_probs=169.3

Q ss_pred             CCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      |...+.||+|+||+||.+...+|..||+|+......+.+.+|+.+++++ +||||+++++++.+++..|+|||||+ |+|
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            4446889999999998877778999999987666667788999999876 89999999999999999999999996 699


Q ss_pred             cccccCCCcCCC--cccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-------------CceEEcccc
Q 022118          158 SIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-------------FIAKVADAG  222 (302)
Q Consensus       158 ~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~-------------~~~kl~DfG  222 (302)
                      .+++........  ....+..++.++.|++.||+|||+  .+|+||||||+|||++.+             +.+||+|||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            999854321111  111333457799999999999999  679999999999999654             489999999


Q ss_pred             cccccCCCCCC--CCCccccCcccccchhhhcc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCC--------
Q 022118          223 LRNFLGRTDVA--GPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSP--------  284 (302)
Q Consensus       223 la~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~~--------  284 (302)
                      +++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.....        
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~  253 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG  253 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHT
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcC
Confidence            99877543221  12234578999999999876       678999999999999999999 9999964311        


Q ss_pred             -------------CChhhHHHHHHHHhhcc
Q 022118          285 -------------DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 -------------~~~~~l~~~~~~~~~~~  301 (302)
                                   ..+.++.+++.+||..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  283 (434)
T 2rio_A          254 IFSLDEMKCLHDRSLIAEATDLISQMIDHD  283 (434)
T ss_dssp             CCCCCCCTTCCCHHHHHHHHHHHHHHTCSS
T ss_pred             CCCcccccccccccchHHHHHHHHHHhhCC
Confidence                         01357889999999765

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-41  Score=291.84  Aligned_cols=218  Identities=23%  Similarity=0.347  Sum_probs=176.8

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---------hHHHHHHHHHhccC----CCCceeeEEeE
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---------TQEFIDEVCFLASI----QHRNLVTLLGY  138 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~E~~~l~~l----~H~nIv~l~~~  138 (302)
                      ....++|++.+.||+|+||.||+|... ++..||+|......         ...+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            445678999999999999999999864 58899999875432         22355788888888    89999999999


Q ss_pred             EeeCCeeeEEEec-cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCce
Q 022118          139 CQENNLQFLIYEY-IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIA  216 (302)
Q Consensus       139 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~  216 (302)
                      +...+..++|||| +.+++|.+++.     ....+++..++.++.|++.||+|||+  .+|+||||||+||+++ +++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYIT-----EKGPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 78999999983     23468899999999999999999999  6799999999999999 88999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhccCCCC-CccchhhHHHHHHHHHhCCCCCCC----------CCCC
Q 022118          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSS----------LSPD  285 (302)
Q Consensus       217 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dvws~Gvil~el~~g~~p~~~----------~~~~  285 (302)
                      ||+|||+++......    .....++..|+|||.+.+..+. .++||||||+++|||++|+.||..          .+..
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  255 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH  255 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTT
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCccc
Confidence            999999998765432    2345688889999999877775 489999999999999999999974          2345


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||..+
T Consensus       256 ~~~~~~~li~~~l~~~  271 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPK  271 (312)
T ss_dssp             SCHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHccCC
Confidence            6788999999999865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=303.70  Aligned_cols=220  Identities=21%  Similarity=0.242  Sum_probs=171.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ...+|+..+.||+|+||+|+.....+++.||+|++.......+.+|+++++++ +||||+++++++.+.+..|+|||||+
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            34568888999999999987666677899999998776666778999999998 89999999999999999999999996


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----CCceEEcccccccccC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLG  228 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-----~~~~kl~DfGla~~~~  228 (302)
                       |+|.+++...    ........+..++.|++.||.|||+  .+|+||||||+|||++.     ...+||+|||+++...
T Consensus       102 -g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          102 -ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             -EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             -CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence             5898888532    2233344567899999999999999  67999999999999953     2367899999998765


Q ss_pred             CCCC-CCCCccccCcccccchhhhc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC-------------------
Q 022118          229 RTDV-AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVS-GREASSSLSP-------------------  284 (302)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~~-------------------  284 (302)
                      .... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||.....                   
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK  254 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence            4321 12234567899999999987   4567889999999999999999 8999864311                   


Q ss_pred             CChhhHHHHHHHHhhcc
Q 022118          285 DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ~~~~~l~~~~~~~~~~~  301 (302)
                      ..+..+.+++.+||..+
T Consensus       255 ~~~~~~~~li~~~L~~d  271 (432)
T 3p23_A          255 HEDVIARELIEKMIAMD  271 (432)
T ss_dssp             HHHHHHHHHHHHHSCSS
T ss_pred             cccHHHHHHHHHHHhCC
Confidence            11234678999999765

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.5e-40  Score=285.16  Aligned_cols=220  Identities=22%  Similarity=0.367  Sum_probs=173.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEee-----------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQE-----------  141 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----------  141 (302)
                      .++|+..+.||+|+||.||+|... ++..||+|.....  ..+.+.+|+.++++++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            356888999999999999999965 6889999986432  23567899999999999999999998865           


Q ss_pred             --CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 022118          142 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (302)
Q Consensus       142 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~  219 (302)
                        .+..++||||+++|+|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCCCCEEEe
Confidence              3567999999999999999842    23567788899999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCC------------CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCC-------
Q 022118          220 DAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREAS-------  279 (302)
Q Consensus       220 DfGla~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~-------  279 (302)
                      |||+++.......            ........++..|+|||.+.+. .++.++|||||||++|||+++..+.       
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~  238 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL  238 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHH
Confidence            9999987643210            1122345688899999999865 6899999999999999999832210       


Q ss_pred             -----------CCCCCCChhhHHHHHHHHhhcc
Q 022118          280 -----------SSLSPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       280 -----------~~~~~~~~~~l~~~~~~~~~~~  301 (302)
                                 ...+...+..+.+++.+||..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  271 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD  271 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSS
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcC
Confidence                       1122334566899999999865

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-40  Score=291.99  Aligned_cols=215  Identities=20%  Similarity=0.287  Sum_probs=158.5

Q ss_pred             hcCCCcC-CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHH-HHhccCCCCceeeEEeEEee----CCeeeEE
Q 022118           76 TKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEV-CFLASIQHRNLVTLLGYCQE----NNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~----~~~~~lv  148 (302)
                      .++|++. +.||+|+||.||+|... +++.||+|.....  ....+|+ ..++.++||||+++++++..    ....++|
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            4567774 46999999999999976 5899999987543  2333444 34567799999999999976    4457999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN  225 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~  225 (302)
                      |||+++|+|.+++...   ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       105 ~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          105 MECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999998532   23468999999999999999999999  67999999999999976   4569999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------  283 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------  283 (302)
                      ......    .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||....                      
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          180 ETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             eccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            654322    234567889999999988889999999999999999999999995422                      


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...+.++.+++.+||..+
T Consensus       256 ~~~~~~~~~~~li~~~L~~d  275 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTD  275 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSS
T ss_pred             hhccCCHHHHHHHHHHCCCC
Confidence              234678899999999765

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-40  Score=292.36  Aligned_cols=196  Identities=22%  Similarity=0.283  Sum_probs=166.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CC-cEEEEEecCCCC--hHHHHHHHHHhccCCCCc------eeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DG-MLVAIKKRPGAP--TQEFIDEVCFLASIQHRN------LVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~--~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||+||+|... ++ ..||+|......  .+.+.+|+.++++++|+|      ++.+++++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            467899999999999999999965 34 689999876533  356778999998887665      99999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---------------
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---------------  210 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill---------------  210 (302)
                      ++||||+ ++++.+++..   .....+++..+..++.|++.||+|||+  .+|+||||||+|||+               
T Consensus        98 ~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccccccccc
Confidence            9999999 5566666632   123468899999999999999999998  679999999999999               


Q ss_pred             ----CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          211 ----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       211 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                          +.++.+||+|||+++.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                56789999999999865432     23457889999999999999999999999999999999999999754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.5e-42  Score=303.61  Aligned_cols=209  Identities=18%  Similarity=0.182  Sum_probs=170.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----------hHHHHHHHHHhccCC---------CCceeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQ---------HRNLVTL  135 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~---------H~nIv~l  135 (302)
                      .++|++.+.||+|+||+||+|.. ++..||+|.+....           .+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45678889999999999999998 68999999754321           267889999988875         7777776


Q ss_pred             EeEEe-----------------e-------------CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHH
Q 022118          136 LGYCQ-----------------E-------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA  185 (302)
Q Consensus       136 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~  185 (302)
                      .+.+.                 +             .+..|+||||+++|++.+.+.      +..+++..+..++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHHHH
Confidence            66542                 2             678899999999997776662      24578999999999999


Q ss_pred             HHHHHhh-cCCCCceecCCCCCCeeeCCCC--------------------ceEEcccccccccCCCCCCCCCccccCccc
Q 022118          186 KGLAHLH-SLSPRVVHKDFKTANVLVDEDF--------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEI  244 (302)
Q Consensus       186 ~~l~~LH-~~~~~ivHrdlkp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~  244 (302)
                      .||+||| +  .+|+||||||+|||++.++                    .+||+|||+|+....       ....||+.
T Consensus       172 ~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred             HHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence            9999999 8  6799999999999999887                    899999999987643       23478899


Q ss_pred             ccchhhhccCCCCCccchhhHHHH-HHHHHhCCCCCCCC----------------C--------CCChhhHHHHHHHHhh
Q 022118          245 FLASEVKEFRRFSEKSDVYSFGVF-LLELVSGREASSSL----------------S--------PDSSQDLVELMIKCMG  299 (302)
Q Consensus       245 ~~aPE~~~~~~~~~~~Dvws~Gvi-l~el~~g~~p~~~~----------------~--------~~~~~~l~~~~~~~~~  299 (302)
                      |+|||++.+.. +.++||||++++ .+++++|..||...                .        +..++++.+++++|+.
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~  321 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN  321 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence            99999998776 889999998776 88899999998531                0        1235678999999987


Q ss_pred             cc
Q 022118          300 KE  301 (302)
Q Consensus       300 ~~  301 (302)
                      ++
T Consensus       322 ~d  323 (336)
T 2vuw_A          322 FS  323 (336)
T ss_dssp             SS
T ss_pred             cC
Confidence            64

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-39  Score=290.89  Aligned_cols=211  Identities=22%  Similarity=0.268  Sum_probs=173.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCC-CC-----ceeeEEeEEeeCCeee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-HR-----NLVTLLGYCQENNLQF  146 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~~~~  146 (302)
                      .++|++.+.||+|+||+||+|... +++.||+|......  ...+.+|+.+++.++ |+     +|+++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            568999999999999999999965 57899999876543  245667888887764 44     5999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLR  224 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~--~~~~~kl~DfGla  224 (302)
                      +||||++ |+|.+++...   ....+++..+..++.|++.||.|||++..+|+||||||+|||++  .++.+||+|||++
T Consensus       133 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999996 5898888432   22458899999999999999999996446899999999999994  5788999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHh
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM  298 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~  298 (302)
                      +..+..     .....+|+.|+|||++.+..|+.++|||||||++|||++|+.||....   ..+....+.+..
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~  274 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN---EVDQMNKIVEVL  274 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHH
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHh
Confidence            876432     234578889999999999999999999999999999999999998643   345555554443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-40  Score=296.73  Aligned_cols=196  Identities=18%  Similarity=0.248  Sum_probs=165.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCC--hHHHHHHHHHhccCC-----------CCceeeEEeEEee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQE  141 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~  141 (302)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|......  .+.+.+|+.++++++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            45789999999999999999996 468899999876543  355788999988875           8999999999986


Q ss_pred             CC----eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeC-----
Q 022118          142 NN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVD-----  211 (302)
Q Consensus       142 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~ivHrdlkp~Nill~-----  211 (302)
                      .+    ..+++|||+ +++|.+++...   ....+++..+..++.|++.||+|||+  + +|+||||||+|||++     
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCCC
Confidence            54    679999999 88999888432   23458899999999999999999998  5 799999999999994     


Q ss_pred             -CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          212 -EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       212 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                       ..+.+||+|||+++.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence             4458999999999876432     23346888999999999999999999999999999999999999754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-39  Score=313.09  Aligned_cols=209  Identities=21%  Similarity=0.301  Sum_probs=175.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc--CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCe-----
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----  144 (302)
                      .++|++.+.||+|+||.||++...  ++..||+|.......    ..+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            468999999999999999999975  588999998754332    357899999999999999999999987765     


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||+++++|.+++.       ..+++..++.++.|++.||.|||+  .+||||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEEecccc
Confidence            699999999999987762       268999999999999999999999  679999999999999985 8999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----CCC-----hhhHHHHH
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----PDS-----SQDLVELM  294 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----~~~-----~~~l~~~~  294 (302)
                      +.....      ....||+.|+|||++.+. ++.++|||||||++|||++|.+||....     ...     +..+.+++
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li  301 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL  301 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHH
T ss_pred             hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHH
Confidence            876432      345688999999998765 4889999999999999999999886431     111     25678899


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||.++
T Consensus       302 ~~~l~~d  308 (681)
T 2pzi_A          302 RRAIDPD  308 (681)
T ss_dssp             HHHTCSS
T ss_pred             hhhccCC
Confidence            9999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=282.93  Aligned_cols=218  Identities=21%  Similarity=0.304  Sum_probs=161.7

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChH----H-HHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ----E-FIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~-~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..++|+..+.||+|+||.||+|... ++..||+|........    + +.++..+++.++||||+++++++.+++..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3467888899999999999999975 6889999986544321    2 33444567888999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+ ++.+..+..    .....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~-~~~~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 444443331    1245688999999999999999999982 269999999999999999999999999997654


Q ss_pred             CCCCCCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      ...   ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||....                    
T Consensus       177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (318)
T 2dyl_A          177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH  253 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred             CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence            322   123446888899999984     5678999999999999999999999997521                    


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ...+.++.+++.+||..+
T Consensus       254 ~~~~~~l~~li~~~l~~d  271 (318)
T 2dyl_A          254 MGFSGDFQSFVKDCLTKD  271 (318)
T ss_dssp             SCCCHHHHHHHHHHTCSC
T ss_pred             CCCCHHHHHHHHHHccCC
Confidence            134678999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.2e-39  Score=277.01  Aligned_cols=188  Identities=14%  Similarity=0.073  Sum_probs=161.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC-CcEEEEEecCCCCh------HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||.||+|.... ++.||+|.+.....      +.+.+|+.++++++||||+++++++..++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3579999999999999999999764 89999998765432      5688999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++++|.+++..       .....++..++.|++.||+|||+  .+|+||||||+|||+++++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999999831       13455678899999999999999  679999999999999999999998554      


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------CC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------PD  285 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------~~  285 (302)
                                      |++       .++.++|||||||++|||++|+.||....                       ..
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence                            222       37889999999999999999999997532                       23


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .+.++.+++.+||.+|
T Consensus       232 ~~~~l~~li~~~l~~d  247 (286)
T 3uqc_A          232 IPFQISAVAARSVQGD  247 (286)
T ss_dssp             SCHHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHHcccC
Confidence            4677899999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.3e-39  Score=305.04  Aligned_cols=198  Identities=23%  Similarity=0.336  Sum_probs=167.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee------CCe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~  144 (302)
                      .++|++.+.||+|+||.||+|... ++..||+|......    .+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999864 58899999865442    3457889999999999999999999765      667


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADA  221 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~---~kl~Df  221 (302)
                      .++||||+++|+|.+++....  ....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            799999999999999985432  23458888999999999999999999  67999999999999987664   999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      |+++......   ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~  224 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL  224 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence            9998765432   2234578899999999999999999999999999999999999995

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.8e-38  Score=272.44  Aligned_cols=194  Identities=19%  Similarity=0.275  Sum_probs=163.1

Q ss_pred             cCCCcC-CeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHh-ccCCCCceeeEEeEEee----CCeeeEEE
Q 022118           77 KNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLLGYCQE----NNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~lv~  149 (302)
                      ++|.+. +.||+|+||.||++... ++..||+|....  ...+.+|++++ +..+||||+++++++..    .+..++||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            456665 78999999999999974 588999998753  45677899888 66699999999999987    67789999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccc
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  226 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~~  226 (302)
                      ||+++|+|.+++...   ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.   ++.+||+|||++..
T Consensus        95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           95 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             CCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            999999999998431   23468999999999999999999999  67999999999999998   78999999999865


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----------------------
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-----------------------  283 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-----------------------  283 (302)
                      ..                        +..|+.++|||||||++|||++|+.||....                       
T Consensus       170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            32                        1346789999999999999999999996432                       


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...+.++.+++.+||..+
T Consensus       226 ~~~~~~~~~~li~~~l~~d  244 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTE  244 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSS
T ss_pred             cccCCHHHHHHHHHHcccC
Confidence             234678999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-38  Score=284.96  Aligned_cols=215  Identities=13%  Similarity=0.107  Sum_probs=163.6

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC------CChHHHHHHHHHhccCCC-Ccee---------e------
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLV---------T------  134 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~H-~nIv---------~------  134 (302)
                      .|...+.||+|+||+||+|.+. +++.||+|....      ...+.+.+|+.+++.++| +|..         .      
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4666789999999999999954 689999997552      124568899999999977 2211         1      


Q ss_pred             ------EEeEEee-----CCeeeEEEeccCCCCccccccCCC--cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceec
Q 022118          135 ------LLGYCQE-----NNLQFLIYEYIPNGSVSIHLYGPS--QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK  201 (302)
Q Consensus       135 ------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHr  201 (302)
                            +..++..     ....+++|+++ +++|.+++....  ......+++..++.++.|++.||+|||+  .+|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iiHr  235 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHT  235 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEECS
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence                  1111111     12346667765 678988873110  1124567788899999999999999999  679999


Q ss_pred             CCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhh----------ccCCCCCccchhhHHHHHHH
Q 022118          202 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK----------EFRRFSEKSDVYSFGVFLLE  271 (302)
Q Consensus       202 dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Dvws~Gvil~e  271 (302)
                      ||||+|||++.++.+||+|||+++..+..     .....| +.|+|||++          ....|+.++|||||||++||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999876543     223455 789999998          55568899999999999999


Q ss_pred             HHhCCCCCCCCC------------CCChhhHHHHHHHHhhcc
Q 022118          272 LVSGREASSSLS------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       272 l~~g~~p~~~~~------------~~~~~~l~~~~~~~~~~~  301 (302)
                      |++|+.||....            ...++++.+++.+||.++
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  351 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP  351 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSS
T ss_pred             HHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCC
Confidence            999999998642            345688999999999865

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.9e-35  Score=276.48  Aligned_cols=181  Identities=17%  Similarity=0.043  Sum_probs=125.4

Q ss_pred             eeeeCCCeeEEEEE-EcCCcEEEEEecCCCC-------------hHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           84 LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-------------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        84 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------------~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ..+.|++|.+..++ ...|..+++|.+....             .++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35566666666554 3457788999754321             23588999999999 799999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||++|++|.+.+..     ...++..   .++.||+.||+|+|+  +|||||||||+|||++++|.+||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999943     3445543   478999999999999  779999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCC
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE  277 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~  277 (302)
                      ...  ......+||+.|+|||++.+ .+..++|+||+|++++++.++..
T Consensus       391 ~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          391 QDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            432  12345679999999999876 46778999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=1.1e-31  Score=250.73  Aligned_cols=182  Identities=19%  Similarity=0.189  Sum_probs=143.6

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..+.||+|+||.||++. ..+..+++|+.....           .+++.+|++++++++||||+++..++...+..|+||
T Consensus       340 ~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            35789999999999994 346778888643221           134789999999999999996666666778889999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+++++|.+++..             +..++.|++.||+|||+  ++|+||||||+|||+++  .+||+|||+++....
T Consensus       419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            99999999999832             45789999999999999  67999999999999999  999999999988754


Q ss_pred             CCCCC-----CCccccCcccccchhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 022118          230 TDVAG-----PSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       230 ~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      .....     ......||+.|+|||++..  ..|+..+|+||...-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22111     1135678999999999987  678899999999999999998888775

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=2.7e-27  Score=203.86  Aligned_cols=161  Identities=17%  Similarity=0.070  Sum_probs=123.9

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---------------------hHHHHHHHHHhccCC
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASIQ  128 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~  128 (302)
                      ..+......|++.+.||+|+||.||+|...++..||+|......                     ...+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            34444455677779999999999999999779999999864321                     345789999999998


Q ss_pred             CCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       129 H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      |   +++.+++.. +..|+||||+++++|.+ +..           .....++.|++.||.|||+  .+|+||||||+||
T Consensus       163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NI  224 (282)
T 1zar_A          163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNV  224 (282)
T ss_dssp             T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSE
T ss_pred             C---CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHE
Confidence            4   555554433 55699999999999987 411           1234689999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc----------CCCCCccchhh
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF----------RRFSEKSDVYS  264 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----------~~~~~~~Dvws  264 (302)
                      |++ ++.+||+|||+++..               ..++|||.+..          ..|+..+|+|.
T Consensus       225 Ll~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEE-TTEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999 999999999998642               22678888754          34555666664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=7.2e-23  Score=173.99  Aligned_cols=133  Identities=18%  Similarity=0.106  Sum_probs=102.0

Q ss_pred             CCcCCeeeeCCCeeEEEEEE-cCCcE--EEEEecCCCC---------------------------hHHHHHHHHHhccCC
Q 022118           79 FSDKNLIGEGKFGEVYKGLL-QDGML--VAIKKRPGAP---------------------------TQEFIDEVCFLASIQ  128 (302)
Q Consensus        79 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~l~  128 (302)
                      |++.+.||+|+||.||+|.. .+|..  ||+|......                           ...+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999997 67888  9999743221                           025778999999998


Q ss_pred             CCce--eeEEeEEeeCCeeeEEEeccCC-C----CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhh-cCCCCcee
Q 022118          129 HRNL--VTLLGYCQENNLQFLIYEYIPN-G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVH  200 (302)
Q Consensus       129 H~nI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~~~ivH  200 (302)
                      |+++  ...+++    +..++||||+.+ |    +|.+...        ..++.....++.|++.||.||| +  .+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~--~givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQE--AELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHHT--SCEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence            7754  444432    356899999942 4    4443321        1123456789999999999999 8  67999


Q ss_pred             cCCCCCCeeeCCCCceEEccccccccc
Q 022118          201 KDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       201 rdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||||+|||+++  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=6.5e-20  Score=162.57  Aligned_cols=139  Identities=14%  Similarity=0.118  Sum_probs=96.7

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-----------------ChHHHH--------HHHHHhcc
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----------------PTQEFI--------DEVCFLAS  126 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----------------~~~~~~--------~E~~~l~~  126 (302)
                      +.....-|++.+.||+|+||.||+|...+|+.||+|.....                 ....+.        +|...|.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            33334458899999999999999999989999999963311                 111122        34555555


Q ss_pred             CCCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 022118          127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA  206 (302)
Q Consensus       127 l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~  206 (302)
                      +.+.++....-+...  ..++||||+++++|......           .....++.|++.+|.|||+  .+||||||||.
T Consensus       170 L~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~  234 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK--HGLIHGDFNEF  234 (397)
T ss_dssp             HHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTT
T ss_pred             HHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHH
Confidence            543333211111111  23799999999888655411           1234578999999999998  67999999999


Q ss_pred             CeeeCCCC----------ceEEccccccc
Q 022118          207 NVLVDEDF----------IAKVADAGLRN  225 (302)
Q Consensus       207 Nill~~~~----------~~kl~DfGla~  225 (302)
                      |||+++++          .+.|+||+=+-
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcc
Confidence            99998776          38899998553

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=1.7e-13  Score=116.03  Aligned_cols=140  Identities=14%  Similarity=0.083  Sum_probs=109.8

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCC---CChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEe
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ....|+....++.|+.+.||++... +..+++|....   .....+.+|.++++.+. +.++.++++++...+..|+|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3456777778888888999999754 67899998654   34456889999998884 6788899999999899999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-----------------------------------  195 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----------------------------------  195 (302)
                      |++|.+|.+.+..          ......++.+++.++..||+..                                   
T Consensus        91 ~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           91 EADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             CCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             ecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            9999988765311          1112357788999999999720                                   


Q ss_pred             ----------------------CCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          196 ----------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       196 ----------------------~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                                            ..++|+|++|.||+++++..+.|.||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  348999999999999876667899998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.40  E-value=3.4e-13  Score=113.74  Aligned_cols=128  Identities=18%  Similarity=0.181  Sum_probs=97.0

Q ss_pred             eeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCCCCc--eeeEEeEEeeCCeeeEEEeccCCCCccccccC
Q 022118           86 GEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN--LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  163 (302)
Q Consensus        86 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  163 (302)
                      +.|..+.||++...+|..+++|.........+.+|.++++.+.+.+  +.+++++...++..++||||++|.+|.  ...
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~  106 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH  106 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence            3555699999987777889999866554566889999998885434  567889888888889999999998884  210


Q ss_pred             CCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------
Q 022118          164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS------------------------------------------------  195 (302)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------------------------------------------  195 (302)
                              ..   ...++.+++..+..||+..                                                
T Consensus       107 --------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          107 --------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             --------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             --------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence                    11   1246677778888888632                                                


Q ss_pred             --------CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          196 --------PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       196 --------~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                              ..++|+|++|.||++++++.+.|.|||.+..
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    1299999999999998877778999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=1.2e-11  Score=109.62  Aligned_cols=138  Identities=14%  Similarity=0.239  Sum_probs=104.9

Q ss_pred             cCCeeeeCCCeeEEEEEEcCCcEEEEEecC--CCC----hHHHHHHHHHhccCC--CCceeeEEeEEeeC---CeeeEEE
Q 022118           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GAP----TQEFIDEVCFLASIQ--HRNLVTLLGYCQEN---NLQFLIY  149 (302)
Q Consensus        81 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lv~  149 (302)
                      ..+.++.|.++.||+....+ ..+++|+..  ...    ...+.+|..+++.+.  +.++.+++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999988654 567888765  322    346788999998886  46688999988876   4579999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-----------------------------------  194 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------------------------------  194 (302)
                      ||++|..+.+..       ...++......++.+++..|..||+.                                   
T Consensus       121 e~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          121 EFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             ECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999998875422       23356777788899999999999972                                   


Q ss_pred             ---------------------CCCceecCCCCCCeeeCCCCc--eEEcccccccc
Q 022118          195 ---------------------SPRVVHKDFKTANVLVDEDFI--AKVADAGLRNF  226 (302)
Q Consensus       195 ---------------------~~~ivHrdlkp~Nill~~~~~--~kl~DfGla~~  226 (302)
                                           ...++|+|++|.||+++.++.  +.|.||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 145999999999999987753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=1.6e-11  Score=106.28  Aligned_cols=184  Identities=18%  Similarity=0.183  Sum_probs=115.6

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccC-CCCc--eeeEEeEEeeCC---eeeEEEeccCC
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASI-QHRN--LVTLLGYCQENN---LQFLIYEYIPN  154 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l-~H~n--Iv~l~~~~~~~~---~~~lv~e~~~~  154 (302)
                      .+.++.|....||+..    ..+++|..... ....+.+|.++++.+ .+..  +.+.+......+   ..|+|||+++|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            4679999999999863    45778875433 245688899998777 3322  455555544433   34899999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL----------------------------------------  194 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----------------------------------------  194 (302)
                      .++....       ...++..+...++.+++..+..||+.                                        
T Consensus       101 ~~l~~~~-------~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          101 VPLTPLL-------LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCHHH-------HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             eECCccc-------cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            8876432       12345555566666777776666641                                        


Q ss_pred             ----------------CCCceecCCCCCCeeeCC--CCceEEcccccccccCCCC-CCCCCccccCcccccchhhhcc--
Q 022118          195 ----------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVKEF--  253 (302)
Q Consensus       195 ----------------~~~ivHrdlkp~Nill~~--~~~~kl~DfGla~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~--  253 (302)
                                      ...++|+|++|.||++++  +..+.+.||+.+..-.+.. ........   . -..|+....  
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~-~~~~~~~~~~l  249 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---E-EYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---T-SCCHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---c-ccCHHHHHHHH
Confidence                            124799999999999988  5678999999886532210 00000000   0 012221110  


Q ss_pred             CCC------------CCccchhhHHHHHHHHHhCCCCCC
Q 022118          254 RRF------------SEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       254 ~~~------------~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      ..|            ....+.|+++.++|.+.+|..+|-
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            011            122589999999999999987753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.71  E-value=3.6e-08  Score=83.42  Aligned_cols=134  Identities=22%  Similarity=0.232  Sum_probs=94.0

Q ss_pred             eeeeCCCe-eEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEeccCCCCcccc
Q 022118           84 LIGEGKFG-EVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH  160 (302)
Q Consensus        84 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~  160 (302)
                      .+..|..| .||+.... ++..+++|..+......+.+|...|+.+. +-.+.++++++.+++..++|||+++|.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            45556555 68987754 45678899877666667888999887763 44477889999999999999999998776544


Q ss_pred             ccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------------
Q 022118          161 LYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---------------------------------------------  195 (302)
Q Consensus       161 l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------------------------------------------  195 (302)
                      ...         .......++.+++..|.-||...                                             
T Consensus       111 ~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          111 LEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            310         01112234445555555555321                                             


Q ss_pred             -----------CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          196 -----------PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       196 -----------~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                                 ..++|+|+.+.||+++.++.+-|.||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       1279999999999999888778999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.59  E-value=1.9e-07  Score=80.71  Aligned_cols=134  Identities=16%  Similarity=0.137  Sum_probs=87.2

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-ChHHHHHHHHHhccCCCC---ceeeEEeEEe-eCCeeeEEEeccCCCC
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQ-ENNLQFLIYEYIPNGS  156 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lv~e~~~~g~  156 (302)
                      .+.++.|....||+.    +..+++|..... ....+.+|.++++.+.+.   .+.+.+.++. ..+..+++|||++|..
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            456888888899987    456777774322 235678999999888642   3667777764 4456789999999988


Q ss_pred             ccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 022118          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS-------------------------------------------  193 (302)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-------------------------------------------  193 (302)
                      +.....       ..++......++.++...|..||+                                           
T Consensus       100 l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A          100 LGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             Cchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            765221       111222223333333333333332                                           


Q ss_pred             ---------------CCCCceecCCCCCCeeeCC---CCc-eEEcccccccc
Q 022118          194 ---------------LSPRVVHKDFKTANVLVDE---DFI-AKVADAGLRNF  226 (302)
Q Consensus       194 ---------------~~~~ivHrdlkp~Nill~~---~~~-~kl~DfGla~~  226 (302)
                                     ....++|+|+.|.||+++.   ++. +.|.||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           1234799999999999987   355 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=3.2e-07  Score=80.79  Aligned_cols=77  Identities=9%  Similarity=0.021  Sum_probs=55.1

Q ss_pred             Cee-eeCCCeeEEEEEEc-------CCcEEEEEecCCCC------hHHHHHHHHHhccCC-C--CceeeEEeEEeeC---
Q 022118           83 NLI-GEGKFGEVYKGLLQ-------DGMLVAIKKRPGAP------TQEFIDEVCFLASIQ-H--RNLVTLLGYCQEN---  142 (302)
Q Consensus        83 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~---  142 (302)
                      +.| +.|....+|+....       ++..+++|......      ...+.+|..+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888899988754       25678888755422      256788988888773 2  3577888887665   


Q ss_pred             CeeeEEEeccCCCCccc
Q 022118          143 NLQFLIYEYIPNGSVSI  159 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~  159 (302)
                      +..|+||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999887754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=2.8e-06  Score=74.03  Aligned_cols=142  Identities=18%  Similarity=0.267  Sum_probs=79.0

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCC-----CCceeeEE-e--EEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-----HRNLVTLL-G--YCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~-~--~~~~~~~~~lv~e~~~~  154 (302)
                      +.|+.|..+.||+....++ .+++|.... ...++..|..+++.+.     .|.++... |  +....+..+++|||++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            3455567889999887655 488888765 3344555555555442     34444311 1  12345677999999998


Q ss_pred             CCccc--------------cccCCCc----CC-----CcccCHHH-------------------------------HHHH
Q 022118          155 GSVSI--------------HLYGPSQ----VS-----RQKLEFKH-------------------------------RLSI  180 (302)
Q Consensus       155 g~L~~--------------~l~~~~~----~~-----~~~~~~~~-------------------------------~~~~  180 (302)
                      ..+..              .++....    ..     .....|..                               ...+
T Consensus       116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (346)
T 2q83_A          116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF  195 (346)
T ss_dssp             BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence            76531              0110000    00     00011211                               0011


Q ss_pred             HHHHHHHHHHhhc-----------CCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          181 ALGAAKGLAHLHS-----------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       181 ~~~i~~~l~~LH~-----------~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ...+..++.+|+.           ....++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1223345566652           236799999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.12  E-value=5.8e-06  Score=73.84  Aligned_cols=72  Identities=14%  Similarity=0.077  Sum_probs=48.4

Q ss_pred             CCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----------ChHHHHHHHHHhccCCC--C-ceeeEEeEEeeCCeeeE
Q 022118           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----------PTQEFIDEVCFLASIQH--R-NLVTLLGYCQENNLQFL  147 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~H--~-nIv~l~~~~~~~~~~~l  147 (302)
                      .+.+|.|..+.||++... ++..+++|.....          ...++..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 4678999964321          23456788888876632  3 44566654  3455689


Q ss_pred             EEeccCCC
Q 022118          148 IYEYIPNG  155 (302)
Q Consensus       148 v~e~~~~g  155 (302)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=5.1e-05  Score=65.45  Aligned_cols=75  Identities=19%  Similarity=0.164  Sum_probs=60.5

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCC---CCceeeEEeEEeeCCeeeEEEeccCCCCc
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      .+.|+.|....+|+... ++..+++|.........+..|.+.|+.+.   ...+.+.+.++...+..++||||+++..+
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            46788999999999875 35678889866555667889988888773   36788899998888889999999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.88  E-value=7.7e-05  Score=63.44  Aligned_cols=76  Identities=17%  Similarity=0.171  Sum_probs=54.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---hHHHHHHHHHhccCC-C--CceeeEEeEEeeCCeeeEEEec
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQ-H--RNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .......+|.|..+.||+.+..+|+.+.+|..+...   ...+.+|.+.|+.+. .  -.+.+.+++.    ..+++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344567899999999999999999999999855432   346788988887663 2  2345555542    34799999


Q ss_pred             cCCCCc
Q 022118          152 IPNGSV  157 (302)
Q Consensus       152 ~~~g~L  157 (302)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.76  E-value=6.7e-05  Score=65.20  Aligned_cols=142  Identities=10%  Similarity=0.010  Sum_probs=71.8

Q ss_pred             CeeeeCCCee-EEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCC--CCceeeEEeEEeeCCeeeEEEeccCCCCccc
Q 022118           83 NLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (302)
Q Consensus        83 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (302)
                      +.|+.|.... +|+....++..+++|..+......+..|..+++.+.  .-.+.+++.+....+  +++||++.+..+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~  101 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTE  101 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHH
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHH
Confidence            4455554443 666655446677777655433244556777666553  233566666643333  78999987655543


Q ss_pred             cccCC---------------------CcCCCcccCHHHHH---------H-----------HHHHHHHHHHHh----hcC
Q 022118          160 HLYGP---------------------SQVSRQKLEFKHRL---------S-----------IALGAAKGLAHL----HSL  194 (302)
Q Consensus       160 ~l~~~---------------------~~~~~~~~~~~~~~---------~-----------~~~~i~~~l~~L----H~~  194 (302)
                      .+...                     .......++.....         .           ....+...+..+    ...
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            32110                     00000111111000         0           000111122222    111


Q ss_pred             CCCceecCCCCCCeeeCCC----CceEEcccccccc
Q 022118          195 SPRVVHKDFKTANVLVDED----FIAKVADAGLRNF  226 (302)
Q Consensus       195 ~~~ivHrdlkp~Nill~~~----~~~kl~DfGla~~  226 (302)
                      ...++|+|+.+.||+++.+    +.+.|.||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            2469999999999999875    6789999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.69  E-value=9.9e-05  Score=66.38  Aligned_cols=70  Identities=11%  Similarity=0.185  Sum_probs=43.8

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEec-------CCC-----ChHHHHHHHHHhc-cCCCCceeeEEeEEeeCCeeeEE
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKR-------PGA-----PTQEFIDEVCFLA-SIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~-------~~~-----~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .+.+|.|..+.||++.. ++..+++|..       ...     ....+..|+..+. ......+.+++.+.  ++..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46789999999999864 4677999931       111     1222333333222 22234667777765  5667999


Q ss_pred             Eecc-CC
Q 022118          149 YEYI-PN  154 (302)
Q Consensus       149 ~e~~-~~  154 (302)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.61  E-value=0.00065  Score=58.44  Aligned_cols=143  Identities=11%  Similarity=0.036  Sum_probs=77.1

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCC-CChHHHHHHHHHhccCCCCc--eeeEEeE------EeeCCeeeEEEeccC
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRN--LVTLLGY------CQENNLQFLIYEYIP  153 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lv~e~~~  153 (302)
                      +.|+.|....+|+....++ .+++|.... .....+..|..++..+....  +.+++..      ....+..+++|+|++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            4456677788999887655 577887665 24456677877776653111  2333321      123456789999999


Q ss_pred             CCCcccc--------------ccCCC---cCCC----cccCHHHHHH------------HHHHHHHHHHHhhc-----CC
Q 022118          154 NGSVSIH--------------LYGPS---QVSR----QKLEFKHRLS------------IALGAAKGLAHLHS-----LS  195 (302)
Q Consensus       154 ~g~L~~~--------------l~~~~---~~~~----~~~~~~~~~~------------~~~~i~~~l~~LH~-----~~  195 (302)
                      |..+...              ++...   ....    ....|.....            +...+...++++.+     ..
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            8664321              01000   0000    0001111000            00113334444442     12


Q ss_pred             CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       196 ~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      .+++|+|+.+.||++++++.+.+.||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            4699999999999999876678999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.46  E-value=0.00035  Score=63.03  Aligned_cols=73  Identities=18%  Similarity=0.178  Sum_probs=50.0

Q ss_pred             CCeeeeCCCeeEEEEEEcC--------CcEEEEEecCCCCh-HHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEec
Q 022118           82 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT-QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      .+.|+.|....+|+....+        +..+++|....... ..+.+|..+++.+. +.-..++++.+.  +  .+|+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~  153 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY  153 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence            3567778889999998653        46788988744233 66778998888774 322356676553  2  389999


Q ss_pred             cCCCCcc
Q 022118          152 IPNGSVS  158 (302)
Q Consensus       152 ~~~g~L~  158 (302)
                      ++|.++.
T Consensus       154 l~G~~l~  160 (429)
T 1nw1_A          154 IPSRPLS  160 (429)
T ss_dssp             CCEEECC
T ss_pred             eCCcccC
Confidence            9875543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.41  E-value=0.00058  Score=58.32  Aligned_cols=69  Identities=9%  Similarity=0.013  Sum_probs=42.2

Q ss_pred             CCeeeeCCCeeEEEEEEcCCcEEEEEecCCCCh--HHHHHHHHHhccCCCCce-eeEEeEEeeCCeeeEEEecc-CCCCc
Q 022118           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYI-PNGSV  157 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~-~~g~L  157 (302)
                      .+.|+.|....+|+.     ..+++|.......  ....+|..+++.+...++ .+++++.  ++.-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            577888999999998     4477776543221  123567777766532122 4555543  33457999999 66554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.40  E-value=0.0013  Score=56.77  Aligned_cols=74  Identities=9%  Similarity=0.138  Sum_probs=48.6

Q ss_pred             CeeeeCCCeeEEEEEEcCCcEEEEEecCC--CChHHHHHHHHHhccCCC--CceeeEEeE-----EeeCCeeeEEEeccC
Q 022118           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQH--RNLVTLLGY-----CQENNLQFLIYEYIP  153 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~H--~nIv~l~~~-----~~~~~~~~lv~e~~~  153 (302)
                      ..++ |....||+....+|..+++|....  .....+..|..++..+..  -.+.+++..     ....+..+++|||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            4566 778889988776677789998753  245667778887776631  123444432     123455688999998


Q ss_pred             CCCc
Q 022118          154 NGSV  157 (302)
Q Consensus       154 ~g~L  157 (302)
                      |..+
T Consensus       111 G~~~  114 (328)
T 1zyl_A          111 GRQF  114 (328)
T ss_dssp             CEEC
T ss_pred             CCCC
Confidence            7654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.24  E-value=0.0026  Score=57.77  Aligned_cols=72  Identities=14%  Similarity=0.055  Sum_probs=45.8

Q ss_pred             CeeeeCCCeeEEEEEEcC-CcEEEEEecCCCChH--HHHHHHHHhccCCCCce-eeEEeEEeeCCeeeEEEeccCCCCcc
Q 022118           83 NLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVS  158 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~  158 (302)
                      +.|+.|-...+|+....+ +..+++|........  +-.+|..+++.+...++ .++++.+.  +  .+||||++|.+|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l~  189 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYALS  189 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccCC
Confidence            467778788999998765 467888875432211  12578888887754333 56777663  2  2599999976553

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.13  E-value=0.0015  Score=57.76  Aligned_cols=140  Identities=15%  Similarity=0.148  Sum_probs=79.7

Q ss_pred             CeeeeCCCeeEEEEEEc--------CCcEEEEEecCCC--ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +.+.-|-...+|+....        ++..+++|.....  ......+|..+++.+. +.-..++++.+.+    -+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            55766778889998864        2467888875432  3455678988887763 3223566666543    299999


Q ss_pred             cCCCCcccc-c----------------cCCCcCCCccc--CHHHHHHHHHHHHH-------------------HHHH---
Q 022118          152 IPNGSVSIH-L----------------YGPSQVSRQKL--EFKHRLSIALGAAK-------------------GLAH---  190 (302)
Q Consensus       152 ~~~g~L~~~-l----------------~~~~~~~~~~~--~~~~~~~~~~~i~~-------------------~l~~---  190 (302)
                      ++|..|..- +                +..........  -+.++..+..++..                   .+..   
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421 1                11000001111  23344444333321                   1222   


Q ss_pred             -hhcC--CCCceecCCCCCCeeeCCC----CceEEcccccccc
Q 022118          191 -LHSL--SPRVVHKDFKTANVLVDED----FIAKVADAGLRNF  226 (302)
Q Consensus       191 -LH~~--~~~ivHrdlkp~Nill~~~----~~~kl~DfGla~~  226 (302)
                       |...  ...++|+|+.+.||+++.+    +.+.+.||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             2221  2358999999999999876    7899999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.00  E-value=0.0044  Score=53.89  Aligned_cols=31  Identities=23%  Similarity=0.212  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       196 ~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      ..++|+|+.+.||++++++.+.+.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.87  E-value=0.0012  Score=58.08  Aligned_cols=71  Identities=15%  Similarity=0.112  Sum_probs=42.2

Q ss_pred             CeeeeCCCeeEEEEEEcC---------CcEEEEEecCCCChH--HHHHHHHHhccCCCCc-eeeEEeEEeeCCeeeEEEe
Q 022118           83 NLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~--~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e  150 (302)
                      +.++.|....+|+....+         +..+++|........  ....|.++++.+...+ +.++++..  +  -++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            457778888899988653         257888875543221  2357777777663222 44666544  2  368999


Q ss_pred             ccCCCCc
Q 022118          151 YIPNGSV  157 (302)
Q Consensus       151 ~~~~g~L  157 (302)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987654

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.11  E-value=0.015  Score=33.77  Aligned_cols=31  Identities=13%  Similarity=0.084  Sum_probs=15.9

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Q 022118            6 AAIFGAAAGAVALMGIIFFLSWFCLYRNRSV   36 (302)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   36 (302)
                      +.|.+.+++.+++++++++++|++.+||+..
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            4455555555555555555555555554443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=95.91  E-value=0.01  Score=33.38  Aligned_cols=31  Identities=16%  Similarity=0.109  Sum_probs=21.6

Q ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHHHHHHh
Q 022118            2 SVTLAAIFGAAAGAVALMGIIFFLSWFCLYR   32 (302)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   32 (302)
                      +.+-+.+.++++++++.+++++++.+++++|
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            3567788888888887666666666665544

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.11  E-value=0.039  Score=32.04  Aligned_cols=28  Identities=18%  Similarity=0.171  Sum_probs=12.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHhhcC
Q 022118            8 IFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (302)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (302)
                      |.+.+++.+++++++++++|++.+|++.
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            3333444444444444555555544443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.73  E-value=0.13  Score=46.00  Aligned_cols=71  Identities=8%  Similarity=-0.012  Sum_probs=45.3

Q ss_pred             CeeeeCCCeeEEEEEEcC--------CcEEEEEecCCCCh--HHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEec
Q 022118           83 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT--QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~--~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      +.+..|-...+|+....+        +..++++.......  -+-.+|..+++.+. +.-..++++.+  +  -++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            456667778899988653        57788887543321  12357888777763 32245556533  2  2789999


Q ss_pred             cCCCCc
Q 022118          152 IPNGSV  157 (302)
Q Consensus       152 ~~~g~L  157 (302)
                      ++|..|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998665

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.68  E-value=0.061  Score=43.34  Aligned_cols=102  Identities=13%  Similarity=0.099  Sum_probs=64.0

Q ss_pred             CccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 022118          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (302)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~  235 (302)
                      +|.+.|    ......+++.+++.++.|.+.+|.-+-.. ..-..+=..|..|++..+|.|.+.+ +.+.          
T Consensus        34 SL~eIL----~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEIL----RLYNQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHH----HHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHH----HHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence            566666    23567899999999999999998776210 0011233456899999999988764 1110          


Q ss_pred             CccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCC
Q 022118          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA  278 (302)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p  278 (302)
                          .....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                0111256777652 3345677899999999998875555

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=94.23  E-value=0.19  Score=30.43  Aligned_cols=33  Identities=15%  Similarity=0.350  Sum_probs=23.1

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Q 022118            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (302)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (302)
                      +.+.++++++++.++++++++++.|-|..-+|+
T Consensus        10 vp~wiIi~svl~GLllL~li~~~LwK~GFFkR~   42 (54)
T 2knc_A           10 IPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRN   42 (54)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTT
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHcCcccCC
Confidence            456777777777777777777777766554443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=94.08  E-value=0.14  Score=29.58  Aligned_cols=9  Identities=33%  Similarity=0.604  Sum_probs=4.5

Q ss_pred             hhHHHHHHH
Q 022118            6 AAIFGAAAG   14 (302)
Q Consensus         6 ~~~~~~~~~   14 (302)
                      ..+++.+++
T Consensus        12 ~~Ia~~vVG   20 (44)
T 2jwa_A           12 TSIISAVVG   20 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             cchHHHHHH
Confidence            335555555

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=93.72  E-value=0.21  Score=30.16  Aligned_cols=33  Identities=21%  Similarity=0.306  Sum_probs=22.9

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Q 022118            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (302)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (302)
                      +.+.++++++++.++++++++++.|-|..-+|+
T Consensus         7 vp~WiIi~svl~GLLLL~Lii~~LwK~GFFKR~   39 (54)
T 2l8s_A            7 VPLWVILLSAFAGLLLLMLLILALWKIGFFKRP   39 (54)
T ss_dssp             CCTHHHHHHHHHHHHHHHHHHHHHHHHHHTTSC
T ss_pred             CchHHHHHHHHHHHHHHHHHHHHHHHcCcccCC
Confidence            456777777777777777777777766554444

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.27  E-value=0.72  Score=36.93  Aligned_cols=87  Identities=9%  Similarity=0.043  Sum_probs=62.1

Q ss_pred             CCCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 022118          127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA  206 (302)
Q Consensus       127 l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~  206 (302)
                      -.||+.+.. ..-.+.+.+.+.++  ...+...+-      .-...+...+++++.+|+....+++.    -+|--+.|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~--~~~~~~~f~------~ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYD--INDNHTPFD------NIKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEEC--CCTTSEEGG------GGGGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEE--cCcccCCHH------HHHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecc
Confidence            368888866 45555555444444  333333332      23566788899999999988877775    588889999


Q ss_pred             CeeeCCCCceEEcccccccc
Q 022118          207 NVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       207 Nill~~~~~~kl~DfGla~~  226 (302)
                      |++++.++.+++.--|+...
T Consensus       109 NL~f~~~~~p~i~~RGik~~  128 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNV  128 (215)
T ss_dssp             GEEECTTSCEEESCCEETTT
T ss_pred             eEEEcCCCCEEEEEccCccC
Confidence            99999999999998887543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.14  E-value=0.82  Score=36.73  Aligned_cols=85  Identities=8%  Similarity=0.023  Sum_probs=58.7

Q ss_pred             CCCceeeEEeEEeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHH-HhhcCCCCceecCCCCC
Q 022118          128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA-HLHSLSPRVVHKDFKTA  206 (302)
Q Consensus       128 ~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~LH~~~~~ivHrdlkp~  206 (302)
                      .||++  --..-.+++...+.++.-+  +...+-      .-...+...+++++.+++.... +++.    -+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~--~~~~f~------~i~~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPS--SFLTFA------AIRKTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCT--TCEEHH------HHHTSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCc--ccCcHH------HHHhcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence            57777  2233355555555555432  222222      1245677888999999998887 6665    688889999


Q ss_pred             CeeeCCCCceEEcccccccc
Q 022118          207 NVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       207 Nill~~~~~~kl~DfGla~~  226 (302)
                      |+++|.++.+++.-.|+-..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES  133 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT
T ss_pred             eEEEeCCCcEEEEEcCCccc
Confidence            99999999999998887543

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=91.92  E-value=0.25  Score=26.65  Aligned_cols=29  Identities=21%  Similarity=0.369  Sum_probs=21.3

Q ss_pred             CccchhhHHHHHHHHHHHHHHHHHHHHHH
Q 022118            1 MSVTLAAIFGAAAGAVALMGIIFFLSWFC   29 (302)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   29 (302)
                      +..+.+.+.+++++.++..++++++++++
T Consensus         2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~~   30 (33)
T 2l34_A            2 STVSPGVLAGIVVGDLVLTVLIALAVYFL   30 (33)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCcceEEeEeHHHHHHHHHHHHHHhhe
Confidence            45678888999888887766666666654

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=91.77  E-value=0.11  Score=29.73  Aligned_cols=24  Identities=25%  Similarity=0.391  Sum_probs=9.6

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHH
Q 022118            6 AAIFGAAAGAVALMGIIFFLSWFC   29 (302)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~   29 (302)
                      +.+++.+++.++++++++++.|++
T Consensus        13 ~~I~~~vv~Gv~ll~~iv~~~~~~   36 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLLVLAGVGFFI   36 (41)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             EEEEeehhHHHHHHHHHHHHheeE
Confidence            344444444444433233333433

>2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A

Probab=89.40  E-value=0.62  Score=26.64  Aligned_cols=32  Identities=16%  Similarity=0.351  Sum_probs=21.2

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 022118            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNR   34 (302)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   34 (302)
                      +.+.++++++++.++++++++++.|-|..-+|
T Consensus         8 vp~wiIi~s~l~GLllL~li~~~LwK~GFFkR   39 (42)
T 2k1a_A            8 IPIWWVLVGVLGGLLLLTILVLAMWKVGFFKR   39 (42)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHTTTTCC
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence            45667777777777777777777776654433

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=85.84  E-value=1.1  Score=28.02  Aligned_cols=13  Identities=23%  Similarity=0.271  Sum_probs=5.2

Q ss_pred             HHHHHHHHHHHHH
Q 022118           18 LMGIIFFLSWFCL   30 (302)
Q Consensus        18 ~~~~~~~~~~~~~   30 (302)
                      +++++.+.+++|.
T Consensus        20 lll~~glcI~ccv   32 (70)
T 2klu_A           20 LLLFIGLGIFFSV   32 (70)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhh
Confidence            3333444444343

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.21  E-value=0.12  Score=46.79  Aligned_cols=59  Identities=7%  Similarity=0.030  Sum_probs=18.6

Q ss_pred             CcCCeeeeCCCeeEEEEEEcC-CcEEEE------EecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEee
Q 022118           80 SDKNLIGEGKFGEVYKGLLQD-GMLVAI------KKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~  141 (302)
                      ...+.||   ||.||++.+.. ..+||+      |....     .....+.+|..+++.++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3446676   99999998754 356787      54332     222457788889999999999999887654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.27  E-value=0.53  Score=41.58  Aligned_cols=29  Identities=21%  Similarity=0.359  Sum_probs=24.8

Q ss_pred             ceecCCCCCCeee------CCCCceEEcccccccc
Q 022118          198 VVHKDFKTANVLV------DEDFIAKVADAGLRNF  226 (302)
Q Consensus       198 ivHrdlkp~Nill------~~~~~~kl~DfGla~~  226 (302)
                      ++|+|+.+.||++      +++..+.+.||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999998754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	302
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-41
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-41
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-39
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-31
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 4e-50
 Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 39/262 (14%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFL 124
           ++  +     +    IG G FG VYKG       VA+K     APT    Q F +EV  L
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
              +H N++  +GY     L  ++ ++    S+  HL+        K E    + IA   
Sbjct: 59  RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQT 113

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           A+G+ +LH+    ++H+D K+ N+ + ED   K+ D GL     R   +    Q++   +
Sbjct: 114 AQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 245 FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR----------------------EAS 279
           ++A EV   ++   +S +SDVY+FG+ L EL++G+                         
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231

Query: 280 SSLSPDSSQDLVELMIKCMGKE 301
           S +  +  + +  LM +C+ K+
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKK 253

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 44/211 (20%), Positives = 91/211 (43%), Gaps = 17/211 (8%)

Query: 72  LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLA 125
           + L   +F   + +G G  G V+K      G+++A K      +P     + I E+  L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLH 59

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
                 +V   G    +    +  E++  GS+   L         ++  +    +++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVI 114

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
           KGL +L     +++H+D K +N+LV+     K+ D G+   L  +     ++       +
Sbjct: 115 KGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 169

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++ E  +   +S +SD++S G+ L+E+  GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-47
 Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 27/245 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +       +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L     +  + ++I EY+ NGS+   L  P   S  KL     L +A   A+G+A +   
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
           +   +H+D + AN+LV +    K+AD GL   +   +             + A E   + 
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG 185

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSS------------------LSPDSSQDLVELMIK 296
            F+ KSDV+SFG+ L E+V+                            +  ++L +LM  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 297 CMGKE 301
           C  + 
Sbjct: 246 CWKER 250

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-46
 Identities = 62/245 (25%), Positives = 104/245 (42%), Gaps = 27/245 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
              +    IG G+FG V+ G   +   VAIK  +      ++FI+E   +  + H  LV 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L G C E     L++E++ +G     L    +  R     +  L + L   +G+A+L   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
              V+H+D    N LV E+ + KV+D G+  F+        +      + + + EV  F 
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFS 177

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDS------------------SQDLVELMIK 296
           R+S KSDV+SFGV + E+ S  +       +S                  S  + ++M  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237

Query: 297 CMGKE 301
           C  + 
Sbjct: 238 CWKER 242

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (394), Expect = 4e-46
 Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 35/251 (13%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 128
            K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H N +   G     +  +L+ EY    +  +         ++ L+     ++  GA +GL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGL 128

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
           A+LHS    ++H+D K  N+L+ E  + K+ D G  + +   +    +    A E+ LA 
Sbjct: 129 AYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR------------------EASSSLSPDSSQDL 290
           +     ++  K DV+S G+  +EL   +                  E+ +  S   S+  
Sbjct: 187 DEG---QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243

Query: 291 VELMIKCMGKE 301
              +  C+ K 
Sbjct: 244 RNFVDSCLQKI 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-45
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 27/245 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           K+ +    +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L G C +    F+I EY+ NG +  +L       R + + +  L +     + + +L   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
           S + +H+D    N LV++  + KV+D GL  ++   +             +   EV  + 
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYS 176

Query: 255 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDS-----------------SQDLVELMIK 296
           +FS KSD+++FGV + E+ S G+      +                    S+ +  +M  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 297 CMGKE 301
           C  ++
Sbjct: 237 CWHEK 241

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 9e-45
 Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 27/258 (10%)

Query: 65  RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEV 121
                ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E 
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +  I+H NLV LLG C      ++I E++  G++  +L    + +RQ++     L +A
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMA 121

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              +  + +L       +H+D    N LV E+ + KVAD GL   +   D     +    
Sbjct: 122 TQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKF 178

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA------------------SSSLS 283
              + A E   + +FS KSDV++FGV L E+ +   +                       
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238

Query: 284 PDSSQDLVELMIKCMGKE 301
               + + ELM  C    
Sbjct: 239 EGCPEKVYELMRACWQWN 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-44
 Identities = 69/251 (27%), Positives = 103/251 (41%), Gaps = 33/251 (13%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH 129
            L++  K       IG+G+FG+V  G    G  VA+K  +  A  Q F+ E   +  ++H
Sbjct: 3   ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRH 59

Query: 130 RNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
            NLV LLG   +E    +++ EY+  GS+  +L       R  L     L  +L   + +
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAM 116

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +L       VH+D    NVLV ED +AKV+D GL      T   G          + A 
Sbjct: 117 EYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAP 169

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREA------------------SSSLSPDSSQDL 290
           E    ++FS KSDV+SFG+ L E+ S                                 +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229

Query: 291 VELMIKCMGKE 301
            E+M  C   +
Sbjct: 230 YEVMKNCWHLD 240

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-44
 Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 27/245 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           ++   +  +G+G FGEV+ G       VAIK  K      + F+ E   +  ++H  LV 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L     E  + +++ EY+  GS+   L G    + + L     + +A   A G+A++   
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
               VH+D + AN+LV E+ + KVAD GL   +   +           + + A E   + 
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYG 189

Query: 255 RFSEKSDVYSFGVFLLELVSGREA------------------SSSLSPDSSQDLVELMIK 296
           RF+ KSDV+SFG+ L EL +                           P+  + L +LM +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249

Query: 297 CMGKE 301
           C  KE
Sbjct: 250 CWRKE 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (381), Expect = 2e-44
 Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 44/273 (16%)

Query: 67  FQMEELSLATKNFSDK---------NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAP 113
           F  E+ + A + F+ +          +IG G+FGEV  G L    +  + VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 114 T----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           T    ++F+ E   +    H N++ L G   ++    +I E++ NGS    L    + + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS----LDSFLRQND 122

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
            +      + +  G A G+ +L       VH+D    N+LV+ + + KV+D GL  FL  
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 230 TDVAGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-------- 278
                  +          + A E  ++R+F+  SDV+S+G+ + E++S  E         
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 279 ----------SSSLSPDSSQDLVELMIKCMGKE 301
                           D    L +LM+ C  K+
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKD 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 9e-44
 Identities = 55/252 (21%), Positives = 98/252 (38%), Gaps = 31/252 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           ++     IG G +G   K     DG ++  K+        A  Q  + EV  L  ++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 132 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           +V        + N   +++ EY   G ++  +   ++  RQ L+ +  L +       L 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALK 123

Query: 190 HLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
             H  S     V+H+D K ANV +D     K+ D GL   L        +   T    ++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP--YYM 181

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-----------------SQD 289
           + E      ++EKSD++S G  L EL +     ++ S                    S +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241

Query: 290 LVELMIKCMGKE 301
           L E++ + +  +
Sbjct: 242 LNEIITRMLNLK 253

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-43
 Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 34/259 (13%)

Query: 70  EELSLATKNFSDKNL-IGEGKFGEVYKGLLQ---DGMLVAIKK----RPGAPTQEFIDEV 121
           ++L L   N    ++ +G G FG V +G+ +     + VAIK        A T+E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +  + +  +V L+G CQ   L  L+ E    G +   L G     R+++   +   + 
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              + G+ +L       VH+D    NVL+     AK++D GL   LG  D    +     
Sbjct: 116 HQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 242 DEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA------------------SSSL 282
             + + A E   FR+FS +SDV+S+GV + E +S  +                       
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233

Query: 283 SPDSSQDLVELMIKCMGKE 301
            P+   +L  LM  C   +
Sbjct: 234 PPECPPELYALMSDCWIYK 252

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-41
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 13/206 (6%)

Query: 77  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRN 131
           +++     +GEG +GEV           VA+K    KR     +    E+C    + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V   G+ +E N+Q+L  EY   G +   +          +              G+ +L
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           H +   + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ 
Sbjct: 120 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 252 EFRRF-SEKSDVYSFGVFLLELVSGR 276
           + R F +E  DV+S G+ L  +++G 
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE 203

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 2e-41
 Identities = 64/281 (22%), Positives = 102/281 (36%), Gaps = 49/281 (17%)

Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK----RPGAPTQEF 117
           ++  L     N      IGEG FG V++         +   +VA+K            +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------- 163
             E   +A   + N+V LLG C       L++EY+  G ++  L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 164 -----PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 218
                 S      L    +L IA   A G+A+L     + VH+D  T N LV E+ + K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181

Query: 219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
           AD GL   +   D             ++  E   + R++ +SDV+++GV L E+ S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 279 ------------------SSSLSPDSSQDLVELMIKCMGKE 301
                               +   +   +L  LM  C  K 
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 282

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-41
 Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 34/246 (13%)

Query: 83  NLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
             +G+G FG+VYK    +  +L A K    +     ++++ E+  LAS  H N+V LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
               N  +++ E+   G+V   +        + L       +       L +LH    ++
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDN--KI 131

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 254
           +H+D K  N+L   D   K+AD G+     RT     S        A E+ +    K+ R
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD-R 190

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDS-------------------SQDLVELMI 295
            +  K+DV+S G+ L+E+         L+P                     S +  + + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250

Query: 296 KCMGKE 301
           KC+ K 
Sbjct: 251 KCLEKN 256

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-41
 Identities = 57/260 (21%), Positives = 101/260 (38%), Gaps = 41/260 (15%)

Query: 65  RRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEF 117
           R++ +E       +F     +G+GKFG VY     Q   ++A+K              + 
Sbjct: 1   RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
             EV   + ++H N++ L GY  +    +LI EY P G+V   L         K + +  
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRT 108

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
            +     A  L++ HS   RV+H+D K  N+L+      K+AD G       +      +
Sbjct: 109 ATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT 162

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR----------------EASSS 281
            +     +L  E+ E R   EK D++S GV   E + G+                    +
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222

Query: 282 LSPDSSQDLVELMIKCMGKE 301
                ++   +L+ + +   
Sbjct: 223 FPDFVTEGARDLISRLLKHN 242

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-40
 Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 24/257 (9%)

Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA 112
           +   + +A +  +   S    +F    +IG G FG VY G L D     +  A+K     
Sbjct: 9   LNPELVQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66

Query: 113 PTQ----EFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQV 167
                  +F+ E   +    H N+++LLG C        ++  Y+ +G     L    + 
Sbjct: 67  TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRN 122

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 227
                  K  +   L  AKG+  L S   + VH+D    N ++DE F  KVAD GL   +
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 228 GRTDVAGP--SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 285
              +       +       ++A E  + ++F+ KSDV+SFGV L EL++         P 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PY 235

Query: 286 SSQDLVELMIKCMGKER 302
              +  ++ +  +   R
Sbjct: 236 PDVNTFDITVYLLQGRR 252

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-40
 Identities = 63/252 (25%), Positives = 110/252 (43%), Gaps = 34/252 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQ 128
             + + +IG G+FGEVYKG+L+       + VAIK      T+    +F+ E   +    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H N++ L G   +     +I EY+ NG++   L         +      + +  G A G+
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGM 123

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLA 247
            +L +     VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A
Sbjct: 124 KYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASS------------------SLSPDSSQD 289
            E   +R+F+  SDV+SFG+ + E+++  E                         D    
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241

Query: 290 LVELMIKCMGKE 301
           + +LM++C  +E
Sbjct: 242 IYQLMMQCWQQE 253

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-40
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 29/225 (12%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID--EVCFLASIQHRNLVTLLGYC 139
           +  IG+G+FGEV++G    G  VA+K       + +    E+     ++H N++  +   
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 140 QENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL- 194
            ++N      +L+ +Y  +GS+  +L      +R  +  +  + +AL  A GLAHLH   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 195 -----SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---------RTDVAGPSSQVT 240
                 P + H+D K+ N+LV ++    +AD GL                   G    + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM- 179

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 285
           A E+   S   +     +++D+Y+ G+   E+             
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-40
 Identities = 44/205 (21%), Positives = 90/205 (43%), Gaps = 14/205 (6%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRN 131
            K ++    IG+G  G VY  + +  G  VAI+    +     +  I+E+  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V  L      +  +++ EY+  GS++  +          ++     ++     + L  L
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFL 132

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           HS   +V+H+D K+ N+L+  D   K+ D G    +         S +     ++A EV 
Sbjct: 133 HSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVV 188

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR 276
             + +  K D++S G+  +E++ G 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-40
 Identities = 55/247 (22%), Positives = 99/247 (40%), Gaps = 40/247 (16%)

Query: 85  IGEGKFGEVYKGLL-QDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G F  VYKGL  +  + VA  +        +  Q F +E   L  +QH N+V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 139 CQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
            +          L+ E + +G++  +L        + ++ K   S      KGL  LH+ 
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 195 SPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           +P ++H+D K  N+ +       K+ D GL      +     +  V     F+A E+ E 
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE- 186

Query: 254 RRFSEKSDVYSFGVFLLELVSGR-------------------EASSSLSPDSSQDLVELM 294
            ++ E  DVY+FG+ +LE+ +                        +S    +  ++ E++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246

Query: 295 IKCMGKE 301
             C+ + 
Sbjct: 247 EGCIRQN 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-39
 Identities = 52/248 (20%), Positives = 95/248 (38%), Gaps = 35/248 (14%)

Query: 81  DKNLIGEGKFGEVYKGLLQD---GMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 132
           +   +G G FG V KG  Q       VA+K         A   E + E   +  + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V ++G C+  +   L+ E    G ++ +L        + ++ K+ + +    + G+ +L 
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE 124

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 VH+D    NVL+     AK++D GL +      +     +       + A E  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREA------------------SSSLSPDSSQDLVEL 293
            + +FS KSDV+SFGV + E  S  +                            +++ +L
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242

Query: 294 MIKCMGKE 301
           M  C   +
Sbjct: 243 MNLCWTYD 250

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 3e-39
 Identities = 59/267 (22%), Positives = 97/267 (36%), Gaps = 45/267 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI 127
             S    +G G FG+V +            M VA+K  +P A   E    + E+  L+ +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 128 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-------------GPSQVSRQKLE 173
             H N+V LLG C       +I EY   G +   L                 +     L+
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
            +  LS +   AKG+A L S     +H+D    N+L+    I K+ D GL   +      
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS------------ 281
                      ++A E      ++ +SDV+S+G+FL EL S   +               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 282 -------LSPDSSQDLVELMIKCMGKE 301
                      +  ++ ++M  C   +
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDAD 288

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 7e-39
 Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 34/250 (13%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPT----QEFIDEVCFLASIQH 129
           F    ++G G FG VYKGL         + VAIK+   A +    +E +DE   +AS+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            ++  LLG C  + +  LI + +P G     L    +  +  +  ++ L+  +  AKG+ 
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L     R+VH+D    NVLV      K+ D GL   LG  +    +        ++A E
Sbjct: 126 YLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREA------------------SSSLSPDSSQDLV 291
               R ++ +SDV+S+GV + EL++                           P  + D+ 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243

Query: 292 ELMIKCMGKE 301
            +M+KC   +
Sbjct: 244 MIMVKCWMID 253

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 8e-39
 Identities = 61/262 (23%), Positives = 114/262 (43%), Gaps = 42/262 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGAPT----QEFIDEVCFLASI-Q 128
            +   +++IGEG FG+V K  ++     M  AIK+     +    ++F  E+  L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHR 177
           H N++ LLG C+     +L  EY P+G++   L           +  +  +   L  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           L  A   A+G+ +L     + +H+D    N+LV E+++AK+AD GL +      V     
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMG 186

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS---------------- 281
           ++     ++A E   +  ++  SDV+S+GV L E+VS                       
Sbjct: 187 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 282 --LSPDSSQDLVELMIKCMGKE 301
                +   ++ +LM +C  ++
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREK 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 9e-39
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 34/244 (13%)

Query: 84  LIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
            IGEG+FG+V++G+        + VAIK      +      F+ E   +    H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           +G   EN + ++I E    G     L    QV +  L+    +  A   +  LA+L   S
Sbjct: 74  IGVITENPV-WIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLE--S 126

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
            R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRR
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRR 185

Query: 256 FSEKSDVYSFGVFLLELVSGREASS------------------SLSPDSSQDLVELMIKC 297
           F+  SDV+ FGV + E++                          + P+    L  LM KC
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 245

Query: 298 MGKE 301
              +
Sbjct: 246 WAYD 249

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-38
 Identities = 60/265 (22%), Positives = 103/265 (38%), Gaps = 35/265 (13%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY+G+       +    VAIK    A +     EF++
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEF 174
           E   +      ++V LLG   +     +I E +  G +  +L        +         
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
              + +A   A G+A+L++   + VH+D    N +V EDF  K+ D G+   +  TD   
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS-------------- 280
              +      +++ E  +   F+  SDV+SFGV L E+ +  E                 
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

Query: 281 ----SLSPDSSQDLVELMIKCMGKE 301
                   +    L ELM  C    
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYN 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-38
 Identities = 40/247 (16%), Positives = 81/247 (32%), Gaps = 30/247 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           +F    ++GEG F  V     L      AIK                  E   ++ + H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
             V L    Q++   +    Y  NG +  ++           +              L +
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEY 123

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
           LH     ++H+D K  N+L++ED   ++ D G    L        ++       +++ E+
Sbjct: 124 LHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR----------------EASSSLSPDSSQDLVELM 294
              +   + SD+++ G  + +LV+G                 +              +L+
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241

Query: 295 IKCMGKE 301
            K +  +
Sbjct: 242 EKLLVLD 248

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  134 bits (337), Expect = 2e-37
 Identities = 51/250 (20%), Positives = 87/250 (34%), Gaps = 35/250 (14%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLV 133
           ++     +G G FG V++      G   A K       +  +    E+  ++ ++H  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L    +++N   +IYE++  G +   +         K+     +       KGL H+H 
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 194 LSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
                VH D K  N++         K+ D GL   L            T    F A EV 
Sbjct: 143 N--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSSLSPDSSQDLV 291
           E +     +D++S GV    L+SG                         S     S+D  
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 292 ELMIKCMGKE 301
           + + K +  +
Sbjct: 258 DFIRKLLLAD 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-37
 Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 37/255 (14%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK------RPGAPTQEFIDEVCFLAS 126
           K+      +G+G FG V +G         + VA+K              +FI EV  + S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           + HRNL+ L G      +  ++ E  P GS    L    +  +           A+  A+
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
           G+ +L   S R +H+D    N+L+    + K+ D GL R      D             +
Sbjct: 123 GMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP------------------DS 286
            A E  + R FS  SD + FGV L E+ + G+E    L+                   D 
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240

Query: 287 SQDLVELMIKCMGKE 301
            QD+  +M++C   +
Sbjct: 241 PQDIYNVMVQCWAHK 255

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 4e-37
 Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 44/266 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
                  +GEG FG+V                  VA+K      T+    + I E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 126 SI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLE 173
            I +H+N++ LLG C ++   ++I EY   G++  +L           Y PS    ++L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
            K  +S A   A+G+ +L S   + +H+D    NVLV ED + K+AD GL   +   D  
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--------------- 278
             ++       ++A E    R ++ +SDV+SFGV L E+ +   +               
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 279 ---SSSLSPDSSQDLVELMIKCMGKE 301
                    + + +L  +M  C    
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAV 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-36
 Identities = 55/272 (20%), Positives = 92/272 (33%), Gaps = 50/272 (18%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASI 127
           N     ++G G FG+V              + VA+K              + E+  +  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 128 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG------------------PSQVS 168
             H N+V LLG C  +   +LI+EY   G +  +L                      +  
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 228
              L F+  L  A   AKG+  L       VH+D    NVLV    + K+ D GL   + 
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA---------- 278
                           ++A E      ++ KSDV+S+G+ L E+ S              
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 279 ---------SSSLSPDSSQDLVELMIKCMGKE 301
                           +++++  +M  C   +
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  128 bits (322), Expect = 7e-36
 Identities = 50/261 (19%), Positives = 94/261 (36%), Gaps = 44/261 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------------QEFIDEVCFL 124
           N+  K ++G G    V + +        A+K                   +  + EV  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 125 ASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
             +  H N++ L    + N   FL+++ +  G +  +L       +  L  K    I   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRA 118

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP---SSQVT 240
             + +  LH L   +VH+D K  N+L+D+D   K+ D G    L   +       +    
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASS 280
           A EI   S       + ++ D++S GV +  L++G                     +  S
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236

Query: 281 SLSPDSSQDLVELMIKCMGKE 301
               D S  + +L+ + +  +
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQ 257

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-35
 Identities = 46/254 (18%), Positives = 86/254 (33%), Gaps = 38/254 (14%)

Query: 77  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 129
           K   +K      +G G+FG V++ +          K  K  G        E+  L   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           RN++ L    +      +I+E+I    +   +      S  +L  +  +S      + L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQ 116

Query: 190 HLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
            LHS    + H D +  N++         K+ + G    L   D             + A
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE---YYA 171

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSSLSPDSS 287
            EV +    S  +D++S G  +  L+SG                             + S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231

Query: 288 QDLVELMIKCMGKE 301
            + ++ + + + KE
Sbjct: 232 IEAMDFVDRLLVKE 245

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 18/230 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +++D  +IG G FG VY+  L   G LVAIKK      +    E+  +  + H N+V L 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLR 79

Query: 137 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
            +   +  +       L+ +Y+P     +  +     ++Q L   +         + LA+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAY 137

Query: 191 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +H  S  + H+D K  N+L+D D  + K+ D G    L R +     S + +        
Sbjct: 138 IH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPEL 193

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG 299
           +     ++   DV+S G  L EL+ G+        DS  D +  +IK +G
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ---PIFPGDSGVDQLVEIIKVLG 240

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  125 bits (315), Expect = 3e-34
 Identities = 46/237 (19%), Positives = 86/237 (36%), Gaps = 24/237 (10%)

Query: 72  LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---------KRPGAPTQEFIDEV 121
           L++   +FS   +IG G FGEVY       G + A+K         K+           +
Sbjct: 1   LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +++     +V +       +    I + +  G +  HL                   A
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYA 113

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                GL H+H  +  VV++D K AN+L+DE    +++D GL     +            
Sbjct: 114 AEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167

Query: 242 DEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKC 297
              ++A EV ++   +   +D +S G  L +L+ G             ++  + +  
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  124 bits (313), Expect = 5e-34
 Identities = 46/244 (18%), Positives = 86/244 (35%), Gaps = 35/244 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
            +G G FG V++ +    G +   K              +E+  +  + H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           ++     LI E++  G +   +         K+     ++    A +GL H+H     +V
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH--SIV 149

Query: 200 HKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H D K  N++ +  +    K+ D GL   L   ++       TA   F A E+ +     
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVG 206

Query: 258 EKSDVYSFGVFLLELVSGR--------------------EASSSLSPDSSQDLVELMIKC 297
             +D+++ GV    L+SG                     E         S +  + +   
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266

Query: 298 MGKE 301
           + KE
Sbjct: 267 LQKE 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 8e-34
 Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 16/228 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           NF     IGEG +G VYK      G +VA+KK              I E+  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V LL      N  +L++E++                   +      S      +GLA  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           H  S RV+H+D K  N+L++ +   K+AD GL    G   V   + +V          + 
Sbjct: 119 H--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILL 175

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG 299
             + +S   D++S G    E+V+ R        DS  D +  + + +G
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL---FPGDSEIDQLFRIFRTLG 220

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-33
 Identities = 52/248 (20%), Positives = 97/248 (39%), Gaps = 33/248 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-------RPGAPTQEFIDEVCFLASIQH 129
           +F    ++G+G FG+V+     +     AIK                 +++     + +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             L  +    Q     F + EY+  G +  H+      S  K +       A     GL 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQ 117

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
            LH  S  +V++D K  N+L+D+D   K+AD G+       D    +   T D  ++A E
Sbjct: 118 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD--YIAPE 173

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS----------------SQDLVEL 293
           +   ++++   D +SFGV L E++ G+        +                  ++  +L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233

Query: 294 MIKCMGKE 301
           ++K   +E
Sbjct: 234 LVKLFVRE 241

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-32
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 22/228 (9%)

Query: 83  NLIGEGKFGEVYKG-LLQDGMLVAIKK--------RPGAPTQEFIDEVCFLASIQHRNLV 133
           + +GEG+F  VYK        +VAIKK              +  + E+  L  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            LL      +   L+++++      I      + +   L   H  +  L   +GL +LH 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH- 117

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KE 252
               ++H+D K  N+L+DE+ + K+AD GL    G  + A     VT    + A E+   
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR--WYRAPELLFG 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
            R +    D+++ G  L EL+        L  DS  D +  + + +G 
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF---LPGDSDLDQLTRIFETLGT 219

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (301), Expect = 1e-32
 Identities = 48/248 (19%), Positives = 99/248 (39%), Gaps = 35/248 (14%)

Query: 77  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           ++F     +G G FG V+      +G   A+K             +   DE   L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             ++ + G  Q+    F+I +YI  G +   L        Q+         A      L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LH  S  ++++D K  N+L+D++   K+ D G   ++           +     ++A E
Sbjct: 119 YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE 171

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR----------------EASSSLSPDSSQDLVEL 293
           V   + +++  D +SFG+ + E+++G                  A     P  ++D+ +L
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231

Query: 294 MIKCMGKE 301
           + + + ++
Sbjct: 232 LSRLITRD 239

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-32
 Identities = 50/232 (21%), Positives = 96/232 (41%), Gaps = 14/232 (6%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHR 130
              +++ + IGEG +G V       + + VAIKK          Q  + E+  L   +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N++ +    +   ++ +   Y+    +   LY    +  Q L   H         +GL +
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASE 249
           +HS    V+H+D K +N+L++     K+ D GL        D  G  ++  A   + A E
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 250 V-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
           +    + +++  D++S G  L E++S R            D +  ++  +G 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR---PIFPGKHYLDQLNHILGILGS 231

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (298), Expect = 4e-32
 Identities = 53/258 (20%), Positives = 89/258 (34%), Gaps = 42/258 (16%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLAS 126
            ++  D     +++G G F EV      +   LVAIK               +E+  L  
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           I+H N+V L    +     +LI + +  G +   +       +     +    +      
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLD 118

Query: 187 GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
            + +LH     +VH+D K  N+L    DED    ++D GL        V    S      
Sbjct: 119 AVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTP 173

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSSLS 283
            ++A EV   + +S+  D +S GV    L+ G                     E  S   
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233

Query: 284 PDSSQDLVELMIKCMGKE 301
            D S    + +   M K+
Sbjct: 234 DDISDSAKDFIRHLMEKD 251

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (295), Expect = 5e-32
 Identities = 51/261 (19%), Positives = 98/261 (37%), Gaps = 43/261 (16%)

Query: 77  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLA 125
            + SD+     ++G G   EV+    L+    VA+K       R  +    F  E    A
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 126 SIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           ++ H  +V +    +       L +++ EY+   ++   ++     +   +  K  + + 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 117

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 240
             A + L   H     ++H+D K AN+++      KV D G+ R      +    ++ V 
Sbjct: 118 ADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASS 280
               +L+ E         +SDVYS G  L E+++G                        S
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235

Query: 281 SLSPDSSQDLVELMIKCMGKE 301
           +     S DL  +++K + K 
Sbjct: 236 ARHEGLSADLDAVVLKALAKN 256

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  116 bits (291), Expect = 2e-31
 Identities = 53/228 (23%), Positives = 88/228 (38%), Gaps = 16/228 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 132
            +     IGEG +G VYK     G   A+KK              I E+  L  ++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V L           L++E++        L     V    LE     S  L    G+A+ H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
               RV+H+D K  N+L++ +   K+AD GL    G       + ++          +  
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMG 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
            +++S   D++S G    E+V+G          S  D +  + + +G 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT---PLFPGVSEADQLMRIFRILGT 219

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-31
 Identities = 56/266 (21%), Positives = 100/266 (37%), Gaps = 44/266 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 127
                  +G G FG+V +              VA+K        +  +  + E+  L  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 128 QHR-NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYG-----------PSQVSRQKLEF 174
            H  N+V LLG C +      +I E+   G++S +L             P  + +  L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
           +H +  +   AKG+  L S   + +H+D    N+L+ E  + K+ D GL   + +     
Sbjct: 134 EHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS------------- 281
                     ++A E    R ++ +SDV+SFGV L E+ S   +                
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 282 ------LSPDSSQDLVELMIKCMGKE 301
                     ++ ++ + M+ C   E
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGE 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (286), Expect = 1e-30
 Identities = 39/225 (17%), Positives = 74/225 (32%), Gaps = 18/225 (8%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-Q 140
            IG G FG++Y G  +  G  VAIK         +   E      +Q    +  + +C  
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           E +   ++ E +      +  +       +K   K  L +A      + ++HS     +H
Sbjct: 74  EGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSK--NFIH 126

Query: 201 KDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKE 252
           +D K  N L+    +  +  + D GL                    +     + +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKC 297
               S + D+ S G  L+    G      L   + +   E + + 
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 52/269 (19%), Positives = 96/269 (35%), Gaps = 47/269 (17%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQE 116
           F+ E +      +     +G G+F  V K      G+  A K          R G   ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
              EV  L  IQH N++TL    +      LI E +  G +   L       ++ L  + 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEE 114

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGRTDV 232
                     G+ +LH  S ++ H D K  N+++ +        K+ D GL + +   + 
Sbjct: 115 ATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 171

Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---------------- 276
                 +     F+A E+  +     ++D++S GV    L+SG                 
Sbjct: 172 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

Query: 277 ----EASSSLSPDSSQDLVELMIKCMGKE 301
               E       ++S    + + + + K+
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKD 258

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  113 bits (283), Expect = 4e-30
 Identities = 39/230 (16%), Positives = 77/230 (33%), Gaps = 18/230 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVT 134
            ++     IGEG FG +++G  L +   VAIK  P  +   +  DE      +     + 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
            + Y  +  L  ++   +   S+   L     +  +K   K     A      +  +H  
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 195 SPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFLGRTDVAGPSSQVTADEI----- 244
              +V++D K  N L+            V D G+  F                 +     
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELM 294
           +++      R  S + D+ + G   +  + G      L   +++   E +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-29
 Identities = 52/236 (22%), Positives = 87/236 (36%), Gaps = 19/236 (8%)

Query: 75  ATKNFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQE--------FIDEVCFL 124
           A + +     IGEG +G+V+K   L   G  VA+K+      +E         +  +  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALG 183
            + +H N+V L   C  +         +    V         +V    +  +    +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
             +GL  LHS   RVVH+D K  N+LV      K+AD GL             + V    
Sbjct: 125 LLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTL 179

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG 299
            + A EV     ++   D++S G    E+   +         S  D +  ++  +G
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL---FRGSSDVDQLGKILDVIG 232

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-28
 Identities = 36/219 (16%), Positives = 76/219 (34%), Gaps = 13/219 (5%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQ- 140
           ++G G  G+V +    +     A+K     P  +   EV       Q  ++V ++   + 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYEN 76

Query: 141 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
                    ++ E +  G +   +        Q    +    I     + + +LHS+   
Sbjct: 77  LYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHSI--N 131

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           + H+D K  N+L        +       F   T      +       ++A EV    ++ 
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIK 296
           +  D++S GV +  L+ G     S    +    ++  I+
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 3e-28
 Identities = 48/235 (20%), Positives = 90/235 (38%), Gaps = 17/235 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
            +     IG+G FGEV+K    + G  VA+KK              + E+  L  ++H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 132 LVTLLGYCQENNLQFLIYE---YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           +V L+  C+     +   +   Y+        L G       K        +      GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR---TDVAGPSSQVTADEIF 245
            ++H    +++H+D K ANVL+  D + K+AD GL         +     +++V      
Sbjct: 131 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
               +   R +    D++  G  + E+ +       +  ++ Q  + L+ +  G 
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI---MQGNTEQHQLALISQLCGS 240

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-28
 Identities = 51/248 (20%), Positives = 87/248 (35%), Gaps = 32/248 (12%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
            +F    L+G+G FG+V        G   A+K                + E   L + +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             L  L    Q ++    + EY   G +  HL        +    +            L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALE 119

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS    VV++D K  N+++D+D   K+ D GL            +   T +  +LA E
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--YLAPE 175

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS----------------SQDLVEL 293
           V E   +    D +  GV + E++ GR    +   +                 S +   L
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 294 MIKCMGKE 301
           +   + K+
Sbjct: 236 LAGLLKKD 243

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 5e-28
 Identities = 49/242 (20%), Positives = 83/242 (34%), Gaps = 34/242 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASIQ--HRN 131
           L+G G FG VY G+ + D + VAIK                     EV  L  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           ++ LL + +  +   LI E                  R  L+ +   S      + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHC 126

Query: 192 HSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
           H+    V+H+D K  N+L+D +    K+ D G    L  T      +      ++   E 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180

Query: 251 KEFRRF-SEKSDVYSFGVFLLELVSGR----------EASSSLSPDSSQDLVELMIKCMG 299
             + R+    + V+S G+ L ++V G                     S +   L+  C+ 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240

Query: 300 KE 301
             
Sbjct: 241 LR 242

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-26
 Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 16/230 (6%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           + +     IGEG +G V+K    +   +VA+K+              + E+C L  ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V L      +    L++E+                    L+ +   S      KGL  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGF 116

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
            H  S  V+H+D K  N+L++ +   K+A+ GL    G   V   S++V          +
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVL 173

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
              + +S   D++S G    EL +          +   D ++ + + +G 
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGT 221

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 2e-26
 Identities = 55/286 (19%), Positives = 105/286 (36%), Gaps = 37/286 (12%)

Query: 39  TSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL- 97
            ++ GS + SV+       E  +++          L    F     +G G FG V     
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKH 62

Query: 98  LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 151
            + G   A+K             +  ++E   L ++    LV L    ++N+  +++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD 211
           +  G +  HL         +    H    A        +LHSL   ++++D K  N+L+D
Sbjct: 123 VAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLID 175

Query: 212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLE 271
           +    +V D G         V G +  +      LA E+   + +++  D ++ GV + E
Sbjct: 176 QQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 272 LVSGREASSSLSPDS----------------SQDLVELMIKCMGKE 301
           + +G     +  P                  S DL +L+   +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-26
 Identities = 45/236 (19%), Positives = 92/236 (38%), Gaps = 28/236 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
             + D   +G G +G V   +  + G  VAIKK     +     +    E+  L  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 131 NLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           N++ LL     +         +L+  ++      +          +KL       +    
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-------KHEKLGEDRIQFLVYQM 130

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
            KGL ++H+    ++H+D K  N+ V+ED   K+ D GL            +  V     
Sbjct: 131 LKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 184

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGK 300
                +  + R+++  D++S G  + E+++G+   +        D ++ ++K  G 
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK---TLFKGSDHLDQLKEIMKVTGT 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (251), Expect = 3e-25
 Identities = 42/229 (18%), Positives = 93/229 (40%), Gaps = 19/229 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTL 135
           ++     +G GK+ EV++ + + +   V +K       ++   E+  L +++   N++TL
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95

Query: 136 LGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
               ++  +    L++E++ N               Q L             K L + HS
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS 147

Query: 194 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +   ++H+D K  NV++D E    ++ D GL  F         + +V +        + +
Sbjct: 148 M--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVD 203

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMGKE 301
           ++ +    D++S G  L  ++  +E         + D +  + K +G E
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVRIAKVLGTE 250

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 3e-24
 Identities = 53/265 (20%), Positives = 93/265 (35%), Gaps = 42/265 (15%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK-------RPGAPTQEFI 118
           E++ +  +NF    ++G G +G+V+          G L A+K        +    T+   
Sbjct: 19  EKVGI--ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 119 DEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
            E   L  I+    LVTL    Q      LI +YI  G +  HL       R++      
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEV 131

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
                     L HLH L   ++++D K  N+L+D +    + D GL       +      
Sbjct: 132 QIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189

Query: 238 QVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGR-------------------- 276
                E      V+       +  D +S GV + EL++G                     
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249

Query: 277 EASSSLSPDSSQDLVELMIKCMGKE 301
           ++      + S    +L+ + + K+
Sbjct: 250 KSEPPYPQEMSALAKDLIQRLLMKD 274

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 4e-24
 Identities = 52/250 (20%), Positives = 105/250 (42%), Gaps = 32/250 (12%)

Query: 67  FQMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQE 116
           F  +EL+       ++    + +G G +G V      + G+ VA+KK     +     + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQK 171
              E+  L  ++H N++ LL                +  ++    ++      + V  QK
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN------NIVKCQK 117

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L   H   +     +GL ++H  S  ++H+D K +N+ V+ED   K+ D GL        
Sbjct: 118 LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

Query: 232 VAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 290
               +++   A EI L      +  +++  D++S G  + EL++GR   +        D 
Sbjct: 176 TGYVATRWYRAPEIML-----NWMHYNQTVDIWSVGCIMAELLTGR---TLFPGTDHIDQ 227

Query: 291 VELMIKCMGK 300
           ++L+++ +G 
Sbjct: 228 LKLILRLVGT 237

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.4 bits (241), Expect = 7e-24
 Identities = 37/235 (15%), Positives = 80/235 (34%), Gaps = 19/235 (8%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
            +G G F  V+    + +   VA+K  +     T+   DE+  L  +   +         
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 141 ENNLQFLIYEYIPNGSVSI-----------HLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            + L+ L +      +               L    +   + +   +   I+     GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 190 HLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
           ++H     ++H D K  NVL++  D    +    + +           +       + + 
Sbjct: 140 YMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQDLVELMIKCMGK 300
           EV     +   +D++S    + EL++G    E     S     D +  +I+ +G+
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 6e-21
 Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 28/235 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           K + +   IG G  G V           VAIKK     +     +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 131 NLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           N+++LL         +E    +L+ E +      +         + +L+ +    +    
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQM 128

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
             G+ HLH  S  ++H+D K +N++V  D   K+ D GL    G +      +       
Sbjct: 129 LCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 183

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG 299
           + A EV     + E  D++S G  + E+V  +            D    +I+ +G
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK---ILFPGRDYIDQWNKVIEQLG 235

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 7e-17
 Identities = 34/211 (16%), Positives = 63/211 (29%), Gaps = 47/211 (22%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------------QEFIDEVCFLASIQH 129
            L+GEGK   V+    +      +K  + G  +              F       A  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 130 RNLVTLLGYCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
           R L  L G        +    ++ E I    +                 ++   +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
           + +A  +     +VH D    NVLV E+ I  + D            +    +    E  
Sbjct: 114 EEVAKFY--HRGIVHGDLSQYNVLVSEEGI-WIIDFPQ---------SVEVGEEGWRE-I 160

Query: 246 LASEVKEF-----RRFSEKSDVYSFGVFLLE 271
           L  +V+       R +  + D+ S    +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	302
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.53
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.97
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.6
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.51

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=373.61  Aligned_cols=218  Identities=23%  Similarity=0.340  Sum_probs=188.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|++.+.||+|+||+||+|... +++.||+|.+...    ..+++.+|++++++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46889999999999999999975 5899999975432    234688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      |++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        85 ~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999983     34578999999999999999999999  679999999999999999999999999999876544


Q ss_pred             CCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC-------------------CChhhHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSP-------------------DSSQDLV  291 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~~~~-------------------~~~~~l~  291 (302)
                      .........||+.|+|||++.+..| +.++||||+||++|||++|+.||.....                   ..++++.
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence            4444556789999999999988876 5689999999999999999999975321                   2356778


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+||.++
T Consensus       238 ~li~~~L~~d  247 (271)
T d1nvra_         238 ALLHKILVEN  247 (271)
T ss_dssp             HHHHHHSCSS
T ss_pred             HHHHHHcCCC
Confidence            9999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=373.68  Aligned_cols=219  Identities=29%  Similarity=0.482  Sum_probs=180.2

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +..++|++.+.||+|+||+||+|+.+  ..||||.+...     ..+.+.+|++++++++||||+++++++.+ +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            34578999999999999999999864  35999986432     23578899999999999999999998764 567999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ||||++|+|.+++..    ....+++..+..++.||+.||+|||+  ++||||||||+|||+++++.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999999843    34568999999999999999999999  679999999999999999999999999998876


Q ss_pred             CCCCCCCCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------  283 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------  283 (302)
                      ............||+.|+|||++.+   ..|+.++|||||||++|||+||+.||...+                      
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            5443334456678999999999864   358999999999999999999999997532                      


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      .+.++++.++|.+||..+
T Consensus       236 ~~~~~~l~~li~~cl~~d  253 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKK  253 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSS
T ss_pred             ccchHHHHHHHHHHcCCC
Confidence            244678999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=366.67  Aligned_cols=214  Identities=25%  Similarity=0.383  Sum_probs=189.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|+.. +++.||+|.+.      ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999975 58899999753      334567889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++|+|.+++.     ....+++..+..++.||+.||+|||+  ++||||||||+|||+++++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999983     34568999999999999999999999  6799999999999999999999999999986543


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~~  293 (302)
                      .    ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                +...++++.++
T Consensus       159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  234 (263)
T d2j4za1         159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL  234 (263)
T ss_dssp             C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred             C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            2    234567999999999999999999999999999999999999999843                23456788999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.++
T Consensus       235 i~~~L~~d  242 (263)
T d2j4za1         235 ISRLLKHN  242 (263)
T ss_dssp             HHHHTCSS
T ss_pred             HHHHccCC
Confidence            99999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=369.51  Aligned_cols=215  Identities=21%  Similarity=0.380  Sum_probs=188.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecC---CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ++|+..+.||+|+||+||+|.. .+|+.||+|.+.   ....+.+.+|++++++++||||+++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999996 468999999753   234567899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++.      ...+++..+..++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+|+.+.....
T Consensus       100 ~gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999998762      3468999999999999999999999  6799999999999999999999999999987654322


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhhHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQDLVEL  293 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~l~~~  293 (302)
                        ......||+.|+|||++.+..|+.++|||||||++|||++|+.||....                   ...++++.++
T Consensus       172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (293)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred             --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence              2345679999999999999999999999999999999999999997432                   2235678899


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.++
T Consensus       250 i~~~L~~d  257 (293)
T d1yhwa1         250 LNRCLDMD  257 (293)
T ss_dssp             HHHHTCSS
T ss_pred             HHHHccCC
Confidence            99999876

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=371.78  Aligned_cols=218  Identities=18%  Similarity=0.245  Sum_probs=187.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|... +++.||+|.+.      ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46899999999999999999975 68999999753      334567899999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++|+|.+++.     ....+++..+..++.|++.||+|||+  ++||||||||+|||+++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999998873     44678999999999999999999999  6799999999999999999999999999998765


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~~  293 (302)
                      ...........||+.|+|||++.+..|+.++||||+||++|||++|+.||...                +...++++.++
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL  240 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            44444445567999999999999999999999999999999999999999743                23456788889


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+||.++
T Consensus       241 i~~~L~~d  248 (288)
T d1uu3a_         241 VEKLLVLD  248 (288)
T ss_dssp             HHTTSCSS
T ss_pred             HHHHccCC
Confidence            99998765

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-54  Score=364.32  Aligned_cols=218  Identities=29%  Similarity=0.451  Sum_probs=179.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      ++|+..+.||+|+||+||+|.+.++..||||+++..  ..+++.+|++++++++||||++++|+|..++..++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            568888999999999999999988889999986543  456799999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~  234 (302)
                      |+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++........ 
T Consensus        85 g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          85 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            999998843    34568899999999999999999999  67999999999999999999999999999877543322 


Q ss_pred             CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhC-CCCCCCC-----------------CCCChhhHHHHHHH
Q 022118          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSL-----------------SPDSSQDLVELMIK  296 (302)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g-~~p~~~~-----------------~~~~~~~l~~~~~~  296 (302)
                      ......+|..|+|||++.+..|+.++|||||||++|||+|+ ++||...                 +...++++.+++.+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            23345688999999999999999999999999999999995 5555532                 24557889999999


Q ss_pred             Hhhcc
Q 022118          297 CMGKE  301 (302)
Q Consensus       297 ~~~~~  301 (302)
                      ||.++
T Consensus       238 cl~~~  242 (263)
T d1sm2a_         238 CWKER  242 (263)
T ss_dssp             HTCSS
T ss_pred             HccCC
Confidence            99876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-54  Score=372.14  Aligned_cols=224  Identities=27%  Similarity=0.451  Sum_probs=191.2

Q ss_pred             HHHHhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        72 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      +++..++|+..+.||+|+||+||+|.+. ++..||+|+++..  ..+++.+|+++|++++|||||++++++.+++..++|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            3345567888899999999999999976 4889999986543  456799999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ||||++|+|.+++..   .....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+|+...
T Consensus        92 ~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          92 TEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            999999999998843   234678999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC------------------CCCCChhhH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS------------------LSPDSSQDL  290 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~------------------~~~~~~~~l  290 (302)
                      ..... ......++..|+|||++.+..|+.++|||||||++|||++|..||..                  .+...++++
T Consensus       167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  245 (287)
T d1opja_         167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  245 (287)
T ss_dssp             SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence            43222 12334578889999999999999999999999999999997766542                  123567889


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||..+
T Consensus       246 ~~li~~cl~~d  256 (287)
T d1opja_         246 YELMRACWQWN  256 (287)
T ss_dssp             HHHHHHHTCSS
T ss_pred             HHHHHHHcCCC
Confidence            99999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-54  Score=365.93  Aligned_cols=222  Identities=27%  Similarity=0.461  Sum_probs=188.3

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++..++|++.+.||+|+||+||+|.++++..||||.+...  ..+.+.+|++++++++|||||+++|++.+ +..++|||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            3445678889999999999999999988889999986543  45679999999999999999999998764 56799999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+++|+|.+++..   .....+++..++.++.||+.||.|||+  ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        88 y~~~g~L~~~~~~---~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTS---HHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999988743   233468999999999999999999999  67999999999999999999999999999987653


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCC-CCCC-----------------CCCCChhhHHH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE-ASSS-----------------LSPDSSQDLVE  292 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~-p~~~-----------------~~~~~~~~l~~  292 (302)
                      ... ......+|+.|+|||++.+..|+.++|||||||++|||+||.. |+..                 .++..++++.+
T Consensus       163 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence            322 2334568889999999999999999999999999999999654 4442                 12456788999


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+||..+
T Consensus       242 li~~cl~~~  250 (272)
T d1qpca_         242 LMRLCWKER  250 (272)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHcCCC
Confidence            999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=355.50  Aligned_cols=219  Identities=27%  Similarity=0.455  Sum_probs=192.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCC--CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      .++|+..+.||+|+||+||+|+++++..||+|.++.  ...+++.+|+.++++++||||++++|++.+++..++||||++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            368999999999999999999998888999997543  455789999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|..++..    ....+++..+.+++.|+++||+|||+  ++|+||||||+|||+++++.+||+|||+++.+......
T Consensus        83 ~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          83 NGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999988742    34568889999999999999999999  67999999999999999999999999999877654332


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~  295 (302)
                       ......+|..|+|||.+.+..|+.++|||||||++|||+| |+.||...                 +...+.++.+++.
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence             2344678899999999999999999999999999999998 89999853                 2455678999999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||.++
T Consensus       236 ~cl~~d  241 (258)
T d1k2pa_         236 SCWHEK  241 (258)
T ss_dssp             HTTCSS
T ss_pred             HHccCC
Confidence            999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=364.69  Aligned_cols=222  Identities=23%  Similarity=0.358  Sum_probs=176.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEee--CCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv  148 (302)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|.+....     .+.+.+|++++++++||||+++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56889999999999999999965 58999999865433     2457899999999999999999999864  4567999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC---CCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ||||++|+|.+++.... .....+++..++.++.|++.||+|||+.+   .+||||||||+|||+++++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999884321 13457899999999999999999999732   349999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC-----------------CCCChh
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~-----------------~~~~~~  288 (302)
                      .......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...                 +...++
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  240 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD  240 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            8754322  233567899999999999999999999999999999999999999743                 234567


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||..+
T Consensus       241 ~l~~li~~~L~~d  253 (269)
T d2java1         241 ELNEIITRMLNLK  253 (269)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHcCCC
Confidence            8999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=375.80  Aligned_cols=197  Identities=21%  Similarity=0.298  Sum_probs=173.4

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..++|++.+.||+|+||+||+|... +++.||+|..+..    ..+++.+|+.+|++++|||||++++++.+++..|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567999999999999999999965 6899999975432    2456889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++|+|.+++.     ....+++..+..++.|++.||.|||+. ++|+||||||+|||+++++.+||+|||+|+...+
T Consensus        84 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999983     345689999999999999999999962 3699999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..    .....||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus       158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            22    2356899999999999999999999999999999999999999964

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-53  Score=365.88  Aligned_cols=220  Identities=27%  Similarity=0.481  Sum_probs=177.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .++|+..+.||+|+||+||+|.+..    ...||+|......    .++|.+|+++|++++|||||+++|++.+++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3567778999999999999998653    2368999865443    2468899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      |||||++|+|.+++..    ....+++.+++.++.||+.||+|||+  ++|+||||||+|||+++++++||+|||+++.+
T Consensus       105 v~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccceEc
Confidence            9999999999998742    34568999999999999999999999  67999999999999999999999999999877


Q ss_pred             CCCCCCC---CCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCC
Q 022118          228 GRTDVAG---PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDS  286 (302)
Q Consensus       228 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~  286 (302)
                      .......   ......+|+.|+|||.+.+..|+.++|||||||++|||+| |+.||...                 +.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            5432211   1223457889999999999999999999999999999998 89999743                 2356


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      +.++.+++.+||.++
T Consensus       259 ~~~l~~li~~cl~~~  273 (299)
T d1jpaa_         259 PSALHQLMLDCWQKD  273 (299)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             hHHHHHHHHHHcCCC
Confidence            788999999999876

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=365.90  Aligned_cols=217  Identities=25%  Similarity=0.371  Sum_probs=185.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +.|++.+.||+|+||+||+|... ++..||+|.++..   ..+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888899999999999999975 5889999986443   3356889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++..    ....+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        92 ~~g~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             TTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999988732    24568999999999999999999999  6799999999999999999999999999976533211


Q ss_pred             CCCCccccCcccccchhhhc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChh
Q 022118          233 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQ  288 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~  288 (302)
                        ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||....                   ...++
T Consensus       166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             --cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence              123457899999999984     5568999999999999999999999997532                   23357


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||.++
T Consensus       244 ~~~~li~~~L~~d  256 (288)
T d2jfla1         244 NFKDFLKKCLEKN  256 (288)
T ss_dssp             HHHHHHHHHSCSS
T ss_pred             HHHHHHHHHccCC
Confidence            8899999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=364.51  Aligned_cols=212  Identities=28%  Similarity=0.421  Sum_probs=183.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ..|+..+.||+|+||+||+|... ++..||+|.+....      .+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34888999999999999999965 58899999864332      235789999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++|+|..++     .....+++..+..++.||+.||.|||+  ++||||||||+|||+++++.+||+|||+|+....
T Consensus        95 E~~~~g~l~~~~-----~~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHH-----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999987665     234678999999999999999999999  6799999999999999999999999999986543


Q ss_pred             CCCCCCCccccCcccccchhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------CCChh
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLS------------------PDSSQ  288 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------~~~~~  288 (302)
                            .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||....                  ...++
T Consensus       168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~  241 (309)
T d1u5ra_         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE  241 (309)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred             ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH
Confidence                  234579999999999864   468999999999999999999999997432                  23467


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||.++
T Consensus       242 ~~~~li~~~L~~d  254 (309)
T d1u5ra_         242 YFRNFVDSCLQKI  254 (309)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHCcCC
Confidence            8999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=365.77  Aligned_cols=217  Identities=23%  Similarity=0.275  Sum_probs=190.9

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      .++|++.+.||+|+||+||+|+.. +++.||+|.++      ....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            357899999999999999999964 68999999754      33456788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ||||++|+|.+++.     ....+++..+..++.|++.||+|||+  ++||||||||+|||++++|.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~-----~~~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhh-----cccCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999883     45678899999999999999999999  679999999999999999999999999998754


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~  292 (302)
                      ...  ......+||+.|+|||++.+..|+.++||||+||++|||++|++||...                +...+++..+
T Consensus       157 ~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~d  234 (337)
T d1o6la_         157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence            322  2234568999999999999999999999999999999999999999753                3456778899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++.+|+.++
T Consensus       235 li~~~L~~d  243 (337)
T d1o6la_         235 LLAGLLKKD  243 (337)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHhhccCC
Confidence            999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=356.61  Aligned_cols=212  Identities=26%  Similarity=0.395  Sum_probs=177.8

Q ss_pred             CcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEee----CCeeeEEE
Q 022118           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY  149 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~  149 (302)
                      +..+.||+|+||+||+|... ++..||+|.+...     ..+.+.+|+++|++++||||+++++++.+    ++..|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999975 5889999975322     23468899999999999999999999875    34579999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~-~~~~~kl~DfGla~~~~  228 (302)
                      |||++|+|.+++.     ....+++..+..++.||+.||+|||+.+.+|+||||||+|||++ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHh-----ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999983     34578999999999999999999998444599999999999996 57899999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCChhh
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDSSQD  289 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~~~~  289 (302)
                      ..    ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||....                   ...+++
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence            32    2345679999999999865 69999999999999999999999997432                   134567


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||.++
T Consensus       242 ~~~li~~~l~~d  253 (270)
T d1t4ha_         242 VKEIIEGCIRQN  253 (270)
T ss_dssp             HHHHHHHHSCSS
T ss_pred             HHHHHHHHccCC
Confidence            899999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=359.81  Aligned_cols=218  Identities=28%  Similarity=0.462  Sum_probs=184.6

Q ss_pred             cCCCcCC-eeeeCCCeeEEEEEEc---CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|...+ .||+|+||+||+|.+.   ++..||||.++...    .+++.+|+++|++++|||||+++|++.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455556 4999999999999754   35679999865433    2468899999999999999999999865 467999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      ||||++|+|.+++..    .+..+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++.+.
T Consensus        87 mE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999998732    34578999999999999999999999  679999999999999999999999999999876


Q ss_pred             CCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhh
Q 022118          229 RTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~  289 (302)
                      .... ........+|+.|+|||++.+..|+.++|||||||++|||+| |+.||...                 ++..+++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  240 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  240 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            5432 223345568899999999999999999999999999999998 99999743                 2456788


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.++|.+||.++
T Consensus       241 l~~li~~cl~~~  252 (285)
T d1u59a_         241 LYALMSDCWIYK  252 (285)
T ss_dssp             HHHHHHHTTCSS
T ss_pred             HHHHHHHHcCCC
Confidence            999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-52  Score=364.22  Aligned_cols=216  Identities=22%  Similarity=0.300  Sum_probs=173.7

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      .+.|++.+.||+|+||+||+|... +++.||+|.+...    ....+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356899999999999999999975 5889999985432    23457799999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEccccccccc
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFL  227 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~---~~~~~kl~DfGla~~~  227 (302)
                      ||++|+|.+++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||++   +++.+||+|||+|+..
T Consensus        88 ~~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHH-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhh-----cccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999983     34678999999999999999999999  6799999999999994   5789999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCCh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSS  287 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~  287 (302)
                      ....   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||....                    ++.+
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  237 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS  237 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence            5432   2334679999999999999999999999999999999999999997421                    2446


Q ss_pred             hhHHHHHHHHhhcc
Q 022118          288 QDLVELMIKCMGKE  301 (302)
Q Consensus       288 ~~l~~~~~~~~~~~  301 (302)
                      +++.+++.+||.++
T Consensus       238 ~~~~~li~~~L~~d  251 (307)
T d1a06a_         238 DSAKDFIRHLMEKD  251 (307)
T ss_dssp             HHHHHHHHHHSCSS
T ss_pred             HHHHHHHHHHccCC
Confidence            78899999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=369.18  Aligned_cols=226  Identities=25%  Similarity=0.388  Sum_probs=188.4

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcC------CcEEEEEecCCC----ChHHHHHHHHHhccC-CCCceeeEEeEEeeC
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~----~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~  142 (302)
                      +..++|++.+.||+|+||+||+|+...      ...||+|.....    ....+.+|+.+++++ +|||||++++++.++
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            445678899999999999999998542      236999975432    345688999999988 899999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCcC------------------CCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQV------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  204 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlk  204 (302)
                      +..|+|||||++|+|.+++......                  ....+++..++.++.|++.||+|||+  ++|||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDlK  191 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLA  191 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCS
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCc
Confidence            9999999999999999999543211                  12458899999999999999999999  679999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022118          205 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS  283 (302)
Q Consensus       205 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~  283 (302)
                      |+|||++.++.+||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |+.||...+
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654433322334567899999999999999999999999999999998 899997532


Q ss_pred             ------------------CCChhhHHHHHHHHhhcc
Q 022118          284 ------------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ------------------~~~~~~l~~~~~~~~~~~  301 (302)
                                        ...++++.++|.+||..+
T Consensus       272 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~d  307 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD  307 (325)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence                              355788999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.3e-52  Score=360.99  Aligned_cols=213  Identities=22%  Similarity=0.359  Sum_probs=188.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|.+.      ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56889999999999999999974 58999999753      334567889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      |||++|+|..++     .....+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 E~~~gg~l~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHH-----HHTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccc-----cccccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999998887     345667888889999999999999998  6799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~~  293 (302)
                      .     .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...                ++..++++.++
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  231 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL  231 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            2     23467999999999999999999999999999999999999999743                23456788999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.++
T Consensus       232 i~~~L~~d  239 (316)
T d1fota_         232 LSRLITRD  239 (316)
T ss_dssp             HHHHTCSC
T ss_pred             HHHHhhhC
Confidence            99998765

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=358.02  Aligned_cols=211  Identities=25%  Similarity=0.416  Sum_probs=177.6

Q ss_pred             CeeeeCCCeeEEEEEEcC---CcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccCC
Q 022118           83 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  154 (302)
                      +.||+|+||+||+|.+..   ++.||+|.++...     .+++.+|+++|++++||||++++|+|.. +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   4689999865332     3468999999999999999999999865 457899999999


Q ss_pred             CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 022118          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  233 (302)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~-~  233 (302)
                      |+|.+++.     ....+++..+..++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++....... .
T Consensus        92 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh-----hccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999883     34568999999999999999999999  6799999999999999999999999999987654322 2


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~l~~~~~  295 (302)
                      .......||+.|+|||.+.+..|+.++|||||||++|||+| |+.||...                 +...+.++.++|.
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence            22344578899999999999999999999999999999998 89999743                 2456788999999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..+
T Consensus       245 ~cl~~d  250 (277)
T d1xbba_         245 LCWTYD  250 (277)
T ss_dssp             HHTCSS
T ss_pred             HHcCCC
Confidence            999876

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=353.83  Aligned_cols=219  Identities=28%  Similarity=0.481  Sum_probs=177.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCC-----cEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      +.|+..++||+|+||.||+|.+...     ..||||.+.....    .++.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577789999999999999986532     4799998754432    358899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      ||||+.+|++.+.+.    .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        87 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHH----HTTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhh----cccccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999988773    234578999999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC------------------CCCCChh
Q 022118          228 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS------------------LSPDSSQ  288 (302)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~------------------~~~~~~~  288 (302)
                      ..... ........||..|+|||++.+..|+.++|||||||++|||++|..|+..                  .+.+.+.
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence            54322 1223345688899999999999999999999999999999996655432                  2345678


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.+++.+||.++
T Consensus       241 ~l~~li~~cl~~~  253 (283)
T d1mqba_         241 AIYQLMMQCWQQE  253 (283)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHCcCC
Confidence            8999999999876

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-51  Score=361.68  Aligned_cols=216  Identities=23%  Similarity=0.314  Sum_probs=187.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh---HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ++|++.+.||+|+||+||+|... +|..||+|.+.....   +.+.+|+.++++++||||+++++++.+++..|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999965 689999998765443   45789999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccccccCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~--~~~~~kl~DfGla~~~~~~  230 (302)
                      ++|+|.+++..    ....+++..+..++.||+.||+|||+  ++||||||||+|||++  .++.+||+|||+++.+...
T Consensus       106 ~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999998842    24568999999999999999999999  6799999999999995  4689999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l  290 (302)
                      .   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+                    ...++++
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  256 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  256 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            2   2345678999999999999999999999999999999999999997532                    1235678


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||.+|
T Consensus       257 ~~li~~~L~~d  267 (350)
T d1koaa2         257 KDFIRKLLLAD  267 (350)
T ss_dssp             HHHHHHHCCSS
T ss_pred             HHHHHHHccCC
Confidence            88999998775

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.2e-51  Score=361.27  Aligned_cols=216  Identities=21%  Similarity=0.308  Sum_probs=187.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC---hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ++|++.+.||+|+||+||+|... +|..||+|.+....   ...+.+|++++++++||||+++++++.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46899999999999999999964 68999999865443   245788999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccccccCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~--~~~~~kl~DfGla~~~~~~  230 (302)
                      ++|+|.+++..    ....+++..+..++.||+.||+|||+  ++||||||||+|||++  .++.+||+|||+|+.....
T Consensus       109 ~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999887732    34568999999999999999999998  6799999999999997  6789999999999887543


Q ss_pred             CCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhH
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDL  290 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l  290 (302)
                      .   ......+|+.|+|||++.+..|+.++||||+||++|||++|+.||....                    ...++++
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            2   2345678899999999999999999999999999999999999997532                    2346778


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||.++
T Consensus       260 ~~li~~~L~~d  270 (352)
T d1koba_         260 KDFIKNLLQKE  270 (352)
T ss_dssp             HHHHHTTSCSS
T ss_pred             HHHHHHHccCC
Confidence            89999998765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=352.66  Aligned_cols=216  Identities=22%  Similarity=0.300  Sum_probs=186.8

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||+||+|... +|+.||+|.++..         ..+.+.+|+.+|++++||||+++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            356899999999999999999975 6899999974321         246789999999999999999999999999999


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA  221 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~----~~kl~Df  221 (302)
                      |+|||||++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++    .+|++||
T Consensus        89 ~iv~E~~~gg~L~~~i~-----~~~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhc-----cccccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999983     34578999999999999999999999  6799999999999998776    5999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC------------------
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS------------------  283 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~------------------  283 (302)
                      |+++......   ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||...+                  
T Consensus       162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            9998765432   2334568889999999999999999999999999999999999997532                  


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        +..+.++.+++.+||.++
T Consensus       239 ~~~~~s~~~~~li~~~L~~d  258 (293)
T d1jksa_         239 YFSNTSALAKDFIRRLLVKD  258 (293)
T ss_dssp             HHTTSCHHHHHHHHTTSCSS
T ss_pred             hcCCCCHHHHHHHHHHccCC
Confidence              234567788999998765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-51  Score=360.65  Aligned_cols=213  Identities=21%  Similarity=0.284  Sum_probs=189.3

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  149 (302)
                      ++|++.+.||+|+||+||+|++. +|+.||+|.+.      ....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46899999999999999999975 68999999753      234567889999999999999999999999999999999


Q ss_pred             eccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 022118          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (302)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~  229 (302)
                      ||+.+|+|..++.     ....+++..+..++.||+.||.|||+  .+||||||||+|||++.++.+||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~-----~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999998883     34568999999999999999999999  6799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC----------------CCCChhhHHHH
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL----------------SPDSSQDLVEL  293 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~----------------~~~~~~~l~~~  293 (302)
                      .     .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...                +...++++.++
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  268 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL  268 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence            2     33567999999999999999999999999999999999999999853                23456789999


Q ss_pred             HHHHhhcc
Q 022118          294 MIKCMGKE  301 (302)
Q Consensus       294 ~~~~~~~~  301 (302)
                      +.+|+.++
T Consensus       269 i~~~L~~d  276 (350)
T d1rdqe_         269 LRNLLQVD  276 (350)
T ss_dssp             HHHHSCSC
T ss_pred             HHHHhhhC
Confidence            99999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-52  Score=354.55  Aligned_cols=220  Identities=29%  Similarity=0.485  Sum_probs=181.0

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC--hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      ..++|++.+.||+|+||+||+|...++..||+|.++...  .+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            345788999999999999999999888889999875443  467999999999999999999999985 45689999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|..++..   .....+++..++.++.||+.||+|||+  ++|+||||||+|||+++++++||+|||+++.......
T Consensus        94 ~~g~l~~~~~~---~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSH---HHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCchhhhhhh---cccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999988743   223568999999999999999999999  6799999999999999999999999999987654332


Q ss_pred             CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCC-CC-----------------CCCCChhhHHHHH
Q 022118          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS-SS-----------------LSPDSSQDLVELM  294 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~-~~-----------------~~~~~~~~l~~~~  294 (302)
                      . ......+|+.|+|||.+....++.++|||||||++|||++|..|| ..                 .+...++++.+++
T Consensus       169 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         169 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             e-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence            2 233456889999999999999999999999999999999965554 32                 2345678899999


Q ss_pred             HHHhhcc
Q 022118          295 IKCMGKE  301 (302)
Q Consensus       295 ~~~~~~~  301 (302)
                      .+||..+
T Consensus       248 ~~cl~~d  254 (285)
T d1fmka3         248 CQCWRKE  254 (285)
T ss_dssp             HHHTCSS
T ss_pred             HHHcccC
Confidence            9999765

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-51  Score=355.49  Aligned_cols=230  Identities=28%  Similarity=0.426  Sum_probs=192.0

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEE
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYC  139 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~  139 (302)
                      .+++.+.++|++.+.||+|+||+||+|+..      ++..||||+++...    .+++.+|++++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344556778999999999999999999864      35789999876543    34689999999999999999999999


Q ss_pred             eeCCeeeEEEeccCCCCccccccCCC-------------------cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 022118          140 QENNLQFLIYEYIPNGSVSIHLYGPS-------------------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH  200 (302)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivH  200 (302)
                      .+.+..+++|||+++|+|.+++....                   ......+++..++.++.|++.||+|||+  ++|||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivH  163 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVH  163 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEe
Confidence            99999999999999999999884321                   1123458899999999999999999998  67999


Q ss_pred             cCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCC-CCC
Q 022118          201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EAS  279 (302)
Q Consensus       201 rdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~-~p~  279 (302)
                      |||||+|||+|.++.+||+|||+|+...............+++.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998775544444444567888999999999999999999999999999999996 567


Q ss_pred             CCC-----------------CCCChhhHHHHHHHHhhcc
Q 022118          280 SSL-----------------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       280 ~~~-----------------~~~~~~~l~~~~~~~~~~~  301 (302)
                      ...                 +...++++.+++.+||..+
T Consensus       244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~  282 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL  282 (301)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCC
Confidence            632                 3456788999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-50  Score=358.71  Aligned_cols=214  Identities=22%  Similarity=0.312  Sum_probs=183.5

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC------ChHHHHH---HHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFID---EVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~---E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|.+...      ....+.+   |+.+++.++||||+++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999975 5899999976422      2222333   477888899999999999999999999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +|||||++|+|.+++.     ....+++..+..++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHH-----hcccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999983     34567889999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------CCC
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------PDS  286 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------~~~  286 (302)
                      .....    .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||....                   ...
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF  232 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSS
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Confidence            65432    344579999999999874 578999999999999999999999997422                   345


Q ss_pred             hhhHHHHHHHHhhcc
Q 022118          287 SQDLVELMIKCMGKE  301 (302)
Q Consensus       287 ~~~l~~~~~~~~~~~  301 (302)
                      ++++.+++.+||.++
T Consensus       233 s~~~~~li~~~L~~d  247 (364)
T d1omwa3         233 SPELRSLLEGLLQRD  247 (364)
T ss_dssp             CHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHcccC
Confidence            678899999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=351.32  Aligned_cols=216  Identities=24%  Similarity=0.367  Sum_probs=187.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecC------CCChHHHHHHHHHhc-cCCCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLA-SIQHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|++.+.||+|+||+||+|... +++.||+|.+.      ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888999999999999999975 58999999864      334456777777765 68999999999999999999999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~  228 (302)
                      |||+++|+|.+++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~-----~~~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999983     44668899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------CCChhhHHH
Q 022118          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------PDSSQDLVE  292 (302)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------~~~~~~l~~  292 (302)
                      ...  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+                ...+.++.+
T Consensus       155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~d  232 (320)
T d1xjda_         155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  232 (320)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            332  22344678999999999999999999999999999999999999997532                344678899


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      ++++||.++
T Consensus       233 li~~~L~~d  241 (320)
T d1xjda_         233 LLVKLFVRE  241 (320)
T ss_dssp             HHHHHSCSS
T ss_pred             HHHHhcccC
Confidence            999999765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=353.87  Aligned_cols=218  Identities=29%  Similarity=0.481  Sum_probs=181.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CC----cEEEEEecCC----CChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DG----MLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  147 (302)
                      .+|+..+.||+|+||+||+|.+. +|    .+||+|++..    ...+++.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999864 33    3689997543    2346789999999999999999999999865 5678


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +|||+.+|+|.+++.    .....+++..++.++.||+.||+|||+  ++||||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHH----HTSSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccc----ccccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            899999999988873    235678999999999999999999999  67999999999999999999999999999987


Q ss_pred             CCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChhh
Q 022118          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQD  289 (302)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~~  289 (302)
                      .............||+.|+|||.+.+..|+.++|||||||++|||+| |++||...                 ++..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            65444444455678999999999999999999999999999999998 78898743                 2355678


Q ss_pred             HHHHHHHHhhcc
Q 022118          290 LVELMIKCMGKE  301 (302)
Q Consensus       290 l~~~~~~~~~~~  301 (302)
                      +.+++.+||..+
T Consensus       242 ~~~li~~cl~~d  253 (317)
T d1xkka_         242 VYMIMVKCWMID  253 (317)
T ss_dssp             HHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCC
Confidence            999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-51  Score=348.86  Aligned_cols=219  Identities=29%  Similarity=0.476  Sum_probs=174.9

Q ss_pred             HhcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCeee
Q 022118           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        75 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  146 (302)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|..+....    +.+.+|++++++++||||++++|++. ++..|
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            34578889999999999999998642    45799998754432    45889999999999999999999986 46789


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                      +||||+++|+|.+++.    .....+++..++.++.||+.||+|||+  ++|+||||||+||++++++.+||+|||+|+.
T Consensus        84 iv~E~~~~g~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEECCTTEEHHHHHH----HTTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEeccCCcHHhhhh----ccCCCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhhee
Confidence            9999999999998863    234568999999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC-----------------CCCChh
Q 022118          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL-----------------SPDSSQ  288 (302)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~-----------------~~~~~~  288 (302)
                      ....... ......+|+.|+|||.+.+..|+.++|||||||++|||++ |.+||...                 ++..++
T Consensus       158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            6543322 2344568889999999999999999999999999999998 89998743                 245678


Q ss_pred             hHHHHHHHHhhcc
Q 022118          289 DLVELMIKCMGKE  301 (302)
Q Consensus       289 ~l~~~~~~~~~~~  301 (302)
                      ++.++|.+||..+
T Consensus       237 ~~~~li~~cl~~d  249 (273)
T d1mp8a_         237 TLYSLMTKCWAYD  249 (273)
T ss_dssp             HHHHHHHHHTCSS
T ss_pred             HHHHHHHHHcCCC
Confidence            8999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-50  Score=344.23  Aligned_cols=219  Identities=21%  Similarity=0.307  Sum_probs=179.6

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------hHHHHHHHHHhccCCCCceeeEEeEEeeCC----e
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENN----L  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~  144 (302)
                      .++|++.+.||+|+||+||+|... +++.||+|.++...      .+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            356999999999999999999964 68999999865432      235789999999999999999999998654    3


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+||||+++|+|..++.     ....+++.++..++.||+.||+|||+  ++||||||||+|||++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhc-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhh
Confidence            789999999999998872     34578999999999999999999998  67999999999999999999999999998


Q ss_pred             cccCCCC-CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------
Q 022118          225 NFLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------  283 (302)
Q Consensus       225 ~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------  283 (302)
                      +...... .........||+.|+|||++.+..|+.++|||||||++|||+||+.||....                    
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            7654332 2223445679999999999999999999999999999999999999997532                    


Q ss_pred             CCChhhHHHHHHHHhhcc
Q 022118          284 PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ~~~~~~l~~~~~~~~~~~  301 (302)
                      ++.++++.+++++|+.++
T Consensus       239 ~~~s~~l~~li~~~L~~d  256 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKN  256 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSS
T ss_pred             cCCCHHHHHHHHHHccCC
Confidence            244678899999999775

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.4e-50  Score=342.01  Aligned_cols=215  Identities=23%  Similarity=0.351  Sum_probs=185.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC------------hHHHHHHHHHhccCC-CCceeeEEeEEeeC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQEN  142 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~  142 (302)
                      ++|++.+.||+|+||+||+|+.. +++.+|+|.++...            .+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57889999999999999999964 68899999754322            124788999999997 99999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfG  222 (302)
                      +..|+|||||++|+|.+++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999993     34578999999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcc------CCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------
Q 022118          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLS-------------  283 (302)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------  283 (302)
                      +++.+....   ......||+.|+|||.+.+      ..|+.++||||+||++|||++|+.||...+             
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~  232 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  232 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence            998875532   2345678999999998863      357889999999999999999999998543             


Q ss_pred             -------CCChhhHHHHHHHHhhcc
Q 022118          284 -------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -------~~~~~~l~~~~~~~~~~~  301 (302)
                             ...++++.+++.+||.++
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~~  257 (277)
T d1phka_         233 QFGSPEWDDYSDTVKDLVSRFLVVQ  257 (277)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSS
T ss_pred             CCCCcccccCCHHHHHHHHHHccCC
Confidence                   134567889999999876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=341.23  Aligned_cols=215  Identities=32%  Similarity=0.461  Sum_probs=177.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-hHHHHHHHHHhccCCCCceeeEEeEEee-CCeeeEEEeccC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIP  153 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~  153 (302)
                      .++|+..+.||+|+||.||+|..+ |..||+|.++... .+.+.+|++++++++||||++++|++.+ ++..|+||||++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            456778899999999999999985 7889999876543 5679999999999999999999999865 456799999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~~  233 (302)
                      +|+|.+++...   ....+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+|++|||+++.....   
T Consensus        85 ~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          85 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999998421   23458999999999999999999999  67999999999999999999999999999865432   


Q ss_pred             CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-----------------CCChhhHHHHHH
Q 022118          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS-----------------PDSSQDLVELMI  295 (302)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~-----------------~~~~~~l~~~~~  295 (302)
                        .....+|..|+|||.+.+..|++++|||||||++|||+| |++||...+                 ...++++.++++
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence              233457788999999999999999999999999999998 788887432                 345688999999


Q ss_pred             HHhhcc
Q 022118          296 KCMGKE  301 (302)
Q Consensus       296 ~~~~~~  301 (302)
                      +||..|
T Consensus       235 ~cl~~d  240 (262)
T d1byga_         235 NCWHLD  240 (262)
T ss_dssp             HHTCSS
T ss_pred             HHcccC
Confidence            999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=347.74  Aligned_cols=230  Identities=24%  Similarity=0.375  Sum_probs=180.8

Q ss_pred             HHHHHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEEeE
Q 022118           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGY  138 (302)
Q Consensus        70 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~  138 (302)
                      .++++..++|++.+.||+|+||.||+|...      +++.||+|.+.....    +.+.+|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344455678999999999999999999853      246899998764432    3467788877766 78999999999


Q ss_pred             EeeC-CeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 022118          139 CQEN-NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA  206 (302)
Q Consensus       139 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~  206 (302)
                      +.++ +..++|||||++|+|.+++.....           .....+++..++.++.||+.||+|||+  ++||||||||+
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~  163 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR  163 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCcc
Confidence            8765 467999999999999999853321           123458899999999999999999999  67999999999


Q ss_pred             CeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhC-CCCCCCCC--
Q 022118          207 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLS--  283 (302)
Q Consensus       207 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g-~~p~~~~~--  283 (302)
                      |||+++++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++| .+||....  
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999877655444445567899999999999999999999999999999999987 56776432  


Q ss_pred             ----------------CCChhhHHHHHHHHhhcc
Q 022118          284 ----------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 ----------------~~~~~~l~~~~~~~~~~~  301 (302)
                                      +..++++.+++.+||..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  277 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  277 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence                            345678999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-50  Score=348.00  Aligned_cols=216  Identities=20%  Similarity=0.246  Sum_probs=185.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCCh--HHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEeccC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ++|++.+.||+|+||+||+|... +++.||+|.++....  ..+.+|+++|+.++||||+++++++.+++..|+|||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            57889999999999999999975 588999998766554  347799999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC--CceEEcccccccccCCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~--~~~kl~DfGla~~~~~~~  231 (302)
                      +|+|.+++..    ....+++.++..++.||+.||+|||+  .+|+||||||+|||++.+  ..+||+|||+++......
T Consensus        85 gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          85 GLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999832    23468999999999999999999998  679999999999999854  589999999998764422


Q ss_pred             CCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--------------------CCChhhHH
Q 022118          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--------------------PDSSQDLV  291 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~--------------------~~~~~~l~  291 (302)
                         ......+++.|+|||...+..|+.++||||+||++|||++|+.||....                    ...++++.
T Consensus       159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence               2334568889999999999999999999999999999999999997533                    13456678


Q ss_pred             HHHHHHhhcc
Q 022118          292 ELMIKCMGKE  301 (302)
Q Consensus       292 ~~~~~~~~~~  301 (302)
                      +++.+|+.+|
T Consensus       236 ~li~~~L~~d  245 (321)
T d1tkia_         236 DFVDRLLVKE  245 (321)
T ss_dssp             HHHHTTSCSS
T ss_pred             HHHHHHccCC
Confidence            8888888765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=342.88  Aligned_cols=191  Identities=25%  Similarity=0.354  Sum_probs=164.0

Q ss_pred             CCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--------hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEecc
Q 022118           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +++||+|+||+||+|... +++.||+|+++...        .+.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999964 58999999864322        245889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      +++++....     .....+++..+..++.||+.||+|||+  ++|+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            998877665     235668888999999999999999999  6799999999999999999999999999987654332


Q ss_pred             CCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          233 AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                        ......+|+.|+|||++.. ..|+.++|||||||++|||++|++||..
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence              2334578999999998865 4689999999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=345.32  Aligned_cols=226  Identities=28%  Similarity=0.433  Sum_probs=187.5

Q ss_pred             HHhcCCCcCCeeeeCCCeeEEEEEEcC--------CcEEEEEecCCCCh----HHHHHHHHHhccC-CCCceeeEEeEEe
Q 022118           74 LATKNFSDKNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (302)
Q Consensus        74 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~~~  140 (302)
                      +..++|++.+.||+|+||.||+|+...        +..||+|++.....    .++.+|...+.++ +||||++++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            455688889999999999999998532        34799998765443    4577888888887 8999999999999


Q ss_pred             eCCeeeEEEeccCCCCccccccCCCc-----------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 022118          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (302)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nil  209 (302)
                      +++..++|||||++|+|.+++.....           .....+++..++.++.||+.||+|||+  .+||||||||+|||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiL  167 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeeccccee
Confidence            99999999999999999999954321           123568999999999999999999999  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------
Q 022118          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------  282 (302)
Q Consensus       210 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------  282 (302)
                      ++.++.+||+|||+++...............+++.|+|||.+.+..|+.++|||||||++|||++ |++||...      
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            99999999999999998766555445566778899999999999999999999999999999998 78888742      


Q ss_pred             -----------CCCChhhHHHHHHHHhhcc
Q 022118          283 -----------SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 -----------~~~~~~~l~~~~~~~~~~~  301 (302)
                                 +...++++.+++.+||.++
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~d  277 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAV  277 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSS
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCC
Confidence                       2355788999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=342.75  Aligned_cols=219  Identities=28%  Similarity=0.408  Sum_probs=176.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEcC----CcEEEEEecCCC------ChHHHHHHHHHhccCCCCceeeEEeEEeeCCee
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  145 (302)
                      .++|++.+.||+|+||.||+|++..    ...||+|.+...      ..+++.+|+++|++++||||++++|++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3568889999999999999998532    247899976432      13468999999999999999999999976 467


Q ss_pred             eEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ++||||+++|++.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhc----ccCCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchhhh
Confidence            899999999999988732    34568999999999999999999999  679999999999999999999999999999


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCC------------------CCC
Q 022118          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL------------------SPD  285 (302)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~------------------~~~  285 (302)
                      ........ .......+|..|+|||.+.+..|+.++|||||||++|||+| |+.||...                  +..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  239 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence            87544321 22334567888999999999999999999999999999998 89999743                  235


Q ss_pred             ChhhHHHHHHHHhhcc
Q 022118          286 SSQDLVELMIKCMGKE  301 (302)
Q Consensus       286 ~~~~l~~~~~~~~~~~  301 (302)
                      .++++.+++++||.++
T Consensus       240 ~~~~l~~li~~cl~~d  255 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHK  255 (273)
T ss_dssp             CCHHHHHHHHHHTCSS
T ss_pred             ccHHHHHHHHHHcCCC
Confidence            5789999999999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=348.40  Aligned_cols=216  Identities=18%  Similarity=0.254  Sum_probs=181.5

Q ss_pred             hcCCCcCC-eeeeCCCeeEEEEEE-cCCcEEEEEecCCCChHHHHHHHHHhcc-CCCCceeeEEeEEee----CCeeeEE
Q 022118           76 TKNFSDKN-LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLAS-IQHRNLVTLLGYCQE----NNLQFLI  148 (302)
Q Consensus        76 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~~lv  148 (302)
                      .++|++.. .||+|+||+||+|.. .+++.||+|.++.  ...+.+|++++.+ .+||||+++++++.+    .+..|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            35787764 699999999999996 4689999998753  4567899998765 589999999999875    3567999


Q ss_pred             EeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccccccc
Q 022118          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN  225 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~---~~~~kl~DfGla~  225 (302)
                      ||||++|+|.+++...   ....+++..+..++.||+.||+|||+  .+|+||||||+|||+++   ++.+||+|||+|+
T Consensus        88 mEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccccceee
Confidence            9999999999998431   23568999999999999999999999  67999999999999975   5679999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------------------
Q 022118          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---------------------  284 (302)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~~---------------------  284 (302)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.....                     
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~  239 (335)
T d2ozaa1         163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  239 (335)
T ss_dssp             ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred             eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence            765432   23456799999999999999999999999999999999999999964321                     


Q ss_pred             ---CChhhHHHHHHHHhhcc
Q 022118          285 ---DSSQDLVELMIKCMGKE  301 (302)
Q Consensus       285 ---~~~~~l~~~~~~~~~~~  301 (302)
                         ..++++.+++++|+.++
T Consensus       240 ~~~~~s~~~~~li~~~L~~d  259 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTE  259 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSS
T ss_pred             ccccCCHHHHHHHHHHccCC
Confidence               12467889999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=337.49  Aligned_cols=214  Identities=29%  Similarity=0.489  Sum_probs=179.8

Q ss_pred             CCeeeeCCCeeEEEEEEcC----CcEEEEEecCCCC----hHHHHHHHHHhccCCCCceeeEEeEEee-CCeeeEEEecc
Q 022118           82 KNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI  152 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~  152 (302)
                      .++||+|+||+||+|.+.+    ...||||+++...    .+++.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998643    2368999875432    2458999999999999999999999876 46789999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~~  232 (302)
                      ++|+|.+++..    .....++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999998843    34556788889999999999999998  6799999999999999999999999999987754332


Q ss_pred             C--CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC------------------CCCChhhHHH
Q 022118          233 A--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL------------------SPDSSQDLVE  292 (302)
Q Consensus       233 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~------------------~~~~~~~l~~  292 (302)
                      .  .......+|..|+|||.+....++.++||||||+++|||+||+.||...                  +...++++.+
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~  265 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE  265 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence            2  2233457899999999999999999999999999999999987776531                  2345678999


Q ss_pred             HHHHHhhcc
Q 022118          293 LMIKCMGKE  301 (302)
Q Consensus       293 ~~~~~~~~~  301 (302)
                      +|.+||.+|
T Consensus       266 li~~cl~~d  274 (311)
T d1r0pa_         266 VMLKCWHPK  274 (311)
T ss_dssp             HHHHHTCSS
T ss_pred             HHHHHcCCC
Confidence            999999876

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=337.25  Aligned_cols=197  Identities=27%  Similarity=0.391  Sum_probs=168.4

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|++.+.||+|+||+||+|.. .+++.||+|.++..     ..+++.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4788999999999999999996 46899999986432     34678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      |+.++.+.....    .....+++..+..++.|++.||+|||+  .+||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~~~~~----~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHH----TTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            998654443321    235668999999999999999999999  67999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..  ......+|+.|+|||......+ +.++||||+||++|||++|+.||..
T Consensus       156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence            22  2345578999999998877664 7899999999999999999999964

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=343.48  Aligned_cols=227  Identities=26%  Similarity=0.389  Sum_probs=190.8

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeC
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~  142 (302)
                      .+..++|+..+.||+|+||+||+|.+.      ++..||||+++....    ..+.+|++++++++||||++++|++..+
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            344567888899999999999999853      257899998765432    3478999999999999999999999999


Q ss_pred             CeeeEEEeccCCCCccccccCCC-----cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          143 NLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      +..++||||+++|+|.+++....     ......+++..+..++.|++.||.|||+  ++|+||||||+|||+++++++|
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceEE
Confidence            99999999999999999884321     1122456889999999999999999999  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCC-CCCCCC--------------
Q 022118          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSL--------------  282 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~-~p~~~~--------------  282 (302)
                      |+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+||. +||...              
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999998776544433344557889999999999999999999999999999999984 777642              


Q ss_pred             ---CCCChhhHHHHHHHHhhcc
Q 022118          283 ---SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---~~~~~~~l~~~~~~~~~~~  301 (302)
                         +...+..+.++|.+||.++
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~  275 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYN  275 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCcccchHHHHHHHHHHcCCC
Confidence               2455678999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=338.88  Aligned_cols=215  Identities=23%  Similarity=0.351  Sum_probs=182.2

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC---------ChHHHHHHHHHhccCC--CCceeeEEeEEeeCC
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENN  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~  143 (302)
                      .++|++.+.||+|+||+||+|... +++.||+|.+...         ...++.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357899999999999999999965 6899999975321         1234678999999886  899999999999999


Q ss_pred             eeeEEEeccCC-CCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEccc
Q 022118          144 LQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADA  221 (302)
Q Consensus       144 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-~~~~kl~Df  221 (302)
                      ..|+||||+.+ +++.+++     .....+++..+..++.|++.||+|||+  ++|+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~-----~~~~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHH-----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 5666666     234678999999999999999999999  67999999999999985 579999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhccCCC-CCccchhhHHHHHHHHHhCCCCCCC----------CCCCChhhH
Q 022118          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSS----------LSPDSSQDL  290 (302)
Q Consensus       222 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dvws~Gvil~el~~g~~p~~~----------~~~~~~~~l  290 (302)
                      |+|+......    .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||..          .+...++++
T Consensus       156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~  231 (273)
T d1xwsa_         156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC  231 (273)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHH
T ss_pred             ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHH
Confidence            9998754432    335679999999999988776 5678999999999999999999985          235667899


Q ss_pred             HHHHHHHhhcc
Q 022118          291 VELMIKCMGKE  301 (302)
Q Consensus       291 ~~~~~~~~~~~  301 (302)
                      .+++.+||.++
T Consensus       232 ~~li~~~L~~d  242 (273)
T d1xwsa_         232 QHLIRWCLALR  242 (273)
T ss_dssp             HHHHHHHTCSS
T ss_pred             HHHHHHHccCC
Confidence            99999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=339.80  Aligned_cols=220  Identities=27%  Similarity=0.486  Sum_probs=182.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcC-Cc--EEEEEecCCC----ChHHHHHHHHHhccC-CCCceeeEEeEEeeCCeeeEE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQD-GM--LVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~----~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  148 (302)
                      ++|+..+.||+|+||+||+|.+.+ +.  .||||+....    ..+.+.+|+++|+++ +||||++++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999998653 44  5778875322    345789999999998 799999999999999999999


Q ss_pred             EeccCCCCccccccCCC-----------cCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 022118          149 YEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (302)
Q Consensus       149 ~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~k  217 (302)
                      |||+++|+|.+++....           ......+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcCCCceE
Confidence            99999999999985431           1234678999999999999999999999  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCC-CCCCCC--------------
Q 022118          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSL--------------  282 (302)
Q Consensus       218 l~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~-~p~~~~--------------  282 (302)
                      |+|||+++......   ......+|..|+|||.+.+..|+.++|||||||++|||++|. +||...              
T Consensus       168 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         168 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             ECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             Eccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999998654322   223456888999999999999999999999999999999976 567632              


Q ss_pred             ---CCCChhhHHHHHHHHhhcc
Q 022118          283 ---SPDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       283 ---~~~~~~~l~~~~~~~~~~~  301 (302)
                         +...++++.+++.+||.++
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~d  266 (309)
T d1fvra_         245 LEKPLNCDDEVYDLMRQCWREK  266 (309)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSS
T ss_pred             CCCCccCCHHHHHHHHHHcCCC
Confidence               2345688999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=342.29  Aligned_cols=227  Identities=25%  Similarity=0.396  Sum_probs=190.1

Q ss_pred             HHHhcCCCcCCeeeeCCCeeEEEEEEc------CCcEEEEEecCCCC----hHHHHHHHHHhccC-CCCceeeEEeEEee
Q 022118           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (302)
Q Consensus        73 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~~~  141 (302)
                      ++..++|++.+.||+|+||.||+|.+.      ++..||||++....    ...+.+|+.+++++ +|||||++++++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            344567888999999999999999852      35689999876543    23578999999998 79999999999999


Q ss_pred             CCeeeEEEeccCCCCccccccCCCc-------------CCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Ni  208 (302)
                      ++..+++||||++|+|.+++.....             .....+++..+..++.||+.||+|||+  +++|||||||+||
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~NI  176 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNI  176 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccccc
Confidence            9999999999999999999854321             123468899999999999999999999  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC----
Q 022118          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS----  283 (302)
Q Consensus       209 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~-g~~p~~~~~----  283 (302)
                      +++.++.+|++|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |.+||...+    
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999998765444444455678999999999999999999999999999999999 566665432    


Q ss_pred             --------------CCChhhHHHHHHHHhhcc
Q 022118          284 --------------PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --------------~~~~~~l~~~~~~~~~~~  301 (302)
                                    ...+.++.+++.+||..+
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~d  288 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD  288 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCC
Confidence                          345688899999999765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-48  Score=332.07  Aligned_cols=196  Identities=26%  Similarity=0.358  Sum_probs=168.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEec
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  151 (302)
                      ++|+..+.||+|+||+||+|++++++.||+|++....     .+++.+|+.+|++++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788899999999999999999999999999865432     45789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 022118          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (302)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~~  231 (302)
                      +.++++..+.     .....+++..+..++.||+.||+|||+  .+||||||||+|||++.++.+|++|||++.......
T Consensus        82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9887776665     345779999999999999999999999  679999999999999999999999999998765433


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      .  ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence            2  23344678889999998765 568999999999999999999999963

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=337.01  Aligned_cols=197  Identities=25%  Similarity=0.401  Sum_probs=162.9

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCChHHHHHHHH--HhccCCCCceeeEEeEEeeCC----eeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVC--FLASIQHRNLVTLLGYCQENN----LQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~--~l~~l~H~nIv~l~~~~~~~~----~~~lv~e  150 (302)
                      ++|...+.||+|+||.||+|+. +|..||||.++.....++.+|.+  .+..++||||+++++++.+++    ..|+|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            3566678899999999999986 58899999987666666555555  456789999999999998654    5689999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      ||++|+|.+++.      +..+++..+..++.|++.||+|||+.      .++||||||||+|||++.++.+||+|||++
T Consensus        82 y~~~g~L~~~l~------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cccCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999993      34688999999999999999999973      358999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCccccCcccccchhhhccCC------CCCccchhhHHHHHHHHHhCCCCCC
Q 022118          225 NFLGRTDV--AGPSSQVTADEIFLASEVKEFRR------FSEKSDVYSFGVFLLELVSGREASS  280 (302)
Q Consensus       225 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dvws~Gvil~el~~g~~p~~  280 (302)
                      +.......  ........||+.|+|||++.+..      ++.++|||||||+||||+||..||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            87754322  22234567999999999987653      5778999999999999999988764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=330.87  Aligned_cols=197  Identities=25%  Similarity=0.358  Sum_probs=165.1

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-C-CcEEEEEecC-----CCChHHHHHHHHHhccC---CCCceeeEEeEEee----
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-D-GMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQE----  141 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~----  141 (302)
                      .++|++.+.||+|+||+||+|... + ++.||+|.+.     ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 5679999743     22334567888877665   89999999999863    


Q ss_pred             -CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 022118          142 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (302)
Q Consensus       142 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~D  220 (302)
                       ....+++|||++++++.....    .....+++..+..++.|++.||+|||+  ++||||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCeeecc
Confidence             246799999999887754442    245678899999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       221 fGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ||+++......   ......||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus       160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~  217 (305)
T d1blxa_         160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  217 (305)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence            99988654322   23456789999999999999999999999999999999999999964

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.4e-46  Score=320.09  Aligned_cols=219  Identities=18%  Similarity=0.242  Sum_probs=183.5

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-CChHHHHHHHHHhccCCC-CceeeEEeEEeeCCeeeEEEecc
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      .++|++.+.||+|+||+||+|++. +++.||+|..+. .....+.+|++.++.++| +|++.+++++......++||||+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            357899999999999999999965 588999997543 334567889999999965 89999999999999999999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----CCceEEccccccccc
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFL  227 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~-----~~~~kl~DfGla~~~  227 (302)
                       +++|.+++.    .....++..++..++.|++.||+|||+  ++|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        84 -~~~l~~~~~----~~~~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 -GPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHH----hhccchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence             678888873    234568999999999999999999999  67999999999999964     578999999999876


Q ss_pred             CCCCC-----CCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------
Q 022118          228 GRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS-------------------  283 (302)
Q Consensus       228 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------  283 (302)
                      .....     ........||+.|+|||++.+..|+.++|||||||++|||++|+.||....                   
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            54321     112345679999999999999999999999999999999999999997432                   


Q ss_pred             -----CCChhhHHHHHHHHhhcc
Q 022118          284 -----PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -----~~~~~~l~~~~~~~~~~~  301 (302)
                           .+.++++.+++..||..+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~  259 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLA  259 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCC
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCC
Confidence                 234567888888888754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=329.60  Aligned_cols=217  Identities=23%  Similarity=0.292  Sum_probs=183.1

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc----CCcEEEEEecCC-------CChHHHHHHHHHhccCCC-CceeeEEeEEeeCCe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNL  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~  144 (302)
                      ++|++.+.||+|+||+||+|...    +|+.||+|.++.       ...+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56899999999999999999852    478999997542       234568899999999966 899999999999999


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .+++|||+.+|+|.+++.     ....+.+..+..++.|++.||+|+|+  ++|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~-----~~~~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHH-----hcccccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999983     44567788899999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccC--CCCCccchhhHHHHHHHHHhCCCCCCCCC-------------------
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLS-------------------  283 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dvws~Gvil~el~~g~~p~~~~~-------------------  283 (302)
                      +........ ......+++.|++||.+.+.  .++.++|||||||+||||++|+.||....                   
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~  255 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  255 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC
Confidence            876443222 23455788899999998765  46889999999999999999999997432                   


Q ss_pred             -CCChhhHHHHHHHHhhcc
Q 022118          284 -PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 -~~~~~~l~~~~~~~~~~~  301 (302)
                       ...++++.+++.+||.++
T Consensus       256 ~~~~s~~~~~li~~~l~~d  274 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKD  274 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSS
T ss_pred             cccCCHHHHHHHHHHcccC
Confidence             245678899999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-46  Score=320.12  Aligned_cols=218  Identities=19%  Similarity=0.213  Sum_probs=177.8

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-CChHHHHHHHHHhccCCCCce-eeEEeEEeeCCeeeEEEeccC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIP  153 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~  153 (302)
                      ++|++.+.||+|+||+||+|... +++.||+|.... ...+++..|+++++.++|+|+ +.+.++..+.+..++||||+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            46999999999999999999964 588999997443 334568899999999987665 555556677788899999995


Q ss_pred             CCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccccCCC
Q 022118          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~---~~~~~kl~DfGla~~~~~~  230 (302)
                       +++.+.+.    .....+++..+..++.|++.||+|||+  ++||||||||+|||++   .+..+||+|||+|+.....
T Consensus        87 -~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          87 -PSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             -CBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             -Cchhhhhh----hccCCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence             45555542    235678999999999999999999999  6799999999999985   4557999999999987543


Q ss_pred             CCC-----CCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC----------------------
Q 022118          231 DVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS----------------------  283 (302)
Q Consensus       231 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~----------------------  283 (302)
                      ...     .......||+.|+|||.+.+..|+.++|||||||++|||++|+.||....                      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  239 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence            321     12345679999999999999999999999999999999999999997532                      


Q ss_pred             --CCChhhHHHHHHHHhhcc
Q 022118          284 --PDSSQDLVELMIKCMGKE  301 (302)
Q Consensus       284 --~~~~~~l~~~~~~~~~~~  301 (302)
                        ...++++.+++.+||..+
T Consensus       240 ~~~~~p~~~~~li~~cl~~~  259 (299)
T d1ckia_         240 LCKGYPSEFATYLNFCRSLR  259 (299)
T ss_dssp             HTTTSCHHHHHHHHHHHHSC
T ss_pred             hccCCCHHHHHHHHHHccCC
Confidence              234577889999999865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=328.63  Aligned_cols=197  Identities=23%  Similarity=0.343  Sum_probs=164.0

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEE-cCCcEEEEEecCCCCh----HHHHHHHHHhccCCCCceeeEEeEEeeCCe----eeE
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL----QFL  147 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~l  147 (302)
                      .+|++.+.||+|+||+||+|.. .+++.||+|++.....    +++.+|+++|++++||||+++++++..+..    .++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4688999999999999999986 4689999998764432    367899999999999999999999976542    355


Q ss_pred             EEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 022118          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (302)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~  227 (302)
                      +++|+.+|+|.+++.      ...+++..+..++.|++.||+|||+  ++||||||||+|||+++++.+||+|||+++..
T Consensus        88 l~~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            666777999999983      3468999999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          228 GRTDV-AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..... ........||+.|+|||++. ...|+.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~  215 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG  215 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence            54322 22345567899999999985 45678999999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=330.60  Aligned_cols=196  Identities=27%  Similarity=0.365  Sum_probs=161.8

Q ss_pred             CCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCCCCceeeEEeEEeeC------CeeeEEEe
Q 022118           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLIYE  150 (302)
Q Consensus        78 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv~e  150 (302)
                      +|+..++||+|+||+||+|+.. +++.||+|++.... ....+|+++|++++||||+++++++...      ...|+|||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            5778899999999999999975 58999999865432 2345799999999999999999998643      24689999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGR  229 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~  229 (302)
                      ||+++.+......  ......+++..+..++.||+.||+|||+  ++|+||||||+|||++.++ .+||+|||+++....
T Consensus       100 y~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_         100 YVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             CCSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             ccCCccHHHHHhh--hhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9987654433211  1235678999999999999999999998  6799999999999999775 899999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          230 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ..   ......++..|+|||.+.+ ..|+.++||||+||++|||++|+.||..
T Consensus       176 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         176 GE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             TS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             Cc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence            33   2334578889999998765 5789999999999999999999999964

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-45  Score=322.77  Aligned_cols=192  Identities=20%  Similarity=0.286  Sum_probs=168.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCChHHHHHHHHHhccCC-CCceeeEEeEEeeC--CeeeEEEecc
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYEYI  152 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e~~  152 (302)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++....+++.+|+++|++++ ||||+++++++...  ...++|||||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            57999999999999999999974 68999999988888889999999999995 99999999999754  5689999999


Q ss_pred             CCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCCC
Q 022118          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTD  231 (302)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~-~~kl~DfGla~~~~~~~  231 (302)
                      ++++|....        ..+++..+..++.||+.||+|||+  ++||||||||+|||++.++ .+||+|||+|+......
T Consensus       115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999987654        358899999999999999999999  6799999999999998655 69999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                         ......+|+.|+|||.+.+. .|+.++||||+||++|||++|+.||..
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~  232 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  232 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence               23455788999999998765 479999999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=319.48  Aligned_cols=213  Identities=21%  Similarity=0.324  Sum_probs=174.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCC-----CChHHHHHHHHHhccCCCCceeeEEeEEee--------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE--------  141 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------  141 (302)
                      .++|++.+.||+|+||+||+|... +|+.||||++..     ....++.+|+++|++++||||+++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367899999999999999999974 689999997532     234568899999999999999999999865        


Q ss_pred             CCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 022118          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (302)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~Df  221 (302)
                      ++..|++|||+.++++....     .....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeec
Confidence            34579999999988776554     345678889999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCC--CCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHh
Q 022118          222 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCM  298 (302)
Q Consensus       222 Gla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~  298 (302)
                      |+++.......  ........+|+.|+|||.+.+. .|+.++||||+||++|||++|+.||...+   ..+....+.+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHHHHHHHhc
Confidence            99987754332  2233445799999999998765 68999999999999999999999997533   445555555544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=325.79  Aligned_cols=192  Identities=23%  Similarity=0.372  Sum_probs=159.4

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeCC------
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------  143 (302)
                      .++|++.+.||+|+||+||+|... +++.||+|++....     .+.+.+|+++|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            457889999999999999999965 58999999876432     245789999999999999999999998765      


Q ss_pred             eeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 022118          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (302)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGl  223 (302)
                      ..|+||||+ +.+|....      ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM------KHEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH------HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHH------HhccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccccccccc
Confidence            459999999 45666554      24568999999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      |+.....     .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence            9876432     3445788999999998764 568999999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-44  Score=308.28  Aligned_cols=212  Identities=22%  Similarity=0.330  Sum_probs=177.7

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCC-----ChHHHHHHHHHhccCCCCceeeEEeEEeeCCeeeEEEe
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  150 (302)
                      ++|++.+.||+|+||+||+|+.. +++.||+|.++..     ...++.+|+.+++.++||||+++++++.+++..++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47889999999999999999964 6889999975322     23568899999999999999999999999999999999


Q ss_pred             ccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 022118          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (302)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~~~~~  230 (302)
                      ++.+++|..++.     ....+++..+..++.|++.||+|||+  ++||||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccc-----cccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999999887762     34677889999999999999999999  67999999999999999999999999999887543


Q ss_pred             CCCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhh
Q 022118          231 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELMIKCMG  299 (302)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~~~~~~~~~~~l~~~~~~~~~  299 (302)
                      ..  ......++..|+|||.+.... ++.++||||+||++|||++|+.||...  .+..+....+...++
T Consensus       155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~--~~~~~~~~~~~~~~~  220 (292)
T d1unla_         155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLG  220 (292)
T ss_dssp             CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHC
T ss_pred             Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC--CCHHHHHHHHHhhcC
Confidence            32  223345677899999987665 689999999999999999999997543  334555565555444

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=317.06  Aligned_cols=193  Identities=23%  Similarity=0.356  Sum_probs=162.0

Q ss_pred             hcCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC-----Ce
Q 022118           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (302)
Q Consensus        76 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~  144 (302)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++....     .+++.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            357999999999999999999964 68999999876432     23578999999999999999999998643     34


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .+++|+|+.+|+|.+++.      ...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~------~~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcc------cccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchh
Confidence            477788889999999882      3468999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSS  281 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dvws~Gvil~el~~g~~p~~~  281 (302)
                      ......     .....++..|+|||...+.. ++.++||||+||++|||++|+.||.+
T Consensus       169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            765432     33456888899999877664 58899999999999999999999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=312.14  Aligned_cols=193  Identities=23%  Similarity=0.330  Sum_probs=156.2

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC-----hHHHHHHHHHhccCCCCceeeEEeEEeeC------Ce
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------NL  144 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~  144 (302)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++....     .+++.+|+.++++++||||+++++++...      +.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999975 58999999865332     23578999999999999999999999643      57


Q ss_pred             eeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 022118          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (302)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl~DfGla  224 (302)
                      .|+|||||.++++. .+       ...+++..+..++.|++.||+|||+  .||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~-~~-------~~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VI-------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHH-HH-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHH-hh-------hcCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceeeechhhh
Confidence            79999999876554 33       2457899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022118          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (302)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~  282 (302)
                      +......   ......+|+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            8764422   234557888999999999999999999999999999999999999754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.8e-38  Score=276.76  Aligned_cols=199  Identities=19%  Similarity=0.224  Sum_probs=158.6

Q ss_pred             cCCCcCCeeeeCCCeeEEEEEEc-CCcEEEEEecCCCC--hHHHHHHHHHhccCC-----------CCceeeEEeEEeeC
Q 022118           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQEN  142 (302)
Q Consensus        77 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~  142 (302)
                      .+|++.+.||+|+||+||+|+.. +|+.||||++....  .+.+.+|+.+++.++           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            35899999999999999999964 68999999876543  356778998887764           57899999988643


Q ss_pred             --CeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC------
Q 022118          143 --NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF------  214 (302)
Q Consensus       143 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~------  214 (302)
                        ...+++|+++..+.......  .......+++..+..++.|++.||+|||+. .+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccc
Confidence              45677777766554332221  123456788899999999999999999973 5699999999999998665      


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022118          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (302)
Q Consensus       215 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dvws~Gvil~el~~g~~p~~~~~  283 (302)
                      .+|++|||.+......     .....+|+.|+|||++....|+.++||||+||+++||++|+.||....
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            3899999999765432     344578999999999999999999999999999999999999998654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=6.7e-27  Score=188.05  Aligned_cols=159  Identities=17%  Similarity=0.104  Sum_probs=116.3

Q ss_pred             CcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCCC---------------------hHHHHHHHHHhccCCCCceeeEEeE
Q 022118           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASIQHRNLVTLLGY  138 (302)
Q Consensus        80 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~H~nIv~l~~~  138 (302)
                      .+.+.||+|+||+||+|...+|+.||+|......                     .....+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3467899999999999998899999999633110                     0123467888999999999998865


Q ss_pred             EeeCCeeeEEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 022118          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (302)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ivHrdlkp~Nill~~~~~~kl  218 (302)
                      ..    .+++|||+++..+...            +......++.|++.++.|||+  .+|+||||||+|||+++++ ++|
T Consensus        83 ~~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~~-~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEEG-IWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETTE-EEE
T ss_pred             cC----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCCC-EEE
Confidence            32    3799999987655332            223345788999999999999  6799999999999999755 889


Q ss_pred             cccccccccCCCCCCCCCccccCcccccch------hhhccCCCCCccchhhHHHH
Q 022118          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLAS------EVKEFRRFSEKSDVYSFGVF  268 (302)
Q Consensus       219 ~DfGla~~~~~~~~~~~~~~~~~~~~~~aP------E~~~~~~~~~~~Dvws~Gvi  268 (302)
                      +|||+|.....+..          ..|...      +. -...|+.++|+||..--
T Consensus       144 iDFG~a~~~~~~~~----------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGW----------REILERDVRNIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTH----------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCc----------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence            99999876532211          012111      11 13568899999997643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=1.6e-07  Score=76.91  Aligned_cols=144  Identities=15%  Similarity=0.095  Sum_probs=91.7

Q ss_pred             HHHHHhcCCCcCCeeeeCCCeeEEEEEEcCCcEEEEEecCCC---ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeee
Q 022118           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQF  146 (302)
Q Consensus        71 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~  146 (302)
                      ++......|+..+..+-++.+.||+... ++..+.+|+....   ....+.+|...+..+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3444445565544433344568998764 4555677764432   3345678888776553 444677888888889999


Q ss_pred             EEEeccCCCCccccccCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcCC-------------------------------
Q 022118          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-------------------------------  195 (302)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-------------------------------  195 (302)
                      +||++++|.++.......       ..   ...++.+++..+..||+..                               
T Consensus        87 lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999988775433110       01   1123344444455555310                               


Q ss_pred             --------------------------CCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          196 --------------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       196 --------------------------~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                                                ..++|+|+.|.||++++++..-|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      137999999999999987777899998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.53  E-value=1.1e-07  Score=77.43  Aligned_cols=129  Identities=18%  Similarity=0.170  Sum_probs=87.7

Q ss_pred             eeeCC-CeeEEEEEEcCCcEEEEEecCCCChHHHHHHHHHhccCC--CCceeeEEeEEeeCCeeeEEEeccCCCCccccc
Q 022118           85 IGEGK-FGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL  161 (302)
Q Consensus        85 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  161 (302)
                      +..|. .+.||+.....+..+++|..+......+..|...++.+.  .-.+.+++++..+++..++||++++|.++....
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~   97 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH   97 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc
Confidence            34444 367899888778788999877766667788888887663  334677888888888899999999887664321


Q ss_pred             cCCCcCCCcccCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 022118          162 YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-----------------------------------------------  194 (302)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----------------------------------------------  194 (302)
                      .          ...   ..+.++...|.-||+.                                               
T Consensus        98 ~----------~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          98 L----------APA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             C----------CHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             c----------cHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            0          000   1112223333333321                                               


Q ss_pred             ---------CCCceecCCCCCCeeeCCCCceEEcccccccc
Q 022118          195 ---------SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (302)
Q Consensus       195 ---------~~~ivHrdlkp~Nill~~~~~~kl~DfGla~~  226 (302)
                               ...++|+|+.|.||+++++..+-|.||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                     01379999999999999877788999987653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=1.8e-05  Score=68.43  Aligned_cols=73  Identities=15%  Similarity=0.136  Sum_probs=47.7

Q ss_pred             CCeeeeCCCeeEEEEEEcC-CcEEEEEecCC----------CChHHHHHHHHHhccC-CC--CceeeEEeEEeeCCeeeE
Q 022118           82 KNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG----------APTQEFIDEVCFLASI-QH--RNLVTLLGYCQENNLQFL  147 (302)
Q Consensus        82 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----------~~~~~~~~E~~~l~~l-~H--~nIv~l~~~~~~~~~~~l  147 (302)
                      .+.||.|....||+....+ +..+++|...+          ....+...|.+.++.+ .+  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3578999999999998654 56788885221          1234566788777655 22  456666655  3455689


Q ss_pred             EEeccCCCC
Q 022118          148 IYEYIPNGS  156 (302)
Q Consensus       148 v~e~~~~g~  156 (302)
                      +||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.97  E-value=0.0017  Score=54.09  Aligned_cols=68  Identities=12%  Similarity=0.139  Sum_probs=44.6

Q ss_pred             CeeEEEEEEcCCcEEEEEecCCC--ChHHHHHHHHHhccCCC-----CceeeEE--eEEeeCCeeeEEEeccCCCCc
Q 022118           90 FGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQH-----RNLVTLL--GYCQENNLQFLIYEYIPNGSV  157 (302)
Q Consensus        90 ~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~H-----~nIv~l~--~~~~~~~~~~lv~e~~~~g~L  157 (302)
                      --.||++...+|..+++|...+.  ..+++..|...+..|..     +..+..-  ......+..+.++++++|..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            35899999999999999986543  45667888887776632     1111111  122345667889999876543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.60  E-value=0.0038  Score=53.37  Aligned_cols=72  Identities=17%  Similarity=0.175  Sum_probs=47.4

Q ss_pred             CeeeeCCCeeEEEEEEcC--------CcEEEEEecCCC-ChHHHHHHHHHhccCC-CCceeeEEeEEeeCCeeeEEEecc
Q 022118           83 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGA-PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  152 (302)
Q Consensus        83 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~  152 (302)
                      +.|+-|-.-.+|++...+        ...+.++..... ......+|..+++.+. +.-..++++++.+    .+|+||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            567778888999998653        245666664422 2334567888888773 4334577777643    5899999


Q ss_pred             CCCCcc
Q 022118          153 PNGSVS  158 (302)
Q Consensus       153 ~~g~L~  158 (302)
                      +|..+.
T Consensus       124 ~g~~l~  129 (395)
T d1nw1a_         124 PSRPLS  129 (395)
T ss_dssp             CEEECC
T ss_pred             ccccCC
Confidence            876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.51  E-value=0.013  Score=48.12  Aligned_cols=157  Identities=11%  Similarity=-0.013  Sum_probs=78.6

Q ss_pred             CHHHHHHHhcCCCcCCeee-----eCCCeeEEEEEEcCCcEEEEEecCC-CChHHHHHHHHHhccCCC-----CceeeE-
Q 022118           68 QMEELSLATKNFSDKNLIG-----EGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQH-----RNLVTL-  135 (302)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~H-----~nIv~l-  135 (302)
                      +.+++......|...+...     .|---+.|+....+|+ +++|.... ...+.+..|++++..+..     |..+.. 
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence            3455555666776644433     4555778988876665 78887644 344556667777766532     211111 


Q ss_pred             Ee--EEeeCCeeeEEEeccCCCCcccccc--------------------CCCcCCC----------------cccCHHHH
Q 022118          136 LG--YCQENNLQFLIYEYIPNGSVSIHLY--------------------GPSQVSR----------------QKLEFKHR  177 (302)
Q Consensus       136 ~~--~~~~~~~~~lv~e~~~~g~L~~~l~--------------------~~~~~~~----------------~~~~~~~~  177 (302)
                      -|  +....+....++.+..+......-.                    .......                ........
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence            00  1122334456666665543321110                    0000000                00000011


Q ss_pred             HHHHHHHHHHHHHhhc--CCCCceecCCCCCCeeeCCCCceEEccccccc
Q 022118          178 LSIALGAAKGLAHLHS--LSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (302)
Q Consensus       178 ~~~~~~i~~~l~~LH~--~~~~ivHrdlkp~Nill~~~~~~kl~DfGla~  225 (302)
                      ...+......+.-.+.  ...++||+|+.++|++++.+...-|.||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1122222222222221  23569999999999999988878899999874